<SEC-DOCUMENT>0001022079-23-000093.txt : 20230428
<SEC-HEADER>0001022079-23-000093.hdr.sgml : 20230428
<ACCEPTANCE-DATETIME>20230428161032
ACCESSION NUMBER:		0001022079-23-000093
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		62
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230428
DATE AS OF CHANGE:		20230428

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			QUEST DIAGNOSTICS INC
		CENTRAL INDEX KEY:			0001022079
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				161387862
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12215
		FILM NUMBER:		23866161

	BUSINESS ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094
		BUSINESS PHONE:		9735202700

	MAIL ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CORNING CLINICAL LABORATORIES INC
		DATE OF NAME CHANGE:	19960903
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>dgx-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:6a67f40b-d353-490b-97be-70efe774e456,g:809066a9-06e1-46b8-9b20-d9684581a006,d:1aa6fd61af824301a74dfe106295204d--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dgx="http://questdiagnostics.com/20230331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:srt="http://fasb.org/srt/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>dgx-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80L2ZyYWc6ZjRjYjJhYjk4MDdmNGZlZjhhY2MzMjBlYzI0YjBmMWUvdGFibGU6Y2Y2ODM5NWY2ZDcyNDA1NmJjOTc1YjU3M2Q1YzA5ZWMvdGFibGVyYW5nZTpjZjY4Mzk1ZjZkNzI0MDU2YmM5NzViNTczZDVjMDllY18xLTEtMS0xLTk2OTAw_bdef9320-f3bb-4ea3-884a-f91813c2877b">0001022079</ix:nonNumeric><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80L2ZyYWc6ZjRjYjJhYjk4MDdmNGZlZjhhY2MzMjBlYzI0YjBmMWUvdGFibGU6Y2Y2ODM5NWY2ZDcyNDA1NmJjOTc1YjU3M2Q1YzA5ZWMvdGFibGVyYW5nZTpjZjY4Mzk1ZjZkNzI0MDU2YmM5NzViNTczZDVjMDllY18yLTEtMS0xLTk2OTAw_eaae2e4b-5ba9-4368-971c-97d5d45f1cb7">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80L2ZyYWc6ZjRjYjJhYjk4MDdmNGZlZjhhY2MzMjBlYzI0YjBmMWUvdGFibGU6Y2Y2ODM5NWY2ZDcyNDA1NmJjOTc1YjU3M2Q1YzA5ZWMvdGFibGVyYW5nZTpjZjY4Mzk1ZjZkNzI0MDU2YmM5NzViNTczZDVjMDllY18zLTEtMS0xLTk2OTAw_607c692f-0a83-4c0b-8f12-bb26f5988d7a">2023</ix:nonNumeric><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80L2ZyYWc6ZjRjYjJhYjk4MDdmNGZlZjhhY2MzMjBlYzI0YjBmMWUvdGFibGU6Y2Y2ODM5NWY2ZDcyNDA1NmJjOTc1YjU3M2Q1YzA5ZWMvdGFibGVyYW5nZTpjZjY4Mzk1ZjZkNzI0MDU2YmM5NzViNTczZDVjMDllY180LTEtMS0xLTk2OTAw_bdd58fab-8e1e-4482-9d44-cf3233b56689">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80L2ZyYWc6ZjRjYjJhYjk4MDdmNGZlZjhhY2MzMjBlYzI0YjBmMWUvdGFibGU6Y2Y2ODM5NWY2ZDcyNDA1NmJjOTc1YjU3M2Q1YzA5ZWMvdGFibGVyYW5nZTpjZjY4Mzk1ZjZkNzI0MDU2YmM5NzViNTczZDVjMDllY181LTEtMS0xLTk2OTAw_ac1d3dd8-7194-48d8-84a5-790b43b87e6e">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="dgx-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c7aaabb9e3f43c18d9412ca50c62173_I20230414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i62a8002be6c545879eef8e9350936b33_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f825bb08aff4a16a22babce12a7813b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib84cedd020e943f08a613b4d09834d7f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i367251b8c6384daaa5fa30fad01b58e5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6223da0135b64cee99f192d6f1af6c1a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c3a6f02e5244194aa47bf148a80d73f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4034fabdd7ca4912917c75ef9a0a2da9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecb39988efab48f8b58484b98bbfee1b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8146dfedf0844767b0319b9e33973cf6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0325c9b10a83489b85899f5559dce780_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25f1cfe1d1c6418d846c108e8dd55e7c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8e71edf5ebf4c21a564d4ed2747d817_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43ece8747ef74f40a72853ca02aaf1c9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c0a89d33c674daf9b3eb9a19226f643_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e493e3bc38e440db1ddd741cfb4d78b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe4f154b292c4c6f9438d1ec93548719_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55c17b5aea5546bdb1833d5556b00d76_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29c8b878fec14566ae04a50e70d4aa38_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c9092aaf58347c0933f9fcbc2136ed5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54d2ac712edf4a2dab69b472e9d2878e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7e8cf83a7dc44a0b5d83088a7a8262b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2868e6f7df8844f0be25707868867359_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i675af17646064d258fea61e6c5bb5a32_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8a0a67b493b41f5a943c81b90b2832b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic457675ae82d42ceb6dbe6499c6a8c8f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53987f4feaf540ce9006d5da84098d82_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6943c51ef54c40e2bfbd3af614ae55de_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fa2bae89497491fa69b9d23e041264d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91094720d34a44d897464e1473c8cc65_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i682bff3b2c334ee9937658977d7ac55e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64eccbb460d743ce8ef414fce3a61c10_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie694bee7816f4bac9b9f899958f5a1cb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0371ca26d314e109241b4b21346af30_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0776303025b041b981adf6ee7f921409_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8582d590e6f74053acd191b3c70e414b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67ca08b42d004c858f5fa9da26c20186_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd9747cff8044052a06af97e9d9ca8fa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70085dbbaf5747e084e12a45a4a75993_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7afb377aee1d435eb24550dbdcd7ec70_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0eb006769543403b857f1208edc96f39_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9c6221361d444248eec701d6facf066_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i026b244d8b664bf18f9db5bf951e1018_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95ea8d4904774f0aa70206e0d1464ca0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfeed34c59e04d0f968039f01139270f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1877888b4e3b4f5589b7bd09d1d25f8e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68ebbfe16e6d4925bb4ccf798eff1e19_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia73437118858471aab7c03547980000d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia15188e0ab8642c396b4a96aebce5582_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2547ee5e7d94359a91b49b7221ab320_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c2789456b4f4655b65a9ce676bc382b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if55d00add9b34a659909dea8aab579c3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if40cce849d804c9d9ade9ef0ff872500_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b282120e5684071822469ae84204d65_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i460b190c7af34171a28a620ddf6d0f9b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4deefe47748e49dd9b5f6d19dde3517d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee1c43167736475396bb0f00c1706266_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b765f813058424c84db7601e651042b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee0fda822a8640319a5856d56a336d6f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b880299f57a4a9b9824c017900d1138_I20150701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">dgx:UMassJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i481a0bb184b14bad9d931200d5d31852_I20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i667912428a7248bfb81aa3ff7ab6bf9c_I20211130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i220fe343315542498e86e7895d5cb139_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id37a126b68964d6a8e53b08d24ae39c2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c4b1b27b14f4358b79dcebe17500b25_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibef99765bb424b0a98ea7a9577ad7abd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if15719cfaad14b7dbfdf71b40a4c65d9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e11296045604f51a55e048533a906a4_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f567083983b48babafdc73d6c6901c7_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f78891156cb4c548d0f6277115ee3eb_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia90feb97a113427e947ad9d0fd0a3fa3_D20230201-20230201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia10ad287b0cd4193a14609ca8a3021dc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5761244dc05a4e05ba1c36f1739ffa78_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0773aae3a1a24aabbc51451a0ca743da_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4e5f3cb386b4fc98d6b4476305eabe9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dgx:A401kPlanLawsuitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>dgx:claim</xbrli:measure></xbrli:unit><xbrli:context id="ice7ecc3f1344426eb38edcacb95102d0_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dgx:A401kPlanLawsuitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic641d132cbe14e8eb7c6b478bf547c1a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dgx:DataSecurityIncidentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51a030df6d10457797f31c05e00c6fbd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0ed27f0259f4eddad39f6d6f9166f22_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92e626d8b4994af79d894bbd7fca8a13_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb2184019e3a41bba34f394de7b2cfc9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ed346c5690e4ddc8d0b23a92ec0f7f2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dd1a321696c48c5be41b31ca63c5571_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd435f0f382f4a7885ef56b501114dd0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3973c12fa954740845e01c52214f022_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b6d35b5d67546ce9f6822c84cfcf9e5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61ed8ec37ceb4a73a0b35d0de8357758_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f57bd433a114ad99ef7c771bd566d82_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib70af9ca8a1f4946a10a38788730eceb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e58a48918dd4becb0dd4cc40ca69a88_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5597494df62b463093771d2b719b6894_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d860d57e4ad449a887c67967f28d5d6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied62521cf257403a89d19d00c5aa5abe_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2a765cc64784441973b1aec2bd7c985_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cdf174765f04a2f86be3ef952803845_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85e225a2df9640b3ab2e1ea93558ed16_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7a6fd94d88447269386a6a9f798ce52_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a00ddd1f78d4eabbd3eec75dce18984_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i355eb3cfa48643c89a8544abcf920805_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cc506733bc54c4c939d04e93b12a019_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ba6898f5dce4da790f1d70a1becead8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5513c4320b84b8187a84d0c7bb3c2e7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dadd8bb7e9b49f1a84da6abd44b2b54_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfc7432b93a741d59d3b948cc6fd7457_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23e66b0f67b94bb2b097b5144c24e807_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie21be809ef3c4dcbbd5ed7e71d98fbd4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c6c0ad027434a8e877b0382b926c96d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26268270d1b14e71a865a97e2c5c435a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie11d9750588e417cb37a21a52c132fcd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i772cad9a0b3d4082b300fc534f745257_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61a15314b5e742e0b281c2024f9d2632_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if148e27d61634341a1c6b7a4d2b7f1ed_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55811dcbf9b144cc912c05f6c566ce5a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa6205a62b6b4428bd03ee3946847d9b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86ad2c45fc2c42a69d24854e11d851c2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e102be4f8254b1dbbc70aa3bdc19865_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4911193ea2f4d57910161a9d6712993_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ffb964e5c344410af806c81f53963c1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6029d63b27f74dce9c2c1865b3c36922_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib21559178668493e8f63bc406234ef9d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e2af1eeb8384a619b904007a6cb8f29_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03db1044dc514a8eae7a1f57881a63d3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i552e3aecfd8f4491b6039419f80524b3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b19a5afa8014eac9ccbf727527f2ea6_D20230417-20230417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:NewYorkPresbyterianMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-17</xbrli:startDate><xbrli:endDate>2023-04-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c77555441f446579e41076eec2f33b5_D20230401-20230428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">us-gaap:ScenarioPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:HaystackOncologyIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1280f4be54c54da0986529d7da684b6d_I20230428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">us-gaap:ScenarioPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:HaystackOncologyIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i1aa6fd61af824301a74dfe106295204d_1"></div><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents </a></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.861%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">UNITED STATES</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">WASHINGTON, DC 20549</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGV4dHJlZ2lvbjo4YTkxNTBhMTA0ZTY0NzNlOTkwMzgyNjg1MjlkOTI5NV8xOTE5_a9bbce95-c71f-4f5d-94e3-28559dccf326">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One) </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGV4dHJlZ2lvbjo4YTkxNTBhMTA0ZTY0NzNlOTkwMzgyNjg1MjlkOTI5NV8xOTEy_3e83ce04-d12b-4d62-91e3-0ef7eaf24e4d">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGV4dHJlZ2lvbjo4YTkxNTBhMTA0ZTY0NzNlOTkwMzgyNjg1MjlkOTI5NV8xNTI_c3aa2bad-7b46-4441-95c1-908e1cdab092">March 31, 2023</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Or</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGV4dHJlZ2lvbjo4YTkxNTBhMTA0ZTY0NzNlOTkwMzgyNjg1MjlkOTI5NV8xOTEz_0f52b0cc-b11a-4bde-a47f-28ad385f938c">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from to</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGV4dHJlZ2lvbjo4YTkxNTBhMTA0ZTY0NzNlOTkwMzgyNjg1MjlkOTI5NV8xOTE0_da57bd58-87a9-4a90-896e-a1f4d467db22">001-12215</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGV4dHJlZ2lvbjo4YTkxNTBhMTA0ZTY0NzNlOTkwMzgyNjg1MjlkOTI5NV8xOTE1_35e073b5-5c85-48cd-b8f9-9b77d4bd956f">Quest Diagnostics Inc</ix:nonNumeric>orporated</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:519.00pt"><tr><td style="width:1.0pt"></td><td style="width:105.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:85.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:36.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:201.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZTQ0NWRmMjE3OTY4NDNhZGI0NzViOGY0YmMxNTMwMDEvdGFibGVyYW5nZTplNDQ1ZGYyMTc5Njg0M2FkYjQ3NWI4ZjRiYzE1MzAwMV8wLTAtMS0xLTk2OTAw_8986fb44-89b0-47cc-8fe3-91ca53075b9e">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZTQ0NWRmMjE3OTY4NDNhZGI0NzViOGY0YmMxNTMwMDEvdGFibGVyYW5nZTplNDQ1ZGYyMTc5Njg0M2FkYjQ3NWI4ZjRiYzE1MzAwMV8wLTUtMS0xLTk2OTAw_87e9ea47-de03-4f99-9c92-9bdf13cf33f2">16-1387862</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State of Incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification Number)</span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZTQ0NWRmMjE3OTY4NDNhZGI0NzViOGY0YmMxNTMwMDEvdGFibGVyYW5nZTplNDQ1ZGYyMTc5Njg0M2FkYjQ3NWI4ZjRiYzE1MzAwMV8yLTAtMS0xLTk2OTAw_f3fde4b5-063a-431e-80fe-ccb961b8e1d6">500 Plaza Drive</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZTQ0NWRmMjE3OTY4NDNhZGI0NzViOGY0YmMxNTMwMDEvdGFibGVyYW5nZTplNDQ1ZGYyMTc5Njg0M2FkYjQ3NWI4ZjRiYzE1MzAwMV8zLTAtMS0xLTk2OTAw_d4b88750-23fe-4559-a311-445af12cde50">Secaucus,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZTQ0NWRmMjE3OTY4NDNhZGI0NzViOGY0YmMxNTMwMDEvdGFibGVyYW5nZTplNDQ1ZGYyMTc5Njg0M2FkYjQ3NWI4ZjRiYzE1MzAwMV8zLTEtMS0xLTk2OTAw_90502f46-66dc-43d7-82e2-8ba7149537b8">NJ</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZTQ0NWRmMjE3OTY4NDNhZGI0NzViOGY0YmMxNTMwMDEvdGFibGVyYW5nZTplNDQ1ZGYyMTc5Njg0M2FkYjQ3NWI4ZjRiYzE1MzAwMV8zLTItMS0xLTk2OTAw_94cad71e-8168-4131-af91-35f4438370a3">07094</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZTQ0NWRmMjE3OTY4NDNhZGI0NzViOGY0YmMxNTMwMDEvdGFibGVyYW5nZTplNDQ1ZGYyMTc5Njg0M2FkYjQ3NWI4ZjRiYzE1MzAwMV80LTAtMS0xLTk2OTAw_f8c6dbaa-2dde-4a34-a5c3-8f6e7bcf9732">(973)</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZTQ0NWRmMjE3OTY4NDNhZGI0NzViOGY0YmMxNTMwMDEvdGFibGVyYW5nZTplNDQ1ZGYyMTc5Njg0M2FkYjQ3NWI4ZjRiYzE1MzAwMV80LTEtMS0xLTk2OTAw_3eedb943-7bb5-4fc8-9c99-c2b9371d303e">520-2700</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.055%"><tr><td style="width:1.0%"></td><td style="width:30.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZWM3MWQ1NDdkMmU1NGVjMzk4MTExZGEyZmZkNmIzZjEvdGFibGVyYW5nZTplYzcxZDU0N2QyZTU0ZWMzOTgxMTFkYTJmZmQ2YjNmMV8xLTAtMS0xLTk2OTAw_d2e3256a-3636-4943-ada3-c206bf4ef9bf">Common Stock, $0.01 Par Value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZWM3MWQ1NDdkMmU1NGVjMzk4MTExZGEyZmZkNmIzZjEvdGFibGVyYW5nZTplYzcxZDU0N2QyZTU0ZWMzOTgxMTFkYTJmZmQ2YjNmMV8xLTEtMS0xLTk2OTAw_9a8c1cf9-532c-47bb-8323-c931f8880f21">DGX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZWM3MWQ1NDdkMmU1NGVjMzk4MTExZGEyZmZkNmIzZjEvdGFibGVyYW5nZTplYzcxZDU0N2QyZTU0ZWMzOTgxMTFkYTJmZmQ2YjNmMV8xLTItMS0xLTk2OTAw_ae99efe4-7efe-4f68-882e-ea7612b7c3b3">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGV4dHJlZ2lvbjo4YTkxNTBhMTA0ZTY0NzNlOTkwMzgyNjg1MjlkOTI5NV8xOTE2_dbd7485b-06bb-4258-90f8-a2b26776687a">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGV4dHJlZ2lvbjo4YTkxNTBhMTA0ZTY0NzNlOTkwMzgyNjg1MjlkOTI5NV8xOTE3_0f26a649-6a61-40b9-b333-6e2013d483d2">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.166%"><tr><td style="width:1.0%"></td><td style="width:42.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.353%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6MTZjOTY1NjBkMzI2NDgyNjg4ZTM5YWIzNWRkYWM2NjgvdGFibGVyYW5nZToxNmM5NjU2MGQzMjY0ODI2ODhlMzlhYjM1ZGRhYzY2OF8wLTAtMS0xLTk2OTAw_0a32d9a6-a09a-4a3d-bc5d-38a3418801a6">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6MTZjOTY1NjBkMzI2NDgyNjg4ZTM5YWIzNWRkYWM2NjgvdGFibGVyYW5nZToxNmM5NjU2MGQzMjY0ODI2ODhlMzlhYjM1ZGRhYzY2OF8xLTMtMS0xLTk2OTAw_3ccb1717-7d78-43b5-9367-1ed4c4c03281">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6MTZjOTY1NjBkMzI2NDgyNjg4ZTM5YWIzNWRkYWM2NjgvdGFibGVyYW5nZToxNmM5NjU2MGQzMjY0ODI2ODhlMzlhYjM1ZGRhYzY2OF8yLTMtMS0xLTk2OTAw_a9851e33-f9b5-4dca-9cce-eb71870f5ac8">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGV4dHJlZ2lvbjo4YTkxNTBhMTA0ZTY0NzNlOTkwMzgyNjg1MjlkOTI5NV8xOTE4_78b1b4f1-ddd1-44cc-a671-5c172d69c315">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;14, 2023, there were outstanding <ix:nonFraction unitRef="shares" contextRef="i4c7aaabb9e3f43c18d9412ca50c62173_I20230414" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGV4dHJlZ2lvbjo4YTkxNTBhMTA0ZTY0NzNlOTkwMzgyNjg1MjlkOTI5NV8xODU0_b074e52e-c18c-4214-a866-5207be24e48d">112,009,197</ix:nonFraction> shares of the registrant&#8217;s common stock, $.01 par value.</span></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i1aa6fd61af824301a74dfe106295204d_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents </a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.101%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 1. Financial Statements (unaudited)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Index to unaudited consolidated financial statements filed as part of this report:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_13">Consolidated Statements of Operations for the Three Months Ended March 31, 2023 and 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_16">Consolidated Statements of Comprehensive Income for the Three Months Ended March 31, 2023 and 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_16">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_19">Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_22">Consolidated Statements of Cash Flows for the Three Months Ended March 31,</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_22"> 2023 and 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_22">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_25">Consolidated Statements of Stockholders&#8217; Equity for the Three Months Ended March 31, 2023 and 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_25">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_28">Notes to Consolidated Financial Statements</a> (unaudited)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_28">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_76">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_76">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_76">21</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_91">Item 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_76">See Item 2. &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_91">31</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_94">Item 4. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_94">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_94">31</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i1aa6fd61af824301a74dfe106295204d_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents </a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE MONTHS ENDED MARCH&#160;31, 2023 AND 2022 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div style="text-align:center"><span><br/></span></div><div id="i1aa6fd61af824301a74dfe106295204d_13"></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.327%"><tr><td style="width:1.0%"></td><td style="width:75.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.029%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.030%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMi0xLTEtMS05NjkwMA_d726ad43-0a4e-4cda-b8f9-a27ff8c2f9bc">2,331</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMi0zLTEtMS05NjkwMA_7fe8f77e-23cc-4c1e-a978-be09d83fac9a">2,611</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNS0xLTEtMS05NjkwMA_6398fe7f-7d75-43b3-9a8a-551ce3e7d1b8">1,560</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNS0zLTEtMS05NjkwMA_dbb84979-c584-45cd-90c5-3accdaf01d4a">1,646</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNi0xLTEtMS05NjkwMA_f5c2dbcc-0ba7-46aa-909f-5e52d0f9e0c7">439</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNi0zLTEtMS05NjkwMA_7bd023d3-f7ba-434b-a129-e7b4fc6ad17c">425</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNy0xLTEtMS05NjkwMA_9cd08d07-680f-4743-93c6-24c750df1af5">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNy0zLTEtMS05NjkwMA_1814a4ba-74ac-412c-b411-32182422496f">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfOS0xLTEtMS05NjkwMA_ca55d43c-fefa-49b8-acaf-246ad11274c0">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfOS0zLTEtMS05NjkwMA_d7a01de4-d3ab-46bf-8fea-b3f82d2b17e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net </span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTAtMS0xLTEtOTY5MDA_346c6ce0-1135-4ede-b6e3-e1d0ed108ba6">2,026</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTAtMy0xLTEtOTY5MDA_fe3dac06-6de3-4a0c-8cfc-414fae45d5be">2,098</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTItMS0xLTEtOTY5MDA_983d5305-6a34-474a-8f8d-f1ddf393465c">305</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTItMy0xLTEtOTY5MDA_ddbfafb8-24b1-43d0-baa4-5d1d62df4f84">513</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTUtMS0xLTEtOTY5MDA_2e9b1687-d303-496d-9882-ea0d9f460c0c">35</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTUtMy0xLTEtOTY5MDA_6d89a979-afec-4c4c-a641-81e1cfa23377">37</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTYtMS0xLTEtOTY5MDA_bd347def-e07a-4c78-b88d-23d5bf090436">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTYtMy0xLTEtOTY5MDA_3939f484-c7a7-4909-856a-567e13487a12">24</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-operating expense, net</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTctMS0xLTEtOTY5MDA_168294cb-3698-4e49-9683-3322e7866ba5">28</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTctMy0xLTEtOTY5MDA_55c07ae5-4a46-48b5-8900-ca7f4390ca43">61</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTktMS0xLTEtOTY5MDA_f2895cce-8b69-4ff6-9c36-75da7fb02dc3">277</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTktMy0xLTEtOTY5MDA_d04eb703-e5ba-422e-aaf1-0a0675ca7d25">452</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMjAtMS0xLTEtOTY5MDA_c1198e97-480d-415a-bad7-96c909d70023">65</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMjAtMy0xLTEtOTY5MDA_627d4470-395f-44ff-b48b-c7ffcf9f763c">110</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMjEtMS0xLTEtOTY5MDA_d9fe4ec0-8848-4a56-8b75-d72c31863ec7">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMjEtMy0xLTEtOTY5MDA_d2a78198-e39e-4d06-9fcb-506fdc78aba8">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMjQtMS0xLTEtOTY5MDA_20176249-567a-4f20-9ab1-c8ec894a2ed6">217</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMjQtMy0xLTEtOTY5MDA_0fe2eeb7-9c36-407b-a93a-32fd365171e0">373</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMjUtMS0xLTEtOTY5MDA_1c7a5c80-98d4-4375-8450-c00f315e9bd8">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMjUtMy0xLTEtOTY5MDA_b081c97f-a899-49b2-b10d-39398f733fa4">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMjYtMS0xLTEtOTY5MDA_d79fe2ef-8f40-4373-8b66-566ed803c96e">202</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMjYtMy0xLTEtOTY5MDA_4ff9adf0-a1b6-41bf-8143-a95a86e355a0">355</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMzYtMS0xLTEtOTY5MDA_bcc2f39f-c0ce-4069-bc13-adbfb48d2ff6">1.80</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMzYtMy0xLTEtOTY5MDA_bd48c333-84b4-424d-9767-6d1433a7a497">2.97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNDEtMS0xLTEtOTY5MDA_35595f6c-834f-42e3-b004-fa8da869c4cd">1.78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNDEtMy0xLTEtOTY5MDA_6d34c564-6389-4293-8d7b-e17bad48a012">2.92</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average common shares outstanding:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNDQtMS0xLTEtOTY5MDA_523a0087-4fc5-45a1-852a-2ea3f4c342ee">112</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNDQtMy0xLTEtOTY5MDA_dbff6ad6-8d98-453f-9186-740313640847">119</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNDYtMS0xLTEtOTY5MDA_f1d6ee3b-d254-492b-8b60-dc3c78f2f12a">113</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNDYtMy0xLTEtOTY5MDA_fe209ca3-eca6-4be0-af55-1bd99db3eb37">121</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i1aa6fd61af824301a74dfe106295204d_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents </a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE MONTHS ENDED MARCH&#160;31, 2023 AND 2022</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.327%"><tr><td style="width:1.0%"></td><td style="width:75.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.029%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.618%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfMi0xLTEtMS05NjkwMA_20176249-567a-4f20-9ab1-c8ec894a2ed6">217</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfMi0zLTEtMS05NjkwMA_0fe2eeb7-9c36-407b-a93a-32fd365171e0">373</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfNS0xLTEtMS05NjkwMA_fef6c289-540e-41b5-8cfb-32ec3f1acb69">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfNS0zLTEtMS05NjkwMA_7fee765e-e4b5-4af3-96ac-79a16156961a">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfOS0xLTEtMS05NjkwMA_ca888376-71a3-4b14-a40b-ad5409302ce0">3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfOS0zLTEtMS05NjkwMA_85d6b1fb-0528-4775-b4c8-770270e5a077">2</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfMTEtMS0xLTEtOTY5MDA_f3e913d3-2d89-408c-b6ab-ec25dc16ac29">220</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfMTEtMy0xLTEtOTY5MDA_d32364ee-4ea5-4a53-9513-0b1954ed6526">371</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfMTItMS0xLTEtOTY5MDA_c06422d6-1cf4-4c6a-a931-3b534d26c13d">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfMTItMy0xLTEtOTY5MDA_6bb6c706-4438-4a6b-a731-411dfde7d11d">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfMTMtMS0xLTEtOTY5MDA_484cd988-eaa3-4af6-8111-5b6a9c97ecbc">205</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfMTMtMy0xLTEtOTY5MDA_f6c0207b-0eb4-4404-80cf-096007440c02">353</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i1aa6fd61af824301a74dfe106295204d_19"></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents </a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MARCH&#160;31, 2023 AND DECEMBER&#160;31, 2022 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMy0xLTEtMS05NjkwMA_ca56d49a-b374-4559-84b9-02afde1d8772">175</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMy0zLTEtMS05NjkwMA_3be419f5-a6e7-4081-bb7c-eb3d160a47b3">315</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNC0wLTEtMS05NjkwMC90ZXh0cmVnaW9uOmY0M2VkNzFlYmFlNzQ0NzFhZGZhYWM1MzUwYTRhNDM0Xzcw_708e716a-4e1f-4114-bb13-c8cfc233d9a0"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNC0wLTEtMS05NjkwMC90ZXh0cmVnaW9uOmY0M2VkNzFlYmFlNzQ0NzFhZGZhYWM1MzUwYTRhNDM0Xzcw_71339670-eae1-40cb-b79e-8f779e03ed61">30</ix:nonFraction></ix:nonFraction> as of both March&#160;31, 2023 and December&#160;31, 2022</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNC0xLTEtMS05NjkwMA_9375fb9f-de04-4d7b-a424-f49a5b63f4dd">1,254</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNC0zLTEtMS05NjkwMA_126fbc3e-47c4-4160-b25d-e44577c9bcba">1,195</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNS0xLTEtMS05NjkwMA_587a3d4a-1ac1-4491-b3c7-eb309f04370d">190</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNS0zLTEtMS05NjkwMA_f82a1351-02ac-47b2-8166-3812b055dfb7">192</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNi0xLTEtMS05NjkwMA_fc0e8914-b214-4bf8-b893-f4b7cf5eef37">195</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNi0zLTEtMS05NjkwMA_c7ce6b08-7bfb-466c-8f73-209518a99d0d">196</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfOC0xLTEtMS05NjkwMA_c7f71a57-fbe4-4e9c-8440-6a039774e050">1,814</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfOC0zLTEtMS05NjkwMA_6787842b-2e64-4b09-9788-9ad1a623b689">1,898</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfOS0xLTEtMS05NjkwMA_9c376fbf-292c-4942-99f4-76e0c988c98d">1,795</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfOS0zLTEtMS05NjkwMA_e29a916b-54eb-47db-92df-91b54a04c36f">1,766</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTAtMS0xLTEtOTY5MDA_0011c229-b7a1-4a34-b0d4-93760e558c36">589</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTAtMy0xLTEtOTY5MDA_064125ba-0497-4673-adc8-c979972142da">585</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTEtMS0xLTEtOTY5MDA_3b3bdfbe-2d40-49a9-80e0-5bf0b0703676">7,241</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTEtMy0xLTEtOTY5MDA_da56cf22-4dc1-4cb1-adaa-cb02a2ccd056">7,220</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTItMS0xLTEtOTY5MDA_0a2f32e2-e2d6-4114-ae58-3b4180d89c7b">1,077</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTItMy0xLTEtOTY5MDA_52aabce5-fa1d-43bc-9496-c2d548b05fb7">1,092</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investments in equity method investees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTMtMS0xLTEtOTY5MDA_b68390ba-b103-47c8-a316-53493757963e">128</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTMtMy0xLTEtOTY5MDA_1a73633b-1a35-4b51-9aa6-1a219dafc11a">132</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTQtMS0xLTEtOTY5MDA_febffaab-5391-44f8-b92d-075f39e118c0">150</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTQtMy0xLTEtOTY5MDA_536fe4d7-47cc-459c-90fc-38ac940206d5">144</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTYtMS0xLTEtOTY5MDA_e2493985-9e77-41e1-ab70-a7cd03391638">12,794</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTYtMy0xLTEtOTY5MDA_e1339401-9feb-44d5-a979-5fa9cd0da84a">12,837</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjAtMS0xLTEtOTY5MDA_acdd4b88-74d2-4c69-84eb-4d3df860de6c">1,198</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjAtMy0xLTEtOTY5MDA_247b84ad-8fac-4734-8b8d-482067b96820">1,396</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjEtMS0xLTEtOTY5MDA_5d866d6e-c87d-4822-9658-75043618adea">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjEtMy0xLTEtOTY5MDA_bd138ecf-e2fb-4a50-a226-068b6610c0c3">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjItMS0xLTEtOTY5MDA_9600b2e8-2443-48d3-b0d6-172c39bec439">155</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjItMy0xLTEtOTY5MDA_c9c4af36-047c-4a1e-b3f4-8c0ab1a05e10">153</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjQtMS0xLTEtOTY5MDA_08e24efd-b7e5-434c-9555-c41aed340b17">1,355</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjQtMy0xLTEtOTY5MDA_e604e7ea-5920-4448-b0a8-89f792f0f4ea">1,551</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjUtMS0xLTEtOTY5MDA_ff563619-8ba3-47c3-a8c4-398f5cb097f9">3,975</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjUtMy0xLTEtOTY5MDA_1b0c8a96-bcd8-4eef-ae28-b4e7312f3a9a">3,978</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjYtMS0xLTEtOTY5MDA_0bd2da0f-d0ed-4425-977b-dbfe24b255ad">490</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjYtMy0xLTEtOTY5MDA_32c611c8-7b82-40de-9170-b170945fef7e">489</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjctMS0xLTEtOTY5MDA_8537bcb5-826d-4f26-b488-27829de1db15">809</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjctMy0xLTEtOTY5MDA_72dade52-86ba-4468-9846-06c3baefd6d0">812</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjktMS0xLTEtOTY5MDA_3a8be7f4-5cf4-4975-bfc2-c2fff8c16c89"></ix:nonFraction></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjktMy0xLTEtOTY5MDA_8d938ee9-e942-4210-a30a-306606098be7"></ix:nonFraction></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzAtMS0xLTEtOTY5MDA_cd176cda-cc3c-4171-842c-9b8264e7c3bf">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzAtMy0xLTEtOTY5MDA_40711e87-afd1-4768-b8a4-6aa0edd8f61a">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quest Diagnostics stockholders&#8217; equity:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzMtMC0xLTEtOTY5MDAvdGV4dHJlZ2lvbjpjY2UzNjE1MGFkZmM0NjBmODY5ZGQ1Nzk3YzU4ZTc0Zl8yOA_c0a33be8-d530-4c81-8f92-1c2950be09bb"><ix:nonFraction unitRef="usdPerShare" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzMtMC0xLTEtOTY5MDAvdGV4dHJlZ2lvbjpjY2UzNjE1MGFkZmM0NjBmODY5ZGQ1Nzk3YzU4ZTc0Zl8yOA_ffecf9a3-0d3f-496d-86ae-a18e8ad893af">0.01</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzMtMC0xLTEtOTY5MDAvdGV4dHJlZ2lvbjpjY2UzNjE1MGFkZmM0NjBmODY5ZGQ1Nzk3YzU4ZTc0Zl80Mg_7dd12a37-7917-4026-9a11-d2f9273d9414"><ix:nonFraction unitRef="shares" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzMtMC0xLTEtOTY5MDAvdGV4dHJlZ2lvbjpjY2UzNjE1MGFkZmM0NjBmODY5ZGQ1Nzk3YzU4ZTc0Zl80Mg_f403ba90-482c-4ff7-b02d-cc7ce357cdbc">600</ix:nonFraction></ix:nonFraction> shares authorized as of both March&#160;31, 2023 and December&#160;31, 2022; <ix:nonFraction unitRef="shares" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzMtMC0xLTEtOTY5MDAvdGV4dHJlZ2lvbjpjY2UzNjE1MGFkZmM0NjBmODY5ZGQ1Nzk3YzU4ZTc0Zl84NQ_2fca0a54-9ef0-47a0-bb1d-a9d0ab22dbdb"><ix:nonFraction unitRef="shares" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzMtMC0xLTEtOTY5MDAvdGV4dHJlZ2lvbjpjY2UzNjE1MGFkZmM0NjBmODY5ZGQ1Nzk3YzU4ZTc0Zl84NQ_5633a930-6176-4ec6-89ec-12bf2cdf7b97">162</ix:nonFraction></ix:nonFraction> shares issued as of both March&#160;31, 2023 and December&#160;31, 2022</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzMtMS0xLTEtOTY5MDA_6ef709ef-6cb9-4a2f-b846-7939b3ba7852">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzMtMy0xLTEtOTY5MDA_52069338-3b39-49b1-8398-5553e07b5797">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzQtMS0xLTEtOTY5MDA_36541a3d-bd8b-4cf5-91e3-35bd3146edf8">2,266</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzQtMy0xLTEtOTY5MDA_e33d5f20-9e2b-452b-9874-6d8ef5c5a97b">2,295</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzUtMS0xLTEtOTY5MDA_9759caa5-ca56-4169-80f9-963d4a1c71d5">8,412</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzUtMy0xLTEtOTY5MDA_d4a05249-218a-4a44-a54e-d67e99e6d1cc">8,290</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzYtMS0xLTEtOTY5MDA_787106b0-c66d-4881-9143-797438818f6b">18</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzYtMy0xLTEtOTY5MDA_e5bfc769-1cb7-47bc-95bd-7fbff4dc5c9d">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost; <ix:nonFraction unitRef="shares" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzctMC0xLTEtOTY5MDAvdGV4dHJlZ2lvbjo2ZDBmYjZkYzM0ZGQ0NTQ1ODlhZTY1YzNkMzY4ZmRkZV8yOQ_86cb3c73-e37a-4a7a-880d-f4d97e9c5dcd">50</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzctMC0xLTEtOTY5MDAvdGV4dHJlZ2lvbjo2ZDBmYjZkYzM0ZGQ0NTQ1ODlhZTY1YzNkMzY4ZmRkZV8zNg_86bbd200-ee4c-4663-953f-52de75a97ff0">51</ix:nonFraction> shares as of March&#160;31, 2023 and December&#160;31, 2022, respectively</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzctMS0xLTEtOTY5MDA_c3545913-0e7b-4ad7-989c-d7c9fd7715ce">4,612</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzctMy0xLTEtOTY5MDA_28ff279c-8a81-4c2b-bfd4-9d67c5be82ae">4,673</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Quest Diagnostics stockholders&#8217; equity</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzgtMS0xLTEtOTY5MDA_8fa69b91-acc7-43c3-82ba-b071860718d7">6,050</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzgtMy0xLTEtOTY5MDA_8bfa5d78-1bff-45e1-a5a4-c6ba2400fa81">5,893</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzktMS0xLTEtOTY5MDA_cd54d85d-f10d-4426-bd79-22eb1dc022e3">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzktMy0xLTEtOTY5MDA_14a90eae-a5dd-4a6b-9e21-a108161778f9">37</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNDAtMS0xLTEtOTY5MDA_1690df83-145a-4d75-b85b-7820625c5bf2">6,088</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNDAtMy0xLTEtOTY5MDA_0cffd4c4-3dc6-4613-bb6f-f6d4ebb47f2a">5,930</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNDEtMS0xLTEtOTY5MDA_7da5605a-500d-4b1f-bae9-9de573ecd911">12,794</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNDEtMy0xLTEtOTY5MDA_ac39ee98-2ced-4948-a685-1d800aa3c53b">12,837</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i1aa6fd61af824301a74dfe106295204d_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents </a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE MONTHS ENDED MARCH&#160;31, 2023 AND 2022 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions) </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMy0xLTEtMS05NjkwMA_35ca6eb0-4949-4c7b-9a39-3ff0143af817">217</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMy0zLTEtMS05NjkwMA_523cccac-319f-4b2a-88b6-a29910afd372">373</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNS0xLTEtMS05NjkwMA_127e9e3b-29b3-4212-b8b3-d467eb8ff65e">107</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNS0zLTEtMS05NjkwMA_00da19d4-e45d-4dd1-b439-eaca72268db0">106</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit for credit losses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNi0xLTEtMS05NjkwMA_627cb5d0-f1d1-4e2f-b638-1d4e5026ac58">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNi0zLTEtMS05NjkwMA_2bd15ab8-1c4f-40ad-8014-2dca0470832a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNy0xLTEtMS05NjkwMA_50b0455d-1d75-40ad-bba1-191a51176ba6">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNy0zLTEtMS05NjkwMA_491cb675-0be5-44ce-b34f-24b4ae103b89">43</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfOC0xLTEtMS05NjkwMA_f9e3f459-827e-40c1-bdd6-2568fd7e9242">24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfOC0zLTEtMS05NjkwMA_a4ed8188-78eb-4623-9547-5339b776d130">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTEtMS0xLTEtOTY5MDA_fe3da6ba-bf11-4bbb-99a6-cabb0ba8e52e">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTEtMy0xLTEtOTY5MDA_5ce8750a-a8fd-4851-add1-b6948125e023">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTMtMS0xLTEtOTY5MDA_9042f22d-b424-4c66-8d43-16dc91db8556">58</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTMtMy0xLTEtOTY5MDA_0382cd65-53e0-4119-85e3-d54bc5a31bd0">72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTQtMS0xLTEtOTY5MDA_0a079598-7909-4208-9bc4-a7ee02584ccf">211</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTQtMy0xLTEtOTY5MDA_86c06334-5cd7-4316-93c0-7977b7ae391c">165</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTUtMS0xLTEtOTY5MDA_f74e7909-291c-4fcd-a7c5-990f7fbe4972">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTUtMy0xLTEtOTY5MDA_43f3a81b-9e3b-426d-a065-14a29950d1e4">95</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTctMS0xLTEtOTY5MDA_f922813a-9cc2-468a-93e4-7489f4739f33">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTctMy0xLTEtOTY5MDA_e3212a43-c7f6-4f1e-b688-33c8805e3912">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTgtMS0xLTEtOTY5MDA_96555fec-c482-4063-9c0d-7dc4ef31c482">94</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTgtMy0xLTEtOTY5MDA_b049b89f-509e-4a5c-91a0-b5483d6bbdfe">480</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMjEtMS0xLTEtOTY5MDA_9cd68964-3c2c-4a20-be9c-8eea82eaac77">31</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMjEtMy0xLTEtOTY5MDA_b45aaf51-ca74-4831-94b8-d725a4bba834">105</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMjQtMS0xLTEtOTY5MDA_a7e1c317-5486-408a-9684-a41a89e8b80e">127</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMjQtMy0xLTEtOTY5MDA_5036183d-57de-4f74-a59c-83bed22635ab">63</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in investments and other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMjctMS0xLTEtOTY5MDA_12c6417a-a601-483b-80df-3d8381f6f9dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMjctMy0xLTEtOTY5MDA_18aed478-ecef-4fa8-a034-f8125b4c63bb">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMjgtMS0xLTEtOTY5MDA_58243ffd-6af1-44bc-850f-47d59b262c28">158</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMjgtMy0xLTEtOTY5MDA_af85dee9-5bc1-41b9-aaf0-d8f0890e4c98">169</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzEtMS0xLTEtOTY5MDA_67a25e70-de58-4ba4-8e7d-5ec681c1a638">140</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzEtMy0xLTEtOTY5MDA_b238a9ef-22a3-44a9-ae61-456c1bbc4fef">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzItMS0xLTEtOTY5MDA_63f52da3-8322-49f1-822e-df3a8d82117d">140</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzItMy0xLTEtOTY5MDA_e66cb3e3-10d7-4519-b58a-dc6ad6d21d99">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzMtMS0xLTEtOTY5MDA_1c314553-9276-473a-a386-f0cdcc01e0e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzMtMy0xLTEtOTY5MDA_4ba797a6-3c66-488b-ab3c-b9785b1f9070">373</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzQtMS0xLTEtOTY5MDA_f811a3b9-b1f7-4ddb-b5e8-54680116204d">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzQtMy0xLTEtOTY5MDA_53716784-bbd8-41ce-a8bc-64a56aa1e710">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee payroll tax withholdings on stock issued under stock-based compensation plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzUtMS0xLTEtOTY5MDA_68758102-e450-4233-9535-a42813a55128">28</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzUtMy0xLTEtOTY5MDA_834e14c5-644f-40a8-853a-701db8f5343f">27</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzYtMS0xLTEtOTY5MDA_33049076-c3c9-4a8f-819c-ee62ae522b63">74</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzYtMy0xLTEtOTY5MDA_99f3aab5-f08f-493c-8438-1a5f59aa9e27">74</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzctMS0xLTEtOTY5MDA_668a9b22-988d-4e17-8802-3b5e0fa6fb0b">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzctMy0xLTEtOTY5MDA_62cdff5c-3e8e-48d8-bec1-15ad08e77702">20</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financing activities, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNDAtMS0xLTEtOTY5MDA_af18f301-71cd-430a-b128-ecb99d356c33">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNDAtMy0xLTEtOTY5MDA_673a9945-2d1e-4c1f-83d3-e0aa7044ebfb">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNDEtMS0xLTEtOTY5MDA_4b673617-46bf-48c9-9c3b-ce969760fb5d">76</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNDEtMy0xLTEtOTY5MDA_692bfb95-3b3f-405b-b9d3-3116d28daa9d">471</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net change in cash and cash equivalents and restricted cash</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNDMtMS0xLTEtOTY5MDA_ef8134eb-4be0-4d09-b58b-d1c7a4aacf88">140</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNDMtMy0xLTEtOTY5MDA_1fbec2c1-e8a8-48dc-8257-713c5f93f81f">160</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents and restricted cash, beginning of period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNDUtMS0xLTEtOTY5MDA_1c6281c5-6bf6-485c-afcd-1b8729f27d87">315</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f825bb08aff4a16a22babce12a7813b_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNDUtMy0xLTEtOTY5MDA_43f25c89-7f55-4d86-82de-dcaec7d83496">872</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents and restricted cash, end of period</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNDYtMS0xLTEtOTY5MDA_4171434f-c111-48d8-a012-55f68d96f1d8">175</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib84cedd020e943f08a613b4d09834d7f_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNDYtMy0xLTEtOTY5MDA_65682a12-ff47-44eb-81e0-0be85e73b90e">712</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i1aa6fd61af824301a74dfe106295204d_25"></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents </a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE MONTHS ENDED MARCH&#160;31, 2023 AND 2022 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:28.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quest Diagnostics Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares of<br/>Common Stock<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Compre-<br/>hensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock, at<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stock-<br/>holders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Non-controlling Interest</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, December 31, 2022</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i367251b8c6384daaa5fa30fad01b58e5_I20221231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTctMS0xLTEtOTY5MDA_bf462fb7-5632-45dd-a369-73e19e2c7059">111</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i367251b8c6384daaa5fa30fad01b58e5_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTctMy0xLTEtOTY5MDA_e6f1fdcf-92e3-4048-8b08-eb1f6b8880a5">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6223da0135b64cee99f192d6f1af6c1a_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTctNS0xLTEtOTY5MDA_f53fe899-24b8-4d07-ad0b-14f29fe5f85c">2,295</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c3a6f02e5244194aa47bf148a80d73f_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTctNy0xLTEtOTY5MDA_504ae585-3ab0-47bc-994d-5a5d339861b3">8,290</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4034fabdd7ca4912917c75ef9a0a2da9_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTctOS0xLTEtOTY5MDA_3a54b311-1ce3-4c5d-adff-b026843e9930">21</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb39988efab48f8b58484b98bbfee1b_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTctMTEtMS0xLTk2OTAw_a99adba6-f5bd-42f4-84b1-b84fe8127b41">4,673</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8146dfedf0844767b0319b9e33973cf6_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTctMTMtMS0xLTk2OTAw_ac71386f-3f8e-4e07-ac7f-b6075d114413">37</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTctMTUtMS0xLTk2OTAw_f148120c-b0d8-42c3-a937-ea6dd9704f9d">5,930</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTctMTgtMS0xLTk2OTAw_ace5271c-519e-451c-9f1d-f90e3150a637">77</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTgtNy0xLTEtOTY5MDA_d79fe2ef-8f40-4373-8b66-566ed803c96e">202</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0325c9b10a83489b85899f5559dce780_D20230101-20230331" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTgtMTMtMS0xLTk2OTAw_c920a9cd-27fe-455d-b7a4-48ea60b86e99">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTgtMTUtMS0xLTk2OTAw_7f739101-c2d8-45e8-984c-1b77142483f3">216</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTgtMTgtMS0xLTk2OTAw_a3643ed4-fa27-4d17-ae73-549930a9df14">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25f1cfe1d1c6418d846c108e8dd55e7c_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTktOS0xLTEtOTY5MDA_7771a109-e828-451b-8ffe-c0b994d33706">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTktMTUtMS0xLTk2OTAw_25f27f6c-c890-44e4-b356-5f25fa469506">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8e71edf5ebf4c21a564d4ed2747d817_D20230101-20230331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjAtNy0xLTEtOTY5MDA_281e7192-5aa7-4bd8-ba93-e655e48b6cd5">80</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjAtMTUtMS0xLTk2OTAw_3382dadc-6219-45d5-b07b-b1d714e6a714">80</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0325c9b10a83489b85899f5559dce780_D20230101-20230331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjEtMTMtMS0xLTk2OTAw_28ab34e1-e735-401c-9299-39452527385e">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjEtMTUtMS0xLTk2OTAw_1864a9cc-46d0-407f-81bd-71c1010cd08b">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjEtMTgtMS0xLTk2OTAw_084ab352-2d78-49d4-9be3-9b33dd7d777e">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i43ece8747ef74f40a72853ca02aaf1c9_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjItMS0xLTEtOTY5MDA_92256f1c-30ef-4966-a8b7-bb6580112c75">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0a89d33c674daf9b3eb9a19226f643_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjItNS0xLTEtOTY5MDA_cb09157d-ddaf-4357-8a64-9b55a7e8bb85">42</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e493e3bc38e440db1ddd741cfb4d78b_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjItMTEtMS0xLTk2OTAw_32d3266f-133d-456a-a804-95ca92b03fc0">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjItMTUtMS0xLTk2OTAw_eb11a2df-7e0d-4dcd-8b5f-ebda789b153d">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c0a89d33c674daf9b3eb9a19226f643_D20230101-20230331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjMtNS0xLTEtOTY5MDA_93a1f63f-7434-4670-8b54-4c404c9abd7d">24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjMtMTUtMS0xLTk2OTAw_7115c1ab-43de-4ba9-824f-75e4f3bd207c">24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0a89d33c674daf9b3eb9a19226f643_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjQtNS0xLTEtOTY5MDA_1eb2e29f-e913-4f96-95d8-585576dfac94">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e493e3bc38e440db1ddd741cfb4d78b_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjQtMTEtMS0xLTk2OTAw_a2ced9b4-5699-4ff1-8198-9a7dbe861041">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjQtMTUtMS0xLTk2OTAw_b731f225-db71-4955-bda7-947369aa0371">30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares to cover employee payroll tax withholdings on stock </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;issued under stock-based compensation plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c0a89d33c674daf9b3eb9a19226f643_D20230101-20230331" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjUtNS0xLTEtOTY5MDA_6c7d94a6-a56d-4a07-aaf6-772320b5cad5">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e493e3bc38e440db1ddd741cfb4d78b_D20230101-20230331" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjUtMTEtMS0xLTk2OTAw_3a2521ff-08c2-4d8c-945a-4367213f66cd">18</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjUtMTUtMS0xLTk2OTAw_28283809-1483-458f-8008-4be29869fa9a">28</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, March 31, 2023</span></td><td colspan="2" style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibe4f154b292c4c6f9438d1ec93548719_I20230331" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjgtMS0xLTEtOTY5MDA_e5e6778d-85cb-40ca-96a8-7d866ba38302">112</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4f154b292c4c6f9438d1ec93548719_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjgtMy0xLTEtOTY5MDA_c17ac3f6-cbb6-42f4-8703-19bc6ec98dee">2</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55c17b5aea5546bdb1833d5556b00d76_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjgtNS0xLTEtOTY5MDA_78f7d001-e48c-412b-b12e-cbd9cfc521d5">2,266</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29c8b878fec14566ae04a50e70d4aa38_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjgtNy0xLTEtOTY5MDA_1f1ea6db-2aa5-4342-88eb-5742821d2396">8,412</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c9092aaf58347c0933f9fcbc2136ed5_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjgtOS0xLTEtOTY5MDA_b61530c5-2fb1-4810-bdf6-5d04bbfcbf35">18</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54d2ac712edf4a2dab69b472e9d2878e_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjgtMTEtMS0xLTk2OTAw_07ebf5f6-affb-47f0-a38c-f4b85c19bdcf">4,612</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7e8cf83a7dc44a0b5d83088a7a8262b_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjgtMTMtMS0xLTk2OTAw_b1a2efe4-2895-43fa-a058-66c80bf38f26">38</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjgtMTUtMS0xLTk2OTAw_779aeae6-4650-41b2-862d-83379ddcb685">6,088</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjgtMTgtMS0xLTk2OTAw_fe4543df-ed1d-4696-a2a7-c0f06b096a18">77</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.025%"><tr><td style="width:1.0%"></td><td style="width:28.626%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.440%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:28.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quest Diagnostics Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares of<br/>Common Stock<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Compre-<br/>hensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock, at<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stock-<br/>holders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Non-controlling Interest</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2868e6f7df8844f0be25707868867359_I20211231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMi0xLTEtMS05NjkwMA_12a01df8-34b4-4339-851c-f9ee0ce6a551">119</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2868e6f7df8844f0be25707868867359_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMi0zLTEtMS05NjkwMA_ffeb8271-f4e0-4da6-a6c8-c6e314909477">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i675af17646064d258fea61e6c5bb5a32_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMi01LTEtMS05NjkwMA_d30f4795-1189-4cc0-a7db-d579f1fcaa7d">2,260</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8a0a67b493b41f5a943c81b90b2832b_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMi03LTEtMS05NjkwMA_52c2b016-79b8-4f9a-968a-2cb38631861a">7,649</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic457675ae82d42ceb6dbe6499c6a8c8f_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMi05LTEtMS05NjkwMA_e2759145-3820-4e2a-adc7-875c79cbb3ab">14</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53987f4feaf540ce9006d5da84098d82_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMi0xMS0xLTEtOTY5MDA_57a02023-6d6e-410f-ad06-9f053cc5496c">3,453</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6943c51ef54c40e2bfbd3af614ae55de_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMi0xMy0xLTEtOTY5MDA_c4415972-5dca-4946-87d5-8e65a93a2d78">39</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f825bb08aff4a16a22babce12a7813b_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMi0xNS0xLTEtOTY5MDA_f2001259-464b-417b-a23b-1a014df127de">6,483</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f825bb08aff4a16a22babce12a7813b_I20211231" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMi0xOC0xLTEtOTY5MDA_6b0e834e-ff77-43e8-a85c-11effc654759">79</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa2bae89497491fa69b9d23e041264d_D20220101-20220331" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMy03LTEtMS05NjkwMA_72473e3f-01e9-42cd-8513-92c1c53513b4">355</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91094720d34a44d897464e1473c8cc65_D20220101-20220331" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMy0xMy0xLTEtOTY5MDA_62e166e2-2619-4d53-8124-c72563a23880">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMy0xNS0xLTEtOTY5MDA_0d132d62-e26a-438e-959a-6b03f60e4be1">371</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMy0xOC0xLTEtOTY5MDA_7a98edbc-0bbb-4e6a-8f87-1ee140348e1d">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i682bff3b2c334ee9937658977d7ac55e_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNC05LTEtMS05NjkwMA_788e4a84-4c34-4479-acfd-96f4fa6d8ed2">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNC0xNS0xLTEtOTY5MDA_968cb988-88b5-4b53-8b6c-04077c4d97ce">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa2bae89497491fa69b9d23e041264d_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNS03LTEtMS05NjkwMA_b0ddb4a1-1d8a-4f50-b7cb-226ddc271beb">78</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNS0xNS0xLTEtOTY5MDA_c16f3c5d-313f-4432-adc1-18e8338236da">78</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91094720d34a44d897464e1473c8cc65_D20220101-20220331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNi0xMy0xLTEtOTY5MDA_497d0d26-18ab-4292-b42a-55b492789101">17</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNi0xNS0xLTEtOTY5MDA_14a3750b-ce99-421f-b24e-2853fdb0a13e">17</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNi0xOC0xLTEtOTY5MDA_b0945a5b-7c25-4ce3-8450-d9a94b10a2ba">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i64eccbb460d743ce8ef414fce3a61c10_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNy0xLTEtMS05NjkwMA_13e9e8d9-548c-456f-bea7-8c0f68a41fc4">1</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie694bee7816f4bac9b9f899958f5a1cb_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNy01LTEtMS05NjkwMA_e97c6d0a-8fea-4d3d-af9b-470ecffd97d3">41</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0371ca26d314e109241b4b21346af30_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNy0xMS0xLTEtOTY5MDA_d31a93bd-7cb4-42ab-a6c5-5898e40fa70e">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNy0xNS0xLTEtOTY5MDA_95f1c201-ba9e-431f-ad92-8f708ccfcedf">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie694bee7816f4bac9b9f899958f5a1cb_D20220101-20220331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfOC01LTEtMS05NjkwMA_521da076-c67b-49a2-a3b8-53ea979c64f1">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfOC0xNS0xLTEtOTY5MDA_102afc32-0a4b-46fd-9355-c8968acf541e">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie694bee7816f4bac9b9f899958f5a1cb_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfOS01LTEtMS05NjkwMA_c6afcad3-0cfb-4b06-a468-5c2dff88156c">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0371ca26d314e109241b4b21346af30_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfOS0xMS0xLTEtOTY5MDA_e68bf8e8-1a3c-46c4-8cd9-71cc228a5cc4">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfOS0xNS0xLTEtOTY5MDA_8cf4d822-a26d-4aa9-88d3-4184e566c9d2">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie694bee7816f4bac9b9f899958f5a1cb_D20220101-20220331" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTAtNS0xLTEtOTY5MDA_757851ce-4d26-47f7-965e-48eab6275fc6">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0371ca26d314e109241b4b21346af30_D20220101-20220331" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTAtMTEtMS0xLTEwMTk1NA_a3aee64a-9a28-42ca-a4fd-12d2605acc11">17</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTAtMTUtMS0xLTk2OTAw_a5eae307-8fd4-4478-812c-71ddc2912771">27</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i64eccbb460d743ce8ef414fce3a61c10_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTEtMS0xLTEtOTY5MDA_fbdef9e8-dd93-4901-aa14-7cd18136c92b">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0371ca26d314e109241b4b21346af30_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTEtMTEtMS0xLTk2OTAw_a7e8f975-d582-42d5-9bb8-b0c49cf6dec8">350</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTEtMTUtMS0xLTk2OTAw_40eb40c3-4b20-47e2-b578-87db0d4b0c2b">350</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0776303025b041b981adf6ee7f921409_I20220331" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTMtMS0xLTEtOTY5MDA_bfd33521-403e-4e60-87d7-530e0c5e1116">117</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0776303025b041b981adf6ee7f921409_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTMtMy0xLTEtOTY5MDA_eb0762a0-fc9f-4778-804e-5d03d0b40384">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8582d590e6f74053acd191b3c70e414b_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTMtNS0xLTEtOTY5MDA_a23b2bcb-85d3-4829-8213-31e4488f158e">2,226</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67ca08b42d004c858f5fa9da26c20186_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTMtNy0xLTEtOTY5MDA_822a108a-5d68-41c5-8c25-533df61215c5">7,926</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd9747cff8044052a06af97e9d9ca8fa_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTMtOS0xLTEtOTY5MDA_ba4987fb-1365-4904-b5f3-5ac50b109997">16</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70085dbbaf5747e084e12a45a4a75993_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTMtMTEtMS0xLTk2OTAw_d3d0efbd-b4bd-40b7-8eb2-c6393376dfb3">3,761</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7afb377aee1d435eb24550dbdcd7ec70_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTMtMTMtMS0xLTk2OTAw_53f55d97-4670-43b1-bf18-17dc02a4d4f1">38</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib84cedd020e943f08a613b4d09834d7f_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTMtMTUtMS0xLTk2OTAw_d8ce727a-8b0e-4f12-8a29-21b0a4d54ac4">6,415</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib84cedd020e943f08a613b4d09834d7f_I20220331" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTMtMTgtMS0xLTk2OTAw_918251c9-9fed-4d7d-ac7f-c17eed0a969a">78</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.783%"><tr><td style="width:1.0%"></td><td style="width:28.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.383%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.166%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i1aa6fd61af824301a74dfe106295204d_28"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="i1aa6fd61af824301a74dfe106295204d_31"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zMS9mcmFnOjQ2NTUyYTRlNzdkMjQ0MGQ5NzgzZTA3YTgzYTliNjBkL3RleHRyZWdpb246NDY1NTJhNGU3N2QyNDQwZDk3ODNlMDdhODNhOWI2MGRfMTY2Mw_d808e54a-fe92-48bb-aeac-6e1f13981420" continuedAt="i6802b40964fc48959ac8a9c9694f4053" escape="true">DESCRIPTION OF BUSINESS</ix:nonNumeric></span></div><ix:continuation id="i6802b40964fc48959ac8a9c9694f4053" continuedAt="i7b07b78949514557a1797742a875e21f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7b07b78949514557a1797742a875e21f">&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, consumers, and accountable care organizations ("ACOs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.</ix:continuation>  </span></div><div><span><br/></span></div><div id="i1aa6fd61af824301a74dfe106295204d_34"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNC9mcmFnOjk0NDc0ZmM0YzNlNjRjODViZWU5MmVhNWYyMmExZmNmL3RleHRyZWdpb246OTQ0NzRmYzRjM2U2NGM4NWJlZTkyZWE1ZjIyYTFmY2ZfNDI4Mw_70bebcc6-302b-4be0-aee8-371892cecf9a" continuedAt="i8652cc327015420a8f603e391e16b2fb" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><div style="text-indent:29.25pt"><span><br/></span></div><ix:continuation id="i8652cc327015420a8f603e391e16b2fb" continuedAt="i73697a87ede44cdb8ae00743a00c218a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNC9mcmFnOjk0NDc0ZmM0YzNlNjRjODViZWU5MmVhNWYyMmExZmNmL3RleHRyZWdpb246OTQ0NzRmYzRjM2U2NGM4NWJlZTkyZWE1ZjIyYTFmY2ZfNDI5Mw_d1eb3349-9fe5-44d6-8bff-c51cdfecd986" escape="true">The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#8217;s 2022 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2022 but does not include all the disclosures required by accounting principles generally accepted in the United States (&#8220;GAAP&#8221;).</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The accounting policies of the Company are the same as those set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2022 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNC9mcmFnOjk0NDc0ZmM0YzNlNjRjODViZWU5MmVhNWYyMmExZmNmL3RleHRyZWdpb246OTQ0NzRmYzRjM2U2NGM4NWJlZTkyZWE1ZjIyYTFmY2ZfNDMwMg_55593bb7-1d8a-4422-a382-868023d7e318" escape="true">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</ix:nonNumeric> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Earnings Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNC9mcmFnOjk0NDc0ZmM0YzNlNjRjODViZWU5MmVhNWYyMmExZmNmL3RleHRyZWdpb246OTQ0NzRmYzRjM2U2NGM4NWJlZTkyZWE1ZjIyYTFmY2ZfNDI5Ng_a933e3f3-5858-4448-ab04-e11b9bad7baa" continuedAt="i46ee628956b34e638f9f81c1988c3054" escape="true">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and outstanding stock options granted under its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements, if applicable.  Earnings allocable </ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i73697a87ede44cdb8ae00743a00c218a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i46ee628956b34e638f9f81c1988c3054">to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;New Accounting Standards to be Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNC9mcmFnOjk0NDc0ZmM0YzNlNjRjODViZWU5MmVhNWYyMmExZmNmL3RleHRyZWdpb246OTQ0NzRmYzRjM2U2NGM4NWJlZTkyZWE1ZjIyYTFmY2ZfNDI4Mg_c136680c-4d69-4179-8076-b9a024793998" escape="true">In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement was effective immediately and, due to an accounting update which the Financial Accounting Standards Board issued in December 2022, can be applied to contract modifications through December 31, 2024.  To the extent that, prior to December 31, 2024, the Company enters into any contract modifications for which the optional expedients are applied, the adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div id="i1aa6fd61af824301a74dfe106295204d_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RleHRyZWdpb246NTE3MDA4ZGEyYzQ3NDJhMjg1NjBmODA3OWE4M2I4YThfNzQw_367d0d3b-8c19-4253-95cc-1d35845b041e" continuedAt="i42d4ca018aa44538b76f389b587d44a0" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i42d4ca018aa44538b76f389b587d44a0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RleHRyZWdpb246NTE3MDA4ZGEyYzQ3NDJhMjg1NjBmODA3OWE4M2I4YThfNzQx_9357e120-1986-4034-b482-ca9e1ed6ed9a" continuedAt="i5ef2442c6aea4719991dd71e846fd2df" escape="true">The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="i5ef2442c6aea4719991dd71e846fd2df"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.590%"><tr><td style="width:1.0%"></td><td style="width:77.107%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.411%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfNy0xLTEtMS05NjkwMA_3d37e0f4-df5c-485a-89fa-f13f2011915a">202</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfNy0zLTEtMS05NjkwMA_09229d75-e434-40c3-b10a-44126a166fb0">355</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfOC0xLTEtMS05NjkwMA_04b5326e-fe91-4215-9c64-a09a8426a7f5">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfOC0zLTEtMS05NjkwMA_62d87c83-67e4-48d4-a4f1-4ff4558adbcf">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfOS0xLTEtMS05NjkwMA_cd38ff92-8fe4-4a50-8209-30240ae39506">201</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfOS0zLTEtMS05NjkwMA_ae45cc79-ff5d-4c0d-9baf-f477c91e6015">354</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfMTEtMS0xLTEtOTY5MDA_523a0087-4fc5-45a1-852a-2ea3f4c342ee">112</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfMTEtMy0xLTEtOTY5MDA_dbff6ad6-8d98-453f-9186-740313640847">119</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfMTMtMS0xLTEtOTY5MDA_571bccd4-d5d3-4e46-aaaa-6e9edbb84d85">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfMTMtMy0xLTEtOTY5MDA_a047ba54-44ef-4ca7-9c11-48c2dfe73082">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfMTQtMS0xLTEtOTY5MDA_f1d6ee3b-d254-492b-8b60-dc3c78f2f12a">113</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfMTQtMy0xLTEtOTY5MDA_fe209ca3-eca6-4be0-af55-1bd99db3eb37">121</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfMTctMS0xLTEtOTY5MDA_fc24b4aa-8cf1-4608-84f5-b98611cb0359">1.80</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfMTctMy0xLTEtOTY5MDA_25eab629-d851-4d9e-ad53-e566fe55e453">2.97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfMjItMS0xLTEtOTY5MDA_ae1ac79a-92e0-4cac-9e97-22f62a4f6bac">1.78</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfMjItMy0xLTEtOTY5MDA_dda38252-b238-45a9-be13-148c071319c4">2.92</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During both the three months ended March 31, 2023 and 2022, less than <ix:nonFraction unitRef="shares" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RleHRyZWdpb246NTE3MDA4ZGEyYzQ3NDJhMjg1NjBmODA3OWE4M2I4YThfMzI5ODUzNDg4NDcyOQ_19e349ef-986d-4b4d-9c63-ae1e300f498d"><ix:nonFraction unitRef="shares" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RleHRyZWdpb246NTE3MDA4ZGEyYzQ3NDJhMjg1NjBmODA3OWE4M2I4YThfMzI5ODUzNDg4NDcyOQ_1bf1b9db-c188-4242-a165-5f441ffddcc4">1</ix:nonFraction></ix:nonFraction>&#160;million stock options and performance share units were not included in the calculation of diluted earnings per share due to their antidilutive effect.</span></div></ix:continuation><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i1aa6fd61af824301a74dfe106295204d_1116"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTE2L2ZyYWc6OWIzZDlhODdlMmQ0NDc2Mjk5YjY5YWQyMGQ5OGE1NGMvdGV4dHJlZ2lvbjo5YjNkOWE4N2UyZDQ0NzYyOTliNjlhZDIwZDk4YTU0Y18xNjQ5MjY3NDQ1OTE1_e92d0ffc-7d0f-48bc-9980-96f16646de52" continuedAt="icdf830e57c5047ebaa5e0037de575a17" escape="true">RESTRUCTURING ACTIVITIES</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="icdf830e57c5047ebaa5e0037de575a17" continuedAt="if2e54e2e01cc47d4919c4258fd61bba1"> </ix:continuation></span></div><div><span><br/></span></div><ix:continuation id="if2e54e2e01cc47d4919c4258fd61bba1" continuedAt="i36ae80daa0834af5b47c2ca21de53f91"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Invigorate Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is committed to a program called Invigorate which is designed to reduce its cost structure and improve performance.  Invigorate consists of several flagship programs, with structured plans in each, to drive savings and improve performance across the customer value chain.  These flagship programs include: organization excellence; information technology excellence; procurement excellence; field and customer service excellence; lab excellence; and revenue services excellence.  In addition to these programs, the Company identified key themes to change how it operates including reducing denials and patient price concessions; further digitizing the business; standardization; automation and artificial intelligence; optimization and selecting and retaining talent. The Invigorate program is intended to offset reimbursement pressures and labor and benefit cost increases; free up additional resources to invest in innovation and other growth initiatives; and enable the Company to improve service quality and operating profitability. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i36ae80daa0834af5b47c2ca21de53f91"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Restructuring Charges</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's pre-tax restructuring charges for the three months ended March&#160;31, 2023 and 2022 were $<ix:nonFraction unitRef="usd" contextRef="i0eb006769543403b857f1208edc96f39_D20230101-20230331" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTE2L2ZyYWc6OWIzZDlhODdlMmQ0NDc2Mjk5YjY5YWQyMGQ5OGE1NGMvdGV4dHJlZ2lvbjo5YjNkOWE4N2UyZDQ0NzYyOTliNjlhZDIwZDk4YTU0Y181NDk3NTU4MTg2MjA_aed359dc-264e-4912-a7b2-488021f1f2d7">15</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia9c6221361d444248eec701d6facf066_D20220101-20220331" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTE2L2ZyYWc6OWIzZDlhODdlMmQ0NDc2Mjk5YjY5YWQyMGQ5OGE1NGMvdGV4dHJlZ2lvbjo5YjNkOWE4N2UyZDQ0NzYyOTliNjlhZDIwZDk4YTU0Y181NDk3NTU4MTg2Mjg_51b90672-5e51-4e04-88e4-2d850485d83c">2</ix:nonFraction> million, respectively, entirely related to employee separation costs associated with various workforce reduction initiatives as the Company continued to restructure its organization.  Of the total restructuring charges incurred during the three months ended March&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="i026b244d8b664bf18f9db5bf951e1018_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTE2L2ZyYWc6OWIzZDlhODdlMmQ0NDc2Mjk5YjY5YWQyMGQ5OGE1NGMvdGV4dHJlZ2lvbjo5YjNkOWE4N2UyZDQ0NzYyOTliNjlhZDIwZDk4YTU0Y18zMjk4NTM0ODg3MzQ0_b235e3e0-9665-4f32-826a-fa3c64601b70">9</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="i95ea8d4904774f0aa70206e0d1464ca0_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTE2L2ZyYWc6OWIzZDlhODdlMmQ0NDc2Mjk5YjY5YWQyMGQ5OGE1NGMvdGV4dHJlZ2lvbjo5YjNkOWE4N2UyZDQ0NzYyOTliNjlhZDIwZDk4YTU0Y18zMjk4NTM0ODg3MzU2_c5759ea1-3c53-4ec4-91e7-a6c4158549c9">6</ix:nonFraction>&#160;million were recorded in cost of services and selling, general and administrative expenses, respectively.  Of the total restructuring charges incurred during the three months ended March&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="icfeed34c59e04d0f968039f01139270f_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTE2L2ZyYWc6OWIzZDlhODdlMmQ0NDc2Mjk5YjY5YWQyMGQ5OGE1NGMvdGV4dHJlZ2lvbjo5YjNkOWE4N2UyZDQ0NzYyOTliNjlhZDIwZDk4YTU0Y18zMjk4NTM0ODg3Mzg2_8f7708f9-b8c2-4649-83df-702ae9d76926">1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i1877888b4e3b4f5589b7bd09d1d25f8e_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTE2L2ZyYWc6OWIzZDlhODdlMmQ0NDc2Mjk5YjY5YWQyMGQ5OGE1NGMvdGV4dHJlZ2lvbjo5YjNkOWE4N2UyZDQ0NzYyOTliNjlhZDIwZDk4YTU0Y18zMjk4NTM0ODg3Mzk4_41dbf892-5535-4d03-94fd-e4dda2d20481">1</ix:nonFraction>&#160;million were recorded in cost of services and selling, general and administrative expenses, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Charges for all periods presented were primarily recorded in the Company's DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The restructuring liability as of March&#160;31, 2023 and December&#160;31, 2022, which is included in accounts payable and accrued expenses, was $<ix:nonFraction unitRef="usd" contextRef="i68ebbfe16e6d4925bb4ccf798eff1e19_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTE2L2ZyYWc6OWIzZDlhODdlMmQ0NDc2Mjk5YjY5YWQyMGQ5OGE1NGMvdGV4dHJlZ2lvbjo5YjNkOWE4N2UyZDQ0NzYyOTliNjlhZDIwZDk4YTU0Y181NDk3NTU4MTc1NjY_b0ad26a5-33ed-46a8-8767-dd8ac3b85bd8">38</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ia73437118858471aab7c03547980000d_I20221231" decimals="-6" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTE2L2ZyYWc6OWIzZDlhODdlMmQ0NDc2Mjk5YjY5YWQyMGQ5OGE1NGMvdGV4dHJlZ2lvbjo5YjNkOWE4N2UyZDQ0NzYyOTliNjlhZDIwZDk4YTU0Y181NDk3NTU4MTc1NzQ_50cbe944-34d6-4a17-8fb4-2d97a867e834">44</ix:nonFraction> million, respectively.</span></div></ix:continuation><div><span><br/></span></div><div id="i1aa6fd61af824301a74dfe106295204d_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80MC9mcmFnOjVmNzAzZjI5ZDBjOTQ4YTE5NDVlMmQ3MDM0M2VmMjI3L3RleHRyZWdpb246NWY3MDNmMjlkMGM5NDhhMTk0NWUyZDcwMzQzZWYyMjdfMjkyOA_ae1e9fe6-f955-4a6b-9e30-4a97ecffa079" continuedAt="iadb94512757d43e987e0bf461cd4a4b7" escape="true">BUSINESS ACQUISITIONS</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iadb94512757d43e987e0bf461cd4a4b7" continuedAt="ibfac308fd1254273aacbb3e34aed12aa">&#160;&#160;&#160;&#160;During February 2023, the Company announced that it had entered into a definitive agreement to acquire select assets of the laboratory services business of New York-Presbyterian, which serves providers and patients in New York, as well as the Tri-State Area and beyond. The transaction closed during April 2023.  See Note 15 for further discussion.</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibfac308fd1254273aacbb3e34aed12aa">&#160;&#160;&#160;&#160;For details regarding the Company's 2022 acquisitions, see Note 6 to the audited consolidated financial statements in the Company's 2022 Annual Report on Form 10-K.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div id="i1aa6fd61af824301a74dfe106295204d_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RleHRyZWdpb246ZDQwZTc5YWVmN2NmNGFhYjkwMmE2NTk3MGE2Zjk5MzRfNjM4Nw_83497a4c-a454-4d5d-ba7b-c9da5c73bcfc" continuedAt="i1fd089e127364995826305f15835af73" escape="true">FAIR VALUE MEASUREMENTS  </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i1fd089e127364995826305f15835af73" continuedAt="i219a93ba64f8476bb7a99b263f9c5e88"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RleHRyZWdpb246ZDQwZTc5YWVmN2NmNGFhYjkwMmE2NTk3MGE2Zjk5MzRfNjM4MQ_5c2d0201-4001-4fa9-b70c-6c9517b78b5f" continuedAt="i8ba9b13cd255440a9a29b5b19f8bcd45" escape="true">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i8ba9b13cd255440a9a29b5b19f8bcd45" continuedAt="i1b309d42958047609038fe3c7a9e7cc0"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.260%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.393%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets/Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15188e0ab8642c396b4a96aebce5582_I20230331" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfNi0xLTEtMS05NjkwMA_7dd2318f-e479-43e6-aa36-d97685791d8f">70</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2547ee5e7d94359a91b49b7221ab320_I20230331" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfNi0zLTEtMS05NjkwMA_2ddf9746-04aa-428b-8d96-8c9f77f41e7b">70</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c2789456b4f4655b65a9ce676bc382b_I20230331" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfNi01LTEtMS05NjkwMA_f6e1c6ef-45b8-4a48-aef8-628c0bf916d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55d00add9b34a659909dea8aab579c3_I20230331" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfNi03LTEtMS05NjkwMA_d2cc250d-997c-4779-8059-0aac2d168e9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15188e0ab8642c396b4a96aebce5582_I20230331" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfNy0xLTEtMS05NjkwMA_ee6abb44-f127-4bcd-9d39-81d73026d5ad">49</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2547ee5e7d94359a91b49b7221ab320_I20230331" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfNy0zLTEtMS05NjkwMA_dc15ad28-2de5-4cc6-bf63-e4abedf2d6f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c2789456b4f4655b65a9ce676bc382b_I20230331" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfNy01LTEtMS05NjkwMA_cb1b93b5-4094-4ca0-8912-57b5b3175afe">49</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55d00add9b34a659909dea8aab579c3_I20230331" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfNy03LTEtMS05NjkwMA_88d25a5d-d5cf-48f2-987d-eb28f9728fc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15188e0ab8642c396b4a96aebce5582_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfOS0xLTEtMS05NjkwMA_9449317e-4756-4912-8ae4-193e92fa4fb4">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2547ee5e7d94359a91b49b7221ab320_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfOS0zLTEtMS05NjkwMA_ae46f7c6-63ed-4132-8e8b-5b0c4b53e996">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c2789456b4f4655b65a9ce676bc382b_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfOS01LTEtMS05NjkwMA_23b54d88-a599-4170-a134-769d363fdab0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55d00add9b34a659909dea8aab579c3_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfOS03LTEtMS05NjkwMA_11ab871c-9ae3-4302-ae8f-a0b683ec0036">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15188e0ab8642c396b4a96aebce5582_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTItMS0xLTEtOTY5MDA_68c14d27-9779-4437-a4a3-6a3277af7d52">121</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2547ee5e7d94359a91b49b7221ab320_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTItMy0xLTEtOTY5MDA_49e5134d-af95-4628-98c6-b11299b043f3">70</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c2789456b4f4655b65a9ce676bc382b_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTItNS0xLTEtOTY5MDA_526e75fd-e787-4f9e-93a9-99187d29e998">49</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55d00add9b34a659909dea8aab579c3_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTItNy0xLTEtOTY5MDA_93dcd42f-d33d-4ad6-8ffb-a987eae124e2">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15188e0ab8642c396b4a96aebce5582_I20230331" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTUtMS0xLTEtOTY5MDA_ae8c9279-986e-421b-af19-c2e56095fdc9">126</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2547ee5e7d94359a91b49b7221ab320_I20230331" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTUtMy0xLTEtOTY5MDA_990a8ea5-184c-43cc-b3ab-ffc5ca38a405">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c2789456b4f4655b65a9ce676bc382b_I20230331" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTUtNS0xLTEtOTY5MDA_976b3e47-597e-4b60-9a46-18e6314949f1">126</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55d00add9b34a659909dea8aab579c3_I20230331" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTUtNy0xLTEtOTY5MDA_370bf1cf-e9f6-4a16-ab71-f2d0f7d54634">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15188e0ab8642c396b4a96aebce5582_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTgtMS0xLTEtOTY5MDA_9b5e63e9-b6f5-49be-9b2b-d6374d0cce85">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2547ee5e7d94359a91b49b7221ab320_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTgtMy0xLTEtOTY5MDA_e4e033a2-2457-47ae-8baf-a546721790c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c2789456b4f4655b65a9ce676bc382b_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTgtNS0xLTEtOTY5MDA_36a6b878-8e9b-4087-ae44-8e1b6fbe2e14">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55d00add9b34a659909dea8aab579c3_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTgtNy0xLTEtOTY5MDA_624e0c0e-bb3a-4b87-85a1-b52721604d55">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15188e0ab8642c396b4a96aebce5582_I20230331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMjAtMS0xLTEtOTY5MDA_dac686d0-5cb6-490c-ad20-5eca51c3d106">131</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2547ee5e7d94359a91b49b7221ab320_I20230331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMjAtMy0xLTEtOTY5MDA_624cb57c-42f0-4dcd-865a-99a9f959f528">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c2789456b4f4655b65a9ce676bc382b_I20230331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMjAtNS0xLTEtOTY5MDA_d27dd2c7-8a9f-4a78-8679-ab546923e01f">126</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55d00add9b34a659909dea8aab579c3_I20230331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMjAtNy0xLTEtOTY5MDA_edae0480-deba-4c7a-8e37-3da7a49b934c">5</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15188e0ab8642c396b4a96aebce5582_I20230331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMjItMS0xLTEtOTY5MDA_00ff4d16-0a44-41cb-8161-dad99d1f1506">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2547ee5e7d94359a91b49b7221ab320_I20230331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMjItMy0xLTEtOTY5MDA_b402a616-3649-4add-89cc-9230dc8127a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55d00add9b34a659909dea8aab579c3_I20230331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMjItNy0xLTEtOTY5MDA_1fa011fd-1c59-417c-95b7-1c3406084af1">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i219a93ba64f8476bb7a99b263f9c5e88" continuedAt="i7922716a9a714975bd1bd5243d51ca82"><div style="text-align:center"><ix:continuation id="i1b309d42958047609038fe3c7a9e7cc0"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.345%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.372%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if40cce849d804c9d9ade9ef0ff872500_I20221231" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMy0xLTEtMS05NjkwMA_6bc936e0-6181-4dd9-b015-7f856c5c1bb4">68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b282120e5684071822469ae84204d65_I20221231" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMy0zLTEtMS05NjkwMA_54c5c335-6a16-4a2e-8a62-55d6e2e0e8d2">68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i460b190c7af34171a28a620ddf6d0f9b_I20221231" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMy01LTEtMS05NjkwMA_d8a8ea8c-9881-4358-ae74-a55949c047d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4deefe47748e49dd9b5f6d19dde3517d_I20221231" decimals="-6" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMy03LTEtMS05NjkwMA_830251d2-cf48-41b4-adae-66fe6b4a6016">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if40cce849d804c9d9ade9ef0ff872500_I20221231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfNC0xLTEtMS05NjkwMA_68a9e55f-ebf6-46d6-9e3a-fda1cf8bf7ad">46</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b282120e5684071822469ae84204d65_I20221231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfNC0zLTEtMS05NjkwMA_4aa70230-1a3d-4562-b559-e109579bab14">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i460b190c7af34171a28a620ddf6d0f9b_I20221231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfNC01LTEtMS05NjkwMA_a2a37e71-31a3-4be6-b04a-a8758344d4c2">46</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4deefe47748e49dd9b5f6d19dde3517d_I20221231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfNC03LTEtMS05NjkwMA_ae3b0c81-e365-4e68-bc62-be66eb743359">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if40cce849d804c9d9ade9ef0ff872500_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfNi0xLTEtMS05NjkwMA_7d9ee2a8-3a59-43f0-ac1c-f7ea430aab29">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b282120e5684071822469ae84204d65_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfNi0zLTEtMS05NjkwMA_729e816f-7771-45e8-a516-8d822db000b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i460b190c7af34171a28a620ddf6d0f9b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfNi01LTEtMS05NjkwMA_1513884b-ff82-4211-a76e-fe702b40ac67">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4deefe47748e49dd9b5f6d19dde3517d_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfNi03LTEtMS05NjkwMA_35e16be7-be97-489e-8408-1aa1fab76bf0">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if40cce849d804c9d9ade9ef0ff872500_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTAtMS0xLTEtOTY5MDA_aeb499b2-0fe2-4e5c-9a02-2f89bfa65e2a">116</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b282120e5684071822469ae84204d65_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTAtMy0xLTEtOTY5MDA_6aad954d-e5ba-4f8f-9018-20cec3cc5a3d">68</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i460b190c7af34171a28a620ddf6d0f9b_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTAtNS0xLTEtOTY5MDA_5b12cc0e-c3ae-40b9-9a2c-301d98113cc0">46</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4deefe47748e49dd9b5f6d19dde3517d_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTAtNy0xLTEtOTY5MDA_a2edfbd9-3e55-4fcb-b736-4695b005389f">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if40cce849d804c9d9ade9ef0ff872500_I20221231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTMtMS0xLTEtOTY5MDA_aca2c8ff-14bf-4980-86a9-b12149609c57">120</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b282120e5684071822469ae84204d65_I20221231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTMtMy0xLTEtOTY5MDA_e2dbb4e2-f536-43f4-bd22-697119277507">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i460b190c7af34171a28a620ddf6d0f9b_I20221231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTMtNS0xLTEtOTY5MDA_c6fdddda-14d3-4ad7-bfaf-cec8e6a9793d">120</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4deefe47748e49dd9b5f6d19dde3517d_I20221231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTMtNy0xLTEtOTY5MDA_e7d9d157-ecc1-4a3a-9124-8f1ce074c4da">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if40cce849d804c9d9ade9ef0ff872500_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTUtMS0xLTEtOTY5MDA_d29ffb30-5a89-4726-94d2-2168e6463ee2">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b282120e5684071822469ae84204d65_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTUtMy0xLTEtOTY5MDA_51f71c80-2a49-4977-b4f1-a60e57397f81">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i460b190c7af34171a28a620ddf6d0f9b_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTUtNS0xLTEtOTY5MDA_be39229b-653d-47c6-822a-b8932477be4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4deefe47748e49dd9b5f6d19dde3517d_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTUtNy0xLTEtOTY5MDA_bc9c91ef-1354-4280-82bb-ccb0f7c1f5c5">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if40cce849d804c9d9ade9ef0ff872500_I20221231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTktMS0xLTEtOTY5MDA_fd5a6a2c-d8ad-476c-b1b2-1a5ffde758ce">143</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b282120e5684071822469ae84204d65_I20221231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTktMy0xLTEtOTY5MDA_36a24e94-137b-4e91-ba0f-c151fb756baf">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i460b190c7af34171a28a620ddf6d0f9b_I20221231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTktNS0xLTEtOTY5MDA_004cdd1d-fa6d-40be-bb4c-fe3cdc5e5f09">120</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4deefe47748e49dd9b5f6d19dde3517d_I20221231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTktNy0xLTEtOTY5MDA_6da9909e-ae50-40de-9f8b-2bdb3a30a5a0">23</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if40cce849d804c9d9ade9ef0ff872500_I20221231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMjEtMS0xLTEtOTY5MDA_5c6824f0-fb37-4bf9-ab03-e57474444c44">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b282120e5684071822469ae84204d65_I20221231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMjEtMy0xLTEtOTY5MDA_1271b168-60cd-454d-8f2b-e4d678308d77">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4deefe47748e49dd9b5f6d19dde3517d_I20221231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMjEtNy0xLTEtOTY5MDA_851a52b0-39da-4df9-988f-3278dfdfa76a">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A detailed description regarding the Company's fair value measurements is contained in Note 8 to the audited consolidated financial statements in the Company's 2022 Annual Report on Form 10-K.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-directed stock and bond mutual funds that are classified as trading securities.  The trading securities are classified within Level 1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.</span></div><div style="padding-right:72pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#8220;invested&#8221; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value using discounted cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable.  Significant inputs include cash flows projections and a discount rate. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with previous acquisitions, the Company had contingent consideration obligations based on the achievement of certain testing volume and revenue benchmarks during 2022.  See Note 8 to the audited consolidated financial statements in the Company's 2022 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RleHRyZWdpb246ZDQwZTc5YWVmN2NmNGFhYjkwMmE2NTk3MGE2Zjk5MzRfNjM2OQ_79cafa54-6c08-4af0-baf4-a2052941710f" continuedAt="ica881a26837d47f681f785dba43bb2a9" escape="true">The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i7922716a9a714975bd1bd5243d51ca82"><div style="margin-top:5pt;text-align:center"><ix:continuation id="ica881a26837d47f681f785dba43bb2a9"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December&#160;31, 2022</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee1c43167736475396bb0f00c1706266_I20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjI1OTM5ODM1YmNhODQ2M2ViNzViYzMyODgzZTBjNWEzL3RhYmxlcmFuZ2U6MjU5Mzk4MzViY2E4NDYzZWI3NWJjMzI4ODNlMGM1YTNfMi0xLTEtMS05NjkwMA_fe1befcb-f2a7-45d2-8b44-1b8cf9ae682d">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b765f813058424c84db7601e651042b_D20230101-20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjI1OTM5ODM1YmNhODQ2M2ViNzViYzMyODgzZTBjNWEzL3RhYmxlcmFuZ2U6MjU5Mzk4MzViY2E4NDYzZWI3NWJjMzI4ODNlMGM1YTNfNC0xLTEtMS05NjkwMA_34e49fe7-9511-4a0e-82c5-88584f9a66fc">18</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, March 31, 2023</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee0fda822a8640319a5856d56a336d6f_I20230331" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjI1OTM5ODM1YmNhODQ2M2ViNzViYzMyODgzZTBjNWEzL3RhYmxlcmFuZ2U6MjU5Mzk4MzViY2E4NDYzZWI3NWJjMzI4ODNlMGM1YTNfOC0xLTEtMS05NjkwMA_0a47862d-c16d-4c1f-a15b-f2e5e627b71a">5</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an <ix:nonFraction unitRef="number" contextRef="i5b880299f57a4a9b9824c017900d1138_I20150701" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RleHRyZWdpb246ZDQwZTc5YWVmN2NmNGFhYjkwMmE2NTk3MGE2Zjk5MzRfNTA0Mg_090dc506-9edd-4094-b7db-ac169497b060">18.9</ix:nonFraction>% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of March&#160;31, 2023, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long term growth rates, and a discount rate commensurate with economic risk.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments. As of March&#160;31, 2023 and December&#160;31, 2022, the fair value of the Company&#8217;s debt was estimated at $<ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RleHRyZWdpb246ZDQwZTc5YWVmN2NmNGFhYjkwMmE2NTk3MGE2Zjk5MzRfNjAwMg_4be4df07-6f04-45e7-ab08-0af0d3609609">3.8</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RleHRyZWdpb246ZDQwZTc5YWVmN2NmNGFhYjkwMmE2NTk3MGE2Zjk5MzRfNjAwOQ_2097cfbc-3cc5-4896-bba7-a9df560bf013">3.7</ix:nonFraction> billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.</span></div></ix:continuation><div style="text-indent:29.25pt"><span><br/></span></div><div id="i1aa6fd61af824301a74dfe106295204d_1175"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTc1L2ZyYWc6ZjIyYzkxMzFjYWRhNGQyNGFkZTAzNmYwZGExZjUzNzUvdGV4dHJlZ2lvbjpmMjJjOTEzMWNhZGE0ZDI0YWRlMDM2ZjBkYTFmNTM3NV8xNjQ5MjY3NDQ4MjIx_259f9178-cb39-4d1e-8931-592967ed4c1c" continuedAt="id8a3a8915ee140bd90d92edd73ab51fd" escape="true">DEBT</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id8a3a8915ee140bd90d92edd73ab51fd">&#160;&#160;&#160;&#160;The Company is party to a $<ix:nonFraction unitRef="usd" contextRef="i481a0bb184b14bad9d931200d5d31852_I20211130" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTc1L2ZyYWc6ZjIyYzkxMzFjYWRhNGQyNGFkZTAzNmYwZGExZjUzNzUvdGV4dHJlZ2lvbjpmMjJjOTEzMWNhZGE0ZDI0YWRlMDM2ZjBkYTFmNTM3NV8zMjk4NTM0ODg4MTA5_e7ebd3dc-5a67-465f-b671-a3dab1d07596">750</ix:nonFraction>&#160;million senior unsecured revolving credit facility (the &#8220;Credit Facility&#8221; or "Senior Unsecured Revolving Credit Facility") which matures in November 2026. Under the Credit Facility, the Company can issue letters of credit totaling $<ix:nonFraction unitRef="usd" contextRef="i667912428a7248bfb81aa3ff7ab6bf9c_I20211130" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTc1L2ZyYWc6ZjIyYzkxMzFjYWRhNGQyNGFkZTAzNmYwZGExZjUzNzUvdGV4dHJlZ2lvbjpmMjJjOTEzMWNhZGE0ZDI0YWRlMDM2ZjBkYTFmNTM3NV8zMjk4NTM0ODg4MTIz_98752d14-d75f-4c80-9bb5-b6c474b34004">150</ix:nonFraction>&#160;million (see Note 11). Issued letters of credit reduce the available borrowing capacity under the Credit Facility. Interest on the Credit Facility is based on certain published rates plus an applicable margin based on changes in the Company's public debt ratings.  The Credit Facility was amended during March 2023.  Subsequent to such amendment, at the option of the Company, it may elect to lock into Term Secured Overnight Financing Rate (&#8220;Term SOFR&#8221;)-based interest rate contracts for periods up to six months. For interest on any U.S. Dollar-denominated outstanding amounts not covered under Term SOFR-based interest rate contracts, the Company can opt for an alternate base rate, which is calculated by reference to the prime rate, the federal funds rate or an adjusted Term SOFR rate.  The Company also has the option to borrow in other currencies.  As of March&#160;31, 2023, the Company's borrowing rate for Term SOFR-based loans under the Credit Facility was adjusted Term SOFR plus <ix:nonFraction unitRef="number" contextRef="i220fe343315542498e86e7895d5cb139_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTc1L2ZyYWc6ZjIyYzkxMzFjYWRhNGQyNGFkZTAzNmYwZGExZjUzNzUvdGV4dHJlZ2lvbjpmMjJjOTEzMWNhZGE0ZDI0YWRlMDM2ZjBkYTFmNTM3NV8zMjk4NTM0ODg4MTM3_f95fe52e-fb20-4554-a819-a4362ae9662b">1.00</ix:nonFraction>%. The Credit Facility contains various covenants, including the maintenance of a financial leverage ratio, which could impact the Company's ability to, among other things, incur additional indebtedness. As of both March&#160;31, 2023 and December&#160;31, 2022, there were <ix:nonFraction unitRef="usd" contextRef="id37a126b68964d6a8e53b08d24ae39c2_I20221231" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTc1L2ZyYWc6ZjIyYzkxMzFjYWRhNGQyNGFkZTAzNmYwZGExZjUzNzUvdGV4dHJlZ2lvbjpmMjJjOTEzMWNhZGE0ZDI0YWRlMDM2ZjBkYTFmNTM3NV8zMjk4NTM0ODg4MTQ0_54670c16-534c-4aec-b141-9a07691334ed"><ix:nonFraction unitRef="usd" contextRef="i9c4b1b27b14f4358b79dcebe17500b25_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTc1L2ZyYWc6ZjIyYzkxMzFjYWRhNGQyNGFkZTAzNmYwZGExZjUzNzUvdGV4dHJlZ2lvbjpmMjJjOTEzMWNhZGE0ZDI0YWRlMDM2ZjBkYTFmNTM3NV8zMjk4NTM0ODg4MTQ0_e8886498-8845-49bf-a84c-9034305feffa">no</ix:nonFraction></ix:nonFraction> outstanding borrowings under the Senior Unsecured Revolving Credit Facility.</ix:continuation></span></div><div><span><br/></span></div><div id="i1aa6fd61af824301a74dfe106295204d_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81Mi9mcmFnOmM5NmNjYjQ2NzUwZTRmOGJiZDY1YmI2YmI3NGQ0ZGYyL3RleHRyZWdpb246Yzk2Y2NiNDY3NTBlNGY4YmJkNjViYjZiYjc0ZDRkZjJfMzMyMQ_51c4b88f-0d89-46be-92b4-37411385e271" continuedAt="i78d523334f12416080d96eba5dcb0891" escape="true">FINANCIAL INSTRUMENTS </ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i78d523334f12416080d96eba5dcb0891" continuedAt="i0e2f89554b064204813288fc9ed29033">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81Mi9mcmFnOmM5NmNjYjQ2NzUwZTRmOGJiZDY1YmI2YmI3NGQ0ZGYyL3RleHRyZWdpb246Yzk2Y2NiNDY3NTBlNGY4YmJkNjViYjZiYjc0ZDRkZjJfMzMzNQ_3ed44438-829e-4b34-9c15-766a18b42e2f" continuedAt="i1b8af82eaf564c8eb36b40cba13b8b1c" escape="true">The Company uses derivative financial instruments, from time to time, to manage its exposure to market risks for changes in interest rates and foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. </ix:nonNumeric></ix:continuation></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i0e2f89554b064204813288fc9ed29033" continuedAt="ic56a955b0132441d8f120ead24ace92b"><ix:continuation id="i1b8af82eaf564c8eb36b40cba13b8b1c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and, from time to time, variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Cash Flow Hedges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Fair Value Hedges </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Historically, the Company has entered into various fixed-to-variable interest rate swap agreements in order to convert a portion of the Company's long-term debt into variable interest rate debt.  All such fixed-to-variable interest rate swap agreements have been terminated and proceeds from the terminations have been reflected as basis adjustments to the hedged debt instruments and are being amortized as a reduction of interest expense, net over the remaining terms of such debt instruments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81Mi9mcmFnOmM5NmNjYjQ2NzUwZTRmOGJiZDY1YmI2YmI3NGQ0ZGYyL3RleHRyZWdpb246Yzk2Y2NiNDY3NTBlNGY4YmJkNjViYjZiYjc0ZDRkZjJfMzMzNg_cb1482eb-becc-4b68-a9d1-efa3e30c53f3" continuedAt="ie2842a7433ca489286e51a92b4ae9b14" escape="true">As of March&#160;31, 2023 and December&#160;31, 2022, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:</ix:nonNumeric></span></div><ix:continuation id="ie2842a7433ca489286e51a92b4ae9b14"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:18.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.313%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.315%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibef99765bb424b0a98ea7a9577ad7abd_I20230331" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81Mi9mcmFnOmM5NmNjYjQ2NzUwZTRmOGJiZDY1YmI2YmI3NGQ0ZGYyL3RhYmxlOmYwMmRmZjQwZWMwNDQyNTE4OWM4NTg4ZWM4NmQyZTI4L3RhYmxlcmFuZ2U6ZjAyZGZmNDBlYzA0NDI1MTg5Yzg1ODhlYzg2ZDJlMjhfMi01LTEtMS05NjkwMA_ba5ee918-03bb-4c2f-af28-2daa7117f723">23</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if15719cfaad14b7dbfdf71b40a4c65d9_I20221231" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81Mi9mcmFnOmM5NmNjYjQ2NzUwZTRmOGJiZDY1YmI2YmI3NGQ0ZGYyL3RhYmxlOmYwMmRmZjQwZWMwNDQyNTE4OWM4NTg4ZWM4NmQyZTI4L3RhYmxlcmFuZ2U6ZjAyZGZmNDBlYzA0NDI1MTg5Yzg1ODhlYzg2ZDJlMjhfMi05LTEtMS05NjkwMA_5cbf0f87-6da0-4c50-a88a-5b737986c056">26</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of both March&#160;31, 2023 and December&#160;31, 2022, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="ic56a955b0132441d8f120ead24ace92b" continuedAt="i280a72e557ba4672b0c913b579d201ba">&#160;&#160;&#160;&#160;</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i280a72e557ba4672b0c913b579d201ba">A detailed description regarding the Company's use of derivative financial instruments is contained in Note 16 to the audited consolidated financial statements in the Company's 2022 Annual Report on Form 10-K.</ix:continuation>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div id="i1aa6fd61af824301a74dfe106295204d_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfNDI0OA_d37553fe-8e26-405e-9c8d-89e0d91f61b7" continuedAt="i872da6e5d8054f17bff5636f2e0554ef" escape="true">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</ix:nonNumeric></span></div><ix:continuation id="i872da6e5d8054f17bff5636f2e0554ef" continuedAt="ifb51aeed014147a68a13c5ab454db69e"><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Accumulated Other Comprehensive Loss by Component</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) includes: </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 8); and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax, on available-for-sale debt securities.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ifb51aeed014147a68a13c5ab454db69e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023 and 2022, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes.  </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the first quarter of 2023, the Company's Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMTExNg_a6f88304-a3ed-4381-a5c4-6dd7a61b9a37">0.71</ix:nonFraction> per common share.  During each of the four quarters of 2022, the Company's Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i5e11296045604f51a55e048533a906a4_D20220701-20220930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMTI0OQ_2b929251-0f81-41f2-8d83-a9cf969413f2"><ix:nonFraction unitRef="usdPerShare" contextRef="i5f567083983b48babafdc73d6c6901c7_D20220401-20220630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMTI0OQ_8fd3e18b-7c0c-4198-8f7b-467f850244ef"><ix:nonFraction unitRef="usdPerShare" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMTI0OQ_9c83dbe5-5539-4fdd-832d-31d0e40562be"><ix:nonFraction unitRef="usdPerShare" contextRef="i8f78891156cb4c548d0f6277115ee3eb_D20221001-20221231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMTI0OQ_dfb2f3ee-c80f-4b94-bb1b-0e7769706aa7">0.66</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> per common share. </span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In February 2023, the Company's Board of Directors increased the size of its share repurchase program by $<ix:nonFraction unitRef="usd" contextRef="ia90feb97a113427e947ad9d0fd0a3fa3_D20230201-20230201" decimals="INF" name="dgx:StockRepurchaseProgramAdditionalAmountAuthorized" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMTQwNw_4832b951-061d-4070-bbe7-bfbbd358064b">1</ix:nonFraction>&#160;billion. As of March&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMTQyMQ_9d06061f-a1ce-4eab-b2dd-7382f01b918e">1.3</ix:nonFraction>&#160;billion remained available under the Company&#8217;s share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchases</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i7e493e3bc38e440db1ddd741cfb4d78b_D20230101-20230331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMTY0OTI2NzQ0ODk1MQ_3516ac80-e3fc-4c89-be24-a6ad3e11e0e2">no</ix:nonFraction> shares of its common stock.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="ic0371ca26d314e109241b4b21346af30_D20220101-20220331" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMTc0Mw_d6852050-d034-4317-9b6e-29847cba8caf">2.6</ix:nonFraction> million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="ic0371ca26d314e109241b4b21346af30_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMTc3Nw_c28e6948-dcae-4b56-885d-fd2f4dd197d6">350</ix:nonFraction> million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shares Reissued from Treasury Stock</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023 and 2022, the Company reissued <ix:nonFraction unitRef="shares" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMjcyNg_67b22d2e-5de5-4444-8910-768638e00ca7">0.7</ix:nonFraction> million shares and <ix:nonFraction unitRef="shares" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMjc0MA_6d59fd0b-2d7f-4fc6-8b6b-f3eb43e1a6ef">0.5</ix:nonFraction> million shares, respectively, from treasury stock under its Employee Stock Purchase Plan and its stock-based compensation program.  For details regarding the Company's stock ownership and compensation plans, see Note 18 to the audited consolidated financial statements in the Company's 2022 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Redeemable Noncontrolling Interest</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an <ix:nonFraction unitRef="number" contextRef="i5b880299f57a4a9b9824c017900d1138_I20150701" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMzUxNQ_090dc506-9edd-4094-b7db-ac169497b060">18.9</ix:nonFraction>% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  As of March&#160;31, 2023 and December&#160;31, 2022, the redeemable noncontrolling interest was presented at its fair value.  For further details regarding the fair value of the redeemable noncontrolling interest, see Note 6.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i1aa6fd61af824301a74dfe106295204d_58"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RleHRyZWdpb246YjVmOGJmY2YxNWNlNDhmZWFmZTc0YmE4YTJlZWRkNTBfNDIy_5f6a2576-efaa-4767-846b-f9f6db6f7d26" continuedAt="i85f6d161fd034c41b1e7707a1be239e6" escape="true">SUPPLEMENTAL CASH FLOW AND OTHER DATA</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i85f6d161fd034c41b1e7707a1be239e6" continuedAt="i7994f84054f84d6089388ec7fea4ec5b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RleHRyZWdpb246YjVmOGJmY2YxNWNlNDhmZWFmZTc0YmE4YTJlZWRkNTBfNDE3_8d2c212e-b6b9-4646-a4ff-261fddb9d733" continuedAt="i2901bb1120f64f1398fe651c0e6e6b2e" escape="true">Supplemental cash flow and other data for the three months ended March&#160;31, 2023 and 2022 was as follows:</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2901bb1120f64f1398fe651c0e6e6b2e" continuedAt="i7e2bec9e88af41dab3291d6688f6417e"> </ix:continuation></span></div></ix:continuation><div style="margin-top:5pt"><ix:continuation id="i7994f84054f84d6089388ec7fea4ec5b"><ix:continuation id="i7e2bec9e88af41dab3291d6688f6417e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.844%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMi0xLTEtMS05NjkwMA_7e44ebe0-0225-4cbe-b0ad-4d4779f62e06">81</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMi0zLTEtMS05NjkwMA_5d1e082c-e4c1-4c9d-a437-9e745b6a1526">79</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMy0xLTEtMS05NjkwMA_9cd08d07-680f-4743-93c6-24c750df1af5">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMy0zLTEtMS05NjkwMA_27cee206-1a8d-4963-9922-8a28d4d67d62">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfNC0xLTEtMS05NjkwMA_bcdd3ae7-6fe7-407d-8170-04990075e27b">107</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfNC0zLTEtMS05NjkwMA_d4ab6e8a-5c20-4c25-9352-0553719d88f1">106</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfNi0xLTEtMS05NjkwMA_9398c473-7229-4298-a803-c132352f9e75">37</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfNi0zLTEtMS05NjkwMA_b1d59318-80fd-48c6-9603-1a967292c1a0">37</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfNy0xLTEtMS05NjkwMA_a0c1771f-3971-41bf-b223-6f21a3c000e6">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfNy0zLTEtMS05NjkwMA_9bba2c29-b8f6-4d30-ac72-c1c1285a6341">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfOC0xLTEtMS05NjkwMA_16ce6895-ed77-43b1-a2a4-21d23f9078bf">35</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfOC0zLTEtMS05NjkwMA_fd782ab8-7517-468d-af81-f2505cdc243f">37</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTAtMS0xLTEtOTY5MDA_07c53e48-2144-47ab-88b4-c5cabc62f72f">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTAtMy0xLTEtOTY5MDA_26ccad39-3062-4b6d-b4a6-a13b1e3966de">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTEtMS0xLTEtOTY5MDA_c78e3137-56ce-420b-9ed4-97c79e8cc3f0">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTEtMy0xLTEtOTY5MDA_14b4ab4c-2fa6-4395-a372-d8ced63bda08">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTMtMS0xLTEtOTY5MDA_2b8ad05b-92ce-42f3-8d2c-e59746b9b347">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTMtMy0xLTEtOTY5MDA_37816f4e-4f59-4dfd-a27c-20b099ac85ed">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTUtMS0xLTEtOTY5MDA_205f6a61-100d-4e8d-9660-a8937a70aa0e">80</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib84cedd020e943f08a613b4d09834d7f_I20220331" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTUtMy0xLTEtOTY5MDA_eed6d77a-af0f-492d-9467-d69991210ffb">78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTgtMS0xLTEtOTY5MDA_604aaf59-3e6a-4eba-9696-54a26e24e4f3">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTgtMy0xLTEtOTY5MDA_2aadd86d-d781-4505-a490-366b2fd8d47d">142</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:LiabilitiesAssumed1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTktMS0xLTEtOTY5MDA_c793f8b1-d306-4901-ba5c-c3437ae68050">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTktMy0xLTEtOTY5MDA_e6491455-4a1e-44f8-8247-e3ef359316e6">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMjAtMS0xLTEtOTY5MDA_560f4c10-b95b-4f22-bbff-5dbca1866c0f">31</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMjAtMy0xLTEtOTY5MDA_41e28d47-cf7c-4408-8021-02d53bee121c">127</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="dgx:Mergerconsiderationpaidpayablenet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMjEtMS0xLTEtOTY5MDA_dcfbd8aa-0f8b-4bc4-b7fe-25897c2de1f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" sign="-" name="dgx:Mergerconsiderationpaidpayablenet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMjEtMy0xLTEtOTY5MDA_78f1446b-b539-4fac-ab7f-943842d53714">18</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for business acquisitions</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMjItMS0xLTEtOTY5MDA_450ffb23-6eac-4faa-af5b-29b0d1c9103c">31</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMjItMy0xLTEtOTY5MDA_0362c207-8206-48eb-bda9-0cd7c93cff58">109</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMjMtMS0xLTEtOTY5MDA_a8b37158-87bc-4287-80a3-5e5f39b58738">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMjMtMy0xLTEtOTY5MDA_cbd91692-82b5-457b-9360-c2f11dbff504">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMjQtMS0xLTEtOTY5MDA_1f64e35a-f186-4bee-828b-4b3801709712">31</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMjQtMy0xLTEtOTY5MDA_b2ebfd32-ac30-434f-9668-8ba6edf9cc5c">105</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMzEtMS0xLTEtOTY5MDA_03e378f2-7ee4-44d5-8390-07f85ca97632">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMzEtMy0xLTEtOTY5MDA_203c386e-8d16-4f6e-884b-9d7c4f24f23e">63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div id="i1aa6fd61af824301a74dfe106295204d_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfMTE0NjA_e4987168-6d86-4e93-a588-3ecc3e8e1f89" continuedAt="i819ee37128c54e6c89a36cd0ab1c1c10" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i819ee37128c54e6c89a36cd0ab1c1c10" continuedAt="i9bcf9b6277fb4ec196a3d4efe8fda733"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letters of Credit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company can issue letters of credit totaling $<ix:nonFraction unitRef="usd" contextRef="ia10ad287b0cd4193a14609ca8a3021dc_I20230331" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfMTEx_133ecea2-a029-42fc-a87b-85e47b59731f">100</ix:nonFraction>&#160;million under its $<ix:nonFraction unitRef="usd" contextRef="i5761244dc05a4e05ba1c36f1739ffa78_I20230331" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfMTI0_3f389996-bd9c-44ec-abd8-a79291d210e6">525</ix:nonFraction>&#160;million secured receivables credit facility and $<ix:nonFraction unitRef="usd" contextRef="i0773aae3a1a24aabbc51451a0ca743da_I20230331" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfMTY3_02efcc0d-dae4-45c5-9f23-fc1e14f45872">150</ix:nonFraction>&#160;million under its $<ix:nonFraction unitRef="usd" contextRef="i9c4b1b27b14f4358b79dcebe17500b25_I20230331" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfMTgw_8494e249-f455-4059-8f13-9dd2a8038d73">750</ix:nonFraction>&#160;million senior unsecured revolving credit facility.  For further discussion regarding the Company's secured receivables credit facility and senior unsecured revolving credit facility, see Note 14 to the audited consolidated financial statements in the Company's 2022 Annual Report on Form 10-K and Note 7 above.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i9bcf9b6277fb4ec196a3d4efe8fda733" continuedAt="ic9d5e882cdee48f78cbfc3d3468f3f2b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In support of its risk management program, $<ix:nonFraction unitRef="usd" contextRef="i5761244dc05a4e05ba1c36f1739ffa78_I20230331" decimals="-6" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfNTI2_f8f1766d-030e-4bd0-aecf-d751d7ae4e72">70</ix:nonFraction> million in letters of credit under the secured receivables credit facility were outstanding as of March&#160;31, 2023, providing collateral for current and future automobile liability and workers&#8217; compensation loss payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Lease Obligations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases for which no liability has been recorded.  For further details, see Note 19 to the audited consolidated financial statements in the Company&#8217;s 2022 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.  The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">401(k) Plan Lawsuit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In 2020, <ix:nonFraction unitRef="claim" contextRef="ie4e5f3cb386b4fc98d6b4476305eabe9_I20201231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfMTY0OTI2NzQ2Mzg0MQ_1d2bb1ce-600d-4a4a-87ca-2b19a3c703bc">two</ix:nonFraction> putative class action lawsuits were filed in the U.S. District Court for New Jersey against the Company and other defendants with respect to the Company&#8217;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the <ix:nonFraction unitRef="claim" contextRef="ice7ecc3f1344426eb38edcacb95102d0_I20201031" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfMTY0OTI2NzQ2Mzg0OQ_297f1cda-8eb5-4872-9549-0c993308d770">two</ix:nonFraction> lawsuits under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re: Quest Diagnostics ERISA Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and plaintiffs filed a consolidated amended complaint.  In May 2021, the court denied the Company's motion to dismiss the complaint.  Discovery is proceeding.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">AMCA Data Security Incident</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  </span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#8220;AMCA&#8221;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018 and March 30, 2019 (the &#8220;AMCA Data Security Incident&#8221;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#8217;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#8217;s nor the Company&#8217;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#8217; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases that were then still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss was granted in part and denied in part.  Plaintiffs filed an amended complaint, which the Company also moved to dismiss. The motion is pending. Plaintiffs also filed a motion to further amend the complaint. The Company opposed the motion.  Discovery is proceeding.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ic9d5e882cdee48f78cbfc3d3468f3f2b" continuedAt="i08bc953137184ea597b2c98c38440937"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, the Company has been notified that numerous state attorney general offices were investigating or otherwise seeking information and/or documents, and that certain U.S. senators were seeking information, from the Company related to the AMCA Data Security Incident.  </span></div><div><span><br/></span></div><div style="text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ReproSource Fertility Diagnostics, Inc.</span></div><div style="text-indent:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;ReproSource Fertility Diagnostics, Inc. (&#8220;ReproSource&#8221;), a subsidiary of the Company, is subject to <ix:nonFraction unitRef="claim" contextRef="ic641d132cbe14e8eb7c6b478bf547c1a_I20230331" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfMTY0OTI2NzQ2Mzg1Nw_4976c145-c120-4859-9674-63dc719682f3">two</ix:nonFraction> putative class action lawsuits in the U.S. District Court for Massachusetts: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bickham v. ReproSource Fertility Diagnostics, Inc. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gordon v. ReproSource Fertility Diagnostics, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The class actions are related to a data security incident that occurred in August 2021 in which an unauthorized party may have accessed or acquired protected health information and personally identifiable information of ReproSource patients. The complaints generally allege that ReproSource, among other claims, failed to adequately safeguard customers&#8217; private information. The Company moved to dismiss both complaints.  A third putative class action pertaining to the same data security incident, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trouville v. ReproSource Fertility Diagnostics, Inc.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was filed in California state court.  The Company removed the case to federal court and moved to dismiss and/or transfer it to U.S. District Court for Massachusetts.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cole, et. al v. Quest Diagnostics Incorporated</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;The Company is</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">subject to a putative class action entitled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Cole, et al. v Quest Diagnostics Incorporated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, which was filed in the U. S. District Court for the Eastern District of California, for allegedly conspiring with Facebook to track customers&#8217; internet communications on Company web platforms without authorization, in violation of the California Invasion of Privacy Act and the California Confidentiality of Medical Information Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  The complaint alleged that the Company&#8217;s actions were an invasion of privacy and contributed to a loss of value in plaintiffs&#8217; personally identifiable information.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company moved to dismiss the case or, in the alternative, transfer venue to the U.S. District Court for New Jersey.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Subsequently, plaintiffs filed an amended complaint.  The Company filed a motion to dismiss the amended complaint, which is pending. </span></div><div style="text-indent:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The federal or state governments may bring claims based on the Company's current practices, which it believes are lawful.  In addition, certain federal and state statutes, including the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing or other practices based on the False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistleblowers" as to which the Company cannot determine the extent of any potential liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i08bc953137184ea597b2c98c38440937"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of March&#160;31, 2023, the Company does not believe that material losses related to legal matters are probable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reserves for legal matters totaled $<ix:nonFraction unitRef="usd" contextRef="i51a030df6d10457797f31c05e00c6fbd_I20230331" decimals="-6" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfODM3NA_7a3a976c-7c46-4d5e-afb6-cdf73e0a9d37">1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia0ed27f0259f4eddad39f6d6f9166f22_I20221231" decimals="-6" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfODM4MQ_e0f40d32-1394-49aa-bce1-d45281c6dcf4">2</ix:nonFraction> million as of March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reserves for General and Professional Liability Claims</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is subject to a series of individual claims brought by persons in Ireland related to allegations stemming from pap smear screening services performed by the Company.  In general, claimants have alleged that the results of certain pap smear screening tests performed by the Company and other providers, pursuant to a program coordinated by the Irish government, were incorrect for individuals who were later diagnosed with cervical cancer.  The Irish government and an independent scoping inquiry commissioned by the Irish government found that the Company&#8217;s performance of its screening services for the Irish cervical cancer screening program were in accordance with both Ireland&#8217;s requirements and international standards.  The Company has settled claims made by certain individuals, is a party in multiple lawsuits and may be served as a party in additional lawsuits.  The Company does not believe that the resolution of existing or future claims will have a material adverse effect on its financial position or liquidity, but the ultimate outcomes of these claims are unpredictable and subject to significant uncertainties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $<ix:nonFraction unitRef="usd" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="-6" name="us-gaap:MalpracticeLossContingencyAccrualUndiscounted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfMTA2MzQ_2f4530c4-57c3-41ce-ac62-fc5cd08c135c">168</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="-6" name="us-gaap:MalpracticeLossContingencyAccrualUndiscounted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfMTA2NDE_12a25e94-25bc-4856-9312-ae489d89d168">169</ix:nonFraction> million as of March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;While the basis for claims reserves is actuarially determined losses based upon the Company's historical and projected loss experience, the process of analyzing, assessing and establishing reserve estimates relative to these types of claims involves a high degree of judgment.  Although the Company believes that its present reserves and insurance coverage are sufficient to cover currently estimated exposures, it is possible that the Company may incur liabilities in excess of its recorded reserves or insurance coverage.  Changes in the facts and circumstances associated with claims could have a material impact on the Company&#8217;s results of operations (principally costs of services), cash flows and financial condition in the period that reserve estimates are adjusted or paid.</span></div></ix:continuation><div><span><br/></span></div><div id="i1aa6fd61af824301a74dfe106295204d_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RleHRyZWdpb246ZGMyZTc4MzEyMjA1NGU3ZWJiOTQ2MmUwZWI0MWVmMDFfMjQxNw_26490bbe-d70d-41a6-9adc-8bfdc65c3247" continuedAt="i892d8fa7cdc646c2a9f9a5f267973545" escape="true">BUSINESS SEGMENT INFORMATION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i892d8fa7cdc646c2a9f9a5f267973545" continuedAt="ia4e20346bc6d4ae68513735ce30128e4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, customers, and ACOs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than <ix:nonFraction unitRef="number" contextRef="i92e626d8b4994af79d894bbd7fca8a13_D20230101-20230331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RleHRyZWdpb246ZGMyZTc4MzEyMjA1NGU3ZWJiOTQ2MmUwZWI0MWVmMDFfODAz_6244e8db-3a26-4ec5-9914-326a572ccd89"><ix:nonFraction unitRef="number" contextRef="ieb2184019e3a41bba34f394de7b2cfc9_D20220101-20220331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RleHRyZWdpb246ZGMyZTc4MzEyMjA1NGU3ZWJiOTQ2MmUwZWI0MWVmMDFfODAz_e8eea003-fa12-435b-9430-61d699cf2090">95</ix:nonFraction></ix:nonFraction>% of net revenues in 2023 and 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ia4e20346bc6d4ae68513735ce30128e4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of March&#160;31, 2023, substantially all of the Company&#8217;s services were provided within the United States, and substantially all of the Company&#8217;s assets were located within the United States.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RleHRyZWdpb246ZGMyZTc4MzEyMjA1NGU3ZWJiOTQ2MmUwZWI0MWVmMDFfMjQwMA_476f4162-e6fa-45ba-b356-c67f577b14cd" continuedAt="i94593a3bdf0d4475bb13aa87db44bca3" escape="true">The following table is a summary of segment information for the three months ended March&#160;31, 2023 and 2022.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2022 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i94593a3bdf0d4475bb13aa87db44bca3"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.590%"><tr><td style="width:1.0%"></td><td style="width:77.107%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.411%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ed346c5690e4ddc8d0b23a92ec0f7f2_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMy0xLTEtMS05NjkwMA_7ea34d8f-857c-422f-ba19-c93edd2821d9">2,259</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd1a321696c48c5be41b31ca63c5571_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMy0zLTEtMS05NjkwMA_9fe57965-a31d-4644-9ed5-d8c9710ef1ad">2,541</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd435f0f382f4a7885ef56b501114dd0_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfNC0xLTEtMS05NjkwMA_8cbe9f12-2eb3-4331-937b-10ad8e5c29d5">72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3973c12fa954740845e01c52214f022_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfNC0zLTEtMS05NjkwMA_72acc59f-8617-46b9-bf1f-5152af1e4ff9">70</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfNS0xLTEtMS05NjkwMA_9c3294f1-244a-42a0-ad97-6a744508a51f">2,331</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfNS0zLTEtMS05NjkwMA_39652455-5355-443f-b6d2-746bfe236a44">2,611</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ed346c5690e4ddc8d0b23a92ec0f7f2_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfOC0xLTEtMS05NjkwMA_df2d1994-2413-46d0-ad2e-6ad109194e14">374</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd1a321696c48c5be41b31ca63c5571_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfOC0zLTEtMS05NjkwMA_558f9918-625c-4cea-bdfd-34ab0af03ccb">562</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd435f0f382f4a7885ef56b501114dd0_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfOS0xLTEtMS05NjkwMA_777a33f4-c220-4fcd-8b07-b542317feafd">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3973c12fa954740845e01c52214f022_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfOS0zLTEtMS05NjkwMA_892314cd-eb44-49a7-aac1-a6be2852838d">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b6d35b5d67546ce9f6822c84cfcf9e5_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTAtMS0xLTEtOTY5MDA_2e52d3f2-100f-4c74-9dfd-883a5d1404d7">77</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61ed8ec37ceb4a73a0b35d0de8357758_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTAtMy0xLTEtOTY5MDA_0780416c-e761-4a2d-9e25-d32ed9738424">56</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTEtMS0xLTEtOTY5MDA_18c66df8-a1f6-489c-a35c-2ec354f0a920">305</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTEtMy0xLTEtOTY5MDA_365c5cc5-b9c1-46f5-8127-bf1005e33b7f">513</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTItMS0xLTEtOTY5MDA_168294cb-3698-4e49-9683-3322e7866ba5">28</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTItMy0xLTEtOTY5MDA_55c07ae5-4a46-48b5-8900-ca7f4390ca43">61</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTMtMS0xLTEtOTY5MDA_f2895cce-8b69-4ff6-9c36-75da7fb02dc3">277</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTMtMy0xLTEtOTY5MDA_d04eb703-e5ba-422e-aaf1-0a0675ca7d25">452</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTQtMS0xLTEtOTY5MDA_c1198e97-480d-415a-bad7-96c909d70023">65</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTQtMy0xLTEtOTY5MDA_627d4470-395f-44ff-b48b-c7ffcf9f763c">110</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTUtMS0xLTEtOTY5MDA_d9fe4ec0-8848-4a56-8b75-d72c31863ec7">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTUtMy0xLTEtOTY5MDA_d2a78198-e39e-4d06-9fcb-506fdc78aba8">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTgtMS0xLTEtOTY5MDA_20176249-567a-4f20-9ab1-c8ec894a2ed6">217</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTgtMy0xLTEtOTY5MDA_0fe2eeb7-9c36-407b-a93a-32fd365171e0">373</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTktMS0xLTEtOTY5MDA_1c7a5c80-98d4-4375-8450-c00f315e9bd8">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTktMy0xLTEtOTY5MDA_b081c97f-a899-49b2-b10d-39398f733fa4">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMjAtMS0xLTEtOTY5MDA_d79fe2ef-8f40-4373-8b66-566ed803c96e">202</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMjAtMy0xLTEtOTY5MDA_4ff9adf0-a1b6-41bf-8143-a95a86e355a0">355</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The approximate percentage of net revenues <ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dgx:ScheduleOfRevenuesByMajorServiceTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RleHRyZWdpb246ZGMyZTc4MzEyMjA1NGU3ZWJiOTQ2MmUwZWI0MWVmMDFfMjQwNQ_bf5cd59f-5d62-48c3-8ce5-d3793eb7bb5e" continuedAt="i15dcefc9ee0f4adab86798c73ed21d34" escape="true">by major service for the three months ended March&#160;31, 2023 and 2022 were as follows:</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><ix:continuation id="i15dcefc9ee0f4adab86798c73ed21d34"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"></td><td style="width:77.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.396%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing and other services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6f57bd433a114ad99ef7c771bd566d82_D20230101-20230331" decimals="2" name="dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfMy0xLTEtMS05NjkwMA_d61f5812-5e07-4173-9149-2c04ac4926f8">49</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib70af9ca8a1f4946a10a38788730eceb_D20220101-20220331" decimals="2" name="dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfMy0zLTEtMS05NjkwMA_a8d53a06-b0ab-4cf1-a868-79ad5d1d59e6">41</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e58a48918dd4becb0dd4cc40ca69a88_D20230101-20230331" decimals="2" name="dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfNC0xLTEtMS05NjkwMA_1df56b5b-ce77-4353-b6d2-976d1a206c62">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5597494df62b463093771d2b719b6894_D20220101-20220331" decimals="2" name="dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfNC0zLTEtMS05NjkwMA_0158201d-f047-449f-9494-0bf5b9fcde4d">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6d860d57e4ad449a887c67967f28d5d6_D20230101-20230331" decimals="2" name="dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfNS0xLTEtMS05NjkwMA_89afdb90-6ea7-4396-b8d1-ed52e3ad2180">37</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ied62521cf257403a89d19d00c5aa5abe_D20220101-20220331" decimals="2" name="dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfNS0zLTEtMS05NjkwMA_af468a6c-46ac-44eb-84e7-d7cf08a18219">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia2a765cc64784441973b1aec2bd7c985_D20230101-20230331" decimals="2" name="dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfNi0xLTEtMS05NjkwMA_03816a83-033e-4502-af2e-0816d8dde34e">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7cdf174765f04a2f86be3ef952803845_D20220101-20220331" decimals="2" name="dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfNi0zLTEtMS05NjkwMA_b84b48d8-bd1e-4b23-a2d8-75f1e8df75ac">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i85e225a2df9640b3ab2e1ea93558ed16_D20230101-20230331" decimals="2" name="dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfNy0xLTEtMS05NjkwMA_fbbe0387-c192-4e00-8ca7-a1e7c2ae9c87">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia7a6fd94d88447269386a6a9f798ce52_D20220101-20220331" decimals="2" name="dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfNy0zLTEtMS05NjkwMA_59207cb0-30f4-4acd-9e05-068d97852119">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="INF" name="dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfOC0xLTEtMS05NjkwMA_dbdf44b3-bfe5-434b-be32-d2f849da8391">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="INF" name="dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfOC0zLTEtMS05NjkwMA_8381d561-39dd-4d71-b8fc-bb46d9a12660">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i1aa6fd61af824301a74dfe106295204d_67"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RleHRyZWdpb246ZDQ5MTZiNmZiNTA0NDQ1YjhjYTI0ZjM3YWM0ZGVmYWZfMTYwOQ_518f764c-c13c-42b4-8aa4-5f4f72d74c31" continuedAt="i5a060c1df794421885dc26993f317a88" escape="true">REVENUE RECOGNITION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i5a060c1df794421885dc26993f317a88" continuedAt="iaa43779f349447bc89843e4c596ed71f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DIS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues in the Company&#8217;s DIS business accounted for over <ix:nonFraction unitRef="number" contextRef="ieb2184019e3a41bba34f394de7b2cfc9_D20220101-20220331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RleHRyZWdpb246ZDQ5MTZiNmZiNTA0NDQ1YjhjYTI0ZjM3YWM0ZGVmYWZfOTk_1e97840b-258e-4fa5-9c14-9ce5544c988b"><ix:nonFraction unitRef="number" contextRef="i92e626d8b4994af79d894bbd7fca8a13_D20230101-20230331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RleHRyZWdpb246ZDQ5MTZiNmZiNTA0NDQ1YjhjYTI0ZjM3YWM0ZGVmYWZfOTk_34b6fc44-e4d2-4d4f-a403-119d726910f4">95</ix:nonFraction></ix:nonFraction>% of the Company&#8217;s total net revenues for the three months ended March&#160;31, 2023 and 2022 and are primarily comprised of a high volume of relatively low-dollar transactions. The DIS business, which provides clinical testing services and other services, satisfies its performance obligations and recognizes revenues primarily upon completion of the testing process (when results are reported) or when services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers (Medicare and Medicaid programs), client payers and patients.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding revenue recognition in the Company's DIS business, see Note 3 to the audited consolidated financial statements in the Company's 2022 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company&#8217;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Revenue and Net Accounts Receivable by Customer Type</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RleHRyZWdpb246ZDQ5MTZiNmZiNTA0NDQ1YjhjYTI0ZjM3YWM0ZGVmYWZfMTYxMw_c25839ee-2dc0-4d31-85cf-49754de0a4f8" continuedAt="i3fecc23d1ba1425089c8de412a9f671c" escape="true">The approximate percentage of net revenue by type of customer was as follows:</ix:nonNumeric></span></div><ix:continuation id="i3fecc23d1ba1425089c8de412a9f671c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2a00ddd1f78d4eabbd3eec75dce18984_D20230101-20230331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfMy0xLTEtMS05NjkwMA_0ac80248-8192-432c-97b8-ae9ab3fc00ff">37</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i355eb3cfa48643c89a8544abcf920805_D20220101-20220331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfMy0zLTEtMS05NjkwMA_4ed5cc87-47c4-42cf-8f48-8f0fecec932f">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6cc506733bc54c4c939d04e93b12a019_D20230101-20230331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfNC0xLTEtMS05NjkwMA_f2175ae9-ca2d-40c9-b468-b76a73c2fc6d">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5ba6898f5dce4da790f1d70a1becead8_D20220101-20220331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfNC0zLTEtMS05NjkwMA_a7b35ebf-ff81-4ab2-90cc-7b5639d38d6a">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia5513c4320b84b8187a84d0c7bb3c2e7_D20230101-20230331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfNS0xLTEtMS05NjkwMA_34b8ae70-6206-4ead-b375-3195beb07fa3">40</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3dadd8bb7e9b49f1a84da6abd44b2b54_D20220101-20220331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfNS0zLTEtMS05NjkwMA_8ebf36a3-7554-48ac-9cb2-ce0194fb0cdf">41</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icfc7432b93a741d59d3b948cc6fd7457_D20230101-20230331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfNi0xLTEtMS05NjkwMA_42a77e70-ec7f-45d9-97c2-f8e13feebe89">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i23e66b0f67b94bb2b097b5144c24e807_D20220101-20220331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfNi0zLTEtMS05NjkwMA_11c8d280-ded8-4f16-b616-6c00bb3b087b">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie21be809ef3c4dcbbd5ed7e71d98fbd4_D20230101-20230331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfNy0xLTEtMS05NjkwMA_bb9883df-4657-4be7-8005-d01fe823d93f">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3c6c0ad027434a8e877b0382b926c96d_D20220101-20220331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfNy0zLTEtMS05NjkwMA_816c0dee-81c8-42cf-84f0-ce60ce768b27">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i26268270d1b14e71a865a97e2c5c435a_D20230101-20230331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfOC0xLTEtMS05NjkwMA_1a98f17e-feba-4464-856d-5a9581a8e828">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie11d9750588e417cb37a21a52c132fcd_D20220101-20220331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfOC0zLTEtMS05NjkwMA_1e33ee74-0f04-41b1-82f2-acde30d5e34f">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8ed346c5690e4ddc8d0b23a92ec0f7f2_D20230101-20230331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfOS0xLTEtMS05NjkwMA_c22ac3ce-d68c-4683-b5a5-7bcdeceb2d2a">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2dd1a321696c48c5be41b31ca63c5571_D20220101-20220331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfOS0zLTEtMS05NjkwMA_0080c160-2a7e-44e0-9802-1b6250a27270">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i772cad9a0b3d4082b300fc534f745257_D20230101-20230331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfMTAtMS0xLTEtOTY5MDA_122ca230-b3fa-4044-ae9f-33e9526e98d5">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i61a15314b5e742e0b281c2024f9d2632_D20220101-20220331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfMTAtMy0xLTEtOTY5MDA_10b7885c-b427-482c-b2d6-917bf42dcebb">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfMTEtMS0xLTEtOTY5MDA_59ee42d3-ea7b-4086-b20e-a93918f8b5ba">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfMTEtMy0xLTEtOTY5MDA_4a20eb61-d0c5-476b-8689-817dcfa0318c">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="dgx:AccountsReceivableDisaggregationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RleHRyZWdpb246ZDQ5MTZiNmZiNTA0NDQ1YjhjYTI0ZjM3YWM0ZGVmYWZfMTYwNw_d23919a1-dfbe-473c-82ac-002c7f8480b3" continuedAt="i5ff17e67af2245af90d577171e6eb112" escape="true">The approximate percentage of net accounts receivable by type of customer was as follows:</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="iaa43779f349447bc89843e4c596ed71f"><ix:continuation id="i5ff17e67af2245af90d577171e6eb112"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Insurers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if148e27d61634341a1c6b7a4d2b7f1ed_I20230331" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfMi0xLTEtMS05NjkwMA_42471519-e132-4465-8ec4-a291938d717f">29</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55811dcbf9b144cc912c05f6c566ce5a_I20221231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfMi0zLTEtMS05NjkwMA_8ecc3636-fe80-49cd-ad00-f286b82ba972">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifa6205a62b6b4428bd03ee3946847d9b_I20230331" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfMy0xLTEtMS05NjkwMA_6ca9ec2d-afc8-4cef-ab76-7c1de4c52432">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i86ad2c45fc2c42a69d24854e11d851c2_I20221231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfMy0zLTEtMS05NjkwMA_147bfb0a-10a1-4e3a-8015-d4715021612d">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e102be4f8254b1dbbc70aa3bdc19865_I20230331" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfNC0xLTEtMS05NjkwMA_59183cad-8015-435a-b73b-97d619031c23">43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic4911193ea2f4d57910161a9d6712993_I20221231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfNC0zLTEtMS05NjkwMA_99e22a22-1651-4277-b9b3-bcfa0e9c0297">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9ffb964e5c344410af806c81f53963c1_I20230331" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfNS0xLTEtMS05NjkwMA_35311648-68ce-47c4-8d92-b714add980cd">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6029d63b27f74dce9c2c1865b3c36922_I20221231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfNS0zLTEtMS05NjkwMA_a733bf39-9751-4c88-8a24-e238b1feb1ef">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib21559178668493e8f63bc406234ef9d_I20230331" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfNi0xLTEtMS05NjkwMA_277e2bd0-c66d-43f5-87b8-d5ddbf7dc575">96</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6e2af1eeb8384a619b904007a6cb8f29_I20221231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfNi0zLTEtMS05NjkwMA_0c4479b8-0840-4eb8-8bfc-fd293823430e">96</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03db1044dc514a8eae7a1f57881a63d3_I20230331" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfNy0xLTEtMS05NjkwMA_4c910bec-5e27-4fbc-a143-486e11ebb8e9">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i552e3aecfd8f4491b6039419f80524b3_I20221231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfNy0zLTEtMS05NjkwMA_f9cf71c1-1533-4bfc-a456-80a05109b049">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i62a8002be6c545879eef8e9350936b33_I20230331" decimals="INF" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfOC0xLTEtMS05NjkwMA_48c2e7da-251c-4f95-a82b-03a04a1a70bf">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231" decimals="INF" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfOC0zLTEtMS05NjkwMA_7096997d-0908-4736-94df-453ef4d8238c">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div><span><br/></span></div><div id="i1aa6fd61af824301a74dfe106295204d_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF83MC9mcmFnOjQ5NDc1NGYzNGU1NDRjZjZiNmUxNDE3N2RlZGFkMWExL3RleHRyZWdpb246NDk0NzU0ZjM0ZTU0NGNmNmI2ZTE0MTc3ZGVkYWQxYTFfNTIy_099b8895-3bcf-450d-946c-1d4dabb10f47" continuedAt="idbb2c08611f4444bba8335852b148839" escape="true">TAXES ON INCOME</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idbb2c08611f4444bba8335852b148839">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023 and 2022, the effective income tax rate was <ix:nonFraction unitRef="number" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF83MC9mcmFnOjQ5NDc1NGYzNGU1NDRjZjZiNmUxNDE3N2RlZGFkMWExL3RleHRyZWdpb246NDk0NzU0ZjM0ZTU0NGNmNmI2ZTE0MTc3ZGVkYWQxYTFfOTc_931332af-92e1-4568-9e94-0e1695e19e1f">23.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF83MC9mcmFnOjQ5NDc1NGYzNGU1NDRjZjZiNmUxNDE3N2RlZGFkMWExL3RleHRyZWdpb246NDk0NzU0ZjM0ZTU0NGNmNmI2ZTE0MTc3ZGVkYWQxYTFfMTA0_3597b965-da7b-4855-9805-1ad09e91e170">24.4</ix:nonFraction>%, respectively.  The effective income tax rates benefited from $<ix:nonFraction unitRef="usd" contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF83MC9mcmFnOjQ5NDc1NGYzNGU1NDRjZjZiNmUxNDE3N2RlZGFkMWExL3RleHRyZWdpb246NDk0NzU0ZjM0ZTU0NGNmNmI2ZTE0MTc3ZGVkYWQxYTFfMTA5OTUxMTYyODQ4OA_0c1e1065-43c5-4ab1-9ed3-d6a12b9c9a28"><ix:nonFraction unitRef="usd" contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF83MC9mcmFnOjQ5NDc1NGYzNGU1NDRjZjZiNmUxNDE3N2RlZGFkMWExL3RleHRyZWdpb246NDk0NzU0ZjM0ZTU0NGNmNmI2ZTE0MTc3ZGVkYWQxYTFfMTA5OTUxMTYyODQ4OA_c1cfeb64-b019-431c-94ff-00fa3529118a">5</ix:nonFraction></ix:nonFraction> million of excess tax benefits associated with stock-based compensation arrangements for both the three months ended March&#160;31, 2023 and 2022.</ix:continuation></span></div><div id="i1aa6fd61af824301a74dfe106295204d_73"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF83My9mcmFnOmVhOGZmMGU2MWY5ODQ5Zjc5NDQ2NjdmNTJlYzUwYzQwL3RleHRyZWdpb246ZWE4ZmYwZTYxZjk4NDlmNzk0NDY2N2Y1MmVjNTBjNDBfMTA0Mg_a1727816-cd14-4865-8a9b-ed22d852513f" continuedAt="ib8f7a03b981d4d3c90b282136a5e8829" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ib8f7a03b981d4d3c90b282136a5e8829"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On April 17, 2023, the Company completed the previously announced acquisition of select assets of the laboratory services business of New York-Presbyterian, which serves providers and patients in New York, as well as the Tri-State Area and beyond, in an all-cash transaction for $<ix:nonFraction unitRef="usd" contextRef="i9b19a5afa8014eac9ccbf727527f2ea6_D20230417-20230417" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF83My9mcmFnOmVhOGZmMGU2MWY5ODQ5Zjc5NDQ2NjdmNTJlYzUwYzQwL3RleHRyZWdpb246ZWE4ZmYwZTYxZjk4NDlmNzk0NDY2N2Y1MmVjNTBjNDBfMzI5ODUzNDg4NjE2Mw_31dc8f75-a829-43a5-9079-83fe419a2c39">275</ix:nonFraction>&#160;million.  The acquisition will be accounted for as a business combination.  The Company is in the process of completing the preliminary purchase price allocation of the assets acquired and liabilities assumed. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;During April 2023, the Company announced that it had entered into a definitive agreement to acquire Haystack Oncology, Inc., an early-stage oncology company focused on minimal residual disease testing to aid in the early, accurate detection of residual or recurring cancer and better inform therapy decisions.  Under the terms of the agreement, the Company would pay approximately $<ix:nonFraction unitRef="usd" contextRef="i9c77555441f446579e41076eec2f33b5_D20230401-20230428" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF83My9mcmFnOmVhOGZmMGU2MWY5ODQ5Zjc5NDQ2NjdmNTJlYzUwYzQwL3RleHRyZWdpb246ZWE4ZmYwZTYxZjk4NDlmNzk0NDY2N2Y1MmVjNTBjNDBfMzI5ODUzNDg4ODgxMQ_fa594fac-9c30-428b-80d5-573fcd23df93">300</ix:nonFraction>&#160;million in cash at closing, net of cash acquired.  Additionally, it would pay up to $<ix:nonFraction unitRef="usd" contextRef="i1280f4be54c54da0986529d7da684b6d_I20230428" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF83My9mcmFnOmVhOGZmMGU2MWY5ODQ5Zjc5NDQ2NjdmNTJlYzUwYzQwL3RleHRyZWdpb246ZWE4ZmYwZTYxZjk4NDlmNzk0NDY2N2Y1MmVjNTBjNDBfMzI5ODUzNDg4ODgzMQ_8187177f-aa0a-4f6a-ab8b-859fdbff4b6f">150</ix:nonFraction>&#160;million of additional consideration, which is contingent upon achieving future performance milestones and which is not expected to be paid during 2023.  The transaction is expected to close during the second quarter of 2023 and remains subject to customary closing conditions. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company expects to fund the cash at closing for the acquisitions noted above through a combination of cash on hand and borrowings under the Company's existing credit facilities.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i1aa6fd61af824301a74dfe106295204d_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Company </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diagnostic Information Services</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quest Diagnostics empowers people to take action to improve health outcomes.  We use our extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.  Our diagnostic information services business ("DIS") provides information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  We provide services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, consumers, and accountable care organizations ("ACOs").  We offer the broadest access in the United States to diagnostic information services through our nationwide network of laboratories, patient service centers and phlebotomists in physician offices and our connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  We are the world's leading provider of diagnostic information services.  We provide interpretive consultation with one of the largest medical and scientific staffs in the industry.  Our DIS business makes up greater than 95% of our consolidated net revenues.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We assess our revenue performance for the DIS business based upon, among other factors, volume (measured by test requisitions) and revenue per requisition. Each requisition accompanies patient specimens, indicating the test(s) to be performed and the party to be billed for the test(s).  Revenue per requisition is impacted by various factors, including, among other items, the impact of fee schedule changes (i.e., unit price), test mix, payer mix, and the number of tests per requisition. Management uses number of requisitions and revenue per requisition data to assist with assessing the growth and performance of the business, including understanding trends affecting number of requisitions, pricing and test mix.  Therefore, we believe that information related to changes in these metrics from period to period are useful information for investors as it allows them to assess the performance of the business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Diagnostic Solutions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In our Diagnostic Solutions ("DS") businesses, which represent the balance of our consolidated net revenues, we offer a variety of solutions for life insurers and healthcare organizations and clinicians.  We are the leading provider of risk assessment services for the life insurance industry.  In addition, we offer healthcare organizations and clinicians robust information technology solutions.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">First Quarter Highlights</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:60.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.578%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(dollars in millions, except per share data)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,331</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,611</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Base business revenues (a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,212</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,012</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$119</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$599</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,259</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,541</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue per requisition change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7.7)%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Requisition volume change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.8)%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic requisition volume change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.9)%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$72</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$70</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$305</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$513</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$202</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$355</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.78</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.92</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$94</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$480</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$127</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$63</span></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Excludes COVID-19 testing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impacts that the COVID-19 pandemic had on our DIS revenues, including requisition volume and revenue per requisition are discussed further below under "Results of Operations".</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further discussion of the year-over-year changes for the three months ended March&#160;31, 2023 compared to the three months ended March&#160;31, 2022, see "Results of Operations" below.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Invigorate Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are engaged in a multi-year program called Invigorate, which is designed to reduce our cost structure and improve our performance.  We currently aim annually to achieve savings and productivity improvements of approximately 3% of our costs, which we believe will help offset pressures from the current inflationary environment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Invigorate has consisted of several flagship programs, with structured plans in each, to drive savings and improve performance across the customer value chain. These flagship programs include: organization excellence; information technology excellence; procurement excellence; field and customer service excellence; lab excellence; and revenue services excellence. In addition to these programs, we have identified key themes to change how we operate including reducing denials and patient price concessions; further digitizing our business; standardization; automation and artificial intelligence; optimization and selecting and retaining talent. We believe that our efforts to standardize our information technology systems, equipment and data also foster our efforts to strengthen our foundation for growth and support the value creation initiatives of our clinical franchises by enhancing our operational flexibility, empowering and enhancing the customer experience, facilitating the delivery of actionable insights and bolstering our large data platform.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023, we incurred $19&#160;million of pre-tax charges in connection with our Invigorate program and other restructuring activities, including $15 million of employee separation costs, with the remainder primarily consisting of systems conversion and integration costs.  Most of the charges will result in cash expenditures.  Additional restructuring charges may be incurred in future periods, including as we identify additional opportunities to achieve further savings and productivity improvements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;There have been no significant changes to our critical accounting policies from those disclosed in our 2022 Annual Report on Form 10-K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of New Accounting Standards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adoption of new accounting standards, if any, is discussed in Note 2 to the interim unaudited consolidated financial statements.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The impact of recent accounting pronouncements not yet effective on our consolidated financial statements, if any, is also discussed in Note 2 to the interim unaudited consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span><br/></span></div><div id="i1aa6fd61af824301a74dfe106295204d_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following tables set forth certain results of operations data for the periods presented:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(dollars in millions, except per share amounts)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,259&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,541&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS businesses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,331&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(280)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,560&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,026&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,098&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-operating expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings per common share attributable to Quest Diagnostics' common stockholders</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.92&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM - Not Meaningful</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain results of operations data as a percentage of net revenues for the periods presented:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.844%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS businesses </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net </span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.9&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.3&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Results</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Results for the three months ended March&#160;31, 2023 were affected by certain items that on a net basis decreased diluted earnings per share by $0.26 as follows:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $26 million recorded in amortization of intangible assets or $0.17 per diluted share;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $19 million ($10 million in cost of services and $9 million in selling, general and administrative expenses), or $0.12 per diluted share, primarily associated with workforce reductions, systems conversions and integration incurred in connection with further restructuring and integrating our business; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $3 million in equity in earnings of equity method investees, net of tax, or $0.02 per diluted share, representing net losses associated with changes in the carrying value of our strategic investments; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $5 million, or $0.05 per diluted share, recorded in income tax expense.</span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023, diluted earnings per share benefited from the impact of share repurchases during 2022 on our weighted average shares outstanding as compared to the prior year period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Results for the three months ended March&#160;31, 2022 were affected by certain items that on a net basis decreased diluted earnings per share by $0.30 as follows:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $27 million recorded in amortization of intangible assets or $0.16 per diluted share;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $16 million in other income (expense), net, or $0.10 per diluted share, representing net losses associated with changes in the carrying value of our strategic investments; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $12 million ($3 million in cost of services and $9 million in selling, general and administrative expenses), or $0.07 per diluted share, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating our business; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $2 million in selling, general and administrative, or $0.01 per diluted share, primarily representing costs associated with donations, contributions and other financial support through Quest for Health Equity (our initiative with the Quest Diagnostics Foundation to reduce health disparities in underserved communities); partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $5 million, or $0.04 per diluted share, recorded in income tax expense.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Revenues</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues for the three months ended March&#160;31, 2023 decreased by 10.7% compared to the prior year period. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;DIS revenues for the three months ended March&#160;31, 2023 decreased by 11.1% compared to the prior year period.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The decrease in revenue compared to the prior year period was driven by a decrease in COVID-19 testing, partially offset by growth in the base business (which excludes COVID-19 testing) and, to a lesser extent, the impact of recent acquisitions.  For the three months ended March&#160;31, 2023, recent acquisitions contributed approximately 0.2% to DIS revenues.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">DIS volume decreased by 3.8% compared to the prior year period driven by a decrease in COVID-19 testing, partially offset by growth in the base business and the impact of recent acquisitions, which contributed approximately 0.1% to DIS volume.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue per requisition decreased by 7.7% compared to the prior year period driven by the decrease in COVID-19 molecular testing.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues in the base business (including the impact of recent acquisitions) increased by 10.3% compared to the prior year period.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Testing volume in the base business (including the impact of recent acquisitions) was up 7.9% compared to the prior year period.  We believe that our base testing volume was negatively impacted in the first quarter of 2022 by the surge in COVID-19 associated with the spread of the Omicron variant.  We estimate that the recovery of our base testing volumes due to the easier compare accounted for approximately 4% of our total base testing volume growth during the first quarter of 2023.  </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue per requisition in the base business increased by 2.3% compared to the prior year period principally due to an increase in the number of tests per requisition and changes in test mix and payer mix.</span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;DS revenues for the three months ended March&#160;31, 2023 increased by 2.3% compared to the prior year period primarily due to higher revenues associated with our risk assessment services offered to the life insurance industry.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Services</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cost of services consists principally of costs for obtaining, transporting and testing specimens as well as facility costs used for the delivery of our services.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023, cost of services decreased by $86 million compared to the prior year period.  The decrease was primarily driven by lower supplies and collection expenses associated with reduced COVID-19 testing volumes, partially offset by higher compensation and benefits costs (primarily related to wage increases).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative Expenses ("SG&amp;A")</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;SG&amp;A consist principally of the costs associated with our sales and marketing efforts, billing operations, credit loss expense and general management and administrative support as well as administrative facility costs.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;SG&amp;A increased by $14 million for the three months ended March&#160;31, 2023 compared to the prior year period primarily due to higher costs associated with changes in the value of our deferred compensation obligations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The changes in the value of our deferred compensation obligations is largely offset by changes in the value of the associated investments, which are recorded in other income (expense), net.  For further details regarding our deferred compensation plans, see Note 18 to the audited consolidated financial statements included in our 2022 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Amortization Expense</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023, amortization expense was principally consistent with the prior year period.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Interest Expense, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023, interest expense, net decreased by $2&#160;million compared to the prior year period due to increased interest income resulting from the impact of rising interest rates on our cash and cash equivalents. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Other Income (Expense), Net </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other income (expense), net represents miscellaneous income and expense items related to non-operating activities, such as gains and losses associated with investments and other non-operating assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023, other income (expense), net included $7 million of gains associated with investments in our deferred compensation plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022, other income (expense), net included $16 million of losses associated with changes in the carrying value of our strategic investments and $8&#160;million of losses associated with investments in our deferred compensation plans.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Income Tax Expense </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Income tax expense for the three months ended March&#160;31, 2023 and 2022 was $65 million and $110 million, respectively.  The decrease in income tax expense for the three months ended March&#160;31, 2023 compared to the prior year period was primarily driven by a decrease in income before income taxes and equity in earnings of equity method investees.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The effective income tax rates for the three months ended March 31, 2023 and 2022 were 23.6% and 24.4%, respectively. The effective income tax rate benefited from $5 million of excess tax benefits associated with stock-based compensation arrangements for both the three months ended March&#160;31, 2023 and 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity in Earnings of Equity Method Investees, Net of Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Equity in earnings of equity method investees, net of taxes decreased for the three months ended March&#160;31, 2023 by $26 million compared to the prior year period primarily due to lower demand for COVID-19 testing services at our diagnostic information services joint venture.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i1aa6fd61af824301a74dfe106295204d_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We address our exposure to market risks, principally the risk of changes in interest rates, through a controlled program of risk management that includes the use of derivative financial instruments.  We do not hold or issue derivative financial instruments for speculative purposes.  We seek to mitigate the variability in cash outflows that result from changes in interest rates by maintaining a balanced mix of fixed-rate and variable-rate debt obligations.  In order to achieve this objective, we have historically entered into interest rate swap agreements.  Interest rate swap agreements involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements are recognized as an adjustment to interest expense, net.  We believe that our exposures to foreign exchange impacts and changes in commodity prices are not material to our consolidated results of operations, financial position or cash flows. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of March&#160;31, 2023 and December&#160;31, 2022, the fair value of our debt was estimated at approximately $3.8 billion and $3.7 billion, respectively, principally using quoted prices in active markets and yields for the same or similar types of borrowings, taking into account the underlying terms of the debt instruments.  As of March&#160;31, 2023 and December&#160;31, 2022, the estimated fair value was less than the carrying value of the debt by $215&#160;million and $318&#160;million, respectively.  A hypothetical 10% increase in interest rates (representing 49 basis points as of March&#160;31, 2023 and 51 basis points as of December&#160;31, 2022) would potentially reduce the estimated fair value of our debt by approximately $114&#160;million and $120&#160;million as of March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Borrowings under our secured receivables credit facility and our senior unsecured revolving credit facility are subject to variable interest rates.  As of March&#160;31, 2023, interest on our secured receivables credit facility is based on either commercial paper rates for highly rated issuers, or the Term Secured Overnight Financing Rate ("Term SOFR"), plus a spread.  As of March&#160;31, 2023, interest on our senior unsecured revolving credit facility is based on certain published rates plus an applicable margin based on changes in our public debt ratings. As such, our borrowing cost under this credit arrangement is subject to fluctuations in interest rates and changes in our public debt ratings.  As of March&#160;31, 2023, the borrowing rates under these debt instruments were: for our secured receivables credit facility, commercial paper rates for highly-rated issuers or adjusted Term SOFR, plus a spread of 0.725% to 0.80%; and for our senior unsecured revolving credit facility, adjusted Term SOFR, plus 1.00%.  As of March&#160;31, 2023, there were no borrowings outstanding under either credit facility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A hypothetical 10% change to the variable rate component of our variable rate indebtedness would not materially change our annual interest expense. &#160;&#160;&#160;&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding our outstanding debt, see Note 7 to the interim unaudited consolidated financial statements and Note 14 to the audited consolidated financial statements included in our 2022 Annual Report on Form 10-K.  For details regarding our financial instruments and hedging activities, see Note 8 to the interim unaudited consolidated financial statements and Note 16 to the audited consolidated financial statements included in our 2022 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Associated with Investment Portfolio</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our investment portfolio primarily includes equity investments comprised mostly of strategic holdings in companies concentrated in the life sciences and healthcare industries.  Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) with readily determinable fair values are measured at fair value in prepaid expenses and other current assets in our consolidated balance sheet with changes in fair value recorded in current earnings in our consolidated statement of operations.  Equity investments that do not have readily determinable fair values (which consist of investments in preferred and common shares of private companies) are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We regularly evaluate equity investments that do not have readily determinable fair values to determine if there are any indicators that the investments are impaired.  The carrying value of our equity investments that do not have readily determinable fair values was $4&#160;million as of March&#160;31, 2023.  In conjunction with the preparation of our March&#160;31, 2023 financial statements, we considered whether the carrying values of our investments were impaired and concluded that no such impairment existed.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We do not hedge our equity price risk.  The impact of an adverse movement in equity prices on our holdings in privately held companies cannot be easily quantified as our ability to realize returns on investments depends on, among other things, the enterprises&#8217; ability to raise additional capital or derive cash inflows from continuing operations or through liquidity events such as initial public offerings, mergers or private sales. </span></div><div><span><br/></span></div><div id="i1aa6fd61af824301a74dfe106295204d_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(386)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(471)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents and restricted cash</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents </span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cash and cash equivalents consist of cash and highly-liquid short-term investments with original maturities, at the time of acquisition, of three months or less.  Cash and cash equivalents as of March&#160;31, 2023 totaled $175 million, compared to $315 million as of December&#160;31, 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of March&#160;31, 2023, approximately 20% of our $175 million of consolidated cash and cash equivalents were held outside of the United States.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Operating Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash provided by operating activities for the three months ended March&#160;31, 2023 and 2022 was $94 million and $480 million, respectively.  The $386 million decrease in net cash provided by operating activities for the three months ended March&#160;31, 2023, compared to the prior year period, was primarily a result of:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lower operating income in 2023 as compared to 2022; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher payments associated with an additional payroll cycle in 2023 as compared to 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Days sales outstanding, a measure of billing and collection efficiency, was 47 days as of March&#160;31, 2023, 47 days as of December&#160;31, 2022 and 49 days as of March&#160;31, 2022.   </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Investing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash used in investing activities for the three months ended March&#160;31, 2023 and 2022 was $158 million and $169 million, respectively.  This $11 million decrease in net cash used in investing activities for the three months ended March&#160;31, 2023, compared to the prior year period, was primarily a result of less cash used for business acquisitions, principally offset by increased capital expenditures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Financing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash used in financing activities for the three months ended March&#160;31, 2023 and 2022 was $76 million and $471 million, respectively.  This $395 million decrease in net cash used in financing activities for the three months ended March&#160;31, 2023, compared to the prior year period, was primarily a result of a $373 million decrease in repurchases of our common stock and, to a lesser extent, increased proceeds from stock option exercises.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;During the three months ended March&#160;31, 2023, we borrowed $140&#160;million under our secured receivables credit facility, which was repaid prior to March 31, 2023,</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and there were no borrowings or repayments under our senior unsecured revolving credit facility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended March 31, 2022, there were no borrowings or repayments under our secured receivables credit facility or senior unsecured revolving credit facility.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividend Program</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the first quarter of 2023, our Board of Directors declared a quarterly cash dividend of $0.71 per common share. During each of the four quarters of 2022, our Board of Directors declared a quarterly cash dividend of $0.66 per common share. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In February 2023, our Board of Directors increased the size of our share repurchase program by $1&#160;billion.  As of March&#160;31, 2023, $1.3 billion remained available under our share repurchase authorization. The share repurchase authorization has no set expiration or termination date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023, we repurchased no shares of our common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022, we repurchased 2.6 million shares of our common stock for $350 million.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investees</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our equity method investees primarily consist of a diagnostic information services joint venture and an investment in a fund that purchases strategic holdings in private companies in the healthcare industry.  Such investees are accounted for under the equity method of accounting.  Our investment in equity method investees is less than 5% of our consolidated total assets.  Our proportionate share of income before income taxes associated with our equity method investees is less than 5% of our consolidated income before income taxes and equity in earnings of equity method investees.  We have no material unconditional obligations or guarantees to, or in support of, our equity method investees and their operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In conjunction with the preparation of our March&#160;31, 2023 financial statements, we considered whether the carrying values of our equity method investments were impaired and concluded that no such impairment existed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Requirements and Capital Resources </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We estimate that we will invest approximately $400&#160;million during 2023 for capital expenditures, to support and grow our existing operations, principally related to investments in laboratory equipment and facilities, including laboratory automations and information technology to support our diagnostic offerings.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During April 2023, we completed the previously announced acquisition of select assets of the laboratory services business of New York-Presbyterian in an all-cash transaction for $275&#160;million.  Additionally, during April 2023, we announced that we had entered into a definitive agreement to acquire Haystack Oncology, Inc.  Under the terms of the agreement, we would pay approximately $300&#160;million in cash at closing (net of cash acquired), which is expected to occur during the second quarter of 2023.  Additionally, we would pay up to $150&#160;million of additional consideration, which is contingent upon achieving future performance milestones and which is not expected to be paid during 2023. We expect to fund the cash at closing for the acquisitions noted above through a combination of cash on hand and borrowings under our existing credit facilities.  See Note 15 to the interim unaudited consolidated financial statements for further details.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of March&#160;31, 2023, we had $1.2 billion of borrowing capacity available under our existing credit facilities, including $455&#160;million available under our secured receivables credit facility and $750 million available under our senior unsecured revolving credit facility.  There were no borrowings under these credit facilities as of March&#160;31, 2023. In support of our risk management program, $70 million in letters of credit under the secured receivables credit facility were outstanding as of March&#160;31, 2023.  For further details regarding our credit facilities, see Note 7 to the interim unaudited consolidated financial statements and Note 14 to the audited consolidated financial statements in our 2022 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our secured receivables credit facility is subject to customary affirmative and negative covenants, and certain financial covenants with respect to the receivables that comprise the borrowing base and secure the borrowings under the facility. Our senior unsecured revolving credit facility is also subject to certain financial covenants and limitations on indebtedness.  As of March&#160;31, 2023, we were in compliance with all such applicable financial covenants.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have assessed the impact of the cessation of LIBOR and have identified and evaluated financial instruments and other contracts that refer to LIBOR.  We expect to be able to transition all LIBOR based instruments and contracts to an alternative reference rate on or before the cessation of LIBOR and we do not believe that the cessation of LIBOR, or its replacement with an alternative reference rate or rates, will have a material impact on us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We believe that our cash and cash equivalents and cash from operations, together with our borrowing capacity under our credit facilities, will provide sufficient financial flexibility to fund seasonal and other working capital requirements, capital expenditures, debt service requirements and other obligations, cash dividends on common shares, share repurchases and additional growth opportunities, including acquisitions, for the foreseeable future.  However, should it become necessary, we believe that our credit profile should provide us with access to additional financing in order to fund normal business operations, make interest payments, fund growth opportunities and satisfy upcoming debt maturities. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i1aa6fd61af824301a74dfe106295204d_88"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Some statements and disclosures in this document are forward-looking statements.  Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as &#8220;may,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;plan&#8221; or &#8220;continue.&#8221;  These forward-looking statements are based on our current plans and expectations and are subject to a number of risks and uncertainties that could cause our plans and expectations, including actual results, to differ materially from the forward-looking statements.  Risks and uncertainties that may affect our future results include, but are not limited to, adverse results from pending or future government investigations, lawsuits or private actions, the competitive environment, the complexity of billing, reimbursement and revenue recognition for clinical laboratory testing, changes in government regulations, changing relationships with customers, payers, suppliers and strategic partners and other factors discussed in our most recently filed Annual Report on Form 10-K and subsequently filed Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including those discussed in the &#8220;Business,&#8221; &#8220;Risk Factors,&#8221; &#8220;Cautionary Factors that May Affect Future Results&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; sections of those reports.</span></div><div><span><br/></span></div><div id="i1aa6fd61af824301a74dfe106295204d_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Item 2. "Management's Discussion and Analysis of Financial Condition and Results of Operations."</span></div><div><span><br/></span></div><div id="i1aa6fd61af824301a74dfe106295204d_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management, including our Chief Executive Officer and our Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended).  Based upon that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this quarterly report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the first quarter of 2023, there were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended) that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div id="i1aa6fd61af824301a74dfe106295204d_97"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PART II - OTHER INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="i1aa6fd61af824301a74dfe106295204d_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Note 11 to the interim unaudited consolidated financial statements for information regarding the status of legal proceedings involving the Company.</span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i1aa6fd61af824301a74dfe106295204d_103"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The table below sets forth the information with respect to purchases made by or on behalf of the Company of its common stock during the first quarter of 2023.</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.186%"><tr><td style="width:1.0%"></td><td style="width:45.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.560%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ISSUER PURCHASES OF EQUITY SECURITIES</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of<br/>Shares<br/>Purchased</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price<br/>Paid per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of<br/>Shares Purchased<br/>as Part of Publicly<br/>Announced Plans<br/>or Programs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dollar Value of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares that May</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Yet Be Purchased</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Under the Plans</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">or Programs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2023 &#8211; January 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310,909&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1, 2023 - February 28, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310,909&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,978&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2023 &#8211; March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310,909&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,048&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.93&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310,909&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,912&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146.41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">In February 2023, our Board of Directors increased the size of our share repurchase program by $<ix:nonFraction unitRef="usd" contextRef="ia90feb97a113427e947ad9d0fd0a3fa3_D20230201-20230201" decimals="INF" name="dgx:StockRepurchaseProgramAdditionalAmountAuthorized" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMDMvZnJhZzo4YTgxNjFhMzRkYWE0ODFiODRlNTkwMTE4Njg3Zjg2Ni90ZXh0cmVnaW9uOjhhODE2MWEzNGRhYTQ4MWI4NGU1OTAxMTg2ODdmODY2XzMyOQ_4832b951-061d-4070-bbe7-bfbbd358064b">1</ix:nonFraction>&#160;billion.  Since the share repurchase program&#8217;s inception in May 2003, our Board of Directors has authorized $13&#160;billion of share repurchases of our common stock through March&#160;31, 2023.  The share repurchase authorization has no set expiration or termination date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Includes: (1) shares delivered or attested to in satisfaction of the exercise price and/or tax withholding obligations by holders of stock options (granted under the Company&#8217;s Amended and Restated Employee Long-Term Incentive Plan) who exercised options; and (2) shares withheld (under the terms of grants under the Amended and Restated Employee Long-Term Incentive Plan) to offset tax withholding obligations that occur upon the delivery of outstanding common shares underlying restricted stock units and performance share units.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i1aa6fd61af824301a74dfe106295204d_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="-sec-extract:summary;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt">Exhibits </span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Exhibits:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.091%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx03312023ex22.htm">Subsidiary Guarantors of Securities</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx03312023ex311.htm">Rule 13a-14(a) Certification of Chief Executive Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx03312023ex312.htm">Rule 13a-14(a) Certification of Chief Financial Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx03312023ex321.htm">Section 1350 Certification of Chief Executive Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx03312023ex322.htm">Section 1350 Certification of Chief Financial Officer</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx03312023ex991.htm">Amendment No. 1, dated as of March 31, 2023, relating to the Third Amended and Restated Credit Agreement, dated as of November 23, 2021, among Quest Diagnostics Incorporated, as Borrower, the lenders party thereto, JPMorgan Chase Bank, N.A., as Administrative Agent, and other agents party thereto and which includes, as Exhibit A, the Third Amended and Restated Credit Agreement</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document  - dgx-20230331.xsd</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document - dgx-20230331_cal.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document - dgx-20230331_def.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document - dgx-20230331_lab.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document - dgx-20230331_pre.xml</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i1aa6fd61af824301a74dfe106295204d_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1aa6fd61af824301a74dfe106295204d_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Signatures</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;28, 2023 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest Diagnostics Incorporated</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.087%"><tr><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ James E. Davis</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James E. Davis</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and President</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Sam A. Samad</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sam A. Samad</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div id="i1aa6fd61af824301a74dfe106295204d_112"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-22
<SEQUENCE>2
<FILENAME>dgx03312023ex22.htm
<DESCRIPTION>EX-22
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ia381e52c80284543a909ad1d4c6c1f3c_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Exhibit 22</font></div><div style="text-align:right;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Subsidiary Guarantors of Securities</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">As of April&#160;28, 2023, the following subsidiaries of Quest Diagnostics Incorporated provided, subject to the terms of such senior notes, unconditional and irrevocable guarantees to the senior notes listed below that were issued by Quest Diagnostics Incorporated pursuant to an offering registered under the Securities Act of 1933, as amended&#58;</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:27.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.174%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Securities</font></div></td><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Issuer</font></div></td><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Subsidiary Guarantor</font></div></td><td colspan="3" style="background-color:#dfdfdf;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">State of Organization</font></div></td></tr><tr style="height:14pt"><td colspan="3" rowspan="29" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.95% Senior Notes due 2037</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.75% Senior Notes due 2040</font></div></td><td colspan="3" rowspan="29" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">American Medical Laboratories, Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Consolidated Labs, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Florida</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Florida, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Hospital Services Florida, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Kentucky, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Kentucky</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath New York, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AmeriPath Texas, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Blueprint Genetics Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Diagnostic Pathology Services, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Oklahoma</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ExamOne World Wide, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pennsylvania</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ExamOne World Wide of NJ, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">New Jersey</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Kailash B. Sharma, M.D., Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Georgia</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LabOne, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Missouri</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LabOne of Ohio, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ocmulgee Medical Pathology Association, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Georgia</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Clinical Laboratories, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Holdings Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Maryland</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Incorporated</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Nevada</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Investments LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Connecticut</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Illinois</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Massachusetts</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Nichols Institute</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">California</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics Nichols Institute, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Virginia</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Quest Diagnostics of Pennsylvania Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Specialty Laboratories, Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">California</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Unilab Corporation</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Delaware</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>dgx03312023ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i24b8f8673d564975bbcef8cda03ce3b3_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, James E. Davis, certify that&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Quest Diagnostics Incorporated&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;28, 2023 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.134%"><tr><td style="width:1.0%"></td><td style="width:11.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.908%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; James E. Davis</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James E. Davis</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer and </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President</font></td></tr></table></div><div style="margin-bottom:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>dgx03312023ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ied8a663cc20d4b648ad11dd16e9af195_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Sam Samad, certify that&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Quest Diagnostics Incorporated&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;28, 2023 </font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:31.140%"><tr><td style="width:1.0%"></td><td style="width:14.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sam Samad</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sam Samad</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>dgx03312023ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="icee99910ef804aa8bc2256099e62aeef_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. &#167; 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167; 1350, the undersigned certifies that, to the best of my knowledge, the Quarterly Report on Form 10-Q for the period ended March&#160;31, 2023 of Quest Diagnostics Incorporated, as being filed with the Securities and Exchange Commission concurrently herewith, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. &#167; 78m or 78o(d)) and that the information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Quest Diagnostics Incorporated.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 28, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; James E. Davis</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James E. Davis</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer and </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>dgx03312023ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ifa5b547ac7dc411abae61151d0b256c1_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. &#167; 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167; 1350, the undersigned certifies that, to the best of my knowledge, the Quarterly Report on Form 10-Q for the period ended March&#160;31, 2023 of Quest Diagnostics Incorporated, as being filed with the Securities and Exchange Commission concurrently herewith, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. &#167; 78m or 78o(d)) and that the information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Quest Diagnostics Incorporated.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 28, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sam Samad</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sam Samad</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>dgx03312023ex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic5adb41374c6477a812ea1767bcb9034_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 99.1</font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">__________________________________________________________________________</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THIRD AMENDED AND RESTATED CREDIT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dated as of November 23, 2021</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">among</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">QUEST DIAGNOSTICS INCORPORATED,</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;as Borrower,&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THE LENDERS IDENTIFIED HEREIN,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">JPMORGAN CHASE BANK, N.A.,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as Administrative Agent,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">MORGAN STANLEY SENIOR FUNDING, INC.,</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as Syndication Agent</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">________________________________________________________</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">JPMORGAN CHASE BANK, N.A.,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">MORGAN STANLEY SENIOR FUNDING, INC.,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">MIZUHO BANK, LTD., and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WELLS FARGO SECURITIES, LLC,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as Joint Lead Arrangers and Joint Bookrunners</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">MIZUHO BANK, LTD. and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WELLS FARGO BANK, N.A.<br>as Documentation Agents</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">__________________________________________________________________________</font></div><div style="margin-top:0.2pt;padding-right:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;CS&#38;M Ref. No. 6702-376&#93;</font></div><div style="padding-right:18pt;text-align:right"><font><br></font></div><div style="padding-right:18pt;text-align:right"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ic5adb41374c6477a812ea1767bcb9034_4"></div><hr style="page-break-after:always"><div style="min-height:77.04pt;width:100%"><div style="padding-left:2.87pt;padding-right:2.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</font></div><div style="margin-bottom:10pt;padding-left:5.75pt;padding-right:5.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Page</font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.112%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1 DEFINITIONS AND ACCOUNTING TERMS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Interpretive Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">38</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Accounting Terms&#47;Calculation of Financial Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">39</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Rounding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">40</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Rates&#59; Currency Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">40</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Additional Alternative Currencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">40</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">41</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">References to Agreements and Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">42</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">42</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Rates&#59; Benchmark Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">42</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2 CREDIT FACILITIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">43</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">43</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Subfacility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">45</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Loans Subfacility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">53</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Continuations and Conversions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">54</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Minimum Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">55</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Defaulting Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">55</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Facilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">57</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extension of Revolving Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">59</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3 GENERAL PROVISIONS APPLICABLE TO LOANS AND LETTERS OF CREDIT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">61</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">61</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Place and Manner of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">61</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prepayments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">62</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">63</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payment in Full at Maturity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">64</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Computations of Interest and Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">64</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Pro Rata Treatment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">65</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sharing of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">66</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Capital Adequacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">67</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Alternate Rate of Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">67</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.11</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Illegality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">71</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.12</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Requirements of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">71</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">72</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.14</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">75</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.15</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Determination and Survival of Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">76</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.16</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notification by Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">76</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.17</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Mitigation&#59; Mandatory Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">76</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4 &#91;Reserved&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">77</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5 CONDITIONS PRECEDENT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">77</a></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:77.04pt;width:100%"><div style="margin-bottom:10pt;padding-left:5.75pt;padding-right:5.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Page</font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.112%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Conditions to Effectiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">77</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Conditions to All Extensions of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">78</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6 REPRESENTATIONS AND WARRANTIES</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">79</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Organization and Good Standing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">79</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Due Authorization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">80</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Enforceable Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">80</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Conflicts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">80</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">80</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Condition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">81</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">81</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">81</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">81</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Litigation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">82</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.11</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">82</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.12</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">82</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Licensing and Accreditation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">83</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.14</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">83</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.15</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">83</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.16</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Government Regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">83</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.17</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">83</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.18</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Environmental Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">84</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.19</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">84</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.20</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">85</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.21</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Corruption Laws and Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">85</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.22</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Affected Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">85</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7 AFFIRMATIVE COVENANTS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">85</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Information Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">85</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Covenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">88</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Preservation of Existence and Franchises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">89</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">89</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payment of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">90</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">90</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Maintenance of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">90</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">90</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Audits&#47;Inspections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">90</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiary Guarantees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">91</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.11</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance Program</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">91</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 8 NEGATIVE COVENANTS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">92</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indebtedness of Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">92</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">93</a></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ii</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:77.04pt;width:100%"><div style="margin-bottom:10pt;padding-left:5.75pt;padding-right:5.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Page</font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.112%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sale and Leaseback Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">94</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">94</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fundamental Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">94</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transactions with Affiliates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">94</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9 EVENTS OF DEFAULT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">95</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Events of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">95</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acceleration&#59; Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">97</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Allocation of Payments After Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">98</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10 AGENCY PROVISIONS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">99</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Appointment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">99</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Delegation of Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">100</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exculpatory Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">100</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Reliance on Communications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">100</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">101</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Reliance on Administrative Agent and Other Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">101</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">102</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent in Its Individual Capacity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">103</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Successor Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">103</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agent May&#160;File Proofs of Claim</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">103</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.11</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Certain Lender Representations, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">104</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 11 MISCELLANEOUS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">107</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notices, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">107</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Right of Set-Off</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">110</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benefit of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">110</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Waiver&#59; Remedies Cumulative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">115</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payment of Expenses&#59; Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">115</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendments, Waivers and Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">117</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">119</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">119</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Survival of Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">119</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law&#59; Venue&#59; Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">119</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.11</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Waiver of Jury Trial&#59; Waiver of Consequential Damages</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">120</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.12</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">121</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Further Assurances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">121</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.14</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">121</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.15</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Public Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">122</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.16</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Entirety</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">122</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.17</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Binding Effect&#59; Continuing Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">122</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.18</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PATRIOT Act Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">123</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.19</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Advisory or Fiduciary Responsibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">123</a></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">iii</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:77.04pt;width:100%"><div style="margin-bottom:10pt;padding-left:5.75pt;padding-right:5.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Page</font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.112%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.20</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Judgment Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">124</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.21</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgment and Consent to Bail-In of Affected Financial Institutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><a href="#ic5adb41374c6477a812ea1767bcb9034_10" style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:none">124</a></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">iv</font></div><div><font><br></font></div><div><font><br></font></div></div></div><div id="ic5adb41374c6477a812ea1767bcb9034_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SCHEDULES</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 1.1(a)&#160;&#160;&#160;&#160;Commitment Percentages&#47;Lending Offices</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 2.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Existing Letters of Credit</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 6.10&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Litigation</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 8.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Indebtedness</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 8.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Liens</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 8.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Affiliate Transactions</font></div><div style="margin-bottom:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Schedule 11.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notices</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EXHIBITS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit 2.1(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Notice of Borrowing</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit 2.1(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Revolving Note</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit 2.3(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Swing Line Loan Request</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit 2.3(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Swing Line Loan Note</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit 2.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Notice of Continuation&#47;Conversion</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit 3.13(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Tax Certificate</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit 7.1(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Officer&#8217;s Certificate</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit 7.10&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Guarantee</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exhibit 11.3(b)&#160;&#160;&#160;&#160;Form of Assignment and Assumption</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><div id="ic5adb41374c6477a812ea1767bcb9034_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THIRD AMENDED AND RESTATED CREDIT AGREEMENT, dated as of November&#160;23, 2021 (as amended, amended and restated, supplemented or otherwise modified from time to time, this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), by and among QUEST DIAGNOSTICS INCORPORATED, a Delaware corporation, as Borrower, the various financial institutions and other Persons from time to time parties hereto, as Lenders, JPMORGAN CHASE BANK, N.A., as Administrative Agent, MORGAN STANLEY SENIOR FUNDING, INC., as syndication agent (in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Syndication Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and MIZUHO BANK, LTD. and WELLS FARGO BANK, N.A., as documentation agents (in such capacities, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Documentation Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, for purposes of providing financing for the working capital and general corporate needs of the Borrower and its Subsidiaries, including acquisitions, the Borrower requested a $750,000,000 revolving credit facility (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Credit Facility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, on the Prior Closing Date, the Lenders agreed, on the terms and subject to the conditions hereinafter set forth, to provide the Revolving Credit Facility&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the premises and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree that, subject to the satisfaction of the conditions set forth in Section 5.1, the Existing Credit Agreement shall be and hereby is amended and restated in its entirety as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.36pt;text-decoration:underline"><br><br>DEFINITIONS AND ACCOUNTING TERMS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">As used herein, the following terms shall have the meanings herein specified unless the context otherwise requires&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjusted Daily Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any RFR Borrowing denominated in Dollars, an interest rate per annum equal to (a) the Daily Simple SOFR, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) 0.10%&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> if the Adjusted Daily Simple SOFR as so determined would be less than the Floor, such rate shall be deemed to be equal to the Floor for the purposes of this Credit Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjusted Daily Simple SONIA Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Borrowing denominated in Sterling, an interest rate per annum equal to the Daily Simple SONIA Rate&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> if the Adjusted Daily Simple SONIA Rate as so determined would be less than the Floor, such rate shall be deemed to be equal to the Floor for the purposes of this Credit Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjusted EURIBO Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Term Benchmark Borrowing denominated in Euros for any Interest Period, an interest rate per annum equal to (a)&#160; the EURIBO Rate for such Interest Period multiplied by (b) the Statutory Reserve Rate&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> if the Adjusted EURIBO Rate as so determined would be less than the Floor, such rate shall be deemed to be equal to the Floor for the purposes of this Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjusted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Term Benchmark Borrowing denominated in Dollars for any Interest Period, an interest rate per annum equal to (a) the Term SOFR for such Interest Period, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) 0.10%&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> if the Adjusted Term SOFR as so determined would be less than the Floor, such rate shall be deemed to be equal to the Floor for the purposes of this Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means JPMorgan (or any successor thereto) or any successor administrative agent appointed pursuant to Section 10.9.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Questionnaire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an Administrative Questionnaire in a form supplied by the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Affected Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) any EEA Financial Institution or (b) any UK Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, any other Person directly or indirectly controlling (including but not limited to all directors and officers of such Person), controlled by or under direct or indirect common control with such Person.  A Person shall be deemed to control a corporation if such Person possesses, directly or indirectly, the power (a)&#160;to vote 10% or more of the securities having ordinary voting power for the election of directors of  such corporation or (b)&#160;to direct or cause direction of the management and policies of such corporation, whether through the ownership of voting securities, by contract or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agency Services Address</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any currency, the Administrative Agent&#8217;s address and, as appropriate, account as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> with respect to such currency, or such other address or account with respect to such currency as the Administrative Agent may from time to time designate by written notice to the Borrower and the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agent-Related Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Administrative Agent (including any successor administrative agent) and its Related Parties.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Administrative Agent, the Syndication Agent and the Documentation Agents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreed Currencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Dollars and each Alternative Currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 11.20.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Euro, Sterling</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and each other currency (other than Dollars) that is approved in accordance with Section&#160;1.6.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment and Restatement Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Amendment and Restatement Agreement, dated as of November 23, 2021, among the Borrower, the Lenders party thereto and the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Corruption Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means all laws, rules, and regulations of any jurisdiction applicable to the Borrower or its Subsidiaries from time to time concerning or relating to bribery, money laundering or corruption.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the appropriate applicable percentage corresponding to the Debt Rating of the Borrower in effect from time to time as described below&#58;</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.015%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.113%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.846%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:2.5pt double #000000;border-top:2.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Pricing Level</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:2.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Debt Rating</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:2.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Applicable Percentage for Term Benchmark Revolving Loans and RFR Loans</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:2.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Applicable Percentage for Base Rate Revolving Loans</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:2.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Applicable Percentage for Letter of Credit Fees</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:2.5pt double #000000;border-top:2.5pt double #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Applicable Percentage for Facility Fee on the Revolving Commitments</font></td></tr><tr><td colspan="3" style="border-left:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">I</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> A from S&#38;P&#47;</font></div><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> A2 from Moody&#8217;s</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.630%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.630%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.070%</font></td></tr><tr><td colspan="3" style="border-left:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">II</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A- from S&#38;P&#47;</font></div><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A3 from Moody&#8217;s</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.785%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.785%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.090%</font></td></tr><tr><td colspan="3" style="border-left:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">III</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BBB+ from S&#38;P&#47;</font></div><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Baa1 from Moody&#8217;s</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.900%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.900%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.100%</font></td></tr><tr><td colspan="3" style="border-left:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IV</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BBB from S&#38;P&#47;</font></div><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Baa2 from Moody&#8217;s</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.000%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.000%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.125%</font></td></tr><tr><td colspan="3" style="border-left:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">V</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BBB- from S&#38;P&#47;</font></div><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Baa3 from Moody&#8217;s</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.100%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.100%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.100%</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.150%</font></td></tr><tr><td colspan="3" style="border-bottom:2.5pt double #000000;border-left:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">VI</font></td><td colspan="3" style="border-bottom:2.5pt double #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8804; BB+ or unrated by S&#38;P&#47;</font></div><div style="padding-left:3.45pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8804; Ba1 or unrated by Moody&#8217;s</font></div></td><td colspan="3" style="border-bottom:2.5pt double #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.275%</font></td><td colspan="3" style="border-bottom:2.5pt double #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.275%</font></td><td colspan="3" style="border-bottom:2.5pt double #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.275%</font></td><td colspan="3" style="border-bottom:2.5pt double #000000;border-left:0.75pt solid #000000;border-right:2.5pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0.225%</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Applicable Percentage for Revolving Loans that are Term Benchmark Loans, RFR Loans and Base Rate Loans, for Letter of Credit Fees and for Facility Fees shall, in each case, be determined and adjusted on the date (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Calculation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) three Business Days after the date on which the Borrower&#8217;s Debt Rating is upgraded or downgraded in a manner which requires a change in the then applicable pricing level set forth above.  If at any time there is a split in the Borrower&#8217;s Debt Ratings between S&#38;P and Moody&#8217;s, the Applicable Percentages shall be determined by the higher of the two Debt Ratings (i.e., the lower pricing)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if the two Debt Ratings are more than one level apart, the Applicable Percentage shall be based on the Debt Rating which is one level lower than the higher Debt Rating.  Each Applicable Percentage shall be effective from one Calculation Date until the next Calculation Date.  Any adjustment in the Applicable Percentage shall be applicable to all existing Revolving Loans that are Term Benchmark Loans, RFR Loans and Base Rate Loans and to all existing Letters of Credit as well as any new Revolving Loans, that are Term Benchmark Loans, RFR Loans or Base Rate Loans, made or any new Letters of Credit issued.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any borrowings and payments in any Alternative Currency, the local time in the place of settlement for such Alternative Currency as may be determined by the Administrative Agent (and notified to the Borrower in writing) to be necessary for timely settlement on the relevant date in accordance with normal banking procedures in the place of payment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Approved Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Fund that is administered or managed by (i)&#160;a Lender, (ii)&#160;an Affiliate of a Lender or (iii)&#160;an entity or an Affiliate of an entity that administers or manages a Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Assignee Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means two or more Eligible Assignees that are Affiliates of one another or two or more Approved Funds managed by the same investment advisor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Assignment and Assumption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an Assignment and Assumption substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit 11.3(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Attorney Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means all reasonable and documented out-of-pocket fees and disbursements of any law firm or other external counsel.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Attributable Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to a Sale and Leaseback Transaction, an amount equal to the lesser of&#58; (a)&#160;the fair market value of the Property subject thereto (as determined in good faith by the Borrower&#8217;s board of directors) and (b)&#160;the present value of the total net amount of rent payments to be made under the lease during its remaining term, discounted at the rate of interest set forth or implicit in the terms of the lease, compounded semi-annually.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Authorized Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any of the chief executive officer, president, chief financial officer, corporate controller, treasurer or assistant treasurer of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Available Tenor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as of any date of determination and with respect to the then-current Benchmark for any Agreed Currency, as applicable, any tenor for such Benchmark (or component thereof) or payment period for interest calculated with reference to such Benchmark (or component thereof), as applicable, that is or may be used for determining the length of an Interest Period for any term rate or otherwise, for determining any frequency of making payments of interest calculated pursuant to this Credit Agreement as of such date and not including, for the avoidance of doubt, any tenor for such Benchmark that is then-removed from the definition of &#8220;Interest Period&#8221; pursuant to Section 3.10(f).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Bail-In Action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the exercise of any Write-Down and Conversion Powers by the applicable Resolution Authority in respect of any liability of an Affected Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Bail-In Legislation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) with respect to any EEA Member Country implementing Article 55 of Directive 2014&#47;59&#47;EU of the European Parliament and of the Council of the European Union, the implementing law, regulation, rule or requirement for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule and (b) with respect to the United Kingdom, Part I of the United Kingdom Banking Act 2009 (as amended from time to time) and any other law, regulation or rule applicable in the United Kingdom relating to the resolution of unsound or failing banks, investment firms or other financial institutions or their affiliates (other than through liquidation, administration or other insolvency proceedings).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Bankruptcy Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Bankruptcy Code in Title 11 of the United States Code, as amended, modified, succeeded or replaced from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Bankruptcy Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, that such Person has become the subject of a bankruptcy or insolvency proceeding, or has had a receiver, conservator, trustee, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">administrator, custodian, assignee for the benefit of creditors or similar Person charged with the reorganization or liquidation of its business appointed for it, or, in the good faith determination of the Administrative Agent, has taken any action in furtherance of, or indicating its consent to, approval of or acquiescence in, any such proceeding or appointment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that a Bankruptcy Event shall not result solely by virtue of any ownership interest, or the acquisition of any ownership interest, in such Person by a Governmental Authority&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that such ownership interest does not result in or provide such Person with immunity from the jurisdiction of courts within the United States of America or from the enforcement of judgments or writs of attachment on its assets or permit such Person (or such Governmental Authority) to reject, repudiate, disavow or disaffirm any agreements made by such Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Base Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day, a rate per annum equal to the greatest of (a)&#160;the Prime Rate in effect on such day, (b)&#160;the NYFRB Rate in effect on such day </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#189; of 1% per annum and (c) the Adjusted Term SOFR for a one month Interest Period as published two U.S. Government Securities Business Days prior to such day (or if such day is not a U.S. Government Securities Business Day, the immediately preceding U.S. Government Securities Business Day) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 1% per annum&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that for the purpose of this definition, the Adjusted Term SOFR for any day shall be based on the Term SOFR Reference Rate at approximately 5&#58;00 a.m. Chicago time on such day (or any amended publication time for the Term SOFR Reference Rate, as specified by the CME Term SOFR Administrator in the Term SOFR Reference Rate methodology)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if such rate shall be less than zero, such rate shall be deemed to be zero for all purposes of this Credit Agreement.  Any change in the Base Rate due to a change in the Prime Rate, the NYFRB Rate or the Adjusted Term SOFR shall be effective from and including the effective date of such change in the Prime Rate, the NYFRB Rate or the Adjusted Term SOFR , as the case may be.  If the Base Rate is being used as an alternate rate of interest pursuant to Section 3.10 (for the avoidance of doubt, only until any amendment has become effective pursuant to Section 3.10(b)), then the Base Rate shall be the greater of clauses (a) and (b) above and shall be determined without reference to clause&#160;(c) above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Base Rate Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Loan bearing interest at a rate determined by reference to the Base Rate.  Base Rate Loans may be denominated only in Dollars.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, initially, with respect to any (i) RFR Loan in any Agreed Currency, the applicable Relevant Rate for such Agreed Currency or (ii) Term Benchmark Loan in any Agreed Currency, the Relevant Rate for such Agreed Currency&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if a Benchmark Transition Event and the related Benchmark Replacement Date have occurred with respect to the applicable Relevant Rate or the then-current Benchmark for such Agreed Currency, then &#8220;Benchmark&#8221; means the applicable Benchmark Replacement to the extent that such Benchmark Replacement has replaced such prior benchmark rate pursuant to Section&#160;3.10(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Replacement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any Available Tenor, the first alternative set forth in the order below that can be determined by the Administrative Agent (in consultation with the Borrower) for the applicable Benchmark Replacement Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, in the case of any Loan denominated in an Alternative Currency, &#8220;Benchmark Replacement&#8221; shall mean the alternative set forth in clause (2) below&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;in the case of any Loan denominated in Dollars, the Adjusted Daily Simple SOFR&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;the sum of&#58; (a) the alternate benchmark rate that has been reasonably selected by the Administrative Agent and the Borrower as the replacement for the then-current Benchmark for the applicable Corresponding Tenor giving due consideration to (i) any selection or recommendation of a replacement benchmark rate or the mechanism for determining such a rate by the Relevant Governmental Body and&#47;or (ii) any evolving or then-prevailing market convention for determining a benchmark rate as a replacement for the then-current Benchmark for syndicated credit facilities denominated in the applicable Agreed Currency at such time in the United States and (b) the related Benchmark Replacement Adjustment&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the Benchmark Replacement as determined pursuant to clause (1) or (2) above would be less than the Floor, the Benchmark Replacement will be deemed to be the Floor for the purposes of this Credit Agreement and the other Credit Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Replacement Adjustment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any replacement of the then-current Benchmark with an Unadjusted Benchmark Replacement for any applicable Interest Period and Available Tenor for any setting of such Unadjusted Benchmark Replacement, the spread adjustment, or method for calculating or determining such spread adjustment (which may be a positive or negative value or zero), that has been selected by the Administrative Agent and the Borrower for the applicable Corresponding Tenor giving due consideration to (a) any selection or recommendation of a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement by the Relevant Governmental Body on the applicable Benchmark Replacement Date and&#47;or (b) any evolving or then-prevailing market convention for determining a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement for syndicated credit facilities denominated in the applicable Agreed Currency at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Replacement Conforming Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Benchmark Replacement and&#47;or the Adjusted Term SOFR, any technical, administrative or operational changes (including changes to the definition of &#8220;Base Rate,&#8221; the definition of &#8220;Business Day,&#8221; the definition of &#8220;Interest Period,&#8221; the definition of &#8220;RFR Business Day,&#8221; the definition of &#8220;U.S. Government Securities Business Day,&#8221; timing and frequency of determining rates and making payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, length of lookback periods, the applicability of breakage provisions, and other technical, administrative or operational matters) that the Administrative Agent, in consultation with the Borrower, decides may be appropriate to reflect the adoption and implementation of such Benchmark and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent decides that adoption of any portion of such market practice is not administratively feasible or if the Administrative Agent determines that no market practice for the administration of such Benchmark exists, in such other manner of administration as the Administrative Agent, in consultation with the Borrower, decides is reasonably necessary in connection with the administration of this Credit Agreement and the other Credit Documents).</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Replacement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Benchmark, the earlier to occur of the following events with respect to such then-current Benchmark&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;in the case of clause (1) or (2) of the definition of &#8220;Benchmark Transition Event,&#8221; the later of (a) the date of the public statement or publication of information referenced therein and (b) the date on which the administrator of such Benchmark (or the published component used in the calculation thereof) permanently or indefinitely ceases to provide all Available Tenors of such Benchmark (or such component thereof)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;in the case of clause (3) of the definition of &#8220;Benchmark Transition Event,&#8221; the first date on which such Benchmark (or the published component used in the calculation thereof) has been determined and announced by the regulatory supervisor for the administrator of such Benchmark (or such component thereof) to be no longer representative&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that such non-representativeness will be determined by reference to the most recent statement or publication referenced in such clause (c) and even if any Available Tenor of such Benchmark (or such component thereof) continues to be provided on such date.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;For the avoidance of doubt, (i) if the event giving rise to the Benchmark Replacement Date occurs on the same day as, but earlier than, the Reference Time in respect of any determination, the Benchmark Replacement Date will be deemed to have occurred prior to the Reference Time for such determination and (ii) the &#8220;Benchmark Replacement Date&#8221; will be deemed to have occurred in the case of clause (1) or (2) with respect to any Benchmark upon the occurrence of the applicable event or events set forth therein with respect to all then-current Available Tenors of such Benchmark (or the published component used in the calculation thereof).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Transition Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Benchmark, the occurrence of one or more of the following events with respect to such then-current Benchmark&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(1) a public statement or publication of information by or on behalf of the administrator of such Benchmark (or the published component used in the calculation thereof) announcing that such administrator has ceased or will cease to provide all Available Tenors of such Benchmark (or such component thereof), permanently or indefinitely, provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(2) a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof), the Federal Reserve Board, the NYFRB, the CME Term SOFR Administrator, the central bank for the Agreed Currency applicable to such Benchmark, an insolvency official with jurisdiction over the administrator for such Benchmark (or such component), a resolution authority with jurisdiction over the administrator for such Benchmark (or such component) or a court or an entity with similar insolvency or resolution authority over the administrator for such Benchmark (or such component), in each case, which states that the administrator of such Benchmark (or such component) has ceased or will cease to provide all Available Tenors of such Benchmark (or such component thereof) permanently or indefinitely&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(3) a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof) announcing that all Available Tenors of such Benchmark (or such component thereof) are no longer, or as of a specified future date will no longer be, representative.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For the avoidance of doubt, a &#8220;Benchmark Transition Event&#8221; will be deemed to have occurred with respect to any Benchmark if a public statement or publication of information set forth above has occurred with respect to each then-current Available Tenor of such Benchmark (or the published component used in the calculation thereof).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Unavailability Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Benchmark, the period (if any) (a) beginning at the time that a Benchmark Replacement Date has occurred if, at such time, no Benchmark Replacement has replaced such then-current Benchmark for all purposes hereunder and under any Credit Document in accordance with Section 3.10 and (b) ending at the time that a Benchmark Replacement has replaced such then-current Benchmark for all purposes hereunder and under any Credit Document in accordance with Section 3.10.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Beneficial Ownership Certification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a certification regarding beneficial ownership or control as required by the Beneficial Ownership Regulation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Beneficial Ownership Regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means 31 C.F.R. &#167; 1010.230.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Benefit Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any of (a) an &#8220;employee benefit plan&#8221; (as defined in ERISA) that is subject to Title I of ERISA, (b) a &#8220;plan&#8221; as defined in and subject to Section 4975 of the Code or (c) any Person whose assets include (for purposes of ERISA Section 3(42) or otherwise for purposes of Title I of ERISA or Section 4975 of the Code) the assets of any such &#8220;employee benefit plan&#8221; or &#8220;plan&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Quest Diagnostics Incorporated, a Delaware corporation, together with any successors and permitted assigns.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section&#160;7.1(h).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a)&#160;Revolving Borrowing or (b)&#160;a Swing Line Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowing Minimum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) in the case of a borrowing of Revolving Loans denominated in Dollars, $10,000,000, (b) in the case of a borrowing of Revolving Loans denominated in Euro, EUR10,000,000, (c) in the case of a borrowing of Revolving Loans denominated in Sterling, &#163;10,000,000 and (d) in the case of a borrowing of Revolving Loans denominated in any other Alternative Currency, the smallest amount of such Alternative Currency that is an integral multiple of 1,000,000 units of such currency and that has a Dollar Equivalent in excess of $10,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowing Multiple</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) in the case of a borrowing of Revolving Loans denominated in Dollars, $1,000,000, (b) in the case of a borrowing of Revolving Loans denominated in Euro, EUR1,000,000, (c) in the case of a borrowing of Revolving Loans denominated in Sterling, &#163;1,000,000 and (d) in the case of a borrowing of Revolving Loans denominated in any other Alternative Currency, 1,000,000 units of such currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, any day (other than a Saturday or a Sunday) on which banks are open for business in New York City&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, the term &#8220;Business Day&#8221; shall mean (a) in relation to Term Benchmark Loans referencing the Adjusted Term SOFR and any interest rate settings, fundings, disbursements, settlements or payments of any such Loans referencing the Adjusted Term SOFR or any other dealings of such Loans referencing the Adjusted Term SOFR, such day should also be a U.S. Government Securities Business Day, (b) in relation to Loans denominated in Sterling, any day (other than a Saturday or a Sunday) on which banks are open for business in London, (c) in relation to Loans denominated in Euros and in relation to the calculation or computation of EURIBOR, any day which is a TARGET Day and (d) in relation to RFR Loans and any interest rate settings, fundings, disbursements, settlements or payments of any such RFR Loan, or any other dealings in the applicable Agreed Currency of such RFR Loan, any such day that is only an RFR Business Day.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Calculation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the definition of &#8220;Applicable Percentage&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">CAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the College of American Pathologists.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Capital Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as applied to any Person, any lease of any Property (whether real, personal or mixed) by that Person as lessee which, in accordance with GAAP, is or should be accounted for as a capital lease on the balance sheet of that Person and the amount of such obligation shall be the capitalized amount thereof determined in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Capital Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a)&#160;in the case of a corporation, all classes of capital stock of such corporation, (b)&#160;in the case of a partnership, partnership interests (whether general or limited), (c)&#160;in the case of a limited liability company, membership interests and (d)&#160;any other interest or participation that confers on a Person the right to receive a share of the profits and losses of, or distributions of assets of, the issuing Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Cash and Cash Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;cash and cash equivalents, in accordance with GAAP, and the following items to the extent that they are excluded from cash and cash equivalents in accordance with GAAP&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;direct obligations of, or obligations the principal of and interest on which are unconditionally guaranteed by, the United&#160;States of America (or by any agency thereof to the extent such obligations are backed by the full faith and credit of the United&#160;States of America), in each case maturing within one year from the date of acquisition thereof&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;investments in commercial paper maturing within 270 days from the date of acquisition thereof and having, at such date of acquisition, the highest credit rating obtainable from S&#38;P or from Moody&#8217;s&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;investments in certificates of deposit, banker&#8217;s acceptances and time deposits maturing within 180 days from the date of acquisition thereof issued or guaranteed by or placed with, and money market deposit accounts issued or offered by, any domestic office of any commercial bank organized under the laws of the United&#160;States of America or any State thereof which has a combined capital and surplus and undivided profits of not less than $500,000,000&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;fully collateralized repurchase agreements with a term of not more than 30 days for securities described in clause (b) above and entered into with a financial institution satisfying the criteria described in clause (d) above&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;money market funds that (i)&#160;comply with the criteria set forth in SEC Rule 2a-7 under the Investment Company Act of 1940, and (ii)&#160;are rated AAA by S&#38;P and Aaa by Moody&#8217;s.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Central Bank Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, the greater of (A) (i) for any Loan denominated in (a) Sterling, the Bank of England (or any successor thereto)&#8217;s &#8220;Bank Rate&#8221; as published by the Bank of England (or any successor thereto) from time to time, (b) Euro, one of the following three rates as may be selected by the Administrative Agent in its reasonable discretion&#58; (1) the fixed rate for the main refinancing operations of the European Central Bank (or any successor thereto), or, if that rate is not published, the minimum bid rate for the main refinancing operations of the European Central Bank (or any successor thereto), each as published by the European Central Bank (or any successor thereto) from time to time, (2) the rate for the marginal lending facility of the European Central Bank (or any successor thereto), as published by the European Central Bank (or any successor thereto) from time to time or (3) the rate for the deposit facility of the central banking system of the Participating Member States, as published by the European Central Bank (or any successor thereto) from time to time, and (c) any other Alternative Currency determined after the Restatement Effective Date, a central bank rate as determined by the Administrative Agent in its reasonable discretion </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the applicable Central Bank Rate Adjustment, and (B) 0.00%.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Central Bank Rate Adjustment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day, for any Loan denominated in (a)&#160;Euros, a rate equal to the difference (which may be a positive or negative value or zero) of (i)&#160;the average of the EURIBO Rate for the five most recent Business Days preceding such day for which the Screen Rate was available (excluding, from such averaging, the highest and the lowest EURIBO Rate applicable during such period of five Business Days) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the Central Bank Rate in respect of Euro in effect on the last Business Day in such period, (b) Sterling, a rate equal to the difference (which may be a positive or negative value or zero) of (i) the average of SONIA for the five most recent RFR Business Days preceding such day for which SONIA was available (excluding, from such averaging, the highest and the lowest SONIA applicable during such period of five RFR Business Days) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the Central Bank Rate in respect of Sterling in effect on the last RFR Business Day in such period, and (c) any other Alternative Currency determined after the Restatement Effective Date, a Central Bank Rate Adjustment as determined by the Administrative Agent in its reasonable discretion (in consultation with the Borrower). For purposes of this definition, (x) the term Central Bank Rate shall be determined disregarding clause&#160;(B) of the definition of such term and (y) the EURIBO Rate on any day shall be based on the Screen Rate on such day at approximately the time referred to in the definition of such term for deposits in the applicable Agreed Currency for a maturity of one month. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the occurrence, after the date of this Credit Agreement, of any of the following&#58;  (a)&#160;the adoption or taking effect of any rule, regulation, treaty or other law, (b)&#160;any change in any rule, regulation, treaty or other law or in the administration, interpretation, implementation or application thereof by any Governmental Authority or (c)&#160;the making or issuance of any request, rule, guideline or directive (whether or not having the force of law) of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">any Governmental Authority&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, for all purposes of this Credit Agreement and notwithstanding anything herein to the contrary, (i) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (ii) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed to be a &#8220;Change in Law&#8221;, regardless of the date enacted, adopted, promulgated or issued. Notwithstanding the foregoing, no Lender shall be entitled to seek compensation for costs imposed in accordance with the previous sentence if it shall not be the general policy of such Lender at such time to seek compensation from investment grade borrowers with the same or similar ratings under yield protection provisions in credit agreements with such borrowers that provide for such compensation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means either of the following events&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;any &#8220;person&#8221; or &#8220;group&#8221; (within the meaning of Section&#160;13(d) or 14(d) of the Exchange Act) has become, directly or indirectly, the &#8220;beneficial owner&#8221; (as defined in Rules&#160;13d-3 and 13d-5 under the Exchange Act), by way of merger, consolidation or otherwise, of 35% or more of the Voting Stock of the Borrower on a fully-diluted basis, after giving effect to the conversion and exercise of all outstanding warrants, options and other securities of the Borrower convertible into or exercisable for Voting Stock of the Borrower (whether or not such securities are then currently convertible or exercisable)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;during any period of twelve calendar months, individuals who at the beginning of such period constituted the board of directors of the Borrower together with any new members of such board of directors whose elections by such board or board of directors or whose nomination for election by the stockholders of the Borrower was approved by a vote of a majority of the members of such board of directors then still in office who either were directors at the beginning of such period or whose election or nomination for election was previously so approved cease for any reason to constitute a majority of the directors of the Borrower then in office.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">CLIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Clinical Laboratory Improvement Amendment as set forth at 42&#160;U.S.C.&#160;263a and the regulations promulgated thereunder, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">CME Term SOFR Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means CME Group Benchmark Administration Limited as administrator of the forward-looking term Secured Overnight Financing Rate (SOFR) (or a successor administrator).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">CMS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Centers for Medicare and Medicaid Services of HHS, any successor thereof and any predecessor thereof, including the HCFA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Internal Revenue Code of 1986, as amended, modified, succeeded or replaced from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, without duplication, (a) the Revolving Commitment of each Lender, (b)&#160;the LOC Commitment of each Issuing Lender, (c)&#160;any Incremental Term Commitment of an Incremental Term Lender and (d)&#160;any Incremental Revolving Commitment of an Incremental Revolving Lender.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Corresponding Tenor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">with respect to any Available Tenor means, as applicable, either a tenor (including overnight) or an interest payment period having approximately the same length (disregarding business day adjustment) as such Available Tenor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means this Credit Agreement, the Amendment and Restatement Agreement, the Notes, any Incremental Facility Agreement, the LOC Documents, any Notice of Borrowing, any Swing Line Loan Request, any guarantee agreement delivered pursuant to Section&#160;7.10 and any Issuing Lender Agreement, as such documents may be amended, modified, supplemented or restated from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the definition of &#8220;Required Lenders&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Daily Simple SONIA Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means, for any day (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RFR Interest Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), an interest rate per annum equal to, for any Loan denominated in Sterling, SONIA for the day that is 4 RFR Business Days prior to (A) if such RFR Interest Day is an RFR Business Day, such RFR Interest Day or (B) if such RFR Interest Day is not an RFR Business Day, the RFR Business Day immediately preceding such RFR Interest Day. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Daily Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means, for any day (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR Rate Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), a rate per annum equal to SOFR for the day that is five U.S. Government Securities Business Days prior to (a) if such SOFR Rate Day is a U.S. Government Securities Business Day, such SOFR Rate Day or (b) if such SOFR Rate Day is not a U.S. Government Securities Business Day, the U.S. Government Securities Business Day immediately preceding such SOFR Rate Day, in each case, as such SOFR is published by the SOFR Administrator on the SOFR Administrator&#8217;s Website.  Any change in Daily Simple SOFR due to a change in SOFR shall be effective from and including the effective date of such change in SOFR without notice to the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Debt Rating</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the long-term senior unsecured, non-credit enhanced debt rating of the Borrower from S&#38;P and Moody&#8217;s.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any event, act or condition which with notice or lapse of time, or both, would constitute an Event of Default.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Defaulting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Revolving Lender that (a)&#160;has failed, within two Business Days of the date required to be funded or paid, (i)&#160;to fund any portion of its Loans, (ii)&#160;to fund any portion of its participations in Letters of Credit or Swing Line Loans or (iii)&#160;to pay to any Financing Party any other amount required to be paid by it hereunder, unless, in the case of clause (i) above, such Lender notifies the Administrative Agent in writing that such failure is the result of such Lender&#8217;s good faith determination that a condition precedent to funding (specifically identified in such writing, including, if applicable, by reference to a specific Default) has not been satisfied, (b)&#160;has notified the Borrower or any Financing Party in writing, or has made a public statement, to the effect that it does not intend or expect to comply with any of its funding obligations under this Credit Agreement (unless such writing or public statement indicates that such position is based on such Lender&#8217;s good-faith determination that a condition precedent (specifically identified in such writing, including, if applicable, by reference to a specific Default) to funding a Loan cannot be satisfied) or generally under other agreements in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">which it commits to extend credit, (c)&#160;has failed, within three Business Days after request by a Financing Party made in good faith, to provide a certification in writing from an authorized officer of such Lender that it will comply with its obligations to fund prospective Loans and participations in then outstanding Letters of Credit and Swing Line Loans, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that such Lender shall cease to be a Defaulting Lender pursuant to this clause (c) upon such Financing Party&#8217;s receipt of such certification in form and substance reasonably satisfactory to it and the Administrative Agent, or (d)&#160;has become, or has a Revolving Lender Parent that has become, the subject of a Bankruptcy Event or a Bail-In Action.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any payment of dividends or any other distribution upon any shares of any class of Capital Stock of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Documentation Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dodd-Frank Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the definition of &#8220;Change in Law&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dollar Equivalent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, (a)&#160;with respect to any amount denominated in Dollars, such amount, and (b)&#160;with respect to any amount denominated in any Alternative Currency, the equivalent amount thereof in Dollars as determined by the Administrative Agent at such time on the basis of the Exchange Rate (determined in respect of the most recent Revaluation Date) for the purchase of Dollars with such Alternative Currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dollars</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">$</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means dollars in lawful currency of the United States of America.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Domestic Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each direct and indirect Subsidiary of the Borrower that is domiciled or organized under the laws of any State of the United States or the District of Columbia.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EBITDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any period, with respect to the Borrower and its Subsidiaries on a consolidated basis, (a)&#160;Net Income for such period (excluding the effect of any extraordinary or other non-recurring gains and losses (including any gain or loss from the sale of Property)) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b)&#160;an amount which, in the determination of Net Income for such period, has been deducted for (i)&#160;Interest Expense for such period, (ii)&#160;total Federal, state, foreign or other income or franchise taxes for such period, (iii)&#160;all depreciation and amortization for such period, (iv)&#160;other items of expense during such period that do not involve a cash payment at any time (other than the provision for bad debt in connection with uncollectible accounts receivable), (v)&#160;cash charges during such period for which the Borrower and its Subsidiaries are reimbursed by a third party during such period, (vi)&#160;special or restructuring items during any such period included in Net Income that do not involve a cash payment during such period (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Cash Items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and (vii) expenses charged pursuant to FASB ASC 718, as promulgated in accordance with GAAP, during such period </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (c)&#160;any actual cash payments during the applicable period related to Non-Cash Items expensed or reserved under clauses&#160;(v) and (vi) above </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (d)&#160;Tender Costs during such period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EEA Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) any credit institution or investment firm established in any EEA Member Country that is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country that is a parent of an institution described in clause (a) above or (c) any financial institution established in an EEA Member Country that is a subsidiary of an institution described in clause (a) or (b) above and is subject to consolidated supervision with its parent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EEA Member Country</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any member state of the European Union, Iceland, Liechtenstein and Norway.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EEA Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any public administrative authority or any Person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Signature</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an electronic sound, symbol, or process attached to, or associated with, a contract or other record and adopted by a Person with the intent to sign, authenticate or accept such contract or record.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Eligible Assignee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) a Lender, (b) an Affiliate of a Lender, (c)&#160;an Approved Fund and (d) any other Person approved by the Administrative Agent, each Issuing Lender, the Swing Line Lender and the Borrower (such approval not to be unreasonably withheld)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that (i) the Borrower&#8217;s approval shall not be required during the existence and continuation of an Event of Default, (ii)&#160;neither the Borrower nor an Affiliate of the Borrower shall qualify as an Eligible Assignee, (iii) no competitor of the Borrower identified in a letter dated the Restatement Effective Date of the Borrower to the Administrative Agent (as such letter may be amended, amended and restated, supplemented or otherwise modified by the Borrower from time to time to identify additional Persons engaged in the business in which the Borrower is engaged), which letter shall be made available to the Administrative Agent, shall qualify as an Eligible Assignee, and (iv) no consent of any Issuing Lender shall be required with respect to any Incremental Term Commitment or Incremental Term Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EMU Legislation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the legislative measures of the European Council for the introduction of, changeover to or operation of a single or unified European currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Environmental Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any current or future legally enforceable requirement of any Governmental Authority pertaining to (a) the protection of the indoor or outdoor environment, (b) the conservation, management, or use of natural resources and wildlife, (c) the protection or use of surface water and groundwater, (d) the management, manufacture, possession, presence, use, generation, transportation, treatment, storage, disposal, release, threatened release, abatement, removal, remediation or handling of, or exposure to, any hazardous or toxic substance or material or (e) pollution (including any release to land surface water and groundwater) and includes, without limitation, the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended by the Superfund Amendments and Reauthorization Act of 1986, 42 USC 9601 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Solid Waste Disposal Act, as amended by the Resource Conservation and Recovery Act of 1976 and Hazardous and Solid Waste Amendments of 1984, 42 USC 6901 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Federal Water Pollution Control Act, as amended by the Clean Water Act of 1977, 33 USC 1251 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Clean Air Act of 1966, as amended, 42 USC 7401 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Toxic Substances Control Act of 1976, 15 USC 2601 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Hazardous Materials Transportation Act, 49 USC App. 1801 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Occupational Safety and Health Act of 1970, as amended, 29 USC 651 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Oil Pollution Act of 1990, 33 USC 2701 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Emergency Planning and Community Right-to-Know Act of 1986, 42 USC 11001 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> National Environmental Policy Act of 1969, 42 USC 4321 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Safe Drinking Water Act of 1974, as amended, 42 USC 300(f) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> any analogous implementing or successor law, and any amendment, rule, regulation, order, or directive issued thereunder. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Environmental Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any liability, obligation, loss, claim, action, order or cost, contingent or otherwise (including any liability for damages, costs of environmental remediation, fines, penalties and indemnities), directly or indirectly resulting from or based upon (a)&#160;violation of any Environmental Law, (b)&#160;the generation, use, handling, transportation, storage, treatment or disposal of any Hazardous Materials, (c)&#160;exposure to any Hazardous Materials, (d)&#160;the release or threatened release of any Hazardous Materials or (e) any contract, agreement or other consensual arrangement pursuant to which liability is assumed or imposed with respect to any of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Employee Retirement Income Security Act of 1974, as amended, and any successor statute thereto, as interpreted by the rules and regulations thereunder, all as the same may be in effect from time to time.  References to sections of ERISA shall be construed also to refer to any successor sections.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an entity, whether or not incorporated, which is treated as a single employer with the Borrower under Sections&#160;414(b) or (c) of the Code and solely for purposes of Section 302 of ERISA and Section 412 of the Code under Section 414 of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) with respect to any Single Employer or Multiple Employer Plan, the occurrence of a reportable event within the meaning of Section&#160;4043 of ERISA (unless the 30-day notice requirement with respect to such event was waived by the PBGC) or a substantial cessation of operations within the meaning of Section 4062(e) of ERISA&#59; (b) the withdrawal of the Borrower or any ERISA Affiliate from a Multiple Employer Plan during a plan year in which it was a substantial employer (as such term is defined in Section 4001(a)(2) of ERISA), or the termination of a Multiple Employer Plan&#59; (c) the distribution of a notice of intent to terminate or the actual termination of a Plan pursuant to Section 4041(a)(2) of ERISA&#59; (d) the institution of proceedings to terminate or the actual termination of any Plan by the PBGC under Section 4042 of ERISA&#59; (e) any event or condition which might constitute grounds under Section 4042 of ERISA for the termination of, or the appointment of a trustee to administer, any Plan&#59; (f) the complete or partial withdrawal of the Borrower or any ERISA Affiliate from a Multiemployer Plan&#59; or (g) the conditions for imposition of a lien under Section&#160;303(k) of ERISA exist with respect to any Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EU Bail-In Legislation Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor Person), as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EURIBO Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Term Benchmark Loan denominated in Euros for any Interest Period, the Screen Rate as of the Specified Time on the Quotation Day.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EURIBOR Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Loan bearing interest at a rate determined by reference to the EURIBO Rate.  All Loans denominated in Euros shall be EURIBOR Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Euro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EUR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; mean the lawful currency of the Participating Member States introduced in accordance with the EMU Legislation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any of the events or circumstances specified in Section&#160;9.1.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the United States Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder, as amended, modified, succeeded or replaced from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means on any day, for purposes of determining the Dollar Equivalent of any other currency, the rate at which such other currency may be exchanged into Dollars at the time of determination on such day as set forth on the Bloomberg WCR Page for such currency.  In the event that such rate does not appear on any Bloomberg WCR Page, the Exchange Rate shall be determined by reference to such other publicly available service for displaying exchange rates as may be agreed upon by the Administrative Agent and the Borrower or, in the absence of such an agreement, such Exchange Rate shall instead be the arithmetic average of the spot rates of exchange of the Administrative Agent in the market where its foreign currency exchange operations in respect of such currency are then being conducted, at or about such time as the Administrative Agent shall elect after determining that such rates shall be the basis for determining the Exchange Rate, on such date for the purchase of Dollars for delivery two Business Days later&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if at the time of any such determination, for any reason, no such spot rate is being quoted, the Administrative Agent may use any reasonable method it deems appropriate to determine such rate, and such determination shall be conclusive absent manifest error.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Existing Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means this Credit Agreement, as in effect immediately prior to the occurrence of the Restatement Effective Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Existing Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the outstanding letters of credit originally issued or deemed issued under the Existing Credit Agreement that are identified on Schedule 2.2.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extending Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 2.8(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extension Confirmation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 2.8(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extension Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 2.8(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extension of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as to any Lender, the making or extension of a Loan by such Lender (or a participation therein by a Lender) or the issuance or extension or increase in the face amount of, or participation in, a Letter of Credit by such Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extension Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 2.8(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Facility Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 3.4(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">FAS 842</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 1.3(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">FATCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Sections&#160;1471 through 1474 of the Code (or any amended or successor version that is substantively comparable thereto) and any regulations or official interpretations thereof, any agreements entered into pursuant to Section 1471(b)(1) of the Code and any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement, treaty or convention among Governmental Authorities and implementing such Sections of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Federal Funds Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day, the rate calculated by the NYFRB based on such day&#8217;s federal funds transactions by depository institutions (as determined in such manner as shall set forth on the Federal Reserve Board of New York&#8217;s Website from time to time) and published on the next succeeding Business Day by the NYFRB as the effective federal funds </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">rate&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if such rate shall be less than zero, such rate shall be deemed to be zero for all purposes of this Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Federal Reserve Bank of New York&#8217;s Website</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the website of the NYFRB at http&#58;&#47;&#47;www.newyorkfed.org, or any successor source.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fee Letters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the JPMorgan Fee Letter, the Morgan Stanley Fee Letter, the Mizuho Fee Letter and the Wells Fargo Fee Letter, as such documents may be amended, modified, supplemented or restated from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Financing Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Administrative Agent, each Issuing Lender, the Swing Line Lender and each other Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Floor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the benchmark rate floor, if any, provided in this Credit Agreement (as of the execution and delivery of this Credit Agreement, the modification, amendment or renewal of this Credit Agreement or otherwise) with respect to the Adjusted Term SOFR, the Adjusted Daily Simple SOFR, the Adjusted EURIBO Rate or the Adjusted Daily Simple SONIA Rate, as applicable. For the avoidance of doubt the initial Floor for each of the Adjusted Term SOFR, the Adjusted Daily Simple SOFR, the Adjusted EURIBO Rate and the Adjusted Daily Simple SONIA Rate shall be 0.00%.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Currency Sublimit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 2.1(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each direct and indirect Subsidiary of the Borrower that is not a Domestic Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Person (other than a natural person) that is (or will be) engaged in making, purchasing, holding or otherwise investing in commercial loans and similar extensions of credit in the ordinary course of its business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Funded Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, without duplication, the sum of (a)&#160;all Indebtedness of the Borrower and its Subsidiaries for borrowed money, (b)&#160;all purchase money Indebtedness of the Borrower and its Subsidiaries, (c)&#160;the principal portion of all obligations of the Borrower and its Subsidiaries under Capital Leases, (d)&#160;all drawn but unreimbursed amounts under all letters of credit (other than letters of credit supporting trade payables in the ordinary course of business) issued for the account of the Borrower or any of its Subsidiaries, (e)&#160;all Funded Debt of another Person secured by a Lien on any Property of the Borrower and its Subsidiaries whether or not such Funded Debt has been assumed by a Borrower or any of its Subsidiaries, (f)&#160;all Funded Debt of any partnership or unincorporated joint venture to the extent the Borrower or one of its Subsidiaries is legally obligated with respect thereto and (g)&#160;the amount of principal attributable under any outstanding Synthetic Lease.  It is understood and agreed that Indebtedness incurred pursuant to Hedging Agreements is not Funded Debt.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means generally accepted accounting principles in the United States applied on a consistent basis and subject to Section 1.3.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Government Acts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section&#160;2.2(j)(i).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Governmental Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the government of the United States of America or any other nation or any political subdivision thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government, including any applicable supra-national bodies (such as the European Union or the European Central Bank).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Granting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section&#160;11.3(g).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Guarantee Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, without duplication, any obligations (other than endorsements in the ordinary course of business of negotiable instruments for deposit or collection) guaranteeing any Indebtedness of any other Person in any manner, whether direct or indirect, and including without limitation any obligation, whether or not contingent, (a) to purchase any such Indebtedness or other obligation or any Property constituting security therefor, (b)&#160;to advance or provide funds or other support for the payment or purchase of such Indebtedness or obligation or to maintain working capital, solvency or other balance sheet condition of such other Person (including, without limitation, maintenance agreements, comfort letters, take or pay arrangements, put agreements or similar agreements or arrangements) for the benefit of the holder of Indebtedness of such other Person, (c) to lease or purchase Property, securities or services primarily for the purpose of assuring the owner of such Indebtedness or (d) to otherwise assure or hold harmless the owner of such Indebtedness or obligation against loss in respect thereof.  The amount of any Guarantee Obligation hereunder shall (subject to any limitations set forth therein) be deemed to be an amount equal to the outstanding principal amount (or maximum principal amount, if larger) of the Indebtedness in respect of which such Guarantee Obligation is made.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Hazardous Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any substance, material or waste defined in or regulated under any Environmental Laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">HCFA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the United States Health Care Financing Administration and any successor thereto, including CMS.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Hedging Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, collectively, interest rate protection agreements, foreign currency exchange agreements, commodity purchase or option agreements or other interest or exchange rate or commodity price hedging agreements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">HHS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the United States Department of Health and Human Services and any successor thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">HIPAA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Health Insurance Portability and Accountability Act of 1996, Pub. L. 104-191, Aug. 21, 1996, 110 Stat. 1936 and regulations promulgated thereunder, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an Incremental Revolving Commitment or an Incremental Term Commitment. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Committed Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section&#160;2.7(a). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Facility Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an Incremental Facility Agreement, in form and substance reasonably satisfactory to the Administrative Agent, among the Borrower, the Administrative Agent and one or more Incremental Lenders, establishing Incremental Term Commitments of any Series or Incremental Revolving Commitments and effecting such other amendments hereto and to the other Credit Documents as are contemplated by Section&#160;2.7. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an Incremental Revolving Lender or an Incremental Term Lender. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Lender, the commitment, if any, of such Lender, established pursuant to an Incremental Facility Agreement and Section&#160;2.7, to make Revolving Loans and to acquire participations in Letters of Credit and Swing Line Loans hereunder, expressed as an amount representing the maximum aggregate permitted amount of such Lender&#8217;s Revolving Exposure under such Incremental Facility Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Revolving Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Lender with an Incremental Revolving Commitment. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Term Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Lender, the commitment, if any, of such Lender, established pursuant to an Incremental Facility Agreement and Section&#160;2.7, to make Incremental Term Loans of any Series hereunder, expressed as an amount representing the maximum principal amount of the Incremental Term Loans of such Series to be made by such Lender. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Term Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Lender with an Incremental Term Commitment or an outstanding Incremental Term Loan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Term Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Loan made by an Incremental Term Lender to the Borrower pursuant to Section&#160;2.7. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Term Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to Incremental Term Loans of any Series, the scheduled date on which such Incremental Term Loans shall become due and payable in full hereunder, as specified in the applicable Incremental Facility Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; of any Person means, without duplication, (a) all obligations of such Person for borrowed money, (b) all obligations of such Person evidenced by bonds, debentures, notes or similar instruments, or upon which interest payments are customarily made, (c) all obligations of such Person under conditional sale or other title retention agreements relating to Property purchased by such Person to the extent of the value of such Property (other than customary reservations or retentions of title under agreements with suppliers entered into in the ordinary course of business), (d) all obligations, other than intercompany items, of such Person issued or assumed as the deferred purchase price of property or services purchased by such Person which would appear as liabilities on a balance sheet of such Person, (e) all Indebtedness of others secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any Lien on, or payable out of the proceeds of production from, property owned or acquired by such Person, whether or not the obligations secured thereby have been assumed, (f) all Guarantee Obligations of such Person, (g) the principal portion of all obligations of such Person under (i) Capital Leases and (ii) any synthetic lease, tax retention operating lease, off-balance sheet loan or similar off-balance sheet financing product of such Person where such transaction is considered borrowed money indebtedness for </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">tax purposes but is classified as an operating lease in accordance with GAAP, (h) all obligations of such Person to repurchase any securities which repurchase obligation is related to the issuance thereof, including, without limitation, obligations commonly known as residual equity appreciation potential shares, (i) all net obligations of such Person in respect of Hedging Agreements, (j) the maximum amount of all performance and standby letters of credit issued or bankers&#8217; acceptance facilities created for the account of such Person and, without duplication, all drafts drawn thereunder (to the extent unreimbursed) and (k) the aggregate amount of uncollected accounts receivable of such Person subject at such time to a sale of receivables (or similar transaction) regardless of whether such transaction is effected without recourse to such Person or in a manner that would not be reflected on the balance sheet of such Person in accordance with GAAP.  The Indebtedness of any Person shall include the Indebtedness of any partnership or unincorporated joint venture in which such Person is legally obligated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnified Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 11.5(c)(i).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnitees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 11.5(c)(i).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 11.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section&#160;6.19.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Expense</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to the Borrower and its Subsidiaries on a consolidated basis for any period, all interest expense, including, without duplication, the interest component under Capital Leases, as determined in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) as to Base Rate Loans and Swing Line Loans, the last day of each calendar quarter and the applicable Maturity Date and, in the case of Swing Line Loans, the date on which the principal of such Loans is due and payable as provided in Section 2.3, (b) as to RFR Loans, (x) the date that is on the numerically corresponding day in the calendar month that is one month after the borrowing of such Loan and each one-month anniversary thereafter (or, in each case, if there is no such numerically corresponding day in such month, then the last day of such month) and (y) the applicable Maturity Date and (c) as to Term Benchmark Loans, the last day of each Interest Period applicable to the Borrowing of which such Loan is a part and, in the case of a Term Benchmark Loan with an Interest Period of more than three months&#8217; duration, each day prior to the last day of such Interest Period that occurs at intervals of three months&#8217; duration after the first day of such Interest Period, and the applicable Maturity Date.  If an Interest Payment Date falls on a date which is not a Business Day, such Interest Payment Date shall be deemed to be the next succeeding Business Day, except that in the case of Term Benchmark Loans where the next succeeding Business Day falls in the next succeeding calendar month, then such Interest Payment Date shall be deemed to be the next preceding Business Day.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means with respect to any Term Benchmark Loan, the period commencing on the date of such Borrowing and ending on the numerically corresponding day in the calendar month that is one, three or six months thereafter (in each case, subject to the availability for the Benchmark applicable to the relevant Loan or Commitment for any Agreed Currency), as the Borrower may elect&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that (i)&#160;if any Interest Period would end on a day other than a Business Day, such Interest Period shall be extended to the next succeeding Business Day unless such next succeeding Business Day would fall in the next calendar month, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">20</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">in which case such Interest Period shall end on the next preceding Business Day, (ii)&#160;any Interest Period that commences on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the last calendar month of such Interest Period) shall end on the last Business Day of the last calendar month of such Interest Period and (iii) no tenor that has been removed from (and that has not been subsequently reinstated in) this definition pursuant to Section 3.10(f) shall be available for specification in such Notice of Borrowing or Notice of Continuation&#47;Conversion.  For purposes hereof, the date of a Borrowing initially shall be the date on which such Borrowing is made and, in the case of a Revolving Borrowing, thereafter shall be the effective date of the most recent conversion or continuation of such Borrowing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Issuing Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) JPMorgan, Morgan Stanley Bank, N.A., Mizuho Bank, Ltd., Wells Fargo Bank, N.A. and (b) each other Lender designated by the Borrower as an &#8220;Issuing Lender&#8221; hereunder that has agreed to such designation (and is reasonably acceptable to the Administrative Agent), each in its capacity as an issuer of one or more Letters of Credit hereunder, in each case, so long as such Person shall remain an Issuing Lender hereunder.  Any Issuing Lender may, in its discretion and, in the case of Letters of Credit issued for the benefit of a U.S. Person, subject to the Borrower&#8217;s prior written consent, arrange for one or more Letters of Credit to be issued by Affiliates of such Issuing Lender, in which case the term &#8220;Issuing Lender&#8221; shall include any such Affiliate with respect to Letters of Credit issued by such Affiliate (it being agreed that such Issuing Lender shall, or shall cause such Affiliate to, comply with the requirements of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> with respect to such Letters of Credit).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Issuing Lender Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section&#160;2.2(l).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Issuing Lender Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 3.4(b)(ii).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">JPMorgan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means JPMorgan Chase Bank, N.A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">JPMorgan Engagement Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means that certain letter agreement dated as of November&#160;10, 2021, between the Borrower and JPMorgan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">JPMorgan Fee Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means that certain letter agreement dated as of November 23, 2021, between the Borrower and JPMorgan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Judgment Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 11.20.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, collectively, all international, foreign, federal, state and local statutes, treaties, rules, guidelines, regulations, ordinances, codes and administrative or judicial precedents or authorities, including the interpretation or administration thereof by any Governmental Authority charged with the enforcement, interpretation or administration thereof, and all applicable administrative orders, directed duties, requests, licenses, authorizations and permits of, and agreements with, any Governmental Authority, in each case whether or not having the force of law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lead Arrangers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means JPMorgan, Morgan Stanley, Mizuho Bank, Ltd. and Wells Fargo Securities, LLC.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">21</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any of the Persons identified as a &#8220;Lender&#8221; on the signature pages hereto, any Eligible Assignee which may become a Lender by way of assignment in accordance with the terms hereof and any Incremental Lender, in each case, together with their successors and permitted assigns.  Unless the context otherwise requires, the term &#8220;Lenders&#8221; includes the Swing Line Lender and the Issuing Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lender-Related Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 11.5(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lending Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as to any Lender, the office or offices of such Lender described as such on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;1.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, or such other office or offices as a Lender may from time notify to the Borrower and the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any letter of credit issued for the account of the Borrower by an Issuing Lender pursuant to Section&#160;2.2, as such letter of credit may be amended, modified, extended, renewed or replaced.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Exchange Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any drawing under a Letter of Credit denominated in an Alternative Currency, the rate specified by the applicable Issuing Lender as the rate at which it was (or would have been) able, at or about the time of such drawing, to exchange Dollars into such Alternative Currency for purposes of obtaining an amount of such Alternative Currency equal to the amount of such drawing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section&#160;3.4(b)(i).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Leverage Increase Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 7.2.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Leverage Increase Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 7.2.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Leverage Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as of the last day of each fiscal quarter, the ratio of (a)(i)&#160;Funded Debt on such date </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the aggregate amount of any unrestricted Cash and Cash Equivalents held by the Borrower on a consolidated basis on such date to (b)&#160;EBITDA for the twelve month period ending on such date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lien</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any mortgage, pledge, hypothecation, assignment, deposit arrangement, security interest, encumbrance, lien (statutory or otherwise), preference, priority or charge of any kind, including, without limitation, any agreement to give any of the foregoing, any conditional sale or other title retention agreement, and any lease in the nature thereof (other than operating leases).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Revolving Loans, the Swing Line Loans (or any portion thereof), any Incremental Term Loans and any Incremental Revolving Loans, individually or collectively, as appropriate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Loan Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section&#160;11.3(d).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">LOC Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the commitment of each Issuing Lender to issue Letters of Credit for the account of the Borrower in an aggregate face amount outstanding (together with the amounts of any unreimbursed drawings thereon) at any time of up to the applicable LOC Committed Amount.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">22</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">LOC Committed Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) on the Restatement Effective Date, as to each Issuing Lender specified in clause (a) of the definition &#8220;Issuing Lender&#8221; individually, $37,500,000 (or such different amount as may be agreed among the Borrower and each such Issuing Lender), and (b) at any time, as to all Issuing Lenders collectively, $150,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">LOC Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Letter of Credit, such Letter of Credit, any amendments thereto, any documents delivered in connection therewith, any application therefor, and any agreements, instruments, guarantees or other documents (whether general in application or applicable only to such Letter of Credit) governing or providing for (a) the rights and obligations of the parties concerned or at risk or (b) any collateral security for such obligations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">LOC Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, the sum of (a) the sum of the Dollar Equivalents of the maximum amounts which are, or at any time thereafter may become, available to be drawn under Letters of Credit then outstanding, assuming compliance with all requirements for drawings referred to in such Letters of Credit </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (b) the sum of the Dollar Equivalents of the aggregate amounts of all drawings under Letters of Credit honored by any Issuing Lender but not theretofore reimbursed.  The LOC Obligation of any Revolving Lender at any time shall be its Revolving Loan Commitment Percentage of the total LOC Obligations at such time, adjusted to give effect to any reallocation under Section 2.6(c) of the LOC Obligations of any Defaulting Lender in effect at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Mandatory Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section&#160;2.2(e)(i).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Material Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any acquisition or a series of related acquisitions (other than solely among the Borrower and its Subsidiaries or Affiliates) of (a) Capital Stock in any Person if, after giving effect thereto, such Person will become a Subsidiary or (b) assets comprising all or substantially all the assets of (or all or substantially all the assets constituting a business unit, division, product line or line of business of) any Person&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that the aggregate consideration therefor (including Indebtedness assumed in connection therewith, all obligations in respect of deferred purchase price (including obligations under any purchase price adjustment but excluding earnout or similar payments) and all other consideration payable in connection therewith (including payment obligations in respect of noncompetition agreements or other arrangements representing acquisition consideration)) exceeds $100,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a material adverse effect on (a) the business, operations or financial condition of the Borrower and its Subsidiaries taken as a whole, (b) the ability of the Borrower to perform its obligations under this Credit Agreement or any of the other Credit Documents or (c) the validity or enforceability of this Credit Agreement, any of the other Credit Documents, or the rights and remedies of the Lenders hereunder or thereunder taken as a whole. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Material Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, without duplication (1) any obligation of the Borrower for money borrowed, (2) any obligation of the Borrower evidenced by bonds, debentures, notes or other similar instruments, (3) any reimbursement obligation of the Borrower in respect of letters of credit or other similar instruments which support financial obligations which would otherwise become Indebtedness and (4) any obligation of the Borrower under Capital Leases, in an aggregate principal amount, if and to the extent the aggregate amount of all obligations referred to in such clauses (1) through (4) is greater than $50,000,000&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that &#8220;Material </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">23</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Debt&#8221; shall not include any obligation of the Borrower to any Subsidiary or to any Person with respect to which the Borrower is a Subsidiary&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that &#8220;Material Debt&#8221; shall not include any Obligations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Revolving Maturity Date or the Incremental Term Maturity Date with respect to Incremental Term Loans of any Series, as the context requires.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Medicaid</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the entitlement program under Title XIX of the Social Security Act that provides federal grants to states for medical assistance based on specific eligibility criteria.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Medicaid Provider Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an agreement entered into between a state agency or other such entity administering the Medicaid program and a health care provider or supplier under which the health care provider or supplier agrees to provide services for Medicaid patients in accordance with the terms of the agreement and Medicaid Regulations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Medicaid Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, collectively, (a) all federal statutes (whether set forth in Title XIX of the Social Security Act or elsewhere) affecting Medicaid and any statutes succeeding thereto, (b) all applicable provisions of all federal rules, regulations, manuals and orders and administrative, reimbursement and other guidelines having the force of law of all Governmental Authorities promulgated pursuant to or in connection with the statutes described in clause (a) above, (c) all state statutes and plans for medical assistance enacted in connection with the statutes and provisions described in clauses (a) and (b) above and (d) all applicable provisions of all rules, regulations, manuals and orders and administrative, reimbursement and other guidelines having the force of law of all Governmental Authorities promulgated pursuant to or in connection with the statutes described in clause (c) above and all state administrative, reimbursement and other guidelines of all Governmental Authorities having the force of law promulgated pursuant to or in connection with the statutes described in clause (b) above, in each case, as may be amended, supplemented or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Medical Reimbursement Programs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Medicare, Medicaid and TRICARE programs and any other healthcare program operated by or financed in whole or in part by any foreign, domestic, federal, state or local government and any other non-government funded third party payor programs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Medicare</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means that government-sponsored entitlement program under Title XVIII of the Social Security Act that provides for a health insurance system for eligible elderly and disabled individuals.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Medicare Provider Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an agreement entered into between CMS or other such entity administering the Medicare program on behalf of CMS, and a health care provider or supplier under which the health care provider or supplier agrees to provide services for Medicare patients in accordance with the terms of the agreement and Medicare Regulations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Medicare Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, collectively, all federal statutes (whether set forth in Title XVIII of the Social Security Act or elsewhere) affecting the health insurance program for the aged and disabled established by Title XVIII of the Social Security Act and any statutes succeeding thereto&#59; together with all applicable provisions of all rules, regulations, manuals and orders and administrative, reimbursement and other guidelines having the force of law of all Governmental Authorities (including, without limitation, the HHS, CMS, the OIG, or any Person </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">24</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">succeeding to the functions of any of the foregoing) promulgated pursuant to or in connection with any of the foregoing having the force of law, as each may be amended, supplemented or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Mizuho Fee Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means that certain letter agreement dated as of November 23, 2021, between the Borrower and Mizuho Bank, Ltd.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">MNPI</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means material information concerning the Borrower and its Subsidiaries and their securities that has not been disseminated in a manner making it available to investors generally, within the meaning of Regulation FD under the Securities Act and the Exchange Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Moody&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Moody&#8217;s Investors Service, Inc., or any successor or assignee of the business of such company in the business of rating securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Morgan Stanley</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Morgan Stanley Senior Funding, Inc.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Morgan Stanley Fee Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means that certain letter agreement dated as of November 23, 2021, between the Borrower and Morgan Stanley Bank, N.A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Multiemployer Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Plan which is a multiemployer plan as defined in Section 3(37) or 4001(a)(3) of ERISA to which the Borrower or any ERISA Affiliate is making or accruing an obligation to make contributions or has made or accrued an obligation to make contributions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Multiple Employer Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Plan covered by Title IV of ERISA (other than a Multiemployer Plan) in which the Borrower or any ERISA Affiliate and at least one employer other than the Borrower or any ERISA Affiliate are contributing sponsors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Net Income</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any period, the net income after taxes for such period of the Borrower and its Subsidiaries on a consolidated basis, determined in accordance with GAAP and without duplication.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Net Worth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as of any date of determination, the consolidated stockholder&#8217;s equity of the Borrower and its Subsidiaries calculated on a consolidated basis in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Cash Items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the definition of &#8220;EBITDA&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Consenting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section&#160;11.6.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Defaulting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, any Lender that is not a Defaulting Lender at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Extending Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 2.8(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Revolving Notes, the Swing Line Loan Note and any promissory notes of the Borrower in favor of any Incremental Lender evidencing any Incremental Commitment, as such promissory notes may be amended, modified, supplemented, extended, renewed or replaced from time to time, individually or collectively, as appropriate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">25</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a request by the Borrower for a Loan, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;2.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Continuation&#47;Conversion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a request by the Borrower to continue an existing Term Benchmark Loan to a new Interest Period or to convert a Term Benchmark Loan denominated in Dollars to a Base Rate Loan or a Base Rate Loan to a Term Benchmark Loan denominated in Dollars, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">NYFRB</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Federal Reserve Bank of New York.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">NYFRB Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day, the greater of (a) the Federal Funds Rate in effect on such day and (b) the Overnight Bank Funding Rate in effect on such day (or for any day that is not a Business Day, on the immediately preceding Business Day)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if none of such rates are published for any day that is a Business Day, the term &#8220;NYFRB Rate&#8221; shall mean the rate for a federal funds transaction quoted at 11&#58;00 a.m., New&#160;York&#160;City time, on such day received by the Administrative Agent from a federal funds broker of recognized standing selected by it&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if any of the aforesaid rates shall be less than zero, the term &#8220;NYFRB Rate&#8221; shall be deemed to be zero for all purposes of this Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, without duplication, (a) the due and punctual payment by the Borrower of (i) the principal of and interest (including interest accruing during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or allowable in such proceeding) on the Loans, when and as due, whether at maturity, by acceleration, upon one or more dates set for prepayment or otherwise, (ii) each payment required to be made by the Borrower under this Credit Agreement in respect of any Letter of Credit, when and as due, including payments in respect of reimbursement of disbursements, interest thereon and obligations to provide cash collateral, and (iii) all other monetary obligations of the Borrower under this Credit Agreement and each of the other Credit Documents (including obligations to pay fees and expense reimbursement and indemnification obligations), whether primary, secondary, direct, contingent, fixed or otherwise (including monetary obligations incurred during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or allowable in such proceeding) and (b) the due and punctual performance of all other obligations of the Borrower under or pursuant to this Credit Agreement and each of the other Credit Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">OIG</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Office of Inspector General of HHS and any successor thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Original Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the definition of &#8220;Refinancing Indebtedness&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 3.13(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Overnight Bank Funding Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day, the rate comprised of both overnight federal funds and overnight eurocurrency borrowings by U.S.-managed banking offices of depository institutions, as such composite rate shall be determined by the NYFRB as set forth on its public website from time to time, and published on the next succeeding Business Day by the NYFRB as an overnight bank funding rate (from and after such date as the NYFRB shall commence to publish such composite rate).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">26</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Overnight Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day, (a) with respect to any amount denominated in Dollars, the greater of (i) the Federal Funds Rate and (ii) the Overnight Bank Funding Rate, and (b) with respect to any amount denominated in an Alternative Currency, the rate of interest per annum at which overnight deposits in the applicable Alternative Currency, in an amount approximately equal to the amount with respect to which such rate is being determined, would be offered for such day by a branch or Affiliate of JPMorgan in the applicable offshore interbank market for such currency to major banks in such interbank market.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 11.3(d).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Lenders with a Revolving Loan Commitment Percentage greater than zero.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participating Member State</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each state so described in any EMU Legislation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participation Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Extension of Credit by a Revolving Lender by way of a purchase of a participation in (a)&#160;Letters of Credit or LOC Obligations as provided in Section&#160;2.2, (b)&#160;Swing Line Loans as provided in Section 2.3 or (c)&#160;any Loans as provided in Section 3.8.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PATRIOT Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the USA PATRIOT Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), as amended and supplemented from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in Section 10.11(d)(i).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payment Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it in Section 10.11(d)(ii).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PBGC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Pension Benefit Guaranty Corporation established pursuant to Subtitle A of Title IV of ERISA and any successor thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a)&#160;Liens securing Obligations, if any, (b)&#160;Liens for taxes not yet due or Liens for taxes being contested in good faith by appropriate proceedings for which adequate reserves determined in accordance with GAAP have been established (and as to which the Property subject to any such Lien is not yet subject to foreclosure, sale, collection, levy or loss on account thereof), (c)&#160;Liens in respect of Property imposed by law arising in the ordinary course of business such as materialmen&#8217;s, mechanics&#8217;, warehousemen&#8217;s, carrier&#8217;s, landlords&#8217; and other nonconsensual statutory Liens which are not yet due and payable or which are being contested in good faith by appropriate proceedings for which adequate reserves determined in accordance with GAAP have been established (and as to which the Property subject to any such Lien is not yet subject to foreclosure, sale or loss on account thereof), (d)&#160;Liens (other than Liens imposed under ERISA) consisting of pledges or deposits made in the ordinary course of business to secure payment of worker&#8217;s compensation insurance, unemployment insurance, pensions or social security programs, (e)&#160;Liens arising from good faith deposits in connection with or to secure performance of tenders, bids, leases, government contracts, performance and return-of-money bonds and other similar obligations incurred in the ordinary course of business (other than obligations in respect of the payment of borrowed money), (f)&#160;Liens arising from good faith deposits in connection with or to secure performance of statutory obligations and surety and appeal bonds, (g)&#160;easements, rights-of-way, restrictions (including zoning restrictions), matters of plat, minor defects or irregularities in title and other similar charges or encumbrances not, in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">27</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">any material respect, impairing the use of the encumbered Property for its intended purposes, (h)&#160;judgment Liens in respect of judgments that would not constitute an Event of Default, (i)&#160;Liens arising by virtue of any statutory or common law provision relating to banker&#8217;s liens, rights of setoff or similar rights as to deposit accounts or other funds maintained with a creditor depository institution and (j) Liens with respect to lease filings for notice purposes only.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Receivables Financing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any transaction entered into pursuant to documentation in which (a) the Borrower or one or more Domestic Subsidiaries sells, conveys or otherwise transfers to Quest Receivables and (b) Quest Receivables sells, conveys or otherwise transfers to any other Person or grants a security interest to any Person in, any Receivables (whether now existing or hereafter acquired) of the Borrower or such Domestic Subsidiaries, and any assets related thereto including all collateral securing such Receivables, all contracts and all Guarantee Obligations or other obligations in respect of such Receivables, all proceeds of such Receivables and all other assets that are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving Receivables&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that the purchasers or lenders in such transaction shall have no recourse to the Borrower or any Subsidiary other than recourse of  types and in amounts customary in &#8220;true sale&#8221; receivables securitizations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any individual, partnership, joint venture, firm, corporation, limited liability company, association, trust or other enterprise (whether or not incorporated), or any Governmental Authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any employee benefit plan (as defined in Section 3(3) of ERISA) covered by ERISA that is sponsored, maintained or contributed to by the Borrower or any ERISA Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Platform</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning given thereto in Section 7.1(h).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prime Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the rate of interest per annum publicly announced from time to time by JPMorgan as its prime rate in effect at its principal office in New York City.  Each change in the Prime Rate shall be effective from and including the date such change is publicly announced as being effective.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prior Closing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means March 22, 2018.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any right, title or interest in or to any property or asset of any kind whatsoever, whether real, personal or mixed and whether tangible or intangible.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PTE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a prohibited transaction class exemption issued by the U.S. Department of Labor, as any such exemption may be amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Public Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning given thereto in Section 7.1(h).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Quest Receivables</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Quest Diagnostics Receivables Incorporated, a Delaware corporation, a wholly-owned, bankruptcy-remote, special purpose Subsidiary of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Quotation Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means with respect to any applicable currency for any Interest Period, the day two Business Days prior to the first day of such Interest Period, in each case unless market practice differs for loans such as the applicable Loans priced by reference to rates quoted in the Relevant Interbank Market, in which case the Quotation Day for such currency shall be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">28</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">determined by the Administrative Agent (and notified to the Borrower in writing) in accordance with market practice for such loans priced by reference to rates quoted in the Relevant Interbank Market (and if quotations would normally be given by leading banks for such loans priced by reference to rates quoted in the Relevant Interbank Market on more than one day, the Quotation Day shall be the last of those days).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Receivable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the indebtedness and payment obligations of any Person to the Borrower or any Domestic Subsidiary or acquired by the Borrower or any Domestic Subsidiary (including obligations constituting an account or general intangible or evidenced by a note, instrument, contract, security agreement, chattel paper or other evidence of indebtedness or security) arising from a sale of merchandise or the provision of services in the ordinary course of business by the Borrower or any Domestic Subsidiary or the Person from which such indebtedness and payment obligation were acquired by the Borrower or any Domestic Subsidiary, including (a) any right to payment for goods sold or for services rendered and (b) the right to payment of any interest, sales taxes, finance charges, returned check or late charges and other obligations of such Person with respect thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Reference Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; with respect to any setting of the then-current Benchmark means (a) if such Benchmark is Term SOFR, 5&#58;00 a.m. (Chicago time) on the day that is two U.S. Government Securities Business Days preceding the date of such setting, (b) if such Benchmark is the EURIBO Rate, 11&#58;00&#160;a.m. Brussels time two TARGET Days preceding the date of such setting, (c) if such Benchmark is the Daily Simple SONIA Rate, then four Business Days prior to such setting, (d) if such Benchmark is the Daily Simple SOFR, then four U.S. Government Securities Business Days prior to such setting or (e) if such Benchmark is none of Term SOFR, the EURIBO Rate, the Daily Simple SONIA Rate or Daily Simple SOFR, the time determined by the Administrative Agent in its reasonable discretion (and notified to the Borrower in writing).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Refinancing Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, in respect of any Indebtedness (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Original Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), any Indebtedness that extends, renews or refinances such Original Indebtedness (or any Refinancing Indebtedness in respect thereof)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that (a) the principal amount of such Refinancing Indebtedness shall not exceed the principal amount of such Original Indebtedness&#59; (b)&#160;the stated final maturity of such Refinancing Indebtedness shall not be earlier than that of such Original Indebtedness&#59; (c) such Refinancing Indebtedness shall not be required to be repaid, prepaid, redeemed, repurchased or defeased, whether on one or more fixed dates, upon the occurrence of one or more events or at the option of any holder thereof (except, in each case, upon the occurrence of an event of default or a change in control or as and to the extent such repayment, prepayment, redemption, repurchase or defeasance would have been required pursuant to the terms of such Original Indebtedness) prior to the earlier of (i) the maturity of such Original Indebtedness and (ii)&#160;the date 180 days after the latest Maturity Date, to each case as in effect on the date of such extension, renewal or refinancing&#59; (d) such Refinancing Indebtedness shall not constitute an obligation (including pursuant to a guarantee) of any Subsidiary that shall not have been (or, in the case of after-acquired Subsidiaries, shall not have been required to become) an obligor in respect of such Original Indebtedness&#59; (e) if such Original Indebtedness shall have been subordinated to the obligations under this Credit Agreement, such Refinancing Indebtedness shall also be subordinated to the obligations hereunder on terms not less favorable in any material respect to the Lenders&#59; and (f) such Refinancing Indebtedness shall not be secured by any Lien on any asset other than the assets that secured such Original Indebtedness (or would have been required to secure such Original Indebtedness pursuant to the terms thereof). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">29</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 11.3(c).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Regulation T, U or X</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Regulation T, U or X, respectively, of the Board of Governors of the Federal Reserve System as from time to time in effect and any successor to all or a portion thereof. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Related Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any specified Person, such Person&#8217;s Affiliates and the directors, officers, employees, partners, members, agents and advisors of such Person and of such Person&#8217;s Affiliates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Relevant Governmental Body</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (i) with respect to a Benchmark Replacement in respect of Loans denominated in Dollars, the Federal Reserve Board and&#47;or the NYFRB, the CME Term SOFR Administrator, as applicable, or a committee officially endorsed or convened by the Federal Reserve Board and&#47;or the NYFRB or, in each case, any successor thereto, (ii) with respect to a Benchmark Replacement in respect of Loans denominated in Sterling, the Bank of England, or a committee officially endorsed or convened by the Bank of England or, in each case, any successor thereto, (iii) with respect to a Benchmark Replacement in respect of Loans denominated in Euros, the European Central Bank, or a committee officially endorsed or convened by the European Central Bank or, in each case, any successor thereto, and (iv) with respect to a Benchmark Replacement in respect of Loans denominated in any other currency, (a) the central bank for the currency in which such Benchmark Replacement is denominated or any central bank or other supervisor which is responsible for supervising either (1) such Benchmark Replacement or (2) the administrator of such Benchmark Replacement or (b) any working group or committee officially endorsed or convened by (1) the central bank for the currency in which such Benchmark Replacement is denominated, (2) any central bank or other supervisor that is responsible for supervising either (A) such Benchmark Replacement or (B) the administrator of such Benchmark Replacement, (3) a group of those central banks or other supervisors or (4) the Financial Stability Board or any part thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Relevant Interbank Market</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means with respect to Euros, the European interbank market.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Relevant Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (i) with respect to any Term Benchmark Loan denominated in Dollars, the Adjusted Term SOFR, (ii) with respect to any Term Benchmark Loan denominated in Euros, the EURIBO Rate, (iii) with respect to any RFR Loan denominated in Sterling, the Daily Simple SONIA Rate or (iv) with respect to any RFR Loan denominated in Dollars, the Adjusted Daily Simple SOFR.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Required Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Lenders whose aggregate Credit Exposure (as hereinafter defined) constitutes more than 50% of the Credit Exposure of all Lenders at such time.  For purposes hereof, the term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; as applied to each Lender shall mean (a) at any time prior to the termination of the Commitments, the sum of the Revolving Loan Commitment Percentage of such Lender multiplied by the Revolving Committed Amount, and (b) at any time after the termination of the Commitments, the sum of (i) the principal balance of the outstanding Loans of such Lender </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) such Lender&#8217;s Participation Interests in the face amount of the outstanding Letters of Credit and outstanding Swing Line Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Requirement of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as to any Person, the articles or certificate of incorporation and by-laws or other organizational or governing documents of such Person, and any law, treaty, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">30</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">rule or regulation or final, non-appealable determination of an arbitrator or a court or other Governmental Authority, in each case applicable to or binding upon such Person or to which any of its material Property is subject.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an EEA Resolution Authority or, with respect to any UK&#160;Financial Institution, a UK Resolution Authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restatement Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the date on which the conditions set forth in Section 5.1 shall have been satisfied (or waived in accordance with Section 11.6).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revaluation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a)&#160;with respect to any Loan, each of the following&#58;  (i)&#160;each date of a borrowing of a Loan denominated in an Alternative Currency, and (ii) each date of a continuation of a Term Benchmark Loan denominated in an Alternative Currency pursuant to Section&#160;2.4, and (b)&#160;with respect to any Letter of Credit, each of the following&#58;  (i)&#160;each date of issuance, extension or renewal of a Letter of Credit denominated in an Alternative Currency and the last Business Day of each subsequent calendar quarter, (ii)&#160;each date of an amendment of any Letter of Credit denominated in an Alternative Currency having the effect of increasing the amount thereof, and (iii)&#160;each date of any payment by any Issuing Lender under any Letter of Credit denominated in an Alternative Currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Revolving Loans of the same Type and Agreed Currency, made, converted or continued on the same date and, in the case of Term Benchmark Loans, as to which a single Interest Period is in effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to each Lender, the commitment, if any, of such Lender to make Revolving Loans and to acquire Participation Interests in Letters of Credit and Swing Line Loans hereunder, expressed as an amount representing the maximum aggregate permitted amount of such Lender&#8217;s Revolving Exposure hereunder, as such commitment may be (a)&#160;reduced from time to time pursuant to Section&#160;2.1(d), (b) increased from time to time pursuant to Section&#160;2.7 and (c)&#160;reduced or increased from time to time pursuant to assignments by or to such Lender pursuant to Section&#160;11.3.  The initial amount of each Lender&#8217;s Revolving Commitment is set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;1.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, or in the Assignment and Assumption or the Incremental Facility Agreement pursuant to which such Lender shall have assumed its Revolving Commitment, as applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Committed Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means $750,000,000 or such other amount to which the Revolving Committed Amount may be reduced pursuant to Section&#160;2.1(d) or increased pursuant to Section&#160;2.7.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Credit Facility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the recitals.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Lender at any time, the sum of the Dollar Equivalents of such Lender&#8217;s outstanding Revolving Loans and such Lender&#8217;s LOC Obligations and Swing Line Exposure at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Lender with a Revolving Commitment or Revolving Exposure.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Lender Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Revolving Lender, any Person in respect of which such Lender is a subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">31</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Loan Commitment Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for each Lender, at any time, the percentage identified as its Revolving Loan Commitment Percentage on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 1.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, as such percentage may be modified in connection with any assignment made in accordance with the provisions of Section 11.3 and with the establishment of any Incremental Revolving Commitments (or if the Revolving Commitments have been terminated or expired, such Lender&#8217;s Revolving Commitment most recently in effect, giving effect to any assignments)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that for purposes of Section&#160;2.6, if any Defaulting Lender exists at such time, the Revolving Loan Commitment Percentages shall be calculated disregarding such Defaulting Lender&#8217;s Revolving Commitment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the revolving loans made to the Borrower pursuant to Section&#160;2.1(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the fifth anniversary of the Restatement Effective Date, as such date may be extended pursuant to Section 2.8.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any promissory notes of the Borrower in favor of any of the Lenders evidencing the Revolving Loans provided pursuant to Section 2.1, individually or collectively, as appropriate, as such promissory notes may be amended, modified, supplemented, extended, renewed or replaced from time to time and as evidenced in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit 2.1(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; when used in reference to any Loan or Borrowing, refers to whether such Loan, or the Loans comprising such Borrowing, are bearing interest at a rate determined by reference to the Adjusted Daily Simple SONIA Rate or the Adjusted Daily Simple SOFR. All Borrowings and Loans denominated in Sterling shall be RFR Borrowings and Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RFR Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any Loan denominated in Sterling, any day except for (i)&#160;a Saturday, (ii) a Sunday or (iii)&#160;a day on which banks are closed for general business in London.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RFR Interest Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in the definition of &#8220;Daily Simple SONIA Rate&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">S&#38;P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Standard &#38; Poor&#8217;s Financial Services LLC, a division of S&#38;P Global Inc., and its successors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sale and Leaseback Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any arrangement with any Person providing for the leasing by the Borrower or one of its Subsidiaries of any Property that has been or is to be sold or transferred by the Borrower or any of its Subsidiaries to such Person, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Same Day Funds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) with respect to disbursements and payments in Dollars, immediately available funds, and (b) with respect to disbursements and payments in an Alternative Currency, same day or other funds as may be determined by the Administrative Agent or each applicable Issuing Lender, as the case may be, to be customary in the place of disbursement or payment for the settlement of international banking transactions in the relevant Alternative Currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sanctioned Country</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, a country, region or territory which is the target of any countrywide, region-wide or territory-wide Sanctions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">32</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sanctioned Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, (a) any Person listed in any Sanctions-related list of designated Persons maintained by the Office of Foreign Assets Control of the U.S. Department of the Treasury, the U.S. Department of State or by the United Nations Security Council, the European Union or His Majesty&#8217;s Treasury of the United Kingdom, (b) any Person operating, organized or resident in a Sanctioned Country or (c) any Person owned by controlled by any such Person described in the foregoing clause (a) or (b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means economic or financial sanctions or trade embargoes imposed, administered or enforced from time to time by (a) the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department of State, (b) the United Nations Security Council, (c) the European Union or (d) His Majesty&#8217;s Treasury of the United Kingdom.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Screen Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means in respect of the EURIBO Rate for any Interest Period, the euro interbank offered rate administered by the European Money Markets Institute (or any other person which takes over the administration of that rate) for the relevant period displayed on the applicable Bloomberg L.P. &#8220;BBAM&#8221; screen page (or, in the event such rate does not appear on a page of the Bloomberg L.P. screen, on the appropriate page of such other information service that publishes such rate as shall be selected by the Administrative Agent from time to time in its reasonable discretion).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder, as amended, modified, succeeded or replaced from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Series</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 2.7(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Single Employer Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any Plan which is covered by Title IV of ERISA, but which is not a Multiemployer Plan or a Multiple Employer Plan, that is maintained for employees of the Borrower or ERISA Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Social Security Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Social Security Act as set forth in Title 42 of the United States Code, as amended, and any successor statute thereto, as interpreted by the rules and regulations issued thereunder, in each case as in effect from time to time.  References to sections of the Social Security Act shall be construed also to refer to any successor sections.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a rate equal to the secured overnight financing rate as administered by the SOFR Administrator.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the NYFRB (or a successor administrator of the secured overnight financing rate).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR Administrator&#8217;s Website</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the NYFRB&#8217;s website, currently at http&#58;&#47;&#47;www.newyorkfed.org, or any successor source for the secured overnight financing rate identified as such by the SOFR Administrator from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR Rate Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in the definition of &#8220;Daily Simple SOFR&#8221;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SONIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Business Day, a rate per annum equal to the Sterling Overnight Index Average for such Business Day published by the SONIA Administrator on the SONIA Administrator&#8217;s Website on the immediately succeeding Business Day.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">33</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SONIA Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Bank of England (or any successor administrator of the Sterling Overnight Index Average).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SONIA Administrator&#8217;s Website</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Bank of England&#8217;s website, currently at http&#58;&#47;&#47;www.bankofengland.co.uk, or any successor source for the Sterling Overnight Index Average identified as such by the SONIA Administrator from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SPC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 11.3(g).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Specified Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means&#160;with respect to the EURIBO Rate, 11&#58;00 a.m., Frankfurt time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Statutory Reserve Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a fraction (expressed as a decimal), the numerator of which is the number one and the denominator of which is the number one </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the aggregate of the maximum reserve percentage (including any marginal, special, emergency or supplemental reserves), expressed as a decimal, established by the Federal Reserve Board to which the Administrative Agent is subject with respect to the Adjusted EURIBO Rate for eurocurrency funding (currently referred to as &#8220;Eurocurrency liabilities&#8221; in Regulation D) or any other reserve ratio or analogous requirement of any central banking or financial regulatory authority imposed in respect of the maintenance of the Commitments or the funding of Loans.  Such reserve percentage shall include those imposed pursuant to Regulation D.  Term Benchmark Loans for which the associated Benchmark is adjusted by reference to the Statutory Reserve Rate (per the related definition of such Benchmark) shall be deemed to constitute eurocurrency funding and to be subject to such reserve requirements without benefit of or credit for proration, exemptions or offsets that may be available from time to time to any Lender under Regulation D or any comparable regulation.  The Statutory Reserve Rate shall be adjusted automatically on and as of the effective date of any change in any reserve percentage.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sterling</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#163;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; mean the lawful currency of the United Kingdom.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, as to any Person at any time, (a) any corporation more than 50% of whose stock of any class or classes having by the terms thereof ordinary voting power to elect a majority of the directors of such corporation (irrespective of whether or not at the time, any class or classes of such corporation shall have or might have voting power by reason of the occurrence of any contingency) is at such time owned directly or indirectly by such Person and (b) any partnership, association, joint venture or other entity in which such Person directly or indirectly has more than a 50% equity interest at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at any time, the aggregate principal amount of all Swing Line Loans outstanding at such time.  The Swing Line Exposure of any Revolving Lender at any time shall be its Revolving Loan Commitment Percentage of the total Swing Line Exposure at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means JPMorgan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Loan Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the promissory note of the Borrower in favor of the Swing Line Lender evidencing the Swing Line Loans provided pursuant to Section&#160;2.3, as such promissory note may be amended, modified, supplemented, extended, renewed or replaced from time to time in and as evidenced by the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;2.3(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">34</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Loan Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a request by the Borrower for a Swing Line Loan in substantially the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;2.3(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; have the meanings set forth in Section&#160;2.3(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Subfacility Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; have the meaning set forth in Section 2.3(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Syndication Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Synthetic Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any synthetic lease, tax retention operating lease, off-balance sheet loan or similar off-balance sheet financing product where such transaction is considered borrowed money indebtedness for tax purposes but is classified as an operating lease in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">TARGET Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any day on which the Trans-European Automated Real-time Gross Settlement Express Transfer (TARGET) payment system (or, if such payment system ceases to be operative, such other payment system (if any)&#160;determined by the Administrative Agent (and notified to the Borrower in writing) to be a suitable replacement) is open for the settlement of payments in Euros.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 3.13(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Tender Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the costs incurred by the Borrower in connection with any tender for outstanding indebtedness of the Borrower and the termination of the interest rate swap contracts related thereto, in an aggregate amount not to exceed $100,000,000 during the term of this Credit Agreement.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term Benchmark</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; when used in reference to any Loan or Borrowing, refers to whether such Loan, or the Loans comprising such Borrowing, are bearing interest at a rate determined by reference to the Adjusted EURIBO Rate or the Adjusted Term SOFR.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Term Benchmark Borrowing denominated in Dollars and for any tenor comparable to the applicable Interest Period, the Term SOFR Reference Rate at approximately 5&#58;00 a.m., Chicago time, two U.S. Government Securities Business Days prior to the commencement of such tenor comparable to the applicable Interest Period, as such rate is published by the CME Term SOFR Administrator.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Determination Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to it under the definition of Term SOFR Reference Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a Loan bearing interest at a rate determined by reference to the Adjusted Term SOFR.  All Term Benchmark Loans denominated in Dollars shall be Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Loans.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Reference Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, for any day and time (such day, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Determination Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), with respect to any Term Benchmark Borrowing denominated in Dollars and for any tenor comparable to the applicable Interest Period, the rate per annum published by the CME Term SOFR Administrator and identified by the Administrative Agent as the forward-looking term rate based on SOFR.  If by 5&#58;00 pm (New York City time) on such Term SOFR </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">35</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Determination Day, the &#8220;Term SOFR Reference Rate&#8221; for the applicable tenor has not been published by the CME Term SOFR Administrator and a Benchmark Replacement Date with respect to the Term SOFR Rate has not occurred, then, so long as such day is otherwise a U.S. Government Securities Business Day, the Term SOFR Reference Rate for such Term SOFR Determination Day will be the Term SOFR Reference Rate as published in respect of the first preceding U.S. Government Securities Business Day for which such Term SOFR Reference Rate was published by the CME Term SOFR Administrator, so long as such first preceding U.S. Government Securities Business Day is not more than five U.S. Government Securities Business Days prior to such Term SOFR Determination Day.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Total Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means all items that in accordance with GAAP would be classified as assets of the Borrower and its Subsidiaries on a consolidated basis.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">TRICARE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the United States Department of Defense health care program for service families including, but not limited to, TRICARE Prime, TRICARE Extra and TRICARE Standard, and any successor to or predecessor thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Type</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;, when used in reference to any Loan or Borrowing, refers to whether the rate of interest on such Loan, or on the Loans comprising such Borrowing, is determined by reference to the Adjusted Term SOFR, the Adjusted Daily Simple SOFR, the Adjusted EURIBO Rate, the Base Rate or the Adjusted Daily Simple SONIA Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">UK Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any BRRD Undertaking (as such term is defined under the PRA Rulebook (as amended form time to time) promulgated by the United Kingdom Prudential Regulation Authority) or any person falling within IFPRU 11.6 of the FCA Handbook (as amended from time to time) promulgated by the United Kingdom Financial Conduct Authority, which includes certain credit institutions and investment firms, and certain affiliates of such credit institutions or investment firms.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">UK Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Bank of England or any other public administrative authority having responsibility for the resolution of any UK Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Unadjusted Benchmark Replacement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means the applicable Benchmark Replacement excluding the related Benchmark Replacement Adjustment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Upfront Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in Section 5.1(d).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Government Securities Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any day except for (a) a Saturday, (b) a Sunday or (c) a day on which the Securities Industry and Financial Markets Association recommends that the fixed income departments of its members be closed for the entire day for purposes of trading in United States government securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Voting Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means all classes of the Capital Stock of such Person then outstanding and normally entitled to vote in the election of directors (or similar governing authority).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Wells Fargo Fee Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means that certain letter agreement dated as of November 23, 2021, between the Borrower and Wells Fargo Bank, N.A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">36</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Write-Down and Conversion Powers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, (a) with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule, and (b) with respect to the United Kingdom, any powers of the applicable Resolution Authority under the Bail-In Legislation to cancel, reduce, modify or change the form of a liability of any UK Financial Institution or any contract or instrument under which that liability arises, to convert all or part of that liability into shares, securities or obligations of that person or any other person, to provide that any such contract or instrument is to have effect as if a right had been exercised under it or to suspend any obligation in respect of that liability or any of the powers under that Bail-In Legislation that are related to or ancillary to any of those powers.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Other Interpretive Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">With reference to this Credit Agreement and each other Credit Document, unless otherwise specified herein or in such other Credit Document&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The meanings of defined terms are equally applicable to the singular and plural forms of the defined terms.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">(i)&#160;&#160;&#160;&#160;The words &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">herein</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">hereto</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">hereof</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">hereunder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and words of similar import when used in any Credit Document shall refer to such Credit Document as a whole and not to any particular provisions thereof.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Article, Section, Exhibit and Schedule references are to the Credit Document in which such reference appears.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">The term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">including</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; is by way of example and not limitation.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">The term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; includes any and all instruments, documents, agreements, certificates, notices, reports, financial statements and other writings, however evidenced, whether in physical or electronic form.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">In the computation of periods of time from a specified date to a later specified date, the word &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">from</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">from and including</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;&#59; the words &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">until</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; each mean &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">to but excluding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;&#59; and the word &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">through</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">to and including</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Section headings herein and in the other Credit Documents are included for convenience of reference only and shall not affect the interpretation of this Credit Agreement or any other Credit Document.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">References to &#8220;the date hereof&#8221; or &#8220;the date of this Credit Agreement&#8221;, or phrases of similar import, herein shall mean November 23, 2021. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Accounting Terms&#47;Calculation of Financial Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Except as otherwise expressly provided herein, all accounting terms used herein shall be interpreted, and all financial statements, certificates and reports as to financial matters required to be delivered to the Lenders hereunder shall be prepared, in accordance with GAAP applied on a consistent basis. Except as otherwise expressly provided herein, all accounting terms used herein shall be construed in accordance with GAAP as in effect from time to time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if the Borrower, by notice to the Administrative Agent, shall request an amendment to any provision hereof to eliminate the effect of any change occurring after the date hereof in GAAP or in the application thereof on the operation of such provision (or if the Administrative </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">37</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Agent or the Required Lenders, by notice to the Borrower, shall request an amendment to any provision hereof for such purpose), regardless of whether any such notice is given before or after such change in GAAP or in the application thereof, then such provision shall be interpreted on the basis of GAAP as in effect and applied immediately before such change shall have become effective until such notice shall have been withdrawn or such provision amended in accordance herewith.  Following the delivery of any such notice, the Borrower, the Administrative Agent and the Lenders agree to negotiate in good faith to amend this Credit Agreement in an appropriate manner to eliminate the effect of any such change.  Notwithstanding any other provision contained herein, all terms of an accounting or financial nature used herein shall be construed, and all computations of amounts and ratios referred to herein shall be made, without giving effect to (i) any election under Statement of Financial Accounting Standards 159, The Fair Value Option for Financial Assets and Financial Liabilities, or any successor thereto (including pursuant to the Accounting Standards Codification) to value any Indebtedness of the Borrower or any Subsidiary at &#8220;fair value&#8221;, as defined therein, and (ii) any change in accounting for leases pursuant to GAAP resulting from the adoption of Financial Accountings Standards Board Accounting Standards Update No. 2016-02, Leases (Topic 842) (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">FAS 842</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), to the extent such adoption would require (x) treating any lease (or similar arrangement conveying the right to use) as a capital lease where such lease (or similar arrangement) would not have been required to be so treated under GAAP as in effect on the date hereof or (y) recognizing liabilities on the balance sheet with respect to operating leases under FAS 842.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Notwithstanding anything herein to the contrary, for the purposes of calculating the financial covenant set forth in Section 7.2, (i) income statement items (positive or negative) attributable to any Person or Property acquired by the Borrower or one of its Subsidiaries and Indebtedness incurred in connection with such acquisition shall, without duplication, be treated as if such Person or Property had been acquired or such Indebtedness incurred as of the first day of the twelve month period ending as of the most recently completed fiscal quarter of the Borrower for which financial statements have been delivered pursuant to Section 7.1(a) or (b) (or, prior to the delivery of the first financial statements pursuant to Section 7.1(a) or (b), as of the first day of the twelve month period ending as of the date of the most recent balance sheet delivered to the Lenders prior to the Restatement Effective Date) and (ii) income statement items (positive or negative) attributable to Property disposed of by the Borrower or one of its Subsidiaries and Indebtedness retired in connection with such disposition shall, without duplication, be treated as if such disposition had occurred as of the first day of the twelve month period referred to in the preceding clause (i).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Rounding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Any financial ratio required to be maintained by the Borrower pursuant to this Credit Agreement shall be calculated by dividing the appropriate component by the other component, carrying the result to one place more than the number of places by which such ratio is expressed herein and rounding the result up or down to the nearest number (with a rounding-up if there is no nearest number).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:0.36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">38</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Exchange Rates&#59; Currency Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Administrative Agent shall determine the Exchange Rates as of each Revaluation Date to be used for calculating Dollar Equivalent amounts of Loans and Letters of Credit denominated in Alternative Currencies.  Such Exchange Rates shall become effective as of such Revaluation Date and shall be the Exchange Rates employed in converting any amounts between the applicable currencies until the next Revaluation Date to occur in respect of the applicable Loan or Letter of Credit.  Except for purposes of financial statements delivered by the Borrower hereunder or calculating the financial covenant hereunder or except as otherwise provided herein, the applicable amount of any currency (other than Dollars) for purposes of the Credit Documents shall be such Dollar Equivalent amount at the applicable Exchange Rate on the date of such determination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Additional Alternative Currencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Borrower may from time to time request that Loans be made in a currency other than those specifically listed in the definition of &#8220;Alternative Currency&#8221;&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that (a)&#160;such requested currency is a lawful currency (other than Dollars) that is readily available and freely transferable and convertible into Dollars, (b) such currency may be used by any Lender to make Loans hereunder and&#47;or to permit the Borrower to borrow and repay the principal thereof and to pay the interest thereon without any central bank or other governmental authorization in the country of issue of such currency, unless such authorization has been obtained and is in full force and effect, and (c) prior to any such request, the Borrower, the Administrative Agent and the Revolving Lenders shall have amended this Credit Agreement to provide for an interest rate agreed to by the Borrower, the Administrative Agent and the Revolving Lenders and to include such other administrative requirements as may be necessary to implement such interest rate. In the case of any such request with respect to the making of Loans in any such currency, such request shall be subject to the approval of the Administrative Agent and each of the Revolving Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Any such request shall be made to the Administrative Agent not later than 20&#160;Business Days prior to the date of the desired making of Loans (or such other time or date as may be agreed by the Administrative Agent).  In the case of any such request, the Administrative Agent shall promptly notify each Revolving Lender thereof.  Each Revolving Lender shall notify the Administrative Agent, not later than 10 Business Days after receipt of such request whether it consents, in its sole discretion, to the making of Loans in such requested currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Any failure by a Revolving Lender to respond to such request within the time period specified in the preceding sentence shall be deemed to be a refusal by such Lender to permit Loans to be made in such requested currency.  If the Administrative Agent and all the Revolving Lenders consent to making Loans in such requested currency, the Administrative Agent shall so notify the Borrower and such currency shall thereupon be deemed to be an Alternative Currency hereunder for purposes of any borrowings of Loans. If the Administrative Agent shall fail to obtain consent to any request for an additional currency under this Section 1.6, the Administrative Agent shall promptly so notify the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">39</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Change of Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Each obligation of the Borrower to make a payment denominated in the national currency unit of any member state of the European Union that adopts the Euro as its lawful currency after the Restatement Effective Date shall be redenominated into Euro at the time of such adoption (in accordance with the EMU Legislation).  If, in relation to the currency of any such member state, the basis of accrual of interest expressed in this Credit Agreement in respect of that currency shall be inconsistent with any convention or practice in the London interbank market for the basis of accrual of interest in respect of the Euro, such expressed basis shall be replaced by such convention or practice with effect from the date on which such member state adopts the Euro as its lawful currency&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if any borrowing in the currency of such member state is outstanding immediately prior to such date, such replacement shall take effect, with respect to such borrowing, at the end of the then current Interest Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Each provision of this Credit Agreement shall be subject to such reasonable changes of construction as the Administrative Agent may from time to time specify to be appropriate to reflect the adoption of the Euro by any member state of the European Union and any relevant market conventions or practices relating to the Euro.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Each provision of this Credit Agreement also shall be subject to such reasonable changes of construction as the Administrative Agent may from time to time specify to be appropriate to reflect a change in currency of any other country and any relevant market conventions or practices relating to the change in currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">References to Agreements and Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Unless otherwise expressly provided herein, (a)&#160;references to organizational documents, agreements (including the Credit Documents) and other contractual instruments shall be deemed to include all subsequent amendments, restatements, extensions, supplements and other modifications thereto, but only to the extent that such amendments, restatements, extensions, supplements and other modifications are not prohibited by any Credit Document and (b)&#160;references to any law shall include all statutory and regulatory provisions (having the force of law) consolidating, amending, replacing, supplementing or interpreting such law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Letter of Credit Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Unless otherwise specified, all references herein to the amount of a Letter of Credit at any time shall be deemed to mean the maximum face amount of such Letter of Credit after giving effect to all increases thereof contemplated by such Letter of Credit or the LOC Documents related thereto, whether or not such maximum face amount is in effect at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Interest Rates&#59; Benchmark Notification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The interest rate on a Loan denominated in Dollars or an Alternative Currency may be derived from an interest rate benchmark that may be discontinued or is, or may in the future become, the subject of regulatory reform.   Upon the occurrence of a Benchmark Transition Event, Section&#160;3.10(b) provides a mechanism for determining an alternative rate of interest.  The Administrative Agent does not warrant or accept any responsibility for, and shall not have any liability with respect to, the administration, submission, performance or any other matter related to any interest rate used in this Credit Agreement, or with respect to any alternative or successor rate thereto, or replacement rate thereof, including without limitation, whether the composition or characteristics of any such alternative, successor or replacement reference rate will be similar to, or produce the same value or economic equivalence of, the existing interest rate being replaced or have the same volume or liquidity as did any existing interest rate prior to its discontinuance </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">40</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or unavailability (excluding, in each case, in the event of bad faith, gross negligence or willful misconduct on the part of the Administrative Agent (as determined by a court of competent jurisdiction in a final, non-appealable judgment)). The Administrative Agent and its affiliates and&#47;or other related entities may engage in transactions that affect the calculation of any interest rate used in this Credit Agreement or any alternative, successor or alternative rate (including any Benchmark Replacement) and&#47;or any relevant adjustments thereto,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">in each case, in a manner adverse to the Borrower. The Administrative Agent may select information sources or services in its reasonable discretion to ascertain any interest rate used in this Credit Agreement, any component thereof, or rates referenced in the definition thereof, in each case pursuant to the terms of this Credit Agreement, and shall have no liability to the Borrower, any Lender or any other person or entity for damages of any kind, including direct or indirect, special, punitive, incidental or consequential damages, costs, losses or expenses (whether in tort, contract or otherwise and whether at law or in equity), for any error or calculation of any such rate (or component thereof) provided by any such information source or service.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.36pt;text-decoration:underline"><br><br>CREDIT FACILITIES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Revolving Loan Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to the terms and conditions set forth herein, including but not limited to Section 5.2, each Lender severally agrees to make Revolving Loans to the Borrower, in Dollars or in one or more Alternative Currencies, in an amount equal to its Revolving Loan Commitment Percentage, if any, of any borrowing of Revolving Loans, at any time and from time to time, during the period from and including the Restatement Effective Date to but not including the Revolving Maturity Date (or such earlier date if the Commitments have been terminated as provided herein)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, after giving effect to any borrowing of Revolving Loans, the sum of (i) the aggregate amount of the Dollar Equivalent of Revolving Loans outstanding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) the aggregate amount of the Dollar Equivalent of LOC Obligations outstanding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (iii) the aggregate amount of Swing Line Loans outstanding shall not exceed the Revolving Committed Amount, and the aggregate amount of the Dollar Equivalent of Revolving Loans and LOC Obligations denominated in Alternative Currencies at any time shall not exceed $100,000,000 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Currency Sublimit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Subject to the terms of this Credit Agreement, the Borrower may borrow, repay and reborrow Revolving Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Method of Borrowing for Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By no later than (i) 11&#58;00 a.m., New York City Time, on the date of the requested borrowing of Revolving Loans that will be made as Base Rate Loans, (ii)&#160;1&#58;00 p.m., New York City Time, three U.S. Government Securities Business Days prior to the date of the requested borrowing of Revolving Loans that will be made </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">41</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:0.12pt;text-align:justify;text-indent:0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as Term Benchmark Loans denominated in Dollars, (iii)&#160;12&#58;00 p.m., New York City time, three Business Days prior to the date of the requested borrowing of Revolving Loans that will be made as Term Benchmark Loans denominated in Euros, (iv) 11&#58;00 a.m., New York City time, four RFR Business Days prior to the date of the requested borrowing of Revolving Loans that will be made as RFR Loans denominated in Sterling, or (v) 1&#58;00 p.m., New York City time, three U.S. Government Securities Business Days prior to the date of the requested borrowing of Revolving Loans that will be made as RFR Loans denominated in Dollars (but only if applicable pursuant to Section 3.10) the Borrower shall provide written notice, submitted by fax, email or hand delivery, to the Administrative Agent in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit 2.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (or, in the case of any borrowing of Revolving Loans denominated in Dollars, by telephonic notification, confirmed promptly by written notice, submitted by fax, email or hand delivery, to the Administrative Agent in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;2.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">), each of such telephonic notice and such written Notice of Borrowing setting forth (A)&#160;the amount requested, (B)&#160;whether such Revolving Loans shall accrue interest at the Base Rate, the Adjusted Daily Simple SONIA Rate, the Adjusted Term SOFR, the Adjusted Daily Simple SOFR (only if applicable pursuant to Section 3.10) or the Adjusted EURIBO Rate, (C)&#160;with respect to Revolving Loans that will be Term Benchmark Loans, the Interest Period applicable thereto, (D)&#160;with respect to Revolving Loans that will be Term Benchmark Loans or RFR Loans, the applicable currency thereof, (E)&#160;certification that the Borrower has complied in all respects with Section&#160;5.2 and (F) in the case of a Revolving Loan borrowing requested to finance the reimbursement of a Letter of Credit as provided in Section&#160;2.2(d), the identity of the Issuing Lender that has issued such Letter of Credit.  Each such notice must be received by the Administrative Agent not later than (i) three U.S. Government Securities Business Days prior to the requested date of any borrowing of, conversion to or continuation of Term Benchmark Loans denominated in Dollars or of any conversion of Term Benchmark Loans denominated in Dollars to Base Rate Loans, (ii)&#160;three Business Days prior to the requested date of any borrowing or continuation of Term Benchmark Loans denominated in Euros, (iii) four RFR Business Days prior to the requested date of any borrowing of RFR Loans denominated in Sterling  (or three U.S. Government Securities Business Days in the case of any RFR Loans denominated in Dollars (if applicable pursuant to Section 3.10)) and (iv) on the requested date of any borrowing of Base Rate Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Funding of Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Upon receipt of a Notice of Borrowing, the Administrative Agent shall promptly inform the Lenders as to the terms thereof.  Each Lender shall make its Revolving Loan Commitment Percentage of the requested borrowing of Revolving Loans available to the Administrative Agent in Same Day Funds at the Agency Services Address for the applicable currency not later than 1&#58;00 p.m., New York City Time, in each case on the Business Day specified in the Notice of Borrowing.  The amount of the requested Revolving Loans will then be made available to the Borrower by the Administrative Agent as directed by the Borrower in writing, to the extent the amount of such Revolving Loans are made available to the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No Lender shall be responsible for the failure or delay by any other Lender in its obligation to make Revolving Loans hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the failure of any Lender to fulfill its obligations hereunder shall not relieve any other Lender of its obligations hereunder.  Unless the Administrative Agent shall have been notified by any Lender prior to the time of any such Revolving Loan that such Lender does not intend to make available to the Administrative Agent its portion of the Revolving Loans to be made on such date, the Administrative Agent may assume that such Lender has made such amount available to the Administrative Agent on the date of such Revolving Loans, and the Administrative Agent in reliance upon such assumption may (in its sole discretion but without any obligation to do so) make available to the Borrower a corresponding amount.  If such Lender&#8217;s portion of the Revolving Loans is not in fact made available to the Administrative Agent, the Administrative Agent shall be able to recover from such Lender an amount equal to such corresponding amount which the Administrative Agent has made available to the Borrower.  If such Lender does not pay such amount upon the Administrative Agent&#8217;s demand therefor, the Administrative Agent </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">42</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">will promptly notify the Borrower, and the Borrower shall immediately pay such amount to the Administrative Agent.  The Administrative Agent shall also be entitled to recover from such Lender or the Borrower, as the case may be, interest on such amount in respect of each day from the date an amount equal to such corresponding amount was made available by the Administrative Agent to the Borrower to the date such corresponding amount is recovered by the Administrative Agent at a per annum rate equal to (i) from the Borrower, at the applicable rate for such Revolving Loan pursuant to the Notice of Borrowing or (ii) from such Lender, at the Overnight Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> any administrative, processing or similar fees customarily charged by the Administrative Agent in connection with the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Reductions of Revolving Committed Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Upon at least three Business Days&#8217; prior written notice, the Borrower shall have the right to permanently reduce, without premium or penalty, all or part of the aggregate unused amount of the Revolving Committed Amount at any time or from time to time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that (i)&#160;each partial reduction shall be in an aggregate amount at least equal to $10,000,000 and in integral multiples of $1,000,000 above such amount and (ii)&#160;no reduction shall be made which would reduce the Revolving Committed Amount to an amount less than the aggregate amount of the Dollar Equivalent of outstanding Revolving Loans </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the aggregate amount of the Dollar Equivalent of outstanding LOC Obligations </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the aggregate amount of outstanding Swing Line Loans.  Any reduction in (or termination of) the Revolving Committed Amount pursuant to this Section 2.1(d) shall be permanent and may not be reinstated.  The Administrative Agent shall immediately notify the Lenders of any reduction in the Revolving Committed Amount pursuant to this Section 2.1(d).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Revolving Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Revolving Loans made by each Lender shall be evidenced by a duly executed promissory note of the Borrower to each Lender that requests a Revolving Note in substantially the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit 2.1(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Letter of Credit Subfacility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Issuance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to the terms and conditions hereof and of the LOC Documents, if any, and any other terms and conditions relating to the Borrower which the applicable Issuing Lender may reasonably require (so long as such terms and conditions do not impose any financial obligation on or require any Lien (not otherwise contemplated by this Credit Agreement) to be given by the Borrower or any of its Subsidiaries or conflict with any obligation of, or detract from any action which may be taken by, the Borrower under this Credit Agreement), each Issuing Lender agrees, in reliance upon the agreements of the other Lenders set forth in this Section&#160;2.2, from time to time upon request, to issue (from the Restatement Effective Date to thirty days prior to the Revolving Maturity Date and in a form reasonably acceptable to such Issuing Lender), in Dollars or, to the extent specified by the Borrower in the applicable request for issuance, in one or more Alternative Currencies, and Participants shall participate in, Letters of Credit for the account of the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, after giving effect to the issuance (or drawdown or extension) of any Letter of Credit, (i) the aggregate amount of the Dollar Equivalent of LOC Obligations for such Issuing Lender shall not at any time exceed the LOC Committed Amount of such Issuing Lender, (ii)&#160;the aggregate amount of the Dollar Equivalent of LOC Obligations shall not at any time exceed the aggregate LOC Committed Amount for all Issuing Lenders, (iii)&#160;the sum of (A)&#160;the aggregate amount of the Dollar Equivalent of outstanding LOC Obligations, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (B)&#160;the aggregate amount of the Dollar Equivalent of Revolving Loans outstanding, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (C) the aggregate amount of Swing Line Loans outstanding shall not exceed the Revolving Committed Amount and (iv)&#160;the aggregate amount of the Dollar Equivalent of Revolving Loans and LOC Obligations denominated in Alternative Currencies at any time shall not exceed the Foreign Currency Sublimit.  Each Issuing Lender may require the issuance and expiry date of each Letter of Credit issued by it to be a Business Day.  Each Letter of Credit shall be&#160;a standby letter of credit issued to support the obligations (including pension or insurance obligations), contingent or otherwise, of the Borrower or any of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">43</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">its Subsidiaries.  No Letter of Credit shall have an original expiry date after the earlier of (x) one year from the date of issuance and (y) five Business Days prior to the Revolving Maturity Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that any Letter of Credit may contain customary automatic renewal provisions agreed upon by the Borrower and the relevant Issuing Lender pursuant to which the expiration date of such Letter of Credit shall automatically be extended for a period of up to 12 months (but not to a date later than the date set forth in clause (y) above), subject to a right on the part of such Issuing Lender to prevent any such renewal from occurring by giving notice to the beneficiary in advance of any such renewal.  Each Letter of Credit shall comply with the related LOC Documents.   The Borrower shall promptly examine a copy of each Letter of Credit and each amendment thereto that is delivered to it and, in the event of any claim of noncompliance with the Borrower&#8217;s instructions or other irregularity, the Borrower will immediately notify the relevant Issuing Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Notice and Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The request for the issuance of a Letter of Credit (or the amendment, renewal or extension of an outstanding Letter of Credit (other than an automatic renewal permitted pursuant to paragraph (a) of this Section)) shall be submitted to the Administrative Agent for distribution by the Administrative Agent to the relevant Issuing Lender as specified by  the Borrower by hand delivery, fax or email at least three Business Days prior to the requested date of issuance for the Administrative Agent to coordinate with the respective Issuing Lenders.  Each Issuing Lender will, at least quarterly and more frequently upon request, provide to the Administrative Agent for dissemination to the Lenders a report specifying the Letters of Credit which are then issued and outstanding.  Each Issuing Lender will further provide to the Administrative Agent, promptly upon request, copies of the Letters of Credit and the other LOC Documents.  For the avoidance of any doubt, the Borrower shall be entitled at all times to select which Issuing Lender will be used to issue a Letter of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Participations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each Participant, upon issuance of a Letter of Credit, shall be deemed to have purchased without recourse a risk participation from the relevant Issuing Lender in such Letter of Credit and each LOC Document related thereto and the rights and obligations arising thereunder and any collateral relating thereto, in each case in an amount equal to its Revolving Loan Commitment Percentage of the obligations under such Letter of Credit, and shall absolutely, unconditionally and irrevocably assume, as primary obligor and not as surety, and be obligated to pay to such Issuing Lender therefor and discharge when due, its Revolving Loan Commitment Percentage of the obligations arising under such Letter of Credit.  Without limiting the scope and nature of each Participant&#8217;s participation in any Letter of Credit, to the extent that any Issuing Lender has not been reimbursed as required hereunder or under any such Letter of Credit or pursuant to a Mandatory Borrowing under Section&#160;2.2(e)(i), each such Participant shall fund its Participation Interest in such unreimbursed drawing in accordance with the terms of Section&#160;2.2(e)(ii).  Each Participant acknowledges and agrees that its obligation to acquire participations pursuant to this paragraph in respect of Letters of Credit is absolute and unconditional and shall not be affected by any circumstance whatsoever, including any amendment, renewal or extension of any Letter of Credit (provided that such Letter of Credit shall expire no later than the date set forth in paragraph (a) of this Section), the occurrence and continuance of a Default, any reduction or termination of the Commitments or any force majeure or other event that under any rule of law or uniform practices to which any Letter of Credit is subject permits a drawing to be made under such Letter of Credit after the expiration thereof or of the Commitments, and that each such payment shall be made without any offset, abatement, withholding or reduction whatsoever.  Each Participant further acknowledges and agrees that, in issuing, amending, renewing or extending any Letter of Credit, the relevant Issuing Lender shall be entitled to rely, and shall not incur any liability for relying, upon the representations and warranties of the Borrower deemed made pursuant to Section 5.2.  Any such reimbursement shall not relieve or otherwise impair the obligation of the Borrower to reimburse the relevant Issuing Lender under any Letter of Credit, together with interest as hereinafter provided.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">44</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Reimbursement by Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event of any drawing under any Letter of Credit, the relevant Issuing Lender will promptly notify the Borrower.  Unless the Borrower shall notify such Issuing Lender of its intent to otherwise reimburse such Issuing Lender and shall reimburse such Issuing Lender in same day funds in the currency of such drawing within one hour of receipt of notice of such drawing from such Issuing Lender, (i) if such drawing relates to a Letter of Credit denominated in an Alternative Currency, automatically and with no further action, the obligation of the Borrower to reimburse such drawing shall be permanently converted into an obligation to reimburse the Dollar Equivalent of such drawing, calculated using the Letter of Credit Exchange Rate applicable to such drawing and (ii) the Borrower shall be deemed to have requested a Revolving Loan borrowing in Dollars at the Base Rate in the amount of such drawing or Dollar Equivalent thereof, as the case may be, the proceeds of which will be used to satisfy the Borrower&#8217;s reimbursement obligations.  Pending the satisfaction of the Borrower&#8217;s reimbursement obligations through the making of Revolving Loans pursuant to Section 2.2(e)(i), the unreimbursed amount of such drawing or the Dollar Equivalent thereof, as the case may be, will bear interest, payable from time to time on demand or, if no demand has been made, on the date on which the Borrower reimburses the applicable Letter of Credit in full, at the rate applicable to Base Rate Loans, for the accounts of the relevant Issuing Lender and the Participants, as their interests may appear.  The Borrower&#8217;s reimbursement obligations hereunder shall be absolute, unconditional and irrevocable under all circumstances irrespective of (but without waiver of) (i) any rights of set-off, counterclaim or defense to payment the applicable account party or the Borrower may claim or have against any Issuing Lender, the Administrative Agent, the Lenders, the beneficiary of the Letter of Credit drawn upon or any other Person, including without limitation, any defense based on any failure of the applicable account party or the Borrower to receive consideration, (ii) the legality, validity, regularity or unenforceability of any Letter of Credit, this Credit Agreement or any other Credit Document, (iii) any draft or other document presented under a Letter of Credit proving to be forged, fraudulent or invalid in any respect or any statement therein being untrue or inaccurate in any respect, or (iv) any force majeure or other event that under any rule of law or uniform practices to which any Letter of Credit is subject permits a drawing to be made under such Letter of Credit after the stated expiration date thereof or of the Commitments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Reimbursement by Lenders.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Reimbursement with Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  On any day on which the Borrower shall have requested, or been deemed to have requested, a Revolving Loan borrowing to reimburse a drawing under a Letter of Credit (as set forth in clause (d) above), the Administrative Agent shall give notice to the Lenders, and a Revolving Loan borrowing in the amount of the Borrower&#8217;s reimbursement obligation comprised solely of Base Rate Loans (each such borrowing, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Mandatory Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) shall be made from all Revolving Lenders (without giving effect to any termination of the Commitments pursuant to Section&#160;9.2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">pro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> based on each Revolving Lender&#8217;s respective Revolving Loan Commitment Percentage and the proceeds thereof shall be paid directly to the relevant Issuing Lender for application to the respective LOC Obligations.  Each applicable Lender hereby irrevocably agrees to make such Revolving Loans upon any such request or deemed request on account of each such Mandatory Borrowing in the amount and in the manner specified in the preceding sentence and in accordance with the terms of Section&#160;2.2(e)(iii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">notwithstanding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (A) the amount of Mandatory Borrowing may not comply with the minimum amount for borrowings of Revolving Loans otherwise required hereunder, (B) whether any conditions specified in Section 5.2 are then satisfied or waived, (C) whether a Default or Event of Default then exists, (D) failure of any such request or deemed request for Revolving Loans to be made by the time otherwise required hereunder, (E) the date of such Mandatory Borrowing, (F) any reduction in the Revolving Committed Amount or any termination of the Commitments, or (G) any set-</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">45</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">off, counterclaim, recoupment, defense or other right which such Lender may have against any Issuing Lender, the Borrower or any other Person for any reason whatsoever.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt;text-decoration:underline">Reimbursement Through Funding of Participation Interests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event that any Mandatory Borrowing cannot for any reason be made on the date otherwise required above (including, without limitation, as a result of the commencement of a proceeding under the Bankruptcy Code with respect to the Borrower), the relevant Issuing Lender will promptly notify the Participants of the Dollar amount of any unreimbursed drawing (determined as provided above and adjusted for any payments received from the Borrower on or after the date of such drawing and prior to the funding of the Participation Interests therein) and each Participant shall fund its Participation Interest in such unreimbursed drawing by paying to the relevant Issuing Lender, in Dollars and in immediately available funds, the amount of such Participant&#8217;s Revolving Loan Commitment Percentage of such unreimbursed drawing.  Each Participant&#8217;s obligation to make such payment to such Issuing Lender, and the right of such Issuing Lender to receive the same, shall be absolute and unconditional, shall not be affected by any circumstance whatsoever and without regard to (A) the termination of this Credit Agreement or the Commitments hereunder, (B) the existence of a Default or Event of Default, (C) the acceleration of the obligations hereunder and (D) any set-off, counterclaim, recoupment, defense or other right which such Participant may have against such Issuing Lender, the Borrower or any other Person for any reason whatsoever.  Simultaneously with the making of each such payment by a Participant to any Issuing Lender, such Participant shall, automatically and without any further action on the part of the relevant Issuing Lender or such Participant, acquire a participation in an amount equal to such payment (excluding the portion of such payment constituting interest owing to such Issuing Lender) in the related unreimbursed LOC Obligation and in the interest thereon and in the related LOC Documents, and shall have a claim against the Borrower with respect thereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Funding of Mandatory Borrowing or Participation Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each Revolving Lender and each Participant shall upon any notice pursuant to Section&#160;2.2(e)(i) or Section&#160;2.2(e)(ii), respectively, make its Revolving Loan Commitment Percentage of the unreimbursed drawing or Dollar Equivalent thereof, as the case may be, available to the Administrative Agent, for the benefit of the relevant Issuing Lender, by 1&#58;00 p.m., New York City Time, on the day of the notice if notice is given on or before 11&#58;00 a.m. or by 1&#58;00 p.m., New York City Time, the next Business Day if notice is given after 11&#58;00 a.m., in Dollars in immediately available funds at the Agency Services Address.  The Administrative Agent shall remit the funds so received to such Issuing Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Modification and Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The issuance of any supplement, modification, amendment, renewal, or extensions to any Letter of Credit shall, for purposes hereof, be treated in all respects the same as the issuance of a new Letter of Credit hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Applicability of ISP98</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Unless otherwise expressly agreed by the relevant Issuing Lender and the Borrower when a Letter of Credit is issued, the rules of the &#8220;International Standby Practices 1998&#8221; published by the Institute of International Banking Law &#38; Practice (or such later version thereof as may be in effect at the time of issuance) shall apply to each Letter of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Responsibility of Issuing Lenders.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">It is expressly understood and agreed as between the Lenders that the obligations of each Issuing Lender hereunder to the Participants are only those expressly set forth in this Credit Agreement and that each Issuing Lender shall be entitled to assume </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">46</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that the conditions precedent set forth in Section 5.2 have been satisfied unless it shall have acquired actual knowledge that any such condition precedent has not been satisfied&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that nothing set forth in this Section&#160;2.2 shall be deemed to prejudice the right of any Participant to recover from any Issuing Lender any amounts made available by such Participant to such Issuing Lender pursuant to this Section&#160;2.2 in the event that it is determined by a court of competent jurisdiction by a final and non-appealable judgment that the payment with respect to a Letter of Credit constituted gross negligence or willful misconduct on the part of such Issuing Lender.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">No Issuing Lender shall be under any obligation to issue any Letter of Credit if (a)&#160;any order, judgment or decree of any Governmental Authority or arbitrator shall by its terms purport to enjoin or restrain such Issuing Lender from issuing such Letter of Credit, (b)&#160;any Requirement of Law applicable to such Issuing Lender or any request or directive (whether or not having the force of law) from any Governmental Authority with jurisdiction over such Issuing Lender shall prohibit, or request that such Issuing Lender refrain from, the issuance of letters of credit generally or such Letter of Credit in particular or shall impose upon such Issuing Lender with respect to such Letter of Credit any restriction, reserve or capital requirement (for which such Issuing Lender is not otherwise compensated hereunder) not in effect on the Restatement Effective Date, or shall impose upon any Issuing Lender any unreimbursed loss, cost or expense which was not applicable on the Restatement Effective Date and which such Issuing Lender in good faith deems material to it, or (c)&#160;the issuance of such Letter of Credit would violate one or more policies of such Issuing Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Conflict with LOC Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event of any conflict between this Credit Agreement and any LOC Document, this Credit Agreement shall govern.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Indemnification of Issuing Lenders.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">In addition to its other obligations under this Credit Agreement, the Borrower hereby agrees to protect, indemnify, pay and hold harmless each Issuing Lender from and against any and all claims, demands, liabilities, damages, losses, costs, charges and expenses (including Attorney Costs) that any Issuing Lender may incur or be subject to as a consequence, direct or indirect, of (A) the issuance of any Letter of Credit or (B) the failure of any Issuing Lender to honor a drawing under a Letter of Credit as a result of any act or omission, whether rightful or wrongful, of any present or future de jure or de facto Governmental Authority (all such acts or omissions, herein called &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Government Acts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">As between the Borrower and each Issuing Lender, the Borrower shall assume all risks of the acts, omissions or misuse of any Letter of Credit by the beneficiary thereof.  No Issuing Lender shall be responsible for (except in the case of (A), (B) and (C) below if such Issuing Lender has actual knowledge to the contrary)&#58;  (A)&#160;the form, validity, sufficiency, accuracy, genuineness or legal effect of any document submitted by any party in connection with the application for and issuance of any Letter of Credit, even if it should in fact prove to be in any or all respects invalid, insufficient, inaccurate, fraudulent or forged&#59; (B)&#160;the validity or sufficiency of any instrument transferring or assigning or purporting to transfer or assign any Letter of Credit or the rights or benefits thereunder or proceeds thereof, in whole or in part, that may prove to be invalid or ineffective for any reason&#59; (C)&#160;failure of the beneficiary of a Letter of Credit to comply fully with conditions required in order to draw upon a Letter of Credit&#59; (D)&#160;errors, omissions, interruptions or delays in transmission or delivery of any messages, by mail, cable, telegraph, telex or otherwise, whether or not they be in cipher&#59; (E)&#160;any loss or delay in the transmission or otherwise of any document required in order to make a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">47</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">drawing under a Letter of Credit or of the proceeds thereof and (F)&#160;any consequences arising from causes beyond the control of such Issuing Lender, including, without limitation, any Government Acts.  None of the above shall affect, impair, or prevent the vesting of any Issuing Lender&#8217;s rights or powers hereunder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">In furtherance and extension and not in limitation of the specific provisions hereinabove set forth, any action taken or omitted by any Issuing Lender, under or in connection with any Letter of Credit or the related certificates, if taken or omitted in good faith, shall not put such Issuing Lender under any resulting liability to the Borrower.  It is the intention of the parties that this Credit Agreement shall be construed and applied to protect and indemnify each Issuing Lender against any and all risks involved in the issuance of the Letters of Credit, all of which risks are hereby assumed by the Borrower, including, without limitation, any and all risks of the acts or omissions, whether rightful or wrongful, of any present or future Government Acts.  No Issuing Lender shall, in any way, be liable for any failure by any Issuing Lender or anyone else to pay any drawing under any Letter of Credit as a result of any Government Acts or any other cause beyond the control of such Issuing Lender.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">None of the Administrative Agent, the Lenders or the Issuing Lenders, or any of their Related Parties, shall have any liability or responsibility by reason of or in connection with the issuance or transfer of any Letter of Credit or any payment or failure to make any payment thereunder (irrespective of any of the circumstances referred to in the preceding sentence), or any error, omission, interruption, loss or delay in transmission or delivery of any draft, notice or other communication under or relating to any Letter of Credit (including any document required to make a drawing thereunder), any error in interpretation of technical terms or any consequence arising from causes beyond the control of any Issuing Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that the foregoing shall not be construed to excuse any Issuing Lender from liability to the Borrower to the extent of any direct damages (as opposed to special, indirect, consequential or punitive damages, claims in respect of which are hereby waived by the Borrower to the extent permitted by applicable law) suffered by the Borrower that are caused by such Issuing Lender&#8217;s failure to exercise care when determining whether drafts and other documents presented under a Letter of Credit comply with the terms thereof.&#160; The parties hereto expressly agree that, in the absence of gross negligence or willful misconduct on the part of any Issuing Lender (as finally determined by a court of competent jurisdiction), such Issuing Lender shall be deemed to have exercised care in each such determination.&#160; In furtherance of the foregoing and without limiting the generality thereof, the parties agree that, with respect to documents presented which appear on their face to be in substantial compliance with the terms of a Letter of Credit, the relevant Issuing Lender may, in its sole discretion, either accept and make payment upon such documents without responsibility for further investigation, regardless of any notice or information to the contrary, or refuse to accept and make payment upon such documents if such documents are not in strict compliance with the terms of such Letter of Credit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Nothing in this subsection (j) is intended to limit the reimbursement obligation of the Borrower contained in this Section&#160;2.2.  The obligations of the Borrower under this subsection (j) shall survive the termination of this Credit Agreement.  No act or omission of any current or prior beneficiary of a Letter of Credit shall in any way affect or impair the rights of any Issuing Lender to enforce any right, power or benefit under this Credit Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">Notwithstanding anything to the contrary contained in this subsection&#160;(j), the Borrower shall have no obligation to indemnify any Issuing Lender in respect of any liability incurred by such Issuing Lender arising out of the gross negligence, willful </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">48</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">misconduct or bad faith of such Issuing Lender, as determined by a court of competent jurisdiction by a final and non-appealable judgment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Designation of other Persons as Account Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary set forth in this Credit Agreement, including without limitation Section&#160;2.2(a) hereof, a Letter of Credit issued hereunder may contain a statement to the effect that such Letter of Credit is issued for the account of a Subsidiary of the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that notwithstanding such statement, the Borrower shall be the actual account party for all purposes of this Credit Agreement for such Letter of Credit and such statement shall not affect the Borrower&#8217;s reimbursement obligations hereunder with respect to such Letter of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Designation of Additional Issuing Lenders.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  From time to time, the Borrower may by notice to the Administrative Agent and the Lenders designate as additional Issuing Lenders one or more Lenders that agree to serve in such capacity as provided below.  The acceptance by a Lender of any appointment as an Issuing Lender hereunder shall be evidenced by an agreement (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Issuing Lender Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), which shall be in a form satisfactory to the Borrower and the Administrative Agent, shall set forth the LOC Commitment of such Lender and shall be executed by such Lender, the Borrower and the Administrative Agent and, from and after the effective date of such agreement, (i)&#160;such Lender shall have all the rights and obligations of an Issuing Lender under this Credit Agreement and the other Credit Documents and (ii) references herein and in the other Credit Documents to the term &#8220;Issuing Lender&#8221; shall be deemed to include such Lender in its capacity as an Issuing Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt;text-decoration:underline">Termination of an Issuing Lender.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  An Issuing Lender may be terminated as Issuing Lender by written agreement among the Borrower, the Administrative Agent and such Issuing Lender.  The Administrative Agent shall notify the Lenders of any such termination of an Issuing Lender.  At the time any such termination shall become effective, the Borrower shall pay all unpaid fees accrued for the account of the terminated Issuing Lender pursuant to Section 3.4(b).  After the termination of an Issuing Lender hereunder, the terminated Issuing Lender shall remain a party hereto and shall continue to have all the rights and obligations of an Issuing Lender under this Credit Agreement and the other Credit Documents with respect to Letters of Credit issued by it prior to such termination, but shall not be required to amend, renew (other than automatic renewal pursuant to the terms of such Letter of Credit) or extend any such Letter of Credit or to issue additional Letters of Credit.  The termination of any Issuing Lender shall not affect the LOC Commitment of any other Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Existing Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. As of the Restatement Effective Date, without further action on the part of any Person, each Existing Letter of Credit shall be automatically deemed to be a Letter of Credit issued hereunder for all purposes of this Credit Agreement, and the original issuing lender of each such Letter of Credit shall be the Issuing Lender thereof for all purposes hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Swing Line Loans Subfacility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Swing Line Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Administrative Agent, the Swing Line Lender and the Lenders agree that in order to facilitate the administration of this Credit Agreement and the other Credit Documents, the Swing Line Lender may (but shall have absolutely no obligation to) make loans (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to the Borrower, in Dollars, at any time and from time to time, during the period from and including the Restatement Effective Date to but not including the Revolving Maturity Date (or such earlier date on which the Commitments have been terminated as provided herein) on the terms and subject to the conditions set forth herein and in the other Credit Documents&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, after giving effect to the issuance of any such Swing Line Loan, (i)&#160;the aggregate principal amount of the Swing Line Loans outstanding at any one time shall not exceed $50,000,000 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">49</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Subfacility Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) at any time and (ii)&#160;the sum of (A) the aggregate amount of Swing Line Loans outstanding, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (B) the aggregate amount of the Dollar Equivalent of Revolving Loans outstanding, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (C) the aggregate amount of the Dollar Equivalent of LOC Obligations outstanding shall not exceed the Revolving Committed Amount.  Subject to the terms of this Credit Agreement, the Borrower may borrow, repay and reborrow Swing Line Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Method of Borrowing and Funding Swing Line Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By no later than 1&#58;00&#160;p.m., New York City Time, on the date of the requested borrowing of Swing Line Loans, the Borrower shall provide telephone notice to the Swing Line Lender, followed promptly by a written Swing Line Loan Request in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;2.3(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (which may be submitted by fax), setting forth (i)&#160;the amount of the requested Swing Line Loan and (ii)&#160;the date of the requested Swing Line Loan and complying in all respects with Section&#160;5.2.  If the Swing Line Lender elects to make such Swing Line Loans, the Swing Line Lender shall initiate the transfer of funds representing the Swing Line Loan advance to the Borrower by 3&#58;00 p.m., New York City Time, on the Business Day of the requested borrowing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Repayment and Participations of Swing Line Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower agrees to repay each Swing Line Loan immediately upon the existence of a Default or Event of Default or otherwise on the earlier of the Revolving Maturity Date and the first date after such Swing Line Loan is made that is the 15th or last day of a calendar month and is at least three Business Days after such Swing Line Loan is made&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that on each date that a borrowing of Revolving Loans denominated in Dollars is made, the Borrower shall repay all Swing Line Loans that were outstanding on the date such borrowing was requested.  Each repayment of a Swing Line Loan may be accomplished by requesting Revolving Loans which request is not subject to the conditions set forth in Section&#160;5.2.  In the event that the Borrower shall fail to timely repay any Swing Line Loan, and in any event upon (i)&#160;a request by the Swing Line Lender, (ii)&#160;the occurrence of an Event of Default described in Section&#160;9.1(f) or (iii)&#160;the acceleration of any Loan or termination of any Commitment pursuant to Section&#160;9.2, each Revolving Lender shall promptly irrevocably and unconditionally purchase from the Swing Line Lender, without recourse or warranty, an undivided interest and participation in such Swing Line Loan in an amount equal to such other Lender&#8217;s Revolving Loan Commitment Percentage thereof, by directly purchasing a participation in such Swing Line Loan in such amount (regardless of whether the conditions precedent thereto set forth in Section&#160;5.2 are then satisfied, whether or not the Borrower has submitted a Notice of Borrowing and whether or not the Commitments are then in effect, any Event of Default exists or all the Loans have been accelerated) and paying the proceeds thereof to the Swing Line Lender at the Agency Services Address, or at such other address as the Swing Line Lender may designate, in Dollars and in immediately available funds.  If such Participant does not pay such amount forthwith upon the Swing Line Lender&#8217;s demand therefor, and until such time as such Participant makes the required payment, the Swing Line Lender shall be deemed to continue to have outstanding Swing Line Loans in the amount of such unpaid participation obligation for all purposes of the Credit Documents other than those provisions requiring the other Participants to purchase a participation therein.  Further, such Participant shall be deemed to have assigned any and all payments made of principal and interest on its Loans, and any other amounts due to it hereunder to the Swing Line Lender to fund Swing Line Loans in the amount of the participation in Swing Line Loans that such Participant failed to purchase pursuant to this Section&#160;2.3(c) until such amount has been purchased (as a result of such assignment or otherwise).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Swing Line Loan Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Swing Line Loans made by the Swing Line Lender shall, if requested by the Swing Line Lender, be evidenced by a duly executed promissory note of the Borrower to the Swing Line Lender in substantially the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;2.3(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">50</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Continuations and Conversions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Subject to the terms below, the Borrower shall have the option, on any Business Day, to continue existing Term Benchmark Loans for a subsequent Interest Period, to convert Base Rate Loans into Term Benchmark Loans denominated in Dollars or to convert Term Benchmark Loans denominated in Dollars into Base Rate Loans.  By no later than 11&#58;00 a.m., New York City Time, (a)&#160;on the date of the requested conversion of a Term Benchmark Loan denominated in Dollars to a Base Rate Loan or (b)&#160;three U.S. Government Securities Business Days prior to the date of the requested continuation of a Term Benchmark Loan denominated in Dollars or conversion of a Base Rate Loan to a Term Benchmark Loan denominated in Dollars or (c) three Business Days prior to the date of the requested continuation of a Term Benchmark Loan denominated in Euros, the Borrower shall provide a written Notice of Continuation&#47;Conversion, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit 2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, submitted by hand delivery, fax or email, to the Administrative Agent (or, in the case of a continuation or conversion of Loans denominated in Dollars to Loans denominated in Dollars, telephonic notice, confirmed promptly by hand delivery, fax or email to the Administrative Agent of a written Notice of Continuation&#47;Conversion, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) setting forth (i)&#160;whether the Borrower wishes to continue or convert such Loans and (ii)&#160;if the request is to continue a Term Benchmark Loan or convert a Base Rate Loan to a Term Benchmark Loan, the Interest Period applicable thereto.  Notwithstanding anything herein to the contrary, (A)&#160;except as provided in Section 3.11, Term Benchmark Loans may only be continued or converted into Base Rate Loans on the last day of the Interest Period applicable thereto, (B)&#160;Term Benchmark Loans may not be continued nor may Base Rate Loans be converted into Term Benchmark Loans during the existence and continuation of an Event of Default, (C)&#160;any request to continue a Term Benchmark Loan that fails to comply with the terms hereof or any failure to request a continuation of a Term Benchmark Loan at the end of an Interest Period shall constitute a conversion to a Base Rate Loan on the last day of the applicable Interest Period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that in the case of a failure to timely request a continuation of Term Benchmark Loans denominated in an Alternative Currency or if any such request fails to comply with the terms hereof, such Loans shall be continued as Term Benchmark Loans in their original currency with an Interest Period of one month, and (D)&#160;any failure to state the Interest Period with respect to the continuation of a Term Benchmark Loan or the conversion of a Base Rate Loan to a Term Benchmark Loan shall constitute a request for a one month Interest Period.  No Revolving Loans may be converted into or continued as Revolving Loans denominated in a different currency, but instead must be prepaid in the original currency of such Revolving Loans and reborrowed in the other currency. It is understood and agreed that Swing Line Loans may not be continued or converted.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Minimum Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each request for a borrowing, conversion or continuation shall be subject to the requirements that (a)&#160;each Term Benchmark Loan and RFR Loan shall be in an aggregate amount that is an integral multiple of the Borrowing Multiple and not less than the Borrowing Minimum, (b)&#160;each Base Rate Loan shall be in a minimum amount of the lesser of $5,000,000 (and in integral multiples of $1,000,000 in excess thereof) or the remaining available Revolving Committed Amount, (c)&#160;each Swing Line Loan shall be in a minimum amount of the lesser of $1,000,000 (and in integral multiples of $100,000 in excess thereof) or the remaining available Swing Line Subfacility Amount and (d)&#160;no more than 10 Term Benchmark Loans and RFR Loans shall be outstanding hereunder at any one time.  For the purposes of this Section&#160;2.5, all Term Benchmark Loans denominated in the same currency with the same Interest Periods that begin and end on the same date shall be considered as one Term Benchmark Loan, but Term Benchmark Loans with different Interest Periods, even if they begin on the same date, shall be considered as separate Term Benchmark Loans.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">51</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Defaulting Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any provision of this Credit Agreement to the contrary, if any Revolving Lender becomes a Defaulting Lender, then the following provisions shall apply for so long as such Revolving Lender is a Defaulting Lender&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Facility Fees shall cease to accrue on the Revolving Commitment of such Defaulting Lender pursuant to Section 3.4(a)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the Revolving Commitment and Revolving Exposure of such Defaulting Lender shall not be included in determining whether the Required Lenders or any other requisite Lenders have taken or may take any action hereunder or under any other Credit Document (including any consent to any amendment, waiver or other modification pursuant to Section 11.6)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that any amendment, waiver or other modification requiring the consent of all Lenders or all Lenders affected thereby shall, except as otherwise provided in Section 11.6, require the consent of such Defaulting Lender in accordance with the terms hereof&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">if any Swing Line Exposure or LOC Obligation exists at the time such Revolving Lender becomes a Defaulting Lender then&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">the Swing Line Exposure and LOC Obligations of such Defaulting Lender shall be reallocated among the Non-Defaulting Lenders in accordance with their respective Revolving Loan Commitment Percentages but only to the extent that the sum of all Non-Defaulting Lenders&#8217; Revolving Exposures </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> such Defaulting Lender&#8217;s Swing Line Exposure and LOC Obligations does not exceed the sum of all Non-Defaulting Lenders&#8217; Revolving Commitments&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">if the reallocation described in clause (i) above cannot, or can only partially, be effected, the Borrower shall, within one Business Day following notice by the Administrative Agent (A) first, prepay the portion of such Defaulting Lender&#8217;s Swing Line Exposure that has not been reallocated and (B)&#160;second, cash collateralize for the benefit of the Issuing Lenders the portion of such Defaulting Lender&#8217;s LOC Obligations that has not been reallocated for so long as such LOC Obligations are outstanding by depositing cash in such amount in an account with the Administrative Agent, in the name of the Administrative Agent and for the benefit of the Lenders&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">if the Borrower cash collateralizes any portion of such Defaulting Lender&#8217;s LOC Obligations pursuant to clause (ii) above, the Borrower shall not be required to pay Letter of Credit Fees to such Defaulting Lender pursuant to Section&#160;3.4(b) with respect to such portion of such Defaulting Lender&#8217;s LOC Obligations for so long as such Defaulting Lender&#8217;s LOC Obligations are cash collateralized&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">if any portion of the LOC Obligations of such Defaulting Lender is reallocated pursuant to clause (i) above, then the fees payable to the Lenders pursuant to Sections 3.4(a) and 3.4(b) shall be adjusted to give effect to such reallocation&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">if such Defaulting Lender&#8217;s LOC Obligations or Swing Line Exposure or any portion thereof are not repaid or reallocated or cash collateralized pursuant to clause (i) or (ii) above, then, without prejudice to any rights or remedies of any Issuing Lender or any other Lender hereunder, all Facility Fees </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that otherwise would have been payable to such Defaulting Lender (solely with respect to the portion of such Defaulting Lender&#8217;s Commitment utilized by such LOC Obligations and Swing Line Exposure) and Letter of Credit Fees payable under Section 3.4(b) with respect to such Defaulting Lender&#8217;s LOC Obligations shall be payable to the relevant Issuing Lender and the Swing Line Lender, as its interests may appear, until and to the extent that such LOC Obligation and Swing Line Exposure is reallocated and&#47;or cash collateralized or repaid.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In the event that (x) any event described in Section 9.1(f) with respect to a Revolving Lender Parent shall have occurred following the Restatement Effective Date and for so long as such Event of Default under Section 9.1(f) shall continue or (y) any Issuing Lender has a good faith belief that any Revolving Lender has defaulted in fulfilling its obligations under one or more other agreements in which such Lender commits to extend credit, no Issuing Lender shall be required to issue, amend, renew or extend any Letter of Credit unless such Issuing Lender shall have entered into arrangements with the Borrower or such Revolving Lender satisfactory to such Issuing Lender to defease any risk to it in respect of such Lender hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In the event that the Administrative Agent, the Borrower, the Swing Line Lender and the Issuing Lenders agree that a Defaulting Lender has adequately remedied all matters that caused such Lender to be a Defaulting Lender, then (i)&#160;the Swing Line Exposure and LOC Obligation of the Revolving Lenders shall be readjusted to reflect the inclusion of such Lender&#8217;s Revolving Commitment, (ii)&#160;on such date such Lender shall purchase at par such of the Revolving Loans of the other Revolving Lenders (other than Swing Line Loans) as the Administrative Agent shall determine may be necessary in order for such Revolving Lender to hold such Loans in accordance with its Revolving Loan Commitment Percentage and (iii)&#160;any and all cash collateral provided by the Borrower in respect of such Defaulting Lender&#8217;s Swing Line Exposure or LOC Obligations in accordance with Section&#160;2.6(c)(ii) above shall be immediately released to the Borrower and the Administrative Agent and the Lenders shall promptly execute such documents as may be necessary to give effect to such release.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Incremental Facilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Borrower may on one or more occasions, by written notice to the Administrative Agent and with the consent of the Administrative Agent and the Incremental Lenders, request (i)&#160;during the period from and including the Restatement Effective Date to but not including the Revolving Maturity Date (or any earlier date on which the Commitments have been terminated as provided herein), the establishment of Incremental Revolving Commitments and&#47;or (ii) the establishment of Incremental Term Commitments, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that the aggregate principal amount of all the Incremental Commitments established hereunder shall not exceed $500,000,000 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Committed Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Each such notice shall specify (A) the date on which the Borrower proposes that the Incremental Revolving Commitments or the Incremental Term Commitments, as applicable, shall be effective, which shall be a date not less than 10 Business Days (or such shorter period as may be agreed to by the Administrative Agent) after the date on which such notice is delivered to the Administrative Agent and (B) the amount of the Incremental Revolving Commitments or Incremental Term Commitments, as applicable, being requested (it being agreed that (x) any Lender approached to provide any Incremental Revolving Commitment or Incremental Term Commitment may elect or decline, in its sole discretion, to provide such Incremental Revolving Commitment or Incremental Term Commitment and (y) any Person that the Borrower proposes to become an Incremental Lender, if such Person is not then a Lender, must be an Eligible Assignee).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The terms and conditions of any Incremental Revolving Commitment and loans and other extensions of credit to be made thereunder shall be identical to those of the Revolving Commitments and Loans and other extensions of credit made hereunder, and shall be treated as a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">53</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">single class with such Revolving Commitments and Loans.  The terms and conditions of any Incremental Term Commitments and the Incremental Term Loans to be made thereunder shall be as set forth in the applicable Incremental Facility Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that (i)&#160;no Incremental Term Maturity Date shall be earlier than, and no Incremental Term Loans shall require any repayment or prepayment of any principal amount thereof (other than amortization payments not in excess of 1% per annum of the initial principal amount of such Incremental Term Loans) prior to, the Revolving Maturity Date, (ii)&#160;Incremental Term Loans shall not have the benefit of any guarantees or collateral that do not equally benefit the Revolving Commitments and Loans and (iii)&#160;Incremental Term Loans shall not have the benefit of any representation or warranty, covenant or event of default other than those set forth herein.  Any Incremental Term Commitments established pursuant to an Incremental Facility Agreement that have identical terms and conditions, and any Incremental Term Loans made thereunder, shall be designated as a separate series (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Series</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) of Incremental Term Commitments and Incremental Term Loans for all purposes of this Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Incremental Commitments shall be effected pursuant to one or more Incremental Facility Agreements executed and delivered by the Borrower, each Incremental Lender providing such Incremental Commitments and the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that no Incremental Commitments shall become effective unless (i) no Default or Event of Default shall have occurred and be continuing on the date of effectiveness thereof, both immediately prior to and immediately after giving effect to such Incremental Commitments and the making of Loans and issuance of Letters of Credit thereunder on such date, (ii) on the date of effectiveness thereof, the representations and warranties of the Borrower set forth in the Credit Documents shall be true and correct (A) in the case of the representations and warranties qualified as to materiality, in all respects and (B) otherwise, in all material respects, in each case on and as of such date, except in the case of any such representation and warranty that expressly relates to a prior date, in which case such representation and warranty shall be so true and correct on and as of such prior date, (iii) after giving effect to such Incremental Commitments and the making of Loans and other extensions of credit thereunder on the date of effectiveness thereof, the Borrower shall be in pro forma compliance with the financial covenant set forth in Section 7.2, (iv) the Borrower shall make any payments required to be made pursuant to Section 3.14 in connection with such Incremental Commitments and the related transactions under this Section and (v) the Borrower shall have delivered to the Administrative Agent such legal opinions, board resolutions, secretary&#8217;s certificates, officer&#8217;s certificates and other documents as shall reasonably be requested by the Administrative Agent in connection with any such transaction.  Each Incremental Facility Agreement may, without the consent of any Lender, effect such amendments to this Credit Agreement and the other Credit Documents as may be necessary or appropriate, in the opinion of the Administrative Agent, to give effect to the provisions of this Section.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Upon the effectiveness of an Incremental Commitment of any Incremental Lender, (i) such Incremental Lender shall be deemed to be a &#8220;Lender&#8221; (and a Lender in respect of Commitments and Loans of the applicable class) hereunder, and henceforth shall be entitled to all the rights of, and benefits accruing to, Lenders (or Lenders in respect of Commitments and Loans of the applicable class) hereunder and shall be bound by all agreements, acknowledgements and other obligations of Lenders (or Lenders in respect of Commitments and Loans of the applicable class) hereunder and under the other Credit Documents, and (ii) in the case of any Incremental Revolving Commitment, (A) in the case of an Incremental Lender that does not already have a Revolving Commitment, such Incremental Revolving Commitment shall constitute the Revolving Commitment of such Incremental Lender and (B) in the case of an Incremental Lender that already has a Revolving Commitment, the Revolving Commitment of such Incremental Lender shall be increased by the amount of such Incremental Revolving Commitment, in each case, subject to further increase or reduction from time to time as set forth in the definition of the term &#8220;Revolving Commitment&#8221;.  For the avoidance of doubt, upon the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">54</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">effectiveness of any Incremental Revolving Commitment, the Revolving Exposure of the Incremental Revolving Lender holding such Incremental Revolving Commitment, and the Revolving Loan Commitment Percentages of all the Revolving Lenders, shall automatically be adjusted to give effect thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">On the date of effectiveness of any Incremental Revolving Commitments, each Revolving Lender shall assign to each Incremental Revolving Lender holding such Incremental Revolving Commitment, and each such Incremental Revolving Lender shall purchase from each Revolving Lender, at the principal amount thereof (together with accrued interest), such interests in the Revolving Loans and participations in Letters of Credit and Swing Line Loans outstanding on such date as shall be necessary in order that, after giving effect to all such assignments and purchases, such Revolving Loans and participations in Letters of Credit and Swing Line Loans will be held by all the Revolving Lenders (including such Incremental Revolving Lenders) ratably in accordance with their Revolving Loan Commitment Percentages after giving effect to the effectiveness of such Incremental Revolving Commitment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">Subject to the terms and conditions set forth herein and in the applicable Incremental Facility Agreement, each Incremental Term Lender holding an Incremental Term Commitment of any Series shall make a loan to the Borrower in an amount equal to such Incremental Term Commitment on the date specified in such Incremental Facility Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Administrative Agent shall notify the Lenders promptly upon receipt by the Administrative Agent of any notice from the Borrower referred to in this Section and of the effectiveness of any Incremental Commitments, in each case advising the Lenders of the details thereof and, in the case of effectiveness of any Incremental Revolving Commitments, of the Revolving Loan Commitment Percentages of the Revolving Lenders after giving effect thereto and of the assignments required to be made pursuant to Section&#160;2.7(e).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Extension of Revolving Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Not earlier than 12 months after the Restatement Effective Date, nor later than 30&#160;days prior to the Revolving Maturity Date (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Borrower may not exercise such right more than twice), the Borrower may, upon notice to the Administrative Agent (which shall promptly notify the Lenders), request a one-year extension of the Revolving Maturity Date then in effect (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extension Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that the Revolving Maturity Date may not be extended more than once in any 12-month period.  Within 10 Business Days after the delivery of such Extension Request, each Lender shall notify the Administrative Agent and the Borrower whether or not it consents to such Extension Request (which consent may be given or withheld in such Lender&#8217;s sole and absolute discretion) (each Lender agreeing to a requested extension being called an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extending Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and each Lender declining to agree to a requested extension being called a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Extending Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Any Lender with a then effective Commitment may consent to an Extension Request irrespective of whether such Lender previously had not been an Extending Lender with respect to a previous Extension Request.  Any Lender not responding within the above specified time period shall be deemed not to have consented to such Extension Request.  The Administrative Agent shall promptly notify the Borrower and the Lenders of the Lenders&#8217; responses.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Revolving Maturity Date shall be extended only if the Required Lenders (calculated excluding any Defaulting Lender and prior to giving effect to any replacements of Lenders permitted herein) have consented to the Extension Request.  For each such Extension Request, if so approved, (i) the Revolving Maturity Date, as to Extending Lenders (irrespective of whether such Lender previously had been a Non-Extending Lender), shall be extended to the same date in the following year after giving effect to any prior extensions (such existing Revolving Maturity Date being the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extension Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and (ii) the Revolving Maturity </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">55</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date, as to any Non-Extending Lender, shall remain the Revolving Maturity Date in effect for such Non-Extending Lender prior to the Extension Effective Date.  With respect to any previously Non-Extending Lender who is an Extending Lender with respect to a current Extension Request, by giving its consent, such Extending Lender shall be approving an extension of more than one year.  Non-Extending Lenders shall remain Lenders until the Revolving Maturity Date applicable to such Lenders, at which time their Commitments shall terminate and the Borrower shall repay all Loans owing to such Lenders, together with any accrued interest thereon and any accrued fees and other amounts payable to or for the account of such Non-Extending Lenders hereunder, and shall make such other prepayments of the Loans as shall be required in order that, after giving effect to the termination of the Commitments of, and all payments to, Non-Extending Lenders pursuant to this Section, (i)&#160;no Lender&#8217;s Credit Exposure shall exceed such Lender&#8217;s Commitment and (ii)&#160;the Credit Exposures shall not exceed the total Commitments.  The Administrative Agent and the Borrower shall promptly confirm to the Lenders such extension of the Revolving Maturity Date, specifying the date of such confirmation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extension Confirmation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Extension Effective Date, and the extended Revolving Maturity Date with respect to the Extending Lenders.  As condition precedents to such extension, the Borrower shall deliver to the Administrative Agent (i) such evidence of authorization, reaffirmations and legal opinions as the Administrative Agent may reasonably request and (ii) a certificate of the Borrower dated as of the Extension Confirmation Date signed by an Authorized Officer of the Borrower certifying that immediately before and immediately after giving effect to such extension, the representations and warranties contained in Section 6 made by it are true and correct (A) in the case of the representations and warranties qualified as to materiality, in all respects and (B) otherwise, in all material respects, in each case on and as of the Extension Confirmation Date, except in the case of any such representation and warranty that expressly relates to a prior date, in which case such representation and warranty shall be so true and correct on and as of such earlier date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Notwithstanding anything to the contrary in this Section 2.8,&#160;the Revolving Maturity Date may not be extended with respect to any Issuing Lender without the prior written consent of such Issuing Lender (it being understood and agreed that, in the event any Issuing Lender shall not have consented to any such extension, (i) such Issuing Lender shall continue to have all the rights and obligations of an Issuing Lender hereunder through the applicable existing Revolving Maturity Date and thereafter shall have no obligation to issue, amend, extend or renew any Letter of Credit (but shall continue to be entitled to the benefits hereunder as to Letters of Credit issued prior to such time) and (ii) the Borrower shall cause the LOC Obligations attributable to Letters of Credit issued by such Issuing Lender to be zero no later than the day on which such LOC Obligations would have been required to have been reduced to zero in accordance with the terms hereof without giving effect to the effectiveness of the extension of the applicable existing Revolving Maturity Date pursuant to this Section 2.8 (and, in any event, no later than such existing Revolving Maturity Date) together with any accrued interest thereon, on the existing Revolving Maturity Date).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">In connection with any extension of the Revolving Maturity Date under this Section&#160;2.8, the Administrative Agent and the Borrower may, without the consent of any Lender or Issuing Lender, effect such amendments to this Credit Agreement and the other Credit Documents as may be necessary or appropriate, in the opinion of the Administrative Agent and the Borrower, to give effect to the provisions of this Section 2.8.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.36pt;text-decoration:underline"><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">56</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><br>GENERAL PROVISIONS APPLICABLE<br>TO LOANS AND LETTERS OF CREDIT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Interest Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to Section 3.1(b), (i) each Base Rate Loan shall accrue interest at the Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Applicable Percentage, (ii) each Term Benchmark Loan denominated in Dollars shall accrue interest at the Adjusted Term SOFR for the Interest Period in effect for such Loan </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Applicable Percentage, (iii) each Term Benchmark Loan denominated in Euros shall accrue interest at the Adjusted EURIBO Rate for the Interest Period in effect for such Loan </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Applicable Percentage, (iv) each RFR Loan denominated in Sterling shall accrue interest at the Adjusted Daily Simple SONIA Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Applicable Percentage, (v) each RFR Loan denominated in Dollars shall accrue interest at the Adjusted Daily Simple SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Applicable Percentage and (vi) each Swing Line Loan shall accrue interest at the Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Applicable Percentage.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Default Rate of Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Upon the occurrence, and during the continuation, of an Event of Default pursuant to Section&#160;9.1(a), the principal of and, to the extent permitted by law, interest on the Loans and any other amounts owing hereunder or under the other Credit Documents (including without limitation fees and expenses) but not paid when due shall bear interest, payable on demand, at a per annum rate equal to (i) in the case of overdue principal of any Loan, 2% </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the rate which would otherwise be applicable, or (ii) in the case of any other amount, the Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Applicable Percentage </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 2% per annum.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Interest Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as set forth in clause (b) above, interest on Loans shall be due and payable in arrears on each Interest Payment Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Place and Manner of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All payments to be made by the Borrower shall be made without condition or deduction for any counterclaim, defense, recoupment or setoff.  Except as otherwise expressly provided herein and except with respect to principal of and interest on Loans and drawings under Letters of Credit denominated in an Alternative Currency, all payments by the Borrower hereunder shall be made to the Administrative Agent, for the account of the respective Lenders or the relevant Issuing Lender, as applicable, to which such payment is owed, at the applicable Agency Services Address in Dollars and in Same Day Funds not later than 2&#58;00 p.m. on the date specified herein.  Except as otherwise expressly provided herein, all payments by the Borrower hereunder with respect to principal and interest on Loans or in respect of drawings under Letters of Credit denominated in an Alternative Currency shall be made to the Administrative Agent for the account of the respective Lenders (or for the account of the relevant Issuing Lender, as applicable) to which such payment is owed, at the applicable Agency Services Address in such Alternative Currency and in Same Day Funds not later than the Applicable Time specified by the Administrative Agent to the Borrower in writing on the dates specified herein. Without limiting the generality of the foregoing, the Administrative Agent may require that any payments due under this Credit Agreement be made in the United States.  If, for any reason, the Borrower is prohibited by any Law from making any required payment hereunder in an Alternative Currency, the Borrower shall make such payment in Dollars in the Dollar Equivalent of the Alternative Currency payment amount.  The Administrative Agent will promptly distribute to each Lender its pro rata share of such payment (based upon the applicable Commitments of the Lenders) in like funds as received by wire transfer to such Lender&#8217;s Lending Office.  All payments received by the Administrative Agent (i) after 2&#58;00 p.m. New York City time, in the case of payments in Dollars, or (ii) after the Applicable Time specified by the Administrative Agent in writing to the Borrower in the case of payments in an Alternative Currency, shall in each case be deemed received on the next succeeding Business Day and any applicable interest or fee shall continue to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">57</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">accrue.  If any payment to be made by the Borrower shall come due on a day other than a Business Day, payment shall be made on the next following Business Day, and such extension of time shall be reflected in computing interest or fees, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Prepayments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Voluntary Prepayments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower shall have the right to prepay Loans in whole or in part from time to time without premium or penalty&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Borrower shall notify the Administrative Agent (and, in the case of prepayment of Swing Line Loans, the Swing Line Lender) by telephone (confirmed by telecopy or electronic mail) of any prepayment hereunder (i)&#160;(A)&#160;in the case of prepayment of Term Benchmark Loans denominated in Dollars, not later than 3&#58;00 p.m., New&#160;York City time, three U.S. Government Securities Business Days before the date of prepayment, (B)&#160;in the case of prepayment of Term Benchmark Loans denominated in Euros, not later than 3&#58;00 p.m., New&#160;York City time, three Business Days before the date of prepayment, (C)&#160;in the case of prepayment of RFR Loans denominated in Sterling, not later than four RFR Business Days before the date of prepayment, (D) in the case of prepayment of RFR Loans denominated in Dollars, not later than three U.S. Government Securities Business Days before the date of prepayment and (E)&#160;in the case of prepayment of Base Rate Loans, not later than 11&#58;00&#160;a.m., New&#160;York City time, on the date of prepayment, and (ii)&#160;each such partial prepayment of Term Benchmark Loans, Base Rate Loans or Swing Line Loans shall be in an amount that would be permitted in the case of a borrowing of such Loans in the currency thereof as provided in Section&#160;2.5.  Amounts prepaid pursuant to this Section&#160;3.3(a) shall be applied as the Borrower may elect&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, if the Borrower fails to specify, such prepayment will be applied in the manner set forth in Section&#160;3.3(c) below.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Mandatory Prepayments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If at any time (i)&#160;the sum of the aggregate amount of the Dollar Equivalent of outstanding Revolving Loans </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the aggregate amount of the Dollar Equivalent of outstanding LOC Obligations </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the aggregate amount of outstanding Swing Line Loans exceeds the Revolving Committed Amount, (ii)&#160;the aggregate amount of the Dollar Equivalent of outstanding LOC Obligations exceeds the LOC Committed Amount or (iii)&#160;the aggregate amount of the Dollar Equivalent of Revolving Loans and LOC Obligations in Alternative Currencies exceeds the Foreign Currency Sublimit, the Borrower shall immediately make a principal payment to the Administrative Agent (or with respect to LOC Obligations an amount to be held as cash collateral) in a manner and in an amount (and in the applicable currency) necessary to be in compliance with Sections&#160;2.1, 2.2 and 2.3, as applicable and as directed by the Administrative Agent (any such prepayment with respect to clause&#160;(i) above to be applied as set forth in Section&#160;3.3(c) below).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Application of Prepayments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  All amounts paid pursuant to Section&#160;3.3(b)(i) and, solely if the Borrower has not otherwise elected an application of such amounts as contemplated in Section 3.3(a), all amounts paid pursuant to Section 3.3(a) shall be applied </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> to Swing Line Loans, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, to Revolving Loans (first to Base Rate Loans and then to Term Benchmark Loans in direct order of Interest Period maturities) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">third</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, to a cash collateral account in respect of LOC Obligations.  All prepayments under this Section&#160;3.3 shall be subject to Section&#160;3.14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Facility Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In consideration of the commitments under the Revolving Credit Facility being made available by the Lenders hereunder, the Borrower agrees to pay to the Administrative Agent a per annum fee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Facility Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in Dollars for the pro rata benefit of each Revolving Lender (based upon such Lender&#8217;s pro rata committed portion of the Revolving Committed Amount), which Facility Fee shall be calculated by multiplying, at any time of determination, the Applicable Percentage then in effect for the Facility Fee, by the daily average amount of the Revolving Committed Amount (whether or not drawn or available to be drawn) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">58</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">during the fiscal quarter or other relevant period for which such Facility Fee is being calculated.  The Facility Fee shall accrue from the Restatement Effective Date and shall be due and payable in arrears on the fifteenth day after the end of each fiscal quarter of the Borrower for such fiscal quarter, or period ended thereon, and on the Revolving Maturity Date, with the first such payment to be made on the last day of the first full fiscal quarter following the Restatement Effective Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Letter of Credit Fees.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Letter of Credit Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In consideration of the issuance of Letters of Credit hereunder, the Borrower agrees to pay to the Administrative Agent, for the pro rata benefit of each Revolving Lender (based on each Lender&#8217;s Revolving Loan Commitment Percentage), a per annum fee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in Dollars for each Letter of Credit equal to the Applicable Percentage for Letter of Credit Fees on the average daily maximum amount available to be drawn under each such Letter of Credit (whether or not such maximum amount is then in effect under such Letter of Credit) from the date of issuance to the date of expiration.  The Letter of Credit Fees will be payable in arrears on the fifteenth day following the last day of March, June, September and December of each fiscal year of the Borrower for such fiscal quarter, or period ended thereon, and on the Revolving Maturity Date, with the first such payment to be made on the third Business Day following the last day of the first full fiscal quarter following the Restatement Effective Date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt;text-decoration:underline">Issuing Lender Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In addition to the Letter of Credit Fees payable pursuant to subsection (i) above, the Borrower shall pay to each Issuing Lender for its own account, without sharing by the other Lenders, (A)&#160;the customary, incidental and&#47;or out of pocket charges from time to time of such Issuing Lender for its services in connection with the issuance, amendment, payment, transfer, administration, cancellation and conversion of, and drawings under, Letters of Credit and (B) with respect to each Letter of Credit, a letter of credit fronting fee in Dollars at a rate per annum agreed to between the Borrower and such Issuing Lender of the face amount of each Letter of Credit, payable quarterly on the fifteenth day following the last day of March, June, September and December of each fiscal year of the Borrower for such fiscal quarter, and on the Revolving Maturity Date (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Issuing Lender Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Administrative Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower agrees to pay to the Administrative Agent, for its own account, an annual fee in Dollars as agreed to between the Borrower and the Administrative Agent as set forth in the JPMorgan Engagement Letter.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Payment in Full at Maturity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">On the Revolving Maturity Date, the entire outstanding principal balance of all Revolving Loans, all Swing Line Loans and all LOC Obligations, together with accrued but unpaid interest and all other sums owing with respect thereto, shall be due and payable in full, unless accelerated sooner pursuant to Section 9.2.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Computations of Interest and Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">All computations of interest and fees hereunder shall be made on the basis of the actual number of days elapsed over a year of 360 days&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that in the case of (i) Base Rate Loans and Swing Line Loans that are based upon the Prime Rate, interest shall be computed on the basis of the actual number of days elapsed over a year of 365 or 366 days, as the case may be, (ii) Loans denominated in Sterling, interest shall be computed on the basis of a year of 365 days and (iii) Loans denominated in Alternative Currencies, other than Sterling, as to which market </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">59</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">practice differs from the foregoing, interest shall be computed in accordance with such market practice.  Interest shall accrue from and include the date of borrowing (or continuation or conversion) but exclude the date of payment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">It is the intent of the Lenders and the Borrower to conform to and contract in strict compliance with applicable usury law from time to time in effect.  All agreements between the Lenders and the Borrower are hereby limited by the provisions of this paragraph, which shall override and control all such agreements, whether now existing or hereafter arising and whether written or oral.  In no way, nor in any event or contingency (including but not limited to prepayment or acceleration of the maturity of any obligation), shall the interest taken, reserved, contracted for, charged, or received under this Credit Agreement, under the Notes or otherwise, exceed the maximum nonusurious amount permissible under applicable law.  If, from any possible construction of any of the Credit Documents or any other document, interest would otherwise be payable in excess of the maximum nonusurious amount, any such construction shall be subject to the provisions of this paragraph and such documents shall be automatically reduced to the maximum nonusurious amount permitted under applicable law, without the necessity of execution of any amendment or new document.  If any Lender shall ever receive anything of value which is characterized as interest on the Loans under applicable law and which would, apart from this provision, be in excess of the maximum nonusurious amount, an amount equal to the amount which would have been excessive interest shall, without penalty, be applied to the reduction of the principal amount owing on the Loans and not to the payment of interest, or refunded to the Borrower or the other payor thereof if and to the extent such amount which would have been excessive exceeds such unpaid principal amount of the Loans.  The right to demand payment of the Loans or any other Indebtedness evidenced by any of the Credit Documents does not include the right to accelerate the payment of any interest which has not otherwise accrued on the date of such demand, and the Lenders do not intend to charge or receive any unearned interest in the event of such demand.  All interest paid or agreed to be paid to the Lenders with respect to the Loans shall, to the extent permitted by applicable law, be amortized, prorated, allocated, and spread throughout the full stated term (including any renewal or extension) of the Loans so that the amount of interest on account of such Indebtedness does not exceed the maximum nonusurious amount permitted by applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Pro Rata Treatment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except to the extent otherwise provided herein&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as otherwise provided herein, each Revolving Loan borrowing (including, without limitation, each Mandatory Borrowing), each payment or prepayment of principal of any Revolving Loan, each payment of fees (other than the Issuing Lender Fees retained by each Issuing Lender for its own account and fees under the JPMorgan Engagement Letter and JPMorgan Fee Letter retained by the Administrative Agent for its own account), each reduction of the Revolving Committed Amount and each conversion or continuation of any Revolving Loan shall (except as otherwise provided in Section 3.11) be allocated pro rata among the relevant Lenders in accordance with the respective Revolving Loan Commitment Percentages of such Lenders, as applicable (or, if the Commitments of such Lenders have expired or been terminated, in accordance with the respective principal amounts of the outstanding Revolving Loans and Participation Interests of such Lenders)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, if any Lender shall have failed to pay its applicable pro rata share of any Revolving Loan, then any amount to which such Lender would otherwise be entitled pursuant to this subsection (a) shall instead be payable to the Administrative Agent until the share of such Loan not funded by such Lender has been repaid&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that in the event any amount paid to any Lender pursuant to this subsection (a) is recovered from or must otherwise be returned by the Administrative Agent, each Lender shall, upon the request of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">60</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Administrative Agent, repay to the Administrative Agent the amount so paid to such Lender, with interest for the period commencing on the date such payment is returned by the Administrative Agent until the date the Administrative Agent receives such repayment at a rate per annum equal to (i) if the applicable Loan is denominated in Dollars, during the period to but excluding the date two Business Days after such request, the Federal Funds Rate, and thereafter, the Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 2% per annum and (ii) if the applicable Loan is denominated in an Alternative Currency, during the period to but excluding the date two Business Days after such request, at the customary rate for the applicable currency set by the Administrative Agent for the correction of errors among banks, and thereafter, the Adjusted Term SOFR or the EURIBO Rate, as applicable, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 2% per annum.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as otherwise provided herein, each payment of unreimbursed drawings in respect of LOC Obligations shall be allocated to each Participant pro rata in accordance with its Revolving Loan Commitment Percentage&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, if any Participant shall have failed to pay its applicable pro rata share of any drawing under any Letter of Credit, then any amount to which such Participant would otherwise be entitled pursuant to this subsection (b) shall instead be payable to the relevant Issuing Lender until the share of such unreimbursed drawing not funded by such Lender has been repaid&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that in the event any amount paid to any Participant pursuant to this subsection (b) is recovered from or must otherwise be returned by any Issuing Lender, each Participant shall, upon the request of such Issuing Lender, repay to the Administrative Agent for the account of such Issuing Lender the amount so paid to such Participant, with interest for the period commencing on the date such payment is returned by such Issuing Lender until the date such Issuing Lender receives such repayment at a rate per annum equal to (i) if the applicable drawing under a Letter of Credit is denominated in Dollars, during the period to but excluding the date two Business Days after such request, the Federal Funds Rate, and thereafter, the Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 2% per annum and (ii)&#160;if the applicable drawing under a Letter of Credit is denominated in an Alternative Currency, during the period to but excluding the date two Business Days after such request, at the customary rate for the applicable currency set by the Administrative Agent for the correction of errors among banks, and thereafter, the Adjusted Term SOFR or the EURIBO Rate, as applicable, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 2% per annum.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Swing Line Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Swing Line Lender shall receive, for its own account, all payments or prepayments of principal and interest with respect to the Swing Line Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, upon the funding of the Participants&#8217; participation interests with respect to a Swing Line Loan pursuant to Section&#160;2.3(c), such Participants shall be entitled to receive their pro rata share of any payment or prepayment of principal and interest with respect to such Swing Line Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Sharing of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Lenders agree among themselves that, except to the extent otherwise provided herein, in the event that any Lender shall obtain payment in respect of any Loan, unreimbursed drawing with respect to any LOC Obligations or any other obligation owing to such Lender under this Credit Agreement through the exercise of a right of setoff, banker&#8217;s lien or counterclaim, or pursuant to a secured claim under Section 506 of the Bankruptcy Code or other security or interest arising from, or in lieu of, such secured claim, received by such Lender under any applicable bankruptcy, insolvency or other similar law or otherwise, or by any other means, in excess of its pro rata share of such payment as provided for in this Credit Agreement, such Lender shall promptly pay in cash or purchase from the other Lenders a participation in such Loans, LOC Obligations, and other obligations in such amounts, and make such other adjustments from time to time, as shall be equitable to the end that all Lenders share such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">61</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">payment in accordance with their respective ratable shares as provided for in this Credit Agreement.  The Lenders further agree among themselves that if payment to a Lender obtained by such Lender through the exercise of a right of setoff, banker&#8217;s lien, counterclaim or other event as aforesaid shall be rescinded or must otherwise be restored, each Lender which shall have shared the benefit of such payment shall, by payment in cash or a repurchase of a participation theretofore sold, return its share of that benefit (together with its share of any accrued interest payable with respect thereto) to each Lender whose payment shall have been rescinded or otherwise restored.  The Borrower agrees that any Lender so purchasing such a participation may, to the fullest extent permitted by law, exercise all rights of payment, including setoff, banker&#8217;s lien or counterclaim, with respect to such participation as fully as if such Lender were a holder of such Loan, LOC Obligation or other obligation in the amount of such participation.  Except as otherwise expressly provided in this Credit Agreement, if any Lender or the Administrative Agent shall fail to remit to any other Lender an amount payable by such Lender or the Administrative Agent to such other Lender pursuant to this Credit Agreement on the date when such amount is due, such payments shall be made together with interest thereon for each date from the date such amount is due until the date such amount is paid to the Administrative Agent or such other Lender at a rate per annum equal to the Federal Funds Rate.  If under any applicable bankruptcy, insolvency or other similar law, any Lender receives a secured claim in lieu of a setoff to which this Section 3.8 applies, such Lender shall, to the extent practicable, exercise its rights in respect of such secured claim in a manner consistent with the rights of the Lenders under this Section 3.8 to share in the benefits of any recovery on such secured claim.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Capital Adequacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If, after the date thereof, any Lender determines that a Change in Law has or would have the effect of reducing the rate of return on the capital or assets of such Lender or any corporation controlling such Lender as a consequence of such Lender&#8217;s obligations hereunder (taking into consideration its policies with respect to capital adequacy and liquidity and such Lender&#8217;s desired return on capital), then from time to time upon demand of such Lender (with a copy of such demand to the Administrative Agent), the Borrower shall pay to such Lender such additional amounts as will compensate such Lender for such reduction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Alternate Rate of Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Subject to clauses (b), (c), (d), (e), (f) and (g) of this Section&#160;3.10, if&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">the Administrative Agent determines (which determination shall be conclusive absent manifest error) (A) prior to the commencement of any Interest Period for a Term Benchmark Loan, that adequate and reasonable means do not exist for ascertaining the Adjusted Term SOFR (including because the Term SOFR Reference Rate is not available or published on a current basis) or the Adjusted EURIBO Rate or the EURIBO Rate (including because the Screen Rate is not available or published on a current basis), for the applicable Agreed Currency and such Interest Period or (B) at any time, that adequate and reasonable means do not exist for ascertaining the Daily Simple SONIA Rate, SONIA or the Adjusted Daily Simple SOFR for the applicable Agreed Currency&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">the Administrative Agent is advised by the Required Lenders that (A) prior to the commencement of any Interest Period for a Term Benchmark Borrowing, the Adjusted Term SOFR or the Adjusted EURIBO Rate or the EURIBO Rate for the applicable Agreed Currency and such Interest Period will not adequately and fairly reflect the cost to such Lenders (or Lender) of making or maintaining their Loans (or its Loan) included in such Borrowing for the applicable Agreed Currency and such Interest Period </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">62</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or (B) at any time, the applicable Daily Simple SONIA Rate, SONIA or Adjusted Daily Simple SOFR for the applicable Agreed Currency will not adequately and fairly reflect the cost to such Lenders (or Lender) of making or maintaining their Loans (or its Loan) included in such Borrowing for the applicable Agreed Currency&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">then the Administrative Agent shall give notice thereof to the Borrower and the Lenders by telephone, telecopy or electronic mail as promptly as practicable thereafter and, until (x) the Administrative Agent notifies the Borrower and the Lenders that the circumstances giving rise to such notice no longer exist with respect to the relevant Benchmark and (y) the Borrower delivers a new Notice of Continuation&#47;Conversion in accordance with the terms of Section 2.4 or a new Notice of Borrowing in accordance with the terms of Section 2.1(b), (A)&#160;for Loans denominated in Dollars, (1)&#160;any Notice of Continuation&#47;Conversion that requests the conversion of any Revolving Borrowing to, or continuation of any Revolving Borrowing as, a Term Benchmark Borrowing shall be ineffective and any Notice of Borrowing requests a Term Benchmark Borrowing shall instead be deemed to be a Notice of Continuation&#47;Conversion or a Notice of Borrowing, as applicable, for (x) an RFR Loan denominated in Dollars so long as the Adjusted Daily Simple SOFR is not also the subject of Section 3.10(a)(i) or (ii) above or (y) a Base Rate Loan if the Adjusted Daily Simple SOFR also is the subject of Section 3.10(a)(i) or (ii) above and (2) any Notice of Borrowing that requests an RFR Loan shall instead be deemed to be a Notice of Borrowing for a Base Rate Loan and (B) for Loans denominated in an Alternative Currency, any Notice of Continuation&#47;Conversion that requests a Term Benchmark Loan or an RFR Loan for the relevant rate above in an Alternative Currency, then such request shall be ineffective&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that&#160;if the circumstances giving rise to such notice affect only one Type of Borrowing, then all other Types of Borrowings shall be permitted.  Furthermore, if any Term Benchmark Loan or RFR Loan in any Agreed Currency is outstanding on the date of the Borrower&#8217;s receipt of the notice from the Administrative Agent referred to in this Section 3.10 with respect to a Relevant Rate applicable to such Term Benchmark Loan or RFR Loan, then until (x) the Administrative Agent notifies the Borrower and the Lenders that the circumstances giving rise to such notice no longer exist with respect to the relevant Benchmark and (y) the Borrower delivers a new Notice of Continuation&#47;Conversion in accordance with the terms of Section 2.4 or a new Notice of Borrowing in accordance with the terms of Section 2.1(b), (A) for Loans denominated in Dollars, (1) any Term Benchmark Loan shall on the last day of the Interest Period applicable to such Loan (or the next succeeding Business Day if such day is not a Business Day), be converted by the Administrative Agent to, and shall constitute, (x) an RFR Loan denominated in Dollars so long as the Adjusted Daily Simple SOFR is not also the subject of Section 3.10(a)(i) or (ii) above or (y) a Base Rate Loan if the Adjusted Daily Simple SOFR also is the subject of Section 3.10(a)(i) or (ii) above, on such day, and (2) any RFR Loan shall on and from such day be converted by the Administrative Agent to, and shall constitute a Base Rate Loan and (B) for Loans denominated in an Alternative Currency, (1) any Term Benchmark Loan shall, on the last day of the Interest Period applicable to such Loan (or the next succeeding Business Day if such day is not a Business Day) bear interest at the Central Bank Rate for the applicable Agreed Currency </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Applicable Percentage&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, if the Administrative Agent determines (which determination shall be conclusive and binding absent manifest error) that the Central Bank Rate for the applicable Agreed Currency cannot be determined, any outstanding affected Term Benchmark Loans denominated in any Agreed Currency other than Dollars shall, at the Borrower&#8217;s election prior to such day&#58; (A) be prepaid by the Borrower on such day or (B) solely for the purpose of calculating the interest rate applicable to such Term Benchmark Loan, such Term Benchmark Loan denominated in any Agreed Currency other than Dollars shall be deemed to be a Term Benchmark Loan denominated in Dollars and shall accrue interest at the same interest rate applicable to Term Benchmark Loans denominated in Dollars at such time and (2) any RFR Loan shall bear interest at the Central Bank Rate for the applicable Agreed Currency </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Applicable Percentage&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, if the Administrative Agent determines (which determination shall be conclusive and binding absent manifest error) that the Central Bank Rate for the applicable Alternative Currency cannot be determined, any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">63</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">outstanding affected RFR Loans denominated in any Alternative Currency, at the Borrower&#8217;s election, shall either (A) be converted into Base Rate Loans denominated in Dollars (in an amount equal to the Dollar Equivalent of such Alternative Currency) immediately or (B) be prepaid in full immediately.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Notwithstanding anything to the contrary herein or in any other Credit Document, if a Benchmark Transition Event and its related Benchmark Replacement Date have occurred prior to the Reference Time in respect of any setting of the then-current Benchmark, then (x) if a Benchmark Replacement is determined in accordance with clause (1) of the definition of &#8220;Benchmark Replacement&#8221; for such Benchmark Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Credit Document in respect of such Benchmark setting and subsequent Benchmark settings without any amendment to, or further action or consent of any other party to, this Credit Agreement or any other Credit Document and (y) if a Benchmark Replacement is determined in accordance with clause (2) of the definition of &#8220;Benchmark Replacement&#8221; with respect to any Agreed Currency for such Benchmark Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Credit Document in respect of any Benchmark setting at or after 5&#58;00 p.m. (New York City time) on the fifth (5th) Business Day after the date notice of such Benchmark Replacement is provided to the Lenders without any amendment to, or further action or consent of any other party to, this Credit Agreement or any other Credit Document so long as the Administrative Agent has not received, by such time, written notice of objection to such Benchmark Replacement from Lenders comprising the Required Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">In connection with the implementation of a Benchmark Replacement, notwithstanding anything to the contrary herein or in any other Credit Document, the Administrative Agent, in consultation with the Borrower, will have the right to make  Benchmark Replacement Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Credit Document, any amendments implementing such Benchmark Replacement Conforming Changes will become effective without any further action or consent of any other party to this Credit Agreement or any other Credit Document (other than the Administrative Agent and the Borrower).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Administrative Agent will promptly notify the Borrower and the Lenders of (i)&#160;any occurrence of a Benchmark Transition Event and its related Benchmark Replacement Date, (ii) the implementation of any Benchmark Replacement, (iii)&#160;the effectiveness of any Benchmark Replacement Conforming Changes, (iv) the removal or reinstatement of any tenor of a Benchmark pursuant to clause (f) below and (v) the commencement or conclusion of any Benchmark Unavailability Period.  Any reasonable determination, decision or election that may be made by the Administrative Agent or, if applicable, any Lender (or group of Lenders) pursuant to this Section&#160;3.10, including any determination with respect to a tenor, rate or adjustment or of the occurrence or non-occurrence of an event, circumstance or date and any decision to take or refrain from taking any action or any selection, will be conclusive and binding absent manifest error and may be made in its or their sole discretion and without consent from any other party to this Credit Agreement or any other Credit Document, except, in each case, as expressly required pursuant to this Section&#160;3.10.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">To the extent administratively and operationally feasible, the Administrative Agent shall use commercially reasonable efforts to cooperate with the Borrower&#8217;s requests to ensure that any Benchmark Replacement and any Benchmark Replacement Conforming Changes meet the standards set forth in Treasury Regulation Section 1.1001-6 (or any successor or final version of such regulation or other official guidance issued by the U.S. Internal Revenue Service) so as not to be treated as a &#8220;modification&#8221; (and therefore an exchange) of this Credit Agreement for purposes of Treasury Regulation Section 1.1001-3, it being understood that for these </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">64</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">purposes, the substantially equivalent fair market value requirement of Treasury Regulation Section&#160;1.1001-6(b)(2) shall be deemed satisfied, and it being further understood that the Administrative Agent shall not be required to take any action under this provision that would cause it any commercially unreasonable burden, as determined in good faith by the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Notwithstanding anything to the contrary herein or in any other Credit Document, at any time (including in connection with the implementation of a Benchmark Replacement), (i) if the then-current Benchmark is a term rate (including the Term SOFR or EURIBO Rate) and either (A)&#160;any tenor for such Benchmark is not displayed on a screen or other information service that publishes such rate from time to time as selected by the Administrative Agent in its reasonable discretion or (B) the regulatory supervisor for the administrator of such Benchmark has provided a public statement or publication of information announcing that any tenor for such Benchmark is or will be no longer representative, then the Administrative Agent may modify the definition of &#8220;Interest Period&#8221; for any Benchmark settings at or after such time to remove such unavailable or non-representative tenor and (ii) if a tenor that was removed pursuant to clause (i) above either (A)&#160;is subsequently displayed on a screen or information service for a Benchmark (including a Benchmark Replacement) or (B) is not, or is no longer, subject to an announcement that it is or will no longer be representative for a Benchmark (including a Benchmark Replacement), then the Administrative Agent may modify the definition of &#8220;Interest Period&#8221; for all Benchmark settings at or after such time to reinstate such previously removed tenor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">Upon the Borrower&#8217;s receipt of notice of the commencement of a Benchmark Unavailability Period, the Borrower may revoke any request for a Term Benchmark Loan or RFR Loan or any request for the conversion to or continuation of Term Benchmark Loans to be made, converted or continued during any Benchmark Unavailability Period and, failing that, either (x)&#160;the Borrower will be deemed to have converted any request for (1) a Term Benchmark Borrowing denominated in Dollars into a request for a Borrowing of or conversion to (A) an RFR Loan denominated in Dollars so long as the Adjusted Daily Simple SOFR is not the subject of a Benchmark Transition Event or (B) a Base Rate Loan if the Adjusted Daily Simple SOFR is the subject of a Benchmark Transition Event or (y)&#160;any Term Benchmark Loan or RFR Loan denominated in an Alternative Currency shall be ineffective.  During any Benchmark Unavailability Period or at any time that a tenor for the then-current Benchmark is not an Available Tenor, the component of the Base Rate based upon the then-current Benchmark or such tenor for such Benchmark, as applicable, will not be used in any determination of the Base Rate.  Furthermore, if any Term Benchmark Loan or RFR Loan in any Agreed Currency is outstanding on the date of the Borrower&#8217;s receipt of notice of the commencement of a Benchmark Unavailability Period with respect to a Relevant Rate applicable to such Term Benchmark Loan or RFR Loan, then until such time as a Benchmark Replacement for such Agreed Currency is implemented pursuant to this Section&#160;3.10, (A) if such Term Benchmark Loan is denominated in Dollars, (1) any Term Benchmark Loan shall on the last day of the Interest Period applicable to such Loan (or the next succeeding Business Day if such day is not a Business Day), be converted by the Administrative Agent to, and shall constitute, (x) an RFR Loan denominated in Dollars so long as the Adjusted Daily Simple SOFR is not the subject of a Benchmark Transition Event or (y) a Base Rate Loan if the Adjusted Daily Simple SOFR is the subject of a Benchmark Transition Event, on such day and (2)&#160;any RFR Loan shall on and from such day be converted by the Administrative Agent to, and shall constitute a Base Rate Loan, and (B) for Loans denominated in an Alternative Currency (1) any Term Benchmark Loan shall, on the last day of the Interest Period applicable to such Loan (or the next succeeding Business Day if such day is not a Business Day) bear interest at the Central Bank Rate for the applicable Alternative Currency </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Applicable Percentage&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, if the Administrative Agent determines (which determination shall be conclusive and binding absent manifest error) that the Central Bank Rate for the applicable Alternative Currency cannot be determined, any outstanding affected Term Benchmark Loans denominated in any Alternative Currency shall, at </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">65</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Borrower&#8217;s election prior to such day&#58; (A) be prepaid by the Borrower on such day or (B) solely for the purpose of calculating the interest rate applicable to such Term Benchmark Loan, such Term Benchmark Loan denominated in any Agreed Currency other than Dollars shall be deemed to be a Term Benchmark Loan denominated in Dollars and shall accrue interest at the same interest rate applicable to Term Benchmark Loans denominated in Dollars at such time and (2) any RFR Loan shall bear interest at the Central Bank Rate for the applicable Alternative Currency </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Applicable Percentage&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, if the Administrative Agent determines (which determination shall be conclusive and binding absent manifest error) that the Central Bank Rate for the applicable Alternative Currency cannot be determined, any outstanding affected RFR Loans denominated in any Alternative Currency, at the Borrower&#8217;s election, shall either (A) be converted into Base Rate Loans denominated in Dollars (in an amount equal to the Dollar Equivalent of such Alternative Currency) immediately or (B) be prepaid in full immediately.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Illegality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If any Lender determines that any Requirement of Law has made it unlawful, or that any Governmental Authority has asserted that it is unlawful, for any Lender or its applicable Lending Office to make, maintain or fund Term SOFR Loans or EURIBOR Loans, or materially restricts the authority of such Lender to purchase or sell, or to take deposits of, the applicable currency in the applicable offshore market for such currency, or to determine or charge interest rates based upon the Term SOFR Rate or EURIBO Rate, as applicable, then, on notice thereof by such Lender to the Borrower through the Administrative Agent, any obligation of such Lender to make or continue Term SOFR Loans or EURIBOR Loans or to convert Base Rate Loans to Term SOFR Loans, as applicable, shall be suspended until such Lender notifies the Administrative Agent and the Borrower that the circumstances giving rise to such determination no longer exist.  Upon receipt of such notice, the Borrower shall, upon demand from such Lender (with a copy to the Administrative Agent), prepay or, if applicable, convert all Term Benchmark Loans of such Lender to Base Rate Loans in the Dollar Equivalent of such Term Benchmark Loans, either on the last day of the Interest Period thereof, if such Lender may lawfully continue to maintain such Term Benchmark Loans to such day, or immediately, if such Lender may not lawfully continue to maintain such Term Benchmark Loans.  Upon any such prepayment or conversion, the Borrower shall also pay interest on the amount so prepaid or converted, together with any amounts due with respect thereto pursuant to Section 3.14.  Each Lender agrees to designate a different Lending Office if such designation will avoid the need for such notice and will not, in the good faith judgment of such Lender, otherwise be materially disadvantageous to such Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Requirements of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If any Lender determines that as a result of any Change in Law, or such Lender&#8217;s compliance therewith, there shall be any increase in the cost to such Lender of agreeing to make or making, funding or maintaining Loans or (as the case may be) issuing, participating in or maintaining any Letters of Credit (or of maintaining its obligation to participate in or to issue any Letter of Credit), or a reduction in the amount received or receivable by such Lender in connection with any of the foregoing (excluding for purposes of this Section&#160;3.12 any such increased costs or reduction in amount resulting from (i)&#160;taxes other than capital taxes imposed on such Lender&#8217;s loans, loan principal, letters of credit, commitments, or other obligations, or its deposits, reserves, other liabilities or capital attributable thereto and (ii) reserve requirements utilized in the determination of the Term SOFR Rate or EURIBO Rate, as applicable), then from time to time, within 10 days of demand of such Lender (with a copy of such demand to the Administrative Agent), the Borrower shall pay to such Lender such additional amounts as will compensate such Lender for such increased cost or reduction in yield.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">66</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Any and all payments by or on behalf of the Borrower to or for the account of the Administrative Agent or any Lender under any Credit Document shall be made free and clear of and without deduction for any and all present or future income, stamp or other taxes, duties, levies, imposts, deductions, assessments, fees or other charges imposed by any Governmental Authority, withholdings or similar charges, and all liabilities with respect thereto, but excluding, in the case of the Administrative Agent and each Lender, (x)&#160;any branch profit taxes or taxes imposed on or measured by its net income, (y)&#160;franchise taxes imposed on it (in lieu of net income taxes), in each case by the jurisdiction (or any political subdivision thereof) under the laws of which the Administrative Agent or such Lender, as the case may be, is organized or maintains its Lending Office, and (z) any taxes imposed by FATCA (all such non-excluded present or future income, stamp or other taxes, duties, levies, imposts, deductions, assessments, fees or other charges imposed by any Governmental Authority, withholdings or similar charges, and liabilities being hereinafter referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  If the Borrower shall be required by any Requirement of Law to deduct any Taxes or Other Taxes from or in respect of any sum payable under any Credit Document to the Administrative Agent or any Lender, (i) the sum payable shall be increased as necessary so that after making all required deductions (including deductions applicable to additional sums payable under this Section 3.13(a)), the Administrative Agent or such Lender, as the case may be, receives an amount equal to the sum it would have received had no such deductions been made, (ii) the Borrower shall make such deductions, (iii)&#160;the Borrower shall pay the full amount deducted to the relevant taxation authority or other Governmental Authority in accordance with applicable Requirements of Law and (iv) within 30&#160;days after the date of such payment, the Borrower shall furnish to the Administrative Agent (which shall forward the same to such Lender) the original or a certified copy of a receipt evidencing payment thereof, to the extent such receipt is issued therefor, or other written proof of payment thereof that is reasonably satisfactory to the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">In addition, the Borrower agrees to pay any and all present or future stamp, court or documentary taxes and any other excise or property taxes or charges or similar levies which arise from any payment made under any Credit Document or from the execution, delivery, performance, enforcement or registration of, or otherwise with respect to, any Credit Document (hereinafter referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">&#91;Reserved&#93;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Borrower agrees to indemnify the Administrative Agent and each Lender for (i) the full amount of Taxes and Other Taxes (including any Taxes or Other Taxes imposed or asserted by any jurisdiction on amounts payable under this Section 3.13(d)) paid by the Administrative Agent and such Lender and (ii)&#160;any liability (including penalties, interest and reasonable expenses) arising therefrom or with respect thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">In the case of any payment hereunder or under any other Credit Document by or on behalf of the Borrower through an account or branch outside the United States, or on behalf of the Borrower by a payor that is not a United States person, if the Borrower determines that no taxes are payable in respect thereof, the Borrower shall furnish, or shall cause such payor to furnish, to the Administrative Agent, an opinion of counsel reasonably acceptable to the Administrative Agent stating that such payment is exempt from Taxes.  For purposes of this subsection&#160;(e), the terms &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">United States</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">United States person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall have the meanings specified in Section&#160;7701 of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">Each Lender that is not a &#8220;United States person&#8221; within the meaning of Section&#160;7701(a)(30) of the Code shall deliver to the Borrower and the Administrative Agent, on or prior to the date on which such Lender becomes a Lender under this Credit Agreement, (i) two </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">67</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">duly signed completed copies of either IRS Form W-8BEN or any successor thereto, including IRS Form W-8BEN-E (relating to such Lender and entitling it to an exemption from, or reduction of, withholding tax on all payments to be made to such Lender by the Borrower pursuant to this Credit Agreement), IRS Form W-8ECI or any successor thereto (relating to all payments to be made to such Lender by the Borrower pursuant to this Credit Agreement), or IRS Form W-8IMY or any successor thereto (relating to all payments to be made to such Lender by the Borrower pursuant to this Credit Agreement) as appropriate, or such other evidence satisfactory to the Borrower and the Administrative Agent that such Lender is entitled to an exemption from, or reduction of, United States withholding tax and (ii) in the case of a foreign Lender claiming exemption from United States withholding tax under Section 871(h) or 881(c) of the Code with respect to payments of &#8220;portfolio interest&#8221;, a &#8220;Certificate of Non-Bank Status for Foreign Entities&#8221; substantially in the form of Exhibit 3.13(f) together with the applicable IRS Form W-8, or any subsequent versions thereof or successors thereto, properly completed and duly executed by such foreign Lender claiming complete exemption from, or a reduced rate of, United States withholding tax on payments under this Credit Agreement and the other Credit Documents.  Each Lender that is a &#8220;United States person&#8221; within the meaning of Section&#160;7701(a)(30) of the Code shall deliver to the Borrower and the Administrative Agent, on or prior to the date on which such Lender becomes a Lender under this Credit Agreement two duly signed completed copies of IRS Form&#160;W-9 or any successor thereto or such other evidence satisfactory to the Borrower and the Administrative Agent that such Lender is entitled to an exemption from, or reduction of, United States withholding tax.  If a payment made to a Lender under any Credit Document would be subject to United States withholding tax imposed by FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section&#160;1471(b) or 1472(b) of the Code, as applicable), such Lender shall deliver to the Borrower and Administrative Agent, at the time or times prescribed by law and at such time or times reasonably requested by the Borrower or the Administrative Agent, such documentation prescribed by applicable law (including as prescribed by Section&#160;1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Borrower or the Administrative Agent as may be necessary for the Borrower or the Administrative Agent to comply with its obligations under FATCA, to determine whether such Lender has or has not complied with such Lender&#8217;s obligations under FATCA and, as necessary, to determine the amount to deduct and withhold from such payment.  Solely for purposes of this Section&#160;3.13(f), &#8220;FATCA&#8221; shall include any amendments made to FATCA after the Restatement Effective Date.  Thereafter and from time to time, each such Lender shall (i)&#160;promptly submit to the Administrative Agent such additional duly completed and signed copies of one of such forms (or such successor forms as shall be adopted from time to time by the relevant United States taxing authorities), as appropriate, as may reasonably be requested by the Borrower or the Administrative Agent and then be available under then current United States laws and regulations to avoid, or such evidence as is satisfactory to the Borrower and the Administrative Agent of any available exemption from or reduction of, United States withholding taxes in respect of all payments to be made to such Lender by the Borrower pursuant to this Credit Agreement, (ii)&#160;promptly notify the Administrative Agent of any change in circumstances which would modify or render invalid any claimed exemption or reduction (or it is determined the earlier claimed exemption was incorrectly claimed for any reason), (iii) promptly update any previously delivered form or certification that has expired or become obsolete or inaccurate in any respect (or promptly notify the Borrower and Administrative Agent of its legal inability to do so) and (iv)&#160;take such steps as shall not be materially disadvantageous to it, in the reasonable judgment of such Lender, and as may be reasonably necessary (including the re-designation of its Lending Office) to avoid any Requirement of Law that the Borrower make any deduction or withholding for taxes from amounts payable to such Lender.  If payments to any Lender, at the time such Lender (i) acquires the applicable interest in a Loan or Commitment (other than pursuant to an assignment request by the Borrower under Section 3.17) or (ii) changes its Lending Office, are subject to United States withholding tax at a rate in excess of zero pursuant to a law in effect at that time, withholding tax at such rate shall be considered </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">68</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">excluded from Taxes for purposes of any indemnity or gross up unless and until a lesser rate applies, whereupon  withholding tax at such rate only shall be considered excluded from Taxes for periods thereafter&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, if at the date (i) of any assignment pursuant to which such Lender becomes a party to this Credit Agreement or (ii) such Lender changes its Lending Office, such Lender&#8217;s assignor (or such Lender immediately before it changed its Lending Office) was entitled to payments under subsection (a) of this Section 3.13 in respect of United States withholding tax at such date, then, to such extent, the term Taxes shall include (in addition to withholding taxes that may be imposed in the future or other amounts otherwise includable in Taxes) United States withholding tax, if any, applicable with respect to such Lender on such date.  If such Lender fails to deliver the above forms or other evidence, then the Borrower or the Administrative Agent may withhold from any interest payment to such Lender an amount equal to the applicable withholding tax imposed by the Code, without reduction.  If any Governmental Authority asserts that the Borrower or the Administrative Agent did not properly withhold any tax or other amount from payments made in respect of such Lender, such Lender shall indemnify the Borrower or the Administrative Agent therefor, including all penalties and interest, any taxes imposed by any jurisdiction on the amounts payable to the Borrower or the Administrative Agent under this Section&#160;3.13(f), and costs and expenses (including Attorney Costs) of the Borrower or the Administrative Agent.  For any period with respect to which a Lender has failed to provide the Administrative Agent with the above forms or other evidence (other than if such failure is due to a change in the applicable law, or in the interpretation or application thereof, occurring after the date on which such form or other evidence originally was required to be provided or if such form or other evidence otherwise is not required), such Lender shall not be entitled to indemnification under subsection&#160;(d) of this Section&#160;3.13 nor shall the Borrower be required to make additional payments under subsection (a) of this Section 3.13 with respect to Taxes imposed by the United States by reason of such failure&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that should a Lender become subject to Taxes because of its failure to deliver such form or other evidence required hereunder, the Borrower shall take such steps as such Lender shall reasonably request to assist such Lender in recovering such Taxes.  The obligation of the Lenders under this Section 3.13(f) shall survive the payment of all Obligations and the resignation or replacement of the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">In the event that an additional payment is made under Section&#160;3.13(a) for the account of any Lender and such Lender, in its reasonable judgment, determines that it has finally and irrevocably received or been granted a credit against or release or remission for, or repayment of, any tax paid or payable by it in respect of or calculated with reference to the deduction or withholding giving rise to such payment, such Lender shall, to the extent that it determines that it can do so without prejudice to the retention of the amount of such credit, relief, remission or repayment, pay to the Borrower such amount as such Lender shall, in its reasonable judgment, have determined to be attributable to such deduction or withholding and which will leave such Lender (after such payment) in no worse position than it would have been in if the Borrower had not been required to make such deduction or withholding.  Nothing herein contained shall interfere with the right of a Lender to arrange its tax affairs in whatever manner it thinks fit nor oblige any Lender to claim any tax credit or to disclose any information relating to its tax affairs or any computations in respect thereof or require any Lender to do anything that would prejudice its ability to benefit from any other credits, reliefs, remissions or repayments to which it may be entitled.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">For purposes of determining withholding tax imposed under FATCA, from and after the Restatement Effective Date, the Borrower and the Administrative Agent shall treat (and the Lenders hereby authorize the Administrative Agent to treat) this Credit Agreement as not qualifying as a &#8220;grandfathered obligation&#8221; within the meaning of Treasury Regulation Section 1.1471-2(b)(2)(i).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">69</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Solely for purposes of this Section 3.13, the term &#8220;Credit Document&#8221; includes the Fee Letters.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Upon the written demand of any Lender, the Borrower shall promptly compensate such Lender for and hold such Lender harmless from any loss, cost or expense incurred by it as a result of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">any continuation, conversion, payment or prepayment of any Term Benchmark Loan or RFR Loan, on a day other than the last day of the Interest Period for such Term Benchmark Loan or on the Interest Payment Date of such RFR Loan, as applicable (whether voluntary, mandatory, automatic, by reason of acceleration, or otherwise)&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">any failure by the Borrower (for a reason other than the failure of such Lender to make a Term Benchmark Loan or RFR Loan) to prepay, borrow, continue or convert any Term Benchmark Loan or RFR Loan on the date or in the amount previously requested by the Borrower&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">any assignment required pursuant to Section&#160;2.7(e), Section&#160;3.17 or Section&#160;11.6.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The amount each such Lender shall be compensated pursuant to this Section&#160;3.14 shall include, without limitation, (i)&#160;any loss incurred by such Lender in connection with the re-employment of funds paid, prepaid or repaid, or not borrowed or paid, as the case may be, and (ii)&#160;any reasonable and documented out-of-pocket expenses (including Attorney Costs) incurred and reasonably attributable thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">With respect to Term Benchmark Loans, for purposes of calculating amounts payable by the Borrower to the Lenders under this Section&#160;3.14, each Lender may deem itself to have funded each Term Benchmark Loan made by it at the Term SOFR Rate or EURIBO Rate, as applicable, for such Term Benchmark Loan by a matching deposit or other borrowing in the applicable offshore interbank markets for such currency for a comparable amount and for a comparable period, whether or not such Term Benchmark Loan was in fact so funded.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Determination and Survival of Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All determinations by the Administrative Agent or a Lender of amounts owing under Sections&#160;3.9 through 3.14, inclusive, shall, absent manifest error, be conclusive and binding on the parties hereto.  In determining such amount, the Administrative Agent or such Lender may use any reasonable averaging and attribution methods.  Section&#160;3.9 through 3.14, inclusive, shall survive the termination of this Credit Agreement and the payment of all Obligations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Notification by Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each Lender shall notify the Borrower of any event that will entitle such Lender to compensation under Section 3.9, 3.12, 3.13 or 3.14 as promptly as practicable, but in any event within 90 days after such Lender obtains actual knowledge thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if any Lender fails to give such notice within 90 days after it obtains actual knowledge of such an event, such Lender shall, with respect to compensation payable pursuant to Section 3.9, 3.12, 3.13 or 3.14 in respect of any costs resulting from such event, only be entitled to payment under Section 3.9, 3.12, 3.13 or 3.14 for costs incurred from and after the date 90 days prior to the date that such Lender gives such notice&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, if the event giving rise to such Lender&#8217;s </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">70</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">right to compensation under Section&#160;3.9, 3.12, 3.13 or 3.14 is retroactive in effect, then the 90-day period referred to above shall be extended to include the period of retroactive effect thereof.  If requested by the Borrower, each Lender will furnish to the Borrower within 10 Business Days of the time the Lender requests compensation under Section 3.9, 3.12, 3.13 or 3.14, a certificate setting forth the basis, amount and reasonable detail of computation of each request by such Lender for compensation under Section 3.9, 3.12, 3.13 or 3.14, which certificate shall, except for demonstrable error, be final, conclusive and binding for all purposes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Mitigation&#59; Mandatory Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each Lender shall use reasonable efforts to avoid or mitigate any increased cost or suspension of the availability of an interest rate under Sections 3.9 through and including 3.14 above to the greatest extent practicable (including transferring the Loans to another Lending Office or Affiliate of a Lender) unless, in the reasonable opinion of such Lender, such efforts would be likely to have an adverse effect upon it.  In the event (a) a Lender makes a request to the Borrower for additional payments in accordance with Section 3.9, 3.12, 3.13 or 3.14, or delivers a notice under Section 3.10 or 3.11 or (b) any Lender shall be a Defaulting Lender, then, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that no Default or Event of Default has occurred and is continuing at such time, the Borrower may, (a) in the case of a Lender that makes a request to the Borrower for additional payments in accordance with Section 3.9, 3.12, 3.13 or 3.14, or delivers a notice under Section 3.10 or 3.11, at its own expense (such expense to include, without limitation, any transfer fee payable to the Administrative Agent under Section 11.3(b)), and (b) in the case of a Defaulting Lender, at the replacement Lender&#8217;s expense (such expense to include, without limitation, any transfer fee payable to the Administrative Agent under Section 11.3(b)), and, in each case, in its sole discretion, require such Lender or Defaulting Lender, as the case may be, to transfer and assign in whole (but not in part), without recourse (in accordance with and subject to the terms and conditions of Section 11.3(b)), all of its interests, rights and obligations under this Credit Agreement to an Eligible Assignee which shall assume such assigned obligations (which assignee may be another Lender, if a Lender accepts such assignment)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that (a) such assignment shall not conflict with any law, rule or regulation or order of any court or other Governmental Authority and (b) the Borrower or such assignee shall have paid to the assigning Lender in immediately available funds the principal of and interest accrued to the date of such payment on the portion of the Loans hereunder held by such assigning Lender and all other amounts owed to such assigning Lender hereunder, including amounts owed pursuant to Sections&#160;3.9, 3.12, 3.13 or 3.14 hereof.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.36pt;text-decoration:underline"><br><br>&#91;RESERVED&#93;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.36pt;text-decoration:underline"><br><br>CONDITIONS PRECEDENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Conditions to Effectiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The effectiveness of this Credit Agreement shall be subject to the satisfaction of the following conditions&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Administrative Agent shall have received duly executed counterparts of the Amendment and Restatement Agreement that, when taken together, bear the signatures of the Borrower, each Lender and the Administrative Agent.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">71</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Administrative Agent shall have received a written opinion of Shearman &#38; Sterling LLP and a written opinion of the Deputy General Counsel of the Borrower, each (A) dated the Restatement Effective Date, (B) addressed to the Administrative Agent on behalf of the Lenders and (C) in form and substance consistent with the opinions delivered by Shearman &#38; Sterling LLP and the Deputy General Counsel of the Borrower, respectively, on the Prior Closing Date, but giving effect to the amendment and restatement of the Existing Credit Agreement in the form hereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Administrative Agent shall have received such customary documents and certificates as the Administrative Agent or its counsel may reasonably request relating to the organization, existence and good standing of the Borrower and the authorization of the transactions contemplated hereby by the Borrower, all in form and substance reasonably satisfactory to the Administrative Agent, consistent with those delivered on the Prior Closing Date and giving effect to the Amendment and Restatement Agreement. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Administrative Agent shall have received payment from the Borrower, for the account of each Lender that executes and delivers a counterpart signature page to the Amendment and Restatement Agreement, of an upfront fee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Upfront Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in an amount equal to (i) 0.06% of the amount of the Revolving Commitment of such Lender that does not exceed its Revolving Commitment under the Existing Credit Agreement </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (ii) 0.10%  of the amount by which the Revolving Commitment of such Lender exceeds its Revolving Commitment (if any) under the Existing Credit Agreement.  The Upfront Fee shall be payable in immediately available funds and, once paid, shall not be refundable.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Administrative Agent shall have received, in immediately available funds, payment of all interest and fees accrued to the Restatement Effective Date under the Existing Credit Agreement, as well as costs, fees, out-of-pocket expenses, compensation and other amounts then due and payable in connection with the Existing Credit Agreement, the Amendment and Restatement Agreement or the transactions contemplated thereby, including, to the extent invoiced, all amounts payable under Section 6 of the Amendment and Restatement Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">(i) The Lenders shall have received all documentation and other information required by bank regulatory authorities under applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including the PATRIOT Act to the extent requested at least five days prior to the Restatement Effective Date and (ii) to the extent the Borrower qualifies as a &#8220;legal entity customer&#8221; under the Beneficial Ownership Regulation, any Lender that has requested, in a written notice to the Borrower, a Beneficial Ownership Certification in relation to the Borrower shall have received such Beneficial Ownership Certification (provided that, upon the execution and delivery by such Lender of its signature page to this Credit Agreement, the condition set forth in this clause (ii) shall be deemed to be satisfied).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The representations set forth in paragraphs (b) and (c) of Section 3 of the Amendment and Restatement Agreement and in Section 6 of this Credit Agreement shall be true and correct on and as of the Restatement Effective Date and the Administrative Agent shall have received a certificate of an Authorized Officer of the Borrower, dated the Restatement Effective Date, to such effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Administrative Agent shall notify the Borrower and the Lenders of the Restatement Effective Date and such notice shall be conclusive and binding.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">72</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Conditions to All Extensions of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition to the conditions precedent stated in Section 5.1, the Lenders shall not be obligated to make Loans nor shall any Issuing Lender be required to issue, extend or increase the amount of a Letter of Credit, in each case on or after the Restatement Effective Date unless as of the date thereof&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower shall have delivered (i)&#160;in the case of any Loan, to the Administrative Agent, an appropriate Notice of Borrowing, duly executed and completed, by the time specified in Section 2.1, and (ii)&#160;in the case of any Letter of Credit, to the Administrative Agent for distribution by the Administrative Agent to the relevant Issuing Lender as specified by the Borrower, an appropriate request for issuance of a Letter of Credit in accordance with the provisions of Section&#160;2.2 and (iii) in the case of any Swing Line Loan, to the Swing Line Lender, a Swing Line Loan Request, duly executed and completed, by the time specified in Section 2.3.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The representations and warranties made by the Borrower in this Credit Agreement or any Credit Document (other than, in the case of any Extension of Credit made after the Restatement Effective Date, the representations and warranties set forth in Sections 6.7 and 6.10) are true and correct (i) in the case of any representation and warranty that is qualified by materiality, in all respects and (ii)&#160;otherwise, in all material respects, at and as of the date of such Extension of Credit except to the extent they expressly and exclusively relate to an earlier date in which case such representations and warranties shall be true and correct (x) in the case of any representation and warranty that is qualified by materiality, in all respects and (y)&#160;otherwise, in all material respects, as of such earlier date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">No Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No Default or Event of Default shall exist and be continuing either immediately prior to or immediately after giving effect to such Extension of Credit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Availability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Immediately after giving effect to the making of a Loan (and the application of the proceeds thereof) or to the issuance of a Letter of Credit, as the case may be, (i)&#160;the sum of the Dollar Equivalent of outstanding Revolving Loans </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> the Dollar Equivalent of outstanding LOC Obligations </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> outstanding Swing Line Loans shall not exceed the Revolving Committed Amount and (ii)&#160;the sum of the Dollar Equivalent of outstanding LOC Obligations shall not exceed the LOC Committed Amount.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The delivery of each Notice of Borrowing, each request for a Letter of Credit and each Swing Line Loan Request shall constitute a representation and warranty by the Borrower of the correctness of the matters specified in subsections (b), (c) and (d) above.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.36pt;text-decoration:underline"><br><br>REPRESENTATIONS AND WARRANTIES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower hereby represents to the Administrative Agent and each Lender that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Organization and Good Standing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower and each Domestic Subsidiary (a)&#160;is a corporation duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization, unless, solely with respect to each Domestic Subsidiary, the failure to be so duly organized, validly existing and in good standing would not have or would not reasonably be expected to have a Material </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">73</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Adverse Effect, (b) is duly qualified and in good standing as a foreign organization and authorized to do business in every other jurisdiction where its ownership or operation of property or the conduct of its business would require it to be qualified, in good standing and authorized, unless the failure to be so qualified, in good standing or authorized would not have or would not reasonably be expected to have a Material Adverse Effect and (c) has the power and authority to own and operate its properties and to carry on its business as now conducted and as currently proposed to be conducted.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Due Authorization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower (a) has the power and authority to execute, deliver and perform this Credit Agreement and the other Credit Documents to which it is a party and to incur the obligations herein and therein provided for and (b) has duly taken all necessary action to authorize, and is duly authorized, to execute, deliver and perform this Credit Agreement and the other Credit Documents to which it is a party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Enforceable Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower has duly executed this Credit Agreement and each other Credit Document to which the Borrower is a party and this Credit Agreement and such other Credit Documents constitute legal, valid and binding obligations of the Borrower enforceable against the Borrower in accordance with their respective terms, except as may be limited by bankruptcy or insolvency laws or similar laws affecting creditors&#8217; rights generally or by general equitable principles.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">No Conflicts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Neither the execution and delivery of this Credit Agreement and the other Credit Documents to which it is a party, nor the consummation of the transactions contemplated herein and therein, nor the performance of or compliance with the terms and provisions hereof and thereof by the Borrower will (a) violate, contravene or conflict with any provision of the Borrower&#8217;s organizational documents, (b)&#160;violate, contravene or conflict with any Requirement of Law (including, without limitation, Regulations T, U or X), order, writ, judgment, injunction, decree, license or permit applicable to the Borrower which violation would have or would reasonably be expected to have a Material Adverse Effect, (c) violate, contravene or conflict with contractual provisions of, or cause an event of default under, any indenture, loan agreement, mortgage, deed of trust, or other material contract, agreement or instrument to which the Borrower or any Domestic Subsidiary is a party or by which it or its properties may be bound which violation would have or would reasonably be expected to have a Material Adverse Effect, or (d) result in or require the creation of any Lien upon or with respect to the Properties of the Borrower or any Domestic Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except for consents, approvals and authorizations which have been obtained or the absence of which would not have or would not reasonably be expected to have a Material Adverse Effect, no consent, approval, authorization or order of, or filing, registration or qualification with, any Governmental Authority, equity owner or third party in respect of the Borrower is required in connection with the execution, delivery or performance of this Credit Agreement or any of the other Credit Documents, or the consummation of any transaction contemplated herein or therein by the Borrower.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">74</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Financial Condition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower has heretofore furnished to the Lenders its consolidated balance sheet and income statement, together with related consolidated statements of operations, cash flows and changes in stockholders&#8217; equity as of and for the fiscal year ended December 31, 2020, audited by and accompanied by the opinion of PricewaterhouseCoopers LLP, independent registered public accountants.  Such financial statements, and the financial statements that shall at any time have been delivered to the Administrative Agent and the Lenders pursuant to Sections 7.1(a) and (b)&#58;  (a) have been prepared in accordance with GAAP and (b)&#160;present fairly the consolidated financial condition, results of operations and cash flows of the Borrower and its Subsidiaries as of such date and for such periods.  Since December 31, 2020, there has been no sale, transfer or other disposition by the Borrower or any of its Subsidiaries of any material part of the business or property of the Borrower and its Subsidiaries, taken as a whole, or purchase or other acquisition by any such Person of any business or property (including any Capital Stock of any other Person) material in relation to the consolidated financial condition of the Borrower and its Subsidiaries, taken as a whole, in each case, which is not (i) reflected in the most recent financial statements delivered to the Lenders prior to the date hereof or pursuant to Section 7.1(a) or (b) or in the notes thereto or (ii) otherwise permitted by the terms of this Credit Agreement and communicated to the Administrative Agent and the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Since December 31, 2020, there has been no event or condition that has resulted or could reasonably be expected to result in a material adverse change in or affecting the business, operations or financial condition of the Borrower and its Subsidiaries, taken as a whole, other than as disclosed to the Lenders or in the Borrower&#8217;s filings with the Securities and Exchange Commission prior to the Restatement Effective Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Neither this Credit Agreement, nor any other Credit Document, nor any financial statements delivered to the Administrative Agent or the Lenders nor any other document, certificate or statement furnished to the Administrative Agent or the Lenders by or on behalf of the Borrower in connection with the transactions contemplated hereby, taken as a whole, contains any untrue statement of a material fact or omits to state a material fact necessary in order to make the statements contained therein or herein not materially misleading.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">As of the Restatement Effective Date, to the best knowledge of the Borrower, the information included in the Beneficial Ownership Certification provided on or prior to the Restatement Effective Date to any Lender in connection with this Credit Agreement (if any) is true and correct in all respects.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">No Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No Default or Event of Default has occurred and is continuing or would result from the consummation of the transactions contemplated by this Credit Agreement and the other Credit Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Litigation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 6.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or as disclosed in the Borrower&#8217;s filings with the Securities and Exchange Commission prior to the Restatement Effective Date, no litigation, investigation, claim, criminal prosecution, civil investigative demand, imposition of criminal or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">75</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">civil fines and penalties, or any other proceeding of or before any arbitrator or Governmental Authority is pending or, to the knowledge of the Borrower, threatened by or against the Borrower or any of its Subsidiaries or against any of its or their respective Properties (a) with respect to the Credit Documents or any Extension of Credit or any of the transactions contemplated hereby or (b) which would reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower and each of its Subsidiaries has filed, or caused to be filed, all material tax returns (federal, state, local and foreign) required to be filed and has paid (a) all amounts of taxes shown thereon to be due (including interest and penalties) and (b) all other material taxes, fees, assessments and other governmental charges (including mortgage recording taxes, documentary stamp taxes and intangibles taxes) owing by it, except for such taxes (i) that are not yet delinquent or (ii) that are being contested in good faith and by proper proceedings, and against which adequate reserves are being maintained in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except to the extent the same would not reasonably be expected to have a Material Adverse Effect&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Borrower and each of its Subsidiaries is in compliance with all Requirements of Law (including, without limitation, Environmental Laws, ERISA, HIPAA, Medicaid Regulations and Medicare Regulations) and all material orders, writs, injunctions and decrees applicable to it, or to its Properties.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">(i) Neither the Borrower nor any of its Subsidiaries nor any individual employed by the Borrower or any of its Subsidiaries has been, or may reasonably be expected to be, excluded or suspended from participation in any Medical Reimbursement Program for their corporate or individual actions or failures to act and (ii) there is no member of management continuing to be employed by the Borrower or any of its Subsidiaries who has been, or may reasonably be expected to have, individual criminal culpability for healthcare matters under investigation by any Governmental Authority unless such member of management has been, within a reasonable period of time after discovery of such actual or potential culpability, either suspended or removed from positions of responsibility related to those activities under challenge by the Governmental Authority.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Current billing policies, arrangements, protocols and instructions comply with all material requirements of Medical Reimbursement Programs and are administered by properly trained personnel.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Current medical director compensation arrangements and other arrangements with referring physicians comply with state and federal self-referral and anti-kickback laws, including without limitation 42 U.S.C. Section 1320a-7b(b)(1) - (b)(2) and 42 U.S.C. Section 1395nn.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Licensing and Accreditation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except to the extent the same would not be reasonably expected to have a Material Adverse Effect, the Borrower and each of its Domestic Subsidiaries has, to the extent applicable, (a)&#160;obtained and maintains in good standing all required licenses, permits, authorizations and approvals of each Governmental Authority necessary to the conduct of its business, (b) to the extent prudent and customary in the industry in which it is engaged, has obtained and maintains </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">76</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">accreditation from all generally recognized accrediting agencies (including, but not limited to, CAP), (c) has obtained and maintains CLIA certification, (d) has entered into and maintains in good standing its Medicare Provider Agreements and its Medicaid Provider Agreements and (e)&#160;has ensured that all such required licenses, certifications and accreditations are in full force and effect and have not been revoked or suspended or otherwise limited.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The properties of the Borrower and each of its Subsidiaries are insured with financially sound and reputable insurance companies that are not Affiliates of the Borrower (except to the extent that self-insurance is maintained in reasonable amounts), in such amounts, with such deductibles and covering such risks, as is reasonable and prudent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The proceeds of the Loans have been and will be used solely for the purposes specified in Section&#160;7.8.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Government Regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">&#8220;Margin stock&#8221; within the meaning of Regulation U does not constitute more than 25% of the value of the consolidated assets of the Borrower and its Subsidiaries.  None of the transactions contemplated by the Credit Documents (including, without limitation, the direct or indirect use of the proceeds of the Loans) will violate or result in a violation of Regulations T, U or X.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Borrower is not subject to regulation under the Investment Company Act of 1940, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except as would not reasonably be expected to result in a Material Adverse Effect&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">(i) No ERISA Event has occurred, and, to the best knowledge of the Borrower and each ERISA Affiliate, no event or condition has occurred or exists as a result of which any ERISA Event could reasonably be expected to occur, with respect to any Plan, (ii) no Plan (other than a Multiemployer Plan) has failed to meet the &#8220;minimum funding standard&#8221; (as such term is defined in Section 302 of ERISA and Section 412 of the Code) applicable to such Plan, in each instance, whether or not waived, and no application for a funding waiver or an extension of any amortization period pursuant to Section 412 of the Code has been made with respect to any Plan, (iii) each Plan has been maintained, operated, and funded in compliance with its own terms and in material compliance with the provisions of ERISA, the Code, and any other applicable federal or state laws and (iv) no Lien in favor of the PBGC or a Plan has arisen or is reasonably likely to arise on account of any Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Neither the Borrower nor any ERISA Affiliate has incurred, or, to the best of each such party&#8217;s knowledge, is reasonably expected to incur, any liability under Title IV of ERISA with respect to any Single Employer Plan, other than for the payment of premiums arising in the ordinary course of business, or any withdrawal liability under ERISA to any Multiemployer Plan or Multiple Employer Plan.  Neither the Borrower nor any ERISA Affiliate has received any notification that any Multiemployer Plan is insolvent (within the meaning of Section 4245 of ERISA), or has been terminated (within the meaning of Title IV of ERISA), and no Multiemployer Plan is, to the best of each </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">77</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">such Person&#8217;s knowledge, reasonably expected to be insolvent or terminated.  Neither the Borrower nor any ERISA Affiliate has engaged in a transaction that could be subject to Sections 4069 or 4212(c) of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Environmental Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except with respect to matters that would not reasonably be expected to result in a Material Adverse Effect, neither the Borrower nor any of its Subsidiaries (i)&#160;has failed to comply with any Environmental Law or to obtain, maintain or comply with any permit, license or other approval required under any Environmental Law, (ii)&#160;has become subject to any Environmental Liability, (iii)&#160;has received notice of any claim with respect to any Environmental Liability or (iv)&#160;knows of any basis for any Environmental Liability.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower and each of its Subsidiaries owns, or has the legal right to use, all material patents, trademarks, copyrights and other intellectual property rights (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) necessary for each of them to conduct its business as currently conducted other than as would not be reasonably expected to have a Material Adverse Effect.  To the knowledge of the Borrower and its Subsidiaries, (i) no claim has been asserted and is pending before any Governmental Authority by any Person against the Borrower or any of its Subsidiaries challenging the use, validity or effectiveness of any Intellectual Property owned by the Borrower or any of its Subsidiaries and (ii) the use of any Intellectual Property by the Borrower and its Subsidiaries does not infringe on the rights of any Person, in the case of each of (i) and (ii) except for claims and infringements that, in the aggregate, would not have or reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">As of the Restatement Effective Date and unless the Borrower shall have complied with its obligations under Section 7.10, there are no Domestic Subsidiaries of the Borrower that, individually or together with their Subsidiaries, guarantee Material Debt of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Anti-Corruption Laws and Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower has implemented and maintains in effect policies and procedures designed to ensure compliance by the Borrower, its Subsidiaries and their respective directors, officers, employees and agents with Anti-Corruption Laws and applicable Sanctions, and the Borrower, its Subsidiaries and their respective officers and employees and to the knowledge of the Borrower its directors and agents, are in compliance with Anti-Corruption Laws and applicable Sanctions in all material respects.  None of (a) the Borrower, any Subsidiary or, to the knowledge of the Borrower, any of their respective directors, officers or employees, or (b) to the knowledge of the Borrower, any agent of the Borrower or any Subsidiary that will act in any capacity in connection with or benefit from the credit facility established hereby, is a Sanctioned Person.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No Loan or Letter of Credit, use of the proceeds of any Loan or any Letter of Credit or other transaction contemplated by this Credit Agreement will result in a violation by any party hereto of Anti-Corruption Laws or applicable Sanctions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Affected Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower is not is an Affected Financial Institution.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">78</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.36pt;text-decoration:underline"><br><br>AFFIRMATIVE COVENANTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower hereby covenants and agrees that so long as this Credit Agreement is in effect and until the Loans and LOC Obligations, together with interest and fees and other obligations then due and payable hereunder, have been paid in full (other than contingent obligations for which no claim has been made) and the Commitments and Letters of Credit hereunder shall have terminated or expired (or, in the case of Letters of Credit, the LOC Obligations have been cash collateralized), as applicable&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Information Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will furnish, or cause to be furnished, to the Administrative Agent for the benefit of each of the Lenders&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Annual Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As soon as available, and in any event within 95 days after the close of each fiscal year of the Borrower, a consolidated balance sheet and income statement of the Borrower and its Subsidiaries, as of the end of such fiscal year, together with related consolidated statements of operations, cash flows and changes in stockholders&#8217; equity for such fiscal year, setting forth in comparative form consolidated figures for the preceding fiscal year, all such consolidated financial information described above to be audited by independent certified public accountants of recognized national standing and whose opinion shall be to the effect that such financial statements fairly present in all material respects the consolidated financial position, results of operations and cash flows of the Borrower and its Subsidiaries as at the end of, and for, such fiscal year in accordance with GAAP and shall not be limited as to the scope of the audit or qualified in any manner.  Notwithstanding the above, it is understood and agreed that filing of the Borrower&#8217;s applicable Form 10-K shall satisfy the requirements of this Section 7.1(a).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Quarterly Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As soon as available, and in any event within 50 days after the close of each of the first three fiscal quarters of the Borrower, a consolidated balance sheet and income statement of the Borrower and its Subsidiaries, as of the end of such fiscal quarter, together with related consolidated statements of operations, cash flows and changes in stockholders&#8217; equity for such fiscal quarter setting forth in each case in comparative form the corresponding consolidated statements of operations and cash flows for the corresponding period of the preceding fiscal year, and accompanied by a certificate of an Authorized Officer of the Borrower to the effect that such quarterly financial statements fairly present in all material respects the consolidated financial condition of the Borrower and its Subsidiaries and in accordance with GAAP, subject to changes resulting from audit and normal year-end audit adjustments.  Notwithstanding the above, it is understood and agreed that filing of the Borrower&#8217;s applicable Form 10-Q shall satisfy the requirements of this Section 7.1(b).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Officer&#8217;s Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  At the time of delivery of the financial statements provided for in Sections 7.1(a) and 7.1(b) above, a certificate of an Authorized Officer of the Borrower substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit 7.1(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, (i) demonstrating compliance with the financial covenant contained in Section 7.2 by calculation thereof as of the end of each such fiscal period, and (ii) stating that no Default or Event of Default exists, or if any Default or Event of Default does exist, specifying the nature and extent thereof and what action the Borrower proposes to take with respect thereto.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">79</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Promptly upon transmission or receipt thereof, copies of all financial statements, proxy statements, notices and reports which the Borrower or any of its Subsidiaries shall send to shareholders of the Borrower generally and, upon request of the Administrative Agent, copies of any filings and registrations with, and reports to or from, any Governmental Authority which has regulatory authority with respect to the Borrower and its Subsidiaries.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Upon the Borrower obtaining knowledge thereof, the Borrower will give written notice to the Administrative Agent promptly (and in any event within five Business Days) of (i)&#160;the occurrence of any Default or Event of Default, specifying the nature and existence thereof and what action the Borrower proposes to take with respect thereto, (ii)&#160;the occurrence of any of the following with respect to the Borrower or any of its Subsidiaries (A) the pendency or commencement of any litigation, arbitration or governmental proceeding against the Borrower or any of its Subsidiaries which has had or would reasonably be expected to have a Material Adverse Effect or (B)&#160;material non-compliance with, or the institution of any proceedings against the Borrower or any of its Subsidiaries with respect to, or the receipt of written notice by such Person of potential liability or responsibility for violation, or alleged violation of, any Requirement of Law (including, without limitation, Environmental Laws) the violation of which has had or would reasonably be expected to have a Material Adverse Effect, (iii)&#160;any change to any Debt Rating of the Borrower, (iv)&#160;any change in the information provided in the Beneficial Ownership Certification delivered to any Lender (if any) that would result in a change to the list of beneficial owners identified in such certification and (v)&#160;any proceeding against the Borrower or any of its Subsidiaries to suspend, revoke or terminate any Medicaid Provider Agreement or Medicare Provider Agreement, or to exclude the Borrower or any of its Subsidiaries from any Medical Reimbursement Program, which is reasonably expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Upon the Borrower or any ERISA Affiliate obtaining knowledge thereof, such Person shall give written notice to the Administrative Agent promptly (and in any event within 10 Business Days) of the occurrence of any of the following events which has had or would be reasonably expected to have a Material Adverse Effect&#58; (i) any ERISA Event, (ii) with respect to any Multiemployer Plan, the receipt of notice as prescribed in ERISA or otherwise of any withdrawal liability assessed against the Borrower or any ERISA Affiliate (within the meaning of Title IV of ERISA), (iii) the failure to make full payment on or before the due date (including extensions) thereof of all amounts which the Borrower or any ERISA Affiliate is required to contribute to each Plan pursuant to its terms and as required to meet the &#8220;minimum funding standard&#8221; (as such term is defined in Section 302 of ERISA and Section 412 of the Code) applicable to such Plan or (iv) any change in the funding status of any Plan that would reasonably be expected to have a Material Adverse Effect&#59; in each case together with a description of any such event or condition or a copy of any such notice and a statement by an Authorized Officer of the Borrower briefly setting forth the details regarding such event, condition, or notice, and the action, if any, which has been or is being taken or is proposed to be taken by such Person with respect thereto.  Promptly upon request, the Borrower shall furnish the Administrative Agent with such additional information concerning any Plan as may be reasonably requested, including, but not limited to, copies of each annual report&#47;return (Form 5500 series), as well as all schedules and attachments thereto required to be filed with the Department of Labor pursuant to ERISA and the Code, respectively, for each &#8220;plan year&#8221; (within the meaning of Section 3(39) of ERISA).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Other Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  With reasonable promptness upon any such request, (x)&#160;such other information regarding the business, properties or financial condition of the Borrower and its Subsidiaries as the Administrative Agent may reasonably request and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">80</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(y)&#160;information and documentation reasonably requested by the Administrative Agent or any Lender for purposes of compliance with applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including the Patriot Act and the Beneficial Ownership Regulation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Public&#47;Private Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower hereby acknowledges that (i)&#160;the Administrative Agent will make available to the Lenders materials and&#47;or information provided by or on behalf of the Borrower hereunder (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) by posting the Borrower Materials on  IntraLinks or another similar electronic system (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Platform</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and (ii)&#160;certain of the Lenders may be &#8220;public-side&#8221; Lenders (i.e., Lenders that do not wish to receive MNPI) (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Public Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  The Borrower hereby agrees that (A)&#160;all Borrower Materials that are to be made available to the Public Lenders shall be clearly and conspicuously marked &#8220;PUBLIC&#8221; which, at a minimum, shall mean that the word &#8220;PUBLIC&#8221; shall appear prominently on the first page thereof, (B)&#160;by marking Borrower Materials &#8220;PUBLIC&#8221;, the Borrower shall be deemed to have authorized the Administrative Agent and the Lenders to treat such Borrower Materials as either publicly available information or not material information (although it may be sensitive and proprietary) with respect to the Borrower or its securities for purposes of United States federal and state securities laws, (C)&#160;all Borrower Materials marked &#8220;PUBLIC&#8221; are permitted to be made available through a portion of the Platform designated as &#8220;Public&#8221; and (D)&#160;the Administrative Agent shall be entitled to treat any Borrower Materials that are not marked &#8220;PUBLIC&#8221; as being suitable only for posting on a portion of the Platform not marked &#8220;Public&#8221;.  Notwithstanding the foregoing, the Borrower shall be under no obligation to mark any Borrower Materials &#8220;PUBLIC&#8221;.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Documents required to be delivered pursuant to Section&#160;7.1(a) or (b) (to the extent any such documents are included in materials otherwise filed with the Securities and Exchange Commission) may be delivered electronically and if so delivered, shall be deemed to have been delivered on the date (i)&#160;on which the Borrower posts such documents, or provides a link thereto on the Borrower&#8217;s website on the Internet at the website address listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or (ii)&#160;on which such documents are posted on the Borrower&#8217;s behalf on an Internet or intranet website, if any, to which each Lender and the Administrative Agent have access (whether a commercial, third-party website or whether sponsored by the Administrative Agent)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that&#58; (A)&#160;the Borrower shall deliver paper copies of such documents to the Administrative Agent or any Lender that requests the Borrower to deliver such paper copies until a written request to cease delivering paper copies is given by the Administrative Agent or such Lender and (B)&#160;the Borrower shall notify (which may be facsimile or electronic mail) the Administrative Agent and each Lender of the posting of any such documents and provide to the Administrative Agent by electronic mail electronic versions (i.e., soft copies) of such documents.  Except for such compliance certificates, the Administrative Agent shall have no obligation to request the delivery or to maintain copies of the documents referred to above, and in any event shall have no responsibility to monitor compliance by the Borrower with any such request for delivery, and each Lender shall be solely responsible for requesting delivery to it or maintaining its copies of such documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Financial Covenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Leverage Ratio, as of the last day of each fiscal quarter of the Borrower, shall be less than or equal to 4.00 to 1.00&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, following the consummation of a Material Acquisition that, on a pro forma basis, would result in an increase in the Leverage Ratio, if the Borrower shall so elect by a notice delivered to the Administrative Agent within 30 days following such completion (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Leverage Increase Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), such maximum Leverage Ratio </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">81</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shall be increased to 4.50 to 1.00 at the end of and for the fiscal quarter during which such Material Acquisition shall have been consummated and at the end of and for each of the following three consecutive fiscal quarters, it being understood and agreed that the Borrower shall have the right, in its sole and absolute discretion, to decide (by written notice to the Administrative Agent) that such increased Leverage Ratio shall be in effect for a shorter period of time (the period during which any such increase in the Leverage Ratio shall actually be in effect (taking into account such Borrower&#8217;s election to shorten the period during which the increased Leverage Ratio shall be in effect) being called a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Leverage Increase Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Notwithstanding the foregoing, after the Borrower elects to make a Leverage Increase Election the Borrower may not make a subsequent Leverage Increase Election until two fiscal quarters have elapsed since the end of the prior Leverage Increase Period.  The Borrower may terminate any Leverage Increase Period by a notice delivered to the Administrative Agent whereupon, on the last day of the fiscal quarter during which such notice was given and on the last day of each fiscal quarter thereafter until another Leverage Increase Period has commenced as provided in this Section, the maximum Leverage Ratio shall be 4.00 to 1.00.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Preservation of Existence and Franchises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will, and will cause its Subsidiaries to, maintain and preserve its existence and any rights, franchises, Intellectual Property and authority that are used or useful in the conduct of business except as permitted by Section 8.4, in each case to the extent and in the manner customary for companies in similar businesses, except where the failure to do so would not reasonably be expected to cause a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except to the extent the failure to do so would not reasonably be expected to have a Material Adverse Effect, the Borrower will, and will cause each of its Subsidiaries to, (a) comply with all Requirements of Law, and all applicable restrictions imposed by all Governmental Authorities, applicable to it and its Property (including, without limitation, Environmental Laws and ERISA), (b) conform with and duly observe in all material respects all laws, rules and regulations and all other valid requirements of any regulatory authority with respect to the conduct of its business, including without limitation, HIPAA, Medicare Regulations, Medicaid Regulations, and all laws, rules and regulations of Governmental Authorities, pertaining to the business of the Borrower and the Domestic Subsidiaries, (c) obtain and maintain all licenses, permits, certifications and approvals of all applicable Governmental Authorities as are required for the conduct of its business as currently conducted and herein contemplated, including without limitation professional licenses, CLIA certifications, Medicare Provider Agreements and Medicaid Provider Agreements, (d) ensure that (i) billing policies, arrangements, protocols and instructions will comply with reimbursement requirements under Medicare, Medicaid and other Medical Reimbursement Programs and will be administered by properly trained personnel, (ii) medical director compensation arrangements and other arrangements with referring physicians will comply with applicable state and federal self-referral and anti-kickback laws, including without limitation 42 U.S.C. Section 1320a-7b(b)(1) - (b)(2) 42 U.S.C. and 42 U.S.C. Section 1395nn and (iii)&#160;no event or related events occur that result in the exclusion of the Borrower or any of its Subsidiaries from participation in any Medical Reimbursement Program and (e)&#160;make commercially reasonable efforts to implement policies that are consistent with HIPAA on or before the date that the Borrower and the Domestic Subsidiaries are required to comply therewith.  The Borrower will maintain in effect and enforce policies and procedures designed to ensure compliance by the Borrower, its Subsidiaries and their respective directors, officers, employees and agents with Anti-Corruption Laws and applicable Sanctions.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">82</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Payment of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will, and will cause its Subsidiaries to, pay, settle or discharge all material taxes, assessments and governmental charges or levies imposed upon it, or upon its income or profits, or upon any of its properties, before they shall become delinquent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Borrower and its Subsidiaries shall not be required to pay any such tax, assessment, charge or levy which is being contested in good faith by appropriate proceedings and as to which adequate reserves have been established in accordance with GAAP, unless the failure to make any such payment (i) would give rise to an immediate right to foreclose or collect on a Lien securing such amounts or (ii) would reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will, and will cause each of its Subsidiaries to, at all times maintain in full force and effect insurance (including worker&#8217;s compensation, liability, casualty and business interruption insurance) with reputable national companies that are not Affiliates of the Borrower (except to the extent that self-insurance is maintained in reasonable amounts), in such amounts, covering such risks and liabilities as is reasonable and prudent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Maintenance of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will, and will cause its Subsidiaries to, maintain and preserve its properties and equipment that are used or useful in the conduct of business in good repair, working order and condition, normal wear and tear excepted, and will make, or cause to be made, in such properties and equipment from time to time all repairs, renewals, replacements, extensions, additions, betterments and improvements thereto as may be needed or proper, in each case to the extent and in the manner customary for companies in similar businesses, except where the failure to do so would not reasonably be expected to cause a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Borrower will use the proceeds of the Loans and the issuance of the Letters of Credit solely for working capital and other general corporate purposes of the Borrower and its Subsidiaries, including acquisitions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Borrower will not request any Loan or Letter of Credit, and the Borrower shall not use, and shall procure that its Subsidiaries and its or their respective directors, officers, employees and agents shall not use, the proceeds of any Loan or Letter of Credit (A) in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any Person in violation of any Anti-Corruption Laws, (B) for the purpose of funding, financing or facilitating any activities, business or transaction of or with any Sanctioned Person, or in any Sanctioned Country, or (C) in any manner that would result in the violation of  any Sanctions applicable to any party hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Audits&#47;Inspections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Upon reasonable notice and during normal business hours, but not more than once per calendar year, the Borrower will, and will cause each of its Subsidiaries to, permit representatives appointed by the Administrative Agent or any Lender, including, without limitation, independent accountants, agents, attorneys and appraisers, to visit and inspect the Borrower&#8217;s or any Subsidiary&#8217;s Property, including its books and records, its accounts receivable and inventory, its facilities and its other business assets, and to make photocopies or photographs thereof and to write down and record any information such representative obtains and shall permit the Administrative Agent, any Lender or its representatives to investigate and verify the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">83</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">accuracy of information provided to the Administrative Agent or the Lenders and to discuss all such matters with the officers, employees and representatives of the Borrower and&#47;or its Subsidiaries&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, during the existence of a Default or Event of Default, the Administrative Agent and the Lenders may request as many inspections as reasonable under the circumstances.  Any expenses incurred in connection with this Section&#160;7.9 shall be for the account of the Lenders unless an Event of Default exists, in which case such reasonable and documented out-of-pocket expenses shall be for the account of the Borrower.  Any representatives appointed by the Administrative Agent shall sign a confidentiality agreement reasonably acceptable to the Borrower prior to any visit, investigation, inspection or verification permitted by this Section&#160;7.9.  Notwithstanding the foregoing, neither the Borrower nor any of its Subsidiaries shall be required to (i) disclose documents where such disclosure could result in the loss of attorney-client privilege or a violation of applicable Laws or (ii) violate any confidentiality agreement with a Person other than the Borrower or a Subsidiary binding on it.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Subsidiary Guarantees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If at any time any Domestic Subsidiary of the Borrower shall guarantee or otherwise become liable for any Material Debt of the Borrower, the Borrower shall so notify the Administrative Agent and promptly thereafter (but in any event within 10 days) shall cause such Domestic Subsidiary to (i) enter into a guarantee agreement, substantially in the form attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit 7.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> hereto and (ii)&#160;deliver such other documentation as the Administrative Agent may reasonably request in connection with the foregoing, including, without limitation, certified resolutions and other organizational and authorizing documents of such Subsidiary and favorable opinions of counsel to such Subsidiary (which shall cover, among other things, the legality, validity, binding effect and enforceability of the guarantee agreement referred to above), all in form, content and scope reasonably satisfactory to the Administrative Agent.  The Borrower further agrees to countersign any such guarantee agreement in the space provided therein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Compliance Program</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will, and will cause each of its Domestic Subsidiaries that operates a clinical laboratory to, maintain, and be operated in accordance with, a compliance program which is reasonably designed to provide effective internal controls that promote adherence to applicable federal and state law and the program requirements of federal and state health plans, and which includes the implementation of internal audits and monitoring on a regular basis to monitor compliance with the requirements of the compliance program and applicable law, regulations and company policies.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.36pt;text-decoration:underline"><br><br>NEGATIVE COVENANTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower hereby covenants and agrees that so long as this Credit Agreement is in effect and until the Loans and LOC Obligations, together with interest, fees and other obligations then due and payable hereunder, have been paid in full (other than contingent obligations for which no claim has been made) and the Commitments and Letters of Credit hereunder shall have terminated or expired (or, in the case of Letters of Credit, the LOC Obligations have been cash collateralized)&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Indebtedness of Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will not permit any of its Subsidiaries to create, incur, assume or permit to exist any Indebtedness, other than&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">84</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Guarantee Obligations under guarantee agreements entered into pursuant to Section 7.10&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Indebtedness existing on the Restatement Effective Date as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Indebtedness in respect of current accounts payable and accrued expenses incurred in the ordinary course of business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Indebtedness owing by a Subsidiary of the Borrower to the Borrower or another Subsidiary of the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that no such Indebtedness shall be assigned or pledged to a Person other than the Borrower or a Subsidiary&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">purchase money Indebtedness (including Capital Leases) to finance the purchase of any Property&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that (i) the total of all such Indebtedness shall not exceed an aggregate principal amount of $175,000,000 at any one time outstanding, (ii)&#160;such Indebtedness when incurred shall not exceed the purchase price of the asset(s) financed and (iii) no such Indebtedness shall be refinanced for a principal amount in excess of the principal balance outstanding thereon at the time of such refinancing&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">Indebtedness arising from Permitted Receivables Financings in an amount not to exceed $1,000,000,000 in the aggregate at any one time outstanding&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Indebtedness evidenced by Hedging Agreements entered into in the ordinary course of business and not for speculative purposes&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">any guarantees of Indebtedness of the Borrower by its Domestic Subsidiaries&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that in the case of any guarantee by a Domestic Subsidiary of Material Debt of the Borrower, such Domestic Subsidiary becomes a guarantor of the Obligations as required by Section 7.10&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Indebtedness of any Person that becomes a Subsidiary after the Restatement Effective Date, and Indebtedness secured by any Property acquired by a Subsidiary after the Restatement Effective Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that such Indebtedness exists at the time such Person becomes a Subsidiary or such Property is acquired, is not created in contemplation thereof or in connection therewith and is not assumed or guaranteed by any Subsidiary of the Borrower (unless such assumption or guarantee is permitted by another clause of this Section 8.1)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Indebtedness incurred after the Restatement Effective Date by Foreign Subsidiaries in an amount not to exceed $400,000,000 (or, the Dollar Equivalent thereof and measured for purposes of this clause (j), solely on the date of incurrence thereof) in the aggregate at any time outstanding&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Refinancing Indebtedness in respect of Indebtedness permitted under clauses (b) and (i) above&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">other secured or unsecured Indebtedness&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that at the time any such Indebtedness is incurred and after giving effect thereto, the aggregate amount of such Indebtedness and all outstanding Indebtedness theretofore incurred under this clause (l) does not exceed 15% of Net Worth at such time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">85</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will not, nor will it permit its Subsidiaries to, create, incur, assume or permit to exist any Lien with respect to any of its Property of any kind (whether real or personal, tangible or intangible), whether now owned or after acquired, other than&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Permitted Liens&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Liens existing on the Restatement Effective Date and identified on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Liens in connection with Indebtedness of the type permitted by Section 8.1(e) incurred by any Subsidiary on the assets financed with such Indebtedness or by Section 8.1(k) (but only in the case of Indebtedness permitted by Section 8.1(k) to the extent the refinanced Indebtedness was secured by Liens on the applicable asset)&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Liens upon Property acquired (or the Property of a Subsidiary that is acquired) after the Restatement Effective Date by the Borrower or its Subsidiaries, which Liens existed on such Property before the time of such acquisition and were not created in anticipation thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; that (A)&#160;no such Lien shall extend to or cover any Property other than the Property so acquired and improvements thereon and proceeds thereof, and (B)&#160;the Indebtedness secured by any such Lien is permitted under Section 8.1(i)&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Liens in connection with Permitted Receivables Financings&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">Liens on Property of non-wholly owned Subsidiaries of the Borrower incurred to finance working capital&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Liens on Property of Foreign Subsidiaries securing Indebtedness of the type permitted by Section 8.1(j) incurred by Foreign Subsidiaries&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">other Liens securing Indebtedness or other obligations&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that at the time any such Lien is incurred and after giving effect thereto, the aggregate amount of Indebtedness and other obligations secured thereby under this clause (h) does not exceed 15% of Net Worth at such time&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">renewals and extensions of the foregoing so long as such Liens (i) do not cover any additional Property, (ii) do not secure additional Indebtedness and (iii)&#160;are not otherwise prohibited by this Credit Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Sale and Leaseback Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will not, and will not permit any of its Subsidiaries to, enter into any Sale and Leaseback Transactions unless, after giving effect thereto, all Attributable Debt in respect of such Sale and Leaseback Transactions (measured, in the case of each such Sale and Leaseback Transaction at the time it is entered into by the Borrower or its Subsidiary) does not exceed 15% of Net Worth. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Nature of Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will not, nor will it permit its Subsidiaries to, alter the character of its business from that conducted as of the Restatement Effective Date or engage in any substantial manner in any business other than (a) the business conducted by the Borrower and its </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">86</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Subsidiaries as of the Restatement Effective Date and (b) other healthcare-related businesses and businesses reasonably related thereto&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that any business incidental, reasonably related or ancillary to the business conducted by the Borrower and the Subsidiaries, taken as a whole, on the Restatement Effective Date or reasonable extensions thereof shall be permitted hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Fundamental Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will not enter into any transaction of merger or consolidation, or liquidate, wind up or dissolve itself, or suffer any such liquidation, winding-up or dissolution, or convey, sell, lease, transfer or otherwise voluntarily dispose of, in one transaction or a series of transactions, all or substantially all of its business or assets, whether now owned or hereafter acquired&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that the Borrower may merge with a Subsidiary of the Borrower or any other Person if (a) the Borrower is the surviving Person and (b) at the time thereof and immediately after giving effect thereto no Default or Event of Default shall have occurred and be continuing or would result from such merger or consolidation. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Transactions with Affiliates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower will not, nor will it permit its Subsidiaries to, enter into any transaction or series of transactions, whether or not in the ordinary course of business, with any officer, director, shareholder or Affiliate other than on terms and conditions substantially as favorable as would be obtainable in a comparable arm&#8217;s-length transaction with a Person other than an officer, director, shareholder, Subsidiary or Affiliate, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">except</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, notwithstanding the foregoing, each of the following shall be permitted&#58;  (a)&#160;transactions between or among the Borrower and its Subsidiaries and transactions between or among Subsidiaries, (b)&#160;advances to employees in the ordinary course of business, (c)&#160;Dividends, (d)&#160;fees, compensation and other benefits paid to, and customary indemnity and reimbursement provided on behalf of, officers, directors and employees of the Borrower or any of its Subsidiaries in the ordinary course of business, (e)&#160;any employment agreements entered into by the Borrower or any of its Subsidiaries in the ordinary course of business, (f)&#160;any Permitted Receivables Financing and (g)&#160;transactions and agreements in existence on the Restatement Effective Date and listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;8.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> and, in each case, any amendment thereto.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.36pt;text-decoration:underline"><br><br>EVENTS OF DEFAULT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Events of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">An Event of Default shall exist upon the occurrence, and during the continuation, of any of the following specified events (each an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower shall default in the payment (i) when due of any principal of any of the Loans or any reimbursement obligation arising from drawings under Letters of Credit or (ii)&#160;within three Business Days of when due of any interest on the Loans or any fees or other amounts owing hereunder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any representation, warranty or statement made or deemed to be made by the Borrower herein, in any of the other Credit Documents, or in any statement or certificate delivered or required to be delivered pursuant hereto or thereto shall prove untrue in any material respect on the date as of which it was made or deemed to have been made.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower shall&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">87</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">default in the due performance or observance of any term, covenant or agreement contained in Sections 7.2, Section 7.3 or Section 7.10 or Section&#160;8&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">default in the due performance or observance by it of any term, covenant or agreement contained in Section 7.1 (excepting Section 7.1(e) for which the unremedied period shall only be five Business Days) and such default shall continue unremedied for a period of ten Business Days&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">default in the due performance or observance by it of any term, covenant or agreement (other than those referred to in subsections (a), (b), (c)(i) or (c)(ii) of this Section 9.1) contained in this Credit Agreement and such default shall continue unremedied for a period of at least 30 days after the earlier of an Authorized Officer of the Borrower becoming aware of such default or notice thereof given by the Administrative Agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Other Credit Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  (i) The Borrower shall default in the due performance or observance of any term, covenant or agreement in any of the other Credit Documents and such default shall continue unremedied for a period of at least 30 days after the earlier of an Authorized Officer of the Borrower becoming aware of such default or notice thereof given by the Administrative Agent, (ii) any Credit Document shall fail to be in full force and effect or the Borrower, or any future guarantor party thereto, shall so assert or (iii) any Credit Document shall fail to give the Administrative Agent and&#47;or the Lenders the rights, powers and privileges purported to be created by such Credit Document.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">&#91;Reserved&#93;.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Bankruptcy, etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The occurrence of any of the following with respect to the Borrower or any Domestic Subsidiary&#58; (i) a court or governmental agency having jurisdiction in the premises shall enter a decree or order for relief in respect of the Borrower or such Domestic Subsidiary in an involuntary case under any applicable bankruptcy, insolvency or other similar law now or hereafter in effect, or appoint a receiver, liquidator, assignee, custodian, trustee, sequestrator, administrator or similar official of the Borrower or such Domestic Subsidiary or for any substantial part of its Property or ordering the winding up or liquidation of, or an administrator in respect of, its affairs, (ii)&#160;an involuntary case under any applicable bankruptcy, insolvency or other similar law now or hereafter in effect is commenced against the Borrower or any Domestic Subsidiary and such petition remains unstayed and in effect for a period of 60 consecutive days, (iii) the Borrower or any Domestic Subsidiary shall commence a voluntary case under any applicable bankruptcy, insolvency or other similar law now or hereafter in effect, or consent to the entry of an order for relief in an involuntary case under any such law, or consent to the appointment or taking possession by a receiver, liquidator, assignee, custodian, trustee, sequestrator, administrator or similar official of such Person or any substantial part of its Property or make any general assignment for the benefit of creditors or (iv) the Borrower or any Domestic Subsidiary shall fail generally, or shall admit in writing its inability, to pay its debts as they become due or any action shall be taken by such Person in furtherance of any of the aforesaid purposes.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Defaults under Other Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  With respect to any Indebtedness in excess of $200,000,000 (other than Indebtedness outstanding under this Credit Agreement) of the Borrower or any of its Subsidiaries (A) such Person shall (x) default in any payment (beyond the applicable grace period with respect thereto, if any) with respect to any such Indebtedness or (y) default (after giving effect to any applicable grace </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">88</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">period) in the observance or performance of any covenant or agreement relating to such Indebtedness or contained in any instrument or agreement evidencing, securing or relating thereto, or any other event or condition shall occur or condition exist, the effect of which default or other event or condition is to cause, or permit, the holder or holders of such Indebtedness (or trustee or agent on behalf of such holders, if any) to require any such Indebtedness to become due prior to its stated maturity, (B) any such Indebtedness shall be declared due and payable, or required to be prepaid other than by a regularly scheduled required prepayment prior to the stated maturity thereof or (C) any such Indebtedness shall mature and remain unpaid.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Judgments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  One or more judgments, orders, or decrees shall be entered against any one or more of the Borrower and its Subsidiaries involving a liability of $200,000,000 or more, in the aggregate, (to the extent not paid, covered by insurance provided by a carrier who has acknowledged coverage or covered by an indemnification from Corning Incorporated or SmithKline Beecham PLC) and such judgments, orders or decrees (i)&#160;are the subject of any enforcement proceeding commenced by any creditor or (ii)&#160;shall continue unsatisfied, undischarged and unstayed for a period ending on the first to occur of (A) the last day on which such judgment, order or decree becomes final and non-appealable or (B) 60 days.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The occurrence of any of the following events or conditions which individually or in the aggregate has had or would reasonably be expected to have a Material Adverse Effect&#58; (i) any Plan (other than a Multiemployer Plan) shall fail to meet the &#8220;minimum funding standard&#8221; (as such term is defined in Section 302 of ERISA and Section 412 of the Code) applicable to each Plan, in each instance, whether or not waived, or any Lien shall arise on the assets of the Borrower or any ERISA Affiliate in favor of the PBGC or a Plan, other than a Multiemployer Plan, (ii) an ERISA Event shall occur or (iii) the Borrower or any ERISA Affiliate fails to pay when due, after the expiration of any applicable grace period, any installment payment with respect to its withdrawal liability under Section 4201 of ERISA under a Multiemployer Plan in an aggregate amount in excess of $200,000,000.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt;text-decoration:underline">Ownership</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  There shall occur a Change of Control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Acceleration&#59; Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Upon the occurrence and during the continuation of an Event of Default, the Administrative Agent may or shall, upon the request and direction of the Required Lenders, take the following actions without prejudice to the rights of the Administrative Agent or any Lender to enforce its claims against the Borrower, except as otherwise specifically provided for herein&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Termination of Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Declare the Commitments terminated whereupon the Commitments shall be immediately terminated.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Acceleration of Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Declare the unpaid principal of and any accrued interest in respect of all Loans, any reimbursement obligations arising from drawings under Letters of Credit and any and all other Indebtedness or obligations of any and every kind owing by the Borrower to any of the Lenders under the Credit Documents to be due whereupon the same shall be immediately due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby waived by the Borrower.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Cash Collateral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Direct the Borrower to pay (and the Borrower agrees that upon receipt of such notice, or upon the occurrence of an Event of Default under Section 9.1(f), it will immediately pay) to the Administrative Agent additional cash, to be held by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">89</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Administrative Agent, for the benefit of the Lenders, in a cash collateral account as additional security for the LOC Obligations in respect of subsequent drawings under all then outstanding Letters of Credit in an amount equal to the maximum aggregate amount which may be drawn under all Letters of Credits then outstanding.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Enforcement of Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  To the extent permitted by law, enforce any and all rights and interests created and existing under the Credit Documents, including, without limitation, all rights of set-off.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if an Event of Default specified in Section 9.1(f) shall occur, then the Commitments shall automatically terminate and all Loans, all reimbursement obligations under Letters of Credit, all accrued interest in respect thereof, all accrued and unpaid fees and other indebtedness or obligations owing to the Lenders hereunder shall immediately become due and payable without the giving of any notice or other action by the Administrative Agent or the Lenders, which notice or other action is expressly waived by the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the fact that enforcement powers reside primarily with the Administrative Agent, each Lender has, to the extent permitted by law, a separate right of payment and shall be considered a separate &#8220;creditor&#8221; holding a separate &#8220;claim&#8221; within the meaning of Section 101(5) of the Bankruptcy Code or any other insolvency statute.  Notwithstanding the foregoing, no Lender shall have any right individually to enforce any guarantee agreement delivered pursuant to Section 7.10, it being understood and agreed that all powers, rights and remedies thereunder may be exercised solely by the Administrative Agent on behalf of the Lenders and the relevant Issuing Lender in accordance with the terms thereof.  Upon the execution of any guarantee pursuant to Section 7.10, each Lender will be deemed, by its acceptance of the benefits of such guarantee, to have agreed to the foregoing provisions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Allocation of Payments After Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any other provisions of this Credit Agreement, after the exercise of any remedies by the Administrative Agent or the Lenders pursuant to Section&#160;9.2 (or after any Event of Default that causes the Commitments to terminate and&#47;or all of the Obligations to be due hereunder), all amounts collected or received by the Administrative Agent or any Lender on account of amounts outstanding under any of the Credit Documents shall be paid over or delivered as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">FIRST, to the payment of all reasonable and documented out-of-pocket costs and expenses (including without limitation reasonable and documented out-of-pocket Attorney Costs) of the Administrative Agent in connection with enforcing the rights of the Lenders under the Credit Documents, pro rata as set forth below&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECOND, to payment of any fees owed to the Administrative Agent, any Issuing Lender, the Swing Line Lender or any Lender, pro rata as set forth below&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THIRD, to the payment of all accrued interest payable to the Lenders hereunder, pro rata as set forth below&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">FOURTH, to the payment of the outstanding principal amount of the Loans and unreimbursed drawings under Letters of Credit, and to the payment or cash collateralization of the outstanding LOC Obligations, pro rata as set forth below&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">FIFTH, to all other obligations which shall have become due and payable under the Credit Documents and not repaid pursuant to clauses &#8220;FIRST&#8221; through &#8220;FOURTH&#8221; above&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">90</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SIXTH, to the payment of the surplus, if any, to whoever may be lawfully entitled to receive such surplus.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In carrying out the foregoing, (a) amounts received shall be applied in the numerical order provided until exhausted prior to application to the next succeeding category&#59; (b) each of the Lenders shall receive an amount equal to its pro rata share (based on the proportion that the then-outstanding Loans, and LOC Obligations held by such Lender bears to the aggregate then-outstanding Loans and LOC Obligations of amounts available to be applied&#59; and (c)&#160;to the extent that any amounts available for distribution pursuant to clause &#8220;FOURTH&#8221; above are attributable to the issued but undrawn amount of outstanding Letters of Credit, such amounts shall be held by the Administrative Agent in a cash collateral account and applied (i)&#160;first, to reimburse the Issuing Lenders from time to time for any drawings under such Letters of Credit and (ii)&#160;then, following the expiration of all Letters of Credit, to all other obligations of the types described in clauses &#8220;FOURTH&#8221; and &#8220;FIFTH&#8221; above in the manner provided in this Section 9.3.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.36pt;text-decoration:underline"><br><br>AGENCY PROVISIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Appointment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Each Lender hereby irrevocably appoints, designates and authorizes the Administrative Agent to take such action on its behalf under the provisions of this Credit Agreement and each other Credit Document and to exercise such powers and perform such duties as are expressly delegated to it by the terms of this Credit Agreement or any other Credit Document, together with such powers as are reasonably incidental thereto.  Notwithstanding any provision to the contrary contained elsewhere herein or in any other Credit Document, the Administrative Agent shall not have any duties or responsibilities, except those expressly set forth herein which duties shall be administrative in nature, nor shall the Administrative Agent have or be deemed to have any fiduciary or trustee relationship with any Lender or participant, and no implied covenants, functions, responsibilities, duties, obligations or liabilities shall be read into this Credit Agreement or any other Credit Document or otherwise exist against the Administrative Agent.  Without limiting the generality of the foregoing sentence, the use of the term &#8220;agent&#8221; herein and in the other Credit Documents with reference to the Administrative Agent is not intended to connote any fiduciary or other implied (or express) obligations arising under agency doctrine of any applicable law.  Instead, such term is used merely as a matter of market custom, and is intended to create or reflect only an administrative relationship between independent contracting parties.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Each Issuing Lender shall have all of the benefits and immunities (i)&#160;provided to the Administrative Agent in this Section 10 with respect to any acts taken by or omissions of any Issuing Lender in connection with Letters of Credit issued by it or proposed to be issued by it and the application and agreements for letters of credit pertaining to the Letters of Credit as fully as if the term &#8220;Administrative Agent&#8221; as used in this Section 10 included such Issuing Lender with respect to such acts or omissions and (ii)&#160;as additionally provided herein with respect to any Issuing Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Anything herein to the contrary notwithstanding, none of the Joint Bookrunners, Syndication Agent, Documentation Agents or Lead Arrangers listed on the cover page hereof shall have any powers, duties or obligations whatsoever under this Credit Agreement or the other Credit Documents, except in its capacity, as applicable, as Administrative Agent, a Lender or an Issuing Lender.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">91</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Delegation of Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Administrative Agent may execute any of its duties under this Credit Agreement or any other Credit Document by or through Affiliates, agents, employees or attorneys-in-fact and shall be entitled to advice of counsel and other consultants or experts concerning all matters pertaining to such duties.  The Administrative Agent shall not be responsible for the negligence or misconduct of any agent or attorney-in-fact that it selects with reasonable care.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Exculpatory Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No Agent-Related Person shall (a) be liable for any action taken or omitted to be taken by any of them under or in connection with this Credit Agreement or any other Credit Document or the transactions contemplated hereby (except for its own gross negligence or willful misconduct in connection with its duties expressly set forth herein) or (b) be responsible in any manner to any Lender or participant for any recital, statement, representation or warranty made by the Borrower or any officer thereof, contained herein or in any other Credit Document, or in any certificate, report, statement or other document referred to or provided for in, or received by the Administrative Agent under or in connection with, this Credit Agreement or any other Credit Document, or the validity, effectiveness, genuineness, enforceability or sufficiency of this Credit Agreement or any other Credit Document, or for any failure of the Borrower or any other party to any Credit Document to perform its obligations hereunder or thereunder.  No Agent-Related Person shall be under any obligation to any Lender or participant to ascertain or to inquire as to the observance or performance of any of the agreements contained in, or conditions of, this Credit Agreement or any other Credit Document, or to inspect the properties, books or records of the Borrower or any of its Affiliates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Reliance on Communications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Administrative Agent shall be entitled to rely, and shall be fully protected in relying, upon any writing, communication, signature, resolution, representation, notice, consent, certificate, affidavit, letter, telegram, facsimile, telex or telephone message, statement or other document or conversation believed by it to be genuine and correct and to have been signed, sent or made by the proper Person or Persons, and upon advice and statements of legal counsel (including counsel to the Borrower), independent accountants and other experts selected by the Administrative Agent.  The Administrative Agent may deem and treat each Lender as the owner of its interests hereunder for all purposes unless a written notice of assignment, negotiation or transfer thereof shall have been delivered to the Administrative Agent in accordance with Section 11.3(b).  The Administrative Agent shall be fully justified in failing or refusing to take any action under any Credit Document unless it shall first receive such advice or concurrence of the Required Lenders as it deems appropriate and, if it so requests, it shall first be indemnified to its satisfaction by the Lenders against any and all liability and expense which may be incurred by it by reason of taking or continuing to take any such action.  The Administrative Agent shall in all cases be fully protected in acting, or in refraining from acting, under this Credit Agreement or any other Credit Document in accordance with a request or consent of the Required Lenders or all the Lenders, if required hereunder, and such request and any action taken or failure to act pursuant thereto shall be binding upon all the Lenders and participants, and their respective successors and assigns.  Where this Credit Agreement expressly permits or prohibits an action unless the Required Lenders otherwise determine, the Administrative Agent shall, and in all other instances, the Administrative Agent may, but shall not be required to, initiate any solicitation for the consent or a vote of the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">For purposes of determining compliance with the conditions specified in Section 5.1, each Lender that has signed this Credit Agreement shall be deemed to have consented to, approved or accepted or to be satisfied with, each document or other matter either sent by the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">92</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Administrative Agent to such Lender for consent, approval, acceptance or satisfaction, or required thereunder to be consented to or approved by or acceptable or satisfactory to a Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Notice of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Administrative Agent shall not be deemed to have knowledge or notice of the occurrence of any Default or Event of Default, except with respect to defaults in the payment of principal, interest and fees required to be paid to the Administrative Agent for the account of the Lenders, unless the Administrative Agent shall have received written notice from a Lender or the Borrower referring to this Credit Agreement, describing such Default or Event of Default and stating that such notice is a &#8220;notice of default.&#8221;  The Administrative Agent will notify the Lenders of its receipt of any such notice.  The Administrative Agent shall take such action with respect to such Default or Event of Default as may be reasonably directed by the Required Lenders in accordance with Section 9.2&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that unless and until the Administrative Agent has received any such direction, the Administrative Agent may (but shall not be obligated to) take such action, or refrain from taking such action, with respect to such Default or Event of Default as it shall deem advisable or in the best interest of the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Non-Reliance on Administrative Agent and Other Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each Lender and Issuing Lender acknowledges that no Agent-Related Person has made any representation or warranty to it, and that no act by the Administrative Agent hereinafter taken, including any consent to and acceptance of any assignment or review of the affairs of the Borrower or any of its Affiliates, shall be deemed to constitute any representation or warranty by any Agent-Related Person to any Lender as to any matter, including whether Agent-Related Persons have disclosed material information in their possession.  Each Lender and Issuing Lender represents to the Administrative Agent that it has, independently and without reliance upon any Agent-Related Person, any Issuing Lender or any other Lender and based on such documents and information as it has deemed appropriate, made its own appraisal of and investigation into the business, prospects, operations, Property, financial and other condition and creditworthiness of the Borrower and its Affiliates, and all applicable bank or other regulatory laws relating to the transactions contemplated hereby, and made its own decision to enter into this Credit Agreement and to extend credit to the Borrower hereunder.  Each Lender and Issuing Lender also represents that it will, independently and without reliance upon any Agent-Related Person, any Issuing Lender or any other Lender and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit analysis, appraisals and decisions in taking or not taking action under this Credit Agreement and the other Credit Documents, and to make such investigations as it deems necessary to inform itself as to the business, prospects, operations, Property, financial and other condition and creditworthiness of the Borrower.  Except for notices, reports and other documents expressly required to be furnished to the Lenders by the Administrative Agent herein, the Administrative Agent shall not have any duty or responsibility to provide any Lender or Issuing Lender with any credit or other information concerning the business, prospects, operations, Property, financial and other condition or creditworthiness of the Borrower or any of its Affiliates which may come into the possession of any Agent-Related Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">To the extent that the Borrower for any reason fails to indefeasibly pay any amount required under Section 11.5 to be paid by it to the Administrative Agent (or any sub-agent thereof), the relevant Issuing Lender or any Agent-Related Person of any of the foregoing, each Lender severally, not jointly, agrees to pay to the Administrative Agent (or any such sub-agent), each relevant Issuing Lender or such Agent-Related Person, as the case may be, such Lender&#8217;s  Revolving Loan Commitment Percentage (determined as of the time that the applicable </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">93</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">unreimbursed expense or indemnity payment is sought) of such unpaid amount&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that the unreimbursed expense or indemnified loss, claim, damage, liability or related expense, as the case may be, was incurred by or asserted against the Administrative Agent (or any such sub-agent) or such Issuing Lender in its capacity as such, or against any Agent-Related Person of any of the foregoing acting for the Administrative Agent (or any such sub-agent) or such Issuing Lender in connection with such capacity.   </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Each Lender shall severally indemnify the Administrative Agent for (i) any Taxes attributable to such Lender and paid by the Administrative Agent (but only to the extent the Borrower has not already indemnified the Administrative Agent for such Taxes and without limiting the obligation of the Borrower to do so), (ii) any taxes attributable to such Lender that are excluded from the definition of Taxes in Section 3.13(a) or 3.13(f) and that are paid by the Administrative Agent, (iii) any taxes attributable to such Lender&#8217;s failure to comply with the provisions of Section 11.3(d) relating to the maintenance of a Participant Register and (iv) any liability arising from or with respect to any taxes described in clauses&#160;(i), (ii) or (iii) above (including any taxes imposed or asserted by any jurisdiction on amounts payable under this Section 10.7(b), penalties, interest and reasonable expenses).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Administrative Agent in Its Individual Capacity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">JPMorgan and its Affiliates may make loans to, issue letters of credit for the account of, accept deposits from, acquire Capital Stock of and generally engage in any kind of banking, trust, financial advisory, underwriting or other business with the Borrower and its Affiliates as though JPMorgan were not the Administrative Agent or an Issuing Lender hereunder and without notice to or consent of the Lenders.  The Lenders and Issuing Lenders acknowledge that, pursuant to such activities, JPMorgan or its Affiliates may receive information regarding the Borrower or its Affiliates (including information that may be subject to confidentiality obligations in favor of the Borrower or such Affiliate) and that the Administrative Agent shall be under no obligation to provide such information to them.  With respect to its Loans, JPMorgan shall have the same rights and powers under this Credit Agreement as any other Lender and may exercise such rights and powers as though it were not the Administrative Agent or an Issuing Lender, and the terms &#8220;Lender&#8221; and &#8220;Lenders&#8221; include JPMorgan in its individual capacity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Successor Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Administrative Agent may resign as Administrative Agent upon 30 days&#8217; notice to the Lenders.  If the Administrative Agent resigns under this Credit Agreement, the Required Lenders shall appoint from among the Lenders a successor administrative agent for the Lenders (such appointment, absent the existence of an Event of Default, to be subject to the consent of the Borrower, which consent of the Borrower shall not be unreasonably withheld or delayed).  If no successor administrative agent is appointed prior to the effective date of the resignation of the Administrative Agent, the Administrative Agent may appoint, after consulting with the Lenders and the Borrower, a successor administrative agent from among the Lenders.  Upon the acceptance of its appointment as successor administrative agent hereunder, such successor administrative agent shall succeed to all the rights, powers and duties of the retiring Administrative Agent and the term &#8220;Administrative Agent&#8221; shall mean such successor administrative agent and the retiring Administrative Agent&#8217;s appointment, powers and duties as Administrative Agent shall be terminated.  After any retiring Administrative Agent&#8217;s resignation hereunder as Administrative Agent, the provisions of this Section 10 and Sections 11.5 and 11.9 shall continue to inure to its benefit as to any actions taken or omitted to be taken by it while it was Administrative Agent under this Credit Agreement.  If no successor administrative agent has accepted appointment as Administrative Agent by the date which is 30 days following a retiring Administrative Agent&#8217;s notice of resignation, the retiring Administrative Agent&#8217;s resignation shall nevertheless thereupon become effective and the Lenders shall perform all of the duties of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">94</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Administrative Agent hereunder until such time, if any, as the Required Lenders appoint a successor agent as provided for above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Agent May&#160;File Proofs of Claim</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In case of the pendency of any receivership, insolvency, liquidation, bankruptcy, reorganization, arrangement, adjustment, composition or other judicial proceeding relative to the Borrower or any of its Subsidiaries, the Administrative Agent (irrespective of whether the principal of any Loan shall then be due and payable as herein expressed or by declaration or otherwise and irrespective of whether the Administrative Agent shall have made any demand on the Borrower) shall be entitled and empowered, by intervention in such proceeding or otherwise&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">to file and prove a claim for the whole amount of the principal and interest owing and unpaid in respect of the Loans and all other Obligations that are owing and unpaid and to file such other documents as may be necessary or advisable in order to have the claims of the Lenders and the Administrative Agent (including any claim for the reasonable and documented out-of-pocket compensation, expenses, disbursements and advances of the Lenders and the Administrative Agent and their respective agents and counsel and all other amounts due the Lenders and the Administrative Agent) allowed in such judicial proceeding&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">to collect and receive any monies or other property payable or deliverable on any such claims and to distribute the same&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by each Lender to make such payments to the Administrative Agent and, in the event that the Administrative Agent shall consent to the making of such payments directly to the Lenders, to pay to the Administrative Agent any amount due for the reasonable and documented out-of-pocket compensation, expenses, disbursements and advances of the Administrative Agent and its agents and counsel, and any other amounts due the Administrative Agent under the Credit Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Nothing contained herein shall be deemed to authorize the Administrative Agent to authorize or consent to or accept or adopt on behalf of any Lender any plan of reorganization, arrangement, adjustment or composition affecting the Obligations or the rights of any Lender or to authorize the Administrative Agent to vote in respect of the claim of any Lender in any such proceeding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Certain Lender Representations, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Each Lender represents and warrants, as of the date such Person became a Lender party hereto, to, and covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of the Administrative Agent and the institutions named as Joint Lead Arrangers, Joint Bookrunners, Syndication Agent and Documentation Agents listed on the cover page hereof and their respective Affiliates, and not, for the avoidance of doubt, to or for the benefit of the Borrower or any of its Subsidiaries, that at least one of the following is and will be true&#58;   </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">such Lender is not using &#8220;plan assets&#8221; (within the meaning of 29 CFR &#167; 2510.3-101, as modified by Section 3(42) of ERISA) of one or more Benefit Plans in connection with the Commitments,</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">the transaction exemption set forth in one or more PTEs, such as PTE 84-14 (a class exemption for certain transactions determined by independent qualified </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">95</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">professional asset managers), PTE 95-60 (a class exemption for certain transactions involving insurance company general accounts), PTE 90-1 (a class exemption for certain transactions involving insurance company pooled separate accounts), PTE 91-38 (a class exemption for certain transactions involving bank collective investment funds) or PTE 96-23 (a class exemption for certain transactions determined by in-house asset managers), is applicable with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Commitments and this Credit Agreement,</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">(A) such Lender is an investment fund managed by a &#8220;Qualified Professional Asset Manager&#8221; (within the meaning of Part VI of PTE 84-14), (B) such Qualified Professional Asset Manager made the investment decision on behalf of such Lender to enter into, participate in, administer and perform the Commitments and this Credit Agreement, (C) the entrance into, participation in, administration of and performance of the Commitments and this Credit Agreement satisfies the requirements of sub-sections (b) through (g) of Part I of PTE 84-14 and (D) to the best knowledge of such Lender, the requirements of subsection (a) of Part I of PTE 84-14 are satisfied with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Commitments and this Credit Agreement, or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">such other representation, warranty and covenant as may be agreed in writing between the Administrative Agent, in its sole discretion, and such Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">In addition, unless clause (i) of the immediately preceding paragraph is true with respect to such Lender or such Lender has not provided another representation, warranty and covenant as provided in clause (iv) of the immediately preceding paragraph, such Lender further represents and warrants, as of the date such Person became a Lender party hereto, to, and covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and the institutions named as Bookrunners, Syndication Agent, Documentation Agents or Lead Arrangers on the cover page hereof and their respective Affiliates, and not, for the avoidance of doubt, to or for the benefit of the Borrower or any of its Subsidiaries, that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">none of the Administrative Agent or any of the institutions named as Joint Lead Arrangers, Joint Bookrunners, Syndication Agent and Documentation Agents on the cover page hereof or their respective Affiliates is a fiduciary with respect to the assets of such Lender (including in connection with the reservation or exercise of any rights by any Person under this Credit Agreement or any documents related to hereto or thereto),</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">the Person making the investment decision on behalf of such Lender with respect to the entrance into, participation in, administration of and performance of the Commitments and this Credit Agreement is independent (within the meaning of 29 CFR &#167; 2510.3-21) and is a bank, an insurance carrier, an investment adviser, a broker-dealer or other person that holds, or has under management or control, total assets of at least $50,000,000, in each case as described in 29 CFR &#167; 2510.3-21(c)(1)(i)(A)-(E),</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">the Person making the investment decision on behalf of such Lender with respect to the entrance into, participation in, administration of and performance of the Commitments and this Credit Agreement is capable of evaluating investment risks independently, both in general and with regard to particular transactions and investment strategies,</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">the Person making the investment decision on behalf of such Lender with respect to the entrance into, participation in, administration of and performance of the Commitments and this Credit Agreement is a fiduciary under ERISA or the Code, or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">96</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">both, with respect to the Commitments and this Credit Agreement and is responsible for exercising independent judgment in evaluating the transactions hereunder, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">no fee or other compensation is being paid directly to the Administrative Agent or any of the institutions named as Joint Lead Arrangers, Joint Bookrunners, Syndication Agent and Documentation Agents on the cover page of this Credit Agreement or their respective Affiliates for investment advice (as opposed to other services) in connection with the Commitments or this Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Administrative Agent and the institutions named as Joint Lead Arrangers, Joint Bookrunners, Syndication Agent and Documentation Agents on the cover page of this Credit Agreement hereby inform the Lenders that each such Person is not undertaking to provide impartial investment advice, or to give advice in a fiduciary capacity, in connection with the transactions contemplated hereby, and that such Person has a financial interest in the transactions contemplated hereby in that such Person or an Affiliate thereof (i) may receive interest or other payments with respect to the Commitments and this Credit Agreement, (ii) may recognize a gain if it extended the Commitments for an amount less than the amount being paid for an interest in the Commitments by such Lender or (iii) may receive fees or other payments in connection with the transactions contemplated hereby or otherwise, including structuring fees, commitment fees, arrangement fees, facility fees, upfront fees, underwriting fees, ticking fees, agency fees, administrative agent or collateral agent fees, utilization fees, minimum usage fees, letter of credit fees, fronting fees, deal-away or alternate transaction fees, amendment fees, processing fees, term out premiums, banker&#8217;s acceptance fees, breakage or other early termination fees or fees similar to the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">(i) Each Lender hereby agrees that (x) if the Administrative Agent notifies&#160;such Lender that the Administrative Agent has determined&#160;in its sole discretion that any funds received by such Lender from the Administrative Agent or any of its Affiliates (whether as a payment, prepayment or repayment of principal, interest, fees or otherwise&#59; individually and collectively, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) were erroneously transmitted to such Lender (whether or not known to such Lender), and demands the return of such Payment (or a portion thereof), such Lender shall promptly, but in no event later than one Business Day thereafter, return to the Administrative Agent the amount of any such Payment (or portion thereof) as to which such a demand was made in same day funds, together with interest thereon in respect of each day from and including the date such Payment (or portion thereof) was received by such Lender to the date such amount is repaid to the Administrative Agent at the greater of the NYFRB Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation from time to time in effect, and (y) to the extent permitted by applicable law, such Lender shall not assert, and hereby waives, as to the Administrative Agent, any claim, counterclaim, defense or right of set-off or recoupment with respect to any demand, claim or counterclaim by the Administrative Agent for the return of any Payments received, including without limitation any defense based on &#8220;discharge for value&#8221; or any similar doctrine.  A notice of the Administrative Agent to any Lender under this Section 10.11(d) shall be conclusive, absent manifest error.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Each Lender hereby further agrees that if it&#160;receives a Payment from the Administrative Agent or any of its Affiliates (x) that is in a different amount than, or on a different date from, that specified in a notice of payment sent by the Administrative Agent (or any of its Affiliates) with respect to such Payment (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payment Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) or (y) that was not preceded or accompanied by a Payment Notice, it shall be on notice, in each such case, that an error has been made with respect to such Payment.&#160; Each Lender agrees that, in each such case, or if it otherwise becomes aware a Payment (or portion thereof) may have been sent in error, such Lender shall promptly notify the Administrative Agent of such occurrence and, upon demand from the Administrative Agent, it shall promptly, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">97</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">but in no event later than one Business Day thereafter, return to the Administrative Agent the amount of any such Payment (or portion thereof) as to which such a demand was made in same day funds, together with interest thereon in respect of each day from and including the date such Payment (or portion thereof) was received by such Lender to the date such amount is repaid to the Administrative Agent at the greater of the NYFRB Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation from time to time in effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">The Borrower hereby agrees that (x) in the event an erroneous Payment (or portion thereof) are not recovered from any Lender that has received such Payment (or portion thereof) for any reason, the Administrative Agent shall be subrogated to all the rights of such Lender with respect to such amount and (y) an erroneous Payment shall not pay, prepay, repay, discharge or otherwise satisfy any Obligations owed by the Borrower, except, in each case, to the extent such erroneous Payment is, and solely with respect to the amount of such erroneous Payment that is, comprised of funds received by the Administrative Agent or any of its Affiliates from the Borrower.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">Each party&#8217;s obligations under this Section 10.11(d) shall survive the resignation or replacement of the Administrative Agent or any transfer of rights or obligations by, or the replacement of, a Lender, the termination of the Commitments or the repayment, satisfaction or discharge of all Obligations under any Credit Document.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.36pt;text-decoration:underline"><br><br>MISCELLANEOUS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Notices, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Unless otherwise expressly provided herein, all notices and other communications provided for hereunder shall be in writing (including by facsimile transmission).  All such written notices shall be mailed by certified or registered mail, faxed or delivered to the applicable address, facsimile number or (subject to subsection&#160;(c) below) electronic mail address, and all notices and other communications expressly permitted hereunder to be given by telephone shall be made to the applicable telephone number, as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">if to the Borrower, to the address, facsimile number, electronic mail address or telephone number specified for the Borrower on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule&#160;11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or to such other address, facsimile number, electronic mail address or telephone number as shall be designated by such party in a notice to the other parties&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">if to the Administrative Agent or to the Swing Line Lender, to JPMorgan Chase Bank, N.A., 10&#160;South Dearborn, Floor L2, Suite IL1-0480, Chicago, IL 60603-2300, Attention of Selena Shofner (Email&#58; selena.shofner&#64;chase.com) with copy(s) to JPMorgan Chase Bank, N.A., Middle Market Servicing, 10&#160;South Dearborn, Floor L2, Suite&#160;IL1-0480, Chicago, IL 60603-2300, Attention of Commercial Banking Group (Facsimile No. (844) 490-5663) (Email&#58; jpm.agency.cri&#64;jpmorgan.com&#59; jpm.agency.servicing.1&#64;jpmorgan.com)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">if to JPMorgan, in its capacity as an Issuing Lender, to JPMorgan Chase Bank, N.A., 10&#160;South Dearborn, Floor L2, Suite&#160;IL1-0480, Chicago, IL 60603-2300, Attention of LC Agency Team (Telephone No. (800) 364-1969) (Facsimile No. (856) 294-5267) (Email&#58; chicago.lc.agency.activity.team&#64;jpmchase.com)&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">98</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">if to Morgan Stanley Bank, N.A., in its capacity as an Issuing Lender, to Morgan Stanley Bank, N.A., 1000 Lancaster Street, Baltimore, MD 21202, United States, Attention of Morgan Stanley Loan Servicing (Facsimile No. (718) 233-2140) (Email&#58; msloanservicing&#64;morganstanley.com)&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">if to Mizuho Bank, Ltd., in its capacity as an Issuing Lender, to Mizuho Bank, Ltd., 1800 Plaza Ten, Harborside Financial Ctr., Jersey City, NJ 07311, United States, Attention of Shirly Wu (Facsimile No. (201) 626-9941) (Email&#58;&#160;LAU_USCorp2&#64;mizuhocbus.com)&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">if to Wells Fargo Bank, N.A., in its capacity as an Issuing Lender, to Wells Fargo Bank, N.A., 401 N. Research Pkwy., Winston-Salem, NC 27101, United States, Attention of SBLC New (Email&#58; SLBC-New&#64;wellsfargo.com)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15.36pt">if to any other Lender, to the address, facsimile number, electronic mail address or telephone number specified in its Administrative Questionnaire provided by the Administrative Agent or to such other address, facsimile number, electronic mail address or telephone number as shall be designated by such party in a notice to the Borrower and the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notices sent by hand or overnight courier service, or mailed by certified or registered mail, shall be deemed to have been given when received&#59; notices sent by facsimile shall be deemed to have been given when sent (except that, if not given during normal business hours for the recipient, such notices shall be deemed to have been given at the opening of business on the next Business Day for the recipient).  Notices delivered through electronic communications to the extent provided in subsection (b) below, shall be effective as provided in such subsection (b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Electronic Communications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notices and other communications to the Lenders hereunder may be delivered or furnished by electronic communication (including e-mail and Internet or intranet websites) pursuant to procedures approved by the Administrative Agent, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that the foregoing shall not apply to notices to any Lender pursuant to Section 2 if such Lender has notified the Administrative Agent that it is incapable of receiving notices under such Section 2 by electronic communication.  The Administrative Agent or the Borrower may, in its discretion, agree to accept notices and other communications to it hereunder by electronic communications pursuant to procedures approved by it, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that approval of such procedures may be limited to particular notices or communications.  Unless the Administrative Agent otherwise prescribes, (i) notices and other communications sent to an e-mail address shall be deemed received upon the sender&#8217;s receipt of an acknowledgement from the intended recipient (such as by the &#8220;return receipt requested&#8221; function, as available, return e-mail or other written acknowledgement), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that if such notice or other communication is not sent during the normal business hours of the recipient, such notice or communication shall be deemed to have been sent at the opening of business on the next Business Day for the recipient, and (ii) notices or communications posted to an Internet or intranet website shall be deemed received upon the deemed receipt by the intended recipient at its e-mail address as described in the foregoing clause&#160;(i) of notification that such notice or communication is available and identifying the website address therefor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">The Platform</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  THE PLATFORM IS PROVIDED &#8220;AS IS&#8221; AND &#8220;AS AVAILABLE.&#8221; THE AGENT-RELATED PERSONS DO NOT WARRANT THE ACCURACY OR COMPLETENESS OF THE BORROWER MATERIALS OR THE ADEQUACY OF THE PLATFORM, AND EXPRESSLY DISCLAIM LIABILITY FOR ERRORS IN OR OMISSIONS FROM THE BORROWER MATERIALS. NO WARRANTY OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY, INCLUDING ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">99</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">INFRINGEMENT OF THIRD PARTY RIGHTS OR FREEDOM FROM VIRUSES OR OTHER CODE DEFECTS, IS MADE BY ANY AGENT-RELATED PERSON IN CONNECTION WITH THE BORROWER MATERIALS OR THE PLATFORM. In no event shall the Agent-Related Persons have any liability to the Borrower, any Lender or any other Person for losses, claims, damages, liabilities or expenses of any kind (whether in tort, contract or otherwise) arising out of the Borrower&#8217;s or the Administrative Agent&#8217;s transmission of Borrower Materials through the Internet, except to the extent that such losses, claims, damages, liabilities or expenses are determined by a court of competent jurisdiction by a final and non-appealable judgment to have resulted from the gross negligence, bad faith or willful misconduct of such Agent-Related Person&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that in no event shall any Agent-Related Person have any liability to the Borrower, any Lender or any other Person for indirect, special, incidental, consequential or punitive damages (as opposed to direct or actual damages).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Effectiveness of Facsimile or Electronically Transmitted Documents and Signatures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Credit Documents may be transmitted and&#47;or signed by facsimile or other electronic means (e.g. &#8220;.pdf&#8221; or &#8220;.tif&#8221;).  The effectiveness of any such documents and signatures shall, subject to applicable law, have the same force and effect as manually-signed originals and shall be binding on the Borrower, the Administrative Agent and the Lenders.  The Administrative Agent may also require that any such documents and signatures be confirmed by a manually-signed original thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the failure to request or deliver the same shall not limit the effectiveness of any document or signature transmitted by facsimile or other electronic means (e.g. &#8220;.pdf&#8221; or &#8220;.tif&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Reliance by Administrative Agent and Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Administrative Agent and the Lenders shall be entitled to rely and act upon any notices (including telephonic notices) purportedly given by or on behalf of the Borrower even if (i)&#160;such notices were not made in a manner specified herein, were incomplete or were not preceded or followed by any other form of notice specified herein, or (ii)&#160;the terms thereof, as understood by the recipient, varied from any confirmation thereof.  The Borrower shall indemnify each Agent-Related Person and each Lender from all losses, costs, expenses and liabilities resulting from the reliance by such Person on each notice purportedly given by or on behalf of the Borrower.  All telephonic notices to and other communications with the Administrative Agent may be recorded by the Administrative Agent, and each of the parties hereto hereby consents to such recording.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Change of Address, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each of the Borrower, the Administrative Agent, each Issuing Lender and the Swing Line Lender may change its address, telecopier or telephone number for notices and other communications hereunder by written notice to the other parties hereto.  Each other Lender may change its address, telecopier or telephone number for notices and other communications hereunder by notice to the Borrower, the Administrative Agent, each Issuing Lender and the Swing Line Lender.  In addition, each Lender agrees to notify the Administrative Agent from time to time to ensure that the Administrative Agent has on record (i) an effective address, contact name, telephone number, telecopier number and electronic mail address to which notices and other communications may be sent and (ii) accurate wire instructions for such Lender.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Right of Set-Off</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition to any rights now or hereafter granted under applicable law or otherwise, and not by way of limitation of any such rights, upon the occurrence of an Event of Default and the commencement of remedies described in Section 9.2, each Lender is authorized at any time and from time to time, without presentment, demand, protest or other notice of any kind (all of which rights being hereby expressly waived), to set-off and to appropriate and apply any and all deposits (general or special) and any other indebtedness at any time held or owing by such Lender (including, without limitation, branches, agencies or Affiliates of such Lender wherever </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">100</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">located) to or for the credit or the account of the Borrower against obligations and liabilities of the Borrower to the Lenders hereunder, under the Notes, the other Credit Documents or otherwise, irrespective of whether the Administrative Agent or the Lenders shall have made any demand hereunder and although such obligations, liabilities or claims, or any of them, may be contingent or unmatured, and any such set-off shall be deemed to have been made immediately upon the occurrence of an Event of Default even though such charge is made or entered on the books of such Lender subsequent thereto.  The Borrower hereby agrees that any Person purchasing a participation in the Loans and Commitments hereunder pursuant to Section 11.3(d) or 3.8 may exercise all rights of set-off with respect to its participation interest as fully as if such Person were a Lender hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Benefit of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The provisions of this Credit Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns permitted hereby, except that the Borrower may not assign or otherwise transfer any of its rights or obligations hereunder without the prior written consent of each Lender and no Lender may assign or otherwise transfer any of its rights or obligations hereunder except (i)&#160;to an Eligible Assignee in accordance with the provisions of subsection&#160;(b) of this Section, (ii)&#160;by way of participation in accordance with the provisions of subsection&#160;(d) of this Section, (iii)&#160;by way of pledge or assignment of a security interest subject to the restrictions of subsection&#160;(f) of this Section or (iv) to an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SPC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> in accordance with the provisions of subsection (g) of this Section (and any other attempted assignment or transfer by any party hereto shall be null and void).  Nothing in this Credit Agreement, expressed or implied, shall be construed to confer upon any Person (other than the parties hereto, their respective successors and assigns permitted hereby, Loan Participants to the extent provided in subsection&#160;(d) of this Section and, to the extent expressly contemplated hereby, the Indemnitees) any legal or equitable right, remedy or claim under or by reason of this Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Assignments by Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any Lender may at any time assign to one or more assignees all or a portion of its rights and obligations under this Credit Agreement (including all or a portion of its Commitment and the Loans (including participations in LOC Obligations and in Swing Line Loans) at the time owing to it)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that any such assignment shall be subject to the following conditions&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Minimum Amounts.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">in the case of an assignment of the entire remaining amount of the assigning Lender&#8217;s Commitment and the Loans at the time owing to it or in the case of an assignment to a Lender, an Affiliate of a Lender or an Approved Fund, no minimum amount need be assigned&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">in any case not described in subsection (b)(i)(A) of this Section, the aggregate amount of the Commitment (which for this purpose includes Loans outstanding thereunder) or, if the applicable Commitment is not then in effect, the principal outstanding balance of the Loans of the assigning Lender subject to each such assignment, shall not be less than $5,000,000 unless the Administrative Agent and, so long as no Event of Default has occurred and is continuing, the Borrower otherwise consents (each such consent not to be unreasonably withheld or delayed)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that concurrent assignments to members of an Assignee Group and concurrent assignments from members of an Assignee Group to a single Eligible Assignee (or to an Eligible Assignee and members of its </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">101</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Assignee Group) will be treated as a single assignment for purposes of determining whether such minimum amount has been met.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt;text-decoration:underline">Proportionate Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Each partial assignment shall be made as an assignment of a proportionate part of all the assigning Lender&#8217;s rights and obligations under this Credit Agreement with respect to the Loans or the Commitment assigned, except that this clause (ii) shall not apply to the Swing Line Lender&#8217;s rights and obligations in respect of Swing Line Loans&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt;text-decoration:underline">Required Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No consent shall be required for any assignment except to the extent required by subsection (b)(i)(B) of this Section and as set forth below&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">the consent of the Borrower (such consent not to be unreasonably withheld or delayed) shall be required unless (1) an Event of Default has occurred and is continuing at the time of such assignment or (2)&#160;such assignment is to a Lender, an Affiliate of a Lender or an Approved Fund, and such consent shall be deemed given if no objection is received by the assigning Lender and the Administrative Agent from the Borrower within five Business Days after notice of such proposed assignment has been delivered to the Borrower&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">the consent of the Administrative Agent (such consent not to be unreasonably withheld or delayed) shall be required for any assignment in respect of the Revolving Credit Facility unless such assignment is to a Lender or an Affiliate of a Lender&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.02pt">the consent of each Issuing Lender (such consent not to be unreasonably withheld or delayed) shall be required for any assignment that increases the obligation of the assignee to participate in exposure under one or more Letters of Credit (whether or not then outstanding)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.36pt">the consent of the Swing Line Lender (such consent not to be unreasonably withheld or delayed) shall be required for any assignment in respect of the Revolving Credit Facility.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt;text-decoration:underline">Assignment and Assumption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The parties to each assignment shall execute and deliver to the Administrative Agent an Assignment and Assumption, together with a processing and recordation fee in the amount of $3,500&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Administrative Agent may, in its sole discretion, elect to waive such processing and recordation fee in the case of any assignment.  The assignee, if it is not a Lender, shall deliver to the Administrative Agent an Administrative Questionnaire.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">No Assignment to Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No such assignment shall be made to the Borrower or any of the Borrower&#8217;s Affiliates or Subsidiaries.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt;text-decoration:underline">No Assignment to Natural Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No such assignment shall be made to a natural person.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Subject to acceptance and recording thereof by the Administrative Agent pursuant to subsection (c) of this Section, from and after the effective date specified in each Assignment and Assumption, the assignee thereunder shall be a party to this Credit Agreement and, to the extent of the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender under this Credit Agreement, and the assigning Lender thereunder shall, to the extent of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">102</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the interest assigned by such Assignment and Assumption, be released from its obligations under this Credit Agreement (and, in the case of an Assignment and Assumption covering all of the assigning Lender&#8217;s rights and obligations under this Credit Agreement, such Lender shall cease to be a party hereto but shall continue to be entitled to the benefits of Sections 3.9, 3.12, 3.13, 3.14 and 11.5 with respect to facts and circumstances occurring prior to the effective date of such assignment).  Upon request, the Borrower (at its expense) shall execute and deliver a Note to the assignee Lender.  Any assignment or transfer by a Lender of rights or obligations under this Credit Agreement that does not comply with this subsection shall be treated for purposes of this Credit Agreement as a sale by such Lender of a participation in such rights and obligations in accordance with subsection (d) of this Section.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Administrative Agent, acting solely for this purpose as an agent of the Borrower, shall maintain at the Agency Service Address a copy of each Assignment and Assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitments of, and principal amounts (and stated interest) of the Loans owing to, each Lender pursuant to the terms hereof from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  The entries in the Register shall be conclusive (absent manifest error), and the Borrower, the Administrative Agent and the Lenders may treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Credit Agreement, notwithstanding notice to the contrary.  The Register shall be available for inspection by the Borrower, at any reasonable time and from time to time upon reasonable prior notice. In addition, the Register shall be available for inspection by any Lender as to entries pertaining to it at any reasonable time and from time to time upon reasonable prior notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Participations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any Lender may at any time, without the consent of, or notice to, the Borrower, any Issuing Lender, the Swing Line Lender or the Administrative Agent, sell participations to any Person (other than a natural person or the Borrower or any of the Borrower&#8217;s Affiliates or Subsidiaries or any competitor of the Borrower identified in a letter dated the Restatement Effective Date of the Borrower to the Administrative Agent (as such letter may be amended, amended and restated, supplemented or otherwise modified by the Borrower from time to time to identify additional Persons engaged in the business in which the Borrower is engaged), which letter shall be made available to the Lenders) (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Loan Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), in all or a portion of such Lender&#8217;s rights and&#47;or obligations under this Credit Agreement (including all or a portion of its Commitment and&#47;or the Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that (i)&#160;such Lender&#8217;s obligations under this Credit Agreement shall remain unchanged, (ii)&#160;such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations and (iii)&#160;the Borrower, the Administrative Agent and the other Lenders shall continue to deal solely and directly with such Lender in connection with such Lender&#8217;s rights and obligations under this Credit Agreement.  Each Lender that sells a participation pursuant to this Section 11.3(d) shall, acting as a non-fiduciary agent of the Borrower solely for the purpose of maintaining a register in order to satisfy the requirements of Section 5f.103-1(c) of the United States Treasury Regulations, maintain a register on which it records the name and address of each Loan Participant to which it has sold a participation and the principal amounts (and stated interest) of each such Loan Participant&#8217;s interest in the Loans or other rights and obligations of such Lender under this Credit Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that no Lender shall have any obligation to disclose all or any portion of the Participant Register to any Person (including the identity of any Loan Participant or any information relating to a Loan Participant&#8217;s interest in any Commitments, Loans, Letters of Credit or its other obligations under any this Credit Agreement) except to the extent that such disclosure is necessary to establish that such Commitment, Loan, Letter of Credit or other obligation is in registered form under Section 5f.103-1(c) of the United States Treasury Regulations.  The entries in the Participant Register shall be conclusive absent manifest error.  Any agreement or instrument pursuant to which a Lender sells such a participation shall provide that such Lender shall retain the sole right to enforce this Credit Agreement and to approve any amendment, modification or waiver of any provision of this </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">103</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Credit Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that such agreement or instrument may provide that such Lender will not, without the consent of the Loan Participant, agree to any amendment, waiver or other modification that would change the amount, interest rate or maturity of the Loans or any other matter that requires unanimous consent of all of the Lenders.  Subject to subsection&#160;(e) of this Section, the Borrower agrees that each Loan Participant shall be entitled to the benefits of Sections&#160;3.9, 3.12, 3.13 and 3.14 to the same extent as if it were a Lender and had acquired its interest by assignment pursuant to subsection&#160;(b) of this Section.  To the extent permitted by law, each Loan Participant also shall be entitled to the benefits of Section&#160;11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as though it were a Lender, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> such Loan Participant agrees to be subject to Section&#160;3.8 as though it were a Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Loan Participant&#8217;s Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  A Loan Participant shall not be entitled to receive any greater payment under Section&#160;3.9, 3.12 or 3.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">than the applicable Lender would have been entitled to receive with respect to the participation sold to such Loan Participant, unless the sale of the participation to such Loan Participant is made with the Borrower&#8217;s prior written consent.  A Loan Participant that would be a foreign Lender if it were a Lender shall not be entitled to the benefits of Section&#160;3.13 unless the Borrower is notified of the participation sold to such Loan Participant, the participating Lender provides the Borrower with an IRS Form W-8IMY and such Loan Participant agrees, for the benefit of the Borrower, to comply with Section&#160;3.13 as though it were a Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Unrestricted Assignments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any Lender may at any time pledge or assign a security interest in all or any portion of its rights under this Credit Agreement (including under its Note(s), if any) to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank, and this Section shall not apply to any such pledge or assignment of a security interest&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that no such pledge or assignment shall release such Lender from any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Special Purpose Entities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary contained herein, so long as any action in accordance with this Section 11.3(g) does not cause increased costs or expenses for the Borrower, any Lender (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Granting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) may grant to a special purpose funding vehicle (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SPC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) the option to fund all or any part of any Loan that such Granting Lender would otherwise be obligated to fund pursuant to this Credit Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that (i)&#160;nothing herein shall constitute a commitment by any SPC to fund any Loan, (ii)&#160;if an SPC elects not to exercise such option or otherwise fails to fund all or any part of such Loan, the Granting Lender shall be obligated to fund such Loan pursuant to the terms hereof, (iii)&#160;no SPC shall have any voting rights pursuant to Section&#160;11.6 and (iv)&#160;with respect to notices, payments and other matters hereunder, the Borrower, the Administrative Agent and the Lenders shall not be obligated to deal with an SPC, but may limit their communications and other dealings relevant to such SPC to the applicable Granting Lender.  The funding of a Loan by an SPC hereunder shall utilize the Commitment of the Granting Lender to the same extent that, and as if, such Loan were funded by such Granting Lender.  Each party hereto hereby agrees that no SPC shall be liable for any indemnity or payment under this Credit Agreement for which a Lender would otherwise be liable for so long as, and to the extent, the Granting Lender provides such indemnity or makes such payment.  Notwithstanding anything to the contrary contained in this Credit Agreement, any SPC may disclose any non-public information relating to its funding of Loans to any rating agency, commercial paper dealer or provider of any surety or guarantee to such SPC so long as such disclosure is clearly designated as being made on a confidential basis.  This Section&#160;11.3(g) may not be amended without the prior written consent of each Granting Lender, all or any part of whose Loan is being funded by an SPC at the time of such amendment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Electronic Execution of Assignments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The words &#8220;execution,&#8221; &#8220;signed,&#8221; &#8220;signature,&#8221; and words of like import in any Assignment and Assumption shall be deemed to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">104</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">include Electronic Signatures or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">No Waiver&#59; Remedies Cumulative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No failure or delay on the part of the Administrative Agent or any Lender in exercising any right, power or privilege hereunder or under any other Credit Document and no course of dealing between the Borrower and the Administrative Agent or any Lender shall operate as a waiver thereof&#59; nor shall any single or partial exercise of any right, power or privilege hereunder or under any other Credit Document preclude any other or further exercise thereof or the exercise of any other right, power or privilege hereunder or thereunder.  The rights and remedies provided herein are cumulative and not exclusive of any rights or remedies which the Administrative Agent or any Lender would otherwise have.  No notice to or demand on the Borrower in any case shall entitle the Borrower to any other or further notice or demand in similar or other circumstances or constitute a waiver of the rights of the Administrative Agent or the Lenders to any other or further action in any circumstances without notice or demand.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Payment of Expenses&#59; Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Borrower shall pay on demand&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">any and all Attorney Costs and reasonable and documented out-of-pocket costs and expenses incurred by the Administrative Agent, the Lead Arrangers and their respective Affiliates in connection with the drafting, negotiation and administration of the Credit Documents and any amendments thereto and the closing of the transactions contemplated thereby&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">all reasonable and documented out-of-pocket costs and expenses (including fees and disbursements of in-house and other attorneys, appraisers and consultants) incurred by the Agents or the Lenders in any workout, restructuring or similar arrangements or, after an Event of Default, in connection with the protection, preservation, exercise or enforcement of any of the terms of the Credit Documents or in connection with any foreclosure, collection or bankruptcy proceedings&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, however, that Attorney Costs shall in each case be limited to the Attorney Costs of one counsel, but excluding the allocated cost of internal counsel and, if necessary, of a single local counsel in each appropriate jurisdiction (which may include a single special counsel acting in multiple jurisdictions). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The foregoing costs and expenses shall include all reasonable and documented out-of-pocket expenses incurred by the Administrative Agent and the reasonable and documented out-of-pocket cost of independent public accountants and other outside experts retained by the Administrative Agent or any Lender.  If requested by the Borrower, the Administrative Agent or a Lender, as applicable, will furnish to the Borrower, within 10 Business Days of such request, a certificate setting forth the basis in reasonable detail with respect to any amounts requested under this Section&#160;11.5(a).  All amounts due under this Section&#160;11.5(a) shall be payable within 20&#160;Business Days after demand therefor.  The agreements in this Section&#160;shall survive the termination of the Commitments and repayment of all Obligations.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">105</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Limitation of Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  To the extent permitted by applicable law, (i) the Borrower shall not assert, and the Borrower hereby waives, any claim against the Administrative Agent, any Lead Arranger, any Syndication Agent, any Documentation Agent, any Issuing Lender and any Lender, and any Related Party of any of the foregoing Persons (each such Person being called a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lender-Related Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) for any Liabilities (as defined below) arising from the use by others of any information or other materials obtained through IntraLinks or other similar information transmission systems in connection with the Credit Agreement (except to the extent they are found by a final, non-appealable judgment of a court of competent jurisdiction to arise from the gross negligence, bad faith or willful misconduct of such Lender-Related Person or its Related Parties), and (ii) no party hereto shall assert, and each such party hereby waives, any Liabilities against (x)&#160;any Lender-Related Person or (y) the Borrower and any Related Party of the Borrower (each such Person being called a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company-Related Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in connection with, or as a result of, this Credit Agreement, any other Credit Document or any agreement or instrument contemplated hereby or thereby, any transactions contemplated hereby or thereby, any Loan or Letter of Credit or the use of the proceeds thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, nothing in this Section 11.5(b) shall relieve the Borrower of any obligation it may have to indemnify an Indemnitee, as provided in Section 11.5(c), against any special, indirect, consequential or punitive damages asserted against such Indemnitee by a third party.  As used in this Section 11.5(b), &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any losses, claims (including intraparty claims), demands, damages or liabilities of any kind.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">The Borrower shall indemnify and hold harmless each Agent, each Lead Arranger, each Lender and their respective Related Parties of the foregoing (collectively the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnitees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) from and against any and all liabilities, obligations, losses, damages, penalties, claims (including intraparty claims), demands, actions, judgments, suits, costs, reasonable and documented out-of-pocket expenses and disbursements (including Attorney Costs, limited to the reasonable and documented out-of-pocket fees and expenses of one counsel representing all Indemnitees, taken as a whole, but excluding the allocated cost of internal counsel, and, if necessary, of a single local counsel in each appropriate jurisdiction (which may include a single special counsel acting in multiple jurisdictions) for all such Indemnitees, taken as whole (and, in the case of an actual or perceived conflict of interest where any Indemnitee affected by such conflict notifies the Borrower of the existence of such conflict and thereafter retains its own counsel, those of another firm of counsel for each such affected Indemnitee and all other Indemnitees similarly situated))) of any kind or nature whatsoever which may at any time be imposed on, incurred by or asserted against any such Indemnitee in any way relating to or arising out of or in connection with (A)&#160;the execution, delivery, enforcement, performance or administration of any Credit Document or any other agreement, letter or instrument delivered in connection with the transactions contemplated thereby or the consummation of the transactions contemplated thereby, (B)&#160;any Commitment or Loan or the use or proposed use of the proceeds therefrom, (C)&#160;any actual or alleged presence or release of Hazardous Materials on or from any property currently or formerly owned or operated by the Borrower or any of its Subsidiaries or any Environmental Liability related in any way to the Borrower or any of its Subsidiaries or (D)&#160;any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on contract, tort or any other theory (including any investigation of, preparation for, or defense of any pending or threatened claim, investigation, litigation or proceeding) and regardless of whether commenced by the Borrower, any Indemnitee or any third party and whether any Indemnitee is a party thereto (all the foregoing, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnified Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that such indemnity shall not, as to any Indemnitee, be available (x) to the extent that such liabilities, obligations, losses, damages, penalties, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">106</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">claims, demands, actions, judgments, suits, costs, expenses or disbursements are determined by a final and non-appealable judgment of a court of competent jurisdiction to have resulted from the gross negligence, bad faith or willful misconduct of such Indemnitee or its Related Parties, (y) to any claim brought by the Borrower against any Indemnitee for a material breach of such Indemnitee&#8217;s (or its Related Parties&#8217;) obligations under this Credit Agreement or the other Credit Documents (to the extent such material breach is determined by a court of competent jurisdiction in a final and non-appealable judgment) or (z) to any liabilities, obligations, losses, damages, penalties, claims, demands, actions, judgments, suits, costs, expenses or disbursements arising from actions, suits or proceedings (including any investigations or inquiries) by any Indemnitee against another Indemnitee (other than actions, suits, proceedings (including any investigations or inquiries) involving (a) alleged conduct or omission by the Borrower or its Affiliates or (b) against the Administrative Agent, any other Agent or any other arranger or bookrunner in its capacity as such).  All amounts due under this Section&#160;11.5(c) shall be payable within 10 Business Days after demand therefor.  The agreements in this Section&#160;shall survive the resignation of the Administrative Agent, the replacement of any Lender, the termination of the Commitments and the repayment, satisfaction or discharge of all the Obligations.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">To the extent that the undertaking to indemnify set forth in Section&#160;11.5(c)(i) may be unenforceable as violative of any applicable law or public policy, the Borrower shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities that is permissible under applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Amendments, Waivers and Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Subject to Section 3.10, neither this Credit Agreement nor any other Credit Document nor any of the terms hereof or thereof may be amended, changed, waived, discharged or terminated unless such amendment, change, waiver, discharge or termination is in writing and signed by the Required Lenders and the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that no such amendment, change, waiver, discharge or termination shall without the consent of each Lender affected thereby&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">extend the Maturity Date of any Loan (except as permitted under Section 2.8) or extend or postpone the time for any payment or prepayment of principal of any Loan or unreimbursed drawing of any Letter of Credit&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">reduce the rate or amount or extend the time of payment of interest (other than as a result of waiving the applicability of any post-default increase in interest rates) thereon or fees hereunder&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">reduce or waive the principal amount of any Loan or unreimbursed drawing of any Letter of Credit&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">increase or extend the Commitment of a Lender (it being understood and agreed that a waiver of any Default or Event of Default or a waiver of any mandatory reduction in the Commitments shall not constitute a change in the terms of any Commitment of any Lender)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">release the Borrower from its obligations or consent to the assignment or transfer by the Borrower of any of its rights and obligations under (or in respect of) the Credit Documents, or release any Domestic Subsidiary from its obligations under any guarantee agreement delivered pursuant to Section 7.10&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">107</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">amend, modify or waive any provision of this Section 11.6 or Section 3.7 (or any other provision providing for the pro rata nature of payments or disbursements to Lenders), 3.8 or 9.1(a)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">reduce any percentage specified in the definition of Required Lenders&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">amend or otherwise modify the definition of Alternative Currency.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the above, (i) no provisions of Section 10 may be amended or modified without the consent of the Administrative Agent, (ii) no provisions of Section&#160;2.2 may be amended or modified without the consent of any Issuing Lender and (iii) no provisions of Section 2.3 may be amended or modified without the consent of the Swing Line Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the fact that the consent of all the Lenders is required in certain circumstances as set forth above, (x) each Lender is entitled to vote as such Lender sees fit on any reorganization plan that affects the Loans or the Letters of Credit, and each Lender acknowledges that the provisions of Section 1126(c) of the Bankruptcy Code supersede the unanimous consent provisions set forth herein and (y) the Required Lenders may consent to allow the Borrower to use cash collateral in the context of a bankruptcy or insolvency proceeding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If, in connection with any proposed amendment, waiver or consent requiring the consent of a greater percentage of the Lenders than the Required Lenders and the consent of the Required Lenders is obtained, but the consent of one or more other Lenders is not obtained (any such Lender which declares in writing that it will not provide such consent or whose consent is not obtained within the applicable period prescribed for such amendment, waiver or consent being referred to herein as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Consenting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), then, so long as the Administrative Agent is not a Non-Consenting Lender, the Borrower may, within 45 days of such Lender becoming a Non-Consenting Lender, give notice in writing to the Administrative Agent and such Non-Consenting Lender of the Borrower&#8217;s intention to cause such Non-Consenting Lender to sell all of such Non-Consenting Lenders&#8217; interests in its Commitments for an amount equal to the principal balances thereof and all accrued interest and fees with respect thereto through the date of sale pursuant to one or more Assignment and Assumptions, such sale being without premium or discount.  In the event of any such notice, such Non-Consenting Lender shall be required to sell and assign such interests (including all of its related rights and obligations) as provided in this Section.  Any such sale of a Non-Consenting Lender&#8217;s Commitments must be to an Eligible Assignee and, unless otherwise agreed to by the Administrative Agent, the Borrower shall be solely responsible for sourcing such Eligible Assignee, at no cost or expense to the Administrative Agent or any Lender.  Any such assignment to an Eligible Assignee pursuant to this Section shall be in accordance with clause (b)(iv) of Section 11.3.  At any time during or after the period during which a proposed amendment, waiver or consent was pending, upon the request of the Borrower, the Administrative Agent shall promptly provide (but in any event within one Business Day) the Borrower with the names, contact information, Commitment percentages, principal balances and any other information reasonably requested for each Lender that, at the time of such request, was either a Non-Consenting Lender or had not yet decided whether or not to approve or consent to such amendment, waiver or consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Credit Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be an original, but all of which shall constitute one and the same instrument.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">108</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The headings of the sections and subsections hereof are provided for convenience only and shall not in any way affect the meaning or construction of any provision of this Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Survival of Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All indemnities set forth herein (including those set forth in Sections 3.9, 3.12, 3.13, 3.14 and 11.5), shall survive the execution and delivery of this Credit Agreement, the making of the Loans, the issuance of the Letters of Credit and the repayment of the Loans, LOC Obligations and other obligations and the termination of the Commitments hereunder.  All representations and warranties made hereunder and in any other Credit Document or other document delivered pursuant hereto or thereto or in connection herewith or therewith shall survive the execution and delivery hereof and thereof. Such representations and warranties have been or will be relied upon by the Administrative Agent and each Lender, regardless of any investigation made by the Administrative Agent or any Lender or on their behalf and notwithstanding that the Administrative Agent or any Lender may have had notice or knowledge of any Default at the time of any Extension of Credit, and shall continue in full force and effect as long as any Loan or any other Obligations hereunder shall remain unpaid or unsatisfied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Governing Law&#59; Venue&#59; Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">THIS CREDIT AGREEMENT AND THE OTHER CREDIT DOCUMENTS AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER AND THEREUNDER SHALL BE GOVERNED BY AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.  Except as provided below in this paragraph, (i) each party hereto irrevocably and unconditionally submits, for itself and its property, to the jurisdiction of the Supreme Court of the State of New York sitting in New York County and of the United States District Court of the Southern District of New York, and any appellate court from any thereof, in any suit, action, proceeding, claim or counterclaim arising out of or relating to this Credit Agreement or any other Credit Document, or for recognition or enforcement of any judgment relating to this Credit Agreement or any other Credit Document, and (ii) each party hereto hereby irrevocably and unconditionally agrees that all claims in respect of any such suit, action, proceeding, claim or counterclaim shall be brought only in such New&#160;York State or, to the extent permitted by law, in such Federal court, or in the courts (or, to the extent permitted by law, Federal courts) of the State of New Jersey.  The Borrower irrevocably consents to the service of process in any suit, action, proceeding, claim or counterclaim with respect to this Credit Agreement or any other Credit Document by the mailing of copies thereof by registered or certified mail, postage prepaid, to it at the address for notices pursuant to Section 11.1, such service to become effective 10 days after such mailing.  Nothing herein shall affect the right of a Lender to serve process in any other manner permitted by law or to commence legal proceedings or otherwise proceed against the Borrower in any other jurisdiction.  The Borrower agrees that a final judgment in any suit, action, proceeding, claim or counterclaim in any court referred to above shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that nothing in this Section&#160;11.10(a) is intended to impair the Borrower&#8217;s right under applicable law to appeal or seek a stay of any judgment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Borrower hereby irrevocably waives any objection which it may now or hereafter have to the laying of venue of any of the aforesaid suits, actions, proceedings, claims or counterclaims arising out of or in connection with this Credit Agreement or any other Credit Document in the courts referred to in subsection&#160;(a) hereof and hereby further irrevocably waives </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">109</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and agrees not to plead or claim in any such court that any such suit, action, proceeding, claim or counterclaim brought in any such court has been brought in an inconvenient forum.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Waiver of Jury Trial&#59; Waiver of Consequential Damages</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EACH OF THE PARTIES TO THIS CREDIT AGREEMENT HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY SUIT, ACTION, PROCEEDING, CLAIM OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS CREDIT AGREEMENT, ANY OF THE OTHER CREDIT DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.  EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PERSON HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS CREDIT AGREEMENT AND THE OTHER CREDIT DOCUMENTS BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.  Each of the parties hereto agrees not to assert any claim against any other party hereto, any of its Affiliates, or any of their respective directors, officers, employees, attorneys or agents, on any theory of liability, for special, indirect, consequential or punitive damages arising out of or otherwise relating to any of the transactions contemplated herein&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that nothing contained in this sentence shall limit the Borrower&#8217;s indemnity obligations under Section 11.5(c).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If any provision of any of the Credit Documents is determined to be illegal, invalid or unenforceable, such provision shall be fully severable and the remaining provisions shall remain in full force and effect and shall be construed without giving effect to the illegal, invalid or unenforceable provisions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Further Assurances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Borrower agrees, upon the reasonable request of the Administrative Agent, to promptly take such actions, as reasonably requested, as is necessary to carry out the intent of this Credit Agreement and the other Credit Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each of the Administrative Agent, the Issuing Lenders and the Lenders agrees to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed (a) to its Affiliates and to its and its Affiliates&#8217; respective partners, directors, officers, employees, agents, advisors and representatives, excluding equity security departments and their members (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential), (b)&#160;to the extent requested by any regulatory authority purporting to have jurisdiction over it (including any self-regulatory authority, such as the National Association of Insurance Commissioners), (c) to the extent required by applicable laws or regulations or by any subpoena or similar legal process, (d) to any other party hereto, (e) in connection with the exercise of any remedies hereunder or under any other Credit Document or any action or proceeding relating to this Credit Agreement or any other Credit Document or the enforcement of rights hereunder or thereunder, (f) subject to either (x) an agreement containing provisions substantially the same as those of this Section or (y) the standard confidentiality undertaking on an IntraLinks or similar website, to (i) any assignee of or Loan Participant in, or any prospective assignee of or Loan Participant in, any of its rights or obligations under this Credit Agreement, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">110</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) to any insurance broker or provider of credit insurance or (iii) any actual or prospective counterparty (or its advisors) to any swap or derivative transaction relating to the Borrower and its obligations, (g) with the prior written consent of the Borrower or (h) to the extent such Information (x) becomes publicly available other than as a result of a breach of this Section or (y) becomes available to the Administrative Agent, any Lender or any of their respective Affiliates on a non-confidential basis from a source other than the Borrower, which source is not known by the applicable Agent, Issuing Lender or Lender to have breached any confidentiality obligation by its disclosure of the Information. In addition, the Administrative Agent and the Lenders may disclose the existence of this Credit Agreement and information about this Credit Agreement to market data collectors, credit ratings agencies, similar service providers to the lending industry and service providers to the Administrative Agent and the Lenders in connection with the administration and management of this Credit Agreement, the other Credit Documents and the Loans. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of this Section, &#8220;Information&#8221; means all information received from the Borrower or any of its Subsidiaries relating to the Borrower or any Subsidiary or any of their respective businesses, other than any such information that is available to the Administrative Agent or any Lender on a non-confidential basis prior to disclosure by the Borrower or any Subsidiary, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, in the case of information received from the Borrower or any Subsidiary after the Restatement Effective Date, such information is clearly identified in writing at the time of delivery as confidential. Any Person required to maintain the confidentiality of Information as provided in this Section shall be considered to have complied with its obligation to do so if such Person has exercised the same degree of care to maintain the confidentiality of such Information as such Person would accord to its own confidential information. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Non-Public Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each Lender acknowledges that all information, including requests for waivers and amendments, furnished by the Borrower or the Administrative Agent pursuant to or in connection with, or in the course of administering, this Credit Agreement will be syndicate-level information, which may contain MNPI.  Each Lender represents to and agrees with the Borrower and the Administrative Agent that (i) it has developed compliance procedures regarding the use of MNPI and that it will handle MNPI in accordance with such procedures and applicable law, including Federal, state and foreign securities laws, (ii) it has identified in its Administrative Questionnaire a credit contact who may receive information that may contain MNPI in accordance with its compliance procedures and applicable law, including Federal, state and foreign securities laws and (iii) it will cause at least one individual at or on behalf of such Public Lender to at all times have selected the &#8220;Private Side Information&#8221; or similar designation on the content declaration screen of the Platform in order to enable such Public Lender or its delegate, in accordance with such Public Lender&#8217;s compliance procedures and applicable law, including United States Federal and state securities Laws, to make reference to Borrower Materials that are not made available through the &#8220;Public Side Information&#8221; portion of the Platform and that may contain MNPI. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Entirety</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Credit Agreement together with the other Credit Documents, the JPMorgan Engagement Letter and the Fee Letters represent the entire agreement of the parties hereto and thereto, and supersede all prior agreements and understandings, oral or written, if any, including any commitment letters, engagement letters or correspondence relating to the Credit Documents or the transactions contemplated herein and therein&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that provisions of commitment letters or engagement letters to which the Borrower and the Agents and their Affiliates are party will survive the execution and delivery of this Credit Agreement to the extent expressly provided therein.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">111</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Binding Effect&#59; Continuing Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">This Credit Agreement shall become effective when it shall have been executed and delivered by the Borrower and the Administrative Agent, and the Administrative Agent shall have received copies hereof (faxed or otherwise) which, when taken together, bear the signatures of each Lender, and thereafter this Credit Agreement shall be binding upon and inure to the benefit of the Borrower, the Administrative Agent and each Lender and their respective successors and assigns.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">This Credit Agreement shall be a continuing agreement and shall remain in full force and effect until all Loans, LOC Obligations, interest, fees and other Obligations have been paid in full (other than contingent obligations for which no claim has been made) and all Commitments and Letters of Credit have been terminated (or, in the case of Letters of Credit, the LOC Obligations have been cash collateralized).  Upon termination, the Borrower shall have no further obligations (other than the indemnification provisions that survive) under the Credit Documents&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that should any payment, in whole or in part, of the Obligations be rescinded or otherwise required to be restored or returned by the Administrative Agent or any Lender, whether as a result of any proceedings in bankruptcy or reorganization or otherwise, then the Credit Documents shall automatically be reinstated and all amounts required to be restored or returned and all reasonable and documented out-of-pocket costs and expenses incurred by the Administrative Agent or any Lender in connection therewith shall be deemed included as part of the Obligations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">PATRIOT Act Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each Lender that is subject to the PATRIOT Act and the Administrative Agent (for itself and not on behalf of any Lender) hereby notifies the Borrower that pursuant to the requirements of the PATRIOT Act, it is required to obtain, verify and record information that identifies the Borrower or any future guarantor, which information includes the name and address of the Borrower or any future guarantor and other information that will allow such Lender or the Administrative Agent, as applicable, to identify the Borrower or any future guarantor in accordance with the PATRIOT Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">No Advisory or Fiduciary Responsibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In connection with all aspects of each transaction contemplated hereby (including in connection with any amendment, waiver or other modification hereof or of any other Credit Document), the Borrower acknowledges and agrees, and acknowledges its Affiliates&#8217; understanding, that&#58; (i) (A) the arranging and other services regarding this Credit Agreement provided by the Agents, the Lenders, the Issuing Lenders and the Lead Arrangers are arm&#8217;s-length commercial transactions between the Borrower and its Affiliates, on the one hand, and the Agents, the Lenders, the Issuing Lenders and the Lead Arrangers, on the other hand, (B) the Borrower has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate, and (C) the Borrower is capable of evaluating, and understands and accepts, the terms, risks and conditions of the transactions contemplated hereby and by the other Credit Documents&#59; (ii) (A) each of the Agents, the Lenders, the Issuing Lenders and the Lead Arrangers is and has been acting solely as a principal and, except as expressly agreed in writing by the relevant parties, has not been, is not, and will not be acting as an advisor, agent or fiduciary for the Borrower or any of its Affiliates, or any other Person and (B) none of the Agents, the Lenders, the Issuing Lenders or Lead Arrangers has any obligation to the Borrower or any of its Affiliates with respect to the transactions contemplated hereby except those obligations expressly set forth herein and in the other Credit Documents&#59; and (iii) the Agents, the Lenders, the Issuing Lenders and the Lead Arrangers and their respective Affiliates may be engaged in a broad range of transactions that involve interests that differ from those of the Borrower and its Affiliates, and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">112</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">none of the Agents, the Lenders, the Issuing Lenders or the Lead Arrangers has any obligation to disclose any of such interests to the Borrower or any of its Affiliates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Judgment Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If, for the purposes of obtaining judgment in any court, it is necessary to convert a sum due hereunder or any other Credit Document in one currency into another currency, the rate of exchange used shall be that at which in accordance with normal banking procedures the Administrative Agent could purchase the first currency with such other currency on the Business Day preceding that on which final judgment is given.  The obligation of the Borrower in respect of any such sum due from it to any Agent or the Lenders hereunder or under the other Credit Documents shall, notwithstanding any judgment in a currency (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Judgment Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) other than that in which such sum is denominated in accordance with the applicable provisions of this Credit Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), be discharged only to the extent that on the Business Day following receipt by the Administrative Agent of any sum adjudged to be so due in the Judgment Currency, the Administrative Agent may in accordance with normal banking procedures purchase the Agreement Currency with the Judgment Currency.  If the amount of the Agreement Currency so purchased is less than the sum originally due to the Administrative Agent from the Borrower in the Agreement Currency, the Borrower agrees, as a separate obligation and notwithstanding any such judgment, to indemnify the Administrative Agent or the Person to whom such obligation was owing against such loss.  If the amount of the Agreement Currency so purchased is greater than the sum originally due to the Administrative Agent in such currency, the Administrative Agent agrees to promptly return the amount of any excess to such Borrower (or to any other Person who may be entitled thereto under applicable law).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Acknowledgment and Consent to Bail-In of Affected Financial Institutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding anything to the contrary in any Credit Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any Affected Financial Institution arising under any Credit Document, to the extent such liability is unsecured, may be subject to the Write-Down and Conversion Powers of the applicable Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">the application of any Write-Down and Conversion Powers by the applicable Resolution Authority to any such liabilities arising hereunder which may be payable to it by any party hereto that is an Affected Financial Institution&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">the effects of any Bail-in Action on any such liability, including, if applicable, (i) a reduction in full or in part or cancellation of any such liability, (ii) a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such Affected Financial Institution, its parent undertaking, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such liability under this Credit Agreement or any other Credit Document or (iii) the variation of the terms of such liability in connection with the exercise of the Write-Down and Conversion Powers of the applicable Resolution Authority.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;REMAINDER OF PAGE INTENTIONALLY LEFT BLANK&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">113</font></div><div><font><br></font></div></div></div><div id="ic5adb41374c6477a812ea1767bcb9034_13"></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div style="margin-bottom:24pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each of the parties hereto has caused a counterpart of this Credit Agreement to be duly executed and delivered as of the date first above written.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.006%"><tr><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#322c2c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">QUEST DIAGNOSTICS INCORPORATED</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#91;&#91;5994610&#93;&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:216pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.006%"><tr><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#322c2c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">JPMORGAN CHASE BANK, N.A.,<br>as Administrative Agent, an Issuing Lender, Swing Line Lender and a Lender</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Signature Page to third Amended and Restated Credit Agreement&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:216pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.006%"><tr><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:24pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">MORGAN STANLEY BANK, N.A.</font><font style="color:#322c2c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,<br>as an Issuing Lender and a Lender</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Signature Page to third Amended and Restated Credit Agreement&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:216pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.006%"><tr><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:24pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">MIZUHO BANK, LTD.</font><font style="color:#322c2c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,<br>as an Issuing Lender and a Lender</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr></table></div><div style="margin-bottom:54pt;padding-left:203.75pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:203.75pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Signature Page to third Amended and Restated Credit Agreement&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:216pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.006%"><tr><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:24pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WELLS FARGO BANK, N.A.</font><font style="color:#322c2c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,<br>as an Issuing Lender and a Lender</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr></table></div><div style="padding-left:203.75pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Signature Page to third Amended and Restated Credit Agreement&#93;</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.16pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="padding-left:216pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.006%"><tr><td style="width:1.0%"></td><td style="width:11.659%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.141%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;NAME OF INSTITUTION&#93;,<br>as a Lender</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;<font style="font-size:7.8pt;position:relative;top:-4.2pt;vertical-align:baseline">1</font></font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> For any Lender requiring a second signature line.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Signature Page to third Amended and Restated Credit Agreement&#93;</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>dgx-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:6a67f40b-d353-490b-97be-70efe774e456,g:809066a9-06e1-46b8-9b20-d9684581a006-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dgx="http://questdiagnostics.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://questdiagnostics.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://questdiagnostics.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>0000003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>0000004 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>0000007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESS" roleURI="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS">
        <link:definition>0000008 - Disclosure - DESCRIPTION OF BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>0000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARE">
        <link:definition>0000010 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGACTIVITIES" roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIES">
        <link:definition>0000011 - Disclosure - RESTRUCTURING ACTIVITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONS" roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONS">
        <link:definition>0000012 - Disclosure - BUSINESS ACQUISITIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>0000013 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://questdiagnostics.com/role/DEBT">
        <link:definition>0000014 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTS" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS">
        <link:definition>0000015 - Disclosure - FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST">
        <link:definition>0000016 - Disclosure - STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATA" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA">
        <link:definition>0000017 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>0000018 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATION" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION">
        <link:definition>0000019 - Disclosure - BUSINESS SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITION" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITION">
        <link:definition>0000020 - Disclosure - REVENUE RECOGNITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TAXESONINCOME" roleURI="http://questdiagnostics.com/role/TAXESONINCOME">
        <link:definition>0000021 - Disclosure - TAXES ON INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTS" roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTS">
        <link:definition>0000022 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>0000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARETables">
        <link:definition>0000024 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>0000025 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSTables" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables">
        <link:definition>0000026 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATATables" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables">
        <link:definition>0000027 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONTables" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables">
        <link:definition>0000028 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONTables" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONTables">
        <link:definition>0000029 - Disclosure - REVENUE RECOGNITION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREDetails" roleURI="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails">
        <link:definition>0000030 - Disclosure - EARNINGS PER SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGACTIVITIESDetails" roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails">
        <link:definition>0000031 - Disclosure - RESTRUCTURING ACTIVITIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails">
        <link:definition>0000032 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails">
        <link:definition>0000033 - Disclosure - FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Assets and Liabilities Unobservable Inputs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSNarrativeDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails">
        <link:definition>0000034 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTDetails" roleURI="http://questdiagnostics.com/role/DEBTDetails">
        <link:definition>0000035 - Disclosure - DEBT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSBalanceSheetsDetails" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails">
        <link:definition>0000036 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails">
        <link:definition>0000037 - Disclosure - STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATADetails" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails">
        <link:definition>0000038 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>0000039 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONDetails" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails">
        <link:definition>0000040 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONDetails" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails">
        <link:definition>0000041 - Disclosure - REVENUE RECOGNITION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TAXESONINCOMEDetails" roleURI="http://questdiagnostics.com/role/TAXESONINCOMEDetails">
        <link:definition>0000042 - Disclosure - TAXES ON INCOME (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTSDetails" roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails">
        <link:definition>0000043 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" abstract="true" name="ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" abstract="false" name="ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" abstract="false" name="ScheduleOfRevenuesByMajorServiceTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dgx_SeniorunsecuredrevolvingcreditfacilityMember" abstract="true" name="SeniorunsecuredrevolvingcreditfacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" abstract="true" name="ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_AccountsReceivableDisaggregationTableTextBlock" abstract="false" name="AccountsReceivableDisaggregationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dgx_DSBusinessesMember" abstract="true" name="DSBusinessesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_COVID19TestingServicesMember" abstract="true" name="COVID19TestingServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" abstract="true" name="ExcludesgeneralandprofessionalliabilityclaimsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_PercentageofNetRevenues" abstract="false" name="PercentageofNetRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent" abstract="false" name="RevenueFromContractWithCustomerExcludingAssessedTaxPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_DescriptionOfBusinessAbstract" abstract="true" name="DescriptionOfBusinessAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" abstract="false" name="NetIncomeLossExcludingRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_GenebasedandesoterictestingservicesMember" abstract="true" name="GenebasedandesoterictestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_DiagnosticInformationServicesBusinessMember" abstract="true" name="DiagnosticInformationServicesBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ClientPayersMember" abstract="true" name="ClientPayersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_UMassJointVentureMember" abstract="true" name="UMassJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_InvigorateProgramMember" abstract="true" name="InvigorateProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_AnatomicpathologytestingservicesMember" abstract="true" name="AnatomicpathologytestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_CapitatedMember" abstract="true" name="CapitatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_StockRepurchaseProgramAdditionalAmountAuthorized" abstract="false" name="StockRepurchaseProgramAdditionalAmountAuthorized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_PercentageofNetAccountsReceivable" abstract="false" name="PercentageofNetAccountsReceivable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dgx_A401kPlanLawsuitMember" abstract="true" name="A401kPlanLawsuitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_Mergerconsiderationpaidpayablenet" abstract="false" name="Mergerconsiderationpaidpayablenet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_NewYorkPresbyterianMember" abstract="true" name="NewYorkPresbyterianMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_PatientsMember" abstract="true" name="PatientsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" abstract="false" name="TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_HaystackOncologyIncMember" abstract="true" name="HaystackOncologyIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_FairValueOfNetAssetsAcquired" abstract="false" name="FairValueOfNetAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_HealthcareInsurersMember" abstract="true" name="HealthcareInsurersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_AllotherservicesMember" abstract="true" name="AllotherservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_DataSecurityIncidentMember" abstract="true" name="DataSecurityIncidentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_RoutineclinicaltestingservicesMember" abstract="true" name="RoutineclinicaltestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_GovernmentPayersMember" abstract="true" name="GovernmentPayersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dgx_FeeforserviceMember" abstract="true" name="FeeforserviceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>dgx-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:6a67f40b-d353-490b-97be-70efe774e456,g:809066a9-06e1-46b8-9b20-d9684581a006-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="dgx-20230331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_ce5e2661-89eb-4129-a853-0f498ae79b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_1819dc43-af99-426d-b4d8-99a06e7178fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ce5e2661-89eb-4129-a853-0f498ae79b52" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_1819dc43-af99-426d-b4d8-99a06e7178fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_5edd7952-1f9d-442d-8dae-b8695bfe106f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ce5e2661-89eb-4129-a853-0f498ae79b52" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_5edd7952-1f9d-442d-8dae-b8695bfe106f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_dcc4d5e0-986d-49e4-acfb-5c0374a0368a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ce5e2661-89eb-4129-a853-0f498ae79b52" xlink:to="loc_us-gaap_CostOfRevenue_dcc4d5e0-986d-49e4-acfb-5c0374a0368a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5b54118b-c479-491d-b73e-72209d1dc815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ce5e2661-89eb-4129-a853-0f498ae79b52" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5b54118b-c479-491d-b73e-72209d1dc815" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_91afd9e0-2766-4ba9-8d14-a840533a2a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_6a0c130d-14a0-4ef0-b3b4-beac7fb3ced6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_91afd9e0-2766-4ba9-8d14-a840533a2a7c" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_6a0c130d-14a0-4ef0-b3b4-beac7fb3ced6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_c4e7b05f-131c-487d-860f-f5a37a1534fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_91afd9e0-2766-4ba9-8d14-a840533a2a7c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_c4e7b05f-131c-487d-860f-f5a37a1534fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9f1f8ddf-fdeb-42f6-bda6-edf45312a92c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_90bf49bc-22a0-4a79-af92-a18050ce9873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9f1f8ddf-fdeb-42f6-bda6-edf45312a92c" xlink:to="loc_us-gaap_CostsAndExpenses_90bf49bc-22a0-4a79-af92-a18050ce9873" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_04723732-7b31-42c0-839f-0aeac81c49f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9f1f8ddf-fdeb-42f6-bda6-edf45312a92c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_04723732-7b31-42c0-839f-0aeac81c49f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c47a292f-04a5-417d-a140-a92f15d5d1a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_014c3f82-0d4a-489e-b22b-933452a03e65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_c47a292f-04a5-417d-a140-a92f15d5d1a5" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_014c3f82-0d4a-489e-b22b-933452a03e65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7b966483-345a-4f18-93d7-68c149628211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_c47a292f-04a5-417d-a140-a92f15d5d1a5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7b966483-345a-4f18-93d7-68c149628211" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_822724bf-ddec-4b35-b9ae-380917302ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_c47a292f-04a5-417d-a140-a92f15d5d1a5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_822724bf-ddec-4b35-b9ae-380917302ee0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2569ef58-8bd2-4767-a17a-679b62ec831e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_77ee551f-b76d-4616-a26c-615e4d92cb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_2569ef58-8bd2-4767-a17a-679b62ec831e" xlink:to="loc_us-gaap_ProfitLoss_77ee551f-b76d-4616-a26c-615e4d92cb7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_11dbdd62-8ad4-4abf-a405-dba8a58a121a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_2569ef58-8bd2-4767-a17a-679b62ec831e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_11dbdd62-8ad4-4abf-a405-dba8a58a121a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_bea5feaa-99e3-4b93-b530-8fecfb1af891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_a159c5ff-22f6-4f9b-9024-99987b261f67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_bea5feaa-99e3-4b93-b530-8fecfb1af891" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_a159c5ff-22f6-4f9b-9024-99987b261f67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4a749448-0a37-46b4-adb2-68504f088053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_bea5feaa-99e3-4b93-b530-8fecfb1af891" xlink:to="loc_us-gaap_OperatingIncomeLoss_4a749448-0a37-46b4-adb2-68504f088053" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="dgx-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2834c384-c81a-4f64-b866-ca78034752fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b51fdd8d-902e-4b8d-b3a7-d8c668ba75fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2834c384-c81a-4f64-b866-ca78034752fe" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b51fdd8d-902e-4b8d-b3a7-d8c668ba75fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_dbc0d9ba-6bc4-4f39-8e3b-89bacdf2d69e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2834c384-c81a-4f64-b866-ca78034752fe" xlink:to="loc_us-gaap_ProfitLoss_dbc0d9ba-6bc4-4f39-8e3b-89bacdf2d69e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_af22d8bc-f767-4f39-9a85-c7987234cb84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_efaeb9c0-1872-4283-98db-7cbbeb27ad1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_af22d8bc-f767-4f39-9a85-c7987234cb84" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_efaeb9c0-1872-4283-98db-7cbbeb27ad1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3b4a263c-0534-4ccf-93c5-2370f37fb844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_af22d8bc-f767-4f39-9a85-c7987234cb84" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3b4a263c-0534-4ccf-93c5-2370f37fb844" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c545c2f0-9e14-49ff-a6a6-8e02b471bb9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_92d0ed60-d9a5-482d-aa69-53c3eb447a37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c545c2f0-9e14-49ff-a6a6-8e02b471bb9b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_92d0ed60-d9a5-482d-aa69-53c3eb447a37" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dgx-20230331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_19570656-470a-4667-908e-8d019cee95bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_66dfd24a-7a57-49a5-8a9d-ccc5e9285fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_19570656-470a-4667-908e-8d019cee95bc" xlink:to="loc_us-gaap_AssetsCurrent_66dfd24a-7a57-49a5-8a9d-ccc5e9285fb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7d359a2d-dbb3-4e27-b1f8-79c53feee814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_19570656-470a-4667-908e-8d019cee95bc" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7d359a2d-dbb3-4e27-b1f8-79c53feee814" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_4a6746a1-360b-4051-bf43-d4aa89b12df1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_19570656-470a-4667-908e-8d019cee95bc" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_4a6746a1-360b-4051-bf43-d4aa89b12df1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_17b3b632-badf-4130-aaa5-bdd7e2e36389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_19570656-470a-4667-908e-8d019cee95bc" xlink:to="loc_us-gaap_Goodwill_17b3b632-badf-4130-aaa5-bdd7e2e36389" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_59368963-af02-41ff-b73f-ae5b8f7a316b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_19570656-470a-4667-908e-8d019cee95bc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_59368963-af02-41ff-b73f-ae5b8f7a316b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_fffa90f7-d226-4542-859e-5629cad94935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_19570656-470a-4667-908e-8d019cee95bc" xlink:to="loc_us-gaap_EquityMethodInvestments_fffa90f7-d226-4542-859e-5629cad94935" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0a0a0076-75d6-4412-9ceb-56c5d60f6be5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_19570656-470a-4667-908e-8d019cee95bc" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0a0a0076-75d6-4412-9ceb-56c5d60f6be5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_62411024-cd4b-4fd3-a0ec-4d932bfff724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3cd0c722-cffb-4dee-95ff-be2637a2ca43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_62411024-cd4b-4fd3-a0ec-4d932bfff724" xlink:to="loc_us-gaap_StockholdersEquity_3cd0c722-cffb-4dee-95ff-be2637a2ca43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_38e1a113-f22c-4885-8be1-b193595d49f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_62411024-cd4b-4fd3-a0ec-4d932bfff724" xlink:to="loc_us-gaap_MinorityInterest_38e1a113-f22c-4885-8be1-b193595d49f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_baaeed3e-bd37-4f12-9a17-d27ab1ba283e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_34bdb656-e141-48fe-84f4-596bbc4db712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_baaeed3e-bd37-4f12-9a17-d27ab1ba283e" xlink:to="loc_us-gaap_CommonStockValue_34bdb656-e141-48fe-84f4-596bbc4db712" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d42c0041-0772-48bb-9f74-6c7bd2feda9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_baaeed3e-bd37-4f12-9a17-d27ab1ba283e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d42c0041-0772-48bb-9f74-6c7bd2feda9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ae3815c6-19c8-4c55-857d-c2882806a147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_baaeed3e-bd37-4f12-9a17-d27ab1ba283e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ae3815c6-19c8-4c55-857d-c2882806a147" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_45c8e750-9795-42f9-80d3-cbcf460d83f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_baaeed3e-bd37-4f12-9a17-d27ab1ba283e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_45c8e750-9795-42f9-80d3-cbcf460d83f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_b81df0fa-10d8-482a-9507-8c486999be91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_baaeed3e-bd37-4f12-9a17-d27ab1ba283e" xlink:to="loc_us-gaap_TreasuryStockValue_b81df0fa-10d8-482a-9507-8c486999be91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d953d2a6-85af-4882-b6a6-1249c4d36ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8ab46a16-2cae-4d83-beea-01ad62f91716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d953d2a6-85af-4882-b6a6-1249c4d36ab3" xlink:to="loc_us-gaap_LiabilitiesCurrent_8ab46a16-2cae-4d83-beea-01ad62f91716" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_601a5ff3-29cf-4a8a-b6c0-14654cf66068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d953d2a6-85af-4882-b6a6-1249c4d36ab3" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_601a5ff3-29cf-4a8a-b6c0-14654cf66068" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_8fc3b7a6-9f96-4c95-a265-330977783820" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d953d2a6-85af-4882-b6a6-1249c4d36ab3" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_8fc3b7a6-9f96-4c95-a265-330977783820" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d0b2299e-1715-4109-ba6c-ca4534db411c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d953d2a6-85af-4882-b6a6-1249c4d36ab3" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d0b2299e-1715-4109-ba6c-ca4534db411c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_7f91eb32-f28a-415e-b71f-8372253b825e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d953d2a6-85af-4882-b6a6-1249c4d36ab3" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_7f91eb32-f28a-415e-b71f-8372253b825e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_788d2feb-cf0f-44f7-95a8-cb749eaf438b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d953d2a6-85af-4882-b6a6-1249c4d36ab3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_788d2feb-cf0f-44f7-95a8-cb749eaf438b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_683f3b96-a14d-4768-89e4-c9288b3e4cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d953d2a6-85af-4882-b6a6-1249c4d36ab3" xlink:to="loc_us-gaap_CommitmentsAndContingencies_683f3b96-a14d-4768-89e4-c9288b3e4cf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8cc72cd7-a7dc-4403-917e-a1e3274866e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_983405e0-f339-42f6-9478-40ae7a481a73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8cc72cd7-a7dc-4403-917e-a1e3274866e8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_983405e0-f339-42f6-9478-40ae7a481a73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b8e509d2-3849-4040-bbd4-6fd85caecd0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8cc72cd7-a7dc-4403-917e-a1e3274866e8" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b8e509d2-3849-4040-bbd4-6fd85caecd0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_843d5880-1d6e-4b2a-8180-194c68a3968e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8cc72cd7-a7dc-4403-917e-a1e3274866e8" xlink:to="loc_us-gaap_InventoryNet_843d5880-1d6e-4b2a-8180-194c68a3968e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c8ec5833-79de-44f4-a3a2-3c9c795e95ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8cc72cd7-a7dc-4403-917e-a1e3274866e8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c8ec5833-79de-44f4-a3a2-3c9c795e95ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ecd75d11-77c9-44a1-a853-29ad39b0e751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_0c7128af-b793-4685-b751-7ae6ccef3df4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ecd75d11-77c9-44a1-a853-29ad39b0e751" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_0c7128af-b793-4685-b751-7ae6ccef3df4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_0abc2b21-014b-4346-b743-a61180d345bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ecd75d11-77c9-44a1-a853-29ad39b0e751" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_0abc2b21-014b-4346-b743-a61180d345bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_77c23870-d26f-42ce-91ae-71586cdc2621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ecd75d11-77c9-44a1-a853-29ad39b0e751" xlink:to="loc_us-gaap_LongTermDebtCurrent_77c23870-d26f-42ce-91ae-71586cdc2621" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dgx-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5bf4cd76-73d0-43fe-982b-e4908aec4d83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e24c55d7-1441-443e-a229-d4e8a40bc68b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5bf4cd76-73d0-43fe-982b-e4908aec4d83" xlink:to="loc_us-gaap_ProfitLoss_e24c55d7-1441-443e-a229-d4e8a40bc68b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_0dbe9e89-40f2-452f-a302-3dd09effa6f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5bf4cd76-73d0-43fe-982b-e4908aec4d83" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_0dbe9e89-40f2-452f-a302-3dd09effa6f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_2b334e97-2eb2-4f2f-87e3-dfdbd542656c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5bf4cd76-73d0-43fe-982b-e4908aec4d83" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_2b334e97-2eb2-4f2f-87e3-dfdbd542656c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7ef739e4-4d98-4dcd-9157-5e4307b661d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5bf4cd76-73d0-43fe-982b-e4908aec4d83" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7ef739e4-4d98-4dcd-9157-5e4307b661d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a206eb58-6af7-40b6-82f6-41bffcc525d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5bf4cd76-73d0-43fe-982b-e4908aec4d83" xlink:to="loc_us-gaap_ShareBasedCompensation_a206eb58-6af7-40b6-82f6-41bffcc525d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_56c4b3e2-eb38-49c6-a484-4f94a5017100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5bf4cd76-73d0-43fe-982b-e4908aec4d83" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_56c4b3e2-eb38-49c6-a484-4f94a5017100" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_af4c7862-b0bb-40d0-9947-581c0fca0374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5bf4cd76-73d0-43fe-982b-e4908aec4d83" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_af4c7862-b0bb-40d0-9947-581c0fca0374" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4b55a5b7-19fa-4314-9a4e-0fa224072592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5bf4cd76-73d0-43fe-982b-e4908aec4d83" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4b55a5b7-19fa-4314-9a4e-0fa224072592" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_bde7142d-4d76-454c-a887-53f9f3e76bce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5bf4cd76-73d0-43fe-982b-e4908aec4d83" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_bde7142d-4d76-454c-a887-53f9f3e76bce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_700e10a8-2821-40ce-a2ef-a60e61344e69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5bf4cd76-73d0-43fe-982b-e4908aec4d83" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_700e10a8-2821-40ce-a2ef-a60e61344e69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d99f325-67d3-4568-b76b-d406754eec1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_95af5553-9818-4a2f-99ee-03ec2cd77de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d99f325-67d3-4568-b76b-d406754eec1f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_95af5553-9818-4a2f-99ee-03ec2cd77de1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_60807e95-235b-46b3-9258-13dc5d431559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d99f325-67d3-4568-b76b-d406754eec1f" xlink:to="loc_us-gaap_RepaymentsOfDebt_60807e95-235b-46b3-9258-13dc5d431559" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f4daf134-b76a-4f1a-a1a6-c5d9f4f66b53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d99f325-67d3-4568-b76b-d406754eec1f" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f4daf134-b76a-4f1a-a1a6-c5d9f4f66b53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_668ed10e-d3cc-4330-9748-ec47c80c43b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d99f325-67d3-4568-b76b-d406754eec1f" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_668ed10e-d3cc-4330-9748-ec47c80c43b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7924adbc-06d4-483f-8e96-7e5e9edadc43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d99f325-67d3-4568-b76b-d406754eec1f" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7924adbc-06d4-483f-8e96-7e5e9edadc43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_5a45af46-76e4-4855-9aab-d4dcd76ad83c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d99f325-67d3-4568-b76b-d406754eec1f" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_5a45af46-76e4-4855-9aab-d4dcd76ad83c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_b5c3def7-dca8-4fcf-9142-496419ac6f79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d99f325-67d3-4568-b76b-d406754eec1f" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_b5c3def7-dca8-4fcf-9142-496419ac6f79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_def3ccb4-cbca-4188-ad45-a01bb25a7b24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d99f325-67d3-4568-b76b-d406754eec1f" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_def3ccb4-cbca-4188-ad45-a01bb25a7b24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c3ce3fc0-be16-489b-8928-85158f91e3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f6bb0461-c41f-4f6d-bcf4-43349c0d4172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c3ce3fc0-be16-489b-8928-85158f91e3ed" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f6bb0461-c41f-4f6d-bcf4-43349c0d4172" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_77962879-f5c4-4d79-b0dd-286fd6eed739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c3ce3fc0-be16-489b-8928-85158f91e3ed" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_77962879-f5c4-4d79-b0dd-286fd6eed739" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c308a70d-0dd8-4d3d-97c5-94ac73cbcbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c3ce3fc0-be16-489b-8928-85158f91e3ed" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c308a70d-0dd8-4d3d-97c5-94ac73cbcbf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_61081cf2-b465-4ad2-a299-6eb66ee62eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_84b7909d-d685-4c0b-918c-740579b79a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_61081cf2-b465-4ad2-a299-6eb66ee62eb7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_84b7909d-d685-4c0b-918c-740579b79a5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_105ef926-f33f-43e6-a818-348611c44c71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_61081cf2-b465-4ad2-a299-6eb66ee62eb7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_105ef926-f33f-43e6-a818-348611c44c71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c3cd8983-8ad4-4893-8549-eed68ce38a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_61081cf2-b465-4ad2-a299-6eb66ee62eb7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c3cd8983-8ad4-4893-8549-eed68ce38a9c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#EARNINGSPERSHAREDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9684675d-235d-4852-a999-ed3412be2e40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_80afee62-8f86-4728-a73e-15d5a216377e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9684675d-235d-4852-a999-ed3412be2e40" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_80afee62-8f86-4728-a73e-15d5a216377e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0066d0fa-cf2e-4902-a17e-be95237e0a15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9684675d-235d-4852-a999-ed3412be2e40" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0066d0fa-cf2e-4902-a17e-be95237e0a15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_2738e8c9-80e8-44a9-9973-bf16d6e48ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b910aa14-71ce-4565-aa3b-3fc2bef59505" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_2738e8c9-80e8-44a9-9973-bf16d6e48ddb" xlink:to="loc_us-gaap_NetIncomeLoss_b910aa14-71ce-4565-aa3b-3fc2bef59505" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_b9ec56f2-e39f-4797-97a2-305a6921d904" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_2738e8c9-80e8-44a9-9973-bf16d6e48ddb" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_b9ec56f2-e39f-4797-97a2-305a6921d904" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_8c80f530-14b9-4c75-bde5-b087c4a2efdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_f4d0337a-9e9a-47e4-8762-86e072486663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_8c80f530-14b9-4c75-bde5-b087c4a2efdf" xlink:to="loc_us-gaap_TradingSecurities_f4d0337a-9e9a-47e4-8762-86e072486663" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_c6614743-3c4a-40a3-bb4a-db7eb7c63d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_8c80f530-14b9-4c75-bde5-b087c4a2efdf" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_c6614743-3c4a-40a3-bb4a-db7eb7c63d8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_02333181-3f84-4d08-bea0-7320267e5b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_8c80f530-14b9-4c75-bde5-b087c4a2efdf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_02333181-3f84-4d08-bea0-7320267e5b2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_9d67b19a-214c-44cd-94de-15a0168479c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_d506887f-7814-4c12-b19b-45a3cd09072a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_9d67b19a-214c-44cd-94de-15a0168479c6" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_d506887f-7814-4c12-b19b-45a3cd09072a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3934ee6d-d6db-4486-b0aa-7c5b84a4c2bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_9d67b19a-214c-44cd-94de-15a0168479c6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3934ee6d-d6db-4486-b0aa-7c5b84a4c2bc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#SUPPLEMENTALCASHFLOWOTHERDATADetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired_e7bd1086-3d2a-434f-95b1-75c2dfeaeb24" xlink:href="dgx-20230331.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_b0322620-d866-4f8a-a9de-e871ae15b61d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired_e7bd1086-3d2a-434f-95b1-75c2dfeaeb24" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_b0322620-d866-4f8a-a9de-e871ae15b61d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_a8a0c8ee-f05d-4283-8b4b-b75598e37823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired_e7bd1086-3d2a-434f-95b1-75c2dfeaeb24" xlink:to="loc_us-gaap_LiabilitiesAssumed1_a8a0c8ee-f05d-4283-8b4b-b75598e37823" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_b3c4b5d5-6c32-4e97-90eb-fa93d32e4953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3cffa808-bfbb-4a52-aed6-580ac2cb1219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_b3c4b5d5-6c32-4e97-90eb-fa93d32e4953" xlink:to="loc_us-gaap_InterestExpense_3cffa808-bfbb-4a52-aed6-580ac2cb1219" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_fb26851a-3f3f-487f-ae6a-70d3b7f57752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_b3c4b5d5-6c32-4e97-90eb-fa93d32e4953" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_fb26851a-3f3f-487f-ae6a-70d3b7f57752" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a8ad7090-4ae8-4ee8-9088-f7c3c0e99156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_5094f0d4-309a-452b-b525-30e1566f4f36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_a8ad7090-4ae8-4ee8-9088-f7c3c0e99156" xlink:to="loc_us-gaap_Depreciation_5094f0d4-309a-452b-b525-30e1566f4f36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_1cff5bc2-ed9b-4255-9991-438f29dd14fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_a8ad7090-4ae8-4ee8-9088-f7c3c0e99156" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_1cff5bc2-ed9b-4255-9991-438f29dd14fc" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>dgx-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:6a67f40b-d353-490b-97be-70efe774e456,g:809066a9-06e1-46b8-9b20-d9684581a006-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="dgx-20230331.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="i02c72857b2aa4d8c94522c672eb03bd7_CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fe82f29d-7a3a-4b3d-9d7c-0b15e1d9b70d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fe82f29d-7a3a-4b3d-9d7c-0b15e1d9b70d" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d75986f2-a955-4a6c-bfc1-c9f5381fb313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d75986f2-a955-4a6c-bfc1-c9f5381fb313" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dfa7cfe0-f026-4368-8194-ea01d0ce8c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dfa7cfe0-f026-4368-8194-ea01d0ce8c1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_5b546009-e68a-4639-9516-166ba9e4a9d9" xlink:href="dgx-20230331.xsd#dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_5b546009-e68a-4639-9516-166ba9e4a9d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_341627e3-fbf7-459b-a584-222589434cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_341627e3-fbf7-459b-a584-222589434cdb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_22693fd6-997c-45fe-bc90-048a7ee75b36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_DividendsCommonStockCash_22693fd6-997c-45fe-bc90-048a7ee75b36" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_c2a4b0be-8218-4052-b257-79d344ac34f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_c2a4b0be-8218-4052-b257-79d344ac34f7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_9460bf3f-f0e2-4046-a4bb-cc2f4d44f1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_9460bf3f-f0e2-4046-a4bb-cc2f4d44f1ca" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_dd17eeb8-34fb-4e26-9a5b-69880abd989a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_dd17eeb8-34fb-4e26-9a5b-69880abd989a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_540a145c-df0b-4ee3-8906-bac6a1f652f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_540a145c-df0b-4ee3-8906-bac6a1f652f0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_986514da-cf3e-4ca7-959e-8a1093aa9a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_986514da-cf3e-4ca7-959e-8a1093aa9a39" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_af9da273-56be-4cee-a286-ddad4170bc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_af9da273-56be-4cee-a286-ddad4170bc9b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_19194982-0f9e-42e1-ac4c-90d2dbe4270e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_19194982-0f9e-42e1-ac4c-90d2dbe4270e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_59bd13cd-c30b-43c4-9a0e-4f76e01b5615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_59bd13cd-c30b-43c4-9a0e-4f76e01b5615" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1839797b-c204-45cc-9cda-a16d2c17ee06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_eb40c716-ef38-417c-a0bc-fd0f823342a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_767233ad-06b4-4af0-91a1-fde35358c5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fe82f29d-7a3a-4b3d-9d7c-0b15e1d9b70d" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_767233ad-06b4-4af0-91a1-fde35358c5b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_b266c5f7-f608-47c4-880c-c9054ecab6b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_767233ad-06b4-4af0-91a1-fde35358c5b8" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_b266c5f7-f608-47c4-880c-c9054ecab6b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_b5f392ed-7fb4-43ff-aa1d-5241c2dcd6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_767233ad-06b4-4af0-91a1-fde35358c5b8" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_b5f392ed-7fb4-43ff-aa1d-5241c2dcd6b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_db5c1ff8-03c0-439b-a987-1d114d1483c1" xlink:href="dgx-20230331.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_767233ad-06b4-4af0-91a1-fde35358c5b8" xlink:to="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_db5c1ff8-03c0-439b-a987-1d114d1483c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_96fc9f75-3b95-413c-bb15-1d6defeacceb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6f0939b2-2337-45cc-8a8d-375a1cf739d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_fe82f29d-7a3a-4b3d-9d7c-0b15e1d9b70d" xlink:to="loc_us-gaap_StatementTable_6f0939b2-2337-45cc-8a8d-375a1cf739d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_abdff726-9e12-422a-81bd-609573358839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6f0939b2-2337-45cc-8a8d-375a1cf739d4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_abdff726-9e12-422a-81bd-609573358839" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_abdff726-9e12-422a-81bd-609573358839_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_abdff726-9e12-422a-81bd-609573358839" xlink:to="loc_us-gaap_EquityComponentDomain_abdff726-9e12-422a-81bd-609573358839_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6b9d488b-3ef7-400f-adbd-cf944dda987b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_abdff726-9e12-422a-81bd-609573358839" xlink:to="loc_us-gaap_EquityComponentDomain_6b9d488b-3ef7-400f-adbd-cf944dda987b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_193d99af-14d3-4ff1-be39-9892f80c3149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6b9d488b-3ef7-400f-adbd-cf944dda987b" xlink:to="loc_us-gaap_CommonStockMember_193d99af-14d3-4ff1-be39-9892f80c3149" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_11754c3e-d488-4c9b-b3f5-f1e0e8d89bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6b9d488b-3ef7-400f-adbd-cf944dda987b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_11754c3e-d488-4c9b-b3f5-f1e0e8d89bf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e55694e5-ce8d-42b3-802a-b7f60fdf8eff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6b9d488b-3ef7-400f-adbd-cf944dda987b" xlink:to="loc_us-gaap_RetainedEarningsMember_e55694e5-ce8d-42b3-802a-b7f60fdf8eff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_470b534c-23b4-413e-aa73-d589b6086ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6b9d488b-3ef7-400f-adbd-cf944dda987b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_470b534c-23b4-413e-aa73-d589b6086ef4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_7ff2e9b1-bcc6-44f0-8799-e7a4d95230ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6b9d488b-3ef7-400f-adbd-cf944dda987b" xlink:to="loc_us-gaap_TreasuryStockMember_7ff2e9b1-bcc6-44f0-8799-e7a4d95230ed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_c4032ef1-b3af-4207-ab7c-e4d21778c8da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6b9d488b-3ef7-400f-adbd-cf944dda987b" xlink:to="loc_us-gaap_NoncontrollingInterestMember_c4032ef1-b3af-4207-ab7c-e4d21778c8da" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#RESTRUCTURINGACTIVITIESDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails" xlink:type="extended" id="i6e10594b4eba47b4abecf749a6d4670a_RESTRUCTURINGACTIVITIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_5e7475bc-21ad-41af-984d-2ae282d45321" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_0ec34cb9-f277-47a7-a568-b55fc4d2ebe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5e7475bc-21ad-41af-984d-2ae282d45321" xlink:to="loc_us-gaap_SeveranceCosts1_0ec34cb9-f277-47a7-a568-b55fc4d2ebe5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_34cbd5e3-1650-4bb5-93bc-f9d35f616e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5e7475bc-21ad-41af-984d-2ae282d45321" xlink:to="loc_us-gaap_RestructuringCharges_34cbd5e3-1650-4bb5-93bc-f9d35f616e57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_7b847853-c156-44f4-872c-fae6808efcf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5e7475bc-21ad-41af-984d-2ae282d45321" xlink:to="loc_us-gaap_RestructuringReserve_7b847853-c156-44f4-872c-fae6808efcf0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1bb90b6b-9343-4706-ab52-682bc6e1dfbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5e7475bc-21ad-41af-984d-2ae282d45321" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1bb90b6b-9343-4706-ab52-682bc6e1dfbc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_769a80aa-ddc6-466d-ac40-e7ba10ba80b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1bb90b6b-9343-4706-ab52-682bc6e1dfbc" xlink:to="loc_us-gaap_RestructuringPlanAxis_769a80aa-ddc6-466d-ac40-e7ba10ba80b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_769a80aa-ddc6-466d-ac40-e7ba10ba80b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_769a80aa-ddc6-466d-ac40-e7ba10ba80b7" xlink:to="loc_us-gaap_RestructuringPlanDomain_769a80aa-ddc6-466d-ac40-e7ba10ba80b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_27a54dc1-a246-474c-b478-111b75fdd416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_769a80aa-ddc6-466d-ac40-e7ba10ba80b7" xlink:to="loc_us-gaap_RestructuringPlanDomain_27a54dc1-a246-474c-b478-111b75fdd416" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InvigorateProgramMember_399263b7-28b2-4162-9417-058a278cfa33" xlink:href="dgx-20230331.xsd#dgx_InvigorateProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_27a54dc1-a246-474c-b478-111b75fdd416" xlink:to="loc_dgx_InvigorateProgramMember_399263b7-28b2-4162-9417-058a278cfa33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_2e2d7848-5d07-416a-b14c-38b90911dd44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1bb90b6b-9343-4706-ab52-682bc6e1dfbc" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_2e2d7848-5d07-416a-b14c-38b90911dd44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_2e2d7848-5d07-416a-b14c-38b90911dd44_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_2e2d7848-5d07-416a-b14c-38b90911dd44" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_2e2d7848-5d07-416a-b14c-38b90911dd44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_6cbfd9fc-0c4a-4cae-baf6-88ca555a353e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_2e2d7848-5d07-416a-b14c-38b90911dd44" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_6cbfd9fc-0c4a-4cae-baf6-88ca555a353e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_3704dc19-9860-454b-9c24-469be5d8c406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6cbfd9fc-0c4a-4cae-baf6-88ca555a353e" xlink:to="loc_us-gaap_CostOfSalesMember_3704dc19-9860-454b-9c24-469be5d8c406" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_89bcd27c-b5aa-428a-80a2-bd81ba3203a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6cbfd9fc-0c4a-4cae-baf6-88ca555a353e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_89bcd27c-b5aa-428a-80a2-bd81ba3203a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4ca425da-4ce7-4430-9f6c-d6a6e94264d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1bb90b6b-9343-4706-ab52-682bc6e1dfbc" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4ca425da-4ce7-4430-9f6c-d6a6e94264d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4ca425da-4ce7-4430-9f6c-d6a6e94264d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4ca425da-4ce7-4430-9f6c-d6a6e94264d2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4ca425da-4ce7-4430-9f6c-d6a6e94264d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_33ecf6fd-ed7f-4db2-b1b1-86972a695546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4ca425da-4ce7-4430-9f6c-d6a6e94264d2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_33ecf6fd-ed7f-4db2-b1b1-86972a695546" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_3ad5734c-d668-45a7-93a7-2b4df0a58224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_33ecf6fd-ed7f-4db2-b1b1-86972a695546" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_3ad5734c-d668-45a7-93a7-2b4df0a58224" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended" id="ia965aadd79544aef99fe12d7b127148c_FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0ebae499-5bbe-40e5-b2ae-e748d1260d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_8c84d31e-a02b-49d4-bb1f-fbee2e9ec3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0ebae499-5bbe-40e5-b2ae-e748d1260d6e" xlink:to="loc_us-gaap_TradingSecurities_8c84d31e-a02b-49d4-bb1f-fbee2e9ec3d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_f960f7b6-4750-4123-9849-a08b68e38d40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0ebae499-5bbe-40e5-b2ae-e748d1260d6e" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_f960f7b6-4750-4123-9849-a08b68e38d40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6b18fbde-37c6-457e-91cb-bd047f0a1496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0ebae499-5bbe-40e5-b2ae-e748d1260d6e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6b18fbde-37c6-457e-91cb-bd047f0a1496" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_47c9bcda-0489-4d9e-95b6-92a1d2931060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0ebae499-5bbe-40e5-b2ae-e748d1260d6e" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_47c9bcda-0489-4d9e-95b6-92a1d2931060" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_1503af56-5957-4fd3-9490-89c3562b1df5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0ebae499-5bbe-40e5-b2ae-e748d1260d6e" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_1503af56-5957-4fd3-9490-89c3562b1df5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0b0384cb-d67e-41d4-8f4d-878676b70838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0ebae499-5bbe-40e5-b2ae-e748d1260d6e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0b0384cb-d67e-41d4-8f4d-878676b70838" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_161b76b3-4614-4b5c-a43b-34cca544562f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0ebae499-5bbe-40e5-b2ae-e748d1260d6e" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_161b76b3-4614-4b5c-a43b-34cca544562f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_9c06b10a-c8a4-4b64-9437-f560393acd0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0ebae499-5bbe-40e5-b2ae-e748d1260d6e" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_9c06b10a-c8a4-4b64-9437-f560393acd0a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6ece82c4-d5f5-4e76-ab7b-3e384bb5d4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0ebae499-5bbe-40e5-b2ae-e748d1260d6e" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6ece82c4-d5f5-4e76-ab7b-3e384bb5d4ae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ca39e87-63ba-44fd-b9b5-3cf8711d1ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6ece82c4-d5f5-4e76-ab7b-3e384bb5d4ae" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ca39e87-63ba-44fd-b9b5-3cf8711d1ac8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_2ca39e87-63ba-44fd-b9b5-3cf8711d1ac8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ca39e87-63ba-44fd-b9b5-3cf8711d1ac8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_2ca39e87-63ba-44fd-b9b5-3cf8711d1ac8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8007bafe-188f-4c3f-96cd-e64d812e8610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ca39e87-63ba-44fd-b9b5-3cf8711d1ac8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8007bafe-188f-4c3f-96cd-e64d812e8610" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_2e3c0782-b88b-45ce-8da0-a05f0098b8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_8007bafe-188f-4c3f-96cd-e64d812e8610" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_2e3c0782-b88b-45ce-8da0-a05f0098b8dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3ea646b6-9c51-4f59-92ce-6263f12d02be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6ece82c4-d5f5-4e76-ab7b-3e384bb5d4ae" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3ea646b6-9c51-4f59-92ce-6263f12d02be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3ea646b6-9c51-4f59-92ce-6263f12d02be_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3ea646b6-9c51-4f59-92ce-6263f12d02be" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3ea646b6-9c51-4f59-92ce-6263f12d02be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d83ec78d-86d4-4b10-ae87-adcab5d769a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3ea646b6-9c51-4f59-92ce-6263f12d02be" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d83ec78d-86d4-4b10-ae87-adcab5d769a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_005ed1a9-b839-4686-9f97-28c637e98904" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d83ec78d-86d4-4b10-ae87-adcab5d769a5" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_005ed1a9-b839-4686-9f97-28c637e98904" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_7f4aa6a1-01d6-4922-904b-f4b213c6fd28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d83ec78d-86d4-4b10-ae87-adcab5d769a5" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_7f4aa6a1-01d6-4922-904b-f4b213c6fd28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_534103e3-0b27-4a87-bd61-294a4c13883b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d83ec78d-86d4-4b10-ae87-adcab5d769a5" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_534103e3-0b27-4a87-bd61-294a4c13883b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails" xlink:type="extended" id="id877e9bfbf1747a79c7f71a62f4aaaa6_FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d3066b9f-a1ec-44bf-b12a-d963c9e16b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4eaa3f21-d0ea-41d1-9f86-c0eb102989a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d3066b9f-a1ec-44bf-b12a-d963c9e16b27" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4eaa3f21-d0ea-41d1-9f86-c0eb102989a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_bbc4ac74-b532-4ff4-84fc-31a7df6b6e74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d3066b9f-a1ec-44bf-b12a-d963c9e16b27" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_bbc4ac74-b532-4ff4-84fc-31a7df6b6e74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9f167e47-8be3-4ea8-9cba-0d0640bae28f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ebf18267-2326-45dd-824e-25e63b5bac89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d3066b9f-a1ec-44bf-b12a-d963c9e16b27" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ebf18267-2326-45dd-824e-25e63b5bac89" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3ffdb197-287d-414a-a95d-4f417e538e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ebf18267-2326-45dd-824e-25e63b5bac89" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3ffdb197-287d-414a-a95d-4f417e538e0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3ffdb197-287d-414a-a95d-4f417e538e0a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3ffdb197-287d-414a-a95d-4f417e538e0a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3ffdb197-287d-414a-a95d-4f417e538e0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bbf5a825-808b-4705-ad98-92cfc5bea842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3ffdb197-287d-414a-a95d-4f417e538e0a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bbf5a825-808b-4705-ad98-92cfc5bea842" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1d434ef3-3e5d-4ef5-bb10-d086a8ea2f04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bbf5a825-808b-4705-ad98-92cfc5bea842" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1d434ef3-3e5d-4ef5-bb10-d086a8ea2f04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_5b125728-5edf-4633-a5c2-f6ba538c0961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ebf18267-2326-45dd-824e-25e63b5bac89" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_5b125728-5edf-4633-a5c2-f6ba538c0961" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5b125728-5edf-4633-a5c2-f6ba538c0961_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_5b125728-5edf-4633-a5c2-f6ba538c0961" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_5b125728-5edf-4633-a5c2-f6ba538c0961_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_4edb9f0d-8c9e-40e5-ab7d-b01a39f9ab19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_5b125728-5edf-4633-a5c2-f6ba538c0961" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_4edb9f0d-8c9e-40e5-ab7d-b01a39f9ab19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember_cec7cf5b-8c8a-4c00-801e-2f387b7a122b" xlink:href="dgx-20230331.xsd#dgx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_4edb9f0d-8c9e-40e5-ab7d-b01a39f9ab19" xlink:to="loc_dgx_ContingentConsiderationMember_cec7cf5b-8c8a-4c00-801e-2f387b7a122b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended" id="i482c092ffe624901814d970fcc22f81f_FAIRVALUEMEASUREMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b9648f94-50cd-402c-ae2a-3ee41df0c81c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_265a4b27-2e7b-4635-aece-4d8d6ffd1b68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b9648f94-50cd-402c-ae2a-3ee41df0c81c" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_265a4b27-2e7b-4635-aece-4d8d6ffd1b68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e178780c-8115-4801-93d8-ae57785f8e93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b9648f94-50cd-402c-ae2a-3ee41df0c81c" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e178780c-8115-4801-93d8-ae57785f8e93" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_b4a07714-6083-4e82-b927-7052069d811f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e178780c-8115-4801-93d8-ae57785f8e93" xlink:to="loc_srt_OwnershipAxis_b4a07714-6083-4e82-b927-7052069d811f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_b4a07714-6083-4e82-b927-7052069d811f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_b4a07714-6083-4e82-b927-7052069d811f" xlink:to="loc_srt_OwnershipDomain_b4a07714-6083-4e82-b927-7052069d811f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_75c9b62e-68dd-4b30-8e58-244383a1d8c2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_b4a07714-6083-4e82-b927-7052069d811f" xlink:to="loc_srt_OwnershipDomain_75c9b62e-68dd-4b30-8e58-244383a1d8c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_5aec1694-d193-4792-9a85-15dabf85a948" xlink:href="dgx-20230331.xsd#dgx_UMassJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_75c9b62e-68dd-4b30-8e58-244383a1d8c2" xlink:to="loc_dgx_UMassJointVentureMember_5aec1694-d193-4792-9a85-15dabf85a948" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#DEBTDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/DEBTDetails" xlink:type="extended" id="idc8397a3077e43ac8b905a57faab179e_DEBTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d9c9d5b6-4d1f-4025-9de2-8f66894354cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3ac4db6b-dcce-42c2-9d31-6b8d522f31cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d9c9d5b6-4d1f-4025-9de2-8f66894354cf" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3ac4db6b-dcce-42c2-9d31-6b8d522f31cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d824d5b8-9ed7-4ece-b11e-74483d91db9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d9c9d5b6-4d1f-4025-9de2-8f66894354cf" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d824d5b8-9ed7-4ece-b11e-74483d91db9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_c7bd05b5-e7b9-438e-ac40-1d8b81d58994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d9c9d5b6-4d1f-4025-9de2-8f66894354cf" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_c7bd05b5-e7b9-438e-ac40-1d8b81d58994" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1ed67c9f-302e-426c-9066-a56c2d17876b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d9c9d5b6-4d1f-4025-9de2-8f66894354cf" xlink:to="loc_us-gaap_DebtInstrumentTable_1ed67c9f-302e-426c-9066-a56c2d17876b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_432dca48-dfe8-423a-9c8a-2b7de3dceced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1ed67c9f-302e-426c-9066-a56c2d17876b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_432dca48-dfe8-423a-9c8a-2b7de3dceced" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_432dca48-dfe8-423a-9c8a-2b7de3dceced_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_432dca48-dfe8-423a-9c8a-2b7de3dceced" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_432dca48-dfe8-423a-9c8a-2b7de3dceced_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7d6f90bc-498b-4a94-af98-da3afcad8b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_432dca48-dfe8-423a-9c8a-2b7de3dceced" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7d6f90bc-498b-4a94-af98-da3afcad8b61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_c82bb24b-cdea-42bd-bf40-8ecd7f41cd64" xlink:href="dgx-20230331.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7d6f90bc-498b-4a94-af98-da3afcad8b61" xlink:to="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_c82bb24b-cdea-42bd-bf40-8ecd7f41cd64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_37fd1de7-da2b-4502-95bf-c95b0251a288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1ed67c9f-302e-426c-9066-a56c2d17876b" xlink:to="loc_us-gaap_CreditFacilityAxis_37fd1de7-da2b-4502-95bf-c95b0251a288" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_37fd1de7-da2b-4502-95bf-c95b0251a288_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_37fd1de7-da2b-4502-95bf-c95b0251a288" xlink:to="loc_us-gaap_CreditFacilityDomain_37fd1de7-da2b-4502-95bf-c95b0251a288_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5acccf40-bfcc-411b-a137-3499ae1f647b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_37fd1de7-da2b-4502-95bf-c95b0251a288" xlink:to="loc_us-gaap_CreditFacilityDomain_5acccf40-bfcc-411b-a137-3499ae1f647b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_2bd8ebb7-d952-4dfc-94bd-f6b283b5e6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_5acccf40-bfcc-411b-a137-3499ae1f647b" xlink:to="loc_us-gaap_LetterOfCreditMember_2bd8ebb7-d952-4dfc-94bd-f6b283b5e6d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_57c3af4a-1847-4359-90b8-9857ded9e989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1ed67c9f-302e-426c-9066-a56c2d17876b" xlink:to="loc_us-gaap_VariableRateAxis_57c3af4a-1847-4359-90b8-9857ded9e989" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_57c3af4a-1847-4359-90b8-9857ded9e989_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_57c3af4a-1847-4359-90b8-9857ded9e989" xlink:to="loc_us-gaap_VariableRateDomain_57c3af4a-1847-4359-90b8-9857ded9e989_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e4e435f6-bddc-4efb-86c7-4a7f29b55c92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_57c3af4a-1847-4359-90b8-9857ded9e989" xlink:to="loc_us-gaap_VariableRateDomain_e4e435f6-bddc-4efb-86c7-4a7f29b55c92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_a91362c9-d26a-4461-9b98-28121146e3bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_e4e435f6-bddc-4efb-86c7-4a7f29b55c92" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_a91362c9-d26a-4461-9b98-28121146e3bc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#FINANCIALINSTRUMENTSBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="extended" id="ic9d7d25748ba404caa1a3ca51ee3223f_FINANCIALINSTRUMENTSBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_d3bfed31-6506-40fa-b367-0b15e7f6954e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_68ce7be9-44ee-4a43-91bc-59ef371279f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d3bfed31-6506-40fa-b367-0b15e7f6954e" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_68ce7be9-44ee-4a43-91bc-59ef371279f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_632f9e69-0d74-4062-bee4-dc3ba4d3590e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_d3bfed31-6506-40fa-b367-0b15e7f6954e" xlink:to="loc_us-gaap_DerivativeTable_632f9e69-0d74-4062-bee4-dc3ba4d3590e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2c00e4f2-06a6-4119-b77e-f0188aee9b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_632f9e69-0d74-4062-bee4-dc3ba4d3590e" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2c00e4f2-06a6-4119-b77e-f0188aee9b34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2c00e4f2-06a6-4119-b77e-f0188aee9b34_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2c00e4f2-06a6-4119-b77e-f0188aee9b34" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2c00e4f2-06a6-4119-b77e-f0188aee9b34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4c7e8458-fd38-4470-b539-f14b21e4df44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2c00e4f2-06a6-4119-b77e-f0188aee9b34" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4c7e8458-fd38-4470-b539-f14b21e4df44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_493bb4ea-4ee8-4fb9-a991-6e65599f6296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4c7e8458-fd38-4470-b539-f14b21e4df44" xlink:to="loc_us-gaap_LongTermDebtMember_493bb4ea-4ee8-4fb9-a991-6e65599f6296" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6b7df0db-9885-473e-9294-ec672a05793f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_632f9e69-0d74-4062-bee4-dc3ba4d3590e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6b7df0db-9885-473e-9294-ec672a05793f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6b7df0db-9885-473e-9294-ec672a05793f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6b7df0db-9885-473e-9294-ec672a05793f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6b7df0db-9885-473e-9294-ec672a05793f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d4fee3d6-0a42-4e35-8320-6ab60e9b9c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6b7df0db-9885-473e-9294-ec672a05793f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d4fee3d6-0a42-4e35-8320-6ab60e9b9c5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_b4ee8982-2ae4-493a-bab1-6d6cabf057af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d4fee3d6-0a42-4e35-8320-6ab60e9b9c5d" xlink:to="loc_us-gaap_FairValueHedgingMember_b4ee8982-2ae4-493a-bab1-6d6cabf057af" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="extended" id="i883f6d4e984c4cf2aebff5247f1f2d43_STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_d9fe64ba-0171-4427-9df9-1dd628536744" xlink:href="dgx-20230331.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_8f775c37-26e0-4a77-958e-554d6b56ef88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_d9fe64ba-0171-4427-9df9-1dd628536744" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_8f775c37-26e0-4a77-958e-554d6b56ef88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_bf5ca2d2-a6ec-4a69-a84c-fe703a726625" xlink:href="dgx-20230331.xsd#dgx_StockRepurchaseProgramAdditionalAmountAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_d9fe64ba-0171-4427-9df9-1dd628536744" xlink:to="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_bf5ca2d2-a6ec-4a69-a84c-fe703a726625" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_dec20b55-b3b3-4f35-82b7-5b7140b60a84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_d9fe64ba-0171-4427-9df9-1dd628536744" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_dec20b55-b3b3-4f35-82b7-5b7140b60a84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_80396f3f-dd98-4581-8da1-5c1ed817af9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_d9fe64ba-0171-4427-9df9-1dd628536744" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_80396f3f-dd98-4581-8da1-5c1ed817af9f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_86658e5a-9747-4891-b0ec-199770047bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_d9fe64ba-0171-4427-9df9-1dd628536744" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_86658e5a-9747-4891-b0ec-199770047bf1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_ac72f4fc-3a25-4979-b8fe-d0ef0bc472dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_d9fe64ba-0171-4427-9df9-1dd628536744" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_ac72f4fc-3a25-4979-b8fe-d0ef0bc472dd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_c078d0f6-ed21-4ed5-ad4c-7ba717db0d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_d9fe64ba-0171-4427-9df9-1dd628536744" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_c078d0f6-ed21-4ed5-ad4c-7ba717db0d46" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_989f5f46-623f-4c45-9738-c75ad9023279" xlink:href="dgx-20230331.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_d9fe64ba-0171-4427-9df9-1dd628536744" xlink:to="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_989f5f46-623f-4c45-9738-c75ad9023279" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_09329139-9e70-4474-ae8a-d361c5ae42df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_989f5f46-623f-4c45-9738-c75ad9023279" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_09329139-9e70-4474-ae8a-d361c5ae42df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_09329139-9e70-4474-ae8a-d361c5ae42df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_09329139-9e70-4474-ae8a-d361c5ae42df" xlink:to="loc_us-gaap_EquityComponentDomain_09329139-9e70-4474-ae8a-d361c5ae42df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a7d645cc-9e2b-418d-bf95-ef578f6c932a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_09329139-9e70-4474-ae8a-d361c5ae42df" xlink:to="loc_us-gaap_EquityComponentDomain_a7d645cc-9e2b-418d-bf95-ef578f6c932a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_fb366ccb-b5a4-4169-85af-6fb6bb0361df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a7d645cc-9e2b-418d-bf95-ef578f6c932a" xlink:to="loc_us-gaap_TreasuryStockMember_fb366ccb-b5a4-4169-85af-6fb6bb0361df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_4c980fe1-f746-489c-877e-0fad4fcda2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a7d645cc-9e2b-418d-bf95-ef578f6c932a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_4c980fe1-f746-489c-877e-0fad4fcda2f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_552efd7a-981c-47ec-9574-dc1ab0aa78db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_989f5f46-623f-4c45-9738-c75ad9023279" xlink:to="loc_srt_OwnershipAxis_552efd7a-981c-47ec-9574-dc1ab0aa78db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_552efd7a-981c-47ec-9574-dc1ab0aa78db_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_552efd7a-981c-47ec-9574-dc1ab0aa78db" xlink:to="loc_srt_OwnershipDomain_552efd7a-981c-47ec-9574-dc1ab0aa78db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_f78a281d-1b95-41e1-b6e3-9ecaed14189b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_552efd7a-981c-47ec-9574-dc1ab0aa78db" xlink:to="loc_srt_OwnershipDomain_f78a281d-1b95-41e1-b6e3-9ecaed14189b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_3bb96c89-3d57-44fa-9104-5871eaffb352" xlink:href="dgx-20230331.xsd#dgx_UMassJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_f78a281d-1b95-41e1-b6e3-9ecaed14189b" xlink:to="loc_dgx_UMassJointVentureMember_3bb96c89-3d57-44fa-9104-5871eaffb352" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended" id="if8c8d506e31d4625a26bdd7300b70cdd_COMMITMENTSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_b4c3e01e-3f4e-412d-828f-03cb3b4fee13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_7e2297aa-c59e-484d-a726-c296df1fcea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b4c3e01e-3f4e-412d-828f-03cb3b4fee13" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_7e2297aa-c59e-484d-a726-c296df1fcea3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_cd8cb3b4-49ba-41f7-9e5c-e51c73cb5e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b4c3e01e-3f4e-412d-828f-03cb3b4fee13" xlink:to="loc_us-gaap_LitigationReserve_cd8cb3b4-49ba-41f7-9e5c-e51c73cb5e2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_86de4baa-a86c-4bfb-ada3-f62eb1e2ee8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_b4c3e01e-3f4e-412d-828f-03cb3b4fee13" xlink:to="loc_us-gaap_LossContingenciesTable_86de4baa-a86c-4bfb-ada3-f62eb1e2ee8c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_158fba02-2141-4545-8cde-72f10cf531da" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_86de4baa-a86c-4bfb-ada3-f62eb1e2ee8c" xlink:to="loc_srt_LitigationCaseAxis_158fba02-2141-4545-8cde-72f10cf531da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_158fba02-2141-4545-8cde-72f10cf531da_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_158fba02-2141-4545-8cde-72f10cf531da" xlink:to="loc_srt_LitigationCaseTypeDomain_158fba02-2141-4545-8cde-72f10cf531da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_44577e08-2fc3-4687-a5c0-73bec8a46ae5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_158fba02-2141-4545-8cde-72f10cf531da" xlink:to="loc_srt_LitigationCaseTypeDomain_44577e08-2fc3-4687-a5c0-73bec8a46ae5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_A401kPlanLawsuitMember_420d1c19-04f3-4246-b7dc-cc79c9b0d5e2" xlink:href="dgx-20230331.xsd#dgx_A401kPlanLawsuitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_44577e08-2fc3-4687-a5c0-73bec8a46ae5" xlink:to="loc_dgx_A401kPlanLawsuitMember_420d1c19-04f3-4246-b7dc-cc79c9b0d5e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DataSecurityIncidentMember_859f9357-1203-4149-95ed-5c26a8741ef8" xlink:href="dgx-20230331.xsd#dgx_DataSecurityIncidentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_44577e08-2fc3-4687-a5c0-73bec8a46ae5" xlink:to="loc_dgx_DataSecurityIncidentMember_859f9357-1203-4149-95ed-5c26a8741ef8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_b275babf-7f6c-45d1-824a-77a4e7ef34f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_86de4baa-a86c-4bfb-ada3-f62eb1e2ee8c" xlink:to="loc_us-gaap_LitigationStatusAxis_b275babf-7f6c-45d1-824a-77a4e7ef34f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_b275babf-7f6c-45d1-824a-77a4e7ef34f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_b275babf-7f6c-45d1-824a-77a4e7ef34f7" xlink:to="loc_us-gaap_LitigationStatusDomain_b275babf-7f6c-45d1-824a-77a4e7ef34f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_a594891b-f4d4-468c-a92b-de18fba02081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_b275babf-7f6c-45d1-824a-77a4e7ef34f7" xlink:to="loc_us-gaap_LitigationStatusDomain_a594891b-f4d4-468c-a92b-de18fba02081" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_4d351fe0-10e5-4a20-b6ff-7cb3867cd23a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_a594891b-f4d4-468c-a92b-de18fba02081" xlink:to="loc_us-gaap_PendingLitigationMember_4d351fe0-10e5-4a20-b6ff-7cb3867cd23a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_431afdd9-acca-4cb0-b53f-6ca0a10f8a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_86de4baa-a86c-4bfb-ada3-f62eb1e2ee8c" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_431afdd9-acca-4cb0-b53f-6ca0a10f8a99" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_431afdd9-acca-4cb0-b53f-6ca0a10f8a99_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_431afdd9-acca-4cb0-b53f-6ca0a10f8a99" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_431afdd9-acca-4cb0-b53f-6ca0a10f8a99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_81463f33-9de6-48d7-aa55-897f16f59552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_431afdd9-acca-4cb0-b53f-6ca0a10f8a99" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_81463f33-9de6-48d7-aa55-897f16f59552" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_8b45ee90-bd38-4d62-b45a-8ace1705fd33" xlink:href="dgx-20230331.xsd#dgx_ExcludesgeneralandprofessionalliabilityclaimsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_81463f33-9de6-48d7-aa55-897f16f59552" xlink:to="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_8b45ee90-bd38-4d62-b45a-8ace1705fd33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4a3bdbae-e722-4812-9b9d-f8f8b7db49d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_837350c5-aa0f-4e3c-91b5-bcab19c89682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4a3bdbae-e722-4812-9b9d-f8f8b7db49d5" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_837350c5-aa0f-4e3c-91b5-bcab19c89682" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_a032dc16-73f8-4a5b-aa2b-080a2c55beb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4a3bdbae-e722-4812-9b9d-f8f8b7db49d5" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_a032dc16-73f8-4a5b-aa2b-080a2c55beb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d35f8a0e-d279-4b0d-a7b2-1ded3f0eaf10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4a3bdbae-e722-4812-9b9d-f8f8b7db49d5" xlink:to="loc_us-gaap_DebtInstrumentTable_d35f8a0e-d279-4b0d-a7b2-1ded3f0eaf10" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f2bc86c6-d8db-477d-885a-ae3203cf2cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d35f8a0e-d279-4b0d-a7b2-1ded3f0eaf10" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f2bc86c6-d8db-477d-885a-ae3203cf2cb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f2bc86c6-d8db-477d-885a-ae3203cf2cb9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f2bc86c6-d8db-477d-885a-ae3203cf2cb9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f2bc86c6-d8db-477d-885a-ae3203cf2cb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ef316e56-3f28-4ade-a1d0-2b2c7cf51035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f2bc86c6-d8db-477d-885a-ae3203cf2cb9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ef316e56-3f28-4ade-a1d0-2b2c7cf51035" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_70319fc2-941b-4b66-9083-0f4bb4e123b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ef316e56-3f28-4ade-a1d0-2b2c7cf51035" xlink:to="loc_us-gaap_SecuredDebtMember_70319fc2-941b-4b66-9083-0f4bb4e123b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_051d1152-0e5c-4eb0-b7c0-c3b2a4220d00" xlink:href="dgx-20230331.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ef316e56-3f28-4ade-a1d0-2b2c7cf51035" xlink:to="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_051d1152-0e5c-4eb0-b7c0-c3b2a4220d00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ccafa66a-90b5-4653-8437-5b116b3f5d07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d35f8a0e-d279-4b0d-a7b2-1ded3f0eaf10" xlink:to="loc_us-gaap_CreditFacilityAxis_ccafa66a-90b5-4653-8437-5b116b3f5d07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ccafa66a-90b5-4653-8437-5b116b3f5d07_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_ccafa66a-90b5-4653-8437-5b116b3f5d07" xlink:to="loc_us-gaap_CreditFacilityDomain_ccafa66a-90b5-4653-8437-5b116b3f5d07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_89b99149-4c95-4f64-9a93-e60500805adf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_ccafa66a-90b5-4653-8437-5b116b3f5d07" xlink:to="loc_us-gaap_CreditFacilityDomain_89b99149-4c95-4f64-9a93-e60500805adf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_a3ee1c4f-0b1a-4d01-9a95-ae1cb56a8d45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_89b99149-4c95-4f64-9a93-e60500805adf" xlink:to="loc_us-gaap_LetterOfCreditMember_a3ee1c4f-0b1a-4d01-9a95-ae1cb56a8d45" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#BUSINESSSEGMENTINFORMATIONDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="extended" id="i0cb7dd6eacda47ccbaa33238f350c077_BUSINESSSEGMENTINFORMATIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_b6f3525c-90df-42b1-a18a-51af3f4dd60b" xlink:href="dgx-20230331.xsd#dgx_PercentageofNetRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_dgx_PercentageofNetRevenues_b6f3525c-90df-42b1-a18a-51af3f4dd60b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_61610d3d-c53a-4362-bc33-2675796f9d69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_61610d3d-c53a-4362-bc33-2675796f9d69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a4c25ac9-0661-4e0b-befe-55a03efdfc9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_us-gaap_OperatingIncomeLoss_a4c25ac9-0661-4e0b-befe-55a03efdfc9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_c073478e-8335-4d04-a912-4ab1f84179c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_c073478e-8335-4d04-a912-4ab1f84179c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_528fb24e-170b-4b3d-b75a-89ad522a703b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_528fb24e-170b-4b3d-b75a-89ad522a703b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b4301dbf-5297-4f19-b177-e4fff04b0e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b4301dbf-5297-4f19-b177-e4fff04b0e2e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_310749fd-ec86-49d0-90e8-be16dc48ae55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_310749fd-ec86-49d0-90e8-be16dc48ae55" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_72e26db6-439d-46c1-816d-df7675d29e28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_us-gaap_ProfitLoss_72e26db6-439d-46c1-816d-df7675d29e28" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_73bcb026-8e4b-4c93-b19b-baa29f42a71f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_73bcb026-8e4b-4c93-b19b-baa29f42a71f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_17b4ea49-3bd8-4c41-9e44-6ae29942a2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_us-gaap_NetIncomeLoss_17b4ea49-3bd8-4c41-9e44-6ae29942a2a2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent_9dd60866-9ffe-4444-b175-1eb04768b433" xlink:href="dgx-20230331.xsd#dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent_9dd60866-9ffe-4444-b175-1eb04768b433" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_df114624-3029-422f-80dc-e444c8bf7eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_df114624-3029-422f-80dc-e444c8bf7eb3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4c3801c7-00ed-433d-9392-b596125bc561" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_df114624-3029-422f-80dc-e444c8bf7eb3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4c3801c7-00ed-433d-9392-b596125bc561" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4c3801c7-00ed-433d-9392-b596125bc561_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4c3801c7-00ed-433d-9392-b596125bc561" xlink:to="loc_us-gaap_SegmentDomain_4c3801c7-00ed-433d-9392-b596125bc561_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_eac580f4-09b3-4533-b675-481d165b5330" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4c3801c7-00ed-433d-9392-b596125bc561" xlink:to="loc_us-gaap_SegmentDomain_eac580f4-09b3-4533-b675-481d165b5330" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_8ab0c18e-8717-4713-bd4e-38997bcb10a3" xlink:href="dgx-20230331.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_eac580f4-09b3-4533-b675-481d165b5330" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_8ab0c18e-8717-4713-bd4e-38997bcb10a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_755a3d35-5aa2-4745-850c-6dc2ad840608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_eac580f4-09b3-4533-b675-481d165b5330" xlink:to="loc_us-gaap_AllOtherSegmentsMember_755a3d35-5aa2-4745-850c-6dc2ad840608" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_48a4a317-7613-4c42-8ad4-f29d9aa29c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_eac580f4-09b3-4533-b675-481d165b5330" xlink:to="loc_us-gaap_CorporateMember_48a4a317-7613-4c42-8ad4-f29d9aa29c0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4e4891fa-4d7f-4fc8-8eb1-70b52485fae2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_df114624-3029-422f-80dc-e444c8bf7eb3" xlink:to="loc_srt_RangeAxis_4e4891fa-4d7f-4fc8-8eb1-70b52485fae2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4e4891fa-4d7f-4fc8-8eb1-70b52485fae2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4e4891fa-4d7f-4fc8-8eb1-70b52485fae2" xlink:to="loc_srt_RangeMember_4e4891fa-4d7f-4fc8-8eb1-70b52485fae2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_af80d2fe-938a-4d1d-bb93-387fd77fa8ad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4e4891fa-4d7f-4fc8-8eb1-70b52485fae2" xlink:to="loc_srt_RangeMember_af80d2fe-938a-4d1d-bb93-387fd77fa8ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5f587754-ffec-46c9-9ecc-40bbdb05f632" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_af80d2fe-938a-4d1d-bb93-387fd77fa8ad" xlink:to="loc_srt_MinimumMember_5f587754-ffec-46c9-9ecc-40bbdb05f632" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6e09e11e-99a5-4dc5-b3aa-197f8210231e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_df114624-3029-422f-80dc-e444c8bf7eb3" xlink:to="loc_srt_ProductOrServiceAxis_6e09e11e-99a5-4dc5-b3aa-197f8210231e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6e09e11e-99a5-4dc5-b3aa-197f8210231e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_6e09e11e-99a5-4dc5-b3aa-197f8210231e" xlink:to="loc_srt_ProductsAndServicesDomain_6e09e11e-99a5-4dc5-b3aa-197f8210231e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e8451989-605d-4b74-a7e2-987b279927ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_6e09e11e-99a5-4dc5-b3aa-197f8210231e" xlink:to="loc_srt_ProductsAndServicesDomain_e8451989-605d-4b74-a7e2-987b279927ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineclinicaltestingservicesMember_06ec9fc2-cd3a-4737-9719-283bf1ae0823" xlink:href="dgx-20230331.xsd#dgx_RoutineclinicaltestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e8451989-605d-4b74-a7e2-987b279927ce" xlink:to="loc_dgx_RoutineclinicaltestingservicesMember_06ec9fc2-cd3a-4737-9719-283bf1ae0823" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember_043b6c26-42a2-41f9-bfa1-73177c54890a" xlink:href="dgx-20230331.xsd#dgx_COVID19TestingServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e8451989-605d-4b74-a7e2-987b279927ce" xlink:to="loc_dgx_COVID19TestingServicesMember_043b6c26-42a2-41f9-bfa1-73177c54890a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember_9686b11c-1f0d-4e4e-909b-7333378ffe86" xlink:href="dgx-20230331.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e8451989-605d-4b74-a7e2-987b279927ce" xlink:to="loc_dgx_GenebasedandesoterictestingservicesMember_9686b11c-1f0d-4e4e-909b-7333378ffe86" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember_fed813df-e440-4a24-a8d7-4f7374f685df" xlink:href="dgx-20230331.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e8451989-605d-4b74-a7e2-987b279927ce" xlink:to="loc_dgx_AnatomicpathologytestingservicesMember_fed813df-e440-4a24-a8d7-4f7374f685df" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember_40ca708c-a12c-4ce6-b762-938307a518fa" xlink:href="dgx-20230331.xsd#dgx_AllotherservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e8451989-605d-4b74-a7e2-987b279927ce" xlink:to="loc_dgx_AllotherservicesMember_40ca708c-a12c-4ce6-b762-938307a518fa" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#REVENUERECOGNITIONDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="extended" id="iee5d13a40eb54c71969dfdfb9f036c83_REVENUERECOGNITIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_b8341d51-4569-42de-8eb5-72ffb0f74966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_98c6265d-4db6-403e-bb82-ca5b5be0ce78" xlink:href="dgx-20230331.xsd#dgx_PercentageofNetRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b8341d51-4569-42de-8eb5-72ffb0f74966" xlink:to="loc_dgx_PercentageofNetRevenues_98c6265d-4db6-403e-bb82-ca5b5be0ce78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable_e1e98f12-2862-4d6d-afc7-3bf549738f7c" xlink:href="dgx-20230331.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b8341d51-4569-42de-8eb5-72ffb0f74966" xlink:to="loc_dgx_PercentageofNetAccountsReceivable_e1e98f12-2862-4d6d-afc7-3bf549738f7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3e67ee-2c0d-4433-bef6-c6aa5755226a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b8341d51-4569-42de-8eb5-72ffb0f74966" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3e67ee-2c0d-4433-bef6-c6aa5755226a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c0fd0634-5186-49de-91eb-34cdfa0e0a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3e67ee-2c0d-4433-bef6-c6aa5755226a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c0fd0634-5186-49de-91eb-34cdfa0e0a07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c0fd0634-5186-49de-91eb-34cdfa0e0a07_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c0fd0634-5186-49de-91eb-34cdfa0e0a07" xlink:to="loc_us-gaap_SegmentDomain_c0fd0634-5186-49de-91eb-34cdfa0e0a07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2b10d222-dc60-4bee-b4d7-96d1f190f3a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c0fd0634-5186-49de-91eb-34cdfa0e0a07" xlink:to="loc_us-gaap_SegmentDomain_2b10d222-dc60-4bee-b4d7-96d1f190f3a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_33beabc6-6d4a-4337-8b78-feb7f325d3b4" xlink:href="dgx-20230331.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2b10d222-dc60-4bee-b4d7-96d1f190f3a1" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_33beabc6-6d4a-4337-8b78-feb7f325d3b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_2ba77399-e3d3-4fe6-b484-c2c8024315a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2b10d222-dc60-4bee-b4d7-96d1f190f3a1" xlink:to="loc_us-gaap_AllOtherSegmentsMember_2ba77399-e3d3-4fe6-b484-c2c8024315a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c18fa311-3ff7-4eb6-9f37-d37a5977480b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3e67ee-2c0d-4433-bef6-c6aa5755226a" xlink:to="loc_srt_RangeAxis_c18fa311-3ff7-4eb6-9f37-d37a5977480b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c18fa311-3ff7-4eb6-9f37-d37a5977480b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c18fa311-3ff7-4eb6-9f37-d37a5977480b" xlink:to="loc_srt_RangeMember_c18fa311-3ff7-4eb6-9f37-d37a5977480b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_58c542ab-11ee-4d22-a70e-4608f034ca4c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c18fa311-3ff7-4eb6-9f37-d37a5977480b" xlink:to="loc_srt_RangeMember_58c542ab-11ee-4d22-a70e-4608f034ca4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b5d51472-30a7-4205-865d-3116e2aae917" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_58c542ab-11ee-4d22-a70e-4608f034ca4c" xlink:to="loc_srt_MinimumMember_b5d51472-30a7-4205-865d-3116e2aae917" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_e129f53f-741d-42ee-8a5c-0431b0ef1132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3e67ee-2c0d-4433-bef6-c6aa5755226a" xlink:to="loc_us-gaap_SubsegmentsAxis_e129f53f-741d-42ee-8a5c-0431b0ef1132" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_e129f53f-741d-42ee-8a5c-0431b0ef1132_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_e129f53f-741d-42ee-8a5c-0431b0ef1132" xlink:to="loc_us-gaap_SubsegmentsDomain_e129f53f-741d-42ee-8a5c-0431b0ef1132_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_9a864a0a-3c02-42b2-a56d-aa6359967150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_e129f53f-741d-42ee-8a5c-0431b0ef1132" xlink:to="loc_us-gaap_SubsegmentsDomain_9a864a0a-3c02-42b2-a56d-aa6359967150" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember_5d5eb2d3-5fe1-4e5d-8bf3-d7aeb269eafa" xlink:href="dgx-20230331.xsd#dgx_HealthcareInsurersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_9a864a0a-3c02-42b2-a56d-aa6359967150" xlink:to="loc_dgx_HealthcareInsurersMember_5d5eb2d3-5fe1-4e5d-8bf3-d7aeb269eafa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember_e55703ff-d821-4b26-bf3a-32aef70ddd35" xlink:href="dgx-20230331.xsd#dgx_GovernmentPayersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_9a864a0a-3c02-42b2-a56d-aa6359967150" xlink:to="loc_dgx_GovernmentPayersMember_e55703ff-d821-4b26-bf3a-32aef70ddd35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember_48669922-08ba-41f7-aabd-49df854b7cff" xlink:href="dgx-20230331.xsd#dgx_ClientPayersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_9a864a0a-3c02-42b2-a56d-aa6359967150" xlink:to="loc_dgx_ClientPayersMember_48669922-08ba-41f7-aabd-49df854b7cff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientsMember_73ed4e4e-1ec4-4851-883d-edd8d1ea4fd9" xlink:href="dgx-20230331.xsd#dgx_PatientsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_9a864a0a-3c02-42b2-a56d-aa6359967150" xlink:to="loc_dgx_PatientsMember_73ed4e4e-1ec4-4851-883d-edd8d1ea4fd9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember_f6b2ab55-ad46-47e4-b1c4-5ff8c9dd0b1c" xlink:href="dgx-20230331.xsd#dgx_DSBusinessesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_9a864a0a-3c02-42b2-a56d-aa6359967150" xlink:to="loc_dgx_DSBusinessesMember_f6b2ab55-ad46-47e4-b1c4-5ff8c9dd0b1c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a423dd34-e44d-4508-80a1-6556b0e6153d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3e67ee-2c0d-4433-bef6-c6aa5755226a" xlink:to="loc_srt_ProductOrServiceAxis_a423dd34-e44d-4508-80a1-6556b0e6153d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a423dd34-e44d-4508-80a1-6556b0e6153d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a423dd34-e44d-4508-80a1-6556b0e6153d" xlink:to="loc_srt_ProductsAndServicesDomain_a423dd34-e44d-4508-80a1-6556b0e6153d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_db4de0db-2c62-4e6f-8aeb-58ae2e9e5d91" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a423dd34-e44d-4508-80a1-6556b0e6153d" xlink:to="loc_srt_ProductsAndServicesDomain_db4de0db-2c62-4e6f-8aeb-58ae2e9e5d91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember_86ced873-6576-4557-a235-0c2f8a7f0648" xlink:href="dgx-20230331.xsd#dgx_FeeforserviceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_db4de0db-2c62-4e6f-8aeb-58ae2e9e5d91" xlink:to="loc_dgx_FeeforserviceMember_86ced873-6576-4557-a235-0c2f8a7f0648" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember_69f70e5b-eab6-4fe7-89ab-d9e6f6079d32" xlink:href="dgx-20230331.xsd#dgx_CapitatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_db4de0db-2c62-4e6f-8aeb-58ae2e9e5d91" xlink:to="loc_dgx_CapitatedMember_69f70e5b-eab6-4fe7-89ab-d9e6f6079d32" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended" id="i278f634d377c4462bc4353bedd93b9b0_SUBSEQUENTEVENTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_28913511-c426-49c5-90a3-143fe9c0119c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_6ececf3c-5591-4d9c-b4dd-b6efa8440148" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_28913511-c426-49c5-90a3-143fe9c0119c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_6ececf3c-5591-4d9c-b4dd-b6efa8440148" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_911ee487-e2d5-440e-8f41-7aaa16608d02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_28913511-c426-49c5-90a3-143fe9c0119c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_911ee487-e2d5-440e-8f41-7aaa16608d02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_6e4035bc-4339-4914-b4df-b94fd9b35e92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_28913511-c426-49c5-90a3-143fe9c0119c" xlink:to="loc_us-gaap_SubsequentEventTable_6e4035bc-4339-4914-b4df-b94fd9b35e92" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_77d2e6fd-9883-4c34-8077-94788fe22788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_6e4035bc-4339-4914-b4df-b94fd9b35e92" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_77d2e6fd-9883-4c34-8077-94788fe22788" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_77d2e6fd-9883-4c34-8077-94788fe22788_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_77d2e6fd-9883-4c34-8077-94788fe22788" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_77d2e6fd-9883-4c34-8077-94788fe22788_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c5efbc1d-a903-4b34-a9de-3a4e4efd98a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_77d2e6fd-9883-4c34-8077-94788fe22788" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c5efbc1d-a903-4b34-a9de-3a4e4efd98a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_3d13bad7-7c21-4519-bda9-cdbf69565dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c5efbc1d-a903-4b34-a9de-3a4e4efd98a4" xlink:to="loc_us-gaap_SubsequentEventMember_3d13bad7-7c21-4519-bda9-cdbf69565dd6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6928b7a4-ec32-4379-9be2-6f8e8f04cc2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_6e4035bc-4339-4914-b4df-b94fd9b35e92" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6928b7a4-ec32-4379-9be2-6f8e8f04cc2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6928b7a4-ec32-4379-9be2-6f8e8f04cc2b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6928b7a4-ec32-4379-9be2-6f8e8f04cc2b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6928b7a4-ec32-4379-9be2-6f8e8f04cc2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a29c171-4497-4660-b657-34e818681377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6928b7a4-ec32-4379-9be2-6f8e8f04cc2b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a29c171-4497-4660-b657-34e818681377" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NewYorkPresbyterianMember_fa0f7793-4558-4be5-9dd6-766deab555f6" xlink:href="dgx-20230331.xsd#dgx_NewYorkPresbyterianMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a29c171-4497-4660-b657-34e818681377" xlink:to="loc_dgx_NewYorkPresbyterianMember_fa0f7793-4558-4be5-9dd6-766deab555f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HaystackOncologyIncMember_db6b7bb1-4854-4396-a8e3-39906c33fa0d" xlink:href="dgx-20230331.xsd#dgx_HaystackOncologyIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a29c171-4497-4660-b657-34e818681377" xlink:to="loc_dgx_HaystackOncologyIncMember_db6b7bb1-4854-4396-a8e3-39906c33fa0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_191669da-866b-4e6e-b958-2ea197bed018" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_6e4035bc-4339-4914-b4df-b94fd9b35e92" xlink:to="loc_srt_StatementScenarioAxis_191669da-866b-4e6e-b958-2ea197bed018" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_191669da-866b-4e6e-b958-2ea197bed018_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_191669da-866b-4e6e-b958-2ea197bed018" xlink:to="loc_srt_ScenarioUnspecifiedDomain_191669da-866b-4e6e-b958-2ea197bed018_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_515a044d-095f-4b70-8888-b6053ec1bb95" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_191669da-866b-4e6e-b958-2ea197bed018" xlink:to="loc_srt_ScenarioUnspecifiedDomain_515a044d-095f-4b70-8888-b6053ec1bb95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScenarioPlanMember_d05e4449-dd00-4b29-9e45-c1d3faf7733f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScenarioPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_515a044d-095f-4b70-8888-b6053ec1bb95" xlink:to="loc_us-gaap_ScenarioPlanMember_d05e4449-dd00-4b29-9e45-c1d3faf7733f" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>dgx-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:6a67f40b-d353-490b-97be-70efe774e456,g:809066a9-06e1-46b8-9b20-d9684581a006-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_TreasuryStockShares_0a504d83-283f-48c7-b31d-9340bc590798_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_f5e0d31b-bb0f-4113-945c-9138ff83584a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_a26fc5a3-401d-4a98-8827-cb1ba5bf775c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac4da488-5c37-42bd-88c8-df57f2426ce4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_07730d3d-8d7f-49ab-bc6f-65adf473f01c_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_c66a1be4-e488-4d81-bc19-67c8db9a5f33_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_df6644ac-b63d-4b48-88c7-8c2fe48ebaba_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class action lawsuits</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_6ab27920-e723-4a1a-8376-32006052fa78_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_76e9e721-a9d9-49e5-bc79-913ea47f6937_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_0b711601-6ef1-42b2-ab0f-4f3a914c4cc5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_6dc66441-4021-40e9-86dd-5476e5e19875_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_d43a766f-dbdf-4726-9331-eb0fd11f4ef0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_4a592b1b-c0a9-4ff2-af5e-7f83a44a072c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_a0067e96-8967-4180-a75a-864d5d5cd355_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_53a7af55-7961-4a84-8f12-0d8a3602887a_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_10c1aeb9-d9cc-4a41-a811-f64746ff83bc_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecurities_0d89e17f-6d61-4961-a07a-89d92acd3c07_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation trading securities</link:label>
    <link:label id="lab_us-gaap_TradingSecurities_label_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecurities" xlink:to="lab_us-gaap_TradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_RoutineclinicaltestingservicesMember_79436113-1d62-466a-aed6-4b70f947c5cc_terseLabel_en-US" xlink:label="lab_dgx_RoutineclinicaltestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing services</link:label>
    <link:label id="lab_dgx_RoutineclinicaltestingservicesMember_label_en-US" xlink:label="lab_dgx_RoutineclinicaltestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing services [Member]</link:label>
    <link:label id="lab_dgx_RoutineclinicaltestingservicesMember_documentation_en-US" xlink:label="lab_dgx_RoutineclinicaltestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineclinicaltestingservicesMember" xlink:href="dgx-20230331.xsd#dgx_RoutineclinicaltestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_RoutineclinicaltestingservicesMember" xlink:to="lab_dgx_RoutineclinicaltestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_4186ac99-c314-4727-aeb7-280eeead9d56_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fe85e141-9098-48b7-9142-59c0bc7ecece_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in Shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9adc7b7d-29f6-42dd-960f-20d169630fb2_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_d753c356-b3c8-4d8a-82c4-cf3941b9d64f_terseLabel_en-US" xlink:label="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excludes general and professional liability claims</link:label>
    <link:label id="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_label_en-US" xlink:label="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excludes general and professional liability claims [Member]</link:label>
    <link:label id="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_documentation_en-US" xlink:label="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excludes general and professional liability claims [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:href="dgx-20230331.xsd#dgx_ExcludesgeneralandprofessionalliabilityclaimsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:to="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_24a38ae7-74b2-4b31-b016-f6e4b77fe1fb_terseLabel_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services</link:label>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_label_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services [Member]</link:label>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_documentation_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember" xlink:href="dgx-20230331.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_GenebasedandesoterictestingservicesMember" xlink:to="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_312dd906-19d3-4c23-b598-0c1c18067a8c_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other operating segments</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_650c0408-c547-42fe-a664-5fb6347fe05a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of liabilities assumed</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAssumed1" xlink:to="lab_us-gaap_LiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_8a2a08cf-74b0-4cbb-afbe-381a2fa405e7_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_4a79731f-1b8c-4755-8ec8-1cde47b76ae2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0cd47dd5-1c4b-474f-b03c-9ca9c3205893_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_170f1457-da6d-44e6-b088-c8f917fd8a68_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_e0082d62-b0b3-420e-97d0-acb9b29dcfcc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_dd01fcb6-4c8c-4fd7-8275-4ad9b2d0c525_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_4a3a7807-50d0-413c-88b6-85b93b8cc519_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_a50e3092-9aa1-4c65-b1cf-0a2ccab0be47_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.01 per share; 600 shares authorized as of both March&#160;31, 2023 and December&#160;31, 2022; 162 shares issued as of both March&#160;31, 2023 and December&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_09bf20cd-fe0d-469b-963d-4b8e7ddf47bd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d09fc438-d8cd-469a-8637-9137a27ea92e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6c76c26f-ec5f-4ffa-b03c-e6229bb255ba_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in investments and other assets</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_93d4a64e-ce2a-407f-845d-b7537880ed48_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_f5c3a6a4-5d04-4575-bbfc-b3add95cb160_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expense, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_c0c459c4-9d4d-4e3d-9018-d124dadb45a5_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_5856563b-54f7-4b44-9c8b-f5f9e8e87fd8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_UMassJointVentureMember_4cb0a1f6-27a5-4e2b-985c-2d79cd921630_terseLabel_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture</link:label>
    <link:label id="lab_dgx_UMassJointVentureMember_label_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture [Member]</link:label>
    <link:label id="lab_dgx_UMassJointVentureMember_documentation_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember" xlink:href="dgx-20230331.xsd#dgx_UMassJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_UMassJointVentureMember" xlink:to="lab_dgx_UMassJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_36ce7c4b-e0af-48e3-8c1b-513d5da7f7c5_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit for credit losses</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:to="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_bc5483fe-3fc8-4904-b944-5154f6571aa5_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_147f46d0-cc18-4e13-976a-773943923245_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7a76d939-9f8f-4ae2-b6d7-e097308a0fc3_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5ce22296-a3c4-444b-9256-37279d0765b2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_4cb20a1f-28bf-4757-bc8d-1e22be5ba2c4_terseLabel_en-US" xlink:label="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Excluding Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:href="dgx-20230331.xsd#dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:to="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_5c4c2440-aa32-4918-8b71-da3e377fcfa5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_30dd995c-0ee7-4fac-8288-0072ce3ea46f_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c34bfa5e-72d1-482a-afb2-60c9dbf07344_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e264022b-3ec1-4bd0-95ba-55138cdd9685_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_6864aecd-1d73-485c-b8e8-882c2bc3b685_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_8ea24f40-db80-44fd-86bf-f546817522b0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_65d69764-fcfe-4b32-b1e9-c76e5ef17b48_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_3395e9b3-da65-4f06-831c-d0956fdeef92_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_994168a5-21ec-4e85-b605-e55fc14df223_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_731b9301-a9a1-42ab-a92c-2a693e6a92af_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock, value</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_2ec21b04-62b4-4fd8-bde1-4e6b4b889392_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity method investees</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_7a8565ec-f4b4-492a-b4d0-fe3f99fbef46_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_cf7aa09b-7a0e-41bb-a781-96c73b5057dc_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4ed8ff17-4e90-420f-a2f5-dbde0cb77cc2_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (less than)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_a37fe124-eff2-4ec2-8aff-dc80c580fb04_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable associated with capital expenditures</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_316e3641-34ac-4e0c-806e-6e03612ed4cc_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DataSecurityIncidentMember_92b4ef7e-9b7e-4dba-8bcf-d995ba39a858_terseLabel_en-US" xlink:label="lab_dgx_DataSecurityIncidentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Data Security Incident</link:label>
    <link:label id="lab_dgx_DataSecurityIncidentMember_label_en-US" xlink:label="lab_dgx_DataSecurityIncidentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Data Security Incident [Member]</link:label>
    <link:label id="lab_dgx_DataSecurityIncidentMember_documentation_en-US" xlink:label="lab_dgx_DataSecurityIncidentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Data Security Incident</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DataSecurityIncidentMember" xlink:href="dgx-20230331.xsd#dgx_DataSecurityIncidentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DataSecurityIncidentMember" xlink:to="lab_dgx_DataSecurityIncidentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_e7eb20e7-79e0-4f05-9d7d-47fedf57a6cb_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_6082c245-e9a4-45d6-8bc7-d8536bae75b9_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_a4bcc103-a873-4892-bd0b-0f563c68dc48_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_58237a6c-6931-4449-ba12-4bb7596c32ae_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_1a38f84f-e0ab-4582-b777-a301ae40f1c2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_b167f680-ea96-4383-b28a-c3d5386f2668_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_d2ae8727-4f2e-46d1-82b3-b6ad8a301671_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Receivables Credit Facility</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_78d6c595-d190-45ce-9449-b6ff70fbf7a3_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_d537f7e2-bc6f-44f7-be88-7a2532c4a28f_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d0b5a07a-ab2b-4764-abe1-2fe1e0a7d0b4_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4fe22891-6c25-4c3a-89f8-c6677cd52562_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_0f7ad3ac-34cd-4a06-9607-2b28f79326cf_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_NewYorkPresbyterianMember_697655b8-430a-49ed-a295-9b92f61a0ac9_terseLabel_en-US" xlink:label="lab_dgx_NewYorkPresbyterianMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York-Presbyterian</link:label>
    <link:label id="lab_dgx_NewYorkPresbyterianMember_label_en-US" xlink:label="lab_dgx_NewYorkPresbyterianMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York-Presbyterian [Member]</link:label>
    <link:label id="lab_dgx_NewYorkPresbyterianMember_documentation_en-US" xlink:label="lab_dgx_NewYorkPresbyterianMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York-Presbyterian</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NewYorkPresbyterianMember" xlink:href="dgx-20230331.xsd#dgx_NewYorkPresbyterianMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_NewYorkPresbyterianMember" xlink:to="lab_dgx_NewYorkPresbyterianMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_dfe3b466-17ac-422f-bc7c-a2c8008ab207_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_edb238e0-5c60-47dd-bcb8-4257501fc1ec_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PercentageofNetRevenues_57d45661-deba-4d9a-9903-cd107f0192e0_terseLabel_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net revenues</link:label>
    <link:label id="lab_dgx_PercentageofNetRevenues_label_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Revenues</link:label>
    <link:label id="lab_dgx_PercentageofNetRevenues_documentation_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues" xlink:href="dgx-20230331.xsd#dgx_PercentageofNetRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PercentageofNetRevenues" xlink:to="lab_dgx_PercentageofNetRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_1425010c-8b82-4ae2-a373-1cdbcf4ba4b2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Segment Reporting Information by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_0b6e72e9-7ac3-4c37-b115-a983a2e8ead9_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_441e3e33-7c58-44c3-b01c-9822459d3ac1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f904309a-aa6f-4081-81d7-5aa20ff94221_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_28b8da77-a627-42dd-b2f5-e055542c64df_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_3de69d6d-9f34-414a-82cb-39b33b39a819_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash surrender value of life insurance policies</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:to="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_0945c076-a025-42a5-b85a-b4a66887b336_terseLabel_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-insurance reserves</link:label>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_label_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Malpractice Loss Contingency, Accrual, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscounted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:to="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_0e2b5c8d-7ff1-4988-9d20-c6506417d88c_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_97fbb6f9-62e8-4186-9b59-61ad7b5edd34_totalLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_CapitatedMember_f35aedab-ff50-409b-b0e3-23339bf56a04_terseLabel_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated</link:label>
    <link:label id="lab_dgx_CapitatedMember_label_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated [Member]</link:label>
    <link:label id="lab_dgx_CapitatedMember_documentation_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember" xlink:href="dgx-20230331.xsd#dgx_CapitatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_CapitatedMember" xlink:to="lab_dgx_CapitatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeOperating_35f0c0f4-a796-4633-bcbe-e29c8b2e3092_terseLabel_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeOperating_label_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Dividend Income, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDividendIncomeOperating" xlink:to="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_b6e60792-d36b-4506-a6f2-33f1266f26e9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_2ed3eb03-639b-483f-8b43-6fc6de553760_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_0f36874f-90b2-43b6-ab20-483503e71714_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Prices in Active Markets for Identical Assets / Liabilities, Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_6ccca351-d91e-485c-9c86-aa435562e176_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_18ebd7a9-e7a8-4915-ae0d-21834710a914_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_497283fa-34b4-4e15-bc23-1d6532e5e781_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_40823796-ec9d-45f0-825f-45e02554359a_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_f7ea958e-101b-41d4-a9ef-758812f9260b_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_c896498b-32fb-4361-9eef-7d7dc66e9944_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_f6d72977-9b8d-414b-bbf3-a9f44903835a_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_8cf6227e-428a-415c-800e-f78fe67b71f3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_0370dde3-79b4-4753-b341-c1cf281186c6_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_GovernmentPayersMember_2e1dc0f0-353f-4e66-bf1e-5c7c553af428_terseLabel_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers</link:label>
    <link:label id="lab_dgx_GovernmentPayersMember_label_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers [Member]</link:label>
    <link:label id="lab_dgx_GovernmentPayersMember_documentation_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember" xlink:href="dgx-20230331.xsd#dgx_GovernmentPayersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_GovernmentPayersMember" xlink:to="lab_dgx_GovernmentPayersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_c032627c-c668-43cc-b120-ff9f75f1c8f7_verboseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases:</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_62be079f-a5b8-4e3c-b310-1c69fc8e2212_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5f013364-09c0-4150-a14b-a60563fefbff_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_c7785e01-fde0-47d0-b5c1-5178f88c154d_terseLabel_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional amount authorized</link:label>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_label_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Amount Authorized</link:label>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_documentation_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Amount Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:href="dgx-20230331.xsd#dgx_StockRepurchaseProgramAdditionalAmountAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:to="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_584252df-a8a6-4f29-bf21-3253a7f4f2e9_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost; 50 and 51 shares as of March&#160;31, 2023 and December&#160;31, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_fc169dbb-ce49-4d97-bded-162c5ce53468_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum contingent consideration payment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_0330d6b2-135c-4f17-9a9b-066500b133bc_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_34baf56d-b1b4-4cef-8c06-19a3a957e034_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_8abd192e-a3cc-4eda-a5c2-54683eecdb50_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_d5c13eac-607f-4762-b1b8-7c1e173e0cd9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_75b70a89-2a87-448e-a409-6b3fa84afa96_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_8830f188-5c15-4797-afdd-602499194f2c_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_c24a7377-dafa-4a38-9ae7-9e0af71a73df_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RESTRUCTURING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_f6fa254a-c78c-455f-af6e-0f9daab5ac74_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2e16cd67-3d7d-4de5-9095-fb30d58e4c0e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6a2695df-5c05-4929-954e-17fbc6ae7cf4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_409ea658-46b2-4a1f-9907-40048860c1de_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_fa74a1a2-765a-4fbf-9c45-174f02bf421c_terseLabel_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Earnings allocated to participating securities</link:label>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_label_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:to="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d9513580-cb02-4d12-895b-56ba7113e402_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Non-controlling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_dda42f78-7707-4acf-865c-092041a63e9d_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_251d0093-e60d-4c61-9394-0b23efd467f7_terseLabel_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Revolving Credit Facility</link:label>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_label_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior unsecured revolving credit facility [Member]</link:label>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_documentation_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior unsecured revolving credit facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:href="dgx-20230331.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:to="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8570a086-0ea7-401f-b475-fffd5cd9b075_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_594955e2-743f-4bb8-a8d1-f227f01bed6d_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt</link:label>
    <link:label id="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_label_en-US" xlink:label="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]</link:label>
    <link:label id="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_documentation_en-US" xlink:label="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:href="dgx-20230331.xsd#dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:to="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6cfd4ceb-72de-4b7d-aec0-74d780ce9dcd_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_88bf0921-f4cd-4655-94e8-c35bb10ae079_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_53584a86-82dc-47ae-a206-4e36cd97e993_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_bc8f20a0-4886-4d0f-9a10-6ea34a980f95_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_c2ed863a-063a-472c-bc8a-5ae01761a6d1_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_a667e0ec-2cb2-4b94-bbff-1829637c8db4_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_9b16d9e1-1e1d-4280-9d44-cafd561a3686_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term SOFR</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_ee2b342a-e79a-48b1-bc86-6eb22a314f8e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_6755a6fc-ba2c-4782-9206-f53c99737735_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</link:label>
    <link:label id="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Amounts Attributable to Parent, Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:to="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7997f347-c2b1-4008-ba91-8c53f559c4e3_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_47ac81c4-32e0-4a9f-954a-d87c35ac1af7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends per common share</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_933c25f5-baeb-48c4-89de-1e000f4431a8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_ea49faf7-cccd-4312-9e27-de36871c2ad2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_965599e1-b788-40a4-8c1a-59ad3ddb8c39_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax restructuring charges</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_d107ae33-ff86-430a-bb46-4fab9420191e_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_2e860fb7-4b6e-4620-9279-8fcfec63f159_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_dfd69e81-a58b-4e5e-98c1-10a083397135_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_b100fa09-1348-444d-845c-4da78d0bcc90_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs and expenses and other operating income:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_4666af62-212c-422a-afaa-ddf25361a1c0_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_73aa66e7-8f87-404a-8e1e-af232a1129f9_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_Mergerconsiderationpaidpayablenet_23e2e25f-91f2-44bb-8bd3-324b3386f04d_terseLabel_en-US" xlink:label="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger consideration payable</link:label>
    <link:label id="lab_dgx_Mergerconsiderationpaidpayablenet_label_en-US" xlink:label="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger consideration paid (payable), net</link:label>
    <link:label id="lab_dgx_Mergerconsiderationpaidpayablenet_documentation_en-US" xlink:label="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger consideration paid (payable), net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Mergerconsiderationpaidpayablenet" xlink:href="dgx-20230331.xsd#dgx_Mergerconsiderationpaidpayablenet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_Mergerconsiderationpaidpayablenet" xlink:to="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_d89985c8-ce91-4186-9dca-e11157005b6c_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_b896112a-0f5a-4210-8fa4-8f090c5e1a67_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax benefit</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_f5b163b3-1400-429e-a983-48ce92f3d0ef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_HealthcareInsurersMember_9675f3db-b85f-45d8-b92f-9be1f42100f0_terseLabel_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers</link:label>
    <link:label id="lab_dgx_HealthcareInsurersMember_label_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers [Member]</link:label>
    <link:label id="lab_dgx_HealthcareInsurersMember_documentation_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember" xlink:href="dgx-20230331.xsd#dgx_HealthcareInsurersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_HealthcareInsurersMember" xlink:to="lab_dgx_HealthcareInsurersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_835bb894-9fe5-42a5-a7b6-660345953977_terseLabel_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation</link:label>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_label_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation [Table Text Block]</link:label>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_documentation_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:href="dgx-20230331.xsd#dgx_AccountsReceivableDisaggregationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:to="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_fb0457ab-6d94-444a-b8dc-96b33b58bf32_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_8bedd1e0-cdeb-4a7c-aa65-68de7556db86_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_03874d40-0db0-4e05-a963-6fdc8d280b8c_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage by noncontrolling owners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_888c1b6d-b77f-4325-bf62-8c0a98460fe6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_52ee6f80-4d33-42bc-b28a-1ef06f4820d0_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_26b00e95-1ec0-47c0-b876-a5504c8fec37_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses, net</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_a2c8e5ed-178c-40c2-a812-4287ad3edb80_terseLabel_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net accounts receivable</link:label>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_label_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Accounts Receivable</link:label>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_documentation_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable" xlink:href="dgx-20230331.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PercentageofNetAccountsReceivable" xlink:to="lab_dgx_PercentageofNetAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_387dcec0-bfe8-4c3f-9692-da69ee196fc7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_0a8fe347-3216-441d-a1fc-a7e174f0f9ec_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_87b7a4a4-4aa6-435e-a9e1-d0e1f2516446_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under benefit plans, shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_7bfa92cb-949b-4bfa-96a7-71f33e25e2ac_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_5cd1aa3b-4675-49a9-a1d1-c269dfd829eb_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AllotherservicesMember_f2bb0b81-3810-43e4-9cb5-137d18fbce8a_terseLabel_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services</link:label>
    <link:label id="lab_dgx_AllotherservicesMember_label_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services [Member]</link:label>
    <link:label id="lab_dgx_AllotherservicesMember_documentation_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember" xlink:href="dgx-20230331.xsd#dgx_AllotherservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AllotherservicesMember" xlink:to="lab_dgx_AllotherservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_8226b999-64d2-4910-a91d-e4653c03f5f8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_c0e3bc5e-c4a8-4ebe-bcea-116cf059ce51_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_eb5cd3a6-903e-479a-8478-412a215734d5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_24af4f31-829b-494d-9923-5a5157dc8101_negatedLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, excess tax benefit, amount</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PatientsMember_fd3447ec-4ed6-48ca-bf97-4377d93c1926_terseLabel_en-US" xlink:label="lab_dgx_PatientsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patients (including coinsurance and deductible responsibilities)</link:label>
    <link:label id="lab_dgx_PatientsMember_label_en-US" xlink:label="lab_dgx_PatientsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patients [Member]</link:label>
    <link:label id="lab_dgx_PatientsMember_documentation_en-US" xlink:label="lab_dgx_PatientsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patients [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientsMember" xlink:href="dgx-20230331.xsd#dgx_PatientsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PatientsMember" xlink:to="lab_dgx_PatientsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2ecdc3a3-74e5-4661-bdba-b3f3e407e30f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1a2bdb38-75a3-4f68-987c-4c27b1516e36_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_ff0ced53-c130-4e77-8e24-3a21a5313cda_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2d6d53e5-7be4-42c0-a313-c499dedf71a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_b65801bb-da70-46ec-9092-e787a0d50d47_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_ce54507e-4431-471b-8dd2-7f678d971104_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_0a9cc2b4-af3b-4ad2-bd3e-ff5b6a9a7f37_negatedTerseLabel_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_label_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:href="dgx-20230331.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:to="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_2618cd25-6105-4f14-9fb3-ba0ef72bee31_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_017ea5c5-74fd-4cf8-a3a7-2c63d4f6e858_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_7ad62ca8-1c50-4435-b750-c27ba56cd951_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_label_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_documentation_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:href="dgx-20230331.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:to="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_c533ba5b-31dd-45c8-9b4a-3bf93e6b8523_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_2a258148-f6fc-4ebe-9c19-076acd856e77_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_1c35d29a-5318-4cc9-bf95-3ad3de6de1a7_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quest Diagnostics stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_bc74331e-0ece-4cf7-8d57-09d6056d23bc_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_212568b0-a394-4021-907c-fa8c20257b71_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_18145489-ffee-483f-a156-2031d3117c39_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_25433178-1bd4-47d7-af59-73888a0e7e8a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS (LOSS) PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_eba626d6-2017-45fb-9929-8d798d0dfba5_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_502d84a8-adf8-482f-98ae-bd8402fc266d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_fe52b4dc-3be1-4b87-9e30-8a40fbf1c358_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DESCRIPTION OF BUSINESS</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_84d7104c-0f59-4316-8e79-2240ccec1e2e_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_af6ed981-cd16-4a53-98f3-9d0cc386c6fc_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_16872fbe-bfcd-4d32-8fb4-7e8f853a06bd_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_460bce31-99a2-486a-b2e6-223e5bc6234d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in Shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_83117031-a0fe-4499-bde9-aafede159ab5_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_324ecdd8-b881-407b-9611-cb4129e4cfd4_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_14a9624c-132c-45db-93dd-113981630968_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for business acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_75460a36-14e0-4f6e-96a0-fb9aefe97395_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DSBusinessesMember_1ce77238-3b92-4f2b-bcbb-3e4ea3b91bb1_terseLabel_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses</link:label>
    <link:label id="lab_dgx_DSBusinessesMember_label_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses [Member]</link:label>
    <link:label id="lab_dgx_DSBusinessesMember_documentation_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember" xlink:href="dgx-20230331.xsd#dgx_DSBusinessesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DSBusinessesMember" xlink:to="lab_dgx_DSBusinessesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DescriptionOfBusinessAbstract_e33e4df5-c16b-4c9d-a0ed-a5351442f531_terseLabel_en-US" xlink:label="lab_dgx_DescriptionOfBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business (Abstract)</link:label>
    <link:label id="lab_dgx_DescriptionOfBusinessAbstract_label_en-US" xlink:label="lab_dgx_DescriptionOfBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business (Abstract)</link:label>
    <link:label id="lab_dgx_DescriptionOfBusinessAbstract_documentation_en-US" xlink:label="lab_dgx_DescriptionOfBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business (Abstract)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DescriptionOfBusinessAbstract" xlink:href="dgx-20230331.xsd#dgx_DescriptionOfBusinessAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DescriptionOfBusinessAbstract" xlink:to="lab_dgx_DescriptionOfBusinessAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_edf209d5-f8c6-4851-a8e8-9d5ff3e8af0e_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_c8323788-6266-46a4-8555-4e9c5bbbd180_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_46b4480e-3646-4511-9738-5daa163dbd25_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_90dd460a-5af5-4fbb-8fea-b768d8cac0ad_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_10af1dba-c6ab-40e8-b615-b2c78ee665de_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_93ec2f04-f9dd-42c8-b25b-b0ecf62cb4a8_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding, amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b24e0b45-3565-41ce-83bb-c65563492d93_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_15abca37-3c99-47f4-8f11-6eff95a21636_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_4dea6b08-d532-421b-b259-ef3dd1d180cd_terseLabel_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DIS business</link:label>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_label_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic Information Services Business [Member]</link:label>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_documentation_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic Information Services Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember" xlink:href="dgx-20230331.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DiagnosticInformationServicesBusinessMember" xlink:to="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_4671e622-e560-4bb4-8e34-250a2dfa644f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_8f6d39e3-2c52-40c6-ba2b-74406a238dcb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_a277f178-09db-49af-9ba4-9b42a201e3ba_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_28373563-48a2-4b29-9037-c9cafb6070ee_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_969c0b0c-8d40-4de4-8431-0072244b3b8e_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_539769d4-9d94-4e92-a088-daf0a4c095af_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7110e7a1-4409-4b96-ada9-0d9f544e624b_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_82fd6ecc-9fb2-4c35-a013-27741275c246_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_595f0142-9d06-4853-bc15-e231d4bff271_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_b72ae111-ec02-4084-aa9b-674aeb20e1c5_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_55d00e37-aad4-4a03-ac4c-14a5f6c57ba0_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes and equity in earnings of equity method investees</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_0614e184-5ae4-42b8-bcac-955ebd8c99a4_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_353e0708-4d25-415b-8f97-0eed073c3708_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_d9da9d74-e6c1-48f2-b572-838b0120f5bf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_50534fab-3b0a-4e0a-bc1f-d7d553ffe2de_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE RECOGITION</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_575e10cc-337c-4c68-8a0c-d31b55cb3dcf_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Cash acquired</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_604932a7-8f5a-4e05-8968-824472bf03fc_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_80f96b39-54ba-4122-a1c0-469e16e1acc7_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_b102bb2e-b823-4562-86d3-f9559bbf425d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_35a735c0-be6a-4b2e-a0f0-7b4f76bc68b5_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_bb069818-387a-48fe-a715-15ef2f3665ee_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateMember_52e3b6bf-5e6b-4c0a-899e-f2d9f3c5d412_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General corporate activities</link:label>
    <link:label id="lab_us-gaap_CorporateMember_label_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateMember" xlink:to="lab_us-gaap_CorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_9bbe4dc8-2f63-4500-a786-34a2d6c886e7_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_58e7970b-729f-424c-8da4-56e16b3a7ef0_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_19f918b1-19a1-4c1d-8173-80d55fa77a5b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_d0930470-93ee-4a26-9f43-3f926f7fb711_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_eecd3faa-1b4c-48c0-a712-1fe0c8314953_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_abf05d64-777c-4cf2-ad6f-b3406305331d_totalLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_676fbc9f-d128-4a49-99b5-ce6e63b37502_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_014bd3c0-6465-4996-a2cc-e016a22c8eef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee payroll tax withholdings on stock issued under stock-based compensation plans</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_20b38c2d-2627-4923-91e8-f67854eaa2ba_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_af594c0a-2423-41e6-af77-b9044f624fb3_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_93d0b17c-c5cb-4cbd-bbea-dcaa21052c0e_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FeeforserviceMember_7c06dbe1-064d-4a4e-bdfe-3611876ab004_terseLabel_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service</link:label>
    <link:label id="lab_dgx_FeeforserviceMember_label_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service [Member]</link:label>
    <link:label id="lab_dgx_FeeforserviceMember_documentation_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember" xlink:href="dgx-20230331.xsd#dgx_FeeforserviceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FeeforserviceMember" xlink:to="lab_dgx_FeeforserviceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_120ece2b-f041-45cb-81fd-8553993ce96f_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_a9f840ed-7bde-440d-b002-9264383c4197_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase authorization remaining available</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e76482c6-6b8e-40a8-b3f1-7f9ef11895bc_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and performance share units</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_33b4e1f2-1923-4724-8d43-7c22d5991ecf_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reissuance of shares for employee benefit plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Treasury Stock Reissued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_8a607553-fbe3-4d0e-a90c-d87093280eea_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_52442b83-b693-4f34-b5e7-d8347452f5eb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_5ed77232-e9b4-4558-a6f2-cdf3e16ab81e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_92001bc0-69f8-480e-9c96-c09843f0df80_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ClientPayersMember_29777e58-0831-422e-bdbe-eb3385b143be_terseLabel_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers</link:label>
    <link:label id="lab_dgx_ClientPayersMember_label_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers [Member]</link:label>
    <link:label id="lab_dgx_ClientPayersMember_documentation_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember" xlink:href="dgx-20230331.xsd#dgx_ClientPayersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ClientPayersMember" xlink:to="lab_dgx_ClientPayersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_f0d76d32-3ef3-4872-a6ba-a2591d5d7146_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_bc8340c0-f961-4495-a0a5-d838d734d4eb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d34b4bc9-2510-4c7c-b22e-b6c25112ee32_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_8bf47427-f176-47d7-843a-e2f3c912710b_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_c59de40e-ad1a-46a4-8170-2d57a8a96a35_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_20cb37a6-57be-45f7-b9dd-7077c44370a7_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_10d628c3-5e6a-43bd-8715-77e3d248f82c_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_bffecdbd-6828-4592-8cd6-a844e65030bd_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use Of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_03630998-67ec-4cfd-9f63-f8a59bee35dd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS ACQUISITIONS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent_34abea3e-e908-429e-bd6c-5593e0a9c1ce_terseLabel_en-US" xlink:label="lab_dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net revenues, percent</link:label>
    <link:label id="lab_dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent_label_en-US" xlink:label="lab_dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax, Percent</link:label>
    <link:label id="lab_dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent_documentation_en-US" xlink:label="lab_dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent" xlink:href="dgx-20230331.xsd#dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent" xlink:to="lab_dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_d8d6b760-9d2a-428d-a1c1-add530fc615f_terseLabel_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge Accounting Basis Adjustment</link:label>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:to="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a06ce069-f7a1-4f58-92a6-4127d45c79d7_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b0ffdbd1-a45b-4c7c-ad3e-ba6d815db940_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, December 31, 2022</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4fafb163-b163-4f66-9233-d770d74e8fab_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, March 31, 2023</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_8173ac8e-c1e8-494d-bb03-389dc07578ee_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_d08372db-e2c4-40df-809f-bd3979ba1f28_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4e9503d9-de92-47db-a16d-da734faedc8e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_2e724164-5d78-4c77-9a65-ba46d81c8e35_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TAXES ON INCOME</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_HaystackOncologyIncMember_7eb17d08-fd48-4123-b06e-116b6d87642f_terseLabel_en-US" xlink:label="lab_dgx_HaystackOncologyIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Haystack Oncology, Inc.</link:label>
    <link:label id="lab_dgx_HaystackOncologyIncMember_label_en-US" xlink:label="lab_dgx_HaystackOncologyIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Haystack Oncology, Inc. [Member]</link:label>
    <link:label id="lab_dgx_HaystackOncologyIncMember_documentation_en-US" xlink:label="lab_dgx_HaystackOncologyIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Haystack Oncology, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HaystackOncologyIncMember" xlink:href="dgx-20230331.xsd#dgx_HaystackOncologyIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_HaystackOncologyIncMember" xlink:to="lab_dgx_HaystackOncologyIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_1768ad7c-b7c9-45f5-8b53-a037739ec8f6_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_de1374a9-9adc-4288-aada-a71119a5ed3e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_45179f4e-dc72-4a3e-9e1f-a4335328365b_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_f99511fe-d39a-4522-82ff-f5ad4a1ea942_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_35f0ff69-d22e-4844-b22b-ca5086d21b7d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_ac743ad8-9d23-4fe5-a7bf-cb8f8734f7d2_terseLabel_en-US" xlink:label="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues by Major Service</link:label>
    <link:label id="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_label_en-US" xlink:label="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues by Major Service [Table Text Block]</link:label>
    <link:label id="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_documentation_en-US" xlink:label="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues by Major Service</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:href="dgx-20230331.xsd#dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:to="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_eddb0389-ff8b-47b2-bfcd-aad796279ecb_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_b5197ce6-c080-4510-8cee-704d5349024e_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_f8754ec2-7412-4198-919e-cbb7fc1c8835_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_fae81730-677f-48ed-af4a-51fe5b8dca63_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of services</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ContingentConsiderationMember_6951c2f2-512d-4e8e-ba45-9e7f45e245e8_terseLabel_en-US" xlink:label="lab_dgx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_dgx_ContingentConsiderationMember_label_en-US" xlink:label="lab_dgx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_dgx_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_dgx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember" xlink:href="dgx-20230331.xsd#dgx_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ContingentConsiderationMember" xlink:to="lab_dgx_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_664f4750-53c8-4a37-bf97-597d8c4c502c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_08c90111-f30d-4f99-8546-7f8d23ef0be0_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, at Cost</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_8034e940-57be-4245-88cb-63d238bd76c4_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Quest Diagnostics stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_2675b91a-0ee5-4749-9ff8-0fc3a4a73f87_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_f2938504-3be2-4d22-940f-b7bb00297c45_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_877be099-a338-497e-af56-c7512f875160_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_bb0d63a5-2049-4833-92fe-767e54cd4af5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_157264af-371b-4ddd-8e41-4babf2c1465d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_c1bf6776-bb30-4a17-9565-a8a5b1a16c2a_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_InvigorateProgramMember_730d4334-a8cc-4e70-a657-d35f3fa9ed55_terseLabel_en-US" xlink:label="lab_dgx_InvigorateProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Invigorate Program</link:label>
    <link:label id="lab_dgx_InvigorateProgramMember_label_en-US" xlink:label="lab_dgx_InvigorateProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Invigorate Program [Member]</link:label>
    <link:label id="lab_dgx_InvigorateProgramMember_documentation_en-US" xlink:label="lab_dgx_InvigorateProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Invigorate Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InvigorateProgramMember" xlink:href="dgx-20230331.xsd#dgx_InvigorateProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_InvigorateProgramMember" xlink:to="lab_dgx_InvigorateProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_84368236-654e-4bee-ae7b-709db3209f66_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_2563d594-073f-4857-bc7b-0deb759cb915_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_2e8dcd9a-247f-45f8-8c3b-23b7880d0274_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_19b38764-1930-40ff-88e3-1482b8fe1afd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_60271ccb-b69f-4d75-b842-b79744aade85_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_52361857-80ab-4fc4-aa78-4d4881b185ef_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_250c9028-4161-492a-87bf-f1d63f6fd332_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_f7b9bcb1-1031-48b9-88d3-d983f9c68259_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_fd110c8b-2f3d-4f81-98c8-7c1cee59d36d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_c673ee1b-3123-4df1-b1eb-065dbfcf5ecf_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScenarioPlanMember_35e09f6c-f2d6-44b3-ab9f-29d28de853ea_terseLabel_en-US" xlink:label="lab_us-gaap_ScenarioPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan</link:label>
    <link:label id="lab_us-gaap_ScenarioPlanMember_label_en-US" xlink:label="lab_us-gaap_ScenarioPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScenarioPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScenarioPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScenarioPlanMember" xlink:to="lab_us-gaap_ScenarioPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_4a804c51-3bda-497e-b93a-b4a694e53148_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_9577f602-04b5-443f-a93d-d6251e999ba5_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_5985d7f3-69b5-43e4-826b-70ebd028afd2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9ad501cf-6aaa-400d-b2e9-aa86f2ca25f5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under benefit plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_998557cd-a4cc-485e-ac93-fb00b7b6a3c6_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_5cd0e9ad-ce63-47b1-a1f4-edbced7c835c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_d8c05b43-cc51-4e5f-b36f-4fcef0cf59c9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_ce90ff76-82b2-4941-b82c-22453c1d905e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_8ee928fa-a6d3-4187-9fd3-7e869c7befce_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_a22608de-f209-43fe-8c1b-9fe8a33424e9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_c0c8e4f0-149c-443c-8584-fc87a482dfe0_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_515892a0-a757-4c4c-aaf1-7df4497ba588_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_e859be83-8ca3-4b67-a2d8-26f25e4a7bd6_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityNetIncome" xlink:to="lab_us-gaap_TemporaryEquityNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_3735392c-87ad-472d-a336-2e4b731864ee_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_364c791e-b1fa-488a-b52a-8aeea83802e6_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_97c72681-fbae-4ef5-bc76-3f1d5fbe7731_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock, shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_4d3e01ee-c761-49a7-b0a1-5bfc91b2f43c_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock- shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a734389-9941-451c-a435-07ea4f2fb4bb_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash and cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_bb0cc412-c481-4cbb-88d8-bc57abe485f3_totalLabel_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_label_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_documentation_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired" xlink:href="dgx-20230331.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired" xlink:to="lab_dgx_FairValueOfNetAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_7569ad37-14dc-4843-877a-f774890a94c8_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_5e0a2c09-ded4-4aef-be69-b4d2d45c514f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for credit losses of $30 as of both March&#160;31, 2023 and December&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_66a798d9-be56-47d0-a326-739d2353b907_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_2fd8db46-35e8-405a-8161-d87c2f2e9670_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_85854e3c-b34c-49a3-95ed-bb17573feb60_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_cef3cdc8-fac9-460d-a332-ee70296afa30_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_db019f3f-e69b-444c-bdb2-e94633e98bea_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_208cd5ee-70e0-45e4-8e87-c3af831a9ffc_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_fbfa9bf4-1885-4876-94fa-4de9e2ed468a_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_15167b7d-9d83-4a0b-8875-59d88d96973b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_7230f94d-7c9d-4b17-b76e-b403af1c6bfe_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_bb0806e5-95e2-4c8b-871c-fd6048d31b6f_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation reserves</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d6671953-805d-426e-b284-6ea3272442e5_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_ccfff1de-fbb0-46c8-becf-ac3ddb49eedf_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_f4eb6a90-35f1-4384-93e6-67e3ffe2ce71_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_58e72d79-b4e9-489d-955a-bef53fedd769_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_1d9aa480-5325-45bf-b32f-d00be1a63e16_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of assets acquired</link:label>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfAssetsAcquired" xlink:to="lab_us-gaap_FairValueOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_8dc1119b-da4f-4871-a1ae-1e5bea4ff8a7_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_91d5658b-a7a0-4308-8aca-37fba15856b3_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_b0d363be-5527-4486-94ea-74784868634f_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-operating expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_d6c6f861-05b4-44d0-89c1-1b4d34db7629_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_85c29617-ca86-46e8-a63e-cbc49a06ec6b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_176bc375-fd22-4f11-9296-e19efbd8279d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_ea36a18e-9a51-4089-887a-58ed65761e2f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_27e1becc-0e6d-4448-a52c-a7983189881e_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_COVID19TestingServicesMember_1b271628-2546-4760-b72e-ed24bb290faa_terseLabel_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services</link:label>
    <link:label id="lab_dgx_COVID19TestingServicesMember_label_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services [Member]</link:label>
    <link:label id="lab_dgx_COVID19TestingServicesMember_documentation_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember" xlink:href="dgx-20230331.xsd#dgx_COVID19TestingServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_COVID19TestingServicesMember" xlink:to="lab_dgx_COVID19TestingServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_29e57c28-e61d-4c72-bcaf-d2c5302466b0_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ec3508f6-bbbb-4950-9205-a7e223946926_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_5edabf6a-60a7-4fbc-8677-9a60ae5d7c77_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_14208b86-d281-45fa-9f86-9deda3076fda_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_36b2d9a6-b4b5-41cd-82ea-eb7c04a0223c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_82f62351-a8c7-4c71-8818-e0a39f4a4103_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_6c054f84-19f7-4725-806a-ec25a0acb5e1_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_73dfe1ee-27c0-462c-acf3-f52f6c30725e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_12980752-92c6-4f8f-bf6b-2040136d04ee_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of equity method investees, net of taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_cae4d092-79b4-4368-b920-4aacfc37e84c_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_62e4c054-9fcc-4f40-bdbf-81d24941b12f_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_378ce8bb-5e9d-4575-806e-3379dbc51c26_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_d1f8d9cb-e07f-4e1d-b3ea-0d7165038bdf_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_label_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_documentation_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:href="dgx-20230331.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:to="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_01e13d5b-7626-4cac-ba68-958395c6f183_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_874b66b1-db5e-4536-9170-312536ff9875_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_31a9ebeb-4b80-4969-a351-e34e1673dd68_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_A401kPlanLawsuitMember_a8d2b066-2c17-4caa-b445-223f3cf23605_terseLabel_en-US" xlink:label="lab_dgx_A401kPlanLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">401(k) Plan Lawsuit</link:label>
    <link:label id="lab_dgx_A401kPlanLawsuitMember_label_en-US" xlink:label="lab_dgx_A401kPlanLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">401(k) Plan Lawsuit [Member]</link:label>
    <link:label id="lab_dgx_A401kPlanLawsuitMember_documentation_en-US" xlink:label="lab_dgx_A401kPlanLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">401(k) Plan Lawsuit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_A401kPlanLawsuitMember" xlink:href="dgx-20230331.xsd#dgx_A401kPlanLawsuitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_A401kPlanLawsuitMember" xlink:to="lab_dgx_A401kPlanLawsuitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_da6c44d2-4383-4141-ab2b-527b94da9351_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards to be Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_212c6fc5-19bc-4084-8aab-d857d29d1da0_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_9c15e8b7-f13f-48e8-ad53-02191dbddd82_terseLabel_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services</link:label>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_label_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services [Member]</link:label>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_documentation_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember" xlink:href="dgx-20230331.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AnatomicpathologytestingservicesMember" xlink:to="lab_dgx_AnatomicpathologytestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9295b0dd-a4b8-4548-a3a8-eb6c202dbcbc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_d76423c2-4fa9-4d43-979d-a03ca12bd342_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased assets obtained in exchange for new operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_cc83017b-bbf1-407a-90f2-fc46170de1a3_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of services</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_0763b488-c9a1-463a-ad95-5598e5e0577d_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_50f31c03-1574-4960-a92f-fe224033decc_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_b5e377d9-0670-4b74-806a-027064d99e72_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>dgx-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:6a67f40b-d353-490b-97be-70efe774e456,g:809066a9-06e1-46b8-9b20-d9684581a006-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://questdiagnostics.com/role/CoverPage" xlink:type="simple" xlink:href="dgx-20230331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_f58143c1-e48a-4387-ad02-8ac3b31392ce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_DocumentType_f58143c1-e48a-4387-ad02-8ac3b31392ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_a00bfec1-675f-4ddf-99bc-9ede19706903" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_DocumentQuarterlyReport_a00bfec1-675f-4ddf-99bc-9ede19706903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_cb02ad52-86fc-4688-89c0-2385782be7da" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_DocumentPeriodEndDate_cb02ad52-86fc-4688-89c0-2385782be7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_d6fd1a32-72d8-4508-9b55-cef7e4d845c5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_DocumentTransitionReport_d6fd1a32-72d8-4508-9b55-cef7e4d845c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_a11fe3f9-1a09-4fda-a1ff-18cc48374e23" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_EntityFileNumber_a11fe3f9-1a09-4fda-a1ff-18cc48374e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_c47245eb-5624-419d-b569-4e93b6325164" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_EntityRegistrantName_c47245eb-5624-419d-b569-4e93b6325164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_95f1b2ae-70f2-445f-a8e9-7df6b963cd0d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_EntityCentralIndexKey_95f1b2ae-70f2-445f-a8e9-7df6b963cd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_ca5af4c5-db2a-4d96-b284-3ffdc664ff7c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_CurrentFiscalYearEndDate_ca5af4c5-db2a-4d96-b284-3ffdc664ff7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_9f6d74b8-a516-4cc8-8790-439bf0abd296" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_DocumentFiscalYearFocus_9f6d74b8-a516-4cc8-8790-439bf0abd296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_f0d036d4-d637-494b-b276-3ca79401aa6a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_DocumentFiscalPeriodFocus_f0d036d4-d637-494b-b276-3ca79401aa6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_605eabc9-b604-4bc0-85d3-dedb369911d2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_AmendmentFlag_605eabc9-b604-4bc0-85d3-dedb369911d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_7bd583b5-0291-4999-b300-a6385c68c929" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_EntityIncorporationStateCountryCode_7bd583b5-0291-4999-b300-a6385c68c929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_d53d08bc-58e5-419d-af24-adb4c6318ebd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_EntityTaxIdentificationNumber_d53d08bc-58e5-419d-af24-adb4c6318ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2374058e-2bdc-4abd-95ec-d0b83c658bd5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_EntityAddressAddressLine1_2374058e-2bdc-4abd-95ec-d0b83c658bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_14c0c1bf-6384-4e16-ade4-c7d775c5ecd6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_EntityAddressCityOrTown_14c0c1bf-6384-4e16-ade4-c7d775c5ecd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_85a1484a-f67d-4d17-a23b-1fa5c7c4e006" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_EntityAddressStateOrProvince_85a1484a-f67d-4d17-a23b-1fa5c7c4e006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c40ab0b9-f6e7-47e6-846f-a7cce59a9dee" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_EntityAddressPostalZipCode_c40ab0b9-f6e7-47e6-846f-a7cce59a9dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_4e797dd0-3808-4939-b509-0b2ba738baf7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_CityAreaCode_4e797dd0-3808-4939-b509-0b2ba738baf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_dfebbed2-9356-46a1-a815-5bdc00c37e34" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_LocalPhoneNumber_dfebbed2-9356-46a1-a815-5bdc00c37e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9f7fecba-57f8-4c60-8d47-b2f8e6b858ac" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_Security12bTitle_9f7fecba-57f8-4c60-8d47-b2f8e6b858ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_72220585-9598-4b0c-888a-01b5f1a814c5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_TradingSymbol_72220585-9598-4b0c-888a-01b5f1a814c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_e36df3dd-bbb7-4b4d-a188-f057e3abe4a2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_SecurityExchangeName_e36df3dd-bbb7-4b4d-a188-f057e3abe4a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_f217b283-d0cd-4019-b328-4239aedebd30" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_EntityCurrentReportingStatus_f217b283-d0cd-4019-b328-4239aedebd30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_cb06ff07-6adc-492c-bb8c-9b569463143e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_EntityInteractiveDataCurrent_cb06ff07-6adc-492c-bb8c-9b569463143e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_db453b4c-9b60-4c41-aa16-f506ddae321d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_EntityFilerCategory_db453b4c-9b60-4c41-aa16-f506ddae321d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_363afbdc-d058-4795-98a2-a54767b675d8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_EntitySmallBusiness_363afbdc-d058-4795-98a2-a54767b675d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_b42b1901-4d7f-4e7b-bd67-a0ce14d32a94" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_EntityEmergingGrowthCompany_b42b1901-4d7f-4e7b-bd67-a0ce14d32a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_4ce34cc8-c774-4b75-92c5-c85d68d191a5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_EntityShellCompany_4ce34cc8-c774-4b75-92c5-c85d68d191a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_ca9f0aa5-af2d-422f-89c2-1b8a6bc8e3e0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43dea715-398a-4c5c-9d7c-eacea493659b" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_ca9f0aa5-af2d-422f-89c2-1b8a6bc8e3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="dgx-20230331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_8fef4ea7-64a7-484e-9ab8-00332083ce80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f81c523e-4cb1-4958-bb79-d0dc777dfb65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8fef4ea7-64a7-484e-9ab8-00332083ce80" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f81c523e-4cb1-4958-bb79-d0dc777dfb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_f54de631-ebf6-46ee-bbc7-5531e09821f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8fef4ea7-64a7-484e-9ab8-00332083ce80" xlink:to="loc_us-gaap_CostOfRevenueAbstract_f54de631-ebf6-46ee-bbc7-5531e09821f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_503e3d5a-ccf3-4f08-a45e-cc62f3358425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_f54de631-ebf6-46ee-bbc7-5531e09821f3" xlink:to="loc_us-gaap_CostOfRevenue_503e3d5a-ccf3-4f08-a45e-cc62f3358425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_03d0f9d2-bff7-40c3-93ae-e342b0bfdfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_f54de631-ebf6-46ee-bbc7-5531e09821f3" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_03d0f9d2-bff7-40c3-93ae-e342b0bfdfd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_90326c05-6a7a-4626-bd44-0a2c24687d52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_f54de631-ebf6-46ee-bbc7-5531e09821f3" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_90326c05-6a7a-4626-bd44-0a2c24687d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_4684d342-2891-4b0e-bdea-481dcefa8c45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_f54de631-ebf6-46ee-bbc7-5531e09821f3" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_4684d342-2891-4b0e-bdea-481dcefa8c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_55c381ed-182c-4a91-a9e5-a564041b9849" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8fef4ea7-64a7-484e-9ab8-00332083ce80" xlink:to="loc_us-gaap_CostsAndExpenses_55c381ed-182c-4a91-a9e5-a564041b9849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c1d53737-e669-44fd-8095-a2fd8cb223f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8fef4ea7-64a7-484e-9ab8-00332083ce80" xlink:to="loc_us-gaap_OperatingIncomeLoss_c1d53737-e669-44fd-8095-a2fd8cb223f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e3b10405-9b1d-4d10-8ca8-b28a313c76e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8fef4ea7-64a7-484e-9ab8-00332083ce80" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e3b10405-9b1d-4d10-8ca8-b28a313c76e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_a3d54d35-a675-4f23-bc64-7f44ac1b7214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e3b10405-9b1d-4d10-8ca8-b28a313c76e3" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_a3d54d35-a675-4f23-bc64-7f44ac1b7214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_02cc2061-6de1-4d9c-92e0-5415b212ef3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e3b10405-9b1d-4d10-8ca8-b28a313c76e3" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_02cc2061-6de1-4d9c-92e0-5415b212ef3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_6de45f85-a471-4bd8-9c8a-1653ece66b85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e3b10405-9b1d-4d10-8ca8-b28a313c76e3" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_6de45f85-a471-4bd8-9c8a-1653ece66b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1e5a24c7-ba3c-47e1-9d58-1f1cdc59d37a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8fef4ea7-64a7-484e-9ab8-00332083ce80" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1e5a24c7-ba3c-47e1-9d58-1f1cdc59d37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e95f4475-d884-418b-8eec-ab3d6c30dbdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8fef4ea7-64a7-484e-9ab8-00332083ce80" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e95f4475-d884-418b-8eec-ab3d6c30dbdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_140098be-b087-44fc-ba57-d08b27d0f24a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8fef4ea7-64a7-484e-9ab8-00332083ce80" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_140098be-b087-44fc-ba57-d08b27d0f24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a394deb7-480e-4b1c-9337-1a7af21ba4c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8fef4ea7-64a7-484e-9ab8-00332083ce80" xlink:to="loc_us-gaap_ProfitLoss_a394deb7-480e-4b1c-9337-1a7af21ba4c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8d7a6e13-5763-40ae-b614-168e31bd6b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8fef4ea7-64a7-484e-9ab8-00332083ce80" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8d7a6e13-5763-40ae-b614-168e31bd6b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6166f21c-ea92-4352-879f-dbed98bc2b72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8fef4ea7-64a7-484e-9ab8-00332083ce80" xlink:to="loc_us-gaap_NetIncomeLoss_6166f21c-ea92-4352-879f-dbed98bc2b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8f9b39b7-3d1d-477f-a561-557d3febbdb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8fef4ea7-64a7-484e-9ab8-00332083ce80" xlink:to="loc_us-gaap_EarningsPerShareAbstract_8f9b39b7-3d1d-477f-a561-557d3febbdb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_0f6a47f5-de01-4464-a900-6c33542a7fce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8f9b39b7-3d1d-477f-a561-557d3febbdb8" xlink:to="loc_us-gaap_EarningsPerShareBasic_0f6a47f5-de01-4464-a900-6c33542a7fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_bde4eb53-289f-406b-a7b8-57476439f41a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8f9b39b7-3d1d-477f-a561-557d3febbdb8" xlink:to="loc_us-gaap_EarningsPerShareDiluted_bde4eb53-289f-406b-a7b8-57476439f41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_150ee22c-fbf6-4457-a30c-af0d025761db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8fef4ea7-64a7-484e-9ab8-00332083ce80" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_150ee22c-fbf6-4457-a30c-af0d025761db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c0106f0d-f5c3-4b94-b404-6785fea79062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_150ee22c-fbf6-4457-a30c-af0d025761db" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c0106f0d-f5c3-4b94-b404-6785fea79062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c5651709-2c07-4a4d-b157-67c1d312a6f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_150ee22c-fbf6-4457-a30c-af0d025761db" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c5651709-2c07-4a4d-b157-67c1d312a6f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="dgx-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_313ec8ed-4691-4e15-9885-2e1546ec0e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9537aedb-62e4-48a7-a0a8-0c205f62f604" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_313ec8ed-4691-4e15-9885-2e1546ec0e64" xlink:to="loc_us-gaap_ProfitLoss_9537aedb-62e4-48a7-a0a8-0c205f62f604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d98275cd-2774-47f4-a3d3-2c5577b30aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_313ec8ed-4691-4e15-9885-2e1546ec0e64" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d98275cd-2774-47f4-a3d3-2c5577b30aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_db174538-6873-46e6-b0d8-dd0c80b4da8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d98275cd-2774-47f4-a3d3-2c5577b30aa9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_db174538-6873-46e6-b0d8-dd0c80b4da8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4d0c47ff-d355-4ea3-8ca2-ba1e3b41a4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d98275cd-2774-47f4-a3d3-2c5577b30aa9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4d0c47ff-d355-4ea3-8ca2-ba1e3b41a4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1193f636-8d42-4810-945f-e5dad0c8e010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_313ec8ed-4691-4e15-9885-2e1546ec0e64" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1193f636-8d42-4810-945f-e5dad0c8e010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2cd3e9a9-463a-4a2a-9d38-7f2365a65e88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_313ec8ed-4691-4e15-9885-2e1546ec0e64" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2cd3e9a9-463a-4a2a-9d38-7f2365a65e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_270e255e-d0b2-4f56-a4ae-87deae477687" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_313ec8ed-4691-4e15-9885-2e1546ec0e64" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_270e255e-d0b2-4f56-a4ae-87deae477687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dgx-20230331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_957bcc08-e0a4-4669-bc6c-b5d4894e4a26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_23970cc7-365a-4309-919d-f4f56822b201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_957bcc08-e0a4-4669-bc6c-b5d4894e4a26" xlink:to="loc_us-gaap_AssetsAbstract_23970cc7-365a-4309-919d-f4f56822b201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f2da0b0b-a4d3-493b-b4fe-f709ebb5d2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_23970cc7-365a-4309-919d-f4f56822b201" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f2da0b0b-a4d3-493b-b4fe-f709ebb5d2c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d9ce3b18-3375-4133-b265-411bc9167b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_23970cc7-365a-4309-919d-f4f56822b201" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d9ce3b18-3375-4133-b265-411bc9167b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9915d44a-b48c-412f-a4c5-1f1590eaafbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_23970cc7-365a-4309-919d-f4f56822b201" xlink:to="loc_us-gaap_InventoryNet_9915d44a-b48c-412f-a4c5-1f1590eaafbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d35d8a2b-f5cb-4d47-b287-6d7e9926416d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_23970cc7-365a-4309-919d-f4f56822b201" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d35d8a2b-f5cb-4d47-b287-6d7e9926416d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9434df6b-fa1e-4b3b-a222-b7b4e24f44b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_23970cc7-365a-4309-919d-f4f56822b201" xlink:to="loc_us-gaap_AssetsCurrent_9434df6b-fa1e-4b3b-a222-b7b4e24f44b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_85323ec1-b5bb-45de-9734-b83a02b89dec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_23970cc7-365a-4309-919d-f4f56822b201" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_85323ec1-b5bb-45de-9734-b83a02b89dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2875ac00-2406-432d-9df8-648d6e864bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_23970cc7-365a-4309-919d-f4f56822b201" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2875ac00-2406-432d-9df8-648d6e864bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5d0b73e7-514e-486e-8354-11312ca71c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_23970cc7-365a-4309-919d-f4f56822b201" xlink:to="loc_us-gaap_Goodwill_5d0b73e7-514e-486e-8354-11312ca71c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_609d4ddc-9f1f-44f0-a4d4-885e255b1ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_23970cc7-365a-4309-919d-f4f56822b201" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_609d4ddc-9f1f-44f0-a4d4-885e255b1ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_e7396caf-d1fa-4018-90fb-ec42b3ce65ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_23970cc7-365a-4309-919d-f4f56822b201" xlink:to="loc_us-gaap_EquityMethodInvestments_e7396caf-d1fa-4018-90fb-ec42b3ce65ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5fc0886a-41c0-44bb-8ddb-679c7999cf73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_23970cc7-365a-4309-919d-f4f56822b201" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5fc0886a-41c0-44bb-8ddb-679c7999cf73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_37b9e716-5514-4a46-9bc4-99ad100b014d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_23970cc7-365a-4309-919d-f4f56822b201" xlink:to="loc_us-gaap_Assets_37b9e716-5514-4a46-9bc4-99ad100b014d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c3e3cf9b-8acf-4af5-8976-b7d5462ee955" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_957bcc08-e0a4-4669-bc6c-b5d4894e4a26" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c3e3cf9b-8acf-4af5-8976-b7d5462ee955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_ca0d6cd2-8cfd-41be-9fef-b7794241e409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c3e3cf9b-8acf-4af5-8976-b7d5462ee955" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_ca0d6cd2-8cfd-41be-9fef-b7794241e409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_d0fa712e-ff06-4dbc-ade4-55a96e8ef7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c3e3cf9b-8acf-4af5-8976-b7d5462ee955" xlink:to="loc_us-gaap_LongTermDebtCurrent_d0fa712e-ff06-4dbc-ade4-55a96e8ef7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_26bd58cc-aa5c-4e15-93df-434fd2cdfebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c3e3cf9b-8acf-4af5-8976-b7d5462ee955" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_26bd58cc-aa5c-4e15-93df-434fd2cdfebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_39a1e5fd-47b5-4788-958b-9d36099be8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c3e3cf9b-8acf-4af5-8976-b7d5462ee955" xlink:to="loc_us-gaap_LiabilitiesCurrent_39a1e5fd-47b5-4788-958b-9d36099be8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_1ec2271a-7e67-4365-824e-d03450f02849" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c3e3cf9b-8acf-4af5-8976-b7d5462ee955" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_1ec2271a-7e67-4365-824e-d03450f02849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_04298a63-38f3-48b0-adff-65f355d1eb23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c3e3cf9b-8acf-4af5-8976-b7d5462ee955" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_04298a63-38f3-48b0-adff-65f355d1eb23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_97d23c7a-262e-4cd6-89aa-b2cf4a8a0c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c3e3cf9b-8acf-4af5-8976-b7d5462ee955" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_97d23c7a-262e-4cd6-89aa-b2cf4a8a0c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_3b9b272f-2af1-4047-82c2-de2d273bb5fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c3e3cf9b-8acf-4af5-8976-b7d5462ee955" xlink:to="loc_us-gaap_CommitmentsAndContingencies_3b9b272f-2af1-4047-82c2-de2d273bb5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_a6164c08-ee41-4787-a1a1-b6c58ca05e74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c3e3cf9b-8acf-4af5-8976-b7d5462ee955" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_a6164c08-ee41-4787-a1a1-b6c58ca05e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1f3ed3ae-ea00-4070-b3a3-e93510a02706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c3e3cf9b-8acf-4af5-8976-b7d5462ee955" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1f3ed3ae-ea00-4070-b3a3-e93510a02706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_69cc0b6d-4c6f-4806-a350-3a404b479103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1f3ed3ae-ea00-4070-b3a3-e93510a02706" xlink:to="loc_us-gaap_StockholdersEquityAbstract_69cc0b6d-4c6f-4806-a350-3a404b479103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_aa61249d-a1c3-4701-a1ea-0d7758dd3e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_69cc0b6d-4c6f-4806-a350-3a404b479103" xlink:to="loc_us-gaap_CommonStockValue_aa61249d-a1c3-4701-a1ea-0d7758dd3e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_de2dbbd7-342b-4ce8-9f12-9e77b9ff9978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_69cc0b6d-4c6f-4806-a350-3a404b479103" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_de2dbbd7-342b-4ce8-9f12-9e77b9ff9978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b34c4063-0170-416e-b400-29b8d7e33abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_69cc0b6d-4c6f-4806-a350-3a404b479103" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b34c4063-0170-416e-b400-29b8d7e33abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ca412b0f-ae8d-4741-a2d3-c471bffeabe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_69cc0b6d-4c6f-4806-a350-3a404b479103" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ca412b0f-ae8d-4741-a2d3-c471bffeabe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_3d04e37e-19b2-49bd-9327-06306c03b56f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_69cc0b6d-4c6f-4806-a350-3a404b479103" xlink:to="loc_us-gaap_TreasuryStockValue_3d04e37e-19b2-49bd-9327-06306c03b56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3f0468ad-106f-43fe-ae78-70567cf9de0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_69cc0b6d-4c6f-4806-a350-3a404b479103" xlink:to="loc_us-gaap_StockholdersEquity_3f0468ad-106f-43fe-ae78-70567cf9de0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_d04079a9-cee8-4de6-9331-344b07b9d824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1f3ed3ae-ea00-4070-b3a3-e93510a02706" xlink:to="loc_us-gaap_MinorityInterest_d04079a9-cee8-4de6-9331-344b07b9d824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8e6f5154-7d09-4062-8809-22c56ed2ac68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1f3ed3ae-ea00-4070-b3a3-e93510a02706" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8e6f5154-7d09-4062-8809-22c56ed2ac68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_747c1bc4-fc89-4e5c-aac7-b727fc0f53f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c3e3cf9b-8acf-4af5-8976-b7d5462ee955" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_747c1bc4-fc89-4e5c-aac7-b727fc0f53f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="dgx-20230331.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_9a850083-e7e2-4e59-ab91-3c67ce828439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_40c7b58a-8e8c-4914-9df3-6d1d7089a23a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9a850083-e7e2-4e59-ab91-3c67ce828439" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_40c7b58a-8e8c-4914-9df3-6d1d7089a23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ea5ebe2f-7f15-48c9-90ee-a0de4d5ace5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9a850083-e7e2-4e59-ab91-3c67ce828439" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ea5ebe2f-7f15-48c9-90ee-a0de4d5ace5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_41c01d37-258f-4a57-9c14-69afa349ac4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9a850083-e7e2-4e59-ab91-3c67ce828439" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_41c01d37-258f-4a57-9c14-69afa349ac4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_62a3dca4-5e37-4186-a2a7-8ede4767385c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9a850083-e7e2-4e59-ab91-3c67ce828439" xlink:to="loc_us-gaap_CommonStockSharesIssued_62a3dca4-5e37-4186-a2a7-8ede4767385c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_c70eeec3-1bcd-4aad-8358-b14175f6ae7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9a850083-e7e2-4e59-ab91-3c67ce828439" xlink:to="loc_us-gaap_TreasuryStockShares_c70eeec3-1bcd-4aad-8358-b14175f6ae7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dgx-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_719a773c-f8dd-489c-9069-672f77cf69bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_89c40499-db8f-420b-93b3-7b6dee83b49a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_719a773c-f8dd-489c-9069-672f77cf69bf" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_89c40499-db8f-420b-93b3-7b6dee83b49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d40d3329-862a-4a5c-afc9-3d0274eac6be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_89c40499-db8f-420b-93b3-7b6dee83b49a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d40d3329-862a-4a5c-afc9-3d0274eac6be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6aeea68d-c143-4d5e-971a-4dfa1edaf75d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d40d3329-862a-4a5c-afc9-3d0274eac6be" xlink:to="loc_us-gaap_ProfitLoss_6aeea68d-c143-4d5e-971a-4dfa1edaf75d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_77a093ba-af73-49f6-b5ac-2b92849035e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d40d3329-862a-4a5c-afc9-3d0274eac6be" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_77a093ba-af73-49f6-b5ac-2b92849035e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a66a4859-ec52-4c25-b1a1-06ae17744df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_77a093ba-af73-49f6-b5ac-2b92849035e0" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a66a4859-ec52-4c25-b1a1-06ae17744df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_69c1690e-85af-4b60-8315-daa29ddd1604" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_77a093ba-af73-49f6-b5ac-2b92849035e0" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_69c1690e-85af-4b60-8315-daa29ddd1604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e2adea1a-5d26-4eee-a196-6df889ff1ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_77a093ba-af73-49f6-b5ac-2b92849035e0" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e2adea1a-5d26-4eee-a196-6df889ff1ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_84997c35-0d27-4b01-b53b-dc45db46e584" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_77a093ba-af73-49f6-b5ac-2b92849035e0" xlink:to="loc_us-gaap_ShareBasedCompensation_84997c35-0d27-4b01-b53b-dc45db46e584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_ca82cc1e-4fa8-41f7-9cf9-038d8f21cb48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_77a093ba-af73-49f6-b5ac-2b92849035e0" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_ca82cc1e-4fa8-41f7-9cf9-038d8f21cb48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bb64174d-b108-4d95-801a-19d35be76ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d40d3329-862a-4a5c-afc9-3d0274eac6be" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bb64174d-b108-4d95-801a-19d35be76ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4ee2c9a7-4299-4f57-b285-52e2450e8719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bb64174d-b108-4d95-801a-19d35be76ffc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4ee2c9a7-4299-4f57-b285-52e2450e8719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ae11964f-cb6b-4468-95e0-1ddc8ab05068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bb64174d-b108-4d95-801a-19d35be76ffc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ae11964f-cb6b-4468-95e0-1ddc8ab05068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_c7915535-500d-4e32-beb0-29c86c006948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bb64174d-b108-4d95-801a-19d35be76ffc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_c7915535-500d-4e32-beb0-29c86c006948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_04326bbf-eaf0-4bdf-a739-25d1d57fce4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bb64174d-b108-4d95-801a-19d35be76ffc" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_04326bbf-eaf0-4bdf-a739-25d1d57fce4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2517dc30-ca03-4769-b8ba-726e81bd5f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d40d3329-862a-4a5c-afc9-3d0274eac6be" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2517dc30-ca03-4769-b8ba-726e81bd5f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b71a1a13-423b-4162-a916-16d17a7ee256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_89c40499-db8f-420b-93b3-7b6dee83b49a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b71a1a13-423b-4162-a916-16d17a7ee256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e1a7ace4-7c17-47f8-9d29-3966cf430259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b71a1a13-423b-4162-a916-16d17a7ee256" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e1a7ace4-7c17-47f8-9d29-3966cf430259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_404ee2ed-aa66-42b4-8725-f0108e8b9c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b71a1a13-423b-4162-a916-16d17a7ee256" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_404ee2ed-aa66-42b4-8725-f0108e8b9c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_5c732242-52da-4985-8b3f-5d0fc39b9d69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b71a1a13-423b-4162-a916-16d17a7ee256" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_5c732242-52da-4985-8b3f-5d0fc39b9d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_815e9742-9d52-42db-be27-47353b00089f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b71a1a13-423b-4162-a916-16d17a7ee256" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_815e9742-9d52-42db-be27-47353b00089f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3299ca4d-49da-4301-b7ef-25fba56e1205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_89c40499-db8f-420b-93b3-7b6dee83b49a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3299ca4d-49da-4301-b7ef-25fba56e1205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_f509f018-f5ec-4852-bb69-712fddcc9a95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3299ca4d-49da-4301-b7ef-25fba56e1205" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_f509f018-f5ec-4852-bb69-712fddcc9a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_89a15434-53a6-4583-8c96-da7bed080624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3299ca4d-49da-4301-b7ef-25fba56e1205" xlink:to="loc_us-gaap_RepaymentsOfDebt_89a15434-53a6-4583-8c96-da7bed080624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e98619c5-9081-4463-88f4-5992371aced7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3299ca4d-49da-4301-b7ef-25fba56e1205" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e98619c5-9081-4463-88f4-5992371aced7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_61e96ba9-361c-43fc-b12c-70ac56f57854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3299ca4d-49da-4301-b7ef-25fba56e1205" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_61e96ba9-361c-43fc-b12c-70ac56f57854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8b054fff-91eb-4956-bee7-dda744f4f00b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3299ca4d-49da-4301-b7ef-25fba56e1205" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8b054fff-91eb-4956-bee7-dda744f4f00b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_871186b7-b379-419e-8720-7430f38744b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3299ca4d-49da-4301-b7ef-25fba56e1205" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_871186b7-b379-419e-8720-7430f38744b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_7c29d015-147b-49c8-b646-13cdfa36cf42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3299ca4d-49da-4301-b7ef-25fba56e1205" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_7c29d015-147b-49c8-b646-13cdfa36cf42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a6ae542b-1a0c-425b-b66c-8417fa005af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3299ca4d-49da-4301-b7ef-25fba56e1205" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a6ae542b-1a0c-425b-b66c-8417fa005af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a078848a-1fc7-4bdf-8e2b-5445f0239fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3299ca4d-49da-4301-b7ef-25fba56e1205" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a078848a-1fc7-4bdf-8e2b-5445f0239fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d7c557ad-07bd-4429-aea1-9099f6ef4bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_89c40499-db8f-420b-93b3-7b6dee83b49a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d7c557ad-07bd-4429-aea1-9099f6ef4bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_50df93a3-1d58-440a-b1f0-507bcea1dd04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_89c40499-db8f-420b-93b3-7b6dee83b49a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_50df93a3-1d58-440a-b1f0-507bcea1dd04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9645f2b2-092c-4a82-a6b3-4b0e0337867d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract_89c40499-db8f-420b-93b3-7b6dee83b49a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9645f2b2-092c-4a82-a6b3-4b0e0337867d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="dgx-20230331.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_f5d33b4a-88c8-440e-8cbd-3f0c72ff6ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6f0939b2-2337-45cc-8a8d-375a1cf739d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_f5d33b4a-88c8-440e-8cbd-3f0c72ff6ea3" xlink:to="loc_us-gaap_StatementTable_6f0939b2-2337-45cc-8a8d-375a1cf739d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_abdff726-9e12-422a-81bd-609573358839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6f0939b2-2337-45cc-8a8d-375a1cf739d4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_abdff726-9e12-422a-81bd-609573358839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6b9d488b-3ef7-400f-adbd-cf944dda987b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_abdff726-9e12-422a-81bd-609573358839" xlink:to="loc_us-gaap_EquityComponentDomain_6b9d488b-3ef7-400f-adbd-cf944dda987b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_193d99af-14d3-4ff1-be39-9892f80c3149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6b9d488b-3ef7-400f-adbd-cf944dda987b" xlink:to="loc_us-gaap_CommonStockMember_193d99af-14d3-4ff1-be39-9892f80c3149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_11754c3e-d488-4c9b-b3f5-f1e0e8d89bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6b9d488b-3ef7-400f-adbd-cf944dda987b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_11754c3e-d488-4c9b-b3f5-f1e0e8d89bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e55694e5-ce8d-42b3-802a-b7f60fdf8eff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6b9d488b-3ef7-400f-adbd-cf944dda987b" xlink:to="loc_us-gaap_RetainedEarningsMember_e55694e5-ce8d-42b3-802a-b7f60fdf8eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_470b534c-23b4-413e-aa73-d589b6086ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6b9d488b-3ef7-400f-adbd-cf944dda987b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_470b534c-23b4-413e-aa73-d589b6086ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_7ff2e9b1-bcc6-44f0-8799-e7a4d95230ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6b9d488b-3ef7-400f-adbd-cf944dda987b" xlink:to="loc_us-gaap_TreasuryStockMember_7ff2e9b1-bcc6-44f0-8799-e7a4d95230ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_c4032ef1-b3af-4207-ab7c-e4d21778c8da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6b9d488b-3ef7-400f-adbd-cf944dda987b" xlink:to="loc_us-gaap_NoncontrollingInterestMember_c4032ef1-b3af-4207-ab7c-e4d21778c8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fe82f29d-7a3a-4b3d-9d7c-0b15e1d9b70d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6f0939b2-2337-45cc-8a8d-375a1cf739d4" xlink:to="loc_us-gaap_StatementLineItems_fe82f29d-7a3a-4b3d-9d7c-0b15e1d9b70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fe82f29d-7a3a-4b3d-9d7c-0b15e1d9b70d" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d75986f2-a955-4a6c-bfc1-c9f5381fb313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d75986f2-a955-4a6c-bfc1-c9f5381fb313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dfa7cfe0-f026-4368-8194-ea01d0ce8c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dfa7cfe0-f026-4368-8194-ea01d0ce8c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_5b546009-e68a-4639-9516-166ba9e4a9d9" xlink:href="dgx-20230331.xsd#dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_5b546009-e68a-4639-9516-166ba9e4a9d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_341627e3-fbf7-459b-a584-222589434cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_341627e3-fbf7-459b-a584-222589434cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_22693fd6-997c-45fe-bc90-048a7ee75b36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_DividendsCommonStockCash_22693fd6-997c-45fe-bc90-048a7ee75b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_c2a4b0be-8218-4052-b257-79d344ac34f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_c2a4b0be-8218-4052-b257-79d344ac34f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_9460bf3f-f0e2-4046-a4bb-cc2f4d44f1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_9460bf3f-f0e2-4046-a4bb-cc2f4d44f1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_dd17eeb8-34fb-4e26-9a5b-69880abd989a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_dd17eeb8-34fb-4e26-9a5b-69880abd989a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_540a145c-df0b-4ee3-8906-bac6a1f652f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_540a145c-df0b-4ee3-8906-bac6a1f652f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_986514da-cf3e-4ca7-959e-8a1093aa9a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_986514da-cf3e-4ca7-959e-8a1093aa9a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_af9da273-56be-4cee-a286-ddad4170bc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_af9da273-56be-4cee-a286-ddad4170bc9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_19194982-0f9e-42e1-ac4c-90d2dbe4270e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_19194982-0f9e-42e1-ac4c-90d2dbe4270e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_59bd13cd-c30b-43c4-9a0e-4f76e01b5615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_59bd13cd-c30b-43c4-9a0e-4f76e01b5615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1839797b-c204-45cc-9cda-a16d2c17ee06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1839797b-c204-45cc-9cda-a16d2c17ee06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_eb40c716-ef38-417c-a0bc-fd0f823342a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ad996d66-c1ca-492e-ae49-533067422062" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_eb40c716-ef38-417c-a0bc-fd0f823342a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_767233ad-06b4-4af0-91a1-fde35358c5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fe82f29d-7a3a-4b3d-9d7c-0b15e1d9b70d" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_767233ad-06b4-4af0-91a1-fde35358c5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_b266c5f7-f608-47c4-880c-c9054ecab6b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_767233ad-06b4-4af0-91a1-fde35358c5b8" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_b266c5f7-f608-47c4-880c-c9054ecab6b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_b5f392ed-7fb4-43ff-aa1d-5241c2dcd6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_767233ad-06b4-4af0-91a1-fde35358c5b8" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_b5f392ed-7fb4-43ff-aa1d-5241c2dcd6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_db5c1ff8-03c0-439b-a987-1d114d1483c1" xlink:href="dgx-20230331.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_767233ad-06b4-4af0-91a1-fde35358c5b8" xlink:to="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_db5c1ff8-03c0-439b-a987-1d114d1483c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_96fc9f75-3b95-413c-bb15-1d6defeacceb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_767233ad-06b4-4af0-91a1-fde35358c5b8" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_96fc9f75-3b95-413c-bb15-1d6defeacceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="simple" xlink:href="dgx-20230331.xsd#DESCRIPTIONOFBUSINESS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DescriptionOfBusinessAbstract_d9b4e267-c670-4ee6-96bd-ec2bbfed2e98" xlink:href="dgx-20230331.xsd#dgx_DescriptionOfBusinessAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_59c0856c-bc0b-4860-856a-784536ffc57c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_DescriptionOfBusinessAbstract_d9b4e267-c670-4ee6-96bd-ec2bbfed2e98" xlink:to="loc_us-gaap_NatureOfOperations_59c0856c-bc0b-4860-856a-784536ffc57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="dgx-20230331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_95001597-34e2-4f3b-9860-459e1203efaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_ac832e53-4e6b-4669-99b3-147b9c508f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_95001597-34e2-4f3b-9860-459e1203efaa" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_ac832e53-4e6b-4669-99b3-147b9c508f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="dgx-20230331.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_828a8928-8556-4cfa-b25e-16392fa93905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_0787214a-c941-4516-a155-9874944bcdfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_828a8928-8556-4cfa-b25e-16392fa93905" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_0787214a-c941-4516-a155-9874944bcdfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIES" xlink:type="simple" xlink:href="dgx-20230331.xsd#RESTRUCTURINGACTIVITIES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_6dbcf552-da1a-4c42-8d0e-4a307fbc0a05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_3f61b7fb-702c-4744-a80a-2f5a5b1139bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_6dbcf552-da1a-4c42-8d0e-4a307fbc0a05" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_3f61b7fb-702c-4744-a80a-2f5a5b1139bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="simple" xlink:href="dgx-20230331.xsd#BUSINESSACQUISITIONS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_abecb552-41d7-47ee-b961-d14034652644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_a611d87c-2112-49ad-bfcf-d0588b19dfd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_abecb552-41d7-47ee-b961-d14034652644" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_a611d87c-2112-49ad-bfcf-d0588b19dfd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="dgx-20230331.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2a9ab066-859c-4566-9750-3efe1a4e0c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_9adb86d9-18a3-4dee-88d8-273788d85a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2a9ab066-859c-4566-9750-3efe1a4e0c2c" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_9adb86d9-18a3-4dee-88d8-273788d85a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBT" xlink:type="simple" xlink:href="dgx-20230331.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_055bf265-cbf6-473b-9625-4ffc9d61956a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_6ec62425-484b-4052-9a93-d314759184c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_055bf265-cbf6-473b-9625-4ffc9d61956a" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_6ec62425-484b-4052-9a93-d314759184c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="dgx-20230331.xsd#FINANCIALINSTRUMENTS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_708be5c8-bb2d-43af-8265-4657c8f1d945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_e453dc0e-c089-4d45-b505-50b754f78ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_708be5c8-bb2d-43af-8265-4657c8f1d945" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_e453dc0e-c089-4d45-b505-50b754f78ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="simple" xlink:href="dgx-20230331.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_e36d2ef2-bc2a-485f-b1b8-084789ee06cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_81da8687-d8be-4c3b-a270-9d52eda36c95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e36d2ef2-bc2a-485f-b1b8-084789ee06cf" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_81da8687-d8be-4c3b-a270-9d52eda36c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA" xlink:type="simple" xlink:href="dgx-20230331.xsd#SUPPLEMENTALCASHFLOWOTHERDATA"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_2c5728c0-165c-4877-9830-2efac535cdd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_4e5e5758-19dc-4dba-a765-52797654e8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_2c5728c0-165c-4877-9830-2efac535cdd2" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_4e5e5758-19dc-4dba-a765-52797654e8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="dgx-20230331.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bf74caf4-7162-4238-b351-687d9011860a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_552a407c-9778-465c-a79f-096a50bdd7ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bf74caf4-7162-4238-b351-687d9011860a" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_552a407c-9778-465c-a79f-096a50bdd7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="simple" xlink:href="dgx-20230331.xsd#BUSINESSSEGMENTINFORMATION"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_abf45fd8-cf75-47bb-8b1b-9bdfc5569234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_56034356-4d50-4318-a95d-918bd45af0bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_abf45fd8-cf75-47bb-8b1b-9bdfc5569234" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_56034356-4d50-4318-a95d-918bd45af0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITION" xlink:type="simple" xlink:href="dgx-20230331.xsd#REVENUERECOGNITION"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a96a4669-6195-482a-9184-fc6ee447f650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_eca94576-05ed-4bff-ab56-5feced99c5cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a96a4669-6195-482a-9184-fc6ee447f650" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_eca94576-05ed-4bff-ab56-5feced99c5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOME" xlink:type="simple" xlink:href="dgx-20230331.xsd#TAXESONINCOME"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d1bf4898-7ca2-400c-b3c7-42a1bb81acbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_387d13a9-60e4-4456-899b-00259973aaa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d1bf4898-7ca2-400c-b3c7-42a1bb81acbf" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_387d13a9-60e4-4456-899b-00259973aaa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="dgx-20230331.xsd#SUBSEQUENTEVENTS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUBSEQUENTEVENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_84009c73-719b-4a20-ac8a-c06b3f6c62ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_9d85212c-0eab-45be-af01-b13ae234db42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_84009c73-719b-4a20-ac8a-c06b3f6c62ec" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_9d85212c-0eab-45be-af01-b13ae234db42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="dgx-20230331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_78e4da04-4f65-402a-b169-8b778ac32a15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1c2d1bf5-d260-41ea-adb9-f94fb5aec821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_78e4da04-4f65-402a-b169-8b778ac32a15" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1c2d1bf5-d260-41ea-adb9-f94fb5aec821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_aed9395e-22d3-4cf4-b1de-a2fea5536396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_78e4da04-4f65-402a-b169-8b778ac32a15" xlink:to="loc_us-gaap_UseOfEstimates_aed9395e-22d3-4cf4-b1de-a2fea5536396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_126ec1d5-6b73-43f8-b165-dcd115b0bf22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_78e4da04-4f65-402a-b169-8b778ac32a15" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_126ec1d5-6b73-43f8-b165-dcd115b0bf22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8b01f2e8-b233-4f91-a566-8bce9f95102b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_78e4da04-4f65-402a-b169-8b778ac32a15" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8b01f2e8-b233-4f91-a566-8bce9f95102b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_147769f4-2fdd-4ddc-b5a2-662befb0c668" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_78e4da04-4f65-402a-b169-8b778ac32a15" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_147769f4-2fdd-4ddc-b5a2-662befb0c668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="dgx-20230331.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5e30b685-c734-4791-a7c9-c722ff3dc817" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_837e0949-a9bd-49e9-b41c-7e0d1cbdc06f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5e30b685-c734-4791-a7c9-c722ff3dc817" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_837e0949-a9bd-49e9-b41c-7e0d1cbdc06f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="dgx-20230331.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_381effb6-42e3-409c-b709-e59885ac00cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_d0aeba6d-b513-4513-8da3-6d6df7882c77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_381effb6-42e3-409c-b709-e59885ac00cf" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_d0aeba6d-b513-4513-8da3-6d6df7882c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_f83e549e-203a-4df6-82bd-249f02a0fe15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_381effb6-42e3-409c-b709-e59885ac00cf" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_f83e549e-203a-4df6-82bd-249f02a0fe15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="dgx-20230331.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a46e40e8-175a-4fa5-8f7c-6f6e53b79c28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_2414ee28-cf74-4e7a-96ca-917718ce43ce" xlink:href="dgx-20230331.xsd#dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a46e40e8-175a-4fa5-8f7c-6f6e53b79c28" xlink:to="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_2414ee28-cf74-4e7a-96ca-917718ce43ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables" xlink:type="simple" xlink:href="dgx-20230331.xsd#SUPPLEMENTALCASHFLOWOTHERDATATables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_9a6289d9-fb50-4167-a69b-7fd315cd1bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_e0ea8d5c-2e84-485e-9876-206154c8333c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_9a6289d9-fb50-4167-a69b-7fd315cd1bc4" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_e0ea8d5c-2e84-485e-9876-206154c8333c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="dgx-20230331.xsd#BUSINESSSEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4d2fbe6c-f4fc-443d-878c-8fa787b27959" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b6a3d2c2-3372-4389-a916-813e7809b1da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4d2fbe6c-f4fc-443d-878c-8fa787b27959" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b6a3d2c2-3372-4389-a916-813e7809b1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_d578b2f5-d0c3-4cca-ad0d-5617c0c362ee" xlink:href="dgx-20230331.xsd#dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4d2fbe6c-f4fc-443d-878c-8fa787b27959" xlink:to="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_d578b2f5-d0c3-4cca-ad0d-5617c0c362ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONTables" xlink:type="simple" xlink:href="dgx-20230331.xsd#REVENUERECOGNITIONTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_67d44fcd-4e60-4bd9-867e-6dc8ab403752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_e8cf37a3-1d74-4d45-a282-aa64cc7959df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_67d44fcd-4e60-4bd9-867e-6dc8ab403752" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_e8cf37a3-1d74-4d45-a282-aa64cc7959df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AccountsReceivableDisaggregationTableTextBlock_1dc36ca4-c865-4608-914e-d735e19f384f" xlink:href="dgx-20230331.xsd#dgx_AccountsReceivableDisaggregationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_67d44fcd-4e60-4bd9-867e-6dc8ab403752" xlink:to="loc_dgx_AccountsReceivableDisaggregationTableTextBlock_1dc36ca4-c865-4608-914e-d735e19f384f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#EARNINGSPERSHAREDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f7d953a3-82ba-466b-8b4f-91cd54925c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_6fb62470-1660-4984-81f7-3d2aff6b324b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f7d953a3-82ba-466b-8b4f-91cd54925c5c" xlink:to="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_6fb62470-1660-4984-81f7-3d2aff6b324b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_08cb59c4-2710-4396-bf7f-1a777a25d771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_6fb62470-1660-4984-81f7-3d2aff6b324b" xlink:to="loc_us-gaap_NetIncomeLoss_08cb59c4-2710-4396-bf7f-1a777a25d771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_fc7f416f-4713-44ce-bcd5-50f91c36f829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_6fb62470-1660-4984-81f7-3d2aff6b324b" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_fc7f416f-4713-44ce-bcd5-50f91c36f829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_3d8f9b5d-9e0e-4a25-b5b6-56e2e57273ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_6fb62470-1660-4984-81f7-3d2aff6b324b" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_3d8f9b5d-9e0e-4a25-b5b6-56e2e57273ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_14221550-14a4-4f5d-8a7d-67a22a838ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_6fb62470-1660-4984-81f7-3d2aff6b324b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_14221550-14a4-4f5d-8a7d-67a22a838ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f08a17be-70b7-4f55-a45e-92361da0f7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_6fb62470-1660-4984-81f7-3d2aff6b324b" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f08a17be-70b7-4f55-a45e-92361da0f7cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_98219c99-a10c-4d3e-b249-c944e107e10d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_6fb62470-1660-4984-81f7-3d2aff6b324b" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_98219c99-a10c-4d3e-b249-c944e107e10d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_d5ea831e-9d73-401b-98ca-2b5499261f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_6fb62470-1660-4984-81f7-3d2aff6b324b" xlink:to="loc_us-gaap_EarningsPerShareBasic_d5ea831e-9d73-401b-98ca-2b5499261f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c6dabe81-e6c3-4dfa-bf57-680d6c01d852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_6fb62470-1660-4984-81f7-3d2aff6b324b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c6dabe81-e6c3-4dfa-bf57-680d6c01d852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_cf405ad4-9e8b-4793-8596-979bb79c1883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f7d953a3-82ba-466b-8b4f-91cd54925c5c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_cf405ad4-9e8b-4793-8596-979bb79c1883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#RESTRUCTURINGACTIVITIESDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f434c6ef-6fd9-4d41-9600-58fee2e91e52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1bb90b6b-9343-4706-ab52-682bc6e1dfbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f434c6ef-6fd9-4d41-9600-58fee2e91e52" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1bb90b6b-9343-4706-ab52-682bc6e1dfbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_769a80aa-ddc6-466d-ac40-e7ba10ba80b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1bb90b6b-9343-4706-ab52-682bc6e1dfbc" xlink:to="loc_us-gaap_RestructuringPlanAxis_769a80aa-ddc6-466d-ac40-e7ba10ba80b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_27a54dc1-a246-474c-b478-111b75fdd416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_769a80aa-ddc6-466d-ac40-e7ba10ba80b7" xlink:to="loc_us-gaap_RestructuringPlanDomain_27a54dc1-a246-474c-b478-111b75fdd416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InvigorateProgramMember_399263b7-28b2-4162-9417-058a278cfa33" xlink:href="dgx-20230331.xsd#dgx_InvigorateProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_27a54dc1-a246-474c-b478-111b75fdd416" xlink:to="loc_dgx_InvigorateProgramMember_399263b7-28b2-4162-9417-058a278cfa33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_2e2d7848-5d07-416a-b14c-38b90911dd44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1bb90b6b-9343-4706-ab52-682bc6e1dfbc" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_2e2d7848-5d07-416a-b14c-38b90911dd44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_6cbfd9fc-0c4a-4cae-baf6-88ca555a353e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_2e2d7848-5d07-416a-b14c-38b90911dd44" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_6cbfd9fc-0c4a-4cae-baf6-88ca555a353e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_3704dc19-9860-454b-9c24-469be5d8c406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6cbfd9fc-0c4a-4cae-baf6-88ca555a353e" xlink:to="loc_us-gaap_CostOfSalesMember_3704dc19-9860-454b-9c24-469be5d8c406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_89bcd27c-b5aa-428a-80a2-bd81ba3203a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6cbfd9fc-0c4a-4cae-baf6-88ca555a353e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_89bcd27c-b5aa-428a-80a2-bd81ba3203a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4ca425da-4ce7-4430-9f6c-d6a6e94264d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1bb90b6b-9343-4706-ab52-682bc6e1dfbc" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4ca425da-4ce7-4430-9f6c-d6a6e94264d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_33ecf6fd-ed7f-4db2-b1b1-86972a695546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4ca425da-4ce7-4430-9f6c-d6a6e94264d2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_33ecf6fd-ed7f-4db2-b1b1-86972a695546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_3ad5734c-d668-45a7-93a7-2b4df0a58224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_33ecf6fd-ed7f-4db2-b1b1-86972a695546" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_3ad5734c-d668-45a7-93a7-2b4df0a58224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_5e7475bc-21ad-41af-984d-2ae282d45321" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1bb90b6b-9343-4706-ab52-682bc6e1dfbc" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_5e7475bc-21ad-41af-984d-2ae282d45321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_0ec34cb9-f277-47a7-a568-b55fc4d2ebe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5e7475bc-21ad-41af-984d-2ae282d45321" xlink:to="loc_us-gaap_SeveranceCosts1_0ec34cb9-f277-47a7-a568-b55fc4d2ebe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_34cbd5e3-1650-4bb5-93bc-f9d35f616e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5e7475bc-21ad-41af-984d-2ae282d45321" xlink:to="loc_us-gaap_RestructuringCharges_34cbd5e3-1650-4bb5-93bc-f9d35f616e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_7b847853-c156-44f4-872c-fae6808efcf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_5e7475bc-21ad-41af-984d-2ae282d45321" xlink:to="loc_us-gaap_RestructuringReserve_7b847853-c156-44f4-872c-fae6808efcf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_22755ab5-8298-43a6-95c3-5c402a28a93c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6ece82c4-d5f5-4e76-ab7b-3e384bb5d4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_22755ab5-8298-43a6-95c3-5c402a28a93c" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6ece82c4-d5f5-4e76-ab7b-3e384bb5d4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ca39e87-63ba-44fd-b9b5-3cf8711d1ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6ece82c4-d5f5-4e76-ab7b-3e384bb5d4ae" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ca39e87-63ba-44fd-b9b5-3cf8711d1ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_8007bafe-188f-4c3f-96cd-e64d812e8610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2ca39e87-63ba-44fd-b9b5-3cf8711d1ac8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_8007bafe-188f-4c3f-96cd-e64d812e8610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_2e3c0782-b88b-45ce-8da0-a05f0098b8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_8007bafe-188f-4c3f-96cd-e64d812e8610" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_2e3c0782-b88b-45ce-8da0-a05f0098b8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3ea646b6-9c51-4f59-92ce-6263f12d02be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6ece82c4-d5f5-4e76-ab7b-3e384bb5d4ae" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3ea646b6-9c51-4f59-92ce-6263f12d02be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d83ec78d-86d4-4b10-ae87-adcab5d769a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3ea646b6-9c51-4f59-92ce-6263f12d02be" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d83ec78d-86d4-4b10-ae87-adcab5d769a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_005ed1a9-b839-4686-9f97-28c637e98904" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d83ec78d-86d4-4b10-ae87-adcab5d769a5" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_005ed1a9-b839-4686-9f97-28c637e98904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_7f4aa6a1-01d6-4922-904b-f4b213c6fd28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d83ec78d-86d4-4b10-ae87-adcab5d769a5" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_7f4aa6a1-01d6-4922-904b-f4b213c6fd28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_534103e3-0b27-4a87-bd61-294a4c13883b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d83ec78d-86d4-4b10-ae87-adcab5d769a5" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_534103e3-0b27-4a87-bd61-294a4c13883b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0ebae499-5bbe-40e5-b2ae-e748d1260d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_6ece82c4-d5f5-4e76-ab7b-3e384bb5d4ae" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0ebae499-5bbe-40e5-b2ae-e748d1260d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_8c84d31e-a02b-49d4-bb1f-fbee2e9ec3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0ebae499-5bbe-40e5-b2ae-e748d1260d6e" xlink:to="loc_us-gaap_TradingSecurities_8c84d31e-a02b-49d4-bb1f-fbee2e9ec3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_f960f7b6-4750-4123-9849-a08b68e38d40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0ebae499-5bbe-40e5-b2ae-e748d1260d6e" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_f960f7b6-4750-4123-9849-a08b68e38d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6b18fbde-37c6-457e-91cb-bd047f0a1496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0ebae499-5bbe-40e5-b2ae-e748d1260d6e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6b18fbde-37c6-457e-91cb-bd047f0a1496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_47c9bcda-0489-4d9e-95b6-92a1d2931060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0ebae499-5bbe-40e5-b2ae-e748d1260d6e" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_47c9bcda-0489-4d9e-95b6-92a1d2931060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_1503af56-5957-4fd3-9490-89c3562b1df5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0ebae499-5bbe-40e5-b2ae-e748d1260d6e" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_1503af56-5957-4fd3-9490-89c3562b1df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0b0384cb-d67e-41d4-8f4d-878676b70838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0ebae499-5bbe-40e5-b2ae-e748d1260d6e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0b0384cb-d67e-41d4-8f4d-878676b70838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_161b76b3-4614-4b5c-a43b-34cca544562f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0ebae499-5bbe-40e5-b2ae-e748d1260d6e" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_161b76b3-4614-4b5c-a43b-34cca544562f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_9c06b10a-c8a4-4b64-9437-f560393acd0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0ebae499-5bbe-40e5-b2ae-e748d1260d6e" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_9c06b10a-c8a4-4b64-9437-f560393acd0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6e175e44-3d4a-4451-b778-86aae90dd135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ebf18267-2326-45dd-824e-25e63b5bac89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6e175e44-3d4a-4451-b778-86aae90dd135" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ebf18267-2326-45dd-824e-25e63b5bac89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3ffdb197-287d-414a-a95d-4f417e538e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ebf18267-2326-45dd-824e-25e63b5bac89" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3ffdb197-287d-414a-a95d-4f417e538e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bbf5a825-808b-4705-ad98-92cfc5bea842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3ffdb197-287d-414a-a95d-4f417e538e0a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bbf5a825-808b-4705-ad98-92cfc5bea842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1d434ef3-3e5d-4ef5-bb10-d086a8ea2f04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bbf5a825-808b-4705-ad98-92cfc5bea842" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1d434ef3-3e5d-4ef5-bb10-d086a8ea2f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_5b125728-5edf-4633-a5c2-f6ba538c0961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ebf18267-2326-45dd-824e-25e63b5bac89" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_5b125728-5edf-4633-a5c2-f6ba538c0961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_4edb9f0d-8c9e-40e5-ab7d-b01a39f9ab19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_5b125728-5edf-4633-a5c2-f6ba538c0961" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_4edb9f0d-8c9e-40e5-ab7d-b01a39f9ab19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember_cec7cf5b-8c8a-4c00-801e-2f387b7a122b" xlink:href="dgx-20230331.xsd#dgx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_4edb9f0d-8c9e-40e5-ab7d-b01a39f9ab19" xlink:to="loc_dgx_ContingentConsiderationMember_cec7cf5b-8c8a-4c00-801e-2f387b7a122b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d3066b9f-a1ec-44bf-b12a-d963c9e16b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ebf18267-2326-45dd-824e-25e63b5bac89" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d3066b9f-a1ec-44bf-b12a-d963c9e16b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4eaa3f21-d0ea-41d1-9f86-c0eb102989a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d3066b9f-a1ec-44bf-b12a-d963c9e16b27" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4eaa3f21-d0ea-41d1-9f86-c0eb102989a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_bbc4ac74-b532-4ff4-84fc-31a7df6b6e74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d3066b9f-a1ec-44bf-b12a-d963c9e16b27" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_bbc4ac74-b532-4ff4-84fc-31a7df6b6e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9f167e47-8be3-4ea8-9cba-0d0640bae28f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d3066b9f-a1ec-44bf-b12a-d963c9e16b27" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9f167e47-8be3-4ea8-9cba-0d0640bae28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_01120bc2-b341-4198-ab41-f7c2f0729ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e178780c-8115-4801-93d8-ae57785f8e93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_01120bc2-b341-4198-ab41-f7c2f0729ff8" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e178780c-8115-4801-93d8-ae57785f8e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_b4a07714-6083-4e82-b927-7052069d811f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e178780c-8115-4801-93d8-ae57785f8e93" xlink:to="loc_srt_OwnershipAxis_b4a07714-6083-4e82-b927-7052069d811f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_75c9b62e-68dd-4b30-8e58-244383a1d8c2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_b4a07714-6083-4e82-b927-7052069d811f" xlink:to="loc_srt_OwnershipDomain_75c9b62e-68dd-4b30-8e58-244383a1d8c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_5aec1694-d193-4792-9a85-15dabf85a948" xlink:href="dgx-20230331.xsd#dgx_UMassJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_75c9b62e-68dd-4b30-8e58-244383a1d8c2" xlink:to="loc_dgx_UMassJointVentureMember_5aec1694-d193-4792-9a85-15dabf85a948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b9648f94-50cd-402c-ae2a-3ee41df0c81c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_e178780c-8115-4801-93d8-ae57785f8e93" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b9648f94-50cd-402c-ae2a-3ee41df0c81c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_265a4b27-2e7b-4635-aece-4d8d6ffd1b68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b9648f94-50cd-402c-ae2a-3ee41df0c81c" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_265a4b27-2e7b-4635-aece-4d8d6ffd1b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_72941174-5913-4273-b94e-1b1e5df9d681" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_01120bc2-b341-4198-ab41-f7c2f0729ff8" xlink:to="loc_us-gaap_DebtInstrumentFairValue_72941174-5913-4273-b94e-1b1e5df9d681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#DEBTDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DEBTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9bbdd329-b0ea-4972-a5bc-fa195a50d86a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1ed67c9f-302e-426c-9066-a56c2d17876b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9bbdd329-b0ea-4972-a5bc-fa195a50d86a" xlink:to="loc_us-gaap_DebtInstrumentTable_1ed67c9f-302e-426c-9066-a56c2d17876b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_432dca48-dfe8-423a-9c8a-2b7de3dceced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1ed67c9f-302e-426c-9066-a56c2d17876b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_432dca48-dfe8-423a-9c8a-2b7de3dceced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7d6f90bc-498b-4a94-af98-da3afcad8b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_432dca48-dfe8-423a-9c8a-2b7de3dceced" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7d6f90bc-498b-4a94-af98-da3afcad8b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_c82bb24b-cdea-42bd-bf40-8ecd7f41cd64" xlink:href="dgx-20230331.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7d6f90bc-498b-4a94-af98-da3afcad8b61" xlink:to="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_c82bb24b-cdea-42bd-bf40-8ecd7f41cd64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_37fd1de7-da2b-4502-95bf-c95b0251a288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1ed67c9f-302e-426c-9066-a56c2d17876b" xlink:to="loc_us-gaap_CreditFacilityAxis_37fd1de7-da2b-4502-95bf-c95b0251a288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5acccf40-bfcc-411b-a137-3499ae1f647b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_37fd1de7-da2b-4502-95bf-c95b0251a288" xlink:to="loc_us-gaap_CreditFacilityDomain_5acccf40-bfcc-411b-a137-3499ae1f647b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_2bd8ebb7-d952-4dfc-94bd-f6b283b5e6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_5acccf40-bfcc-411b-a137-3499ae1f647b" xlink:to="loc_us-gaap_LetterOfCreditMember_2bd8ebb7-d952-4dfc-94bd-f6b283b5e6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_57c3af4a-1847-4359-90b8-9857ded9e989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1ed67c9f-302e-426c-9066-a56c2d17876b" xlink:to="loc_us-gaap_VariableRateAxis_57c3af4a-1847-4359-90b8-9857ded9e989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e4e435f6-bddc-4efb-86c7-4a7f29b55c92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_57c3af4a-1847-4359-90b8-9857ded9e989" xlink:to="loc_us-gaap_VariableRateDomain_e4e435f6-bddc-4efb-86c7-4a7f29b55c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_a91362c9-d26a-4461-9b98-28121146e3bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_e4e435f6-bddc-4efb-86c7-4a7f29b55c92" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_a91362c9-d26a-4461-9b98-28121146e3bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d9c9d5b6-4d1f-4025-9de2-8f66894354cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1ed67c9f-302e-426c-9066-a56c2d17876b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d9c9d5b6-4d1f-4025-9de2-8f66894354cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3ac4db6b-dcce-42c2-9d31-6b8d522f31cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d9c9d5b6-4d1f-4025-9de2-8f66894354cf" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3ac4db6b-dcce-42c2-9d31-6b8d522f31cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d824d5b8-9ed7-4ece-b11e-74483d91db9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d9c9d5b6-4d1f-4025-9de2-8f66894354cf" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d824d5b8-9ed7-4ece-b11e-74483d91db9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_c7bd05b5-e7b9-438e-ac40-1d8b81d58994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d9c9d5b6-4d1f-4025-9de2-8f66894354cf" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_c7bd05b5-e7b9-438e-ac40-1d8b81d58994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#FINANCIALINSTRUMENTSBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_609f8348-0c75-4a48-8a60-43f633e405cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_632f9e69-0d74-4062-bee4-dc3ba4d3590e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_609f8348-0c75-4a48-8a60-43f633e405cf" xlink:to="loc_us-gaap_DerivativeTable_632f9e69-0d74-4062-bee4-dc3ba4d3590e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2c00e4f2-06a6-4119-b77e-f0188aee9b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_632f9e69-0d74-4062-bee4-dc3ba4d3590e" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2c00e4f2-06a6-4119-b77e-f0188aee9b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4c7e8458-fd38-4470-b539-f14b21e4df44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2c00e4f2-06a6-4119-b77e-f0188aee9b34" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4c7e8458-fd38-4470-b539-f14b21e4df44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_493bb4ea-4ee8-4fb9-a991-6e65599f6296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4c7e8458-fd38-4470-b539-f14b21e4df44" xlink:to="loc_us-gaap_LongTermDebtMember_493bb4ea-4ee8-4fb9-a991-6e65599f6296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6b7df0db-9885-473e-9294-ec672a05793f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_632f9e69-0d74-4062-bee4-dc3ba4d3590e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6b7df0db-9885-473e-9294-ec672a05793f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d4fee3d6-0a42-4e35-8320-6ab60e9b9c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6b7df0db-9885-473e-9294-ec672a05793f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d4fee3d6-0a42-4e35-8320-6ab60e9b9c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_b4ee8982-2ae4-493a-bab1-6d6cabf057af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d4fee3d6-0a42-4e35-8320-6ab60e9b9c5d" xlink:to="loc_us-gaap_FairValueHedgingMember_b4ee8982-2ae4-493a-bab1-6d6cabf057af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_d3bfed31-6506-40fa-b367-0b15e7f6954e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_632f9e69-0d74-4062-bee4-dc3ba4d3590e" xlink:to="loc_us-gaap_DerivativeLineItems_d3bfed31-6506-40fa-b367-0b15e7f6954e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_68ce7be9-44ee-4a43-91bc-59ef371279f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d3bfed31-6506-40fa-b367-0b15e7f6954e" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_68ce7be9-44ee-4a43-91bc-59ef371279f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_e3963593-728f-4bd4-ae40-d56a4a6c6ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_989f5f46-623f-4c45-9738-c75ad9023279" xlink:href="dgx-20230331.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e3963593-728f-4bd4-ae40-d56a4a6c6ab0" xlink:to="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_989f5f46-623f-4c45-9738-c75ad9023279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_09329139-9e70-4474-ae8a-d361c5ae42df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_989f5f46-623f-4c45-9738-c75ad9023279" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_09329139-9e70-4474-ae8a-d361c5ae42df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a7d645cc-9e2b-418d-bf95-ef578f6c932a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_09329139-9e70-4474-ae8a-d361c5ae42df" xlink:to="loc_us-gaap_EquityComponentDomain_a7d645cc-9e2b-418d-bf95-ef578f6c932a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_fb366ccb-b5a4-4169-85af-6fb6bb0361df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a7d645cc-9e2b-418d-bf95-ef578f6c932a" xlink:to="loc_us-gaap_TreasuryStockMember_fb366ccb-b5a4-4169-85af-6fb6bb0361df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_4c980fe1-f746-489c-877e-0fad4fcda2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a7d645cc-9e2b-418d-bf95-ef578f6c932a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_4c980fe1-f746-489c-877e-0fad4fcda2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_552efd7a-981c-47ec-9574-dc1ab0aa78db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_989f5f46-623f-4c45-9738-c75ad9023279" xlink:to="loc_srt_OwnershipAxis_552efd7a-981c-47ec-9574-dc1ab0aa78db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_f78a281d-1b95-41e1-b6e3-9ecaed14189b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_552efd7a-981c-47ec-9574-dc1ab0aa78db" xlink:to="loc_srt_OwnershipDomain_f78a281d-1b95-41e1-b6e3-9ecaed14189b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_3bb96c89-3d57-44fa-9104-5871eaffb352" xlink:href="dgx-20230331.xsd#dgx_UMassJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_f78a281d-1b95-41e1-b6e3-9ecaed14189b" xlink:to="loc_dgx_UMassJointVentureMember_3bb96c89-3d57-44fa-9104-5871eaffb352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_d9fe64ba-0171-4427-9df9-1dd628536744" xlink:href="dgx-20230331.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_989f5f46-623f-4c45-9738-c75ad9023279" xlink:to="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_d9fe64ba-0171-4427-9df9-1dd628536744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_8f775c37-26e0-4a77-958e-554d6b56ef88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_d9fe64ba-0171-4427-9df9-1dd628536744" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_8f775c37-26e0-4a77-958e-554d6b56ef88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_bf5ca2d2-a6ec-4a69-a84c-fe703a726625" xlink:href="dgx-20230331.xsd#dgx_StockRepurchaseProgramAdditionalAmountAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_d9fe64ba-0171-4427-9df9-1dd628536744" xlink:to="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_bf5ca2d2-a6ec-4a69-a84c-fe703a726625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_dec20b55-b3b3-4f35-82b7-5b7140b60a84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_d9fe64ba-0171-4427-9df9-1dd628536744" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_dec20b55-b3b3-4f35-82b7-5b7140b60a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_80396f3f-dd98-4581-8da1-5c1ed817af9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_d9fe64ba-0171-4427-9df9-1dd628536744" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_80396f3f-dd98-4581-8da1-5c1ed817af9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_86658e5a-9747-4891-b0ec-199770047bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_d9fe64ba-0171-4427-9df9-1dd628536744" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_86658e5a-9747-4891-b0ec-199770047bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_ac72f4fc-3a25-4979-b8fe-d0ef0bc472dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_d9fe64ba-0171-4427-9df9-1dd628536744" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_ac72f4fc-3a25-4979-b8fe-d0ef0bc472dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_c078d0f6-ed21-4ed5-ad4c-7ba717db0d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_d9fe64ba-0171-4427-9df9-1dd628536744" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_c078d0f6-ed21-4ed5-ad4c-7ba717db0d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#SUPPLEMENTALCASHFLOWOTHERDATADetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_e3961605-2b48-4a67-92a7-769e598ca257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_ed34613f-c9e6-4865-afab-fdb9671c2936" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_e3961605-2b48-4a67-92a7-769e598ca257" xlink:to="loc_us-gaap_Depreciation_ed34613f-c9e6-4865-afab-fdb9671c2936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_6b1cc460-8636-4955-a98f-215ea735c7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_e3961605-2b48-4a67-92a7-769e598ca257" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_6b1cc460-8636-4955-a98f-215ea735c7c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_ebe0ff2b-5387-41f5-8d5f-9001ed07c9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_e3961605-2b48-4a67-92a7-769e598ca257" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_ebe0ff2b-5387-41f5-8d5f-9001ed07c9e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e2d71a07-6041-410b-9f18-35be6a5d7c70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_e3961605-2b48-4a67-92a7-769e598ca257" xlink:to="loc_us-gaap_InterestExpense_e2d71a07-6041-410b-9f18-35be6a5d7c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_6551ca9a-db0d-4c11-8692-378ec54d5488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_e3961605-2b48-4a67-92a7-769e598ca257" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_6551ca9a-db0d-4c11-8692-378ec54d5488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_e9e4b360-cac8-4e68-aef2-5f19659993ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_e3961605-2b48-4a67-92a7-769e598ca257" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_e9e4b360-cac8-4e68-aef2-5f19659993ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_36cebf28-c84f-4423-a9cd-2f434ccb1822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_e3961605-2b48-4a67-92a7-769e598ca257" xlink:to="loc_us-gaap_InterestPaidNet_36cebf28-c84f-4423-a9cd-2f434ccb1822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_06155348-4a4c-4452-9f57-e3874a321d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_e3961605-2b48-4a67-92a7-769e598ca257" xlink:to="loc_us-gaap_IncomeTaxesPaid_06155348-4a4c-4452-9f57-e3874a321d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_5a3ca7f4-d0c4-4d1d-842b-2da9df1cbdc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_e3961605-2b48-4a67-92a7-769e598ca257" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_5a3ca7f4-d0c4-4d1d-842b-2da9df1cbdc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_e0461561-324a-4a89-9c77-62ce533aff5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_e3961605-2b48-4a67-92a7-769e598ca257" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_e0461561-324a-4a89-9c77-62ce533aff5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_e7aa451b-c996-44f6-9e2c-dda2ac24d1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_e3961605-2b48-4a67-92a7-769e598ca257" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_e7aa451b-c996-44f6-9e2c-dda2ac24d1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_39e54765-fb8a-466f-9935-d443f277e9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_e3961605-2b48-4a67-92a7-769e598ca257" xlink:to="loc_us-gaap_LiabilitiesAssumed1_39e54765-fb8a-466f-9935-d443f277e9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired_43fdb7ff-3031-4b54-8196-64451516a7a2" xlink:href="dgx-20230331.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_e3961605-2b48-4a67-92a7-769e598ca257" xlink:to="loc_dgx_FairValueOfNetAssetsAcquired_43fdb7ff-3031-4b54-8196-64451516a7a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Mergerconsiderationpaidpayablenet_4e2548b9-ee85-4866-ab00-710072004e63" xlink:href="dgx-20230331.xsd#dgx_Mergerconsiderationpaidpayablenet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_e3961605-2b48-4a67-92a7-769e598ca257" xlink:to="loc_dgx_Mergerconsiderationpaidpayablenet_4e2548b9-ee85-4866-ab00-710072004e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_53c36c13-1cd0-4852-98c6-fa76605dacc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_e3961605-2b48-4a67-92a7-769e598ca257" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_53c36c13-1cd0-4852-98c6-fa76605dacc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_74a0933c-e9a3-48e1-97fb-832e86300c25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_e3961605-2b48-4a67-92a7-769e598ca257" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_74a0933c-e9a3-48e1-97fb-832e86300c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_66aae602-83c7-42cc-839f-a7c89f751945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_e3961605-2b48-4a67-92a7-769e598ca257" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_66aae602-83c7-42cc-839f-a7c89f751945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_3ae14cde-aa9b-4158-9372-37939e217f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_e3961605-2b48-4a67-92a7-769e598ca257" xlink:to="loc_us-gaap_LeaseCostAbstract_3ae14cde-aa9b-4158-9372-37939e217f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9f681936-2a71-4fc7-9332-aa6d40c25cce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_3ae14cde-aa9b-4158-9372-37939e217f0a" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9f681936-2a71-4fc7-9332-aa6d40c25cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_45dea9c0-363f-44b7-bede-bfa984cea44b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_86de4baa-a86c-4bfb-ada3-f62eb1e2ee8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_45dea9c0-363f-44b7-bede-bfa984cea44b" xlink:to="loc_us-gaap_LossContingenciesTable_86de4baa-a86c-4bfb-ada3-f62eb1e2ee8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_158fba02-2141-4545-8cde-72f10cf531da" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_86de4baa-a86c-4bfb-ada3-f62eb1e2ee8c" xlink:to="loc_srt_LitigationCaseAxis_158fba02-2141-4545-8cde-72f10cf531da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_44577e08-2fc3-4687-a5c0-73bec8a46ae5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_158fba02-2141-4545-8cde-72f10cf531da" xlink:to="loc_srt_LitigationCaseTypeDomain_44577e08-2fc3-4687-a5c0-73bec8a46ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_A401kPlanLawsuitMember_420d1c19-04f3-4246-b7dc-cc79c9b0d5e2" xlink:href="dgx-20230331.xsd#dgx_A401kPlanLawsuitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_44577e08-2fc3-4687-a5c0-73bec8a46ae5" xlink:to="loc_dgx_A401kPlanLawsuitMember_420d1c19-04f3-4246-b7dc-cc79c9b0d5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DataSecurityIncidentMember_859f9357-1203-4149-95ed-5c26a8741ef8" xlink:href="dgx-20230331.xsd#dgx_DataSecurityIncidentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_44577e08-2fc3-4687-a5c0-73bec8a46ae5" xlink:to="loc_dgx_DataSecurityIncidentMember_859f9357-1203-4149-95ed-5c26a8741ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_b275babf-7f6c-45d1-824a-77a4e7ef34f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_86de4baa-a86c-4bfb-ada3-f62eb1e2ee8c" xlink:to="loc_us-gaap_LitigationStatusAxis_b275babf-7f6c-45d1-824a-77a4e7ef34f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_a594891b-f4d4-468c-a92b-de18fba02081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_b275babf-7f6c-45d1-824a-77a4e7ef34f7" xlink:to="loc_us-gaap_LitigationStatusDomain_a594891b-f4d4-468c-a92b-de18fba02081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_4d351fe0-10e5-4a20-b6ff-7cb3867cd23a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_a594891b-f4d4-468c-a92b-de18fba02081" xlink:to="loc_us-gaap_PendingLitigationMember_4d351fe0-10e5-4a20-b6ff-7cb3867cd23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_431afdd9-acca-4cb0-b53f-6ca0a10f8a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_86de4baa-a86c-4bfb-ada3-f62eb1e2ee8c" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_431afdd9-acca-4cb0-b53f-6ca0a10f8a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_81463f33-9de6-48d7-aa55-897f16f59552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_431afdd9-acca-4cb0-b53f-6ca0a10f8a99" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_81463f33-9de6-48d7-aa55-897f16f59552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_8b45ee90-bd38-4d62-b45a-8ace1705fd33" xlink:href="dgx-20230331.xsd#dgx_ExcludesgeneralandprofessionalliabilityclaimsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_81463f33-9de6-48d7-aa55-897f16f59552" xlink:to="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_8b45ee90-bd38-4d62-b45a-8ace1705fd33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_b4c3e01e-3f4e-412d-828f-03cb3b4fee13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_86de4baa-a86c-4bfb-ada3-f62eb1e2ee8c" xlink:to="loc_us-gaap_LossContingenciesLineItems_b4c3e01e-3f4e-412d-828f-03cb3b4fee13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_7e2297aa-c59e-484d-a726-c296df1fcea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b4c3e01e-3f4e-412d-828f-03cb3b4fee13" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_7e2297aa-c59e-484d-a726-c296df1fcea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_cd8cb3b4-49ba-41f7-9e5c-e51c73cb5e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b4c3e01e-3f4e-412d-828f-03cb3b4fee13" xlink:to="loc_us-gaap_LitigationReserve_cd8cb3b4-49ba-41f7-9e5c-e51c73cb5e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d35f8a0e-d279-4b0d-a7b2-1ded3f0eaf10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_45dea9c0-363f-44b7-bede-bfa984cea44b" xlink:to="loc_us-gaap_DebtInstrumentTable_d35f8a0e-d279-4b0d-a7b2-1ded3f0eaf10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f2bc86c6-d8db-477d-885a-ae3203cf2cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d35f8a0e-d279-4b0d-a7b2-1ded3f0eaf10" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f2bc86c6-d8db-477d-885a-ae3203cf2cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ef316e56-3f28-4ade-a1d0-2b2c7cf51035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f2bc86c6-d8db-477d-885a-ae3203cf2cb9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ef316e56-3f28-4ade-a1d0-2b2c7cf51035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_70319fc2-941b-4b66-9083-0f4bb4e123b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ef316e56-3f28-4ade-a1d0-2b2c7cf51035" xlink:to="loc_us-gaap_SecuredDebtMember_70319fc2-941b-4b66-9083-0f4bb4e123b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_051d1152-0e5c-4eb0-b7c0-c3b2a4220d00" xlink:href="dgx-20230331.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ef316e56-3f28-4ade-a1d0-2b2c7cf51035" xlink:to="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_051d1152-0e5c-4eb0-b7c0-c3b2a4220d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ccafa66a-90b5-4653-8437-5b116b3f5d07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d35f8a0e-d279-4b0d-a7b2-1ded3f0eaf10" xlink:to="loc_us-gaap_CreditFacilityAxis_ccafa66a-90b5-4653-8437-5b116b3f5d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_89b99149-4c95-4f64-9a93-e60500805adf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_ccafa66a-90b5-4653-8437-5b116b3f5d07" xlink:to="loc_us-gaap_CreditFacilityDomain_89b99149-4c95-4f64-9a93-e60500805adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_a3ee1c4f-0b1a-4d01-9a95-ae1cb56a8d45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_89b99149-4c95-4f64-9a93-e60500805adf" xlink:to="loc_us-gaap_LetterOfCreditMember_a3ee1c4f-0b1a-4d01-9a95-ae1cb56a8d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4a3bdbae-e722-4812-9b9d-f8f8b7db49d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d35f8a0e-d279-4b0d-a7b2-1ded3f0eaf10" xlink:to="loc_us-gaap_DebtInstrumentLineItems_4a3bdbae-e722-4812-9b9d-f8f8b7db49d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_837350c5-aa0f-4e3c-91b5-bcab19c89682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4a3bdbae-e722-4812-9b9d-f8f8b7db49d5" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_837350c5-aa0f-4e3c-91b5-bcab19c89682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_a032dc16-73f8-4a5b-aa2b-080a2c55beb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4a3bdbae-e722-4812-9b9d-f8f8b7db49d5" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_a032dc16-73f8-4a5b-aa2b-080a2c55beb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_333df291-38e0-46fc-882c-17824570cc57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscounted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_45dea9c0-363f-44b7-bede-bfa984cea44b" xlink:to="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_333df291-38e0-46fc-882c-17824570cc57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#BUSINESSSEGMENTINFORMATIONDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ada8c4d1-a9c0-4294-8b9e-d01b169f2e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_df114624-3029-422f-80dc-e444c8bf7eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ada8c4d1-a9c0-4294-8b9e-d01b169f2e3c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_df114624-3029-422f-80dc-e444c8bf7eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4c3801c7-00ed-433d-9392-b596125bc561" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_df114624-3029-422f-80dc-e444c8bf7eb3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4c3801c7-00ed-433d-9392-b596125bc561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_eac580f4-09b3-4533-b675-481d165b5330" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4c3801c7-00ed-433d-9392-b596125bc561" xlink:to="loc_us-gaap_SegmentDomain_eac580f4-09b3-4533-b675-481d165b5330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_8ab0c18e-8717-4713-bd4e-38997bcb10a3" xlink:href="dgx-20230331.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_eac580f4-09b3-4533-b675-481d165b5330" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_8ab0c18e-8717-4713-bd4e-38997bcb10a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_755a3d35-5aa2-4745-850c-6dc2ad840608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_eac580f4-09b3-4533-b675-481d165b5330" xlink:to="loc_us-gaap_AllOtherSegmentsMember_755a3d35-5aa2-4745-850c-6dc2ad840608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_48a4a317-7613-4c42-8ad4-f29d9aa29c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_eac580f4-09b3-4533-b675-481d165b5330" xlink:to="loc_us-gaap_CorporateMember_48a4a317-7613-4c42-8ad4-f29d9aa29c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4e4891fa-4d7f-4fc8-8eb1-70b52485fae2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_df114624-3029-422f-80dc-e444c8bf7eb3" xlink:to="loc_srt_RangeAxis_4e4891fa-4d7f-4fc8-8eb1-70b52485fae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_af80d2fe-938a-4d1d-bb93-387fd77fa8ad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4e4891fa-4d7f-4fc8-8eb1-70b52485fae2" xlink:to="loc_srt_RangeMember_af80d2fe-938a-4d1d-bb93-387fd77fa8ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5f587754-ffec-46c9-9ecc-40bbdb05f632" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_af80d2fe-938a-4d1d-bb93-387fd77fa8ad" xlink:to="loc_srt_MinimumMember_5f587754-ffec-46c9-9ecc-40bbdb05f632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6e09e11e-99a5-4dc5-b3aa-197f8210231e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_df114624-3029-422f-80dc-e444c8bf7eb3" xlink:to="loc_srt_ProductOrServiceAxis_6e09e11e-99a5-4dc5-b3aa-197f8210231e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e8451989-605d-4b74-a7e2-987b279927ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_6e09e11e-99a5-4dc5-b3aa-197f8210231e" xlink:to="loc_srt_ProductsAndServicesDomain_e8451989-605d-4b74-a7e2-987b279927ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineclinicaltestingservicesMember_06ec9fc2-cd3a-4737-9719-283bf1ae0823" xlink:href="dgx-20230331.xsd#dgx_RoutineclinicaltestingservicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e8451989-605d-4b74-a7e2-987b279927ce" xlink:to="loc_dgx_RoutineclinicaltestingservicesMember_06ec9fc2-cd3a-4737-9719-283bf1ae0823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember_043b6c26-42a2-41f9-bfa1-73177c54890a" xlink:href="dgx-20230331.xsd#dgx_COVID19TestingServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e8451989-605d-4b74-a7e2-987b279927ce" xlink:to="loc_dgx_COVID19TestingServicesMember_043b6c26-42a2-41f9-bfa1-73177c54890a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember_9686b11c-1f0d-4e4e-909b-7333378ffe86" xlink:href="dgx-20230331.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e8451989-605d-4b74-a7e2-987b279927ce" xlink:to="loc_dgx_GenebasedandesoterictestingservicesMember_9686b11c-1f0d-4e4e-909b-7333378ffe86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember_fed813df-e440-4a24-a8d7-4f7374f685df" xlink:href="dgx-20230331.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e8451989-605d-4b74-a7e2-987b279927ce" xlink:to="loc_dgx_AnatomicpathologytestingservicesMember_fed813df-e440-4a24-a8d7-4f7374f685df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember_40ca708c-a12c-4ce6-b762-938307a518fa" xlink:href="dgx-20230331.xsd#dgx_AllotherservicesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e8451989-605d-4b74-a7e2-987b279927ce" xlink:to="loc_dgx_AllotherservicesMember_40ca708c-a12c-4ce6-b762-938307a518fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_df114624-3029-422f-80dc-e444c8bf7eb3" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_b6f3525c-90df-42b1-a18a-51af3f4dd60b" xlink:href="dgx-20230331.xsd#dgx_PercentageofNetRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_dgx_PercentageofNetRevenues_b6f3525c-90df-42b1-a18a-51af3f4dd60b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_61610d3d-c53a-4362-bc33-2675796f9d69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_61610d3d-c53a-4362-bc33-2675796f9d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a4c25ac9-0661-4e0b-befe-55a03efdfc9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_us-gaap_OperatingIncomeLoss_a4c25ac9-0661-4e0b-befe-55a03efdfc9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_c073478e-8335-4d04-a912-4ab1f84179c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_c073478e-8335-4d04-a912-4ab1f84179c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_528fb24e-170b-4b3d-b75a-89ad522a703b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_528fb24e-170b-4b3d-b75a-89ad522a703b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b4301dbf-5297-4f19-b177-e4fff04b0e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b4301dbf-5297-4f19-b177-e4fff04b0e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_310749fd-ec86-49d0-90e8-be16dc48ae55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_310749fd-ec86-49d0-90e8-be16dc48ae55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_72e26db6-439d-46c1-816d-df7675d29e28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_us-gaap_ProfitLoss_72e26db6-439d-46c1-816d-df7675d29e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_73bcb026-8e4b-4c93-b19b-baa29f42a71f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_73bcb026-8e4b-4c93-b19b-baa29f42a71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_17b4ea49-3bd8-4c41-9e44-6ae29942a2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_us-gaap_NetIncomeLoss_17b4ea49-3bd8-4c41-9e44-6ae29942a2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent_9dd60866-9ffe-4444-b175-1eb04768b433" xlink:href="dgx-20230331.xsd#dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e2b2bfee-7b6b-4c7c-813f-6d19bd0a4355" xlink:to="loc_dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent_9dd60866-9ffe-4444-b175-1eb04768b433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#REVENUERECOGNITIONDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_99a83012-75a7-46e2-9d3d-2a732a4364ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3e67ee-2c0d-4433-bef6-c6aa5755226a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_99a83012-75a7-46e2-9d3d-2a732a4364ab" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3e67ee-2c0d-4433-bef6-c6aa5755226a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c0fd0634-5186-49de-91eb-34cdfa0e0a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3e67ee-2c0d-4433-bef6-c6aa5755226a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c0fd0634-5186-49de-91eb-34cdfa0e0a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2b10d222-dc60-4bee-b4d7-96d1f190f3a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c0fd0634-5186-49de-91eb-34cdfa0e0a07" xlink:to="loc_us-gaap_SegmentDomain_2b10d222-dc60-4bee-b4d7-96d1f190f3a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_33beabc6-6d4a-4337-8b78-feb7f325d3b4" xlink:href="dgx-20230331.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2b10d222-dc60-4bee-b4d7-96d1f190f3a1" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_33beabc6-6d4a-4337-8b78-feb7f325d3b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_2ba77399-e3d3-4fe6-b484-c2c8024315a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2b10d222-dc60-4bee-b4d7-96d1f190f3a1" xlink:to="loc_us-gaap_AllOtherSegmentsMember_2ba77399-e3d3-4fe6-b484-c2c8024315a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c18fa311-3ff7-4eb6-9f37-d37a5977480b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3e67ee-2c0d-4433-bef6-c6aa5755226a" xlink:to="loc_srt_RangeAxis_c18fa311-3ff7-4eb6-9f37-d37a5977480b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_58c542ab-11ee-4d22-a70e-4608f034ca4c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c18fa311-3ff7-4eb6-9f37-d37a5977480b" xlink:to="loc_srt_RangeMember_58c542ab-11ee-4d22-a70e-4608f034ca4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b5d51472-30a7-4205-865d-3116e2aae917" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_58c542ab-11ee-4d22-a70e-4608f034ca4c" xlink:to="loc_srt_MinimumMember_b5d51472-30a7-4205-865d-3116e2aae917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_e129f53f-741d-42ee-8a5c-0431b0ef1132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3e67ee-2c0d-4433-bef6-c6aa5755226a" xlink:to="loc_us-gaap_SubsegmentsAxis_e129f53f-741d-42ee-8a5c-0431b0ef1132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_9a864a0a-3c02-42b2-a56d-aa6359967150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_e129f53f-741d-42ee-8a5c-0431b0ef1132" xlink:to="loc_us-gaap_SubsegmentsDomain_9a864a0a-3c02-42b2-a56d-aa6359967150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember_5d5eb2d3-5fe1-4e5d-8bf3-d7aeb269eafa" xlink:href="dgx-20230331.xsd#dgx_HealthcareInsurersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_9a864a0a-3c02-42b2-a56d-aa6359967150" xlink:to="loc_dgx_HealthcareInsurersMember_5d5eb2d3-5fe1-4e5d-8bf3-d7aeb269eafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember_e55703ff-d821-4b26-bf3a-32aef70ddd35" xlink:href="dgx-20230331.xsd#dgx_GovernmentPayersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_9a864a0a-3c02-42b2-a56d-aa6359967150" xlink:to="loc_dgx_GovernmentPayersMember_e55703ff-d821-4b26-bf3a-32aef70ddd35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember_48669922-08ba-41f7-aabd-49df854b7cff" xlink:href="dgx-20230331.xsd#dgx_ClientPayersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_9a864a0a-3c02-42b2-a56d-aa6359967150" xlink:to="loc_dgx_ClientPayersMember_48669922-08ba-41f7-aabd-49df854b7cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientsMember_73ed4e4e-1ec4-4851-883d-edd8d1ea4fd9" xlink:href="dgx-20230331.xsd#dgx_PatientsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_9a864a0a-3c02-42b2-a56d-aa6359967150" xlink:to="loc_dgx_PatientsMember_73ed4e4e-1ec4-4851-883d-edd8d1ea4fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember_f6b2ab55-ad46-47e4-b1c4-5ff8c9dd0b1c" xlink:href="dgx-20230331.xsd#dgx_DSBusinessesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_9a864a0a-3c02-42b2-a56d-aa6359967150" xlink:to="loc_dgx_DSBusinessesMember_f6b2ab55-ad46-47e4-b1c4-5ff8c9dd0b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a423dd34-e44d-4508-80a1-6556b0e6153d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3e67ee-2c0d-4433-bef6-c6aa5755226a" xlink:to="loc_srt_ProductOrServiceAxis_a423dd34-e44d-4508-80a1-6556b0e6153d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_db4de0db-2c62-4e6f-8aeb-58ae2e9e5d91" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a423dd34-e44d-4508-80a1-6556b0e6153d" xlink:to="loc_srt_ProductsAndServicesDomain_db4de0db-2c62-4e6f-8aeb-58ae2e9e5d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember_86ced873-6576-4557-a235-0c2f8a7f0648" xlink:href="dgx-20230331.xsd#dgx_FeeforserviceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_db4de0db-2c62-4e6f-8aeb-58ae2e9e5d91" xlink:to="loc_dgx_FeeforserviceMember_86ced873-6576-4557-a235-0c2f8a7f0648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember_69f70e5b-eab6-4fe7-89ab-d9e6f6079d32" xlink:href="dgx-20230331.xsd#dgx_CapitatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_db4de0db-2c62-4e6f-8aeb-58ae2e9e5d91" xlink:to="loc_dgx_CapitatedMember_69f70e5b-eab6-4fe7-89ab-d9e6f6079d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_b8341d51-4569-42de-8eb5-72ffb0f74966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7d3e67ee-2c0d-4433-bef6-c6aa5755226a" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_b8341d51-4569-42de-8eb5-72ffb0f74966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_98c6265d-4db6-403e-bb82-ca5b5be0ce78" xlink:href="dgx-20230331.xsd#dgx_PercentageofNetRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b8341d51-4569-42de-8eb5-72ffb0f74966" xlink:to="loc_dgx_PercentageofNetRevenues_98c6265d-4db6-403e-bb82-ca5b5be0ce78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable_e1e98f12-2862-4d6d-afc7-3bf549738f7c" xlink:href="dgx-20230331.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b8341d51-4569-42de-8eb5-72ffb0f74966" xlink:to="loc_dgx_PercentageofNetAccountsReceivable_e1e98f12-2862-4d6d-afc7-3bf549738f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#TAXESONINCOMEDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_01c4aee0-2a2d-474a-9153-d55a053ac72d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_64dd092d-5d99-4dc6-b593-570e96f70e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_01c4aee0-2a2d-474a-9153-d55a053ac72d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_64dd092d-5d99-4dc6-b593-570e96f70e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_ff7f31af-c8a2-4bde-9497-a9461ee8638f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_01c4aee0-2a2d-474a-9153-d55a053ac72d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_ff7f31af-c8a2-4bde-9497-a9461ee8638f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="dgx-20230331.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_e3d4be8f-44c8-443d-87d1-e792d35934d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_6e4035bc-4339-4914-b4df-b94fd9b35e92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_e3d4be8f-44c8-443d-87d1-e792d35934d9" xlink:to="loc_us-gaap_SubsequentEventTable_6e4035bc-4339-4914-b4df-b94fd9b35e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_77d2e6fd-9883-4c34-8077-94788fe22788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_6e4035bc-4339-4914-b4df-b94fd9b35e92" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_77d2e6fd-9883-4c34-8077-94788fe22788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c5efbc1d-a903-4b34-a9de-3a4e4efd98a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_77d2e6fd-9883-4c34-8077-94788fe22788" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c5efbc1d-a903-4b34-a9de-3a4e4efd98a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_3d13bad7-7c21-4519-bda9-cdbf69565dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c5efbc1d-a903-4b34-a9de-3a4e4efd98a4" xlink:to="loc_us-gaap_SubsequentEventMember_3d13bad7-7c21-4519-bda9-cdbf69565dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6928b7a4-ec32-4379-9be2-6f8e8f04cc2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_6e4035bc-4339-4914-b4df-b94fd9b35e92" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6928b7a4-ec32-4379-9be2-6f8e8f04cc2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a29c171-4497-4660-b657-34e818681377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6928b7a4-ec32-4379-9be2-6f8e8f04cc2b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a29c171-4497-4660-b657-34e818681377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NewYorkPresbyterianMember_fa0f7793-4558-4be5-9dd6-766deab555f6" xlink:href="dgx-20230331.xsd#dgx_NewYorkPresbyterianMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a29c171-4497-4660-b657-34e818681377" xlink:to="loc_dgx_NewYorkPresbyterianMember_fa0f7793-4558-4be5-9dd6-766deab555f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HaystackOncologyIncMember_db6b7bb1-4854-4396-a8e3-39906c33fa0d" xlink:href="dgx-20230331.xsd#dgx_HaystackOncologyIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4a29c171-4497-4660-b657-34e818681377" xlink:to="loc_dgx_HaystackOncologyIncMember_db6b7bb1-4854-4396-a8e3-39906c33fa0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_191669da-866b-4e6e-b958-2ea197bed018" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_6e4035bc-4339-4914-b4df-b94fd9b35e92" xlink:to="loc_srt_StatementScenarioAxis_191669da-866b-4e6e-b958-2ea197bed018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_515a044d-095f-4b70-8888-b6053ec1bb95" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_191669da-866b-4e6e-b958-2ea197bed018" xlink:to="loc_srt_ScenarioUnspecifiedDomain_515a044d-095f-4b70-8888-b6053ec1bb95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScenarioPlanMember_d05e4449-dd00-4b29-9e45-c1d3faf7733f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScenarioPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_515a044d-095f-4b70-8888-b6053ec1bb95" xlink:to="loc_us-gaap_ScenarioPlanMember_d05e4449-dd00-4b29-9e45-c1d3faf7733f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_28913511-c426-49c5-90a3-143fe9c0119c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_6e4035bc-4339-4914-b4df-b94fd9b35e92" xlink:to="loc_us-gaap_SubsequentEventLineItems_28913511-c426-49c5-90a3-143fe9c0119c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_6ececf3c-5591-4d9c-b4dd-b6efa8440148" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_28913511-c426-49c5-90a3-143fe9c0119c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_6ececf3c-5591-4d9c-b4dd-b6efa8440148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_911ee487-e2d5-440e-8f41-7aaa16608d02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_28913511-c426-49c5-90a3-143fe9c0119c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_911ee487-e2d5-440e-8f41-7aaa16608d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169419344192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Apr. 14, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-12215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Quest Diagnostics Inc<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001022079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">16-1387862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 Plaza Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Secaucus,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(973)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">520-2700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 Par Value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DGX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,009,197<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169419897296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 2,331<span></span>
</td>
<td class="nump">$ 2,611<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Operating costs and expenses and other operating income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of services</a></td>
<td class="nump">1,560<span></span>
</td>
<td class="nump">1,646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">439<span></span>
</td>
<td class="nump">425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other operating expense, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs and expenses, net</a></td>
<td class="nump">2,026<span></span>
</td>
<td class="nump">2,098<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">305<span></span>
</td>
<td class="nump">513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">7<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total non-operating expense, net</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in earnings of equity method investees</a></td>
<td class="nump">277<span></span>
</td>
<td class="nump">452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(65)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of equity method investees, net of taxes</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">217<span></span>
</td>
<td class="nump">373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 202<span></span>
</td>
<td class="nump">$ 355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 1.80<span></span>
</td>
<td class="nump">$ 2.97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 1.78<span></span>
</td>
<td class="nump">$ 2.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in Shares)</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in Shares)</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169419550544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 217<span></span>
</td>
<td class="nump">$ 373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">220<span></span>
</td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 205<span></span>
</td>
<td class="nump">$ 353<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169420175088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses of $30 as of both March&#160;31, 2023 and December&#160;31, 2022</a></td>
<td class="nump">1,254<span></span>
</td>
<td class="nump">1,195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">190<span></span>
</td>
<td class="nump">192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">195<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,814<span></span>
</td>
<td class="nump">1,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,795<span></span>
</td>
<td class="nump">1,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">589<span></span>
</td>
<td class="nump">585<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">7,241<span></span>
</td>
<td class="nump">7,220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,077<span></span>
</td>
<td class="nump">1,092<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity method investees</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">144<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">12,794<span></span>
</td>
<td class="nump">12,837<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities and Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">1,198<span></span>
</td>
<td class="nump">1,396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of long-term operating lease liabilities</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">153<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,355<span></span>
</td>
<td class="nump">1,551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">3,975<span></span>
</td>
<td class="nump">3,978<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">490<span></span>
</td>
<td class="nump">489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">809<span></span>
</td>
<td class="nump">812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Quest Diagnostics stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.01 per share; 600 shares authorized as of both March&#160;31, 2023 and December&#160;31, 2022; 162 shares issued as of both March&#160;31, 2023 and December&#160;31, 2022</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">2,266<span></span>
</td>
<td class="nump">2,295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">8,412<span></span>
</td>
<td class="nump">8,290<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost; 50 and 51 shares as of March&#160;31, 2023 and December&#160;31, 2022, respectively</a></td>
<td class="num">(4,612)<span></span>
</td>
<td class="num">(4,673)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Quest Diagnostics stockholders' equity</a></td>
<td class="nump">6,050<span></span>
</td>
<td class="nump">5,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">6,088<span></span>
</td>
<td class="nump">5,930<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 12,794<span></span>
</td>
<td class="nump">$ 12,837<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169419344192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">600<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169420176928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 217<span></span>
</td>
<td class="nump">$ 373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetCreditLossExpense', window );">Credit for credit losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax benefit</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other, net</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(58)<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(211)<span></span>
</td>
<td class="num">(165)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other assets and liabilities, net</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(105)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(127)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Increase in investments and other assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(158)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from borrowings</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="num">(140)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(373)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(74)<span></span>
</td>
<td class="num">(74)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities, net</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(76)<span></span>
</td>
<td class="num">(471)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents and restricted cash</a></td>
<td class="num">(140)<span></span>
</td>
<td class="num">(160)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, beginning of period</a></td>
<td class="nump">315<span></span>
</td>
<td class="nump">872<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, end of period</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 712<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetCreditLossExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetCreditLossExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169416032672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury Stock, at Cost</div></th>
<th class="th"><div>Non-controlling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Dec. 31, 2021</a></td>
<td class="nump">$ 6,483<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2,260<span></span>
</td>
<td class="nump">$ 7,649<span></span>
</td>
<td class="num">$ (14)<span></span>
</td>
<td class="num">$ (3,453)<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of taxes</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(78)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under benefit plans, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Mar. 31, 2022</a></td>
<td class="nump">6,415<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,226<span></span>
</td>
<td class="nump">7,926<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(3,761)<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Dec. 31, 2021</a></td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Mar. 31, 2022</a></td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Dec. 31, 2022</a></td>
<td class="nump">5,930<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,295<span></span>
</td>
<td class="nump">8,290<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(4,673)<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of taxes</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(80)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under benefit plans, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Mar. 31, 2023</a></td>
<td class="nump">6,088<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2,266<span></span>
</td>
<td class="nump">$ 8,412<span></span>
</td>
<td class="num">$ (18)<span></span>
</td>
<td class="num">$ (4,612)<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Dec. 31, 2022</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Mar. 31, 2023</a></td>
<td class="nump">$ 77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss), Excluding Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169420913920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_DescriptionOfBusinessAbstract', window );"><strong>Description of Business (Abstract)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">DESCRIPTION OF BUSINESS</a></td>
<td class="text">DESCRIPTION OF BUSINESS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div>&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, consumers, and accountable care organizations ("ACOs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DescriptionOfBusinessAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of Business (Abstract)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DescriptionOfBusinessAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169422543520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#8217;s 2022 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2022 but does not include all the disclosures required by accounting principles generally accepted in the United States (&#8220;GAAP&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The accounting policies of the Company are the same as those set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2022 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Earnings Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and outstanding stock options granted under its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements, if applicable.  Earnings allocable </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;New Accounting Standards to be Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement was effective immediately and, due to an accounting update which the Financial Accounting Standards Board issued in December 2022, can be applied to contract modifications through December 31, 2024.  To the extent that, prior to December 31, 2024, the Company enters into any contract modifications for which the optional expedients are applied, the adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169422634032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS (LOSS) PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.590%"><tr><td style="width:1.0%"/><td style="width:77.107%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.411%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.78&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.92&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During both the three months ended March 31, 2023 and 2022, less than 1&#160;million stock options and performance share units were not included in the calculation of diluted earnings per share due to their antidilutive effect.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169422647440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING ACTIVITIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">RESTRUCTURING ACTIVITIES</a></td>
<td class="text">RESTRUCTURING ACTIVITIES <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Invigorate Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is committed to a program called Invigorate which is designed to reduce its cost structure and improve performance.  Invigorate consists of several flagship programs, with structured plans in each, to drive savings and improve performance across the customer value chain.  These flagship programs include: organization excellence; information technology excellence; procurement excellence; field and customer service excellence; lab excellence; and revenue services excellence.  In addition to these programs, the Company identified key themes to change how it operates including reducing denials and patient price concessions; further digitizing the business; standardization; automation and artificial intelligence; optimization and selecting and retaining talent. The Invigorate program is intended to offset reimbursement pressures and labor and benefit cost increases; free up additional resources to invest in innovation and other growth initiatives; and enable the Company to improve service quality and operating profitability. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Restructuring Charges</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's pre-tax restructuring charges for the three months ended March&#160;31, 2023 and 2022 were $15 million and $2 million, respectively, entirely related to employee separation costs associated with various workforce reduction initiatives as the Company continued to restructure its organization.  Of the total restructuring charges incurred during the three months ended March&#160;31, 2023, $9&#160;million, and $6&#160;million were recorded in cost of services and selling, general and administrative expenses, respectively.  Of the total restructuring charges incurred during the three months ended March&#160;31, 2022, $1&#160;million and $1&#160;million were recorded in cost of services and selling, general and administrative expenses, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Charges for all periods presented were primarily recorded in the Company's DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The restructuring liability as of March&#160;31, 2023 and December&#160;31, 2022, which is included in accounts payable and accrued expenses, was $38&#160;million and $44 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169422574640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESS ACQUISITIONS</a></td>
<td class="text">BUSINESS ACQUISITIONS&#160;&#160;&#160;&#160;During February 2023, the Company announced that it had entered into a definitive agreement to acquire select assets of the laboratory services business of New York-Presbyterian, which serves providers and patients in New York, as well as the Tri-State Area and beyond. The transaction closed during April 2023.  See Note 15 for further discussion.&#160;&#160;&#160;&#160;For details regarding the Company's 2022 acquisitions, see Note 6 to the audited consolidated financial statements in the Company's 2022 Annual Report on Form 10-K.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169422601600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS  <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.260%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets/Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.191%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.372%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A detailed description regarding the Company's fair value measurements is contained in Note 8 to the audited consolidated financial statements in the Company's 2022 Annual Report on Form 10-K.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-directed stock and bond mutual funds that are classified as trading securities.  The trading securities are classified within Level 1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.</span></div><div style="padding-right:72pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#8220;invested&#8221; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value using discounted cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable.  Significant inputs include cash flows projections and a discount rate. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with previous acquisitions, the Company had contingent consideration obligations based on the achievement of certain testing volume and revenue benchmarks during 2022.  See Note 8 to the audited consolidated financial statements in the Company's 2022 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.257%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December&#160;31, 2022</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, March 31, 2023</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of March&#160;31, 2023, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long term growth rates, and a discount rate commensurate with economic risk.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments. As of March&#160;31, 2023 and December&#160;31, 2022, the fair value of the Company&#8217;s debt was estimated at $3.8 billion and $3.7 billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169422519472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text">DEBT&#160;&#160;&#160;&#160;The Company is party to a $750&#160;million senior unsecured revolving credit facility (the &#8220;Credit Facility&#8221; or "Senior Unsecured Revolving Credit Facility") which matures in November 2026. Under the Credit Facility, the Company can issue letters of credit totaling $150&#160;million (see Note 11). Issued letters of credit reduce the available borrowing capacity under the Credit Facility. Interest on the Credit Facility is based on certain published rates plus an applicable margin based on changes in the Company's public debt ratings.  The Credit Facility was amended during March 2023.  Subsequent to such amendment, at the option of the Company, it may elect to lock into Term Secured Overnight Financing Rate (&#8220;Term SOFR&#8221;)-based interest rate contracts for periods up to six months. For interest on any U.S. Dollar-denominated outstanding amounts not covered under Term SOFR-based interest rate contracts, the Company can opt for an alternate base rate, which is calculated by reference to the prime rate, the federal funds rate or an adjusted Term SOFR rate.  The Company also has the option to borrow in other currencies.  As of March&#160;31, 2023, the Company's borrowing rate for Term SOFR-based loans under the Credit Facility was adjusted Term SOFR plus 1.00%. The Credit Facility contains various covenants, including the maintenance of a financial leverage ratio, which could impact the Company's ability to, among other things, incur additional indebtedness. As of both March&#160;31, 2023 and December&#160;31, 2022, there were no outstanding borrowings under the Senior Unsecured Revolving Credit Facility.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169422611184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">FINANCIAL INSTRUMENTS</a></td>
<td class="text">FINANCIAL INSTRUMENTS &#160;&#160;&#160;&#160;The Company uses derivative financial instruments, from time to time, to manage its exposure to market risks for changes in interest rates and foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and, from time to time, variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Cash Flow Hedges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Fair Value Hedges </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Historically, the Company has entered into various fixed-to-variable interest rate swap agreements in order to convert a portion of the Company's long-term debt into variable interest rate debt.  All such fixed-to-variable interest rate swap agreements have been terminated and proceeds from the terminations have been reflected as basis adjustments to the hedged debt instruments and are being amortized as a reduction of interest expense, net over the remaining terms of such debt instruments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of March&#160;31, 2023 and December&#160;31, 2022, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:18.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.315%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of both March&#160;31, 2023 and December&#160;31, 2022, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.</span></div>&#160;&#160;&#160;&#160;A detailed description regarding the Company's use of derivative financial instruments is contained in Note 16 to the audited consolidated financial statements in the Company's 2022 Annual Report on Form 10-K.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169422605328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity Attributable to Parent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST<div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Accumulated Other Comprehensive Loss by Component</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) includes: </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 8); and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax, on available-for-sale debt securities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023 and 2022, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes.  </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the first quarter of 2023, the Company's Board of Directors declared a quarterly cash dividend of $0.71 per common share.  During each of the four quarters of 2022, the Company's Board of Directors declared a quarterly cash dividend of $0.66 per common share. </span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In February 2023, the Company's Board of Directors increased the size of its share repurchase program by $1&#160;billion. As of March&#160;31, 2023, $1.3&#160;billion remained available under the Company&#8217;s share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchases</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023, the Company repurchased no shares of its common stock.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022, the Company repurchased 2.6 million shares of its common stock for $350 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shares Reissued from Treasury Stock</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023 and 2022, the Company reissued 0.7 million shares and 0.5 million shares, respectively, from treasury stock under its Employee Stock Purchase Plan and its stock-based compensation program.  For details regarding the Company's stock ownership and compensation plans, see Note 18 to the audited consolidated financial statements in the Company's 2022 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Redeemable Noncontrolling Interest</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  As of March&#160;31, 2023 and December&#160;31, 2022, the redeemable noncontrolling interest was presented at its fair value.  For further details regarding the fair value of the redeemable noncontrolling interest, see Note 6.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169419172992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</a></td>
<td class="text">SUPPLEMENTAL CASH FLOW AND OTHER DATA<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Supplemental cash flow and other data for the three months ended March&#160;31, 2023 and 2022 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for business acquisitions</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI https://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169419172992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letters of Credit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company can issue letters of credit totaling $100&#160;million under its $525&#160;million secured receivables credit facility and $150&#160;million under its $750&#160;million senior unsecured revolving credit facility.  For further discussion regarding the Company's secured receivables credit facility and senior unsecured revolving credit facility, see Note 14 to the audited consolidated financial statements in the Company's 2022 Annual Report on Form 10-K and Note 7 above.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In support of its risk management program, $70 million in letters of credit under the secured receivables credit facility were outstanding as of March&#160;31, 2023, providing collateral for current and future automobile liability and workers&#8217; compensation loss payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Lease Obligations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases for which no liability has been recorded.  For further details, see Note 19 to the audited consolidated financial statements in the Company&#8217;s 2022 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.  The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">401(k) Plan Lawsuit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In 2020, two putative class action lawsuits were filed in the U.S. District Court for New Jersey against the Company and other defendants with respect to the Company&#8217;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the two lawsuits under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re: Quest Diagnostics ERISA Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and plaintiffs filed a consolidated amended complaint.  In May 2021, the court denied the Company's motion to dismiss the complaint.  Discovery is proceeding.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">AMCA Data Security Incident</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  </span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#8220;AMCA&#8221;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018 and March 30, 2019 (the &#8220;AMCA Data Security Incident&#8221;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#8217;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#8217;s nor the Company&#8217;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#8217; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases that were then still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss was granted in part and denied in part.  Plaintiffs filed an amended complaint, which the Company also moved to dismiss. The motion is pending. Plaintiffs also filed a motion to further amend the complaint. The Company opposed the motion.  Discovery is proceeding.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, the Company has been notified that numerous state attorney general offices were investigating or otherwise seeking information and/or documents, and that certain U.S. senators were seeking information, from the Company related to the AMCA Data Security Incident.  </span></div><div><span><br/></span></div><div style="text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ReproSource Fertility Diagnostics, Inc.</span></div><div style="text-indent:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;ReproSource Fertility Diagnostics, Inc. (&#8220;ReproSource&#8221;), a subsidiary of the Company, is subject to two putative class action lawsuits in the U.S. District Court for Massachusetts: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bickham v. ReproSource Fertility Diagnostics, Inc. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gordon v. ReproSource Fertility Diagnostics, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The class actions are related to a data security incident that occurred in August 2021 in which an unauthorized party may have accessed or acquired protected health information and personally identifiable information of ReproSource patients. The complaints generally allege that ReproSource, among other claims, failed to adequately safeguard customers&#8217; private information. The Company moved to dismiss both complaints.  A third putative class action pertaining to the same data security incident, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trouville v. ReproSource Fertility Diagnostics, Inc.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was filed in California state court.  The Company removed the case to federal court and moved to dismiss and/or transfer it to U.S. District Court for Massachusetts.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cole, et. al v. Quest Diagnostics Incorporated</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;The Company is</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">subject to a putative class action entitled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Cole, et al. v Quest Diagnostics Incorporated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, which was filed in the U. S. District Court for the Eastern District of California, for allegedly conspiring with Facebook to track customers&#8217; internet communications on Company web platforms without authorization, in violation of the California Invasion of Privacy Act and the California Confidentiality of Medical Information Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">  The complaint alleged that the Company&#8217;s actions were an invasion of privacy and contributed to a loss of value in plaintiffs&#8217; personally identifiable information.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company moved to dismiss the case or, in the alternative, transfer venue to the U.S. District Court for New Jersey.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Subsequently, plaintiffs filed an amended complaint.  The Company filed a motion to dismiss the amended complaint, which is pending. </span></div><div style="text-indent:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The federal or state governments may bring claims based on the Company's current practices, which it believes are lawful.  In addition, certain federal and state statutes, including the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing or other practices based on the False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistleblowers" as to which the Company cannot determine the extent of any potential liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of March&#160;31, 2023, the Company does not believe that material losses related to legal matters are probable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reserves for legal matters totaled $1 million and $2 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reserves for General and Professional Liability Claims</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is subject to a series of individual claims brought by persons in Ireland related to allegations stemming from pap smear screening services performed by the Company.  In general, claimants have alleged that the results of certain pap smear screening tests performed by the Company and other providers, pursuant to a program coordinated by the Irish government, were incorrect for individuals who were later diagnosed with cervical cancer.  The Irish government and an independent scoping inquiry commissioned by the Irish government found that the Company&#8217;s performance of its screening services for the Irish cervical cancer screening program were in accordance with both Ireland&#8217;s requirements and international standards.  The Company has settled claims made by certain individuals, is a party in multiple lawsuits and may be served as a party in additional lawsuits.  The Company does not believe that the resolution of existing or future claims will have a material adverse effect on its financial position or liquidity, but the ultimate outcomes of these claims are unpredictable and subject to significant uncertainties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $168 million and $169 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;While the basis for claims reserves is actuarially determined losses based upon the Company's historical and projected loss experience, the process of analyzing, assessing and establishing reserve estimates relative to these types of claims involves a high degree of judgment.  Although the Company believes that its present reserves and insurance coverage are sufficient to cover currently estimated exposures, it is possible that the Company may incur liabilities in excess of its recorded reserves or insurance coverage.  Changes in the facts and circumstances associated with claims could have a material impact on the Company&#8217;s results of operations (principally costs of services), cash flows and financial condition in the period that reserve estimates are adjusted or paid.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169422629552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">BUSINESS SEGMENT INFORMATION</a></td>
<td class="text">BUSINESS SEGMENT INFORMATION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, customers, and ACOs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than 95% of net revenues in 2023 and 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of March&#160;31, 2023, substantially all of the Company&#8217;s services were provided within the United States, and substantially all of the Company&#8217;s assets were located within the United States.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table is a summary of segment information for the three months ended March&#160;31, 2023 and 2022.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2022 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.590%"><tr><td style="width:1.0%"/><td style="width:77.107%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.411%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,259&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,541&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,331&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The approximate percentage of net revenues by major service for the three months ended March&#160;31, 2023 and 2022 were as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:77.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.396%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing and other services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169422629552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE RECOGITION</a></td>
<td class="text">REVENUE RECOGNITION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DIS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues in the Company&#8217;s DIS business accounted for over 95% of the Company&#8217;s total net revenues for the three months ended March&#160;31, 2023 and 2022 and are primarily comprised of a high volume of relatively low-dollar transactions. The DIS business, which provides clinical testing services and other services, satisfies its performance obligations and recognizes revenues primarily upon completion of the testing process (when results are reported) or when services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers (Medicare and Medicaid programs), client payers and patients.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding revenue recognition in the Company's DIS business, see Note 3 to the audited consolidated financial statements in the Company's 2022 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company&#8217;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Revenue and Net Accounts Receivable by Customer Type</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The approximate percentage of net revenue by type of customer was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The approximate percentage of net accounts receivable by type of customer was as follows:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Insurers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169422584048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">TAXES ON INCOME</a></td>
<td class="text">TAXES ON INCOME&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023 and 2022, the effective income tax rate was 23.6% and 24.4%, respectively.  The effective income tax rates benefited from $5 million of excess tax benefits associated with stock-based compensation arrangements for both the three months ended March&#160;31, 2023 and 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169422579456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text">SUBSEQUENT EVENTS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On April 17, 2023, the Company completed the previously announced acquisition of select assets of the laboratory services business of New York-Presbyterian, which serves providers and patients in New York, as well as the Tri-State Area and beyond, in an all-cash transaction for $275&#160;million.  The acquisition will be accounted for as a business combination.  The Company is in the process of completing the preliminary purchase price allocation of the assets acquired and liabilities assumed. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;During April 2023, the Company announced that it had entered into a definitive agreement to acquire Haystack Oncology, Inc., an early-stage oncology company focused on minimal residual disease testing to aid in the early, accurate detection of residual or recurring cancer and better inform therapy decisions.  Under the terms of the agreement, the Company would pay approximately $300&#160;million in cash at closing, net of cash acquired.  Additionally, it would pay up to $150&#160;million of additional consideration, which is contingent upon achieving future performance milestones and which is not expected to be paid during 2023.  The transaction is expected to close during the second quarter of 2023 and remains subject to customary closing conditions. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company expects to fund the cash at closing for the acquisitions noted above through a combination of cash on hand and borrowings under the Company's existing credit facilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169419286480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#8217;s 2022 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2022 but does not include all the disclosures required by accounting principles generally accepted in the United States (&#8220;GAAP&#8221;).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use Of Estimates</a></td>
<td class="text">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and outstanding stock options granted under its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements, if applicable.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards to be Adopted</a></td>
<td class="text">In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement was effective immediately and, due to an accounting update which the Financial Accounting Standards Board issued in December 2022, can be applied to contract modifications through December 31, 2024.  To the extent that, prior to December 31, 2024, the Company enters into any contract modifications for which the optional expedients are applied, the adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">The Company uses derivative financial instruments, from time to time, to manage its exposure to market risks for changes in interest rates and foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and, from time to time, variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169422575872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text">The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.590%"><tr><td style="width:1.0%"/><td style="width:77.107%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.411%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.78&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.92&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169422610352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value, Measurement Inputs</a></td>
<td class="text">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.260%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets/Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.191%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.372%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text">The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.257%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.817%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December&#160;31, 2022</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, March 31, 2023</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI https://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169422810864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock', window );">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt</a></td>
<td class="text">As of March&#160;31, 2023 and December&#160;31, 2022, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:18.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.315%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of both March&#160;31, 2023 and December&#160;31, 2022, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169419172992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental Cash Flow and Other Data</a></td>
<td class="text">Supplemental cash flow and other data for the three months ended March&#160;31, 2023 and 2022 was as follows: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for business acquisitions</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169422816336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summary of Segment Reporting Information by Segment</a></td>
<td class="text">The following table is a summary of segment information for the three months ended March&#160;31, 2023 and 2022.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2022 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.590%"><tr><td style="width:1.0%"/><td style="width:77.107%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.411%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,259&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,541&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,331&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,611&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock', window );">Schedule of Revenues by Major Service</a></td>
<td class="text">by major service for the three months ended March&#160;31, 2023 and 2022 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:77.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.396%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing and other services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Revenues by Major Service</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169419320256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">The approximate percentage of net revenue by type of customer was as follows:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.697%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_AccountsReceivableDisaggregationTableTextBlock', window );">Accounts Receivable Disaggregation</a></td>
<td class="text">The approximate percentage of net accounts receivable by type of customer was as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Insurers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_AccountsReceivableDisaggregationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable Disaggregation [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_AccountsReceivableDisaggregationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169420869728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract', window );"><strong>Amounts attributable to Quest Diagnostics&#8217; common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 202<span></span>
</td>
<td class="nump">$ 355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted', window );">Less: Earnings allocated to participating securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</a></td>
<td class="nump">$ 201<span></span>
</td>
<td class="nump">$ 354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock options and performance share units</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 1.80<span></span>
</td>
<td class="nump">$ 2.97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 1.78<span></span>
</td>
<td class="nump">$ 2.92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (less than)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169419902928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING ACTIVITIES (Details) - Invigorate Program - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Pre-tax restructuring charges</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=dgx_InvigorateProgramMember', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=dgx_InvigorateProgramMember', window );">Cost of services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total restructuring charges</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=dgx_InvigorateProgramMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total restructuring charges</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=dgx_InvigorateProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=dgx_InvigorateProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169416585280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details) - Recurring Basis - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Deferred compensation trading securities</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">131<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Quoted Prices in Active Markets for Identical Assets / Liabilities, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Deferred compensation trading securities</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant Other Observable Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Deferred compensation trading securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant Unobservable Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Deferred compensation trading securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169424399168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Assets and Liabilities Unobservable Inputs) (Details) - Significant Unobservable Inputs, Level 3 - Contingent Consideration<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, December 31, 2022</a></td>
<td class="nump">$ 23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Settlements</a></td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, March 31, 2023</a></td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=dgx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169419209696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Narrative) (Details) - USD ($)<br> $ in Billions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt</a></td>
<td class="nump">$ 3.8<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=dgx_UMassJointVentureMember', window );">UMass Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dgx_UMassJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dgx_UMassJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169417241760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Details) - Senior Unsecured Revolving Credit Facility - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember', window );">Term SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169420863376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Balance Sheets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember', window );">Long-term Debt | Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease', window );">Hedge Accounting Basis Adjustment</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4EE<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109999712-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169416563760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details) - USD ($)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 01, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends per common share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.71<span></span>
</td>
<td class="nump">$ 0.66<span></span>
</td>
<td class="nump">$ 0.66<span></span>
</td>
<td class="nump">$ 0.66<span></span>
</td>
<td class="nump">$ 0.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_StockRepurchaseProgramAdditionalAmountAuthorized', window );">Additional amount authorized</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Share repurchase authorization remaining available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued', window );">Reissuance of shares for employee benefit plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=dgx_UMassJointVentureMember', window );">UMass Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock, at Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock- shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_StockRepurchaseProgramAdditionalAmountAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program, Additional Amount Authorized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_StockRepurchaseProgramAdditionalAmountAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dgx_UMassJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dgx_UMassJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169420266128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndDividendIncomeOperating', window );">Interest income</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accounts payable associated with capital expenditures</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividends payable</a></td>
<td class="nump">80<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair value of assets acquired</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Fair value of liabilities assumed</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_FairValueOfNetAssetsAcquired', window );">Fair value of net assets acquired</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_Mergerconsiderationpaidpayablenet', window );">Merger consideration payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for business acquisitions</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Less: Cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Leased assets obtained in exchange for new operating lease liabilities</a></td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 63<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FairValueOfNetAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of net assets acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FairValueOfNetAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_Mergerconsiderationpaidpayablenet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Merger consideration paid (payable), net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_Mergerconsiderationpaidpayablenet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDividendIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.1-5)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDividendIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169416595584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>claim</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MalpracticeLossContingencyAccrualUndiscounted', window );">Self-insurance reserves</a></td>
<td class="nump">$ 168,000,000<span></span>
</td>
<td class="nump">$ 169,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ExcludesgeneralandprofessionalliabilityclaimsMember', window );">Excludes general and professional liability claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Litigation reserves</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Receivables Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">525,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding, amount</a></td>
<td class="nump">70,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Receivables Credit Facility | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember', window );">Senior Unsecured Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember', window );">Senior Unsecured Revolving Credit Facility | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=dgx_A401kPlanLawsuitMember', window );">401(k) Plan Lawsuit | Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Class action lawsuits | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=dgx_DataSecurityIncidentMember', window );">Data Security Incident | Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Class action lawsuits | claim</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MalpracticeLossContingencyAccrualUndiscounted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the accrued liability on an undiscounted basis for malpractice claims (including general and professional liability) at the end of the accounting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MalpracticeLossContingencyAccrualUndiscounted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ExcludesgeneralandprofessionalliabilityclaimsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=dgx_ExcludesgeneralandprofessionalliabilityclaimsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=dgx_A401kPlanLawsuitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=dgx_A401kPlanLawsuitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=dgx_DataSecurityIncidentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=dgx_DataSecurityIncidentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169415919056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 2,331<span></span>
</td>
<td class="nump">$ 2,611<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">305<span></span>
</td>
<td class="nump">513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Non-operating expense, net</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in earnings of equity method investees</a></td>
<td class="nump">277<span></span>
</td>
<td class="nump">452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(65)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of equity method investees, net of taxes</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">217<span></span>
</td>
<td class="nump">373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 202<span></span>
</td>
<td class="nump">$ 355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent', window );">Total net revenues, percent</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_RoutineclinicaltestingservicesMember', window );">Routine clinical testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent', window );">Total net revenues, percent</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember', window );">COVID-19 Testing Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent', window );">Total net revenues, percent</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember', window );">Gene-based and esoteric testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent', window );">Total net revenues, percent</a></td>
<td class="nump">37.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember', window );">Anatomic pathology testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent', window );">Total net revenues, percent</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_AllotherservicesMember', window );">All other services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent', window );">Total net revenues, percent</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 2,259<span></span>
</td>
<td class="nump">$ 2,541<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">$ 374<span></span>
</td>
<td class="nump">$ 562<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All other operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 72<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">General corporate activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="num">$ (77)<span></span>
</td>
<td class="num">$ (56)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Revenues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue from Contract with Customer, Excluding Assessed Tax, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_RoutineclinicaltestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_RoutineclinicaltestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_AllotherservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_AllotherservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169416888592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">96.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare Insurers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">29.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare Insurers | Fee-for-service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">37.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare Insurers | Capitated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Government Payers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Client Payers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">43.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Patients (including coinsurance and deductible responsibilities)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All other operating segments | DS Businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Accounts Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Revenues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_HealthcareInsurersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_HealthcareInsurersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_FeeforserviceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_FeeforserviceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_CapitatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_CapitatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_ClientPayersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_ClientPayersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_PatientsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_PatientsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_DSBusinessesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_DSBusinessesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169419580576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">23.60%<span></span>
</td>
<td class="nump">24.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Share-based compensation, excess tax benefit, amount</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970579&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140169416206048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 17, 2023</div></th>
<th class="th"><div>Apr. 28, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | New York-Presbyterian</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for business acquisitions</a></td>
<td class="nump">$ 275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Haystack Oncology, Inc. | Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Maximum contingent consideration payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_NewYorkPresbyterianMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_NewYorkPresbyterianMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_HaystackOncologyIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_HaystackOncologyIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=us-gaap_ScenarioPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=us-gaap_ScenarioPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>dgx-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:dgx="http://questdiagnostics.com/20230331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="dgx-20230331.xsd" xlink:type="simple"/>
    <context id="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4c7aaabb9e3f43c18d9412ca50c62173_I20230414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2023-04-14</instant>
        </period>
    </context>
    <context id="ifb8069c214264ab183970915c8088bc5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i62a8002be6c545879eef8e9350936b33_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i313674dbdb4b43adbe1b80bb7d67dded_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4f825bb08aff4a16a22babce12a7813b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib84cedd020e943f08a613b4d09834d7f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i367251b8c6384daaa5fa30fad01b58e5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6223da0135b64cee99f192d6f1af6c1a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9c3a6f02e5244194aa47bf148a80d73f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4034fabdd7ca4912917c75ef9a0a2da9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iecb39988efab48f8b58484b98bbfee1b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8146dfedf0844767b0319b9e33973cf6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0325c9b10a83489b85899f5559dce780_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i25f1cfe1d1c6418d846c108e8dd55e7c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic8e71edf5ebf4c21a564d4ed2747d817_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i43ece8747ef74f40a72853ca02aaf1c9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6c0a89d33c674daf9b3eb9a19226f643_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7e493e3bc38e440db1ddd741cfb4d78b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibe4f154b292c4c6f9438d1ec93548719_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i55c17b5aea5546bdb1833d5556b00d76_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i29c8b878fec14566ae04a50e70d4aa38_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3c9092aaf58347c0933f9fcbc2136ed5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i54d2ac712edf4a2dab69b472e9d2878e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if7e8cf83a7dc44a0b5d83088a7a8262b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2868e6f7df8844f0be25707868867359_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i675af17646064d258fea61e6c5bb5a32_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id8a0a67b493b41f5a943c81b90b2832b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic457675ae82d42ceb6dbe6499c6a8c8f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i53987f4feaf540ce9006d5da84098d82_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6943c51ef54c40e2bfbd3af614ae55de_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9fa2bae89497491fa69b9d23e041264d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i91094720d34a44d897464e1473c8cc65_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i682bff3b2c334ee9937658977d7ac55e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i64eccbb460d743ce8ef414fce3a61c10_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie694bee7816f4bac9b9f899958f5a1cb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic0371ca26d314e109241b4b21346af30_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0776303025b041b981adf6ee7f921409_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8582d590e6f74053acd191b3c70e414b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i67ca08b42d004c858f5fa9da26c20186_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibd9747cff8044052a06af97e9d9ca8fa_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i70085dbbaf5747e084e12a45a4a75993_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7afb377aee1d435eb24550dbdcd7ec70_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0eb006769543403b857f1208edc96f39_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia9c6221361d444248eec701d6facf066_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i026b244d8b664bf18f9db5bf951e1018_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i95ea8d4904774f0aa70206e0d1464ca0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icfeed34c59e04d0f968039f01139270f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1877888b4e3b4f5589b7bd09d1d25f8e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i68ebbfe16e6d4925bb4ccf798eff1e19_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia73437118858471aab7c03547980000d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia15188e0ab8642c396b4a96aebce5582_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic2547ee5e7d94359a91b49b7221ab320_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5c2789456b4f4655b65a9ce676bc382b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if55d00add9b34a659909dea8aab579c3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if40cce849d804c9d9ade9ef0ff872500_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7b282120e5684071822469ae84204d65_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i460b190c7af34171a28a620ddf6d0f9b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4deefe47748e49dd9b5f6d19dde3517d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iee1c43167736475396bb0f00c1706266_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3b765f813058424c84db7601e651042b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iee0fda822a8640319a5856d56a336d6f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5b880299f57a4a9b9824c017900d1138_I20150701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dgx:UMassJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="i481a0bb184b14bad9d931200d5d31852_I20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="i667912428a7248bfb81aa3ff7ab6bf9c_I20211130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="i220fe343315542498e86e7895d5cb139_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id37a126b68964d6a8e53b08d24ae39c2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9c4b1b27b14f4358b79dcebe17500b25_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibef99765bb424b0a98ea7a9577ad7abd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if15719cfaad14b7dbfdf71b40a4c65d9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5e11296045604f51a55e048533a906a4_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5f567083983b48babafdc73d6c6901c7_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8f78891156cb4c548d0f6277115ee3eb_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia90feb97a113427e947ad9d0fd0a3fa3_D20230201-20230201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-01</endDate>
        </period>
    </context>
    <context id="ia10ad287b0cd4193a14609ca8a3021dc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5761244dc05a4e05ba1c36f1739ffa78_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0773aae3a1a24aabbc51451a0ca743da_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie4e5f3cb386b4fc98d6b4476305eabe9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dgx:A401kPlanLawsuitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ice7ecc3f1344426eb38edcacb95102d0_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dgx:A401kPlanLawsuitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ic641d132cbe14e8eb7c6b478bf547c1a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dgx:DataSecurityIncidentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i51a030df6d10457797f31c05e00c6fbd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia0ed27f0259f4eddad39f6d6f9166f22_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i92e626d8b4994af79d894bbd7fca8a13_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ieb2184019e3a41bba34f394de7b2cfc9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8ed346c5690e4ddc8d0b23a92ec0f7f2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2dd1a321696c48c5be41b31ca63c5571_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icd435f0f382f4a7885ef56b501114dd0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic3973c12fa954740845e01c52214f022_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8b6d35b5d67546ce9f6822c84cfcf9e5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i61ed8ec37ceb4a73a0b35d0de8357758_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6f57bd433a114ad99ef7c771bd566d82_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib70af9ca8a1f4946a10a38788730eceb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1e58a48918dd4becb0dd4cc40ca69a88_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5597494df62b463093771d2b719b6894_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6d860d57e4ad449a887c67967f28d5d6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ied62521cf257403a89d19d00c5aa5abe_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia2a765cc64784441973b1aec2bd7c985_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7cdf174765f04a2f86be3ef952803845_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i85e225a2df9640b3ab2e1ea93558ed16_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia7a6fd94d88447269386a6a9f798ce52_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2a00ddd1f78d4eabbd3eec75dce18984_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i355eb3cfa48643c89a8544abcf920805_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6cc506733bc54c4c939d04e93b12a019_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5ba6898f5dce4da790f1d70a1becead8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia5513c4320b84b8187a84d0c7bb3c2e7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3dadd8bb7e9b49f1a84da6abd44b2b54_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icfc7432b93a741d59d3b948cc6fd7457_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i23e66b0f67b94bb2b097b5144c24e807_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie21be809ef3c4dcbbd5ed7e71d98fbd4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3c6c0ad027434a8e877b0382b926c96d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i26268270d1b14e71a865a97e2c5c435a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie11d9750588e417cb37a21a52c132fcd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i772cad9a0b3d4082b300fc534f745257_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i61a15314b5e742e0b281c2024f9d2632_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if148e27d61634341a1c6b7a4d2b7f1ed_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i55811dcbf9b144cc912c05f6c566ce5a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifa6205a62b6b4428bd03ee3946847d9b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i86ad2c45fc2c42a69d24854e11d851c2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3e102be4f8254b1dbbc70aa3bdc19865_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic4911193ea2f4d57910161a9d6712993_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9ffb964e5c344410af806c81f53963c1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6029d63b27f74dce9c2c1865b3c36922_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib21559178668493e8f63bc406234ef9d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6e2af1eeb8384a619b904007a6cb8f29_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i03db1044dc514a8eae7a1f57881a63d3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i552e3aecfd8f4491b6039419f80524b3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9b19a5afa8014eac9ccbf727527f2ea6_D20230417-20230417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:NewYorkPresbyterianMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-17</startDate>
            <endDate>2023-04-17</endDate>
        </period>
    </context>
    <context id="i9c77555441f446579e41076eec2f33b5_D20230401-20230428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">us-gaap:ScenarioPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:HaystackOncologyIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-28</endDate>
        </period>
    </context>
    <context id="i1280f4be54c54da0986529d7da684b6d_I20230428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">us-gaap:ScenarioPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:HaystackOncologyIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="claim">
        <measure>dgx:claim</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80L2ZyYWc6ZjRjYjJhYjk4MDdmNGZlZjhhY2MzMjBlYzI0YjBmMWUvdGFibGU6Y2Y2ODM5NWY2ZDcyNDA1NmJjOTc1YjU3M2Q1YzA5ZWMvdGFibGVyYW5nZTpjZjY4Mzk1ZjZkNzI0MDU2YmM5NzViNTczZDVjMDllY18xLTEtMS0xLTk2OTAw_bdef9320-f3bb-4ea3-884a-f91813c2877b">0001022079</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80L2ZyYWc6ZjRjYjJhYjk4MDdmNGZlZjhhY2MzMjBlYzI0YjBmMWUvdGFibGU6Y2Y2ODM5NWY2ZDcyNDA1NmJjOTc1YjU3M2Q1YzA5ZWMvdGFibGVyYW5nZTpjZjY4Mzk1ZjZkNzI0MDU2YmM5NzViNTczZDVjMDllY18yLTEtMS0xLTk2OTAw_eaae2e4b-5ba9-4368-971c-97d5d45f1cb7">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80L2ZyYWc6ZjRjYjJhYjk4MDdmNGZlZjhhY2MzMjBlYzI0YjBmMWUvdGFibGU6Y2Y2ODM5NWY2ZDcyNDA1NmJjOTc1YjU3M2Q1YzA5ZWMvdGFibGVyYW5nZTpjZjY4Mzk1ZjZkNzI0MDU2YmM5NzViNTczZDVjMDllY18zLTEtMS0xLTk2OTAw_607c692f-0a83-4c0b-8f12-bb26f5988d7a">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80L2ZyYWc6ZjRjYjJhYjk4MDdmNGZlZjhhY2MzMjBlYzI0YjBmMWUvdGFibGU6Y2Y2ODM5NWY2ZDcyNDA1NmJjOTc1YjU3M2Q1YzA5ZWMvdGFibGVyYW5nZTpjZjY4Mzk1ZjZkNzI0MDU2YmM5NzViNTczZDVjMDllY180LTEtMS0xLTk2OTAw_bdd58fab-8e1e-4482-9d44-cf3233b56689">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80L2ZyYWc6ZjRjYjJhYjk4MDdmNGZlZjhhY2MzMjBlYzI0YjBmMWUvdGFibGU6Y2Y2ODM5NWY2ZDcyNDA1NmJjOTc1YjU3M2Q1YzA5ZWMvdGFibGVyYW5nZTpjZjY4Mzk1ZjZkNzI0MDU2YmM5NzViNTczZDVjMDllY181LTEtMS0xLTk2OTAw_ac1d3dd8-7194-48d8-84a5-790b43b87e6e">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGV4dHJlZ2lvbjo4YTkxNTBhMTA0ZTY0NzNlOTkwMzgyNjg1MjlkOTI5NV8xOTE5_a9bbce95-c71f-4f5d-94e3-28559dccf326">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGV4dHJlZ2lvbjo4YTkxNTBhMTA0ZTY0NzNlOTkwMzgyNjg1MjlkOTI5NV8xOTEy_3e83ce04-d12b-4d62-91e3-0ef7eaf24e4d">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGV4dHJlZ2lvbjo4YTkxNTBhMTA0ZTY0NzNlOTkwMzgyNjg1MjlkOTI5NV8xNTI_c3aa2bad-7b46-4441-95c1-908e1cdab092">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGV4dHJlZ2lvbjo4YTkxNTBhMTA0ZTY0NzNlOTkwMzgyNjg1MjlkOTI5NV8xOTEz_0f52b0cc-b11a-4bde-a47f-28ad385f938c">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGV4dHJlZ2lvbjo4YTkxNTBhMTA0ZTY0NzNlOTkwMzgyNjg1MjlkOTI5NV8xOTE0_da57bd58-87a9-4a90-896e-a1f4d467db22">001-12215</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGV4dHJlZ2lvbjo4YTkxNTBhMTA0ZTY0NzNlOTkwMzgyNjg1MjlkOTI5NV8xOTE1_35e073b5-5c85-48cd-b8f9-9b77d4bd956f">Quest Diagnostics Inc</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZTQ0NWRmMjE3OTY4NDNhZGI0NzViOGY0YmMxNTMwMDEvdGFibGVyYW5nZTplNDQ1ZGYyMTc5Njg0M2FkYjQ3NWI4ZjRiYzE1MzAwMV8wLTAtMS0xLTk2OTAw_8986fb44-89b0-47cc-8fe3-91ca53075b9e">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZTQ0NWRmMjE3OTY4NDNhZGI0NzViOGY0YmMxNTMwMDEvdGFibGVyYW5nZTplNDQ1ZGYyMTc5Njg0M2FkYjQ3NWI4ZjRiYzE1MzAwMV8wLTUtMS0xLTk2OTAw_87e9ea47-de03-4f99-9c92-9bdf13cf33f2">16-1387862</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZTQ0NWRmMjE3OTY4NDNhZGI0NzViOGY0YmMxNTMwMDEvdGFibGVyYW5nZTplNDQ1ZGYyMTc5Njg0M2FkYjQ3NWI4ZjRiYzE1MzAwMV8yLTAtMS0xLTk2OTAw_f3fde4b5-063a-431e-80fe-ccb961b8e1d6">500 Plaza Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZTQ0NWRmMjE3OTY4NDNhZGI0NzViOGY0YmMxNTMwMDEvdGFibGVyYW5nZTplNDQ1ZGYyMTc5Njg0M2FkYjQ3NWI4ZjRiYzE1MzAwMV8zLTAtMS0xLTk2OTAw_d4b88750-23fe-4559-a311-445af12cde50">Secaucus,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZTQ0NWRmMjE3OTY4NDNhZGI0NzViOGY0YmMxNTMwMDEvdGFibGVyYW5nZTplNDQ1ZGYyMTc5Njg0M2FkYjQ3NWI4ZjRiYzE1MzAwMV8zLTEtMS0xLTk2OTAw_90502f46-66dc-43d7-82e2-8ba7149537b8">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZTQ0NWRmMjE3OTY4NDNhZGI0NzViOGY0YmMxNTMwMDEvdGFibGVyYW5nZTplNDQ1ZGYyMTc5Njg0M2FkYjQ3NWI4ZjRiYzE1MzAwMV8zLTItMS0xLTk2OTAw_94cad71e-8168-4131-af91-35f4438370a3">07094</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZTQ0NWRmMjE3OTY4NDNhZGI0NzViOGY0YmMxNTMwMDEvdGFibGVyYW5nZTplNDQ1ZGYyMTc5Njg0M2FkYjQ3NWI4ZjRiYzE1MzAwMV80LTAtMS0xLTk2OTAw_f8c6dbaa-2dde-4a34-a5c3-8f6e7bcf9732">(973)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZTQ0NWRmMjE3OTY4NDNhZGI0NzViOGY0YmMxNTMwMDEvdGFibGVyYW5nZTplNDQ1ZGYyMTc5Njg0M2FkYjQ3NWI4ZjRiYzE1MzAwMV80LTEtMS0xLTk2OTAw_3eedb943-7bb5-4fc8-9c99-c2b9371d303e">520-2700</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZWM3MWQ1NDdkMmU1NGVjMzk4MTExZGEyZmZkNmIzZjEvdGFibGVyYW5nZTplYzcxZDU0N2QyZTU0ZWMzOTgxMTFkYTJmZmQ2YjNmMV8xLTAtMS0xLTk2OTAw_d2e3256a-3636-4943-ada3-c206bf4ef9bf">Common Stock, $0.01 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZWM3MWQ1NDdkMmU1NGVjMzk4MTExZGEyZmZkNmIzZjEvdGFibGVyYW5nZTplYzcxZDU0N2QyZTU0ZWMzOTgxMTFkYTJmZmQ2YjNmMV8xLTEtMS0xLTk2OTAw_9a8c1cf9-532c-47bb-8323-c931f8880f21">DGX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6ZWM3MWQ1NDdkMmU1NGVjMzk4MTExZGEyZmZkNmIzZjEvdGFibGVyYW5nZTplYzcxZDU0N2QyZTU0ZWMzOTgxMTFkYTJmZmQ2YjNmMV8xLTItMS0xLTk2OTAw_ae99efe4-7efe-4f68-882e-ea7612b7c3b3">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGV4dHJlZ2lvbjo4YTkxNTBhMTA0ZTY0NzNlOTkwMzgyNjg1MjlkOTI5NV8xOTE2_dbd7485b-06bb-4258-90f8-a2b26776687a">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGV4dHJlZ2lvbjo4YTkxNTBhMTA0ZTY0NzNlOTkwMzgyNjg1MjlkOTI5NV8xOTE3_0f26a649-6a61-40b9-b333-6e2013d483d2">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6MTZjOTY1NjBkMzI2NDgyNjg4ZTM5YWIzNWRkYWM2NjgvdGFibGVyYW5nZToxNmM5NjU2MGQzMjY0ODI2ODhlMzlhYjM1ZGRhYzY2OF8wLTAtMS0xLTk2OTAw_0a32d9a6-a09a-4a3d-bc5d-38a3418801a6">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6MTZjOTY1NjBkMzI2NDgyNjg4ZTM5YWIzNWRkYWM2NjgvdGFibGVyYW5nZToxNmM5NjU2MGQzMjY0ODI2ODhlMzlhYjM1ZGRhYzY2OF8xLTMtMS0xLTk2OTAw_3ccb1717-7d78-43b5-9367-1ed4c4c03281">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGFibGU6MTZjOTY1NjBkMzI2NDgyNjg4ZTM5YWIzNWRkYWM2NjgvdGFibGVyYW5nZToxNmM5NjU2MGQzMjY0ODI2ODhlMzlhYjM1ZGRhYzY2OF8yLTMtMS0xLTk2OTAw_a9851e33-f9b5-4dca-9cce-eb71870f5ac8">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGV4dHJlZ2lvbjo4YTkxNTBhMTA0ZTY0NzNlOTkwMzgyNjg1MjlkOTI5NV8xOTE4_78b1b4f1-ddd1-44cc-a671-5c172d69c315">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i4c7aaabb9e3f43c18d9412ca50c62173_I20230414"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xL2ZyYWc6OGE5MTUwYTEwNGU2NDczZTk5MDM4MjY4NTI5ZDkyOTUvdGV4dHJlZ2lvbjo4YTkxNTBhMTA0ZTY0NzNlOTkwMzgyNjg1MjlkOTI5NV8xODU0_b074e52e-c18c-4214-a866-5207be24e48d"
      unitRef="shares">112009197</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMi0xLTEtMS05NjkwMA_d726ad43-0a4e-4cda-b8f9-a27ff8c2f9bc"
      unitRef="usd">2331000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMi0zLTEtMS05NjkwMA_7fe8f77e-23cc-4c1e-a978-be09d83fac9a"
      unitRef="usd">2611000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNS0xLTEtMS05NjkwMA_6398fe7f-7d75-43b3-9a8a-551ce3e7d1b8"
      unitRef="usd">1560000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNS0zLTEtMS05NjkwMA_dbb84979-c584-45cd-90c5-3accdaf01d4a"
      unitRef="usd">1646000000</us-gaap:CostOfRevenue>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNi0xLTEtMS05NjkwMA_f5c2dbcc-0ba7-46aa-909f-5e52d0f9e0c7"
      unitRef="usd">439000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNi0zLTEtMS05NjkwMA_7bd023d3-f7ba-434b-a129-e7b4fc6ad17c"
      unitRef="usd">425000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNy0xLTEtMS05NjkwMA_9cd08d07-680f-4743-93c6-24c750df1af5"
      unitRef="usd">26000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNy0zLTEtMS05NjkwMA_1814a4ba-74ac-412c-b411-32182422496f"
      unitRef="usd">27000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfOS0xLTEtMS05NjkwMA_ca55d43c-fefa-49b8-acaf-246ad11274c0"
      unitRef="usd">-1000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfOS0zLTEtMS05NjkwMA_d7a01de4-d3ab-46bf-8fea-b3f82d2b17e4"
      unitRef="usd">0</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:CostsAndExpenses
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTAtMS0xLTEtOTY5MDA_346c6ce0-1135-4ede-b6e3-e1d0ed108ba6"
      unitRef="usd">2026000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTAtMy0xLTEtOTY5MDA_fe3dac06-6de3-4a0c-8cfc-414fae45d5be"
      unitRef="usd">2098000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTItMS0xLTEtOTY5MDA_983d5305-6a34-474a-8f8d-f1ddf393465c"
      unitRef="usd">305000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTItMy0xLTEtOTY5MDA_ddbfafb8-24b1-43d0-baa4-5d1d62df4f84"
      unitRef="usd">513000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTUtMS0xLTEtOTY5MDA_2e9b1687-d303-496d-9882-ea0d9f460c0c"
      unitRef="usd">-35000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTUtMy0xLTEtOTY5MDA_6d89a979-afec-4c4c-a641-81e1cfa23377"
      unitRef="usd">-37000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTYtMS0xLTEtOTY5MDA_bd347def-e07a-4c78-b88d-23d5bf090436"
      unitRef="usd">7000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTYtMy0xLTEtOTY5MDA_3939f484-c7a7-4909-856a-567e13487a12"
      unitRef="usd">-24000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTctMS0xLTEtOTY5MDA_168294cb-3698-4e49-9683-3322e7866ba5"
      unitRef="usd">-28000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTctMy0xLTEtOTY5MDA_55c07ae5-4a46-48b5-8900-ca7f4390ca43"
      unitRef="usd">-61000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTktMS0xLTEtOTY5MDA_f2895cce-8b69-4ff6-9c36-75da7fb02dc3"
      unitRef="usd">277000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMTktMy0xLTEtOTY5MDA_d04eb703-e5ba-422e-aaf1-0a0675ca7d25"
      unitRef="usd">452000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMjAtMS0xLTEtOTY5MDA_c1198e97-480d-415a-bad7-96c909d70023"
      unitRef="usd">65000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMjAtMy0xLTEtOTY5MDA_627d4470-395f-44ff-b48b-c7ffcf9f763c"
      unitRef="usd">110000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMjEtMS0xLTEtOTY5MDA_d9fe4ec0-8848-4a56-8b75-d72c31863ec7"
      unitRef="usd">5000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMjEtMy0xLTEtOTY5MDA_d2a78198-e39e-4d06-9fcb-506fdc78aba8"
      unitRef="usd">31000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMjQtMS0xLTEtOTY5MDA_20176249-567a-4f20-9ab1-c8ec894a2ed6"
      unitRef="usd">217000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMjQtMy0xLTEtOTY5MDA_0fe2eeb7-9c36-407b-a93a-32fd365171e0"
      unitRef="usd">373000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMjUtMS0xLTEtOTY5MDA_1c7a5c80-98d4-4375-8450-c00f315e9bd8"
      unitRef="usd">15000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMjUtMy0xLTEtOTY5MDA_b081c97f-a899-49b2-b10d-39398f733fa4"
      unitRef="usd">18000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMjYtMS0xLTEtOTY5MDA_d79fe2ef-8f40-4373-8b66-566ed803c96e"
      unitRef="usd">202000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMjYtMy0xLTEtOTY5MDA_4ff9adf0-a1b6-41bf-8143-a95a86e355a0"
      unitRef="usd">355000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMzYtMS0xLTEtOTY5MDA_bcc2f39f-c0ce-4069-bc13-adbfb48d2ff6"
      unitRef="usdPerShare">1.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfMzYtMy0xLTEtOTY5MDA_bd48c333-84b4-424d-9767-6d1433a7a497"
      unitRef="usdPerShare">2.97</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNDEtMS0xLTEtOTY5MDA_35595f6c-834f-42e3-b004-fa8da869c4cd"
      unitRef="usdPerShare">1.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNDEtMy0xLTEtOTY5MDA_6d34c564-6389-4293-8d7b-e17bad48a012"
      unitRef="usdPerShare">2.92</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNDQtMS0xLTEtOTY5MDA_523a0087-4fc5-45a1-852a-2ea3f4c342ee"
      unitRef="shares">112000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNDQtMy0xLTEtOTY5MDA_dbff6ad6-8d98-453f-9186-740313640847"
      unitRef="shares">119000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNDYtMS0xLTEtOTY5MDA_f1d6ee3b-d254-492b-8b60-dc3c78f2f12a"
      unitRef="shares">113000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMy9mcmFnOjBiYjRhNTczYjUzMDRkYzlhOGJkNTYwZDdiMTE4M2VmL3RhYmxlOmMwMGIxYmE3ZDhjYjRiMDFhYmQ4ZWZlNDM4YzAzZDVmL3RhYmxlcmFuZ2U6YzAwYjFiYTdkOGNiNGIwMWFiZDhlZmU0MzhjMDNkNWZfNDYtMy0xLTEtOTY5MDA_fe209ca3-eca6-4be0-af55-1bd99db3eb37"
      unitRef="shares">121000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfMi0xLTEtMS05NjkwMA_20176249-567a-4f20-9ab1-c8ec894a2ed6"
      unitRef="usd">217000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfMi0zLTEtMS05NjkwMA_0fe2eeb7-9c36-407b-a93a-32fd365171e0"
      unitRef="usd">373000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfNS0xLTEtMS05NjkwMA_fef6c289-540e-41b5-8cfb-32ec3f1acb69"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfNS0zLTEtMS05NjkwMA_7fee765e-e4b5-4af3-96ac-79a16156961a"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfOS0xLTEtMS05NjkwMA_ca888376-71a3-4b14-a40b-ad5409302ce0"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfOS0zLTEtMS05NjkwMA_85d6b1fb-0528-4775-b4c8-770270e5a077"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfMTEtMS0xLTEtOTY5MDA_f3e913d3-2d89-408c-b6ab-ec25dc16ac29"
      unitRef="usd">220000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfMTEtMy0xLTEtOTY5MDA_d32364ee-4ea5-4a53-9513-0b1954ed6526"
      unitRef="usd">371000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfMTItMS0xLTEtOTY5MDA_c06422d6-1cf4-4c6a-a931-3b534d26c13d"
      unitRef="usd">15000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfMTItMy0xLTEtOTY5MDA_6bb6c706-4438-4a6b-a731-411dfde7d11d"
      unitRef="usd">18000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfMTMtMS0xLTEtOTY5MDA_484cd988-eaa3-4af6-8111-5b6a9c97ecbc"
      unitRef="usd">205000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xNi9mcmFnOmE0NjcxMWE2ZTNlNzQyOGNiZThkZDkzOTk3MzBkMWVhL3RhYmxlOjZhNGU3ODliZDUzZTRmMzJiZTYzZTAzNTYzMmYwMGM2L3RhYmxlcmFuZ2U6NmE0ZTc4OWJkNTNlNGYzMmJlNjNlMDM1NjMyZjAwYzZfMTMtMy0xLTEtOTY5MDA_f6c0207b-0eb4-4404-80cf-096007440c02"
      unitRef="usd">353000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMy0xLTEtMS05NjkwMA_ca56d49a-b374-4559-84b9-02afde1d8772"
      unitRef="usd">175000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMy0zLTEtMS05NjkwMA_3be419f5-a6e7-4081-bb7c-eb3d160a47b3"
      unitRef="usd">315000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNC0wLTEtMS05NjkwMC90ZXh0cmVnaW9uOmY0M2VkNzFlYmFlNzQ0NzFhZGZhYWM1MzUwYTRhNDM0Xzcw_708e716a-4e1f-4114-bb13-c8cfc233d9a0"
      unitRef="usd">30000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNC0wLTEtMS05NjkwMC90ZXh0cmVnaW9uOmY0M2VkNzFlYmFlNzQ0NzFhZGZhYWM1MzUwYTRhNDM0Xzcw_71339670-eae1-40cb-b79e-8f779e03ed61"
      unitRef="usd">30000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNC0xLTEtMS05NjkwMA_9375fb9f-de04-4d7b-a424-f49a5b63f4dd"
      unitRef="usd">1254000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNC0zLTEtMS05NjkwMA_126fbc3e-47c4-4160-b25d-e44577c9bcba"
      unitRef="usd">1195000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNS0xLTEtMS05NjkwMA_587a3d4a-1ac1-4491-b3c7-eb309f04370d"
      unitRef="usd">190000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNS0zLTEtMS05NjkwMA_f82a1351-02ac-47b2-8166-3812b055dfb7"
      unitRef="usd">192000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNi0xLTEtMS05NjkwMA_fc0e8914-b214-4bf8-b893-f4b7cf5eef37"
      unitRef="usd">195000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNi0zLTEtMS05NjkwMA_c7ce6b08-7bfb-466c-8f73-209518a99d0d"
      unitRef="usd">196000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfOC0xLTEtMS05NjkwMA_c7f71a57-fbe4-4e9c-8440-6a039774e050"
      unitRef="usd">1814000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfOC0zLTEtMS05NjkwMA_6787842b-2e64-4b09-9788-9ad1a623b689"
      unitRef="usd">1898000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfOS0xLTEtMS05NjkwMA_9c376fbf-292c-4942-99f4-76e0c988c98d"
      unitRef="usd">1795000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfOS0zLTEtMS05NjkwMA_e29a916b-54eb-47db-92df-91b54a04c36f"
      unitRef="usd">1766000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTAtMS0xLTEtOTY5MDA_0011c229-b7a1-4a34-b0d4-93760e558c36"
      unitRef="usd">589000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTAtMy0xLTEtOTY5MDA_064125ba-0497-4673-adc8-c979972142da"
      unitRef="usd">585000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTEtMS0xLTEtOTY5MDA_3b3bdfbe-2d40-49a9-80e0-5bf0b0703676"
      unitRef="usd">7241000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTEtMy0xLTEtOTY5MDA_da56cf22-4dc1-4cb1-adaa-cb02a2ccd056"
      unitRef="usd">7220000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTItMS0xLTEtOTY5MDA_0a2f32e2-e2d6-4114-ae58-3b4180d89c7b"
      unitRef="usd">1077000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTItMy0xLTEtOTY5MDA_52aabce5-fa1d-43bc-9496-c2d548b05fb7"
      unitRef="usd">1092000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:EquityMethodInvestments
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTMtMS0xLTEtOTY5MDA_b68390ba-b103-47c8-a316-53493757963e"
      unitRef="usd">128000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTMtMy0xLTEtOTY5MDA_1a73633b-1a35-4b51-9aa6-1a219dafc11a"
      unitRef="usd">132000000</us-gaap:EquityMethodInvestments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTQtMS0xLTEtOTY5MDA_febffaab-5391-44f8-b92d-075f39e118c0"
      unitRef="usd">150000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTQtMy0xLTEtOTY5MDA_536fe4d7-47cc-459c-90fc-38ac940206d5"
      unitRef="usd">144000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTYtMS0xLTEtOTY5MDA_e2493985-9e77-41e1-ab70-a7cd03391638"
      unitRef="usd">12794000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMTYtMy0xLTEtOTY5MDA_e1339401-9feb-44d5-a979-5fa9cd0da84a"
      unitRef="usd">12837000000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjAtMS0xLTEtOTY5MDA_acdd4b88-74d2-4c69-84eb-4d3df860de6c"
      unitRef="usd">1198000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjAtMy0xLTEtOTY5MDA_247b84ad-8fac-4734-8b8d-482067b96820"
      unitRef="usd">1396000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjEtMS0xLTEtOTY5MDA_5d866d6e-c87d-4822-9658-75043618adea"
      unitRef="usd">2000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjEtMy0xLTEtOTY5MDA_bd138ecf-e2fb-4a50-a226-068b6610c0c3"
      unitRef="usd">2000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjItMS0xLTEtOTY5MDA_9600b2e8-2443-48d3-b0d6-172c39bec439"
      unitRef="usd">155000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjItMy0xLTEtOTY5MDA_c9c4af36-047c-4a1e-b3f4-8c0ab1a05e10"
      unitRef="usd">153000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjQtMS0xLTEtOTY5MDA_08e24efd-b7e5-434c-9555-c41aed340b17"
      unitRef="usd">1355000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjQtMy0xLTEtOTY5MDA_e604e7ea-5920-4448-b0a8-89f792f0f4ea"
      unitRef="usd">1551000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjUtMS0xLTEtOTY5MDA_ff563619-8ba3-47c3-a8c4-398f5cb097f9"
      unitRef="usd">3975000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjUtMy0xLTEtOTY5MDA_1b0c8a96-bcd8-4eef-ae28-b4e7312f3a9a"
      unitRef="usd">3978000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjYtMS0xLTEtOTY5MDA_0bd2da0f-d0ed-4425-977b-dbfe24b255ad"
      unitRef="usd">490000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjYtMy0xLTEtOTY5MDA_32c611c8-7b82-40de-9170-b170945fef7e"
      unitRef="usd">489000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjctMS0xLTEtOTY5MDA_8537bcb5-826d-4f26-b488-27829de1db15"
      unitRef="usd">809000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjctMy0xLTEtOTY5MDA_72dade52-86ba-4468-9846-06c3baefd6d0"
      unitRef="usd">812000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjktMS0xLTEtOTY5MDA_3a8be7f4-5cf4-4975-bfc2-c2fff8c16c89"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMjktMy0xLTEtOTY5MDA_8d938ee9-e942-4210-a30a-306606098be7"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzAtMS0xLTEtOTY5MDA_cd176cda-cc3c-4171-842c-9b8264e7c3bf"
      unitRef="usd">77000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzAtMy0xLTEtOTY5MDA_40711e87-afd1-4768-b8a4-6aa0edd8f61a"
      unitRef="usd">77000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzMtMC0xLTEtOTY5MDAvdGV4dHJlZ2lvbjpjY2UzNjE1MGFkZmM0NjBmODY5ZGQ1Nzk3YzU4ZTc0Zl8yOA_c0a33be8-d530-4c81-8f92-1c2950be09bb"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzMtMC0xLTEtOTY5MDAvdGV4dHJlZ2lvbjpjY2UzNjE1MGFkZmM0NjBmODY5ZGQ1Nzk3YzU4ZTc0Zl8yOA_ffecf9a3-0d3f-496d-86ae-a18e8ad893af"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzMtMC0xLTEtOTY5MDAvdGV4dHJlZ2lvbjpjY2UzNjE1MGFkZmM0NjBmODY5ZGQ1Nzk3YzU4ZTc0Zl80Mg_7dd12a37-7917-4026-9a11-d2f9273d9414"
      unitRef="shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzMtMC0xLTEtOTY5MDAvdGV4dHJlZ2lvbjpjY2UzNjE1MGFkZmM0NjBmODY5ZGQ1Nzk3YzU4ZTc0Zl80Mg_f403ba90-482c-4ff7-b02d-cc7ce357cdbc"
      unitRef="shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzMtMC0xLTEtOTY5MDAvdGV4dHJlZ2lvbjpjY2UzNjE1MGFkZmM0NjBmODY5ZGQ1Nzk3YzU4ZTc0Zl84NQ_2fca0a54-9ef0-47a0-bb1d-a9d0ab22dbdb"
      unitRef="shares">162000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzMtMC0xLTEtOTY5MDAvdGV4dHJlZ2lvbjpjY2UzNjE1MGFkZmM0NjBmODY5ZGQ1Nzk3YzU4ZTc0Zl84NQ_5633a930-6176-4ec6-89ec-12bf2cdf7b97"
      unitRef="shares">162000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzMtMS0xLTEtOTY5MDA_6ef709ef-6cb9-4a2f-b846-7939b3ba7852"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzMtMy0xLTEtOTY5MDA_52069338-3b39-49b1-8398-5553e07b5797"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzQtMS0xLTEtOTY5MDA_36541a3d-bd8b-4cf5-91e3-35bd3146edf8"
      unitRef="usd">2266000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzQtMy0xLTEtOTY5MDA_e33d5f20-9e2b-452b-9874-6d8ef5c5a97b"
      unitRef="usd">2295000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzUtMS0xLTEtOTY5MDA_9759caa5-ca56-4169-80f9-963d4a1c71d5"
      unitRef="usd">8412000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzUtMy0xLTEtOTY5MDA_d4a05249-218a-4a44-a54e-d67e99e6d1cc"
      unitRef="usd">8290000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzYtMS0xLTEtOTY5MDA_787106b0-c66d-4881-9143-797438818f6b"
      unitRef="usd">-18000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzYtMy0xLTEtOTY5MDA_e5bfc769-1cb7-47bc-95bd-7fbff4dc5c9d"
      unitRef="usd">-21000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzctMC0xLTEtOTY5MDAvdGV4dHJlZ2lvbjo2ZDBmYjZkYzM0ZGQ0NTQ1ODlhZTY1YzNkMzY4ZmRkZV8yOQ_86cb3c73-e37a-4a7a-880d-f4d97e9c5dcd"
      unitRef="shares">50000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzctMC0xLTEtOTY5MDAvdGV4dHJlZ2lvbjo2ZDBmYjZkYzM0ZGQ0NTQ1ODlhZTY1YzNkMzY4ZmRkZV8zNg_86bbd200-ee4c-4663-953f-52de75a97ff0"
      unitRef="shares">51000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzctMS0xLTEtOTY5MDA_c3545913-0e7b-4ad7-989c-d7c9fd7715ce"
      unitRef="usd">4612000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzctMy0xLTEtOTY5MDA_28ff279c-8a81-4c2b-bfd4-9d67c5be82ae"
      unitRef="usd">4673000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzgtMS0xLTEtOTY5MDA_8fa69b91-acc7-43c3-82ba-b071860718d7"
      unitRef="usd">6050000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzgtMy0xLTEtOTY5MDA_8bfa5d78-1bff-45e1-a5a4-c6ba2400fa81"
      unitRef="usd">5893000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzktMS0xLTEtOTY5MDA_cd54d85d-f10d-4426-bd79-22eb1dc022e3"
      unitRef="usd">38000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfMzktMy0xLTEtOTY5MDA_14a90eae-a5dd-4a6b-9e21-a108161778f9"
      unitRef="usd">37000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNDAtMS0xLTEtOTY5MDA_1690df83-145a-4d75-b85b-7820625c5bf2"
      unitRef="usd">6088000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNDAtMy0xLTEtOTY5MDA_0cffd4c4-3dc6-4613-bb6f-f6d4ebb47f2a"
      unitRef="usd">5930000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNDEtMS0xLTEtOTY5MDA_7da5605a-500d-4b1f-bae9-9de573ecd911"
      unitRef="usd">12794000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xOS9mcmFnOjE0MTNkNjRjNGI2NjRjOGRhNGMwMTI0MTc0NWIyYWI0L3RhYmxlOjk1ZTMwYWEyOWQyNTQ5N2M4MWVjZTZiNzQyNjZmYTQxL3RhYmxlcmFuZ2U6OTVlMzBhYTI5ZDI1NDk3YzgxZWNlNmI3NDI2NmZhNDFfNDEtMy0xLTEtOTY5MDA_ac39ee98-2ced-4948-a685-1d800aa3c53b"
      unitRef="usd">12837000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMy0xLTEtMS05NjkwMA_35ca6eb0-4949-4c7b-9a39-3ff0143af817"
      unitRef="usd">217000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMy0zLTEtMS05NjkwMA_523cccac-319f-4b2a-88b6-a29910afd372"
      unitRef="usd">373000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNS0xLTEtMS05NjkwMA_127e9e3b-29b3-4212-b8b3-d467eb8ff65e"
      unitRef="usd">107000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNS0zLTEtMS05NjkwMA_00da19d4-e45d-4dd1-b439-eaca72268db0"
      unitRef="usd">106000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNi0xLTEtMS05NjkwMA_627cb5d0-f1d1-4e2f-b638-1d4e5026ac58"
      unitRef="usd">-1000000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNi0zLTEtMS05NjkwMA_2bd15ab8-1c4f-40ad-8014-2dca0470832a"
      unitRef="usd">0</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNy0xLTEtMS05NjkwMA_50b0455d-1d75-40ad-bba1-191a51176ba6"
      unitRef="usd">-4000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNy0zLTEtMS05NjkwMA_491cb675-0be5-44ce-b34f-24b4ae103b89"
      unitRef="usd">-43000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfOC0xLTEtMS05NjkwMA_f9e3f459-827e-40c1-bdd6-2568fd7e9242"
      unitRef="usd">24000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfOC0zLTEtMS05NjkwMA_a4ed8188-78eb-4623-9547-5339b776d130"
      unitRef="usd">18000000</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTEtMS0xLTEtOTY5MDA_fe3da6ba-bf11-4bbb-99a6-cabb0ba8e52e"
      unitRef="usd">-3000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTEtMy0xLTEtOTY5MDA_5ce8750a-a8fd-4851-add1-b6948125e023"
      unitRef="usd">-4000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTMtMS0xLTEtOTY5MDA_9042f22d-b424-4c66-8d43-16dc91db8556"
      unitRef="usd">58000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTMtMy0xLTEtOTY5MDA_0382cd65-53e0-4119-85e3-d54bc5a31bd0"
      unitRef="usd">-72000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTQtMS0xLTEtOTY5MDA_0a079598-7909-4208-9bc4-a7ee02584ccf"
      unitRef="usd">-211000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTQtMy0xLTEtOTY5MDA_86c06334-5cd7-4316-93c0-7977b7ae391c"
      unitRef="usd">-165000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTUtMS0xLTEtOTY5MDA_f74e7909-291c-4fcd-a7c5-990f7fbe4972"
      unitRef="usd">11000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTUtMy0xLTEtOTY5MDA_43f3a81b-9e3b-426d-a065-14a29950d1e4"
      unitRef="usd">95000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTctMS0xLTEtOTY5MDA_f922813a-9cc2-468a-93e4-7489f4739f33"
      unitRef="usd">-6000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTctMy0xLTEtOTY5MDA_e3212a43-c7f6-4f1e-b688-33c8805e3912"
      unitRef="usd">-20000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTgtMS0xLTEtOTY5MDA_96555fec-c482-4063-9c0d-7dc4ef31c482"
      unitRef="usd">94000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMTgtMy0xLTEtOTY5MDA_b049b89f-509e-4a5c-91a0-b5483d6bbdfe"
      unitRef="usd">480000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMjEtMS0xLTEtOTY5MDA_9cd68964-3c2c-4a20-be9c-8eea82eaac77"
      unitRef="usd">31000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMjEtMy0xLTEtOTY5MDA_b45aaf51-ca74-4831-94b8-d725a4bba834"
      unitRef="usd">105000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMjQtMS0xLTEtOTY5MDA_a7e1c317-5486-408a-9684-a41a89e8b80e"
      unitRef="usd">127000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMjQtMy0xLTEtOTY5MDA_5036183d-57de-4f74-a59c-83bed22635ab"
      unitRef="usd">63000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMjctMS0xLTEtOTY5MDA_12c6417a-a601-483b-80df-3d8381f6f9dc"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMjctMy0xLTEtOTY5MDA_18aed478-ecef-4fa8-a034-f8125b4c63bb"
      unitRef="usd">1000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMjgtMS0xLTEtOTY5MDA_58243ffd-6af1-44bc-850f-47d59b262c28"
      unitRef="usd">-158000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMjgtMy0xLTEtOTY5MDA_af85dee9-5bc1-41b9-aaf0-d8f0890e4c98"
      unitRef="usd">-169000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzEtMS0xLTEtOTY5MDA_67a25e70-de58-4ba4-8e7d-5ec681c1a638"
      unitRef="usd">140000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzEtMy0xLTEtOTY5MDA_b238a9ef-22a3-44a9-ae61-456c1bbc4fef"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzItMS0xLTEtOTY5MDA_63f52da3-8322-49f1-822e-df3a8d82117d"
      unitRef="usd">140000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzItMy0xLTEtOTY5MDA_e66cb3e3-10d7-4519-b58a-dc6ad6d21d99"
      unitRef="usd">1000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzMtMS0xLTEtOTY5MDA_1c314553-9276-473a-a386-f0cdcc01e0e4"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzMtMy0xLTEtOTY5MDA_4ba797a6-3c66-488b-ab3c-b9785b1f9070"
      unitRef="usd">373000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzQtMS0xLTEtOTY5MDA_f811a3b9-b1f7-4ddb-b5e8-54680116204d"
      unitRef="usd">25000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzQtMy0xLTEtOTY5MDA_53716784-bbd8-41ce-a8bc-64a56aa1e710"
      unitRef="usd">10000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzUtMS0xLTEtOTY5MDA_68758102-e450-4233-9535-a42813a55128"
      unitRef="usd">28000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzUtMy0xLTEtOTY5MDA_834e14c5-644f-40a8-853a-701db8f5343f"
      unitRef="usd">27000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzYtMS0xLTEtOTY5MDA_33049076-c3c9-4a8f-819c-ee62ae522b63"
      unitRef="usd">74000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzYtMy0xLTEtOTY5MDA_99f3aab5-f08f-493c-8438-1a5f59aa9e27"
      unitRef="usd">74000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzctMS0xLTEtOTY5MDA_668a9b22-988d-4e17-8802-3b5e0fa6fb0b"
      unitRef="usd">14000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfMzctMy0xLTEtOTY5MDA_62cdff5c-3e8e-48d8-bec1-15ad08e77702"
      unitRef="usd">20000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNDAtMS0xLTEtOTY5MDA_af18f301-71cd-430a-b128-ecb99d356c33"
      unitRef="usd">15000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNDAtMy0xLTEtOTY5MDA_673a9945-2d1e-4c1f-83d3-e0aa7044ebfb"
      unitRef="usd">14000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNDEtMS0xLTEtOTY5MDA_4b673617-46bf-48c9-9c3b-ce969760fb5d"
      unitRef="usd">-76000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNDEtMy0xLTEtOTY5MDA_692bfb95-3b3f-405b-b9d3-3116d28daa9d"
      unitRef="usd">-471000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNDMtMS0xLTEtOTY5MDA_ef8134eb-4be0-4d09-b58b-d1c7a4aacf88"
      unitRef="usd">-140000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNDMtMy0xLTEtOTY5MDA_1fbec2c1-e8a8-48dc-8257-713c5f93f81f"
      unitRef="usd">-160000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNDUtMS0xLTEtOTY5MDA_1c6281c5-6bf6-485c-afcd-1b8729f27d87"
      unitRef="usd">315000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4f825bb08aff4a16a22babce12a7813b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNDUtMy0xLTEtOTY5MDA_43f25c89-7f55-4d86-82de-dcaec7d83496"
      unitRef="usd">872000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNDYtMS0xLTEtOTY5MDA_4171434f-c111-48d8-a012-55f68d96f1d8"
      unitRef="usd">175000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib84cedd020e943f08a613b4d09834d7f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yMi9mcmFnOjNlOGMyNjY2OTc1OTRkNDY4ZGYyNzgyNDg1MWJjOGRlL3RhYmxlOjBkZjExODFhYmU4NDQwMzU5NDExMGFhZDI0ZDIyYzBlL3RhYmxlcmFuZ2U6MGRmMTE4MWFiZTg0NDAzNTk0MTEwYWFkMjRkMjJjMGVfNDYtMy0xLTEtOTY5MDA_65682a12-ff47-44eb-81e0-0be85e73b90e"
      unitRef="usd">712000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i367251b8c6384daaa5fa30fad01b58e5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTctMS0xLTEtOTY5MDA_bf462fb7-5632-45dd-a369-73e19e2c7059"
      unitRef="shares">111000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i367251b8c6384daaa5fa30fad01b58e5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTctMy0xLTEtOTY5MDA_e6f1fdcf-92e3-4048-8b08-eb1f6b8880a5"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6223da0135b64cee99f192d6f1af6c1a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTctNS0xLTEtOTY5MDA_f53fe899-24b8-4d07-ad0b-14f29fe5f85c"
      unitRef="usd">2295000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9c3a6f02e5244194aa47bf148a80d73f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTctNy0xLTEtOTY5MDA_504ae585-3ab0-47bc-994d-5a5d339861b3"
      unitRef="usd">8290000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4034fabdd7ca4912917c75ef9a0a2da9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTctOS0xLTEtOTY5MDA_3a54b311-1ce3-4c5d-adff-b026843e9930"
      unitRef="usd">-21000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iecb39988efab48f8b58484b98bbfee1b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTctMTEtMS0xLTk2OTAw_a99adba6-f5bd-42f4-84b1-b84fe8127b41"
      unitRef="usd">-4673000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8146dfedf0844767b0319b9e33973cf6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTctMTMtMS0xLTk2OTAw_ac71386f-3f8e-4e07-ac7f-b6075d114413"
      unitRef="usd">37000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTctMTUtMS0xLTk2OTAw_f148120c-b0d8-42c3-a937-ea6dd9704f9d"
      unitRef="usd">5930000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTctMTgtMS0xLTk2OTAw_ace5271c-519e-451c-9f1d-f90e3150a637"
      unitRef="usd">77000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:NetIncomeLoss
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTgtNy0xLTEtOTY5MDA_d79fe2ef-8f40-4373-8b66-566ed803c96e"
      unitRef="usd">202000000</us-gaap:NetIncomeLoss>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i0325c9b10a83489b85899f5559dce780_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTgtMTMtMS0xLTk2OTAw_c920a9cd-27fe-455d-b7a4-48ea60b86e99"
      unitRef="usd">14000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTgtMTUtMS0xLTk2OTAw_7f739101-c2d8-45e8-984c-1b77142483f3"
      unitRef="usd">216000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTgtMTgtMS0xLTk2OTAw_a3643ed4-fa27-4d17-ae73-549930a9df14"
      unitRef="usd">1000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i25f1cfe1d1c6418d846c108e8dd55e7c_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTktOS0xLTEtOTY5MDA_7771a109-e828-451b-8ffe-c0b994d33706"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMTktMTUtMS0xLTk2OTAw_25f27f6c-c890-44e4-b356-5f25fa469506"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="ic8e71edf5ebf4c21a564d4ed2747d817_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjAtNy0xLTEtOTY5MDA_281e7192-5aa7-4bd8-ba93-e655e48b6cd5"
      unitRef="usd">80000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjAtMTUtMS0xLTk2OTAw_3382dadc-6219-45d5-b07b-b1d714e6a714"
      unitRef="usd">80000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i0325c9b10a83489b85899f5559dce780_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjEtMTMtMS0xLTk2OTAw_28ab34e1-e735-401c-9299-39452527385e"
      unitRef="usd">13000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjEtMTUtMS0xLTk2OTAw_1864a9cc-46d0-407f-81bd-71c1010cd08b"
      unitRef="usd">13000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjEtMTgtMS0xLTk2OTAw_084ab352-2d78-49d4-9be3-9b33dd7d777e"
      unitRef="usd">1000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i43ece8747ef74f40a72853ca02aaf1c9_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjItMS0xLTEtOTY5MDA_92256f1c-30ef-4966-a8b7-bb6580112c75"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i6c0a89d33c674daf9b3eb9a19226f643_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjItNS0xLTEtOTY5MDA_cb09157d-ddaf-4357-8a64-9b55a7e8bb85"
      unitRef="usd">-42000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i7e493e3bc38e440db1ddd741cfb4d78b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjItMTEtMS0xLTk2OTAw_32d3266f-133d-456a-a804-95ca92b03fc0"
      unitRef="usd">48000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjItMTUtMS0xLTk2OTAw_eb11a2df-7e0d-4dcd-8b5f-ebda789b153d"
      unitRef="usd">6000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6c0a89d33c674daf9b3eb9a19226f643_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjMtNS0xLTEtOTY5MDA_93a1f63f-7434-4670-8b54-4c404c9abd7d"
      unitRef="usd">24000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjMtMTUtMS0xLTk2OTAw_7115c1ab-43de-4ba9-824f-75e4f3bd207c"
      unitRef="usd">24000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i6c0a89d33c674daf9b3eb9a19226f643_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjQtNS0xLTEtOTY5MDA_1eb2e29f-e913-4f96-95d8-585576dfac94"
      unitRef="usd">-1000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7e493e3bc38e440db1ddd741cfb4d78b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjQtMTEtMS0xLTk2OTAw_a2ced9b4-5699-4ff1-8198-9a7dbe861041"
      unitRef="usd">31000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjQtMTUtMS0xLTk2OTAw_b731f225-db71-4955-bda7-947369aa0371"
      unitRef="usd">30000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i6c0a89d33c674daf9b3eb9a19226f643_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjUtNS0xLTEtOTY5MDA_6c7d94a6-a56d-4a07-aaf6-772320b5cad5"
      unitRef="usd">10000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i7e493e3bc38e440db1ddd741cfb4d78b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjUtMTEtMS0xLTk2OTAw_3a2521ff-08c2-4d8c-945a-4367213f66cd"
      unitRef="usd">18000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjUtMTUtMS0xLTk2OTAw_28283809-1483-458f-8008-4be29869fa9a"
      unitRef="usd">28000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ibe4f154b292c4c6f9438d1ec93548719_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjgtMS0xLTEtOTY5MDA_e5e6778d-85cb-40ca-96a8-7d866ba38302"
      unitRef="shares">112000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibe4f154b292c4c6f9438d1ec93548719_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjgtMy0xLTEtOTY5MDA_c17ac3f6-cbb6-42f4-8703-19bc6ec98dee"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i55c17b5aea5546bdb1833d5556b00d76_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjgtNS0xLTEtOTY5MDA_78f7d001-e48c-412b-b12e-cbd9cfc521d5"
      unitRef="usd">2266000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i29c8b878fec14566ae04a50e70d4aa38_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjgtNy0xLTEtOTY5MDA_1f1ea6db-2aa5-4342-88eb-5742821d2396"
      unitRef="usd">8412000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3c9092aaf58347c0933f9fcbc2136ed5_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjgtOS0xLTEtOTY5MDA_b61530c5-2fb1-4810-bdf6-5d04bbfcbf35"
      unitRef="usd">-18000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i54d2ac712edf4a2dab69b472e9d2878e_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjgtMTEtMS0xLTk2OTAw_07ebf5f6-affb-47f0-a38c-f4b85c19bdcf"
      unitRef="usd">-4612000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if7e8cf83a7dc44a0b5d83088a7a8262b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjgtMTMtMS0xLTk2OTAw_b1a2efe4-2895-43fa-a058-66c80bf38f26"
      unitRef="usd">38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjgtMTUtMS0xLTk2OTAw_779aeae6-4650-41b2-862d-83379ddcb685"
      unitRef="usd">6088000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmI1MjY5YTVkNTJlYzRjM2FiOTliZWE1MTExZGZkMjA3L3RhYmxlcmFuZ2U6YjUyNjlhNWQ1MmVjNGMzYWI5OWJlYTUxMTFkZmQyMDdfMjgtMTgtMS0xLTk2OTAw_fe4543df-ed1d-4696-a2a7-c0f06b096a18"
      unitRef="usd">77000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i2868e6f7df8844f0be25707868867359_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMi0xLTEtMS05NjkwMA_12a01df8-34b4-4339-851c-f9ee0ce6a551"
      unitRef="shares">119000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2868e6f7df8844f0be25707868867359_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMi0zLTEtMS05NjkwMA_ffeb8271-f4e0-4da6-a6c8-c6e314909477"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i675af17646064d258fea61e6c5bb5a32_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMi01LTEtMS05NjkwMA_d30f4795-1189-4cc0-a7db-d579f1fcaa7d"
      unitRef="usd">2260000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id8a0a67b493b41f5a943c81b90b2832b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMi03LTEtMS05NjkwMA_52c2b016-79b8-4f9a-968a-2cb38631861a"
      unitRef="usd">7649000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic457675ae82d42ceb6dbe6499c6a8c8f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMi05LTEtMS05NjkwMA_e2759145-3820-4e2a-adc7-875c79cbb3ab"
      unitRef="usd">-14000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53987f4feaf540ce9006d5da84098d82_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMi0xMS0xLTEtOTY5MDA_57a02023-6d6e-410f-ad06-9f053cc5496c"
      unitRef="usd">-3453000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6943c51ef54c40e2bfbd3af614ae55de_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMi0xMy0xLTEtOTY5MDA_c4415972-5dca-4946-87d5-8e65a93a2d78"
      unitRef="usd">39000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4f825bb08aff4a16a22babce12a7813b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMi0xNS0xLTEtOTY5MDA_f2001259-464b-417b-a23b-1a014df127de"
      unitRef="usd">6483000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i4f825bb08aff4a16a22babce12a7813b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMi0xOC0xLTEtOTY5MDA_6b0e834e-ff77-43e8-a85c-11effc654759"
      unitRef="usd">79000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i9fa2bae89497491fa69b9d23e041264d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMy03LTEtMS05NjkwMA_72473e3f-01e9-42cd-8513-92c1c53513b4"
      unitRef="usd">355000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i91094720d34a44d897464e1473c8cc65_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMy0xMy0xLTEtOTY5MDA_62e166e2-2619-4d53-8124-c72563a23880"
      unitRef="usd">16000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMy0xNS0xLTEtOTY5MDA_0d132d62-e26a-438e-959a-6b03f60e4be1"
      unitRef="usd">371000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMy0xOC0xLTEtOTY5MDA_7a98edbc-0bbb-4e6a-8f87-1ee140348e1d"
      unitRef="usd">2000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i682bff3b2c334ee9937658977d7ac55e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNC05LTEtMS05NjkwMA_788e4a84-4c34-4479-acfd-96f4fa6d8ed2"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNC0xNS0xLTEtOTY5MDA_968cb988-88b5-4b53-8b6c-04077c4d97ce"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i9fa2bae89497491fa69b9d23e041264d_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNS03LTEtMS05NjkwMA_b0ddb4a1-1d8a-4f50-b7cb-226ddc271beb"
      unitRef="usd">78000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNS0xNS0xLTEtOTY5MDA_c16f3c5d-313f-4432-adc1-18e8338236da"
      unitRef="usd">78000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i91094720d34a44d897464e1473c8cc65_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNi0xMy0xLTEtOTY5MDA_497d0d26-18ab-4292-b42a-55b492789101"
      unitRef="usd">17000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNi0xNS0xLTEtOTY5MDA_14a3750b-ce99-421f-b24e-2853fdb0a13e"
      unitRef="usd">17000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNi0xOC0xLTEtOTY5MDA_b0945a5b-7c25-4ce3-8450-d9a94b10a2ba"
      unitRef="usd">3000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i64eccbb460d743ce8ef414fce3a61c10_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNy0xLTEtMS05NjkwMA_13e9e8d9-548c-456f-bea7-8c0f68a41fc4"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie694bee7816f4bac9b9f899958f5a1cb_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNy01LTEtMS05NjkwMA_e97c6d0a-8fea-4d3d-af9b-470ecffd97d3"
      unitRef="usd">-41000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ic0371ca26d314e109241b4b21346af30_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNy0xMS0xLTEtOTY5MDA_d31a93bd-7cb4-42ab-a6c5-5898e40fa70e"
      unitRef="usd">48000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfNy0xNS0xLTEtOTY5MDA_95f1c201-ba9e-431f-ad92-8f708ccfcedf"
      unitRef="usd">7000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie694bee7816f4bac9b9f899958f5a1cb_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfOC01LTEtMS05NjkwMA_521da076-c67b-49a2-a3b8-53ea979c64f1"
      unitRef="usd">18000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfOC0xNS0xLTEtOTY5MDA_102afc32-0a4b-46fd-9355-c8968acf541e"
      unitRef="usd">18000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie694bee7816f4bac9b9f899958f5a1cb_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfOS01LTEtMS05NjkwMA_c6afcad3-0cfb-4b06-a468-5c2dff88156c"
      unitRef="usd">-1000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic0371ca26d314e109241b4b21346af30_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfOS0xMS0xLTEtOTY5MDA_e68bf8e8-1a3c-46c4-8cd9-71cc228a5cc4"
      unitRef="usd">11000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfOS0xNS0xLTEtOTY5MDA_8cf4d822-a26d-4aa9-88d3-4184e566c9d2"
      unitRef="usd">10000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ie694bee7816f4bac9b9f899958f5a1cb_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTAtNS0xLTEtOTY5MDA_757851ce-4d26-47f7-965e-48eab6275fc6"
      unitRef="usd">10000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ic0371ca26d314e109241b4b21346af30_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTAtMTEtMS0xLTEwMTk1NA_a3aee64a-9a28-42ca-a4fd-12d2605acc11"
      unitRef="usd">17000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTAtMTUtMS0xLTk2OTAw_a5eae307-8fd4-4478-812c-71ddc2912771"
      unitRef="usd">27000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i64eccbb460d743ce8ef414fce3a61c10_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTEtMS0xLTEtOTY5MDA_fbdef9e8-dd93-4901-aa14-7cd18136c92b"
      unitRef="shares">3000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic0371ca26d314e109241b4b21346af30_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTEtMTEtMS0xLTk2OTAw_a7e8f975-d582-42d5-9bb8-b0c49cf6dec8"
      unitRef="usd">350000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTEtMTUtMS0xLTk2OTAw_40eb40c3-4b20-47e2-b578-87db0d4b0c2b"
      unitRef="usd">350000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0776303025b041b981adf6ee7f921409_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTMtMS0xLTEtOTY5MDA_bfd33521-403e-4e60-87d7-530e0c5e1116"
      unitRef="shares">117000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0776303025b041b981adf6ee7f921409_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTMtMy0xLTEtOTY5MDA_eb0762a0-fc9f-4778-804e-5d03d0b40384"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8582d590e6f74053acd191b3c70e414b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTMtNS0xLTEtOTY5MDA_a23b2bcb-85d3-4829-8213-31e4488f158e"
      unitRef="usd">2226000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i67ca08b42d004c858f5fa9da26c20186_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTMtNy0xLTEtOTY5MDA_822a108a-5d68-41c5-8c25-533df61215c5"
      unitRef="usd">7926000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibd9747cff8044052a06af97e9d9ca8fa_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTMtOS0xLTEtOTY5MDA_ba4987fb-1365-4904-b5f3-5ac50b109997"
      unitRef="usd">-16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i70085dbbaf5747e084e12a45a4a75993_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTMtMTEtMS0xLTk2OTAw_d3d0efbd-b4bd-40b7-8eb2-c6393376dfb3"
      unitRef="usd">-3761000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7afb377aee1d435eb24550dbdcd7ec70_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTMtMTMtMS0xLTk2OTAw_53f55d97-4670-43b1-bf18-17dc02a4d4f1"
      unitRef="usd">38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib84cedd020e943f08a613b4d09834d7f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTMtMTUtMS0xLTk2OTAw_d8ce727a-8b0e-4f12-8a29-21b0a4d54ac4"
      unitRef="usd">6415000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ib84cedd020e943f08a613b4d09834d7f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8yNS9mcmFnOmE2ZjRkNGYxMzFmMjQ5M2FiNmIzMDNmZWE1ODMzMTIzL3RhYmxlOmQ1MDZmOTMwYjQ3YzQ0MWZiMGU3MGE4MzMwYjVmOWIxL3RhYmxlcmFuZ2U6ZDUwNmY5MzBiNDdjNDQxZmIwZTcwYTgzMzBiNWY5YjFfMTMtMTgtMS0xLTk2OTAw_918251c9-9fed-4d7d-ac7f-c17eed0a969a"
      unitRef="usd">78000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:NatureOfOperations
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zMS9mcmFnOjQ2NTUyYTRlNzdkMjQ0MGQ5NzgzZTA3YTgzYTliNjBkL3RleHRyZWdpb246NDY1NTJhNGU3N2QyNDQwZDk3ODNlMDdhODNhOWI2MGRfMTY2Mw_d808e54a-fe92-48bb-aeac-6e1f13981420">DESCRIPTION OF BUSINESS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Background&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on an industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, consumers, and accountable care organizations ("ACOs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNC9mcmFnOjk0NDc0ZmM0YzNlNjRjODViZWU5MmVhNWYyMmExZmNmL3RleHRyZWdpb246OTQ0NzRmYzRjM2U2NGM4NWJlZTkyZWE1ZjIyYTFmY2ZfNDI4Mw_70bebcc6-302b-4be0-aee8-371892cecf9a">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#x2019;s 2022 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2022 but does not include all the disclosures required by accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The accounting policies of the Company are the same as those set forth in Note 2 to the audited consolidated financial statements contained in the Company&#x2019;s 2022 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and outstanding stock options granted under its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements, if applicable.  Earnings allocable &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;New Accounting Standards to be Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement was effective immediately and, due to an accounting update which the Financial Accounting Standards Board issued in December 2022, can be applied to contract modifications through December 31, 2024.  To the extent that, prior to December 31, 2024, the Company enters into any contract modifications for which the optional expedients are applied, the adoption of this standard is not expected to have a material impact on the Company&#x2019;s consolidated results of operations, financial position or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNC9mcmFnOjk0NDc0ZmM0YzNlNjRjODViZWU5MmVhNWYyMmExZmNmL3RleHRyZWdpb246OTQ0NzRmYzRjM2U2NGM4NWJlZTkyZWE1ZjIyYTFmY2ZfNDI5Mw_d1eb3349-9fe5-44d6-8bff-c51cdfecd986">The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#x2019;s 2022 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2022 but does not include all the disclosures required by accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;).</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNC9mcmFnOjk0NDc0ZmM0YzNlNjRjODViZWU5MmVhNWYyMmExZmNmL3RleHRyZWdpb246OTQ0NzRmYzRjM2U2NGM4NWJlZTkyZWE1ZjIyYTFmY2ZfNDMwMg_55593bb7-1d8a-4422-a382-868023d7e318">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNC9mcmFnOjk0NDc0ZmM0YzNlNjRjODViZWU5MmVhNWYyMmExZmNmL3RleHRyZWdpb246OTQ0NzRmYzRjM2U2NGM4NWJlZTkyZWE1ZjIyYTFmY2ZfNDI5Ng_a933e3f3-5858-4448-ab04-e11b9bad7baa">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and outstanding stock options granted under its Amended and Restated Non-Employee Director Long-Term Incentive Plan, as well as the dilutive effect of accelerated share repurchase agreements, if applicable.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNC9mcmFnOjk0NDc0ZmM0YzNlNjRjODViZWU5MmVhNWYyMmExZmNmL3RleHRyZWdpb246OTQ0NzRmYzRjM2U2NGM4NWJlZTkyZWE1ZjIyYTFmY2ZfNDI4Mg_c136680c-4d69-4179-8076-b9a024793998">In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement was effective immediately and, due to an accounting update which the Financial Accounting Standards Board issued in December 2022, can be applied to contract modifications through December 31, 2024.  To the extent that, prior to December 31, 2024, the Company enters into any contract modifications for which the optional expedients are applied, the adoption of this standard is not expected to have a material impact on the Company&#x2019;s consolidated results of operations, financial position or cash flows.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RleHRyZWdpb246NTE3MDA4ZGEyYzQ3NDJhMjg1NjBmODA3OWE4M2I4YThfNzQw_367d0d3b-8c19-4253-95cc-1d35845b041e">EARNINGS PER SHARE&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.590%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Earnings allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings available to Quest Diagnostics&#x2019; common stockholders &#x2013; basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During both the three months ended March 31, 2023 and 2022, less than 1&#160;million stock options and performance share units were not included in the calculation of diluted earnings per share due to their antidilutive effect.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RleHRyZWdpb246NTE3MDA4ZGEyYzQ3NDJhMjg1NjBmODA3OWE4M2I4YThfNzQx_9357e120-1986-4034-b482-ca9e1ed6ed9a">The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.590%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Earnings allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings available to Quest Diagnostics&#x2019; common stockholders &#x2013; basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfNy0xLTEtMS05NjkwMA_3d37e0f4-df5c-485a-89fa-f13f2011915a"
      unitRef="usd">202000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfNy0zLTEtMS05NjkwMA_09229d75-e434-40c3-b10a-44126a166fb0"
      unitRef="usd">355000000</us-gaap:NetIncomeLoss>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfOC0xLTEtMS05NjkwMA_04b5326e-fe91-4215-9c64-a09a8426a7f5"
      unitRef="usd">1000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfOC0zLTEtMS05NjkwMA_62d87c83-67e4-48d4-a4f1-4ff4558adbcf"
      unitRef="usd">1000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfOS0xLTEtMS05NjkwMA_cd38ff92-8fe4-4a50-8209-30240ae39506"
      unitRef="usd">201000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfOS0zLTEtMS05NjkwMA_ae45cc79-ff5d-4c0d-9baf-f477c91e6015"
      unitRef="usd">354000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfMTEtMS0xLTEtOTY5MDA_523a0087-4fc5-45a1-852a-2ea3f4c342ee"
      unitRef="shares">112000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfMTEtMy0xLTEtOTY5MDA_dbff6ad6-8d98-453f-9186-740313640847"
      unitRef="shares">119000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfMTMtMS0xLTEtOTY5MDA_571bccd4-d5d3-4e46-aaaa-6e9edbb84d85"
      unitRef="shares">1000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfMTMtMy0xLTEtOTY5MDA_a047ba54-44ef-4ca7-9c11-48c2dfe73082"
      unitRef="shares">2000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfMTQtMS0xLTEtOTY5MDA_f1d6ee3b-d254-492b-8b60-dc3c78f2f12a"
      unitRef="shares">113000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfMTQtMy0xLTEtOTY5MDA_fe209ca3-eca6-4be0-af55-1bd99db3eb37"
      unitRef="shares">121000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfMTctMS0xLTEtOTY5MDA_fc24b4aa-8cf1-4608-84f5-b98611cb0359"
      unitRef="usdPerShare">1.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfMTctMy0xLTEtOTY5MDA_25eab629-d851-4d9e-ad53-e566fe55e453"
      unitRef="usdPerShare">2.97</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfMjItMS0xLTEtOTY5MDA_ae1ac79a-92e0-4cac-9e97-22f62a4f6bac"
      unitRef="usdPerShare">1.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RhYmxlOmM1OGUxMzFiZGFkYzQzNDI5YzVkYTczNzc5MWE5YzlmL3RhYmxlcmFuZ2U6YzU4ZTEzMWJkYWRjNDM0MjljNWRhNzM3NzkxYTljOWZfMjItMy0xLTEtOTY5MDA_dda38252-b238-45a9-be13-148c071319c4"
      unitRef="usdPerShare">2.92</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RleHRyZWdpb246NTE3MDA4ZGEyYzQ3NDJhMjg1NjBmODA3OWE4M2I4YThfMzI5ODUzNDg4NDcyOQ_19e349ef-986d-4b4d-9c63-ae1e300f498d"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8zNy9mcmFnOjUxNzAwOGRhMmM0NzQyYTI4NTYwZjgwNzlhODNiOGE4L3RleHRyZWdpb246NTE3MDA4ZGEyYzQ3NDJhMjg1NjBmODA3OWE4M2I4YThfMzI5ODUzNDg4NDcyOQ_1bf1b9db-c188-4242-a165-5f441ffddcc4"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTE2L2ZyYWc6OWIzZDlhODdlMmQ0NDc2Mjk5YjY5YWQyMGQ5OGE1NGMvdGV4dHJlZ2lvbjo5YjNkOWE4N2UyZDQ0NzYyOTliNjlhZDIwZDk4YTU0Y18xNjQ5MjY3NDQ1OTE1_e92d0ffc-7d0f-48bc-9980-96f16646de52">RESTRUCTURING ACTIVITIES &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Invigorate Program&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is committed to a program called Invigorate which is designed to reduce its cost structure and improve performance.  Invigorate consists of several flagship programs, with structured plans in each, to drive savings and improve performance across the customer value chain.  These flagship programs include: organization excellence; information technology excellence; procurement excellence; field and customer service excellence; lab excellence; and revenue services excellence.  In addition to these programs, the Company identified key themes to change how it operates including reducing denials and patient price concessions; further digitizing the business; standardization; automation and artificial intelligence; optimization and selecting and retaining talent. The Invigorate program is intended to offset reimbursement pressures and labor and benefit cost increases; free up additional resources to invest in innovation and other growth initiatives; and enable the Company to improve service quality and operating profitability. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Restructuring Charges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's pre-tax restructuring charges for the three months ended March&#160;31, 2023 and 2022 were $15 million and $2 million, respectively, entirely related to employee separation costs associated with various workforce reduction initiatives as the Company continued to restructure its organization.  Of the total restructuring charges incurred during the three months ended March&#160;31, 2023, $9&#160;million, and $6&#160;million were recorded in cost of services and selling, general and administrative expenses, respectively.  Of the total restructuring charges incurred during the three months ended March&#160;31, 2022, $1&#160;million and $1&#160;million were recorded in cost of services and selling, general and administrative expenses, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Charges for all periods presented were primarily recorded in the Company's DIS business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The restructuring liability as of March&#160;31, 2023 and December&#160;31, 2022, which is included in accounts payable and accrued expenses, was $38&#160;million and $44 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="i0eb006769543403b857f1208edc96f39_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTE2L2ZyYWc6OWIzZDlhODdlMmQ0NDc2Mjk5YjY5YWQyMGQ5OGE1NGMvdGV4dHJlZ2lvbjo5YjNkOWE4N2UyZDQ0NzYyOTliNjlhZDIwZDk4YTU0Y181NDk3NTU4MTg2MjA_aed359dc-264e-4912-a7b2-488021f1f2d7"
      unitRef="usd">15000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ia9c6221361d444248eec701d6facf066_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTE2L2ZyYWc6OWIzZDlhODdlMmQ0NDc2Mjk5YjY5YWQyMGQ5OGE1NGMvdGV4dHJlZ2lvbjo5YjNkOWE4N2UyZDQ0NzYyOTliNjlhZDIwZDk4YTU0Y181NDk3NTU4MTg2Mjg_51b90672-5e51-4e04-88e4-2d850485d83c"
      unitRef="usd">2000000</us-gaap:SeveranceCosts1>
    <us-gaap:RestructuringCharges
      contextRef="i026b244d8b664bf18f9db5bf951e1018_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTE2L2ZyYWc6OWIzZDlhODdlMmQ0NDc2Mjk5YjY5YWQyMGQ5OGE1NGMvdGV4dHJlZ2lvbjo5YjNkOWE4N2UyZDQ0NzYyOTliNjlhZDIwZDk4YTU0Y18zMjk4NTM0ODg3MzQ0_b235e3e0-9665-4f32-826a-fa3c64601b70"
      unitRef="usd">9000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i95ea8d4904774f0aa70206e0d1464ca0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTE2L2ZyYWc6OWIzZDlhODdlMmQ0NDc2Mjk5YjY5YWQyMGQ5OGE1NGMvdGV4dHJlZ2lvbjo5YjNkOWE4N2UyZDQ0NzYyOTliNjlhZDIwZDk4YTU0Y18zMjk4NTM0ODg3MzU2_c5759ea1-3c53-4ec4-91e7-a6c4158549c9"
      unitRef="usd">6000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="icfeed34c59e04d0f968039f01139270f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTE2L2ZyYWc6OWIzZDlhODdlMmQ0NDc2Mjk5YjY5YWQyMGQ5OGE1NGMvdGV4dHJlZ2lvbjo5YjNkOWE4N2UyZDQ0NzYyOTliNjlhZDIwZDk4YTU0Y18zMjk4NTM0ODg3Mzg2_8f7708f9-b8c2-4649-83df-702ae9d76926"
      unitRef="usd">1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i1877888b4e3b4f5589b7bd09d1d25f8e_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTE2L2ZyYWc6OWIzZDlhODdlMmQ0NDc2Mjk5YjY5YWQyMGQ5OGE1NGMvdGV4dHJlZ2lvbjo5YjNkOWE4N2UyZDQ0NzYyOTliNjlhZDIwZDk4YTU0Y18zMjk4NTM0ODg3Mzk4_41dbf892-5535-4d03-94fd-e4dda2d20481"
      unitRef="usd">1000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserve
      contextRef="i68ebbfe16e6d4925bb4ccf798eff1e19_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTE2L2ZyYWc6OWIzZDlhODdlMmQ0NDc2Mjk5YjY5YWQyMGQ5OGE1NGMvdGV4dHJlZ2lvbjo5YjNkOWE4N2UyZDQ0NzYyOTliNjlhZDIwZDk4YTU0Y181NDk3NTU4MTc1NjY_b0ad26a5-33ed-46a8-8767-dd8ac3b85bd8"
      unitRef="usd">38000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ia73437118858471aab7c03547980000d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTE2L2ZyYWc6OWIzZDlhODdlMmQ0NDc2Mjk5YjY5YWQyMGQ5OGE1NGMvdGV4dHJlZ2lvbjo5YjNkOWE4N2UyZDQ0NzYyOTliNjlhZDIwZDk4YTU0Y181NDk3NTU4MTc1NzQ_50cbe944-34d6-4a17-8fb4-2d97a867e834"
      unitRef="usd">44000000</us-gaap:RestructuringReserve>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80MC9mcmFnOjVmNzAzZjI5ZDBjOTQ4YTE5NDVlMmQ3MDM0M2VmMjI3L3RleHRyZWdpb246NWY3MDNmMjlkMGM5NDhhMTk0NWUyZDcwMzQzZWYyMjdfMjkyOA_ae1e9fe6-f955-4a6b-9e30-4a97ecffa079">BUSINESS ACQUISITIONS&#160;&#160;&#160;&#160;During February 2023, the Company announced that it had entered into a definitive agreement to acquire select assets of the laboratory services business of New York-Presbyterian, which serves providers and patients in New York, as well as the Tri-State Area and beyond. The transaction closed during April 2023.  See Note 15 for further discussion.&#160;&#160;&#160;&#160;For details regarding the Company's 2022 acquisitions, see Note 6 to the audited consolidated financial statements in the Company's 2022 Annual Report on Form 10-K.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RleHRyZWdpb246ZDQwZTc5YWVmN2NmNGFhYjkwMmE2NTk3MGE2Zjk5MzRfNjM4Nw_83497a4c-a454-4d5d-ba7b-c9da5c73bcfc">FAIR VALUE MEASUREMENTS  &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets/Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;text-indent:4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;A detailed description regarding the Company's fair value measurements is contained in Note 8 to the audited consolidated financial statements in the Company's 2022 Annual Report on Form 10-K.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-directed stock and bond mutual funds that are classified as trading securities.  The trading securities are classified within Level 1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:72pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#x201c;invested&#x201d; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value using discounted cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable.  Significant inputs include cash flows projections and a discount rate. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with previous acquisitions, the Company had contingent consideration obligations based on the achievement of certain testing volume and revenue benchmarks during 2022.  See Note 8 to the audited consolidated financial statements in the Company's 2022 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of March&#160;31, 2023, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long term growth rates, and a discount rate commensurate with economic risk.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments. As of March&#160;31, 2023 and December&#160;31, 2022, the fair value of the Company&#x2019;s debt was estimated at $3.8 billion and $3.7 billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RleHRyZWdpb246ZDQwZTc5YWVmN2NmNGFhYjkwMmE2NTk3MGE2Zjk5MzRfNjM4MQ_5c2d0201-4001-4fa9-b70c-6c9517b78b5f">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets/Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;text-indent:4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:TradingSecurities
      contextRef="ia15188e0ab8642c396b4a96aebce5582_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfNi0xLTEtMS05NjkwMA_7dd2318f-e479-43e6-aa36-d97685791d8f"
      unitRef="usd">70000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="ic2547ee5e7d94359a91b49b7221ab320_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfNi0zLTEtMS05NjkwMA_2ddf9746-04aa-428b-8d96-8c9f77f41e7b"
      unitRef="usd">70000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i5c2789456b4f4655b65a9ce676bc382b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfNi01LTEtMS05NjkwMA_f6e1c6ef-45b8-4a48-aef8-628c0bf916d6"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="if55d00add9b34a659909dea8aab579c3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfNi03LTEtMS05NjkwMA_d2cc250d-997c-4779-8059-0aac2d168e9d"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="ia15188e0ab8642c396b4a96aebce5582_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfNy0xLTEtMS05NjkwMA_ee6abb44-f127-4bcd-9d39-81d73026d5ad"
      unitRef="usd">49000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="ic2547ee5e7d94359a91b49b7221ab320_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfNy0zLTEtMS05NjkwMA_dc15ad28-2de5-4cc6-bf63-e4abedf2d6f2"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i5c2789456b4f4655b65a9ce676bc382b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfNy01LTEtMS05NjkwMA_cb1b93b5-4094-4ca0-8912-57b5b3175afe"
      unitRef="usd">49000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="if55d00add9b34a659909dea8aab579c3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfNy03LTEtMS05NjkwMA_88d25a5d-d5cf-48f2-987d-eb28f9728fc2"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia15188e0ab8642c396b4a96aebce5582_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfOS0xLTEtMS05NjkwMA_9449317e-4756-4912-8ae4-193e92fa4fb4"
      unitRef="usd">2000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic2547ee5e7d94359a91b49b7221ab320_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfOS0zLTEtMS05NjkwMA_ae46f7c6-63ed-4132-8e8b-5b0c4b53e996"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5c2789456b4f4655b65a9ce676bc382b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfOS01LTEtMS05NjkwMA_23b54d88-a599-4170-a134-769d363fdab0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if55d00add9b34a659909dea8aab579c3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfOS03LTEtMS05NjkwMA_11ab871c-9ae3-4302-ae8f-a0b683ec0036"
      unitRef="usd">2000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia15188e0ab8642c396b4a96aebce5582_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTItMS0xLTEtOTY5MDA_68c14d27-9779-4437-a4a3-6a3277af7d52"
      unitRef="usd">121000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic2547ee5e7d94359a91b49b7221ab320_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTItMy0xLTEtOTY5MDA_49e5134d-af95-4628-98c6-b11299b043f3"
      unitRef="usd">70000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5c2789456b4f4655b65a9ce676bc382b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTItNS0xLTEtOTY5MDA_526e75fd-e787-4f9e-93a9-99187d29e998"
      unitRef="usd">49000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if55d00add9b34a659909dea8aab579c3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTItNy0xLTEtOTY5MDA_93dcd42f-d33d-4ad6-8ffb-a987eae124e2"
      unitRef="usd">2000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ia15188e0ab8642c396b4a96aebce5582_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTUtMS0xLTEtOTY5MDA_ae8c9279-986e-421b-af19-c2e56095fdc9"
      unitRef="usd">126000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ic2547ee5e7d94359a91b49b7221ab320_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTUtMy0xLTEtOTY5MDA_990a8ea5-184c-43cc-b3ab-ffc5ca38a405"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i5c2789456b4f4655b65a9ce676bc382b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTUtNS0xLTEtOTY5MDA_976b3e47-597e-4b60-9a46-18e6314949f1"
      unitRef="usd">126000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="if55d00add9b34a659909dea8aab579c3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTUtNy0xLTEtOTY5MDA_370bf1cf-e9f6-4a16-ab71-f2d0f7d54634"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia15188e0ab8642c396b4a96aebce5582_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTgtMS0xLTEtOTY5MDA_9b5e63e9-b6f5-49be-9b2b-d6374d0cce85"
      unitRef="usd">5000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic2547ee5e7d94359a91b49b7221ab320_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTgtMy0xLTEtOTY5MDA_e4e033a2-2457-47ae-8baf-a546721790c9"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i5c2789456b4f4655b65a9ce676bc382b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTgtNS0xLTEtOTY5MDA_36a6b878-8e9b-4087-ae44-8e1b6fbe2e14"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="if55d00add9b34a659909dea8aab579c3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMTgtNy0xLTEtOTY5MDA_624e0c0e-bb3a-4b87-85a1-b52721604d55"
      unitRef="usd">5000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia15188e0ab8642c396b4a96aebce5582_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMjAtMS0xLTEtOTY5MDA_dac686d0-5cb6-490c-ad20-5eca51c3d106"
      unitRef="usd">131000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic2547ee5e7d94359a91b49b7221ab320_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMjAtMy0xLTEtOTY5MDA_624cb57c-42f0-4dcd-865a-99a9f959f528"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5c2789456b4f4655b65a9ce676bc382b_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMjAtNS0xLTEtOTY5MDA_d27dd2c7-8a9f-4a78-8679-ab546923e01f"
      unitRef="usd">126000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if55d00add9b34a659909dea8aab579c3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMjAtNy0xLTEtOTY5MDA_edae0480-deba-4c7a-8e37-3da7a49b934c"
      unitRef="usd">5000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="ia15188e0ab8642c396b4a96aebce5582_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMjItMS0xLTEtOTY5MDA_00ff4d16-0a44-41cb-8161-dad99d1f1506"
      unitRef="usd">77000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="ic2547ee5e7d94359a91b49b7221ab320_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMjItMy0xLTEtOTY5MDA_b402a616-3649-4add-89cc-9230dc8127a8"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="if55d00add9b34a659909dea8aab579c3_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjA1NmQ3NzEzYmQ3NTRkYTliMmNkNTNlY2UyNDQ1ODg3L3RhYmxlcmFuZ2U6MDU2ZDc3MTNiZDc1NGRhOWIyY2Q1M2VjZTI0NDU4ODdfMjItNy0xLTEtOTY5MDA_1fa011fd-1c59-417c-95b7-1c3406084af1"
      unitRef="usd">77000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:TradingSecurities
      contextRef="if40cce849d804c9d9ade9ef0ff872500_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMy0xLTEtMS05NjkwMA_6bc936e0-6181-4dd9-b015-7f856c5c1bb4"
      unitRef="usd">68000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i7b282120e5684071822469ae84204d65_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMy0zLTEtMS05NjkwMA_54c5c335-6a16-4a2e-8a62-55d6e2e0e8d2"
      unitRef="usd">68000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i460b190c7af34171a28a620ddf6d0f9b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMy01LTEtMS05NjkwMA_d8a8ea8c-9881-4358-ae74-a55949c047d7"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i4deefe47748e49dd9b5f6d19dde3517d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMy03LTEtMS05NjkwMA_830251d2-cf48-41b4-adae-66fe6b4a6016"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="if40cce849d804c9d9ade9ef0ff872500_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfNC0xLTEtMS05NjkwMA_68a9e55f-ebf6-46d6-9e3a-fda1cf8bf7ad"
      unitRef="usd">46000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i7b282120e5684071822469ae84204d65_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfNC0zLTEtMS05NjkwMA_4aa70230-1a3d-4562-b559-e109579bab14"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i460b190c7af34171a28a620ddf6d0f9b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfNC01LTEtMS05NjkwMA_a2a37e71-31a3-4be6-b04a-a8758344d4c2"
      unitRef="usd">46000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i4deefe47748e49dd9b5f6d19dde3517d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfNC03LTEtMS05NjkwMA_ae3b0c81-e365-4e68-bc62-be66eb743359"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if40cce849d804c9d9ade9ef0ff872500_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfNi0xLTEtMS05NjkwMA_7d9ee2a8-3a59-43f0-ac1c-f7ea430aab29"
      unitRef="usd">2000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7b282120e5684071822469ae84204d65_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfNi0zLTEtMS05NjkwMA_729e816f-7771-45e8-a516-8d822db000b6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i460b190c7af34171a28a620ddf6d0f9b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfNi01LTEtMS05NjkwMA_1513884b-ff82-4211-a76e-fe702b40ac67"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4deefe47748e49dd9b5f6d19dde3517d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfNi03LTEtMS05NjkwMA_35e16be7-be97-489e-8408-1aa1fab76bf0"
      unitRef="usd">2000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if40cce849d804c9d9ade9ef0ff872500_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTAtMS0xLTEtOTY5MDA_aeb499b2-0fe2-4e5c-9a02-2f89bfa65e2a"
      unitRef="usd">116000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7b282120e5684071822469ae84204d65_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTAtMy0xLTEtOTY5MDA_6aad954d-e5ba-4f8f-9018-20cec3cc5a3d"
      unitRef="usd">68000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i460b190c7af34171a28a620ddf6d0f9b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTAtNS0xLTEtOTY5MDA_5b12cc0e-c3ae-40b9-9a2c-301d98113cc0"
      unitRef="usd">46000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4deefe47748e49dd9b5f6d19dde3517d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTAtNy0xLTEtOTY5MDA_a2edfbd9-3e55-4fcb-b736-4695b005389f"
      unitRef="usd">2000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="if40cce849d804c9d9ade9ef0ff872500_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTMtMS0xLTEtOTY5MDA_aca2c8ff-14bf-4980-86a9-b12149609c57"
      unitRef="usd">120000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i7b282120e5684071822469ae84204d65_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTMtMy0xLTEtOTY5MDA_e2dbb4e2-f536-43f4-bd22-697119277507"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i460b190c7af34171a28a620ddf6d0f9b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTMtNS0xLTEtOTY5MDA_c6fdddda-14d3-4ad7-bfaf-cec8e6a9793d"
      unitRef="usd">120000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i4deefe47748e49dd9b5f6d19dde3517d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTMtNy0xLTEtOTY5MDA_e7d9d157-ecc1-4a3a-9124-8f1ce074c4da"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="if40cce849d804c9d9ade9ef0ff872500_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTUtMS0xLTEtOTY5MDA_d29ffb30-5a89-4726-94d2-2168e6463ee2"
      unitRef="usd">23000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i7b282120e5684071822469ae84204d65_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTUtMy0xLTEtOTY5MDA_51f71c80-2a49-4977-b4f1-a60e57397f81"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i460b190c7af34171a28a620ddf6d0f9b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTUtNS0xLTEtOTY5MDA_be39229b-653d-47c6-822a-b8932477be4b"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i4deefe47748e49dd9b5f6d19dde3517d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTUtNy0xLTEtOTY5MDA_bc9c91ef-1354-4280-82bb-ccb0f7c1f5c5"
      unitRef="usd">23000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if40cce849d804c9d9ade9ef0ff872500_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTktMS0xLTEtOTY5MDA_fd5a6a2c-d8ad-476c-b1b2-1a5ffde758ce"
      unitRef="usd">143000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i7b282120e5684071822469ae84204d65_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTktMy0xLTEtOTY5MDA_36a24e94-137b-4e91-ba0f-c151fb756baf"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i460b190c7af34171a28a620ddf6d0f9b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTktNS0xLTEtOTY5MDA_004cdd1d-fa6d-40be-bb4c-fe3cdc5e5f09"
      unitRef="usd">120000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i4deefe47748e49dd9b5f6d19dde3517d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMTktNy0xLTEtOTY5MDA_6da9909e-ae50-40de-9f8b-2bdb3a30a5a0"
      unitRef="usd">23000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="if40cce849d804c9d9ade9ef0ff872500_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMjEtMS0xLTEtOTY5MDA_5c6824f0-fb37-4bf9-ab03-e57474444c44"
      unitRef="usd">77000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i7b282120e5684071822469ae84204d65_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMjEtMy0xLTEtOTY5MDA_1271b168-60cd-454d-8f2b-e4d678308d77"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i4deefe47748e49dd9b5f6d19dde3517d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOmYwNzYwOThlNjQzYTRiMTZhMWFjNTJmNDI2MzI1MDI4L3RhYmxlcmFuZ2U6ZjA3NjA5OGU2NDNhNGIxNmExYWM1MmY0MjYzMjUwMjhfMjEtNy0xLTEtOTY5MDA_851a52b0-39da-4df9-988f-3278dfdfa76a"
      unitRef="usd">77000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RleHRyZWdpb246ZDQwZTc5YWVmN2NmNGFhYjkwMmE2NTk3MGE2Zjk5MzRfNjM2OQ_79cafa54-6c08-4af0-baf4-a2052941710f">The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="iee1c43167736475396bb0f00c1706266_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjI1OTM5ODM1YmNhODQ2M2ViNzViYzMyODgzZTBjNWEzL3RhYmxlcmFuZ2U6MjU5Mzk4MzViY2E4NDYzZWI3NWJjMzI4ODNlMGM1YTNfMi0xLTEtMS05NjkwMA_fe1befcb-f2a7-45d2-8b44-1b8cf9ae682d"
      unitRef="usd">23000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i3b765f813058424c84db7601e651042b_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjI1OTM5ODM1YmNhODQ2M2ViNzViYzMyODgzZTBjNWEzL3RhYmxlcmFuZ2U6MjU5Mzk4MzViY2E4NDYzZWI3NWJjMzI4ODNlMGM1YTNfNC0xLTEtMS05NjkwMA_34e49fe7-9511-4a0e-82c5-88584f9a66fc"
      unitRef="usd">18000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="iee0fda822a8640319a5856d56a336d6f_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RhYmxlOjI1OTM5ODM1YmNhODQ2M2ViNzViYzMyODgzZTBjNWEzL3RhYmxlcmFuZ2U6MjU5Mzk4MzViY2E4NDYzZWI3NWJjMzI4ODNlMGM1YTNfOC0xLTEtMS05NjkwMA_0a47862d-c16d-4c1f-a15b-f2e5e627b71a"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i5b880299f57a4a9b9824c017900d1138_I20150701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RleHRyZWdpb246ZDQwZTc5YWVmN2NmNGFhYjkwMmE2NTk3MGE2Zjk5MzRfNTA0Mg_090dc506-9edd-4094-b7db-ac169497b060"
      unitRef="number">0.189</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RleHRyZWdpb246ZDQwZTc5YWVmN2NmNGFhYjkwMmE2NTk3MGE2Zjk5MzRfNjAwMg_4be4df07-6f04-45e7-ab08-0af0d3609609"
      unitRef="usd">3800000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF80Ni9mcmFnOmQ0MGU3OWFlZjdjZjRhYWI5MDJhNjU5NzBhNmY5OTM0L3RleHRyZWdpb246ZDQwZTc5YWVmN2NmNGFhYjkwMmE2NTk3MGE2Zjk5MzRfNjAwOQ_2097cfbc-3cc5-4896-bba7-a9df560bf013"
      unitRef="usd">3700000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTc1L2ZyYWc6ZjIyYzkxMzFjYWRhNGQyNGFkZTAzNmYwZGExZjUzNzUvdGV4dHJlZ2lvbjpmMjJjOTEzMWNhZGE0ZDI0YWRlMDM2ZjBkYTFmNTM3NV8xNjQ5MjY3NDQ4MjIx_259f9178-cb39-4d1e-8931-592967ed4c1c">DEBT&#160;&#160;&#160;&#160;The Company is party to a $750&#160;million senior unsecured revolving credit facility (the &#x201c;Credit Facility&#x201d; or "Senior Unsecured Revolving Credit Facility") which matures in November 2026. Under the Credit Facility, the Company can issue letters of credit totaling $150&#160;million (see Note 11). Issued letters of credit reduce the available borrowing capacity under the Credit Facility. Interest on the Credit Facility is based on certain published rates plus an applicable margin based on changes in the Company's public debt ratings.  The Credit Facility was amended during March 2023.  Subsequent to such amendment, at the option of the Company, it may elect to lock into Term Secured Overnight Financing Rate (&#x201c;Term SOFR&#x201d;)-based interest rate contracts for periods up to six months. For interest on any U.S. Dollar-denominated outstanding amounts not covered under Term SOFR-based interest rate contracts, the Company can opt for an alternate base rate, which is calculated by reference to the prime rate, the federal funds rate or an adjusted Term SOFR rate.  The Company also has the option to borrow in other currencies.  As of March&#160;31, 2023, the Company's borrowing rate for Term SOFR-based loans under the Credit Facility was adjusted Term SOFR plus 1.00%. The Credit Facility contains various covenants, including the maintenance of a financial leverage ratio, which could impact the Company's ability to, among other things, incur additional indebtedness. As of both March&#160;31, 2023 and December&#160;31, 2022, there were no outstanding borrowings under the Senior Unsecured Revolving Credit Facility.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i481a0bb184b14bad9d931200d5d31852_I20211130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTc1L2ZyYWc6ZjIyYzkxMzFjYWRhNGQyNGFkZTAzNmYwZGExZjUzNzUvdGV4dHJlZ2lvbjpmMjJjOTEzMWNhZGE0ZDI0YWRlMDM2ZjBkYTFmNTM3NV8zMjk4NTM0ODg4MTA5_e7ebd3dc-5a67-465f-b671-a3dab1d07596"
      unitRef="usd">750000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i667912428a7248bfb81aa3ff7ab6bf9c_I20211130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTc1L2ZyYWc6ZjIyYzkxMzFjYWRhNGQyNGFkZTAzNmYwZGExZjUzNzUvdGV4dHJlZ2lvbjpmMjJjOTEzMWNhZGE0ZDI0YWRlMDM2ZjBkYTFmNTM3NV8zMjk4NTM0ODg4MTIz_98752d14-d75f-4c80-9bb5-b6c474b34004"
      unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i220fe343315542498e86e7895d5cb139_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTc1L2ZyYWc6ZjIyYzkxMzFjYWRhNGQyNGFkZTAzNmYwZGExZjUzNzUvdGV4dHJlZ2lvbjpmMjJjOTEzMWNhZGE0ZDI0YWRlMDM2ZjBkYTFmNTM3NV8zMjk4NTM0ODg4MTM3_f95fe52e-fb20-4554-a819-a4362ae9662b"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id37a126b68964d6a8e53b08d24ae39c2_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTc1L2ZyYWc6ZjIyYzkxMzFjYWRhNGQyNGFkZTAzNmYwZGExZjUzNzUvdGV4dHJlZ2lvbjpmMjJjOTEzMWNhZGE0ZDI0YWRlMDM2ZjBkYTFmNTM3NV8zMjk4NTM0ODg4MTQ0_54670c16-534c-4aec-b141-9a07691334ed"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9c4b1b27b14f4358b79dcebe17500b25_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMTc1L2ZyYWc6ZjIyYzkxMzFjYWRhNGQyNGFkZTAzNmYwZGExZjUzNzUvdGV4dHJlZ2lvbjpmMjJjOTEzMWNhZGE0ZDI0YWRlMDM2ZjBkYTFmNTM3NV8zMjk4NTM0ODg4MTQ0_e8886498-8845-49bf-a84c-9034305feffa"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81Mi9mcmFnOmM5NmNjYjQ2NzUwZTRmOGJiZDY1YmI2YmI3NGQ0ZGYyL3RleHRyZWdpb246Yzk2Y2NiNDY3NTBlNGY4YmJkNjViYjZiYjc0ZDRkZjJfMzMyMQ_51c4b88f-0d89-46be-92b4-37411385e271">FINANCIAL INSTRUMENTS &#160;&#160;&#160;&#160;The Company uses derivative financial instruments, from time to time, to manage its exposure to market risks for changes in interest rates and foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and, from time to time, variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Derivatives &#x2013; Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Derivatives &#x2013; Fair Value Hedges &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Historically, the Company has entered into various fixed-to-variable interest rate swap agreements in order to convert a portion of the Company's long-term debt into variable interest rate debt.  All such fixed-to-variable interest rate swap agreements have been terminated and proceeds from the terminations have been reflected as basis adjustments to the hedged debt instruments and are being amortized as a reduction of interest expense, net over the remaining terms of such debt instruments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of March&#160;31, 2023 and December&#160;31, 2022, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Accounting Basis Adjustment (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) As of both March&#160;31, 2023 and December&#160;31, 2022, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;A detailed description regarding the Company's use of derivative financial instruments is contained in Note 16 to the audited consolidated financial statements in the Company's 2022 Annual Report on Form 10-K.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81Mi9mcmFnOmM5NmNjYjQ2NzUwZTRmOGJiZDY1YmI2YmI3NGQ0ZGYyL3RleHRyZWdpb246Yzk2Y2NiNDY3NTBlNGY4YmJkNjViYjZiYjc0ZDRkZjJfMzMzNQ_3ed44438-829e-4b34-9c15-766a18b42e2f">The Company uses derivative financial instruments, from time to time, to manage its exposure to market risks for changes in interest rates and foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and, from time to time, variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81Mi9mcmFnOmM5NmNjYjQ2NzUwZTRmOGJiZDY1YmI2YmI3NGQ0ZGYyL3RleHRyZWdpb246Yzk2Y2NiNDY3NTBlNGY4YmJkNjViYjZiYjc0ZDRkZjJfMzMzNg_cb1482eb-becc-4b68-a9d1-efa3e30c53f3">As of March&#160;31, 2023 and December&#160;31, 2022, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Accounting Basis Adjustment (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) As of both March&#160;31, 2023 and December&#160;31, 2022, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.&lt;/span&gt;&lt;/div&gt;</dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="ibef99765bb424b0a98ea7a9577ad7abd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81Mi9mcmFnOmM5NmNjYjQ2NzUwZTRmOGJiZDY1YmI2YmI3NGQ0ZGYyL3RhYmxlOmYwMmRmZjQwZWMwNDQyNTE4OWM4NTg4ZWM4NmQyZTI4L3RhYmxlcmFuZ2U6ZjAyZGZmNDBlYzA0NDI1MTg5Yzg1ODhlYzg2ZDJlMjhfMi01LTEtMS05NjkwMA_ba5ee918-03bb-4c2f-af28-2daa7117f723"
      unitRef="usd">23000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="if15719cfaad14b7dbfdf71b40a4c65d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81Mi9mcmFnOmM5NmNjYjQ2NzUwZTRmOGJiZDY1YmI2YmI3NGQ0ZGYyL3RhYmxlOmYwMmRmZjQwZWMwNDQyNTE4OWM4NTg4ZWM4NmQyZTI4L3RhYmxlcmFuZ2U6ZjAyZGZmNDBlYzA0NDI1MTg5Yzg1ODhlYzg2ZDJlMjhfMi05LTEtMS05NjkwMA_5cbf0f87-6da0-4c50-a88a-5b737986c056"
      unitRef="usd">26000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfNDI0OA_d37553fe-8e26-405e-9c8d-89e0d91f61b7">STOCKHOLDERS&#x2019; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Changes in Accumulated Other Comprehensive Loss by Component&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) includes: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Foreign currency translation adjustments;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 8); and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax, on available-for-sale debt securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023 and 2022, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dividend Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the first quarter of 2023, the Company's Board of Directors declared a quarterly cash dividend of $0.71 per common share.  During each of the four quarters of 2022, the Company's Board of Directors declared a quarterly cash dividend of $0.66 per common share. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In February 2023, the Company's Board of Directors increased the size of its share repurchase program by $1&#160;billion. As of March&#160;31, 2023, $1.3&#160;billion remained available under the Company&#x2019;s share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023, the Company repurchased no shares of its common stock.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022, the Company repurchased 2.6 million shares of its common stock for $350 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Shares Reissued from Treasury Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023 and 2022, the Company reissued 0.7 million shares and 0.5 million shares, respectively, from treasury stock under its Employee Stock Purchase Plan and its stock-based compensation program.  For details regarding the Company's stock ownership and compensation plans, see Note 18 to the audited consolidated financial statements in the Company's 2022 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Redeemable Noncontrolling Interest&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  As of March&#160;31, 2023 and December&#160;31, 2022, the redeemable noncontrolling interest was presented at its fair value.  For further details regarding the fair value of the redeemable noncontrolling interest, see Note 6.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMTExNg_a6f88304-a3ed-4381-a5c4-6dd7a61b9a37"
      unitRef="usdPerShare">0.71</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i5e11296045604f51a55e048533a906a4_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMTI0OQ_2b929251-0f81-41f2-8d83-a9cf969413f2"
      unitRef="usdPerShare">0.66</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i5f567083983b48babafdc73d6c6901c7_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMTI0OQ_8fd3e18b-7c0c-4198-8f7b-467f850244ef"
      unitRef="usdPerShare">0.66</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMTI0OQ_9c83dbe5-5539-4fdd-832d-31d0e40562be"
      unitRef="usdPerShare">0.66</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i8f78891156cb4c548d0f6277115ee3eb_D20221001-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMTI0OQ_dfb2f3ee-c80f-4b94-bb1b-0e7769706aa7"
      unitRef="usdPerShare">0.66</us-gaap:CommonStockDividendsPerShareDeclared>
    <dgx:StockRepurchaseProgramAdditionalAmountAuthorized
      contextRef="ia90feb97a113427e947ad9d0fd0a3fa3_D20230201-20230201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMTQwNw_4832b951-061d-4070-bbe7-bfbbd358064b"
      unitRef="usd">1000000000</dgx:StockRepurchaseProgramAdditionalAmountAuthorized>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMTQyMQ_9d06061f-a1ce-4eab-b2dd-7382f01b918e"
      unitRef="usd">1300000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i7e493e3bc38e440db1ddd741cfb4d78b_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMTY0OTI2NzQ0ODk1MQ_3516ac80-e3fc-4c89-be24-a6ad3e11e0e2"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ic0371ca26d314e109241b4b21346af30_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMTc0Mw_d6852050-d034-4317-9b6e-29847cba8caf"
      unitRef="shares">2600000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic0371ca26d314e109241b4b21346af30_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMTc3Nw_c28e6948-dcae-4b56-885d-fd2f4dd197d6"
      unitRef="usd">350000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMjcyNg_67b22d2e-5de5-4444-8910-768638e00ca7"
      unitRef="shares">700000</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMjc0MA_6d59fd0b-2d7f-4fc6-8b6b-f3eb43e1a6ef"
      unitRef="shares">500000</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i5b880299f57a4a9b9824c017900d1138_I20150701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81NS9mcmFnOmNmMDBhZTIxMjFiNTRmYTNhMjcxY2RiMjVhZDNkOGQ4L3RleHRyZWdpb246Y2YwMGFlMjEyMWI1NGZhM2EyNzFjZGIyNWFkM2Q4ZDhfMzUxNQ_090dc506-9edd-4094-b7db-ac169497b060"
      unitRef="number">0.189</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RleHRyZWdpb246YjVmOGJmY2YxNWNlNDhmZWFmZTc0YmE4YTJlZWRkNTBfNDIy_5f6a2576-efaa-4767-846b-f9f6db6f7d26">SUPPLEMENTAL CASH FLOW AND OTHER DATA&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Supplemental cash flow and other data for the three months ended March&#160;31, 2023 and 2022 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Businesses acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merger consideration payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for business acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RleHRyZWdpb246YjVmOGJmY2YxNWNlNDhmZWFmZTc0YmE4YTJlZWRkNTBfNDE3_8d2c212e-b6b9-4646-a4ff-261fddb9d733">Supplemental cash flow and other data for the three months ended March&#160;31, 2023 and 2022 was as follows: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Businesses acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merger consideration payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for business acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:Depreciation
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMi0xLTEtMS05NjkwMA_7e44ebe0-0225-4cbe-b0ad-4d4779f62e06"
      unitRef="usd">81000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMi0zLTEtMS05NjkwMA_5d1e082c-e4c1-4c9d-a437-9e745b6a1526"
      unitRef="usd">79000000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMy0xLTEtMS05NjkwMA_9cd08d07-680f-4743-93c6-24c750df1af5"
      unitRef="usd">26000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMy0zLTEtMS05NjkwMA_27cee206-1a8d-4963-9922-8a28d4d67d62"
      unitRef="usd">27000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfNC0xLTEtMS05NjkwMA_bcdd3ae7-6fe7-407d-8170-04990075e27b"
      unitRef="usd">107000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfNC0zLTEtMS05NjkwMA_d4ab6e8a-5c20-4c25-9352-0553719d88f1"
      unitRef="usd">106000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:InterestExpense
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfNi0xLTEtMS05NjkwMA_9398c473-7229-4298-a803-c132352f9e75"
      unitRef="usd">37000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfNi0zLTEtMS05NjkwMA_b1d59318-80fd-48c6-9603-1a967292c1a0"
      unitRef="usd">37000000</us-gaap:InterestExpense>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfNy0xLTEtMS05NjkwMA_a0c1771f-3971-41bf-b223-6f21a3c000e6"
      unitRef="usd">2000000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfNy0zLTEtMS05NjkwMA_9bba2c29-b8f6-4d30-ac72-c1c1285a6341"
      unitRef="usd">0</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfOC0xLTEtMS05NjkwMA_16ce6895-ed77-43b1-a2a4-21d23f9078bf"
      unitRef="usd">-35000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfOC0zLTEtMS05NjkwMA_fd782ab8-7517-468d-af81-f2505cdc243f"
      unitRef="usd">-37000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestPaidNet
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTAtMS0xLTEtOTY5MDA_07c53e48-2144-47ab-88b4-c5cabc62f72f"
      unitRef="usd">32000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTAtMy0xLTEtOTY5MDA_26ccad39-3062-4b6d-b4a6-a13b1e3966de"
      unitRef="usd">32000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTEtMS0xLTEtOTY5MDA_c78e3137-56ce-420b-9ed4-97c79e8cc3f0"
      unitRef="usd">33000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTEtMy0xLTEtOTY5MDA_14b4ab4c-2fa6-4395-a372-d8ced63bda08"
      unitRef="usd">23000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTMtMS0xLTEtOTY5MDA_2b8ad05b-92ce-42f3-8d2c-e59746b9b347"
      unitRef="usd">22000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTMtMy0xLTEtOTY5MDA_37816f4e-4f59-4dfd-a27c-20b099ac85ed"
      unitRef="usd">22000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTUtMS0xLTEtOTY5MDA_205f6a61-100d-4e8d-9660-a8937a70aa0e"
      unitRef="usd">80000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="ib84cedd020e943f08a613b4d09834d7f_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTUtMy0xLTEtOTY5MDA_eed6d77a-af0f-492d-9467-d69991210ffb"
      unitRef="usd">78000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTgtMS0xLTEtOTY5MDA_604aaf59-3e6a-4eba-9696-54a26e24e4f3"
      unitRef="usd">31000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTgtMy0xLTEtOTY5MDA_2aadd86d-d781-4505-a490-366b2fd8d47d"
      unitRef="usd">142000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTktMS0xLTEtOTY5MDA_c793f8b1-d306-4901-ba5c-c3437ae68050"
      unitRef="usd">0</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMTktMy0xLTEtOTY5MDA_e6491455-4a1e-44f8-8247-e3ef359316e6"
      unitRef="usd">15000000</us-gaap:LiabilitiesAssumed1>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMjAtMS0xLTEtOTY5MDA_560f4c10-b95b-4f22-bbff-5dbca1866c0f"
      unitRef="usd">31000000</dgx:FairValueOfNetAssetsAcquired>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMjAtMy0xLTEtOTY5MDA_41e28d47-cf7c-4408-8021-02d53bee121c"
      unitRef="usd">127000000</dgx:FairValueOfNetAssetsAcquired>
    <dgx:Mergerconsiderationpaidpayablenet
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMjEtMS0xLTEtOTY5MDA_dcfbd8aa-0f8b-4bc4-b7fe-25897c2de1f0"
      unitRef="usd">0</dgx:Mergerconsiderationpaidpayablenet>
    <dgx:Mergerconsiderationpaidpayablenet
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMjEtMy0xLTEtOTY5MDA_78f1446b-b539-4fac-ab7f-943842d53714"
      unitRef="usd">-18000000</dgx:Mergerconsiderationpaidpayablenet>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMjItMS0xLTEtOTY5MDA_450ffb23-6eac-4faa-af5b-29b0d1c9103c"
      unitRef="usd">31000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMjItMy0xLTEtOTY5MDA_0362c207-8206-48eb-bda9-0cd7c93cff58"
      unitRef="usd">109000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMjMtMS0xLTEtOTY5MDA_a8b37158-87bc-4287-80a3-5e5f39b58738"
      unitRef="usd">0</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMjMtMy0xLTEtOTY5MDA_cbd91692-82b5-457b-9360-c2f11dbff504"
      unitRef="usd">4000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMjQtMS0xLTEtOTY5MDA_1f64e35a-f186-4bee-828b-4b3801709712"
      unitRef="usd">31000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMjQtMy0xLTEtOTY5MDA_b2ebfd32-ac30-434f-9668-8ba6edf9cc5c"
      unitRef="usd">105000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMzEtMS0xLTEtOTY5MDA_03e378f2-7ee4-44d5-8390-07f85ca97632"
      unitRef="usd">44000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF81OC9mcmFnOmI1ZjhiZmNmMTVjZTQ4ZmVhZmU3NGJhOGEyZWVkZDUwL3RhYmxlOjBhOTk3NWI3MWJmYTRkMTk5OGFmM2Y5OWU1OTc4YThjL3RhYmxlcmFuZ2U6MGE5OTc1YjcxYmZhNGQxOTk4YWYzZjk5ZTU5NzhhOGNfMzEtMy0xLTEtOTY5MDA_203c386e-8d16-4f6e-884b-9d7c4f24f23e"
      unitRef="usd">63000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfMTE0NjA_e4987168-6d86-4e93-a588-3ecc3e8e1f89">COMMITMENTS AND CONTINGENCIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Letters of Credit&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company can issue letters of credit totaling $100&#160;million under its $525&#160;million secured receivables credit facility and $150&#160;million under its $750&#160;million senior unsecured revolving credit facility.  For further discussion regarding the Company's secured receivables credit facility and senior unsecured revolving credit facility, see Note 14 to the audited consolidated financial statements in the Company's 2022 Annual Report on Form 10-K and Note 7 above.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In support of its risk management program, $70 million in letters of credit under the secured receivables credit facility were outstanding as of March&#160;31, 2023, providing collateral for current and future automobile liability and workers&#x2019; compensation loss payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent Lease Obligations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases for which no liability has been recorded.  For further details, see Note 19 to the audited consolidated financial statements in the Company&#x2019;s 2022 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Certain Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.  The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;401(k) Plan Lawsuit&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In 2020, two putative class action lawsuits were filed in the U.S. District Court for New Jersey against the Company and other defendants with respect to the Company&#x2019;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the two lawsuits under the caption &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re: Quest Diagnostics ERISA Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and plaintiffs filed a consolidated amended complaint.  In May 2021, the court denied the Company's motion to dismiss the complaint.  Discovery is proceeding.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;AMCA Data Security Incident&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#x201c;AMCA&#x201d;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#x2019;s system between August 1, 2018 and March 30, 2019 (the &#x201c;AMCA Data Security Incident&#x201d;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#x2019;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#x2019;s nor the Company&#x2019;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#x2019; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases that were then still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss was granted in part and denied in part.  Plaintiffs filed an amended complaint, which the Company also moved to dismiss. The motion is pending. Plaintiffs also filed a motion to further amend the complaint. The Company opposed the motion.  Discovery is proceeding.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In addition, the Company has been notified that numerous state attorney general offices were investigating or otherwise seeking information and/or documents, and that certain U.S. senators were seeking information, from the Company related to the AMCA Data Security Incident.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:72pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ReproSource Fertility Diagnostics, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:72pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;ReproSource Fertility Diagnostics, Inc. (&#x201c;ReproSource&#x201d;), a subsidiary of the Company, is subject to two putative class action lawsuits in the U.S. District Court for Massachusetts: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bickham v. ReproSource Fertility Diagnostics, Inc. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Gordon v. ReproSource Fertility Diagnostics, Inc.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The class actions are related to a data security incident that occurred in August 2021 in which an unauthorized party may have accessed or acquired protected health information and personally identifiable information of ReproSource patients. The complaints generally allege that ReproSource, among other claims, failed to adequately safeguard customers&#x2019; private information. The Company moved to dismiss both complaints.  A third putative class action pertaining to the same data security incident, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Trouville v. ReproSource Fertility Diagnostics, Inc.,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; was filed in California state court.  The Company removed the case to federal court and moved to dismiss and/or transfer it to U.S. District Court for Massachusetts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:72pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cole, et. al v. Quest Diagnostics Incorporated&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&#160;&#160;&#160;The Company is&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;subject to a putative class action entitled &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Cole, et al. v Quest Diagnostics Incorporated&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, which was filed in the U. S. District Court for the Eastern District of California, for allegedly conspiring with Facebook to track customers&#x2019; internet communications on Company web platforms without authorization, in violation of the California Invasion of Privacy Act and the California Confidentiality of Medical Information Act&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;  The complaint alleged that the Company&#x2019;s actions were an invasion of privacy and contributed to a loss of value in plaintiffs&#x2019; personally identifiable information.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company moved to dismiss the case or, in the alternative, transfer venue to the U.S. District Court for New Jersey.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Subsequently, plaintiffs filed an amended complaint.  The Company filed a motion to dismiss the amended complaint, which is pending. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:72pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The federal or state governments may bring claims based on the Company's current practices, which it believes are lawful.  In addition, certain federal and state statutes, including the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing or other practices based on the False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistleblowers" as to which the Company cannot determine the extent of any potential liability.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of March&#160;31, 2023, the Company does not believe that material losses related to legal matters are probable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Reserves for legal matters totaled $1 million and $2 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reserves for General and Professional Liability Claims&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is subject to a series of individual claims brought by persons in Ireland related to allegations stemming from pap smear screening services performed by the Company.  In general, claimants have alleged that the results of certain pap smear screening tests performed by the Company and other providers, pursuant to a program coordinated by the Irish government, were incorrect for individuals who were later diagnosed with cervical cancer.  The Irish government and an independent scoping inquiry commissioned by the Irish government found that the Company&#x2019;s performance of its screening services for the Irish cervical cancer screening program were in accordance with both Ireland&#x2019;s requirements and international standards.  The Company has settled claims made by certain individuals, is a party in multiple lawsuits and may be served as a party in additional lawsuits.  The Company does not believe that the resolution of existing or future claims will have a material adverse effect on its financial position or liquidity, but the ultimate outcomes of these claims are unpredictable and subject to significant uncertainties.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $168 million and $169 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;While the basis for claims reserves is actuarially determined losses based upon the Company's historical and projected loss experience, the process of analyzing, assessing and establishing reserve estimates relative to these types of claims involves a high degree of judgment.  Although the Company believes that its present reserves and insurance coverage are sufficient to cover currently estimated exposures, it is possible that the Company may incur liabilities in excess of its recorded reserves or insurance coverage.  Changes in the facts and circumstances associated with claims could have a material impact on the Company&#x2019;s results of operations (principally costs of services), cash flows and financial condition in the period that reserve estimates are adjusted or paid.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia10ad287b0cd4193a14609ca8a3021dc_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfMTEx_133ecea2-a029-42fc-a87b-85e47b59731f"
      unitRef="usd">100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i5761244dc05a4e05ba1c36f1739ffa78_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfMTI0_3f389996-bd9c-44ec-abd8-a79291d210e6"
      unitRef="usd">525000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i0773aae3a1a24aabbc51451a0ca743da_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfMTY3_02efcc0d-dae4-45c5-9f23-fc1e14f45872"
      unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i9c4b1b27b14f4358b79dcebe17500b25_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfMTgw_8494e249-f455-4059-8f13-9dd2a8038d73"
      unitRef="usd">750000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i5761244dc05a4e05ba1c36f1739ffa78_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfNTI2_f8f1766d-030e-4bd0-aecf-d751d7ae4e72"
      unitRef="usd">70000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ie4e5f3cb386b4fc98d6b4476305eabe9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfMTY0OTI2NzQ2Mzg0MQ_1d2bb1ce-600d-4a4a-87ca-2b19a3c703bc"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ice7ecc3f1344426eb38edcacb95102d0_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfMTY0OTI2NzQ2Mzg0OQ_297f1cda-8eb5-4872-9549-0c993308d770"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ic641d132cbe14e8eb7c6b478bf547c1a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfMTY0OTI2NzQ2Mzg1Nw_4976c145-c120-4859-9674-63dc719682f3"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LitigationReserve
      contextRef="i51a030df6d10457797f31c05e00c6fbd_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfODM3NA_7a3a976c-7c46-4d5e-afb6-cdf73e0a9d37"
      unitRef="usd">1000000</us-gaap:LitigationReserve>
    <us-gaap:LitigationReserve
      contextRef="ia0ed27f0259f4eddad39f6d6f9166f22_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfODM4MQ_e0f40d32-1394-49aa-bce1-d45281c6dcf4"
      unitRef="usd">2000000</us-gaap:LitigationReserve>
    <us-gaap:MalpracticeLossContingencyAccrualUndiscounted
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfMTA2MzQ_2f4530c4-57c3-41ce-ac62-fc5cd08c135c"
      unitRef="usd">168000000</us-gaap:MalpracticeLossContingencyAccrualUndiscounted>
    <us-gaap:MalpracticeLossContingencyAccrualUndiscounted
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82MS9mcmFnOmViZmVmYmU4ZTk2ODQ4YzJiZDYyMDUwYjE3YTYxNTI4L3RleHRyZWdpb246ZWJmZWZiZThlOTY4NDhjMmJkNjIwNTBiMTdhNjE1MjhfMTA2NDE_12a25e94-25bc-4856-9312-ae489d89d168"
      unitRef="usd">169000000</us-gaap:MalpracticeLossContingencyAccrualUndiscounted>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RleHRyZWdpb246ZGMyZTc4MzEyMjA1NGU3ZWJiOTQ2MmUwZWI0MWVmMDFfMjQxNw_26490bbe-d70d-41a6-9adc-8bfdc65c3247">BUSINESS SEGMENT INFORMATION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, customers, and ACOs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than 95% of net revenues in 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of March&#160;31, 2023, substantially all of the Company&#x2019;s services were provided within the United States, and substantially all of the Company&#x2019;s assets were located within the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table is a summary of segment information for the three months ended March&#160;31, 2023 and 2022.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#x2019;s 2022 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.590%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues &lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating earnings (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income before income taxes and equity in earnings of equity method investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity in earnings of equity method investees, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The approximate percentage of net revenues by major service for the three months ended March&#160;31, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Routine clinical testing and other services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;COVID-19 testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gene-based and esoteric (including advanced diagnostics) testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anatomic pathology testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="i92e626d8b4994af79d894bbd7fca8a13_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RleHRyZWdpb246ZGMyZTc4MzEyMjA1NGU3ZWJiOTQ2MmUwZWI0MWVmMDFfODAz_6244e8db-3a26-4ec5-9914-326a572ccd89"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ieb2184019e3a41bba34f394de7b2cfc9_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RleHRyZWdpb246ZGMyZTc4MzEyMjA1NGU3ZWJiOTQ2MmUwZWI0MWVmMDFfODAz_e8eea003-fa12-435b-9430-61d699cf2090"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RleHRyZWdpb246ZGMyZTc4MzEyMjA1NGU3ZWJiOTQ2MmUwZWI0MWVmMDFfMjQwMA_476f4162-e6fa-45ba-b356-c67f577b14cd">The following table is a summary of segment information for the three months ended March&#160;31, 2023 and 2022.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#x2019;s 2022 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.590%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues &lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating earnings (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income before income taxes and equity in earnings of equity method investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity in earnings of equity method investees, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8ed346c5690e4ddc8d0b23a92ec0f7f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMy0xLTEtMS05NjkwMA_7ea34d8f-857c-422f-ba19-c93edd2821d9"
      unitRef="usd">2259000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2dd1a321696c48c5be41b31ca63c5571_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMy0zLTEtMS05NjkwMA_9fe57965-a31d-4644-9ed5-d8c9710ef1ad"
      unitRef="usd">2541000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd435f0f382f4a7885ef56b501114dd0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfNC0xLTEtMS05NjkwMA_8cbe9f12-2eb3-4331-937b-10ad8e5c29d5"
      unitRef="usd">72000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic3973c12fa954740845e01c52214f022_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfNC0zLTEtMS05NjkwMA_72acc59f-8617-46b9-bf1f-5152af1e4ff9"
      unitRef="usd">70000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfNS0xLTEtMS05NjkwMA_9c3294f1-244a-42a0-ad97-6a744508a51f"
      unitRef="usd">2331000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfNS0zLTEtMS05NjkwMA_39652455-5355-443f-b6d2-746bfe236a44"
      unitRef="usd">2611000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8ed346c5690e4ddc8d0b23a92ec0f7f2_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfOC0xLTEtMS05NjkwMA_df2d1994-2413-46d0-ad2e-6ad109194e14"
      unitRef="usd">374000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2dd1a321696c48c5be41b31ca63c5571_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfOC0zLTEtMS05NjkwMA_558f9918-625c-4cea-bdfd-34ab0af03ccb"
      unitRef="usd">562000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icd435f0f382f4a7885ef56b501114dd0_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfOS0xLTEtMS05NjkwMA_777a33f4-c220-4fcd-8b07-b542317feafd"
      unitRef="usd">8000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic3973c12fa954740845e01c52214f022_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfOS0zLTEtMS05NjkwMA_892314cd-eb44-49a7-aac1-a6be2852838d"
      unitRef="usd">7000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8b6d35b5d67546ce9f6822c84cfcf9e5_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTAtMS0xLTEtOTY5MDA_2e52d3f2-100f-4c74-9dfd-883a5d1404d7"
      unitRef="usd">-77000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i61ed8ec37ceb4a73a0b35d0de8357758_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTAtMy0xLTEtOTY5MDA_0780416c-e761-4a2d-9e25-d32ed9738424"
      unitRef="usd">-56000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTEtMS0xLTEtOTY5MDA_18c66df8-a1f6-489c-a35c-2ec354f0a920"
      unitRef="usd">305000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTEtMy0xLTEtOTY5MDA_365c5cc5-b9c1-46f5-8127-bf1005e33b7f"
      unitRef="usd">513000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTItMS0xLTEtOTY5MDA_168294cb-3698-4e49-9683-3322e7866ba5"
      unitRef="usd">-28000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTItMy0xLTEtOTY5MDA_55c07ae5-4a46-48b5-8900-ca7f4390ca43"
      unitRef="usd">-61000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTMtMS0xLTEtOTY5MDA_f2895cce-8b69-4ff6-9c36-75da7fb02dc3"
      unitRef="usd">277000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTMtMy0xLTEtOTY5MDA_d04eb703-e5ba-422e-aaf1-0a0675ca7d25"
      unitRef="usd">452000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTQtMS0xLTEtOTY5MDA_c1198e97-480d-415a-bad7-96c909d70023"
      unitRef="usd">65000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTQtMy0xLTEtOTY5MDA_627d4470-395f-44ff-b48b-c7ffcf9f763c"
      unitRef="usd">110000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTUtMS0xLTEtOTY5MDA_d9fe4ec0-8848-4a56-8b75-d72c31863ec7"
      unitRef="usd">5000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTUtMy0xLTEtOTY5MDA_d2a78198-e39e-4d06-9fcb-506fdc78aba8"
      unitRef="usd">31000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTgtMS0xLTEtOTY5MDA_20176249-567a-4f20-9ab1-c8ec894a2ed6"
      unitRef="usd">217000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTgtMy0xLTEtOTY5MDA_0fe2eeb7-9c36-407b-a93a-32fd365171e0"
      unitRef="usd">373000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTktMS0xLTEtOTY5MDA_1c7a5c80-98d4-4375-8450-c00f315e9bd8"
      unitRef="usd">15000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMTktMy0xLTEtOTY5MDA_b081c97f-a899-49b2-b10d-39398f733fa4"
      unitRef="usd">18000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMjAtMS0xLTEtOTY5MDA_d79fe2ef-8f40-4373-8b66-566ed803c96e"
      unitRef="usd">202000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjFkZTUyOTM2OWE4NTQyZDVhOGM1NzZmOTc3ODYzMzI2L3RhYmxlcmFuZ2U6MWRlNTI5MzY5YTg1NDJkNWE4YzU3NmY5Nzc4NjMzMjZfMjAtMy0xLTEtOTY5MDA_4ff9adf0-a1b6-41bf-8143-a95a86e355a0"
      unitRef="usd">355000000</us-gaap:NetIncomeLoss>
    <dgx:ScheduleOfRevenuesByMajorServiceTableTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RleHRyZWdpb246ZGMyZTc4MzEyMjA1NGU3ZWJiOTQ2MmUwZWI0MWVmMDFfMjQwNQ_bf5cd59f-5d62-48c3-8ce5-d3793eb7bb5e">by major service for the three months ended March&#160;31, 2023 and 2022 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Routine clinical testing and other services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;COVID-19 testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gene-based and esoteric (including advanced diagnostics) testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anatomic pathology testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</dgx:ScheduleOfRevenuesByMajorServiceTableTextBlock>
    <dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent
      contextRef="i6f57bd433a114ad99ef7c771bd566d82_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfMy0xLTEtMS05NjkwMA_d61f5812-5e07-4173-9149-2c04ac4926f8"
      unitRef="number">0.49</dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent>
    <dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent
      contextRef="ib70af9ca8a1f4946a10a38788730eceb_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfMy0zLTEtMS05NjkwMA_a8d53a06-b0ab-4cf1-a868-79ad5d1d59e6"
      unitRef="number">0.41</dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent>
    <dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent
      contextRef="i1e58a48918dd4becb0dd4cc40ca69a88_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfNC0xLTEtMS05NjkwMA_1df56b5b-ce77-4353-b6d2-976d1a206c62"
      unitRef="number">0.05</dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent>
    <dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent
      contextRef="i5597494df62b463093771d2b719b6894_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfNC0zLTEtMS05NjkwMA_0158201d-f047-449f-9494-0bf5b9fcde4d"
      unitRef="number">0.23</dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent>
    <dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent
      contextRef="i6d860d57e4ad449a887c67967f28d5d6_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfNS0xLTEtMS05NjkwMA_89afdb90-6ea7-4396-b8d1-ed52e3ad2180"
      unitRef="number">0.37</dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent>
    <dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent
      contextRef="ied62521cf257403a89d19d00c5aa5abe_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfNS0zLTEtMS05NjkwMA_af468a6c-46ac-44eb-84e7-d7cf08a18219"
      unitRef="number">0.28</dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent>
    <dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent
      contextRef="ia2a765cc64784441973b1aec2bd7c985_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfNi0xLTEtMS05NjkwMA_03816a83-033e-4502-af2e-0816d8dde34e"
      unitRef="number">0.06</dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent>
    <dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent
      contextRef="i7cdf174765f04a2f86be3ef952803845_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfNi0zLTEtMS05NjkwMA_b84b48d8-bd1e-4b23-a2d8-75f1e8df75ac"
      unitRef="number">0.05</dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent>
    <dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent
      contextRef="i85e225a2df9640b3ab2e1ea93558ed16_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfNy0xLTEtMS05NjkwMA_fbbe0387-c192-4e00-8ca7-a1e7c2ae9c87"
      unitRef="number">0.03</dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent>
    <dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent
      contextRef="ia7a6fd94d88447269386a6a9f798ce52_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfNy0zLTEtMS05NjkwMA_59207cb0-30f4-4acd-9e05-068d97852119"
      unitRef="number">0.03</dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent>
    <dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfOC0xLTEtMS05NjkwMA_dbdf44b3-bfe5-434b-be32-d2f849da8391"
      unitRef="number">1</dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent>
    <dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82NC9mcmFnOmRjMmU3ODMxMjIwNTRlN2ViYjk0NjJlMGViNDFlZjAxL3RhYmxlOjVmMmZlOTllZDgyMTQwNjJhM2NkMjJiMGQxMmQyNTg1L3RhYmxlcmFuZ2U6NWYyZmU5OWVkODIxNDA2MmEzY2QyMmIwZDEyZDI1ODVfOC0zLTEtMS05NjkwMA_8381d561-39dd-4d71-b8fc-bb46d9a12660"
      unitRef="number">1</dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RleHRyZWdpb246ZDQ5MTZiNmZiNTA0NDQ1YjhjYTI0ZjM3YWM0ZGVmYWZfMTYwOQ_518f764c-c13c-42b4-8aa4-5f4f72d74c31">REVENUE RECOGNITION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DIS&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Net revenues in the Company&#x2019;s DIS business accounted for over 95% of the Company&#x2019;s total net revenues for the three months ended March&#160;31, 2023 and 2022 and are primarily comprised of a high volume of relatively low-dollar transactions. The DIS business, which provides clinical testing services and other services, satisfies its performance obligations and recognizes revenues primarily upon completion of the testing process (when results are reported) or when services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers (Medicare and Medicaid programs), client payers and patients.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For further details regarding revenue recognition in the Company's DIS business, see Note 3 to the audited consolidated financial statements in the Company's 2022 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DS&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company&#x2019;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Revenue and Net Accounts Receivable by Customer Type&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The approximate percentage of net revenue by type of customer was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare insurers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fee-for-service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total healthcare insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The approximate percentage of net accounts receivable by type of customer was as follows:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare Insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="ieb2184019e3a41bba34f394de7b2cfc9_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RleHRyZWdpb246ZDQ5MTZiNmZiNTA0NDQ1YjhjYTI0ZjM3YWM0ZGVmYWZfOTk_1e97840b-258e-4fa5-9c14-9ce5544c988b"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i92e626d8b4994af79d894bbd7fca8a13_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RleHRyZWdpb246ZDQ5MTZiNmZiNTA0NDQ1YjhjYTI0ZjM3YWM0ZGVmYWZfOTk_34b6fc44-e4d2-4d4f-a403-119d726910f4"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RleHRyZWdpb246ZDQ5MTZiNmZiNTA0NDQ1YjhjYTI0ZjM3YWM0ZGVmYWZfMTYxMw_c25839ee-2dc0-4d31-85cf-49754de0a4f8">The approximate percentage of net revenue by type of customer was as follows:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare insurers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fee-for-service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total healthcare insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="i2a00ddd1f78d4eabbd3eec75dce18984_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfMy0xLTEtMS05NjkwMA_0ac80248-8192-432c-97b8-ae9ab3fc00ff"
      unitRef="number">0.37</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i355eb3cfa48643c89a8544abcf920805_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfMy0zLTEtMS05NjkwMA_4ed5cc87-47c4-42cf-8f48-8f0fecec932f"
      unitRef="number">0.39</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i6cc506733bc54c4c939d04e93b12a019_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfNC0xLTEtMS05NjkwMA_f2175ae9-ca2d-40c9-b468-b76a73c2fc6d"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i5ba6898f5dce4da790f1d70a1becead8_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfNC0zLTEtMS05NjkwMA_a7b35ebf-ff81-4ab2-90cc-7b5639d38d6a"
      unitRef="number">0.02</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ia5513c4320b84b8187a84d0c7bb3c2e7_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfNS0xLTEtMS05NjkwMA_34b8ae70-6206-4ead-b375-3195beb07fa3"
      unitRef="number">0.40</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i3dadd8bb7e9b49f1a84da6abd44b2b54_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfNS0zLTEtMS05NjkwMA_8ebf36a3-7554-48ac-9cb2-ce0194fb0cdf"
      unitRef="number">0.41</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="icfc7432b93a741d59d3b948cc6fd7457_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfNi0xLTEtMS05NjkwMA_42a77e70-ec7f-45d9-97c2-f8e13feebe89"
      unitRef="number">0.12</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i23e66b0f67b94bb2b097b5144c24e807_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfNi0zLTEtMS05NjkwMA_11c8d280-ded8-4f16-b616-6c00bb3b087b"
      unitRef="number">0.11</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ie21be809ef3c4dcbbd5ed7e71d98fbd4_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfNy0xLTEtMS05NjkwMA_bb9883df-4657-4be7-8005-d01fe823d93f"
      unitRef="number">0.33</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i3c6c0ad027434a8e877b0382b926c96d_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfNy0zLTEtMS05NjkwMA_816c0dee-81c8-42cf-84f0-ce60ce768b27"
      unitRef="number">0.32</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i26268270d1b14e71a865a97e2c5c435a_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfOC0xLTEtMS05NjkwMA_1a98f17e-feba-4464-856d-5a9581a8e828"
      unitRef="number">0.12</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ie11d9750588e417cb37a21a52c132fcd_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfOC0zLTEtMS05NjkwMA_1e33ee74-0f04-41b1-82f2-acde30d5e34f"
      unitRef="number">0.13</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i8ed346c5690e4ddc8d0b23a92ec0f7f2_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfOS0xLTEtMS05NjkwMA_c22ac3ce-d68c-4683-b5a5-7bcdeceb2d2a"
      unitRef="number">0.97</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i2dd1a321696c48c5be41b31ca63c5571_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfOS0zLTEtMS05NjkwMA_0080c160-2a7e-44e0-9802-1b6250a27270"
      unitRef="number">0.97</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i772cad9a0b3d4082b300fc534f745257_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfMTAtMS0xLTEtOTY5MDA_122ca230-b3fa-4044-ae9f-33e9526e98d5"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i61a15314b5e742e0b281c2024f9d2632_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfMTAtMy0xLTEtOTY5MDA_10b7885c-b427-482c-b2d6-917bf42dcebb"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfMTEtMS0xLTEtOTY5MDA_59ee42d3-ea7b-4086-b20e-a93918f8b5ba"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmQ3MGM4ZmViNzFlYzRiNWVhYmU3OThjOTJjNzllNTg0L3RhYmxlcmFuZ2U6ZDcwYzhmZWI3MWVjNGI1ZWFiZTc5OGM5MmM3OWU1ODRfMTEtMy0xLTEtOTY5MDA_4a20eb61-d0c5-476b-8689-817dcfa0318c"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:AccountsReceivableDisaggregationTableTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RleHRyZWdpb246ZDQ5MTZiNmZiNTA0NDQ1YjhjYTI0ZjM3YWM0ZGVmYWZfMTYwNw_d23919a1-dfbe-473c-82ac-002c7f8480b3">The approximate percentage of net accounts receivable by type of customer was as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare Insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dgx:AccountsReceivableDisaggregationTableTextBlock>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="if148e27d61634341a1c6b7a4d2b7f1ed_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfMi0xLTEtMS05NjkwMA_42471519-e132-4465-8ec4-a291938d717f"
      unitRef="number">0.29</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i55811dcbf9b144cc912c05f6c566ce5a_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfMi0zLTEtMS05NjkwMA_8ecc3636-fe80-49cd-ad00-f286b82ba972"
      unitRef="number">0.28</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ifa6205a62b6b4428bd03ee3946847d9b_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfMy0xLTEtMS05NjkwMA_6ca9ec2d-afc8-4cef-ab76-7c1de4c52432"
      unitRef="number">0.07</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i86ad2c45fc2c42a69d24854e11d851c2_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfMy0zLTEtMS05NjkwMA_147bfb0a-10a1-4e3a-8015-d4715021612d"
      unitRef="number">0.06</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i3e102be4f8254b1dbbc70aa3bdc19865_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfNC0xLTEtMS05NjkwMA_59183cad-8015-435a-b73b-97d619031c23"
      unitRef="number">0.43</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ic4911193ea2f4d57910161a9d6712993_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfNC0zLTEtMS05NjkwMA_99e22a22-1651-4277-b9b3-bcfa0e9c0297"
      unitRef="number">0.44</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i9ffb964e5c344410af806c81f53963c1_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfNS0xLTEtMS05NjkwMA_35311648-68ce-47c4-8d92-b714add980cd"
      unitRef="number">0.17</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i6029d63b27f74dce9c2c1865b3c36922_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfNS0zLTEtMS05NjkwMA_a733bf39-9751-4c88-8a24-e238b1feb1ef"
      unitRef="number">0.18</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ib21559178668493e8f63bc406234ef9d_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfNi0xLTEtMS05NjkwMA_277e2bd0-c66d-43f5-87b8-d5ddbf7dc575"
      unitRef="number">0.96</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i6e2af1eeb8384a619b904007a6cb8f29_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfNi0zLTEtMS05NjkwMA_0c4479b8-0840-4eb8-8bfc-fd293823430e"
      unitRef="number">0.96</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i03db1044dc514a8eae7a1f57881a63d3_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfNy0xLTEtMS05NjkwMA_4c910bec-5e27-4fbc-a143-486e11ebb8e9"
      unitRef="number">0.04</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i552e3aecfd8f4491b6039419f80524b3_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfNy0zLTEtMS05NjkwMA_f9cf71c1-1533-4bfc-a456-80a05109b049"
      unitRef="number">0.04</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i62a8002be6c545879eef8e9350936b33_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfOC0xLTEtMS05NjkwMA_48c2e7da-251c-4f95-a82b-03a04a1a70bf"
      unitRef="number">1</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i313674dbdb4b43adbe1b80bb7d67dded_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF82Ny9mcmFnOmQ0OTE2YjZmYjUwNDQ0NWI4Y2EyNGYzN2FjNGRlZmFmL3RhYmxlOmI2MDc2ZGEwMjU3ZjRmNzc5MjBiMTBjOTg4MWMxNGIxL3RhYmxlcmFuZ2U6YjYwNzZkYTAyNTdmNGY3NzkyMGIxMGM5ODgxYzE0YjFfOC0zLTEtMS05NjkwMA_7096997d-0908-4736-94df-453ef4d8238c"
      unitRef="number">1</dgx:PercentageofNetAccountsReceivable>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF83MC9mcmFnOjQ5NDc1NGYzNGU1NDRjZjZiNmUxNDE3N2RlZGFkMWExL3RleHRyZWdpb246NDk0NzU0ZjM0ZTU0NGNmNmI2ZTE0MTc3ZGVkYWQxYTFfNTIy_099b8895-3bcf-450d-946c-1d4dabb10f47">TAXES ON INCOME&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2023 and 2022, the effective income tax rate was 23.6% and 24.4%, respectively.  The effective income tax rates benefited from $5 million of excess tax benefits associated with stock-based compensation arrangements for both the three months ended March&#160;31, 2023 and 2022.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF83MC9mcmFnOjQ5NDc1NGYzNGU1NDRjZjZiNmUxNDE3N2RlZGFkMWExL3RleHRyZWdpb246NDk0NzU0ZjM0ZTU0NGNmNmI2ZTE0MTc3ZGVkYWQxYTFfOTc_931332af-92e1-4568-9e94-0e1695e19e1f"
      unitRef="number">0.236</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF83MC9mcmFnOjQ5NDc1NGYzNGU1NDRjZjZiNmUxNDE3N2RlZGFkMWExL3RleHRyZWdpb246NDk0NzU0ZjM0ZTU0NGNmNmI2ZTE0MTc3ZGVkYWQxYTFfMTA0_3597b965-da7b-4855-9805-1ad09e91e170"
      unitRef="number">0.244</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="ifb8069c214264ab183970915c8088bc5_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF83MC9mcmFnOjQ5NDc1NGYzNGU1NDRjZjZiNmUxNDE3N2RlZGFkMWExL3RleHRyZWdpb246NDk0NzU0ZjM0ZTU0NGNmNmI2ZTE0MTc3ZGVkYWQxYTFfMTA5OTUxMTYyODQ4OA_0c1e1065-43c5-4ab1-9ed3-d6a12b9c9a28"
      unitRef="usd">-5000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF83MC9mcmFnOjQ5NDc1NGYzNGU1NDRjZjZiNmUxNDE3N2RlZGFkMWExL3RleHRyZWdpb246NDk0NzU0ZjM0ZTU0NGNmNmI2ZTE0MTc3ZGVkYWQxYTFfMTA5OTUxMTYyODQ4OA_c1cfeb64-b019-431c-94ff-00fa3529118a"
      unitRef="usd">-5000000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF83My9mcmFnOmVhOGZmMGU2MWY5ODQ5Zjc5NDQ2NjdmNTJlYzUwYzQwL3RleHRyZWdpb246ZWE4ZmYwZTYxZjk4NDlmNzk0NDY2N2Y1MmVjNTBjNDBfMTA0Mg_a1727816-cd14-4865-8a9b-ed22d852513f">SUBSEQUENT EVENTS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On April 17, 2023, the Company completed the previously announced acquisition of select assets of the laboratory services business of New York-Presbyterian, which serves providers and patients in New York, as well as the Tri-State Area and beyond, in an all-cash transaction for $275&#160;million.  The acquisition will be accounted for as a business combination.  The Company is in the process of completing the preliminary purchase price allocation of the assets acquired and liabilities assumed. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&#160;&#160;&#160;During April 2023, the Company announced that it had entered into a definitive agreement to acquire Haystack Oncology, Inc., an early-stage oncology company focused on minimal residual disease testing to aid in the early, accurate detection of residual or recurring cancer and better inform therapy decisions.  Under the terms of the agreement, the Company would pay approximately $300&#160;million in cash at closing, net of cash acquired.  Additionally, it would pay up to $150&#160;million of additional consideration, which is contingent upon achieving future performance milestones and which is not expected to be paid during 2023.  The transaction is expected to close during the second quarter of 2023 and remains subject to customary closing conditions. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company expects to fund the cash at closing for the acquisitions noted above through a combination of cash on hand and borrowings under the Company's existing credit facilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i9b19a5afa8014eac9ccbf727527f2ea6_D20230417-20230417"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF83My9mcmFnOmVhOGZmMGU2MWY5ODQ5Zjc5NDQ2NjdmNTJlYzUwYzQwL3RleHRyZWdpb246ZWE4ZmYwZTYxZjk4NDlmNzk0NDY2N2Y1MmVjNTBjNDBfMzI5ODUzNDg4NjE2Mw_31dc8f75-a829-43a5-9079-83fe419a2c39"
      unitRef="usd">275000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i9c77555441f446579e41076eec2f33b5_D20230401-20230428"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF83My9mcmFnOmVhOGZmMGU2MWY5ODQ5Zjc5NDQ2NjdmNTJlYzUwYzQwL3RleHRyZWdpb246ZWE4ZmYwZTYxZjk4NDlmNzk0NDY2N2Y1MmVjNTBjNDBfMzI5ODUzNDg4ODgxMQ_fa594fac-9c30-428b-80d5-573fcd23df93"
      unitRef="usd">300000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i1280f4be54c54da0986529d7da684b6d_I20230428"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF83My9mcmFnOmVhOGZmMGU2MWY5ODQ5Zjc5NDQ2NjdmNTJlYzUwYzQwL3RleHRyZWdpb246ZWE4ZmYwZTYxZjk4NDlmNzk0NDY2N2Y1MmVjNTBjNDBfMzI5ODUzNDg4ODgzMQ_8187177f-aa0a-4f6a-ab8b-859fdbff4b6f"
      unitRef="usd">150000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <dgx:StockRepurchaseProgramAdditionalAmountAuthorized
      contextRef="ia90feb97a113427e947ad9d0fd0a3fa3_D20230201-20230201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhYTZmZDYxYWY4MjQzMDFhNzRkZmUxMDYyOTUyMDRkL3NlYzoxYWE2ZmQ2MWFmODI0MzAxYTc0ZGZlMTA2Mjk1MjA0ZF8xMDMvZnJhZzo4YTgxNjFhMzRkYWE0ODFiODRlNTkwMTE4Njg3Zjg2Ni90ZXh0cmVnaW9uOjhhODE2MWEzNGRhYTQ4MWI4NGU1OTAxMTg2ODdmODY2XzMyOQ_4832b951-061d-4070-bbe7-bfbbd358064b"
      unitRef="usd">1000000000</dgx:StockRepurchaseProgramAdditionalAmountAuthorized>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>57
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MCZ?0GYU848_AD&AID6@MCU2@%HUWJN13$'OV!..:=S];08_ACECICE@M=U2
M3L'*P7CS1["N[)\.*#I]9]"U+A4<PQ^QTA^Q _XHXU2"5X/A F\&??>M%>P8
M?HB5?HCA%N:#S!S"2L;89.6 2(\Y;=9W'"O?,;P0*[T0P\W+8Z!A&B87A+(W
M\[<$NHU402ZMD+C21$81#$DS+;VO)^1[Y]2A9 KF\3,/[8L)N%Y3\M(A,=S@
MP/3:#^(EF;U$<QE:@0\L(;W_W8IU#'_$2G_$< >SRR"Y?O96/%Z*R@GH :&[
M+S.K&<+#FO*59HC5,D.["5F^,I+E$481NW\_H/C%NA@\P:.:<I8FB-4R0;>Q
M%BK?!3"33;X#MW+BBE6<Q_ ]K/0]K/9J$+AW, )+J>S=#Z[S@2NHZV//$R $
M,GXN:24^AOUAI?UAM>S/+.)A2"[3!&XG]GJ+ZU3.T/"XAGQNZ7K<6J[G.A)J
M:1KF>U#0*S &T9K'UM0>$*P$Q>.:@I:FQ\4]RRZ1*P&)Q/!PF6J\8U@?M[0^
M+NY:=CWMJW%]EFV>D4^I!BL;FP'42OR-3,WV.^1JO4S-[-@^C2AECC.@@_ZP
M\[0/V=G;(S3U+]LZ38AG5@7R[<+B:K$].\XV)3OEX_G>[D=NJF]"0K& 4.>T
M#^]7^79I?J+E.MMQG$NM990=K@3WA3(/P/V%E'IW8EY0;%J/_@502P,$%
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MXO,9&9H!F<7?G#VKVC4RKBR$^&YN;J.+3F 8L9@MM8&@\+=C,Q;'!@EX_"A
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M1@,>2F- WY="Z*>%.: >&9/_ %!+ P04    " !-@9Q6BMR5[H0&  #Y&P
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M+W=O<FMS:&5E=',O<VAE970Y+GAM;-U86V_CN!7^*X07V-T"B>TXV=W!3!+
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M+&(^@.)&TP#<-3-R=?+.#@Z<58#?VON. ?,L9);I!,ERULCM2&KHMD$&4!I
M,O&9=ORI1# X@9<J)U&@KW40F!M<MCT??.9B_?D!$;0TB?L:/'"6M>,D4&1
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M+ACP^=IR)7:+$*#_H\U_ 5!+ P04    " !-@9Q6!(3(AU4)  !='   &0
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MZ+JOF,]+]E:F*5UJJVPI'*X0 GK9EU^6_GQYU1?>WJL< ;V.L@2,2HPH:?E
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M?!Z93&MOD'_::;WLTA26@0=Y))=!J54#D *YY-I@(*:TM2E7 >G]GT#V]C8
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MT."BW_5 NH;G%EI4MLFLA*:69:<9?2.@- HD7PNAFX4QT'YU3/X#4$L#!!0
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MLB%2\SU5-9>%A]/JPVV?>NSP[%8>.<IQ@HIMF8&L+I&58"?$O>B'*!B;MTN
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M.PJWYUI(-+R"Z'1\>I*1[]XFW22Z)KT'<A=!;1I6>,ZQEP/87SD0TD]$P?!
M7/P-4$L#!!0    ( $V!G%;$F-HHOPH  ,(<   9    >&PO=V]R:W-H965T
M<R]S:&5E=#(S+GAM;-U9:V_;.A+]*X0O<-L+.,^^@C8)X#S:-;9-LDF[B\5B
M/] 2;;&12%V2LN/]]7MF2,ER:KOW[L?]DE@6.9S'F3,S].G"ND=?*!7$4U4:
M?S8H0JC?'QSXK%"5]/NV5@9OIM95,N#1S0Y\[93,>5-5'AP?'KX]J*0V@_-3
M_N[.G9_:)I3:J#LG?%-5TBTO5&D79X.C0?O%O9X5@;XX.#^MY4P]J/"MOG-X
M.NBDY+I2QFMKA%/3L\'HZ/W%":WG!7_7:N%[GP59,K'VD1[&^=G@D!12I<H"
M29#X-U>7JBQ)$-3X/<D<=$?2QO[G5OI'MAVV3*17E[;\A\Y#<38X&8A<3653
MAGN[^(M*]KPA>9DM/?\5B[CVS>N!R!H?;)4V0X-*F_A?/B4_]#:<'&[9<)PV
M'+/>\2#6\DH&>7[J[$(X6@UI](%-Y=U03AL*RD-P>*NQ+YP_?/OR973_3W'[
M43R,/]V,/XXO1S=?Q>CR\O;;S=?QS2=Q=_MY?#F^?A O[VRI,ZW\;Z<' 4>3
M@(,L'7,1CSG><LPK\<6:4'AQ;7*5K^\_@,J=WL>MWA?'.P5^D6Y?O#H:BN/#
MXU<[Y+WJ_/"*Y;W:(F^49;8Q09N9:,T4_QI-?'# S;\W&1SEO=XLCW+IO:]E
MILX&2!:OW%P-SG_]Y>CMX8<=VK[NM'V]2_KYA?3:"SL5=R3;!$D(WZ3D;C%?
M"R6T"<KI2C1&-KD.*A>9-1XNR"4]3+61)M.R%!ZG**1C\)2,E%5"EJ60^7>@
M-'Z_*'160*(($&QK;2COH&4E#1*<U@CIE# J4]Z# @1(14@QE=JMQ-,&6(6L
M8@M!/X[-\T-H5L&9!5'"G#3'LQKV5(3F, %KL53Z0DQ!.5Y(DT.ZS1X+6^;*
M^1="_=[H$$\G37&"MKD7=72FRO>%N'[*5 UUH0.6N(7V2N3:9Z7U*A^RY;Z!
ML7WSR39H+(4AOBAA1=8X1Y R,C1.0>QMM 9?M2:V2K1Q:)5A1]G0.4N72ZS)
M=2:)QN@<VM5*"84,</-23)103S6"0[%+HJ<-M%TJRAB!D/O_+>B^L$V9TP%$
M_A1E[/G>F,BN"QT*/NR/"T3\R@9LT +F$M&59OGK+R?'1^\^>,KL8S$RIL&V
M>U5;!V@805PLC@[W_AJ-8;OV%$(\D27.4"+6,IPKQ0+A0\3A+ZC@;/4G%90,
MP"L$H)HH%Y,W4<ZQF#0XQ((E*$C)%(8%G9&0@IA3L@!M#F=,EJA!'<O4 $:F
MZQ(K9LH %67)[X&ZE4N^&5;U@73RXB6YYOCPPZ?1Z(X_'GWX;7\'F[SIV.3-
M3AKX!D3<3L6U#[JB@S81R6X)% AD3RUCJI+;MH2<W$ZM!.4?8X:,:7WD^TP1
M+)X> >=6+4YDZ=$^U,P'$?1R.B4JBLE ((&_9$5>YNAAO0IQ:ZGE1)?@AR1J
M%21:"+TH+LQ16_;$4P@P;?IMA@WV;5/'J;DR35* $M5X/.0-L\1J$P.$B0 H
M'V6A83:)J9YQ&N8:=KL6U2"EE9]V0>)M!XFW.P-Z+9V!$E[<X9"' F2T"12[
M97Q=Y?0+#ZJ90T-X W8$IYF@F)7Q1K<,1D% (XF<,GM R53I("<EO$*]E2=(
MY'JN<Z1[)$@ +J!6UY%2/?%M%]\A^1.5RCK4"%K\G&]4:R-2SV81N S0JFY8
M7K< H0"MD(S&MX$*"[N7E8"*J!0"0(&BJIRM[X*P"F+C9I3L3)994S+E@ [8
M&*X/*J1R!I3!.R 7MAL&_PUH">)*RYFQB'"&,AAK3B+XYU;@:^S:YI@A'4OJ
M+[A=)7#.P3TSU)J&2"YFPDIG@+8)P+8A-6'BE2X;VO7_:R0(!;51S* U02"Q
MBV5JKVU AFNFZIP\095XNZ1>6G?)?/=S$6TQB84D+4F*4$/4.R$FD$U\2)R"
M@WA2BY60(<OI-7.2.AL\H2#VRRU2<P3>HKR@_?>*F2P7UU5=VJ52XK,UL[VO
M"E5W#*&&M;E#J>7EVY59/Y!4V'C,#3*].^H*-2 +B/>V,X=4DQ>*VDZ_S3]4
M0TOJLHA@V /@U,9E!68W(6=.19H>"HVU=8U>GU!(+=\ZR!(TMU),/TS,V;'N
MK0@J5^ '*OS/=.XMAG.TCZG03ZH?@//'5-I%_.\ZXG^WD[1O,$?W9J$'"JYT
M.7,O6K]1;JD_V50,=LL=&X&1#0TSFJ=#IF;QL2N>&P^\L/@'.O$-N1#LL>BW
M3SZM2S-'[2RY'6JJ"OZEV2("$=)G#9H\R@>8H @$,0@I#]'(.<2+F+\GGD@'
MM0/U@S82F 27D@JQ84%<J[5_9"ZA!KT-*;T ?',\C:G+GDCSB.Z*1 'V).CE
MX//XXO9^\%OJ8"7E16H=@$=H;O '9U UI/$36"U4/HM30QF'H4+71)*4@E3F
M!!8:+[->8[12GX\3-&J9N/B99=W $&-,?1$W0^3XB<IDXU7L73;X(]D _QOX
M+HNM&_7=,2%Y3JLJE6MLH0:7ZG)RH5SS>%-S8Q7#^6?A@>"U;3IWYS3_&;*%
M$SQ:UGI35!;-DXX%GWSE;#,K5OM3A_^:+(MQ5D^!&U)X=4A].XU5]L<-PSZM
M"AHD';$$6[K<=CP!;65SAUD*2:Z[J3*9$4^0>5P6T89ZV^6"CM-(/YX%2A^R
MAQI#1[[4T"[C06K3R+4V$VT9PE<];VV]CHJXWKR]BX5..A8ZV<D65S2TQ4%W
M!8.Q 54VG"B;^&>WQ%XSBB9.I;DP'K&R2*^.&*;>6E<QWS5=-?!,0A,*%S3X
M.8X/_+5[1']#E!"#BGJ#:8)''IZVJ<%QW1A#7:F>H=EL'*44D3?RB&-)BV;+
MMKS$DI$R<$V0\ M9KQ4T"%T !GO 0QPA?K)^_75)U7OU>I.:R_:(%37M<HF=
MK\:^[BP2VXECA^R+?G *X@Y/G:'&)(^&IKV-X^[&V4SE/%8S0Q,!T[3F?;Q<
M2I,7T@7U0);#WCA%[]!D:;07]$B5>C<"XH5Q+*SIVJ33!>(+/=%!T)42BW-,
M1=SU_018K+E'AE*+3*O0G,!IS_W0W2TPD40>^:GHM2$J0\7188^<M,=U(UYZ
MM%/N5/&EE!=<ZGC^3D(L93;)*6F3D^5^+&44/JY@]^3WOK(Z13YRSCJN8I4T
M# ]F"48 ?:!#$:4.;;0B5Q.P$X(_BWS3.SK-#M0EX1Q(W"Z-;L*F94.#,S20
M_GD*QN3\@/ M,)"[8:^J:Y>*[)SJE2_HVJDB3Z71(FR*$95G[BNHQ8RW!_'N
M35/D:/!E1#V[E.1KO\3'SY.;O9;XO"7O-8"\^-%73-_H)^/URY/*]U@4U]P-
M9#:7$(J6,JYB83TL/3\,=:_BMFKRO:WK#!69%1H^9&-@&1E@YWR=!762+DT<
M$%#GT, R6[3M;=2!;EB6/'N3@S!31!_1_1"U92;=B\6K (H<H0(>YE&FKP)=
MBK?ZK8>*: 6O*?LS'KXXK;AU^ &QSXBR!\'N-2%J;LMD=VS2:?9_BL@BJVNY
M3+?B, ,VI59BM8 GHW+9NPQ$-@,V"'EL M*]T;ZX064!J$*9,G2BPD*I6,*Y
M-5*.9P(5NP4,479F]'_BZ$'NZRZIU](SW3\-:3+?6+4/>K\K5<K-^-<S'X^,
M/S%UWW8_T(WB[U*KY?'7/33_"+H7I9IBZ^'^NS>#>*O3/@1;\Z]4$QN"K?AC
MH20\1 OP?FK1L:<'.J#[V?+\OU!+ P04    " !-@9Q6<ILWT$X#  #4!P
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M6:*RK(=NL]M<69-Z4C^*U_<=U?>:4Q %9J3:;IWW M#U'5(OK"K]W%XI2[>
M?\WIVD7M!.@\4\KN%LY <Y&/?P%02P,$%     @ 38&<5B'<9(\T!   S@L
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M2].D$=;&U3LLE1Z1( PJA@AZ9-7N0OR:U&9V6(C!GK[]\26V$ R+S?)(X@F
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MR#2Z&%)&=7O?M!NK:C_CM\I2*OPK=4J.VBG0]YU2]KAQ!_27_N1O4$L#!!0
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MU9R<GUV0,^(3G5(%FC!!'@4S^DMMXHYQCIN"<V?UX=@WB&@7\N,]SDV)$Y[
MB<B=%";59"$22-[[^RBMTA>^ZKL)6P/>475)HN +"3MAU,!S^^_=PQ:<J$IW
MY.)%)^+-,ED(HPDU1K&GPM G#L1(\D<!VI YHQLAM6&Q_OQI$ ;]:Q+++,/3
MCN<@?DXE3T#I45-:RV6OFI>UM6"D<QK#Q,./78/:@C?]_"GH=:Z;<O*+@KW+
MT%65H:NVZ--[+%U,H&SX.$E-B2BC]UQT6\.V4]RZL;^MZSNVB;K=RN8==K?"
M[K9B_PY:C\B"*L'$!O>7<QE3 XGESJE"6I93@^^(AKA0S#!HQ"]7Z=;0@@/X
M-HMWZ+T*O=>*_@:]Q<_^_YQ(XMX%U[:@LIA0D9"$\<(<?L&EQ%[##AV*/+:)
MNE?-,ON5S'ZKS)^NHN..T"THO*$J(645PRM.&R2W6_2U%-($WS_.?G!XO)IL
MALWP@PI^T J_LMDF,K=7GW8)SD&Y2US$4$H@A:W*3<R##\_4L478S#NL>(>_
M+MDM9V78D,KH +[!)CSQ202=MVNQTRK@QIWD<[S,$LDYQ3.."2_Q+QJOM3)<
MOTYQ.3@@;3 *+X?]$ZRU*SQH99V7^?LOM$$#;?\(]]@*<4^<C"!\PPU;<6?"
M,+?EV+_5JB&!EY@7>.N3M9*9/3 YEG[7Z\DU@=<B50DCYQQK+C$I%<T:PP^/
M?:M)J<ZOM589J(WK.#72X35>=B'5;-75SEPO=S!_8[M=U[*]A2E;9>PQ-@R_
M:@YK#-FY["./*KO/<F!D[AJX)VFP'72/*7;LH*P!OE]+:5X'=H'J?X#I/U!+
M P04    " !-@9Q6FD3M;*<#  "-$0  &0   'AL+W=O<FMS:&5E=',O<VAE
M970S,2YX;6RU6%UOXC@4_2M6=K2:D:;-%]"/A4@MZ>X@34<(:.=AM0\FN01K
MDIBU#73^_=A.FB:01F7DOD#L^!S?<^+K^&:XI^P'7P,(])2E.1]9:R$VU[;-
MHS5DF)_3#>3RSHJR# O99(G--PQPK$%9:GN.,[ S3'(K&.J^*0N&="M2DL.4
M(;[-,LQ^WD)*]R/+M9X[9B19"]5A!\,-3F .XF$S9;)E5RPQR2#GA.:(P6ID
MW;C7H>LK@![Q2&#/:]=(25E2^D,U)O'(<E1$D$(D% 66?SL80YHJ)AG'_R6I
M5<VI@/7K9_:_M7@I9HDYC&GZG<1B/;(N+13#"F]3,:/[+U *ZBN^B*9<_Z)]
M.=:Q4+3E@F8E6$:0D;SXQT^E$36 Y&D'>"7 .P3T7@'X)<!_*Z!7 GK:F4**
M]B'$ @=#1O>(J=&235UH,S5:RB>Y>NYSP>1=(G$BF-W-%[.'\>)A-OGV#[H9
M+R:/D\7D;HX^AB P2?DG=(8F^8XDE&$!:,IHPG F.Q_F(?KXX1/Z@$B.[DF:
MRL?(A[:002EJ.RH#N"T"\%X)P$?W-!=KCN[R&.(FWI9B*D7>LZ);KY/P'K-S
MY+N?D>=X?DL\X[?#O19XV T/(7H-WE#C5\_'UWS^:\\'N&#;2&P9R1,TIEP@
MG,=(=@/; ?KWJQR/)@(R_E^;]P5YKYU<[2G7?(,C&%ERT]",5O#G'^[ ^:O-
M.)-DH2&RAJF]RM1>%WLP97 F\)/<M^KF1FO,$FA=P@7=0-.IG707N/VAO:N;
M<SS$:XX(.V/Z3<7]2G&_4_%-%-%M+CB:XI]XF8)>1+*3;2%&7PE>DI0(TBZ^
MD_G4-622+#1$UG!T4#DZ>,_$')@TU219:(BL8>I%9>I%YS)MFEKRM]E7T/1K
MV>9?'B1DYTRGFG)QE-V]7C5?0^IE)?6R4ZI>,72%U-0D:L^\3H93%XE)LM 0
M6<.YJ\JYJ_?,O"N3IIHD"PV1-4QUG9>#H-.Y(!=4X/3MK\22K9Z"5P<9V#+$
M/7@G=L?TNYIKAU^W4_-<UAM2YV>40 Y,RE<+"<?RG$VD#5B5)*W:.UE/74-&
MV4)3;$U'O1='O?=,SI+=E+,FV4)3;$UG7PH!M_-(?')^^D>OK,%A?AX/.<I/
MH\=TNU:G9B C5_4^1_IH6A1X56_U3>%&5]('_;?N];CX,O!"4WRHD.5;0G*.
M4EA)2N?\0NX^K*C]BX:@&UT-+ZF0M;6^7 ..@:D!\OZ*4O'<4!-47V""7U!+
M P04    " !-@9Q6$BS/.I4%  #7'P  &0   'AL+W=O<FMS:&5E=',O<VAE
M970S,BYX;6S%F5US&C<4AO^*AF8ZR8R319(!.\7,X*_6,W;CFCB]Z/1"+,)H
MLJR()'#:7]^CA:Q8I!4.A<F-S2[O.?OJZ.-!VNZS5)_UA'.#ODZS7)\U)L;,
MWB>)3B=\RO0[.>,Y?#.6:LH,7*JG1,\49Z,B:)HEI-EL)U,F\D:O6]R[5[VN
MG)M,Y/Q>(3V?3IGZYYQG\OFL@1O?;CR(IXFQ-Y)>=\:>^(";Q]F]@JNDS#(2
M4YYK(7.D^/BLT<?O+^BI#2@4GP1_UFN?D6W*4,K/]N)F=-9H6D<\XZFQ*1C\
M6_ +GF4V$_CXLDK:*)]I ]<_?\M^730>&C-DFE_([$\Q,I.SQDD#C?B8S3/S
M()]_XZL&M6R^5&:Z^(N>5]IF Z5S;>1T%0P.IB)?_F=?5X58"\#'-0%D%4!>
M&D!7 ;1HZ-)9T:Q+9EBOJ^0S4E8-V>R'HC9%-+1&Y+8;!T;!MP+B3.^Z?_.
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MZ3+5MV+]!0I!7<,7BU39?[+.^_8]A\1+I456@'$$&>/YDSX61FP!D*<:$!2
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M.W(LX21=D\[XS2NCKW]J<Q<DS(*$V9 P!Q+F0L(\(%C#L:>U8T]5]+$5KL.
MT("CA*3(9W$L!_.BEVSSG9)UK.]*V*" Y=.;]5@_&1@C;;WKI[9$_7XSD7U(
M(N>01.XAB3R@I]!HKU[=7CUE>UT$09A/N'"$<,PR*A#.Q(JEX3_[0U'98B6M
MOU,A0]_^-:LU469\;#\ ";,A80XDS(6$>4"PAJ_ZM:_Z2E_-\U=>+@22+/57
M<AY>VPJ+<H60KT'R,0JOY40K'[S:W*;,X]C^H?^S=;OMUK4@\[4A80XDS(6$
M>4"PAML&M=L&2K?=52[C^41)R/4NS](GQ/,9TWNTQE'6ZBXE\UAW0<(L2)@-
M"7,@8>[@IS>RVVM](3V@;!OF&M;F&BK--2,AYQFF?C$-KU9\"Y8B$B<1>R($
M/1)*%J% 281IF]&4_&.-5L*&S6G.7O\%F:$-"7,@86[;H^CM.0<HPX9S/M;.
M^:ATSL,-YAQ]9J&<5GTE5&3MLV EY%A[0,(L2)@-"7,@82XDS ."-0QGZ,^A
M+_V7B!A4Q0 R+2C- J79H#0'E.:"TCPH6M.Z.U%;0]E;WFZH-.HJ3/+0@2^[
M2[R40^L3HDV+LB)9JR>5_*,]"4FS0&DV*,T!I;F@-*^BY=;<&>2-X<=ZF&^Z
MS7QVFZETV_UVE3 O5PE8H GCHM572M+1OH*D6: T&Y3F@-)<4)H'16NZ[SFN
M;_P:@7T#-+(/2K- :38HS0&EN: T#XK6M.YS@-]01_@5L98/U>JXU8F@L?Z*
MUML=%?;6P* 9VJ T!Y3F5K3==;!YLO^1 2K+IFN>/S,8ZN\,_R]"IX8>;1K0
M+Q*@-!N4YH#27./GCSXOQ>F@,BY=INWL 8E)NBSV W'DY]^IRNT0]=5ZS]%%
ML=-F[_K$.'/+G4//F'(CTPU.ER'E*"(+B=1/!K(":;DWJ#P1+"EVFCPR(5A<
M'*X(EF-UGD#>7S FMB=Y!O4.K?&_4$L#!!0    ( $V!G%;;3II,J00  .@1
M   9    >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;*U8VV[;.!#]%<);%"W0
M1B+E6US;@.,D2(%D&^2R?5CL RW1-E%)5$7:3OOU.Y0<R18IU@7Z8HO2S/#,
MX>5P.-Z)_)M<,Z;02Q*G<M)9*Y6-/$^&:Y90>28REL*7I<@3JJ"9KSR9Y8Q&
MA5,2>\3W^UY">=J9CHMW]_ET+#8JYBF[SY'<) G-?URP6.PF'=QY??' 5VNE
M7WC3<497[)&IY^P^AY9718EXPE+)18IRMIQT9G@T)T0[%!;_<+:3!\](I[(0
MXIMN?(XF'5\C8C$+E0Y!X6_+YBR.=23 \7T?M%/UJ1T/GU^C7Q?)0S(+*ME<
MQ%]YI-:3SK"#(K:DFU@]B-T-VR?4T_%"$<OB%^U*VP'T&&ZD$LG>&=H)3\M_
M^K(GXL !XM@=R-Z!-!VZ+0[!WB$H$BV1%6E=4D6GXUSL4*ZM(9I^*+@IO"$;
MGNIA?%0Y?.7@IZ:/S_?WMU=W5W\_S6[1?/9X@ZYOOWQ%;VF2?4)?GFZN'M#E
M[&F&WETR17DLWZ./Z/GQ$KU[\QZ]03Q%=SR.83SDV%, 1P?UPGW7%V77I*7K
M -V)5*TENDHC%AW[>Y!&E0MYS>6". />T?P,!?@#(CX)+'CFI[L3!YR@HC8H
MX@5MU&ZR+&8PY16-T9S*-;J&18.NRG<2_3M;2)7#//[/QET9NVN/K1?W2&8T
M9),.K%[)\BWK3-_^A?O^)UOB?RC8$0W=BH:N*_KTDD'0D--BU;(7V'\DLR5<
M1ND74?3FLYT.\=C;'J9AF@S.*Y,C<+T*7,\);I:(7/&?OP171ND=]$SZ#7 6
MDX$=7+\"US^=.9I&B)Z(MF] P?Z@ ==FT[?C'51X!TZ\GU/%8/XH%[2!T>W'
MH G-;7,$;5A!&YX&C:>A2*S(AN;X-7"9%KX=U7F%ZORW"/N 4J9LV,XMC/0:
MZ&PV+:QAOU8'_S2$&>61=8OWC6Z#)F]NFV-D![J%?X%,#R12](7)=G38[#EH
MHC-M2-""CM3HB'M?"4.QT9M\1G_01<P0E5+HI<PB$'BU1B'-N-:%8N0CKC;
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MANSZ)(&B$2BT)IVZ \"G[  P: < BD:@T)K$Z@X 0W8 V*KM?2/WYBW+S!;
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M<:W*YNC/NC]'\T]02P$"% ,4    " !-@9Q6!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( $V!G%9M
M\R8)[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( $V!G%:97)PC$ 8  )PG   3              "  <P!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ 38&<5N H9)_&!0
MP!X  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( $V!G%:V^A''?P4  .,6   8              " @0D.
M  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " !-@9Q6"BDJ
MQ%,#   ^"@  &               @(&^$P  >&PO=V]R:W-H965T<R]S:&5E
M=#,N>&UL4$L! A0#%     @ 38&<5HK<E>Z$!@  ^1L  !@
M ("!1Q<  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( $V!
MG%:C>86&W0(  /D'   8              " @0$>  !X;"]W;W)K<VAE971S
M+W-H965T-2YX;6Q02P$"% ,4    " !-@9Q6/;[9\VL&  #=&P  &
M        @($4(0  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%
M  @ 38&<5JJ,Y;D,"@  5F   !@              ("!M2<  'AL+W=O<FMS
M:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( $V!G%:>KL>$%0(  -8$   8
M              " @?<Q  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"
M% ,4    " !-@9Q6O_139@,(  "Q%   &               @(%"-   >&PO
M=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ 38&<5EH%;@B0 P
MCP@  !D              ("!>SP  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX
M;6Q02P$"% ,4    " !-@9Q6(SYH"%$%  #J#   &0              @(%"
M0   >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( $V!G%;W
MM766+P,  -T&   9              " @<I%  !X;"]W;W)K<VAE971S+W-H
M965T,3(N>&UL4$L! A0#%     @ 38&<5@2$R(=5"0  71P  !D
M     ("!,$D  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $V!G%;P() ^ZQ(  %4V   9              "
M@7)I  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ 38&<
M5A[TX4(S!P  (A(  !D              ("!E'P  'AL+W=O<FMS:&5E=',O
M<VAE970Q.2YX;6Q02P$"% ,4    " !-@9Q6^]J$8'0%  #W#   &0
M        @('^@P  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0
M   ( $V!G%;@6M@2E@(  /$%   9              " @:F)  !X;"]W;W)K
M<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ 38&<5JG,FR^U!   + H
M !D              ("!=HP  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q0
M2P$"% ,4    " !-@9Q6Q)C:*+\*  #"'   &0              @(%BD0
M>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( $V!G%9RFS?0
M3@,  -0'   9              " @5B<  !X;"]W;W)K<VAE971S+W-H965T
M,C0N>&UL4$L! A0#%     @ 38&<5B'<9(\T!   S@L  !D
M ("!W9\  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " !-
M@9Q6AV[EDC4#   &!P  &0              @(%(I   >&PO=V]R:W-H965T
M<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( $V!G%8Q6KP"L ,  &((   9
M          " @;2G  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#
M%     @ 38&<5AIH^HU_!0  2 T  !D              ("!FZL  'AL+W=O
M<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " !-@9Q6)(Z@!U,#
M"   &0              @(%1L0  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM
M;%!+ 0(4 Q0    ( $V!G%;^-J)1V ,   \,   9              " @=NT
M  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ 38&<5II$
M[6RG P  C1$  !D              ("!ZK@  'AL+W=O<FMS:&5E=',O<VAE
M970S,2YX;6Q02P$"% ,4    " !-@9Q6$BS/.I4%  #7'P  &0
M    @('(O   >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    (
M $V!G%:3A2:[YP(  )P&   9              " @93"  !X;"]W;W)K<VAE
M971S+W-H965T,S,N>&UL4$L! A0#%     @ 38&<5C/X"\SJ @  * H  !D
M             ("!LL4  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"
M% ,4    " !-@9Q6N#VH\3\#  "F#@  &0              @('3R   >&PO
M=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( $V!G%:6,BE+:@(
M !,&   9              " @4G,  !X;"]W;W)K<VAE971S+W-H965T,S8N
M>&UL4$L! A0#%     @ 38&<5NG@[MUY!0  K24  !D              ("!
MZLX  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " !-@9Q6
MVTZ:3*D$  #H$0  &0              @(&:U   >&PO=V]R:W-H965T<R]S
M:&5E=#,X+GAM;%!+ 0(4 Q0    ( $V!G%8'AN=_F 4  *\P   9
M      " @7K9  !X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%
M  @ 38&<5D"T)!)Y!@  QR8  !D              ("!2=\  'AL+W=O<FMS
M:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    " !-@9Q6 &]#9>H%  !2+@
M&0              @('YY0  >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+
M 0(4 Q0    ( $V!G%9>G&,4EP(  &0&   9              " @1KL  !X
M;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ 38&<5GK:<>R=
M P  TQ(  !D              ("!Z.X  'AL+W=O<FMS:&5E=',O<VAE970T
M,RYX;6Q02P$"% ,4    " !-@9Q6R@F!ES(#   D$P  #0
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:+GAM;%!+!08     ,P S -P-  #M_@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>129</ContextCount>
  <ElementCount>208</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>46</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS</Role>
      <ShortName>DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - RESTRUCTURING ACTIVITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIES</Role>
      <ShortName>RESTRUCTURING ACTIVITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - BUSINESS ACQUISITIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSACQUISITIONS</Role>
      <ShortName>BUSINESS ACQUISITIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST</Role>
      <ShortName>STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - BUSINESS SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - REVENUE RECOGNITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITION</Role>
      <ShortName>REVENUE RECOGNITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - TAXES ON INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/TAXESONINCOME</Role>
      <ShortName>TAXES ON INCOME</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTS</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - REVENUE RECOGNITION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITIONTables</Role>
      <ShortName>REVENUE RECOGNITION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/REVENUERECOGNITION</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - EARNINGS PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSPERSHAREDetails</Role>
      <ShortName>EARNINGS PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/EARNINGSPERSHARETables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - RESTRUCTURING ACTIVITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails</Role>
      <ShortName>RESTRUCTURING ACTIVITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIES</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Assets and Liabilities Unobservable Inputs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Assets and Liabilities Unobservable Inputs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - DEBT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DEBTDetails</Role>
      <ShortName>DEBT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/DEBT</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails</Role>
      <ShortName>STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - REVENUE RECOGNITION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITIONDetails</Role>
      <ShortName>REVENUE RECOGNITION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/REVENUERECOGNITIONTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - TAXES ON INCOME (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/TAXESONINCOMEDetails</Role>
      <ShortName>TAXES ON INCOME (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/TAXESONINCOME</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="dgx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - SUBSEQUENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails</Role>
      <ShortName>SUBSEQUENT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUBSEQUENTEVENTS</ParentRole>
      <Position>43</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept TreasuryStockShares in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. dgx-20230331.htm 4</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept TreasuryStockMember in us-gaap/2022 used in 14 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. dgx-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="dgx-20230331.htm">dgx-20230331.htm</File>
    <File>dgx-20230331.xsd</File>
    <File>dgx-20230331_cal.xml</File>
    <File>dgx-20230331_def.xml</File>
    <File>dgx-20230331_lab.xml</File>
    <File>dgx-20230331_pre.xml</File>
    <File>dgx03312023ex22.htm</File>
    <File>dgx03312023ex311.htm</File>
    <File>dgx03312023ex312.htm</File>
    <File>dgx03312023ex321.htm</File>
    <File>dgx03312023ex322.htm</File>
    <File>dgx03312023ex991.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="472">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>63
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dgx-20230331.htm": {
   "axisCustom": 0,
   "axisStandard": 21,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 472,
    "http://xbrl.sec.gov/dei/2022": 29
   },
   "contextCount": 129,
   "dts": {
    "calculationLink": {
     "local": [
      "dgx-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "dgx-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "dgx-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dgx-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dgx-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "dgx-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 354,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 5
   },
   "keyCustom": 11,
   "keyStandard": 197,
   "memberCustom": 22,
   "memberStandard": 24,
   "nsprefix": "dgx",
   "nsuri": "http://questdiagnostics.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://questdiagnostics.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - EARNINGS PER SHARE",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://questdiagnostics.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - RESTRUCTURING ACTIVITIES",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIES",
     "shortName": "RESTRUCTURING ACTIVITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - BUSINESS ACQUISITIONS",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://questdiagnostics.com/role/BUSINESSACQUISITIONS",
     "shortName": "BUSINESS ACQUISITIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - FAIR VALUE MEASUREMENTS",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - DEBT",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://questdiagnostics.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - FINANCIAL INSTRUMENTS",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTS",
     "shortName": "FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST",
     "shortName": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - BUSINESS SEGMENT INFORMATION",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION",
     "shortName": "BUSINESS SEGMENT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - REVENUE RECOGNITION",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITION",
     "shortName": "REVENUE RECOGNITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - TAXES ON INCOME",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://questdiagnostics.com/role/TAXESONINCOME",
     "shortName": "TAXES ON INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - SUBSEQUENT EVENTS",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://questdiagnostics.com/role/SUBSEQUENTEVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "menuCat": "Policies",
     "order": "23",
     "role": "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - EARNINGS PER SHARE (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://questdiagnostics.com/role/EARNINGSPERSHARETables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - FINANCIAL INSTRUMENTS (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables",
     "shortName": "BUSINESS SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - REVENUE RECOGNITION (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITIONTables",
     "shortName": "REVENUE RECOGNITION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - EARNINGS PER SHARE (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails",
     "shortName": "EARNINGS PER SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0eb006769543403b857f1208edc96f39_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - RESTRUCTURING ACTIVITIES (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails",
     "shortName": "RESTRUCTURING ACTIVITIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0eb006769543403b857f1208edc96f39_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "ia15188e0ab8642c396b4a96aebce5582_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "ia15188e0ab8642c396b4a96aebce5582_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "iee1c43167736475396bb0f00c1706266_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Assets and Liabilities Unobservable Inputs) (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Assets and Liabilities Unobservable Inputs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "iee1c43167736475396bb0f00c1706266_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i62a8002be6c545879eef8e9350936b33_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i62a8002be6c545879eef8e9350936b33_I20230331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i9c4b1b27b14f4358b79dcebe17500b25_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - DEBT (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://questdiagnostics.com/role/DEBTDetails",
     "shortName": "DEBT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DebtInstrumentCarryingAmount",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i9c4b1b27b14f4358b79dcebe17500b25_I20230331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "ibef99765bb424b0a98ea7a9577ad7abd_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
     "shortName": "FINANCIAL INSTRUMENTS (Balance Sheets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "ibef99765bb424b0a98ea7a9577ad7abd_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails",
     "shortName": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i62a8002be6c545879eef8e9350936b33_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MalpracticeLossContingencyAccrualUndiscounted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i62a8002be6c545879eef8e9350936b33_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MalpracticeLossContingencyAccrualUndiscounted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i62a8002be6c545879eef8e9350936b33_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i62a8002be6c545879eef8e9350936b33_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dgx:PercentageofNetRevenues",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
     "shortName": "BUSINESS SEGMENT INFORMATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "dgx:RevenueFromContractWithCustomerExcludingAssessedTaxPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dgx:PercentageofNetRevenues",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - REVENUE RECOGNITION (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
     "shortName": "REVENUE RECOGNITION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i62a8002be6c545879eef8e9350936b33_I20230331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "dgx:PercentageofNetAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - TAXES ON INCOME (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://questdiagnostics.com/role/TAXESONINCOMEDetails",
     "shortName": "TAXES ON INCOME (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - SUBSEQUENT EVENTS (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails",
     "shortName": "SUBSEQUENT EVENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i9b19a5afa8014eac9ccbf727527f2ea6_D20230417-20230417",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i62a8002be6c545879eef8e9350936b33_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i62a8002be6c545879eef8e9350936b33_I20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetCreditLossExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i2868e6f7df8844f0be25707868867359_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i2868e6f7df8844f0be25707868867359_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - DESCRIPTION OF BUSINESS",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS",
     "shortName": "DESCRIPTION OF BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20230331.htm",
      "contextRef": "i0f5c05955a0747c39ecf4e3c799c39d3_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 46,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dgx_A401kPlanLawsuitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "401(k) Plan Lawsuit",
        "label": "401(k) Plan Lawsuit [Member]",
        "terseLabel": "401(k) Plan Lawsuit"
       }
      }
     },
     "localname": "A401kPlanLawsuitMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_AccountsReceivableDisaggregationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable Disaggregation [Table Text Block]",
        "label": "Accounts Receivable Disaggregation [Table Text Block]",
        "terseLabel": "Accounts Receivable Disaggregation"
       }
      }
     },
     "localname": "AccountsReceivableDisaggregationTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_AllotherservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All other services [Member]",
        "label": "All other services [Member]",
        "terseLabel": "All other services"
       }
      }
     },
     "localname": "AllotherservicesMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_AnatomicpathologytestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anatomic pathology testing services [Member]",
        "label": "Anatomic pathology testing services [Member]",
        "terseLabel": "Anatomic pathology testing services"
       }
      }
     },
     "localname": "AnatomicpathologytestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_COVID19TestingServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19 Testing Services",
        "label": "COVID-19 Testing Services [Member]",
        "terseLabel": "COVID-19 Testing Services"
       }
      }
     },
     "localname": "COVID19TestingServicesMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_CapitatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitated [Member]",
        "label": "Capitated [Member]",
        "terseLabel": "Capitated"
       }
      }
     },
     "localname": "CapitatedMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ClientPayersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Client Payers [Member]",
        "label": "Client Payers [Member]",
        "terseLabel": "Client Payers"
       }
      }
     },
     "localname": "ClientPayersMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration [Member]",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent Consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_DSBusinessesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DS Businesses [Member]",
        "label": "DS Businesses [Member]",
        "terseLabel": "DS Businesses"
       }
      }
     },
     "localname": "DSBusinessesMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_DataSecurityIncidentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Data Security Incident",
        "label": "Data Security Incident [Member]",
        "terseLabel": "Data Security Incident"
       }
      }
     },
     "localname": "DataSecurityIncidentMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_DescriptionOfBusinessAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of Business (Abstract)",
        "label": "Description of Business (Abstract)",
        "terseLabel": "Description of Business (Abstract)"
       }
      }
     },
     "localname": "DescriptionOfBusinessAbstract",
     "nsuri": "http://questdiagnostics.com/20230331",
     "xbrltype": "stringItemType"
    },
    "dgx_DiagnosticInformationServicesBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostic Information Services Business [Member]",
        "label": "Diagnostic Information Services Business [Member]",
        "terseLabel": "DIS business"
       }
      }
     },
     "localname": "DiagnosticInformationServicesBusinessMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ExcludesgeneralandprofessionalliabilityclaimsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excludes general and professional liability claims [Member]",
        "label": "Excludes general and professional liability claims [Member]",
        "terseLabel": "Excludes general and professional liability claims"
       }
      }
     },
     "localname": "ExcludesgeneralandprofessionalliabilityclaimsMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FairValueOfNetAssetsAcquired": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of net assets acquired",
        "label": "Fair value of net assets acquired",
        "totalLabel": "Fair value of net assets acquired"
       }
      }
     },
     "localname": "FairValueOfNetAssetsAcquired",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_FeeforserviceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fee-for-service [Member]",
        "label": "Fee-for-service [Member]",
        "terseLabel": "Fee-for-service"
       }
      }
     },
     "localname": "FeeforserviceMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_GenebasedandesoterictestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gene-based and esoteric testing services [Member]",
        "label": "Gene-based and esoteric testing services [Member]",
        "terseLabel": "Gene-based and esoteric testing services"
       }
      }
     },
     "localname": "GenebasedandesoterictestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_GovernmentPayersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Payers [Member]",
        "label": "Government Payers [Member]",
        "terseLabel": "Government Payers"
       }
      }
     },
     "localname": "GovernmentPayersMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_HaystackOncologyIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Haystack Oncology, Inc.",
        "label": "Haystack Oncology, Inc. [Member]",
        "terseLabel": "Haystack Oncology, Inc."
       }
      }
     },
     "localname": "HaystackOncologyIncMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_HealthcareInsurersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Healthcare Insurers [Member]",
        "label": "Healthcare Insurers [Member]",
        "terseLabel": "Healthcare Insurers"
       }
      }
     },
     "localname": "HealthcareInsurersMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_InvigorateProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Invigorate Program [Member]",
        "label": "Invigorate Program [Member]",
        "terseLabel": "Invigorate Program"
       }
      }
     },
     "localname": "InvigorateProgramMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_Mergerconsiderationpaidpayablenet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merger consideration paid (payable), net",
        "label": "Merger consideration paid (payable), net",
        "terseLabel": "Merger consideration payable"
       }
      }
     },
     "localname": "Mergerconsiderationpaidpayablenet",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss), Excluding Redeemable Noncontrolling Interest",
        "label": "Net Income (Loss), Excluding Redeemable Noncontrolling Interest",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLossExcludingRedeemableNoncontrollingInterest",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_NewYorkPresbyterianMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New York-Presbyterian",
        "label": "New York-Presbyterian [Member]",
        "terseLabel": "New York-Presbyterian"
       }
      }
     },
     "localname": "NewYorkPresbyterianMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_PatientsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patients [Member]",
        "label": "Patients [Member]",
        "terseLabel": "Patients (including coinsurance and deductible responsibilities)"
       }
      }
     },
     "localname": "PatientsMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_PercentageofNetAccountsReceivable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Net Accounts Receivable",
        "label": "Percentage of Net Accounts Receivable",
        "terseLabel": "Net accounts receivable"
       }
      }
     },
     "localname": "PercentageofNetAccountsReceivable",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_PercentageofNetRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Net Revenues",
        "label": "Percentage of Net Revenues",
        "terseLabel": "Percentage of net revenues"
       }
      }
     },
     "localname": "PercentageofNetRevenues",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_RevenueFromContractWithCustomerExcludingAssessedTaxPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from Contract with Customer, Excluding Assessed Tax, Percent",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax, Percent",
        "terseLabel": "Total net revenues, percent"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTaxPercent",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_RoutineclinicaltestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Routine clinical testing services",
        "label": "Routine clinical testing services [Member]",
        "terseLabel": "Routine clinical testing services"
       }
      }
     },
     "localname": "RoutineclinicaltestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Revenues by Major Service",
        "label": "Schedule of Revenues by Major Service [Table Text Block]",
        "terseLabel": "Schedule of Revenues by Major Service"
       }
      }
     },
     "localname": "ScheduleOfRevenuesByMajorServiceTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]",
        "label": "Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt"
       }
      }
     },
     "localname": "ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]",
        "label": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]",
        "terseLabel": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]",
        "label": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]",
        "terseLabel": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_SeniorunsecuredrevolvingcreditfacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior unsecured revolving credit facility [Member]",
        "label": "Senior unsecured revolving credit facility [Member]",
        "terseLabel": "Senior Unsecured Revolving Credit Facility"
       }
      }
     },
     "localname": "SeniorunsecuredrevolvingcreditfacilityMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_StockRepurchaseProgramAdditionalAmountAuthorized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Program, Additional Amount Authorized",
        "label": "Stock Repurchase Program, Additional Amount Authorized",
        "terseLabel": "Additional amount authorized"
       }
      }
     },
     "localname": "StockRepurchaseProgramAdditionalAmountAuthorized",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "label": "Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_UMassJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UMass Joint Venture [Member]",
        "label": "UMass Joint Venture [Member]",
        "terseLabel": "UMass Joint Venture"
       }
      }
     },
     "localname": "UMassJointVentureMember",
     "nsuri": "http://questdiagnostics.com/20230331",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r316",
      "r317",
      "r318",
      "r319",
      "r390",
      "r463",
      "r481",
      "r489",
      "r490",
      "r502",
      "r510",
      "r516",
      "r558",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r275",
      "r464",
      "r504",
      "r515",
      "r553",
      "r554",
      "r559",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r275",
      "r464",
      "r504",
      "r515",
      "r553",
      "r554",
      "r559",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r316",
      "r317",
      "r318",
      "r319",
      "r383",
      "r390",
      "r394",
      "r395",
      "r396",
      "r462",
      "r463",
      "r481",
      "r489",
      "r490",
      "r502",
      "r510",
      "r516",
      "r548",
      "r558",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r316",
      "r317",
      "r318",
      "r319",
      "r383",
      "r390",
      "r394",
      "r395",
      "r396",
      "r462",
      "r463",
      "r481",
      "r489",
      "r490",
      "r502",
      "r510",
      "r516",
      "r548",
      "r558",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r219",
      "r391",
      "r523",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r219",
      "r391",
      "r523",
      "r524",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.",
        "label": "Accounts Payable and Accrued Liabilities [Member]",
        "terseLabel": "Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r280",
      "r281"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for credit losses of $30 as of both March\u00a031, 2023 and December\u00a031, 2022"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r174",
      "r474",
      "r486",
      "r487"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r21",
      "r24",
      "r106",
      "r455",
      "r482",
      "r483",
      "r527",
      "r528",
      "r529",
      "r539",
      "r540",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r5"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r397",
      "r398",
      "r399",
      "r539",
      "r540",
      "r541",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedLabel": "Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r91",
      "r92",
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r247",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "All other operating segments"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r175",
      "r282",
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r43",
      "r66",
      "r68"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DepreciationDepletionAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense",
        "verboseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share (less than)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r140",
      "r154",
      "r172",
      "r201",
      "r259",
      "r265",
      "r271",
      "r284",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r422",
      "r426",
      "r441",
      "r514",
      "r556",
      "r557",
      "r565"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r167",
      "r177",
      "r201",
      "r284",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r422",
      "r426",
      "r441",
      "r514",
      "r556",
      "r557",
      "r565"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r62",
      "r283",
      "r288",
      "r466"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "verboseLabel": "Available-for-sale debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r116",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r417",
      "r508",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r94",
      "r95",
      "r417",
      "r508",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Maximum contingent consideration payment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r96",
      "r97",
      "r420"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r99",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "BUSINESS ACQUISITIONS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r47",
      "r48",
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accounts payable associated with capital expenditures"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r34"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "verboseLabel": "Less: Cash acquired"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r45",
      "r169",
      "r491"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r39",
      "r45",
      "r50"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents and restricted cash, end of period",
        "periodStartLabel": "Cash and cash equivalents and restricted cash, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r39",
      "r135"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect [Abstract]",
        "terseLabel": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "SUPPLEMENTAL CASH FLOW &amp; OTHER DATA"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashSurrenderValueFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).",
        "label": "Cash Surrender Value, Fair Value Disclosure",
        "terseLabel": "Cash surrender value of life insurance policies"
       }
      }
     },
     "localname": "CashSurrenderValueFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r15",
      "r145",
      "r160"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r71",
      "r313",
      "r314",
      "r488",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends per common share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r539",
      "r540",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r4",
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance, shares",
        "periodStartLabel": "Balance, shares"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r4",
      "r514"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.01 per share; 600 shares authorized as of both March\u00a031, 2023 and December\u00a031, 2022; 162 shares issued as of both March\u00a031, 2023 and December\u00a031, 2022"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r25",
      "r180",
      "r182",
      "r190",
      "r470",
      "r478"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to Quest Diagnostics"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r103",
      "r104",
      "r109",
      "r180",
      "r182",
      "r189",
      "r469",
      "r477"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r102",
      "r109",
      "r180",
      "r182",
      "r188",
      "r468",
      "r476"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetCreditLossExpense": {
     "auth_ref": [
      "r287",
      "r379",
      "r503"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, Credit Loss Expense (Reversal)",
        "terseLabel": "Credit for credit losses"
       }
      }
     },
     "localname": "ContractWithCustomerAssetCreditLossExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateMember": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate Segment [Member]",
        "terseLabel": "General corporate activities"
       }
      }
     },
     "localname": "CorporateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r30",
      "r201",
      "r284",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r441",
      "r556"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of services"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Operating costs and expenses and other operating income:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of services"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating costs and expenses, net"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r75",
      "r199",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r345",
      "r352",
      "r353",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r1",
      "r142",
      "r153",
      "r356"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Amount outstanding"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r343",
      "r440",
      "r498",
      "r499"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value of debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r13",
      "r81",
      "r82",
      "r83",
      "r84",
      "r136",
      "r137",
      "r139",
      "r152",
      "r205",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r335",
      "r341",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r354",
      "r451",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation liabilities"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r43",
      "r93",
      "r405",
      "r410",
      "r411",
      "r538"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax benefit"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r43",
      "r69"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DepreciationDepletionAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r43",
      "r254"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "totalLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r125",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "FINANCIAL INSTRUMENTS"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r114",
      "r117",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r110",
      "r111",
      "r112",
      "r114",
      "r115",
      "r119",
      "r120",
      "r121",
      "r123",
      "r124",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r110",
      "r111",
      "r114",
      "r115",
      "r122",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r85"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r0",
      "r2",
      "r141",
      "r155"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.",
        "label": "Dividends Payable",
        "terseLabel": "Dividends payable"
       }
      }
     },
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings per share attributable to Quest Diagnostics\u2019 common stockholders:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r191",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r220",
      "r222",
      "r232",
      "r233",
      "r234",
      "r238",
      "r432",
      "r433",
      "r471",
      "r479",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r191",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r222",
      "r232",
      "r233",
      "r234",
      "r238",
      "r432",
      "r433",
      "r471",
      "r479",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r53",
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r235",
      "r236",
      "r237",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "EARNINGS (LOSS) PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r560",
      "r561"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount",
        "negatedLabel": "Share-based compensation, excess tax benefit, amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r80",
      "r163",
      "r183",
      "r184",
      "r185",
      "r206",
      "r207",
      "r208",
      "r210",
      "r216",
      "r218",
      "r240",
      "r285",
      "r369",
      "r397",
      "r398",
      "r399",
      "r406",
      "r407",
      "r431",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r448",
      "r455",
      "r482",
      "r483",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r63",
      "r260",
      "r525"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Investments in equity method investees"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r126",
      "r133",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r343",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r435",
      "r459",
      "r460",
      "r461",
      "r498",
      "r499",
      "r505",
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r129",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r434",
      "r435",
      "r436",
      "r437",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedging"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r343",
      "r384",
      "r389",
      "r435",
      "r459",
      "r505",
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted Prices in Active Markets for Identical Assets / Liabilities, Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r343",
      "r384",
      "r389",
      "r435",
      "r460",
      "r498",
      "r499",
      "r505",
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r343",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r435",
      "r461",
      "r498",
      "r499",
      "r505",
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "verboseLabel": "Significant Unobservable Inputs, Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r127",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Fair Value, Measurement Inputs"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r128"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedLabel": "Settlements"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r127"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Balance, March 31, 2023",
        "periodStartLabel": "Balance, December 31, 2022"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r343",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r459",
      "r460",
      "r461",
      "r498",
      "r499",
      "r505",
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r438",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring Basis"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r127",
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofAssetsandLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r47",
      "r48",
      "r49"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails": {
       "order": 1.0,
       "parentTag": "dgx_FairValueOfNetAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Fair Value of Assets Acquired",
        "terseLabel": "Fair value of assets acquired"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r170",
      "r289",
      "r465",
      "r496",
      "r514",
      "r546",
      "r547"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease": {
     "auth_ref": [
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.",
        "label": "Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)",
        "terseLabel": "Hedge Accounting Basis Adjustment"
       }
      }
     },
     "localname": "HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Amounts Attributable to Parent, Disclosures [Abstract]",
        "terseLabel": "Amounts attributable to Quest Diagnostics\u2019 common stockholders:"
       }
      }
     },
     "localname": "IncomeAmountsAttributableToReportingEntityDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r259",
      "r264",
      "r270",
      "r273",
      "r495"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes and equity in earnings of equity method investees"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r27",
      "r43",
      "r63",
      "r147",
      "r161",
      "r256"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "terseLabel": "Equity in earnings of equity method investees, net of taxes"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r202",
      "r402",
      "r403",
      "r404",
      "r408",
      "r412",
      "r414",
      "r415",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "TAXES ON INCOME"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOME"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r203",
      "r217",
      "r218",
      "r257",
      "r400",
      "r409",
      "r413",
      "r480"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r40",
      "r46"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other assets and liabilities, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Redeemable Non-controlling Interest [Abstract]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r223",
      "r224",
      "r225",
      "r234",
      "r393"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Stock options and performance share units"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r65",
      "r67"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndDividendIncomeOperating": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.",
        "label": "Interest and Dividend Income, Operating",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestAndDividendIncomeOperating",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r138",
      "r151",
      "r186",
      "r253",
      "r450"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "terseLabel": "Interest expense, net",
        "totalLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r193",
      "r196",
      "r197"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r176",
      "r492",
      "r514"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "verboseLabel": "Leases:"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding, amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r9",
      "r144",
      "r158",
      "r514",
      "r537",
      "r545",
      "r564"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r47",
      "r48",
      "r49"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails": {
       "order": 2.0,
       "parentTag": "dgx_FairValueOfNetAssetsAcquired",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Liabilities Assumed",
        "terseLabel": "Fair value of liabilities assumed"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r168",
      "r201",
      "r284",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r423",
      "r426",
      "r427",
      "r441",
      "r514",
      "r556",
      "r565",
      "r566"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r10"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit facility capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r15",
      "r550"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Litigation reserves"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r1"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-Term Debt and Lease Obligation",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-Term Debt [Member]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r13",
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r72",
      "r73",
      "r315",
      "r316",
      "r317",
      "r551",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r551",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Class action lawsuits"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MalpracticeLossContingencyAccrualUndiscounted": {
     "auth_ref": [
      "r550"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the accrued liability on an undiscounted basis for malpractice claims (including general and professional liability) at the end of the accounting period.",
        "label": "Malpractice Loss Contingency, Accrual, Undiscounted",
        "terseLabel": "Self-insurance reserves"
       }
      }
     },
     "localname": "MalpracticeLossContingencyAccrualUndiscounted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r19",
      "r143",
      "r157",
      "r201",
      "r284",
      "r320",
      "r322",
      "r323",
      "r324",
      "r327",
      "r328",
      "r441"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r85"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Ownership percentage by noncontrolling owners"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r241",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "DESCRIPTION OF BUSINESS"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r195"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r195"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r39",
      "r41",
      "r44"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r28",
      "r44",
      "r148",
      "r162",
      "r166",
      "r178",
      "r181",
      "r185",
      "r201",
      "r209",
      "r211",
      "r212",
      "r213",
      "r214",
      "r217",
      "r218",
      "r230",
      "r259",
      "r264",
      "r270",
      "r273",
      "r284",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r433",
      "r441",
      "r495",
      "r556"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income attributable to Quest Diagnostics",
        "totalLabel": "Net income attributable to Quest Diagnostics"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r105",
      "r108",
      "r178",
      "r181",
      "r217",
      "r218",
      "r529"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r221",
      "r226",
      "r227",
      "r228",
      "r229",
      "r231",
      "r234"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Earnings available to Quest Diagnostics\u2019 common stockholders \u2013 basic and diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Standards to be Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r100",
      "r369",
      "r539",
      "r540",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Non-operating expense, net",
        "totalLabel": "Total non-operating expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r259",
      "r264",
      "r270",
      "r273",
      "r495"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income",
        "verboseLabel": "Total operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r453"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r453"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r452"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r171"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r26",
      "r80",
      "r179",
      "r182",
      "r187",
      "r442",
      "r447",
      "r448",
      "r467",
      "r475",
      "r527",
      "r528"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive income (loss)",
        "verboseLabel": "Other comprehensive income (loss), net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedLabel": "Other operating expense, net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted": {
     "auth_ref": [
      "r231"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted",
        "terseLabel": "Less: Earnings allocated to participating securities"
       }
      }
     },
     "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r530",
      "r531"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Increase in investments and other assets"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Purchases of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r192"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Employee payroll tax withholdings on stock issued under stock-based compensation plans"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r35",
      "r419"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash paid for business acquisitions"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Business acquisitions, net of cash acquired",
        "terseLabel": "Business acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r526"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r532"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from borrowings"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r533",
      "r535"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r37",
      "r90"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r166",
      "r178",
      "r181",
      "r194",
      "r201",
      "r209",
      "r217",
      "r218",
      "r259",
      "r264",
      "r270",
      "r273",
      "r284",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r421",
      "r424",
      "r425",
      "r433",
      "r441",
      "r472",
      "r495",
      "r511",
      "r512",
      "r529",
      "r556"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r70",
      "r159",
      "r473",
      "r514"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r76",
      "r77",
      "r78",
      "r79"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "terseLabel": "Redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityFairValue": {
     "auth_ref": [
      "r76",
      "r77",
      "r78",
      "r79"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Fair Value",
        "terseLabel": "Redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r534"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedTerseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r300",
      "r302",
      "r305",
      "r311",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "RESTRUCTURING ACTIVITIES"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r43",
      "r306",
      "r308",
      "r549"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Total restructuring charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r301",
      "r302",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r302",
      "r307"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "terseLabel": "Restructuring reserve"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r6",
      "r85",
      "r156",
      "r485",
      "r487",
      "r514"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r163",
      "r206",
      "r207",
      "r208",
      "r210",
      "r216",
      "r218",
      "r285",
      "r397",
      "r398",
      "r399",
      "r406",
      "r407",
      "r431",
      "r482",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r250",
      "r251",
      "r263",
      "r268",
      "r269",
      "r275",
      "r276",
      "r278",
      "r378",
      "r380",
      "r464"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net revenues",
        "verboseLabel": "Total net revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r381",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUE RECOGITION"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r454",
      "r513"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Leased assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScenarioPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The scenario under which facts represent plans as distinct from actual.",
        "label": "Scenario, Plan [Member]",
        "terseLabel": "Plan"
       }
      }
     },
     "localname": "ScenarioPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow and Other Data"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r301",
      "r302",
      "r303",
      "r304",
      "r308",
      "r309",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r58",
      "r59",
      "r60",
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r58",
      "r59",
      "r60",
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summary of Segment Reporting Information by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Receivables Credit Facility"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "terseLabel": "Term SOFR"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r247",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r273",
      "r278",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r304",
      "r310",
      "r496",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r259",
      "r262",
      "r267",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "BUSINESS SEGMENT INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Pre-tax restructuring charges"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r52",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r165",
      "r247",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r273",
      "r278",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r304",
      "r310",
      "r496",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r18",
      "r80",
      "r163",
      "r183",
      "r184",
      "r185",
      "r206",
      "r207",
      "r208",
      "r210",
      "r216",
      "r218",
      "r240",
      "r285",
      "r369",
      "r397",
      "r398",
      "r399",
      "r406",
      "r407",
      "r431",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r448",
      "r455",
      "r482",
      "r483",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r206",
      "r207",
      "r208",
      "r240",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r3",
      "r4",
      "r80",
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under benefit plans, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued": {
     "auth_ref": [
      "r4",
      "r80",
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.",
        "label": "Stock Issued During Period, Shares, Treasury Stock Reissued",
        "terseLabel": "Reissuance of shares for employee benefit plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesTreasuryStockReissued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r3",
      "r4",
      "r85",
      "r89"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under benefit plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r18",
      "r80",
      "r85"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Share repurchase authorization remaining available"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r4",
      "r7",
      "r8",
      "r61",
      "r514",
      "r537",
      "r545",
      "r564"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Quest Diagnostics stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Quest Diagnostics stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r100",
      "r101",
      "r107",
      "r163",
      "r164",
      "r184",
      "r206",
      "r207",
      "r208",
      "r210",
      "r216",
      "r285",
      "r369",
      "r397",
      "r398",
      "r399",
      "r406",
      "r407",
      "r431",
      "r442",
      "r443",
      "r448",
      "r455",
      "r483",
      "r484",
      "r537",
      "r545",
      "r564"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance, value",
        "periodStartLabel": "Balance, value",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r88",
      "r200",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r449",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r449",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r449",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r449",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r456",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r16",
      "r201",
      "r284",
      "r441"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "periodEndLabel": "Balance, Value",
        "periodStartLabel": "Balance, Value"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of net income or loss attributable to temporary equity interest.",
        "label": "Temporary Equity, Net Income",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "TemporaryEquityNetIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradingSecurities": {
     "auth_ref": [
      "r146",
      "r173",
      "r493"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI",
        "terseLabel": "Deferred compensation trading securities"
       }
      }
     },
     "localname": "TradingSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r17",
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock, at Cost"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r17",
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r4",
      "r80",
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Purchases of treasury stock, shares",
        "terseLabel": "Purchases of treasury stock- shares"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r17",
      "r86",
      "r87"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost; 50 and 51 shares as of March\u00a031, 2023 and December\u00a031, 2022, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r80",
      "r85",
      "r86"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Purchases of treasury stock",
        "terseLabel": "Purchases of treasury stock, value"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r301",
      "r302",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r55",
      "r56",
      "r57",
      "r242",
      "r243",
      "r244",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use Of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r221",
      "r234"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in Shares)",
        "totalLabel": "Weighted average common shares outstanding - diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r220",
      "r234"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in Shares)",
        "verboseLabel": "Weighted average common shares outstanding - basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "https://asc.fasb.org/topic&trid=2155941",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.1-5)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4EE",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109999712-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "https://asc.fasb.org/topic&trid=2134446",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r517": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r518": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r519": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r521": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r522": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126970579&loc=d3e23163-113944",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>64
<FILENAME>0001022079-23-000093-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001022079-23-000093-xbrl.zip
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ME!'"$^6$C58(+EW(RY@,4*V0#N.@Y,J09AXQS^F1B1JOG58Z14^XD-)&S*W
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M;)_EOM,NCD;+QS,52^YE=&[J@ 2(<!<QV/J,#/5V[1X11FD/I9Y\DIZ<K =
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M;8P8AM$\]9_%.U;Q0(N% JT7<.=Q@ =]"9W3QQP8=#_.RP]0-@EER-,CMXC
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MT]QDF5(6HI3YQ+'."^Z5\"@27!V@4B+KI4:4!DN\ S40V-H&>X!3EYZBN_\
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M6)_-+YF3PH9>B.U15NAWI]"GS5Z?-- R)Q-">5DW?>:/1?AC?NE*8(NY ">
MI+WT%7]8:P@BFAA!B"RM*:M [*S%EP9LMZ#&,]CN VRSRIIKXFP).,,V -BX
M"\@R4-N46VX"P<PJ#6!;J4RYRP2B:C\<LF88?'4B%PS=>I(\U,/X<>KIAYP;
MK\Z->)D:_-6Y]LX\L0!/[+Z:4\I1!Q:YT$A1&4 I.X*L]R6BHE31RZ IIVL;
M=,$]U5DUKYZ#G?%U&_B:U<.&!Z^(4DBJ8!$O:3IGA4LD&--6RM(3AB\]V.ZA
M_>7I=A8H4_@Q).]+\K$5>)7,G>HXOO44Y9(-FSN;?Z@:.24",\.CVBW*ZP<W
MB)1KS6>/B8%Y4Z9\_9$0Q*VU2&M3(F>LQ=:H("B@]@$"Y;*1\T#3#QEKMX:U
MF<PEP@4E!3;(@ .!N!($F6K5O]1<$2H"D.)ETWP/;?"LDCI^=61ZA_"X=N]\
MC&E:#:O3YYU+IY?C37.\Z3QV9)UB9)G'^*9S_7&*NAX$%]I?TG;ZQVE[WO/B
MUT4]"+HO'6,7MD+][TYOVNY[9\V>5>)"*K$Q9WYJS&FDU"/+*4?<E252GC-$
M2N\T\58)4:YMB'RZ_9,P/3/D[@)RL[F=F:+.EP()%C#BA&BD1&#("PZ=9QBQ
M'J]MR/F369?,#%TY;7UL3JMT.=5F$><&X^"G:V(Y&O4.)X^N9I6W=8^DN/:Z
M/\YE]LP\LQ#/O)M3[1@Z4@NMD-18(TZQ0MHZCHP,X.@*Q9V+:3]V#DY=)A@^
MA'+/,+Q-&,Z>^%@Z7#+&D7 ^G<]*2J29PX!**:TT@6GBUC9(*98XWF555/W.
M65!J.%/WCU.S+YUCGFCC+& N3"DEL\="[/%^?GE(\E#I;PHT@7AT'O2W$TAK
M'&6T@>N42>$2'9[7AU;>2<^HNS?4S>ALSB(SBJ1C'YD%T[D$U&'PV E/&4P$
M]B3PM0T]K[(?VD5?]4B353$TJC7:*Y:U<BS*?4\G5+VQ.UUM?&6.VR/3:88<
MJ;\8#[IYZT-3J@@S2#M'$2\5?&*!(\F5CEPR'1E;VWB _?'9^%B:280,OML"
MWXP1$A@EU'"&G(PEF/XD(%LJA1AS2F&1)@Y2_/N"!T ^V7"5RY,C-Z^;'"V?
M/GVO<PS0+REO]=M)K[P\?3],GLX9SVR>=4SFF85XYG ^!* 40L3@D.,*E#PN
M&:A[[)'TCH?(2/H9G)V;G5VX+&<39KC>Z>1$ANO=P77&++"8:POF-Q)8!\2-
M<$@3@Y$57#%?6NLC.-]<+>G!T-/W38:NKE!Z/^GW%PBWO)-7/B*S:?9,B7;O
M2QCF=+(YO'<%1O3EM7LY'L)OPR$,X/^,V_71DO547CJ/KW(1JBN#X!_GW-Z#
MQOJ^-:=5'NM6?[-NY&EWA"&8%KLQ\<WDBL\6Q"(6Q*?Y+6?:^5+IDB/FJ ,+
M@H+Q$+1#*@2C:##&2;FVP7)<T#)![O9/.\B0NT/(S1KM7!@3!4'.2([ 4"=(
M<ZN0EU08;JU1C*=4LTL5!+1RBXDK5^!5,I F,_MUQ+1OC\:#'#5]'Y;0VT&:
MCAZ=ONV8WFBSY[?AU^,DDDEY(5*>#Y V,A#'B$2"JQ)QG%8W2\61X<0H'11H
MW)1NG\ZGV\^&T&,VA#+B;@UQLQOP,2NAPSP2T@?$(]A"1B3/@]G@*2V9,'9M
MHURJU'\K9U2L7(%7R0J:QC^D_ ;UI&=]_E:* >N?"PI[G);1,AA&K_L#(&@7
M@A^^'O2[5?C)SG3Z^?PZ4TZU?@L</A\31J@K.9$&F1+Z#EQ9BQ3V$3&OF"*Q
MC-J[!\RUGLVG!S*?KHW+C+_%\#=C0Q%E@N=2H>!"!!O**&0PXRBF#$:6NY)9
M>]\GCJRD@O])0-AX6)UR<.G2YA,,!EN.K>17Q)EDGOE5GID/"Q.*<A:C1Z6)
MH.>Y!3=-8& <Z86VM*2.II.-%D@-DT/"EAFT=Q<SGD%[=Z"=,0Y,5,*'H)&P
M#D!+K$;&1(R\BEAI'+C3";2E7A[0YKBP1V0]S<:%Q7;/]%R."\MQ8<L_HB^O
MW=2GK<<S@'O0_PIESQ-\MS_!=V[V8&<X' -QA-VX%6Q>=UG(+/@V'_%52D-%
MD& '!*$0MX8C%:1'(KA2$4=,R9)9P!]@+]E3G*][T.FZ'Z LSYC?#OIF@[\H
M4T:'B"@U##QI T9Y*,$\%Z4CUCH>0\RGD]X&L/;"\60V.@5M>QC4CU--/VB$
MTO=&SMKY!ORP,Z^=6134 S4H1BGB.A*D* W(IR0T'EB!2'^Y=LYQ2"L]7Y9Q
M=;NXFDV@4);.LL 0P2GSHB :6:$,\JXTOO24>*WS2MG-/>/QP!V98:AT[2A%
MQ8P'IU"(OOO\.+7NDD2_ $],6GXWONIWN_U>=>)K-M]OA4;FCTA(,<)<"(8T
ME27BDAEDF"I1Q,X[ATG *1E<#GAY*GKZ.E#,D%L,<K/Y%ZV16IH2L70@"8=^
M0L8RAZR62E@2-99X;8/)I0H47B7=O7T2!JX]#$EU5QJ[Z!]7.YZSYK[+:>V*
M'7;KEIYV0=Y<N1A;S._CB8H0PRQ8]R2"G>^]!3L_*"1XJ3 A)<4<_&?Z -E:
MGZ)N7I;)[8RU6\':[ X>)DDI%4?6>H4X<0$9Z"H$_2=*8TB0)!T:GI,2_I)V
M[AYW^J<AI",,!OU.)QUH4'QMCXZ.^IU4"?"X>Q.UW1X.TS%&XYX/@_HG9$V*
M7'7];CK9R%08/.Z8QZK:EV*S[E[HF%'PK7[+G'SXWD_@(>P?F4%XF7KDU;D.
MR32T$ W-'XM0*BD4P10%+C#BE(%W+IA AE?YBH4@*3B5YF,+EPE^=^:)9_C=
M-?QFSS1B/!#N!*A]'A''1B$EF$$2IR-#HV"<I:/%[G?C_",R +;:*5*ZY],A
M1NV<;^SN%/=N/&OJ/']W4WXXF%//C&&NL2R18TXC;E1$BFB'0BBI"8)26[*U
M#3F?4CBKYT>HGC/(;@=D,TI8Z\B,L0)%#/CBFCFD.%.(&!&%-D8'*N\=9(]*
M"0]'@[8=5S-(Q:A?0!LFP"2//.UH: -V!F$X AT]&/7"(#O8]Z*G&^U>?] >
MG>Y,FC_SR$(\,I_0H2R5T992I)7R" Q[B90"UYI9$7 T9;0X;2C/RGJ9D'8?
MRCHC[5>1-J.Q2^I\!(I$+*B N/(*V> ((L)XK(*4$E]^HD].?Y737RT%1=7G
M'EZVJS.?>GCGT0/G H^J?G@][8:\@?Y&% W7YG."1J(B=!"2Q($QQ+!!EM"4
M;,=JZ#]1NG3B(<FQ!,N&O#N-)<C(NP/DS1I'DAFMN4#4$S".'(E(,<]0P,9(
MS'FP\7(W)$<6_$)VJ\M4><YNM5S9K3+;_"K;S.^(YQ;XIB02\=)&<,6<1M![
M%KF@2RU+'*WP:QMR_FCCG-QJ%3%[[\FM,F9O ;.S%H*F8 -H@9AE*>I 6&2!
M;Q$CI/14>6,T8);+Z^_HR\FM<G*K!8VG(],[K+)_UT?"]7S](?QGW/X"Z)[F
M D_SI8.V&X7Z^N.<&%D.JRG1;_I_^WL7[)VU?G6*5<]?_.&<Y%NH>=_/GVKO
M.N/4&]LG=8?OF5'8CC&X/ F^&(O/;Z<,41$&WASB-F#$/:YV95ODB9.&&^.B
MNB(745YO>HP&5(;O<L-W-OUXM,%11U!01J4U+(<4%1))PIR(F@&Z8\HPFA>Q
M'M^:T ]R?E[7$%HO;#AL]WIIQJD?B^,*OX_3.EJ 71EAI>3>>LLM9\;;0(!O
MK96^E!Z\RK]W$JD2^K,YZU_BTDR-"U'C_*84XDJJ2(J*MS'M6A<.F>@\@KZ4
M5$<JO:K.U<V+1\N&/QY!AUF+E8F1&U(:2JVQ+A!J)%BKML(?R?A;,OS-9HU@
MD8)!JI&,0H!GH4HP37Q WIG@ 'R,ZW)M ["8EY#N3]V'=##:58K^XJQ272UH
MA-F)I5^;N5ZZ()K_NO-F>#3$7%*C,*8VE$YPH:0.(:J@F<":E9:QBIBO$4:3
MB?G^B'E^.Q GDG#&(W*$D#KNT6!"D1"Q5%Z7D?@TY2,7-(QN#2_W8U5ELLMD
M]T.RLXJ[X#VF.&BP9< :+<'V3#.D8+IX&6LO,)/=DI'=["JE*!4UP&[@2DB4
MXI:0(@$C;(,203*KTZGBDBQHA3XXV3VV*;9<X"=:X-]&QG8"_.O;7S9^AS_3
M.\[AP86TYV6B,C9^MX/?-LYPF6];D=ON4=73I.I;1Z$P+B5>,KW3-,'=ZX_@
MZ68 /_>J[:*' ].IMHM6*9./PC! &<TH5,'%SZZLX.0M5#^C DIRW!^VD\)X
M/DAY3]I?PHNO;3\ZFAH<YVZ<: O\_19C03.,1U??LN)]("Z6\/S?5-K*HB'&
ME-&7Q,1TQ"4F1G(? \$EU2+E"OR;BK7I34=GL3O'YC @.PCF,S(1*OC<=+Z:
MT^':;Q?:H=ON30M$)91XMIFO;)48[ZQ5:D4/%F-_4*6_>5YE"TM24":S-&4I
MC@;)#/['S_M' M82AR<4O4H6=)I]^OTW,S\\KQZ[2S""Y^;7JA'\[OWV?JO8
MVME\T]S=;^V\VB]VFJ]V]][N[FVVMK>*S>96L?_^Y?X.2.SM;.\O$2(OK\^K
MW>;^[I\[6U7I]UOP3V.[V=HO=E_#M]U7_^^/W3^WMO?VJ_S9\D6Q_>[]3NN@
M6/IJO=[=*UI_;,/_>]O;16.WV?ICO]@&!V.K:&SNO?JC-N8962_2#%75;<E[
M6_Z*_7/<,V/?!L_P7\M?UG:O@,=V4H:&Q4M[ Y56F8XS+AE4MF..A^'Y],.+
MJ>G9[E5%KFYZT36#0U .$Y6<]/B,NU6]K[X\41L:%#ZG27-,C.S)BR=*Y5FE
M5&;\Q/H:5<]$2:Z\C)]=?>U'CRV?45S>Z*D_OL:XR&7-9;V#LG+*5Z:LJ]2N
MN:P+E/7Z\QB+U(JP:[U_Y29ILN2CG'O+DEDRPR1+9LDEE,PPR9)9,L,D2V;)
M#),LF24S3+)DEEP&R0R3+)DE,TRR9);,,,F263+#)$MFR660S##)DEDRPR1+
M9LD,DRR9)3-,LF267 ;)5<@YIJZ5<NQU?Y!V2Q>MHT$(10/DCX;%=L\'7S3,
MP!T5TVUV5R82G:_V;>3%I_(ZK5EO'ENF]GPW3L<6;[7-8:\_A$(-B^I$[J-^
MQX?!\&PGYG_&[='I/3?I$HE>'WV_<O#! F5>B;&U?V0&\+!^K#97UN>]U\.K
M^F%W/!J.3"_5YW9'UB+Y;Y:[!>LVJUJK;K>?M]-MG03R>!IQ$\J:\@N83M60
M;TW;HYVZ45^9X_8(?L_-NGBS[H61@1]]U9#;9I#R>%]]7EQNR1\,4.?&W7''
MC":-69TK.>7,XT% U>>CT!NVOX3BS_XP-_--FKF5#H08#TZ_T^EZ84:3=AY>
M?6#QXU?4S7ZO'F,I!^&@W^DDE9R^3X][O\Z >ZR-T^J/)IJC&C,3,%ZPCVL*
MO ,;>7&[<R6:="_X$+I5_HPT],Z-NF(ZXBZTXV+N:YT+%3^X'UL]\'FR+]KN
M&HWRTG1,SX7U8BNXT+5A,'5EZ6,ZA'5V@"R8*758N12S1V:4D@IBE2N9XMX8
M(Z)A.!J/B14JB&L?F5%9VQ7*:]?EG(>RMBRY4)O[DURH7;CGT][GYIN#D\:W
MUUUXCVC0U^UF=P?>U^Q^_+!-=K<:WQJMG6]GN5"[._"< W'0^NMSL_5O>/?>
MIW3/;JO33O*-UO8)O/,SO(O-YD(]^/3^M/FI<]3\\(XTNG]]:KYI?#OXL"-V
M/\!S6E"OUFNHWSNHEX^-EIM+_&PC+VFT$HF24<2%]\BP4B/) M&!.HF%7ML@
M9/[$QNOD0KWOQ,XWLJYN!:L/-R%WHZ3.RYNT^1>9Z)*3>VZ)ALY/P-5&Q=DA
M9F_[@U2*S=%HT+;C*IE4JP\J])P&G2K03%B+$M9,\N901A*]BTC3P!#'7"%E
ML4+!DEA:I10V8FWC9JF;,UUENGIHNBHI9=Y@PH0MN0M!ZT@T]3#J32P=,?=-
M5[$_Z)H1%.QD]+PW[B+?KY*#IO=F+EN0RYHSQE<4+ :E-:+<*L0]E@C4DD6$
M1ZIC$%$)!URV3O7-SMW(?);Y[*'Y3#MFRHAI$)1SHKDQ7-I(N#(*>\EBYK,5
MYK,9VTQ@;H)0 C%C,8)^=DAK[I$PPC.F54DL6]M0P&?S9\]F/LM\]F#56^2<
M;8X9C\9Z+YWAFE!-I),B1&VPH=[HJPGMBN.ULV/Y(.2U.V.,,2.X980@XI)C
MZ80'8RQ&9#$M%6=@B#,,QMC\1-A5IV9GTLJDM2RD%9QE6BL5@+FXBLH*Q16W
M6ED;0R#VP4@KFV.W.%4&;%;/[W^FNZW-KW\;K8VWID116(\XC1Q!IQ-D%0>_
MDU!I.5G;X.NE9)G5,JLM1?46(#5%>.EC\!$KSF4I+69$6QW U9#,Q3+/["\Y
M735FZ,I)PE09$8LJ(![2=)B38(&56 I/".<$W$<FL^^8"6MYJK?(4B1AI>3>
M>LLM9Z":P?)2V%KI2^E]\'DN;)79[/U%-DMSG(1B!PZD5V!\.8:,9A(%4WJO
M)>91^[4-L0YNY4H0VJ_'QV5VR^QV#79KA>YQ?V &IS6UO3*#03JK<[/;'_=&
M-R&Z82:SA<GL<-8T"X)*XI @&DPS 9]T)!Y%C0,C IN2R;4-N6RFV2INL+P<
MA\TP*MHPN+OAZ6[W^_ENSTM[=L5C:^>)%D?AL-!"&"RY=$P'%WE@3FH-7SS[
M>ROMM,4$$U1]8#]C7!A<.]782IM8,EDN1):'<ZN@7NH8:(A(18X19Y(A9<L2
MB;(,7F'F= E6$?3,8F2Y%);=\HL^%0Y@5#AM"3:*<:6M$DKK*(30W@6I\+4Y
MP!^>7,3_]LG$POJ^'21/>-T*4<Q->#E-L='.(RICLJJ$1U8:CK@")Q%;50:=
M@N_YRA#%4P'?;2G@#+Y[!-_,_(R,DNG418ZF^1D1%-**.T2LE(13KEAD:;V_
M7!GT77^#8L;IS0SEF:F),^AF-"Z,QMD)!E9R%CR'(4,EXIY(9 )8SH*GN!NC
M?20<5.']8_&V-KE6W]L]'WJCYTC/GRW_D)"J,AM [5)6@VD^@WJR8;WHA5'1
MC\7(G(0[VFZ>19^Z/45%)"X&XHDK.5%>\=(1K(+R7H@@W<(\70WH5^?'\W<3
M"TA[-[;,2>;LA3C[\US I 0[R1"L45 T&5#$(A7!CW'8IJAOQB0NUS;F(XN6
MWWQ:?M$G0@RW;L!E8K@#8IASK8#/J8RE0TYIC#@/'%DF2@0_BVAXJ<6J,L/]
M9!Q<@?6HK?:7-MBR?IC@UC&#X+-Q^"C9>I$H<Z>"),%'$6SDCA(C2NYY\!3(
MVRLB%Z;KLU%V+@?,*S,\RA2]"$5_VIQ;HZ**0%=IBH0QX&Y;KY UFJ%0@L'-
ME2V=%VL;:CXRZ:JP\*5@YZ<J^E3XY=;-P<POM\0O<R8@8XIZXQTJ*=$IKY1
M%DN++/&2\% :F>;S5HU@LOEW9OX-Z[@[Z+)A,>H7O0NK5$5[LDQ5')O!J!<&
M>>HPBV;]=6M!&U/]U6CW^H,J_+^&VU9P*9MN>#WH=R] ]*K0V#_J3019WRVD
M[[;G0SFH,I;Q0%"03"".4X LU1HQS0455#(E0&.0Z^^SS%$<JV=.9C@^&!QG
MS$^B2FZT<XB7'@,<942*6(\D<="=V'FL[*K \6F$=3P(<%/\U5E,1ZAC.BX
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MH\0I!ZHU8WKI,#TW-5720,HR4$1+ J#V@B%%*$=.4E$R\/J4PFL;I%S,/'I
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M5"#N D.*"XR\-II;@M,,Y=K&]?,/+/&>DN7W_':&PW%*&YXB25Q]PLXP3;(
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MP7<V+?;3A%,UGJ;HKUAW*\$_C;GJG9=4=- >?BY,DAYVS_7UL(@3=NZT8RK
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M!#\=,!-[^W_^H2B1+X8%L  M-GN@-SO%7CCNIX7F7O$:VK8@&/V_B6^0ZH7
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MCVXL5R[?>1>HL]LL].*;A>R-V>5;._O79T++LB8+]H^\Q,Y%Y\>X<&PU!T=
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M*%3MF IZ-L(E(7+)CQLNZ5YSB8E<\O9>J)PC)W0F=MZ_*A-"P*18.0:*A<2
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M'M32J!F_'9<MRKI_()=50GP1W#?I"7"6 ']1B:CS'#%K!3)!I,@S;;P+U(E
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MH97."%,9-XX8QX'S'2=62WJ_J)DY#&)2T, 88(;$, RL<"J#3RV,QF?6XGA
M48#(N$\<=JRESW/_=OC+NV'L;;-=K'MQT[LSW3T&J!_(RBA@)V1Y,<[RZX$0
M4&I=\C3*@8$???#B@8A8+T3$A!Y1?L?$.E'DUJ_Q^NW?W?580M93QA_UV+N_
MXRE]BL$2):O!/L%@Z7J:/>RQ#SP%6NQAU;V7$OZ0<Z@2+9;J).J#SIMY5&*B
M.9<4]EQ2\SJ>IY^5.LV(<?%J3N#N4D>WO/5GQG>3E+Q)P&"FOU90>0GW?&:J
MP\).<^\]Y5_RU?GL?_A60AZP/@^:].^X> ]AF6KQ;EF\]'5"[MK[LLO&0^K3
M/W9/5Z%X]]S[N+J3JK;Q54RJVL97,:G7O(TK*27GZ8C0Z^HX@R3WMM^M&B.L
M\!DM*^IS,>4D9E8YI9U7/N 09$8Y+B-_**'WG=$V2H+8OZ:'UW$*>W9X4;\Z
MO-AMG+3J,*[#QEZSUC@Z@?>>UAM_GM6W=FCM:H?4MG;8Y"GLT>E&6C_=X+N?
M#FA]JWY2_[3SLWZV#6.OD=K9(:Z='E[53@\N:J<G81B_4]O'O'[Z_:*V\4T8
MJU+A,1)$$L2<4\A@PE$6)!>66V(,6WLO9!6]4^'  G @,S1&^F#/A60X(Y)2
M)I0&9(C'BX)7./!,.' U@0.< ;.G*4<B%A)FFGHDM:"(<R<\]=A+1RL<J'!@
M03C !#9$89OID#*2$4TCM6'G@G X*/,+./":8WV?#Q_(!#XX&9N;2(N4C'I"
MRB72/F-(<ZZ8LIAE+JM"?2N06"A(. ]6(<LR)CU8#DX9#O! X#>?<I*Y"B1>
M&"32"9"0*::<.(IL8!(Q8@ ?G/9(B.!C1IC 1"QO2X)5<I=LZOPDR8L.&\YW
MDQ_% 78G)*UFB#%'\(UN6Y^<=UI-.\-K\OO5UUR0_R&N^_YPV8NP@5>;D?],
M,%+?G/9)2*T\YP%Y$SN;"">0\JE&P6EB@S0ATV[M/5OZUDB_'9<MRKI_()=5
M0GP1W#?I"6!:9S%?!A&=.L2XH,B DH\\P8IGRFA3%9)>7A9<E&%=";HG8+5)
MHUI3G68^(R@%7D/,>($,9AIIF7&9,N:8I:];T!4?-('&VD#[ZS."N5>&[Q9D
MJU:B[QGY<=)^U3XUV$J"?"HX8EY(9&R4?UX(;S*6IOPENYI4]=RK>N[W0=;&
M#]ULQ3P9!!"!<D #@!O3NR."XK=3D1;E"[A>ZH^=[CXL](U_<0M6O#J:?!PJ
M-Z?< 9E3WE,M4:ICGG@:,-*66!0RKUF*M3844)F^7B5I1?EL4=Z A_-9I14M
M@O\F'0(955X2$5"6@:G"N)=(<R*0=+"CS@"]F9?TZE=<^"P.@8H+GY<+)WT%
MA)-42F80J"D4,4H(TID -<]GF!J&M16K<P#_^W'A@MP#E<[Y--PVZ0E(N2?"
M^ Q,?Y4A)I5'H,-(1+0F09M,F(!?1.>L?  OXP-8O@&ORI75PE9>J_LD:=6%
M\+?LC[$H1UR185V=3_YB/%]CN@&A]H;%"E((!P]&A^<6*8TIHD$J$[3@GNJU
M]X14C7@JH%EBH%F8)[("FD4!S62/0:V=XLPASV,/GB #4IA(1+'U-K66Z]3-
MGWY4X4R%,ROI:ZUP9D$X,]E9D!M"K<4>V51[Q+!1H-!0BU),G)*$I$5YRGDC
MKBJ<J7!F);W)%<XL"F<F]!E-O0O&*91ZSD&?L0:9+(W)#(H;C'DJ59C;?USU
M%*Q>6?44G*P>>-,<]2$U]E:\XM/"2OI6\Z_FOX+S7TG@FJ?B6>L&SJI29\LS
MA1<XU1C2Q^8(>0R%W>5F2^=Y,S2]B[VJBGR17J6TSZ6TUZ9/.ZRF5H: "#,!
M,24QDD(K9 @E3 FL+,_6WA.*ESV\JD**E4"*11U+/ (IJAC-Q2#(A-GOJ3.&
M>8H"C\9^&A@RCE(D5$:(HEG&\>H$:58HLA(HLJA#ATK?>&JTF#R,L"(X^$^#
MON'2V#XY0R;H@*RWTH/BD:EXZ%GI&Q52+->Q0:5OO!B"3.H;F5..\ QY:PD@
M2*J1(I0A&8CU.&.6.5TEK+^^*U^1&RQVD86Q DI$L,J;SI>]R:HT]07YD3[T
M<QA&G@-:FV:[6-N;-=\<7?)K#*]P>2Y</ICR)#FJ0C I1EQ+A5A&!5+,442)
M ,V.B=1[NO:>ILNNV/UV3+<HE\RCF*Y2DA;#C!-*$B<A(U9B1#4#9E09F%DL
M$*0%;'.6JBQ(LC).F=^.(Q?EWJ@X\N4X<M+Q87RJ*%4&"1Y+3&96( !:C8Q4
M*07[U'AF*HY<6HY<D!NA4DR?@?,F9*&QRBKB R(I9XC1>,1)C4'6&APR2P*W
M_&44T\I74.5?K]:5U<)6WJTJL;W*SW@ZU]U(;'.5I/&KRM#W*2]=<%R+F/WE
MI(YFB+#($$,1T3P$YS,N+6 287-J0U4V6(4VJ^BSO ]M*F?(8E!HPB1+ 8*8
M5PQ,LLP@^(T@HW% EG 23,:%T>&1SI *B2HD6D5?;:7W+!1Q)MVO&)12YX@#
M>A$N)L%[9 RS*/C4.LL]#U@](NZL0IL*;5;1#UVAS6+19K*TC]-*8>61]AP#
MVCB/5) &4>-,JE.LN<;SNYQ?*A>>5;GPK^R5*^EMG)T+O^<!$L]B>>@$&"F"
M9;?3@LN.DR;@9M?GO2JG='FF\ (.Q1L"J8_1Q\Z /+;_VV_V+J^E8"7[YI%]
MI]M3'D9NA:0L8!1,FB%F@D+:X!1YGK&,P7^6L;7W6;;L,0X53*P$3"S*$S@W
M3%2NP<7 QX3J3&A&#!$2"6QC*U[FD S4( ^;F<D42Y=5Z:05ACRDDDI!(A5%
M5!3Q<GZ62OE\6NDQZ7B1G&A.#4:I<AHQ!\JGDC*@E&;2!1=T)O3+*)^%R?VO
M7B2%]\7;;1'WV2^"/>$3U_SQ_M_%CV=F#7I3=FKZY_6"+.?P-H#Y>KK9\@Y^
MR6VW>5XP=M<?ZV[<L:1WXI.8LJO;E__(DP!\EOR(C):<>1T]G6>^W<N39EYP
MOX;WNJ393NJ=GD]DTNL4]^N^:_:*FE7MPK6BXQ^AV=9MV]0M6 KX8/"<]L0+
M(T@D&VW8Y5:RY\\[W5X"P_L(FF-",/J_]3F7_?V_3?=?[Y=\3QHW*Y!T0O!=
M6%Q@#%C<Q)^=MSJ7'L80EZES'A<D@O!E7.IS';FG>0ZK&1=21W<.^B^L7)%8
MG>3]\_-6L<ZPEFYF';'SEFZO)\G&S:/:/=B$\F( Z#?PFF,/K^XF%\W>R?4H
M08VW)Y%:+#RRV8/K=#>.X0< =$D0&JBFV_2].*/1IR/7['H;+\I['?L]T6V7
MF [\..OWXIZ'?MO%R>I>\4A[G2>>:/BXJPL:O6E3#(./JS?]Q>3=<?@PK,_^
MAV\E) XJ+N@(>9\T?5=W[<EE8KS5_=P7%]@3W3[VUW0Z<GWY!+ALXIT#-G%)
MC%L_3O[;[\3)GG>;MGQ,1,\?<)GN?O?  $;G\'6G?'SY87EQ<@Z+'K<:5J;5
M:YZWXBS,97%=NW]FX%L80KP@3TY\R[U)_$_;@I?^*,86=PE6!3:ZE-RVD_?R
M8JMM!^@@/X<UC^/3[K2?]R*11/-L=+Y3<YVURH #0"8=P(_0*K=UL%)W/F@V
M,78,"('BU\&NSKYLI/;=G9M,'[K)\&VS?=[OE8]SP-L_RAUK1Y)MM2Z3T.V<
MP?" [7\4;M/!/@&NZ;@EQ8JVRM$-$' &I4Z!T(2L1-W29TN':FVS[6!;WJ:B
M4(=_=S2[!<"ZG>.N/EL<AD4;B.)W0R@K_B3O$H"C@G +\"J(M:2MX8S*$9]<
MGG?@TT*E2>+D DB_3KRV?%XI\RY.FO:D>!E0B?U>LC7LGW9GS78SAP][G>Z
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M]\:H/?;(=+W^CG2 P;[5K0M]F:_]:VQ.8/ ,'R[C<<[DDMTZPQ">;(:E\>V
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M6 1CXMYQYX>-!3+R'&1\R_=ZL5)/M++*.WJQ)V5\^USFA<@4H8Q*G5$F33#
M#CH-(=-&F*!L1?XO2/X[5]^4S#AUA"&7 >4S*S%2QG#@ <LR9E* 6K;VGMQ+
M_O_,AX44"/EC/=F)-.1F$!'\[-M2H;RN6I*8X08"_94[.%*T98)>X=E#O]/
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MJ(4+ O8>&#D@&'R&3##&I1Q4+Q;;A=V2)C#H5+Y^5].ZN1J(4BTQ!M5"@&;
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M>.T]D>MJ"I+_-X90CY+^=9)?#/&^":N^C/AV4--Y4:;HSW[K,BD40\+']4$
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MQ0(1+<%<40+X3%&*I*;2,2<R)RCPV72"QPOQV:HK#L529$NN0(SYF^+!H'Z
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MX),@C*FB0>*G%/=&4P-(10ON!THGBH?*VBC%?LS\24AI"V'N40_\!6+WPG-
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M=UQ^]ROY_5?P[Q#5H &9ER GHT>C\:0?QH'WUU^ORO$(-'MB,NX.<R"$]B9
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M\AQ#K5B(=_I*S(?KF_J%-<6J%\+@ZA3I:3' 9@&:::NZ2OV42R,-ED2HJQN
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M"O.B_N5WG16CGKA\D0V<E7(W_3Y?^!8'=H[EAY7H58-SXRR_KCQ SG8B[IS
M<0[_Z?K%E7^XX[[Z;:R7OTN2'1(D5WX=[) KO[ONL7R'D:N_O>ZIUW\7)?1>
MQKKV>&#ID)G^WRVP)M5U]2("QYG-N/(WQP7Y5;=4[7!?!!YQ &WIZ7SI4CKZ
MBA<OB\@B;Y9L^?!^B@N!G#B#?%@:Y/V90?; %D^5P*82?79II2Y0+<&UGM-V
M7DV]I[4B"(#6H/Q:,_[I*$?OG6<?40Y6K *VY]ZH->@TP/"+NV+C%1//\9T/
M,_/T)@\YF'G(:\SX 63SZ1*GE<W[">*X56BF62RNQ8KI!-Y3F-2_UIG)(PG'
MFE.XQ0F!U&!K0Q7%/#!,:Y7J0-)0<&I48!-+;\AI63XJ4.5$O,Z'?=RXP2%\
MR,;=5U5*T_[7*DEJM\SFTB?BZ],X,/"=0;CNQ_[7'HSMRR=X]]')(3WZL,\Z
M)V\O/^W]TSUZ<T@ZWS[UCTX4/._CM\-O![2^!]XU^43?QX<?X/DG!]'AMX_1
MQY-3TMG[\TL'GO'QV_NPT_\8=;XIUCD[_'9X]LD>7@9?_SK9'Q\>!U'G[ L&
M\1(C0J93ZZ=1HGQ&J?6E(-Q7/#1:TY02S0'I;--H^<3!:BV[6E%YMY2+[S!H
MK4IY$BJ%:DU$2$G,8\52%4G#B R)$G&HHB@A-R1<M2IETU3*MP65PJV)$AY'
MO@B)]EG,F,^-CGR=*IZ0P%@B-*J4B"T7R'DDE=+"P'O4#=>EM5T)T>G*J:[4
MYT]:&RK-PL@&-DRI92))T\C8*)910 @!P!4\#,!J%=[:"J_S:@E#I4H:;@GU
MJ9&ASV")?!XFTB>!T*F)%.4ZVGJ9+->)VC  ]?,)7\B34!%J!8]8PH*4128@
M*J*4, O8XV&@2"M\MQ&^1;214*%4Q,&!B4D":$-R7UIB_8A$5%ABF+7@P"3!
MI@C?4X<:CA3)3A)M..HXP:H8\[D25ZSUVE'/I^U-KC_-9Z/?ORLCK'4U-U7Y
M'R\A+UA&RIF%Y6-,^(R*P!>:)WXL$L:B(!41L>AJPL+>3O_?9B?DX4);K:9Z
MKIK*RC2(N0+<26,F)$D!F0:<1"H-TE2JJ V*/3%-M0A30QY'E$61'X7P@['0
M^C+6U$\ L5I#PU@P+"6\'9.GH:DV%L8NG'U+G1Z]RYUQ^B/9+X_PRHU=J:<5
MVUR=?G)E O<ZN2C/,J/B.X3A6<V_%;<VHZ3=_GW C)*I"CYPQSRP &4+5F\!
M5H^6-S2TI9IP+$+)2.BS6*-;30VXU9J 5\*9(0!6PX1M2E"U30EYTCKASE-"
M6IWPPSIAT8&-HM1R3E(_II'RF3+"E]IJ/V1"!L(&H5)RZV44;\PN9PO$VIR.
M9Y+3T:JS'U1GRSL'29*(,+3,5V!/?&:5]E,9)+Z,& U)8HVP>NOE<JWU#0,X
M/Y]LW77*1BM;/RQ;BU AY2!"#"3*2.;:YB6^$(KX(I:&IA%-PQ1D*]D4V6J!
MPCV*]G5%))XG4/CE-L$0&>LPDI&.DXC%RG ;IY2JE"FK+#?1&D@!6_W ;ZU:
MN^.\]I-=5&D.-AR=?(P.]W8_4Q-1'5KJPT);<($2YG-T@=(T%)$F+& Z ;VV
MK-A^;?'"HXE83(Q.C0H3!=9()*$(9!CI0)LTC)(D2M< #*V(W9^(7<Z+6)"D
M 2.Q\DT2$Y\)JGUN:.3KD!H-R"]EE&&480-$[*G#AJ>5R+E8S6D-[/!CV5*;
MI_4>,_&QU74_JNOVE^ $254<:YOZ@MC89RE7O@@CY5.P5A$XLX+38.ME&"P7
M1M_$A*!;((Z?6##O/,^O%<P[$,P%$!+&D8J4BGS)%8"0V$9^2FB"YTJ"(#)A
M*!,+((2$3T(PGSI.V1!P<D7YH>' GT&3JKJD*R[9!C?N (1<X7D!U8?S>F^_
MI'RK^FZE^@Z6,4F<4LZ4],.8ISXSC/L\3D,_#"DU21K'4D1;+^GROD@;XG@\
M0;L#4-$*VGT+V@+&B$ W)L)$/A,,P;\$C,&#P%<BL2SD@1(LW'H9+Q\&: ,=
MWQ7H<&*WB"2:Q?!]OES%]U&A12EOGC1VZ)HSN;_&XFO5N,G\WP2+4V-OW#KS
M'&N&EY_VS;@[Q!+/YZ88F[5V6GYBI^S.HR4S7ZP^?Y4-)D"_HVE#X#_<JI;7
MG>":'F:#80Y+=X!53F'1=@=Z_BG[;F4/W<(>N'5UR3:M(KZ5(CY<0CR6IAR<
M/>.G,N8^LS;V8=5C/XDTJ&(94*U $=,5NSJ;Z.RU49A'B<*T K_! K^ O'3
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MN^$$,)KQ%'R%8_+&IG!EWQ!+ELUP*C#ZL^4.#"9]"4AVH?"VC1*I61@*0@#
M<FYLHI*$2!W%L4YO:O1'FU[7=W2S_KMT#Z=Q'Y\^36>L"OR @]7_U#LZZ?4^
M[9U>'IZ HW7V9_>0=KX<GOV9';YY^_6P__:R<W)*%@,_G0\?+V'\T=&'?[[
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M>VX:KP\ZNYU7![M_><<G\,'A?N?DV/M__BNEA/R.5YX<=-[O[VW\Y'Z9# 1
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MY][ECN>=7"?\A2?-P%@L\^/9?-CW_G4EBTP*?;?\X<>PS(!BX+?U. 6\C^%
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M 1,M"@F"ORXF]L '_G3#?)NYH5@I+@DO"[%4'(8FNQONWRN7UIRE8W "5R
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M?DP7/74WM-XL,YM;%+"6J\O*5/Z2-WSWN'X4B]L=ZR[8,UVP117&Y+AE:57
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MK& O9PNKF'!>N@[2_V0N%2Y519TH3LM\;ZC?51+?$E?N,]RJS]B!NOL(ZM#
MT<#1P'E.X&R4R<_K '\H4L+*S-*+ZF\;NT=[Z\"WYEP -8R71:REQ1FXWYKY
M4(.L277>N3>6W]8C8+LL/$N':V^6 .$*H-,8H:E-4]LV4YM9:YF-6J_1>R&<
MT +#[)F<3*:.=\^Y<9W4M@N,W0]:6NAV.YIW:=ZE>%?[H-YKE PA'F9#Y0;J
M^=NC]2K!6[C[Y[RT2LU$XCY+RERYGVJ]U-V$I7*S0[?*%J/W_[KWKT5K;8O3
MU@$M86\=1FAJT]2VC=2F;7'E0RMMBRN"3/NPUCOL:O:EV5=LCCNL=[4Y3IOC
MM#GNA<!%Q?YG0@?%KYL)'-1#RT%/VG2D34=:F=728'FV4$Z,T-2FJ6T;J4V;
MCLJ'5MIT5(BMK6ZMT=:V(\V_,J%<K9(A1&FU/6T[TK:C=8.+:D1L([KHJ"*]
M?[U_;1K4ID%MK-#"?AFV4$Z,T-2FJ6T;J4V;!LN'5MHT6(BMW4ZM9S8U_]+\
M*S8-=NIMLV0(45IM3YL&RV0:?$O5]'\M=3NQE([Z_)]75;#VD7.^:S;K9A,Q
M[=1-Y9%2ZS+LZO7!8SYU=#NV?2XZH-KN /N"R:YY^%W5+"\8BZ9AL4X^E3IY
M_]YX\[_V'1[6)U]<O4;DVN$EMB2) FO'P*9A@+[T@\UZC2'O]PZ9:;;:S4/>
M:Q\RJV<UAE:#M8:L]9]C7&"CV3#WU3]V#(L/[ ES@G_LG)Y_VC%<-D$L&=V]
MN\(>$(FA0-H)CBS179(Y1Q,O<L.C*!Q[/FP&%B-Z4<!"[L)W;C39MSQJJH+3
M _X!0<',O1W1\<9J_>N^?^S=?&Y>WGQKG476CY.;[[_U?ES\^#3^=OU]\OWX
MV]VW/[^USWY\_?OL^-/X_._+G]\G?]R='7^[O[C^X_[L^/+GY]:Y\^UO#\:=
M-+]/OC;/_OPTN3@^;9S]?73W[7K0^/[;=^?L^JAY]N.G>?;CJ/']4Q?>/[OY
M[OYS_/UOK_WM>G1W#M\[@[EACL;%\2?[XOC2.;_^>7MV?=(^_S%J??\Q:I[;
MO<;W?X\;@\F_7/9G+[KX,1Y?')_ ]T[^/O_M$M;[M7WVYVG[_+<_S(OKH[NS
MZU'SXMB"M7QK_OOOL_N+K_]I=UO-?N_ W&]T3&N_W3AL[/?[_'"_/^SWK=9!
MM]%I]^'^^-^WV=.6MB[JB^RY=<.X BSB H$*D";NEHLCIX0RMDN==YN-1C%V
M8E]'%I^E\<9L93Z-@_-?C)L]9IJ&A&/?BT9C$<HIYE#QG'7JZCV[<O5=T<<$
M5^)ZV.D$FVO;HB,/]BX)N3^Q7?$GML>J1 ?$E*!< I;5Z0J61:TK@W?&KKDG
MC@.[)#JVZ#B)30Q#[*%-/<(1>P( >C"4#$AUK+SC_L FO+,'U"SX+9X1NZ-&
M-&//P0\;7M]1K<*1F^'/V"4;L8FPQ9M*?0)0UPWC3J"ISC0Q/A^)]HNJK6U(
M#=)B[>2S!]N\!@PQ8'?<I?::6-%WS[@=>_%B+?5!T6IZMQEOGQ;-'?@M60$B
M'*V5%A>DUO;8M0 XO>$047L1H$1'T<$ 2$LV+N7J>.X%S87P2=&C7=&>V(7H
M6W5O4S_S((23P84)4./%(1N2<I]8-;(208ST;):>%+:FFRB9W>4Z*.GV<>MI
M']=<3_NXSLZO3V\?UVX*>T41K&&3@WT '-Y>[X)H,@&AJ!AN+]Y<+K-<?C>V
M^W;X_L47N*4=YQ;A2/:>0@[S/LUR]E,\9W/;6="RKE-_'HC.[6:;@4VGWB"M
MXT1@:V \COMFY8+#/+SQEQ>"=U$C/+7A=X5[DGW@L(*Q:/+WS#WE>O7N00L9
MXJH]Y;KUPT9O[5V_NKUZH[=<&[+UA@;! ;R0K:397,%0M-)N7J)':J/LU]CB
M!<IKS!K=-5HM$]4_?@<:R#B<[/QZ%?4#V[+19/);Q%"X]H12D#3Y3%]CJ7X-
M$E5S4J2D]XVDTFT+<;3,NJG)H]3DT3)-01^7$5Q<9HOMF^U=MF=\1)@/ >I*
M__XXMOG0.+D#:B'E\F((3[F_F&;*B\$;"GNKX(9*?U3+,QM]%Y>=V31783:?
M;)>Y YLYFMELRX9*?U3+,INFEFS*SFR:4K(! 9_XBMDZ:&BY1K.:LNQL>5:C
MY9JRLYKF\JQF1:DF9W9H:;/#@Q33Z^G+N>04T^O)RYF\VO#_H7'NU;$VET5^
M;4:FN6QIKIHA?+7N"'W:Z*"^'MN^-=\Q_M'GEAT:1R.?<YP^._&Y=\.IVS?.
M"G/#%]C$@XF_1C"!<6RSD>L%</H!NM,]?XJ[XE8-7__@^;YWR_T:+<'!;_N!
M,65^>(^_^#ST:L8_OYQY_@BPY"-%FWQ@[L^:<5X_JM,41];$=NT@],GS#(ND
M!>+Z/9S!8"-RJV7FI,>W8QL 8LM8"II+.BF,H]JJ(-$B3M4W5/JC6C:&N6'6
M3\^O*G%82V[IE%Q[QK\_7'X&%H*A,P-N''N#B'C=/M&JK7ZWU.^6QS$0+338
M=,J9;]@B$.<4@T$P% J8Q3$+&<@0#C?Z?, B8"[HDJ7OA&P4&!A:@[S-0OK'
M:)]XCF1!ZGO50B9-]Y4YJA7H_NKC[Y4XK$?0_36[\UQO<@]W=,C= +6 J\&8
M3UC""( 3@%PD0J-!.*K?!5:U3EH3966.:@6B_'CTN1*'M1ZB_,B<0>0(-?VS
M[?[LH\B>NJO3%/H?V$_];N)4Z^@UE5;FJ%:@TN.33Y4XK/50Z3$?@M*\')%:
M?*B)M+H;*OU1K4"DGX\^5.*PUD.DGUF?.P_3I\/ZFCZKNZ'2']4*]/GE\J02
MA[4>^OSB\P#H<4E9=^KS(C+5T;"/P+;V-F':1P^68GQAHR+[Y*[(S4;7@^UF
M[(_HEL L<@:_T$/EQ ""W%L"VS;N!)TI3%"8\"'6NDS:H4ID*V/FX=P$J=*D
M([9R7JI'IB/V-IF.6-Z,PQ=?RY8F%[Y,KMH5D",+(Q^S50J(.9M(AD)>BFL]
M1U;C?#@69=E]B?P@8B!\2*>^S_^*;)\\U(%*_$]R=."J&(R9"Y?.T2#$QV:O
MU1:N[TL^(I\Z3(7U'*S(N3?(0X;53^P JS]X/GVFC[501GCW8*4*^$R?CYDS
MQ&H!.!&AKAA0$^[WR(6W:,*D7D51*8CGANO1U+<= <IF5_8V*\G2%D=3K%I*
MXWES*UL']4;W\#&YE6:C;AX4/WYT<N5AO;/DM-LB,7^XKY VO>2>W@9OC7\R
MG/"D#L+RC1U42[5>LQ5$TC%>35B:#L1;VS+4\EY^MTL>JC[0$FUH6?UUS&PL
M2%,K3@'0QUB)WAQH3D##EFT5Q#3E-'&S_9JM55M'[Z_>C/WAOA+GM(* =,4F
MQE$=_\->=SS4=HA'^CA+LZ%E*[#'PM"_L-)B?+NBZ?XQ)_BT$LFEDS@*,[GR
MD)EU)"QIK3:;.[^N6&"K GZ&TK@4VL4NA;=]S[J'_XS#B?/K_P-02P,$%
M  @ 38&<5F'X(OTB#   97,  !    !D9W@M,C R,S S,S$N>'-D[5UM<Z,X
M$OX^OT+GJ]J;K3K'=MZ3G<P6L7'"G8-]!F=V/VW)(#O:8/ BD9?[]=<"$[_P
M(O!D[KAEIJ9F#*B?5O?3:DD-QI]^?EDXZ(GXC'KN5:-ST&X@XEJ>3=WY56-B
M]IOGC9\_?_CPZ2_-YB_7XP'J>5:P("Y'79]@3FST3/D#^F(3]HAFOK= 7SS_
MD3[A9O-S*-3UEJ\^G3]P=-@^/-J]ZE^>XM.SV7%[VK2/3HZ:QQ?PZ>)L2IIG
M;3(C9V?'Y/CD]._SR_/V1?OT%%\TVZ>DTSP^G9XW+Z:'[:9]<7I^?'+>P>WV
M:0CZPBZ9]4 6&(%A+KM\85>-!\Z7EZW6\_/SP?/1@>?/6X?M=J?UR]W ")LV
M5FT=ZCYNM7Z9^D[<_J@E+D\Q(W%S>_[RUOJ/@#!N4SQW/<:IQ0XL;]$2%K>/
MCCJQ@("C.0JHRSAVK;4"[C?YZY*P=!FXW!*7A9YVL]UI'FYILOF;V*::DU9T
ML8$PYSZ=!IST/7_1(S,<." 2N'\$V*$S2FP(!8<(LK<:;%SFV)\3KN,%84ML
MD8+>^/P!(<$372P]GR,W(3[#;!IVE_E<B!TV4,3IP+,P#P-5M&2Q98GV+>)P
M)HZ:XNC@A=F-5G&M 6O.,5Z6TKPI$VE?G2G3@XT [5Q<7+1>1,2E]R U?L+V
M3?&QV3EL'G5*J,T*Q.*ZX:@9R[U'']:CK5P?8KFO[$/JX,J*!9ED>,P*=B-]
ML!9T0BP@K#\IHY 1ZV#N/;5L0HL$_FYS\2$EU+'K>CR4%V=6YY9+ZLZ\Z 2<
M$H1=QJR-R2Q.88ELG#(TPO\NL6_YGB,91ZVE[RV)SREAFYD\!'CPR>RJ ?F\
M&2>IWQP\/8".Q"T2^-N1)RZW0(0X@[4AL:P@_ZK!P/\.B5Q38;N7/BEK-X@P
MF"1"FO_?S;>P4]9\$+$"YT]AO4UF9:T'$>K2/8P7TB9<1]2^:G0]6(*.\!PZ
M)\Y/QEK^6B)4O1:*D6/L=:<^M\,_'=1<KUR;*)1$0O13:U=@!RI@Q!ZZG\//
MNX&^$EXUR1'<"9'"<MO.315;G8R]F>?CH6X,!UI/,=6>8<*_=ZIN&L/^<*2.
M%5.#JZ6<+T>3LG((5!C@3A+3LH&)UJ!HV$=KV.^,];O#N]%8O55U0[M7-1T.
MU?>@+@U6RN%1<0ZW\%&DH*9L7BL#1>^JQJVJFGL/NVT0*5/'>4RML% $]IT5
MTQAA'ZQZ(.!_[+P+1=N(4KY.BO.%/FYA_UA3_K:2F6+<]@?#+^\RJ:W!I*R=
MELB'@(I"V.]\]0USV/WG[7#04\>&^J^)9O[Z'L2EH$H9/"O.X";\WU"DH$9<
M]E2C.]9&8EDV[%]/#$U7C5+C+1U RM"Y6,U39CD>"WPB#M8X@I88J494&).[
M.V7\*T2\=J-K?:VKZ*;2[0XGNJGI-R.(WZZFEN*F(**4K(M=LE; X?A90Z,U
M-HK!:\2?JHQU,-V ;8YQJXQ+K><3LC)..NU=3F((!!@H!*F1[\>J88XG71.\
MK=\H75.[U\R2@R4+0LI$9Y>)+22TAJH1'W'Z5KHPH1I:Z=)$JKR4B<-=)F(8
MM(E3(QKZBC:^5P836.XHQF0<K7K*\) .("7B:)<(@8-"(+2)5",J>NJU66Y=
M!>VECCY.+J.NS1IYM:_IL(?6E(&FBYQ;/K[3Y*5>/TF$=PR#-G!J1$-RCZ;H
MO;':4]4[Y7J@ZD,==F#F>#@ /]]HNJF**;+42G8O!5(B3Q,+VPT]/_SU_+!S
M]M-J3XA (5IK1-LJ4:RS3J1/1J-!F,>505Q=&9JWZABVV4JY;4H>D)3$L^3N
M9(VWKM"@'_!B^1,*@9% KA%5W>'=G6:&60G"6,0MQ*RJE]U/YL%(:4KL^#?0
MPL&UA5<C<N)%JJ'>"&=H>G\XO@MOE.VS8DY!D5*3V-^_K9M7:&@#KD;,C-5[
M59] 7N\.;W2M+",ITC(F#A.[^A4(VD"I$0&F\HMJ#/7R]T>W!:5N3VSA0WDT
MU.MWB].87(L5%@QZ$7GE5M,)6:GC$SOV-02*,&KE^B+EVI'G4(L2]OZ%X#=D
M*6V)_7WQ@C#Z&*NITRW.W?JNB:=..0HS$*14)2H$R3HQ^AB!U8F0U,)6>5;R
M8*34),L(Z56R6O*34IC9@YYL%"D[B=I :I&GCMSD[M?+DU0$3LK6OD6 .O*7
MO54L3YX42\I<HBZ0M_FL(UW)?61YFC(QI/0D:@,I.](ZLK*['NL1CJGS54NZ
M&$+&R5&!>__HXPJM3IQDW,+?@QH)DI2APL\$U)*GU%7SF%C>W*7_)K;"&.$,
MN_: XBEUJ/CJ"^9]3/U[[ 1D#SK?1Z&4]40U(W-!O]:-(N4(M*,-]0AS)#J
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MM_>^)\0G$/7OTL"B%F+7,;/E/0B7\6650=7,60)A4:&&=KNQ],P;87SKS:"
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MLYB-<$FV%7X_0U!Q;EY+HVK=L&T@QG6[_HMY4LS?XF T@?3S3]/Q)7S_(=(
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MSG"OG5*RMLW1-2GN,3Z[YL0N$F^!"P<QEB3$R7O_K2R&9<N+<7P)Z4W?A_X
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M\0BY.[/R# >N4T 0PB4B=60X5IU(R@;M_,0=\-J!@=_?_@SU_T#1WE:R:6Q
MP_0[&0^FTW$_7$[+W=;Y:'T%X)X1(0;*-;$@R[B=P+7,H=GO/7=9XL;&:M\%
M[ SR&5*F747=9I:MRJP>,T&"EXZ(D&PI&<V( RF)]L"=0S#XOS99\]P9L9.
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MOZJ^!I*K7+3].AR?D8 \ YJ/MF!BB83@!%H )B=CLL<%Y"DH\([2['7UMXO
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MZ:=%GZ.#\;C<ILY&,[M7/<DGE]-23'[RNQ]<PF_]CY]ZKERN2FL(\*30NZ%
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M88.<J5'.CFHZ=U\46H.G0NVJBKZPK=_2!+$9TS@ ;F!R*36LV /LZ.B.23I
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M_:&$R3V\I8+@JV B^Z9CN/*ZV_('PK)YMGZU=.B/,#5TY,]!:N@'N@))*S?
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MXEV C<;NW!US=!PY.P8"1W5US $X='0L[NQYUEE7K[V5]='%]HB-QB+VDC2
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MBN2/.NI8_:7W[K^1N793+M=79+5Z5:NOLJ)ZS"1'3%"8!%PH9R#AD CF*=^
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M]F>DZL7S[N,RSW\HJ_$JQE-67H"-G: R].@HNB&\V!TQ#C0+CEC5M7:C4O)
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M]N[ N^U4!X)S8.+8>IW\LO7[UV2^V(KI5DXGGR\ [+TC#8 JTD[4Q_*H.]
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M8(TCR/%*^IJ^8'A*;\12W[0%8YL:FM+:NMU7BIT5N%!9*@2 $ N 1$D 8:D
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M[=%W-]ZPG-OG^#<2>#/42+O=Z>/;YE9YD=]>FE_6DG89U30C/ ,9M:)?(I.
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M5LW_I.0W)7>IEKN8T.KG;YX?GQ]8$T)AM5K46U7_=R:)+#DN4T!ESLQKBDC
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MH LF$<L4H\A+G#D>VJ/<%K2Q#HLT[X?7C=OC@38PJQ]_-T_DNR*&<#MA$BL
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M:9EA()BA7%0J NQA$Q!<(,K24HG2*R;^U,34^&#K82W_'[;P.@.D&PE<!\_
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M<,VD'LQOO_U-+4S##[<+>2L?YXNY);S-_,=N>Y]CE7$E!$A5*:UVE-DB%;D
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MQ,N29T#R0IF]/BP!S7 *8):;OVM-"2Y\5+7/V/!:[8^@I[W/3YI7/@9F<K5
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M&+[!Y!(^X/K:G4ZZ1_Y]C%OGY7R!KYOM?8_GEV4I[,SGZ&I!.O7?1]FRJ+@
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M]B=71T5WV!H5IS>$9(B0/*",P)9<-TX<&!-<SLY5ST-]F:JA[^A[ 5-E930
MKV-8^/$$TG67^IT8+R\NS\L\N/>0QW&\& 4AHZ1:$,K06DNFH71BIH2[8),!
M(7SUVZR7J1JZ)U$O\*JLC ;@=8>#M7J%12\9#S03#[9<MV#DY'D2)$K#0LZ
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MU>=]P)*,H2\$>L;/MH+_*6>I[IS\_N'@Z._;#@!8_<S^YZ:N)K]^7%B:;']
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M$7=/CKH?X>)&04$BWFN-D@R26,,5R11]++#!154[C7I]ZIK,5WHS2-916E.
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M/&L/5O:M<E8K)I,G,0L@,GI#G"H=63RC3GCO? _IZZ\D<KV+ OIG '2_"FP
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M[I2+_RV2$U8\K'J*PDL$U_+'X*Q@XAB^ELJDR=F=J^<L54Z6Q%*!)$T(Q&(
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M(6R="X12KIPSPGM?.R?S.7H&[SQ4!1,K>FC5T4#+EN3D\[MR[X412W$I-LJ
M>/2(BL?<SQ%7[60[S %IF"SVOMT[C[0(%Q>-P*@=%2L]I\1'ZTFD.HBLH^90
M?8#G$[1L'4D]>.Z=]+YD%6<\$@H>F50!"+KIC 0$-V XD(*L?V3_!#%#GU%7
MP,&CJ*F*X-LV(.M4T%^7%F]D7E[U@C=N#;":L?Y;!!@+,OG2##>7K!:*[G)@
MZ#W;8(SU4>#^5OMNO+\6 >_\?#P_R@]>\&/Y[^V2*2W3<#]7)/%2YL[ $Y^"
M(]G)')2':'GMQG;K4=9LBX#7H.11'4I]I330//3S'([R'B[U"[^ ^<ACU"><
M L)Y$J7J6:* 4AG3D,$K);1PM6]L[U,P;(?$GJ"SA9 ;@,C#:O9'B.<:(DN*
MZ(!.@139%LG@ HB),15HR+RVR_0"2<-V+NP)1#75T "J#N&/.X*:32?X95QF
M0*PVK#90ECD@5UP@?]DQXDM=CPT17':*45Z[B>!K:1RV16!/N.M540T \3:[
M>?YH24ECM$/SS'-*1*84"6[AG&C- ^1 H]:U.[0_3<VP0[![ E<EX;<<$#YL
M9W1:FF5N$O@]\:#>^BZM(K3O[DL*! W:*A*-0$"98CM,=/@MYSF+%"VK70_2
M5_>ED_@%TN5Y\?P>O*%$$G%GDMZ/SR]+Z]ZN>^JM^10&J)..>!<0]PX<"9)%
M@C]-+(84J:Z>W+X9J8UV;GH-AAZ=3[V!TEHV5BO+^C>V6,\]K=].!#W:KF?K
MSH5ED'/09?0<^C[4X:9EJ".@G+7*1TJK5Z:\23^"C]WDL\[KVY]\O5RLS+5+
MU$/P.N$^S41I;B:(35X0G73*QEH>36WC_2H"&^Y7\!K</-FOH+J2&O#.;Y@[
M&/LP/N_*#*_X3$>38XB7L]*EJCN<^SR9ACG,OI6UWPF@C'B>1/RK3LFW,LA6
M@$(CC7@JDX12QN"$H]WFTF5T7VF&ZH?%?? Q[%E9_W@>2N5-;] K"N WWY^?
M?EBO%?L][L[;U$A[J4%2L(09A1C)7A&;320Z:U B&!=Y?^'^F]7MER;OUV[N
M-)>N%K>OOEEZW>*Z'?5\=\[#8EJ(@U3^\H$7S"63 +S+IT7/&XPG3L>2N&8,
MLQ&DB"]!LC_J?M[:_=?@\NYTFP:TW+(I?;9H=&.;NLY3WZ;NM4<KNU;]HO.:
M6Y<<R:%DOS-MB-<N$).38"HF%F+URHLWJ'Z]/2)XJ<CR_K(!"MXF%0D'*TLA
M.I2NSQJ9T$S):(40U=.G-B-UZ+RCRMAZ^HRG/P6V;/>>KLS:V.B]^,@W*"OK
MT]P]54 D$\\!="19YDBD%(E88R-NS]Y8$[AQRO5<;57?K#U\P_XD3V<7G;[>
M_;CZY>VJ"-J+Q",G0AA.I+#E#)1A=,4$&$M=8*EV8>R&I#9:A/8:##UMROI3
MVL!S.&]9O*IJF;_[\='_[^GL!,/^<80'1CHI8P,OZ5<TEMR:6-*O:")*,Q/Q
M1YK#:T*0]=XZ\*CLFLCJ6>0M[XN/BP@WW@^??%2/%8\][G_KUJQIDR1"+97Q
M2.B5!?3/K#9 =(K6!TF%4;4SP=ZH[A&]0G]V-BNS5KO!>%>O?>@AVIB%\8*P
M5"+CTNO.<\N)]QJ715ENJ?;MSUJ$_1P5CZ]!SZ,\DNKZ&7C;N\JWF1]#A'%W
MO'V?Q0><L81V-GI)HNV:.E)+')- DA$*F,O"RKS&MO>ZMPZ[[?4)JYXUT/(N
M^# +Z#TL_/B\1K[2]9-Z2UA:26K?&4O9)*<$VA3+@R\C 4L/"9E1^3$IZ;B*
MJO:Q3E\92\L"S^6DY_G]T<XWSN7>9#%>_%AUY:=ST%R:TJZLK#-G)883V1 ,
M-'S..@@N:^?G;D5PH]E+K\'3Z@K=MU!@ YD!A[!8\GLPG<]'U,:@7)2$&U9:
MK3A-0C:9,&^,\5PE8VK70MTCH(62[S=1_*/L\$VUT "$/GF43!Q_]44^)R6Q
MX/H*;BE!2#N3]'F2;K^_7K:%VZM,P%&.)DNF,Y&F9-3(""3@6B6*9ERT0F?+
M:Q\"5B%\6/=M.,B^O=8;@/J]=;KS#?VDI:Q+.[WIY&ZCXVL&1;+9A=*M"KJY
M@;PT;@^:* T<E.%&Q-H'NZ\F<MA"KT:L;G5M;@[7Z<*?5X'KWV%\]J6LQ&\P
M\V=P>'D18':4.U=I?G2YF"\\+M!E$E@<,<DY4PI%*7TI0T$VK3>):-QSN+?"
M@J^=S_<J H>M"QL.IOUI<6.((B5A6LFFHF!GUQ?5RX77,79?Q-?% Y ^^1]=
MELULYB=GR_OL4:;6,Q. &!I,X5D1+\O%,A>:)4^SJ=XF;7NJAZU$&P[.;ZSO
M!KR&)Q;PU:;R:!V/G.7,1>>(9[1T$Q?H%''IRK1S"8P:_*]V]]%7DK@6=O6?
M#[M]:K(!?V%EM=8H*<!]@^'R2J4DGI;6KC9ZPH.2SG'-<O4CJ96$K 4Z\^<#
MW?9::6*??\C&M4\==<(/6T9 EXOOE#T)61FB+4TZ4E8Z6O4,K]?$0?;/#[!-
M--,$Q'90/*D0/_X&MT<2>]_C^66"M+SCNOAZN;BZWGQT>MS)?A2SI,HGB4&>
M#:7R593YMV7TK0LE39Q96[L-9A7"ASV)ZN4H_NT5VO*E8AD2=_QY]Q0_??C;
MSN[I_M_V3_?W3C:_6WSA@173;-8GO%JR3:G3B(O+4N2V,TG'<.Z+XW93(7*+
M3REDU)")SJD;K<B(TY0293, !\>@AW2;-8FKEX[ZQ"MW457+#.T1"\'1@*O3
M"8G6WE!=NEASM/8\H'Q8RJ&_S/H7R1LZ^:8/-#V=AUI76PV$P/<8^G3N)SO?
MQ_.1T<Y;ZCU)*>JR-23BHZ0$3," *>#O0NU2]Y6$#)S3W)?:'_6SWU8'+0+I
M_?3"CR<C;KR2*3+BN2PSR64D01I+&&/!J)QP(=9NN?@$*0U9JLV4_!)L-I#X
MP&F ^Y-OX[/I#-?2I]GT;.8O/D(YN!F)$BB+8 BW@9?Z)TZ<9(9093TW-F8O
MQ LNU#./;PP(FZAM6E>&K=F/8E@[,UN:'T"W4CCP9*RT1"5J"CNE#1O*2%@T
MO(XQE$_M<LL72!JX+&*(S6E+O30 LU/\W .17:T_'0-ZACD2&B6&P]$#";[T
MT;#1*Z6\4 (J ^Q)8AJR4-NJ?-J'_!L 4I'+43[QYZ5[R]+@&EKLMR/.EI,^
M)7&]12YQ5W<!5+*XKU<?!_R0B&&!4TFYCT9B;B/I!J!R N?XJ[/?8 (S?XZ+
M:2==C"<E_ZKKF+'W_2M,YC?,61=BXJ9K!XJBXM83]! Y"<FRX$5I\%-[NMJK
M"!QVV^L'8OUIJ 'XO?/H9$8X^0*P."B?+JHJ=AQE)+E*15A@2@$E)2[K2)+V
M&ISD6E:?W_X4+<-FNKV5+U5%$XTBZFH5"@$QZYP())/+P'5<%BPP8K4SW&NG
ME*R]"3Y-S;"[81UMKP&A#43? (BN"] ^^1]E816C&^/L$NFXVQ=ON=_[I(R0
M14+:XG[O#:X^_(<'F3+URG)>._9;G[KV0+8)'A[>[_6CG 9@]TQP<S">P/X"
M+N8C!48:%2+AS">,<'Q&5U,FPCUPRY-4HOKHH77H&C;1MH$3A\TTU #J3J D
MIN%"[63$1A0B+IDR-XD;W (,KA>O</D$I7)$\P\8QU1W\N^1T.P1PX8Z?N31
M;R[P!O!R7SY?_.P,YJ/"0%(@"-.E*U@("I<7BB>[)%363(/J]5;NBHZAZ^)[
M1L[6HF\-/E?2&9E@I;%*D,B41K<S2V(-1QX\:$LMY)CKCVU_3,>PH=[;PF<3
MT;><Z+1R&$'I27TV&?\#TLY\#HNYG]SU$OUM/];-\Z'JO+??F0S;B>$MIC=P
M;I1"-XQ8[M!3%UX3IZ(@*I:I1MQZ5[U%YYM,;WCWXVX4]-ML>OD5U][2$=40
MP?(H25)9E6Z^Q1$U@0@0MICQ)'WM6YUUZ&IX5L-K4/)D;_M:*FE@+[W#TYT)
M%!]FW9SG^&-Y(Q:]<& -T:*DTDH,NH-#$8J8K6$L,1]KMU9?@ZQ&0%8-"T^#
MK8IB6L+:*H:NCG4LI2;X#(19FXF,(I?^Y(F ELDR#E:SVF[<&F0U@[4Z4%AC
M!LTV>FD4:O.;Z2-79WL<1*3&<A)L2=!7$<HT'4H\59E29X--O7D,S]#5"-AJ
M@6$-L&VEF9;0]N['S9>_CV&&1'WY<0#?X+Q;HP*\ECJ@QQ$5*_7#CCB.K&FN
M168\41YZ]-:>H:R1641OL)764D]+H+N[D![S=[5DDQ40C4W$ZB2)# P74]DN
M?(KH#:>2J=O;U*QU"&S$Z%5$R#IVKXJZ6L+B<G1=)S%V9<LI58#NAT-;+AR1
MVJ+XLBN)NU$+ \XZ6OMZ\QER&L%9?1 \!;<M-=(HN/@5*R9+[[5GA+*DB72<
M$R0^D"P#9R+JG*I/_7J&G$;VT4' M8E&&@67N&)%"<DH.AB$!FZ(]"B=D#0C
MW$DO(Q/6BMH=*)XA9]B;A6'!M8E&FF@-<&=:VV//]L-X@C\;^_,3U&,GT5W_
MM2AT?GM90R%XD,X1%0(024&1P#T0,-(FQC5-NK^883.:&P%J_]'$&ZBT 0MY
M.O/I7J_-D8U6IM(#QJ/#BR8>EW@(+),<NEICB"+5/J-[1$0C?MR;8.!AD<E6
M"FD 465RV\DEOGB"6NK$N.+*9I2=IMF4*<2FFQ+'1;FF=LBC#=KB0DVR-LK6
M(JP1)V\(Y-577 -HO.G ^F$Z*V4X=YH*0UC<664Z,)M# B),J696!DHSF8 >
M")4F4\^DJYW\O2YMK6RY V"R%_4UX3LN$RU6K3!I8BG2\81*6[I].&2E] -V
MW+/$G6!4US:-3Q(S;-;NL-"KHJ &&C"^OWIMZ6H%D_E5WM RN^?'[KF?S\=Y
M#.EP.HF=]5^,F*+"9Z6)<JJT0DUHXZ6CQ+HHE.:!I5S[./G51 [;Z7909/:K
MT 8V[7>7<Q34?(X,!I1EX:_,D4+1%EFB',>HW?MLCVB@&-VAQ4]E@I1DZ"7;
M++NQBMKH8*@5M<\*-R!SV!ZW@Z*V;Z4V@-L[.9.K]@VF64"J!9&:E7,S%8F7
M(A!1!G,J*7$EUIY!^#Q%PS:_'12-%575P!9_# G@HOC)Q>B7D7O3KBA\?X+@
MAOEB[W\N<3G=,#IRD:+#3#V)MO3S#UKB?B ,P2V""B=\3+3V )%7DCALV]Q!
MH=FG,G_*!'T4]OFX>\4TOX.S\:3T8_63M'<UH:)3T7R:5^6N?YY,0ZEC*.)<
M7CGTD,G?#X']I_R_@6#?HC9  S,*I"0BE>X94C$2C+'$:N_!T928Z"W[I<_:
M@$-8O(?9^%O7QZ/3P8UG='5/EXXF-\EUI8/[8ZW<5_/R?@1"9I9K0[C@Y:PD
MH4/%)1"N0(N@@H^V]E2TOGEJY,)@6W0^>1O5 A0:<+#7S>3*.076Y;R84@.'
M<O=.X5=9,@-*6*CNWE1,Q>P?IDV@:<,TSE>HMB7 KI58$4)6WG)%+.UZRE-%
M?'*VI"'FJ )X*VLW-?H3IG&^!B%;I7&^1ETM87%%Z@U+4DC(@@@HHH*LRATS
M)8GB-F7!\_PF:9RO289J)(WS52!X13+4:S32Q(76G>5Y_S"Z6Y4J,*X,MT1!
MRD1J(8A7D9.L@\<U&:G3M;O2/$M0(_?\C>_$6RJR):-WK_G31I)]*(XK R A
M!9<I"CBZJZ,>'W#G"91YX;+SN!GUA>R^F&K$ &\/P*>@W00:!FY@_\3MR]7^
M$R&:F%5 1FSI]D<I[G ,+4@6U@3C&></TJ-7MK%_]B6-P*P-,$S[T$Q+%KC^
M7G=[WIX$U1IE33R#2*0,F:"9\"0Y+5#V3 =>N[W46_#52.97TUY**[!J::G=
MB5S^/EY\>7Q6?Y_A^7WQW,AO>;\DP7N1.</0 WRYA&?$9:M)I( !"7?6^=J9
MD;TPTLANTPQ>USC[>%OP;+R"OJ(\I^EDX6>+0=?1$Y(X@<7B_&K*> A1^F@D
M"4IP(G/IIB9S)()YD]"%U6!Z.VBISLV?-H@>=D55AM'KEY5;+JL)G)76N UO
M32XS;4 :8@,(@K;&$A>#)S11+6DH+0]K9U0-MS7]C'Y>RUO3:\"SY=:T-[F[
MBMXJ=^;0SY8S0"JGO#QZ;K^9*L^S\18))I0Q3D/D) C)T(EQ%N-X_"J;R#,U
MW.7<6Q^"H9I/ C/66!J)94P1:2DZ;B(AXZ",L2I;<+4'EO_DS2=?@Y*-FD^^
M1B4#1J/SV6)T],<$G_-E_+4[L@W24V.8))K:8FE+ZR_'#3%4<:I=0G[6VJ;Q
MR7=PA-_=8NC12QL!2C5]3FL(MQ547)V/&A5=T!R(MBD1&00E%I0E7$IAA6?)
MQK7R'=;%Q9"7&ULJ;I7Z-Y#BP%<.GS_Z^?S_G8XGB[^AJ-!Z7G?^\!"9=I(D
MYLK(#<>)\U81II(/V2KOI'W!4WGF\0TH?!-53>O*K:7SR4W3ZH/3TF;D5]&(
M\J,\HK'$($( 2)8RC9;UUM.SSWXIPW9?W&0?&D2E#4#XXW@RG6$(>5V,<;/"
M/\$L%LV>H:COUVTL/S+B6GE9&AMQ,*'<6RMD- *1R2:=<V)!UPXB-B:V%>?I
M+3 U'4+!#2"Y-%#8GY2!'UT3X)MR(@Q4)&,&A><8[BG<"'1+)! 6&*B47=*V
M=J;6$Z0T8CIKQWHU!-]R'=?[O7>GFY\XW?WK:N=*3Y)4Z?2HJ/06)C<H<2&D
M)+@CH;O\<H837T;S9,^<\HHFJVO7(:RFI*ZMN!J3!TF;Z#(1%!U:R74DCFI=
M1I-%GHI+H6OW3UQ!QK [506]/V\=7B_J!G:6@^GD#)]V45@I,Z^7@V,%3]%+
M2U(&BSP(3US)7^+!)! IXDZ9*L-E%1W#XV4KY3ZL8M]6T@VBY3I41I_)X1:+
MRZ?DU6,D2WS&;39YX7/TR8;J">.K*1D6,=MK^ 7(;"#N@0^13F RGLXN)_-R
MN0=I!M^FY]_0#8_XS7B1?;RZL%PF2UH> I>!Q%1,,0^)A"S+L4M,)DL6DY8O
M>"2O?6=;@-E$O],W$'8#EF>WX^'#%0_+XC&#<5H"@W(IO385Y:6U5R81_Z5<
M,<]M[2#],17#QCVU]Z@MI=P<3JX6E/(QQ@+ND".N*L8"\4P8(J1S'EC6TM1V
M?U?1,:RQV5:WST)E T$W )8#6.##CO*2E^N)1R%9" &%XA0G,F5</Q*M8]:!
M6Q$4Z%2[0\4J.EH"RR;:?>C*;"OJ!N#R-S\;%Q-[[!=+WTZ9B#NR](19:8@4
M90H-#98XJ]"Y2ZX,\*@,E8<T#)N-5GO_V4K"C2'D:M& !%E&=Y.04BRUP8%8
M'<O(!).Y"TI%5[M/P&,JAC4FVVGU&8AL(.(&0'*R=,^/OL%L,C[[LKBZ)9F<
M%99.IGEV\YO]28+O)W_XK^4W5S;3.R8TCXXDKDN+&LV("Q@<<,LX8U*#"+6O
M5;<BN!WH;8*6Z5"J:P"G]XW[[8U=<M&ETD-9)I;+C9TB+@$G-FMM'<I6QMJ)
MW$^0,FS'Z]J;7PUY-P";0OBUGW?M0'[TW\<7EQ?OIK/9] ]<+KO^*_YF\6,D
M?)0IZ$!2++>O/&($D@0C.MBD.,^"5<?2:^AKZ01Z0T \ZJ7:DW8:0-Y]>75E
M!"=(BT]'D[O[ !LERR4*$!T.2&CXR\5_8 R(D=**Y%@*KM_KL*=I:^D\J0[B
M>M%*<VC;];/9#UP[.Q?3R\EB%$U(5 5%P 2''JX%@FN)$I9LL"PIZUSMTL'G
MZ&DI2NP#55M(O^7LC _[ASN'N_L[!_N')Z?'G[L*F[MY5MOTQUWWT?7JA39B
MIEK2QW6IW"UHYCN3]#NDLX*;B+]:CJIYG"&@J<M62$MH- K#!/S*>DT15UD+
M 9*J'OS=C<G=WJQ=O_IJ0)_@V8%VA"8C<9%J3@* 1)= !"\3QNZT]MC#!R0,
M[82]#7(>&[C-]=# [GAW91^43Q=UE;,?'BD%F3FAVNMRB.Q*BUT@F3)K/8 +
MHO;.^!0MK0!K P4_G-=10]J-HN:Z/U,T8*6R)"=AB92&EGIZ1S(KXXQ!IBS?
M C<MG*?6T?8:$-I ] V J&15G%YE55R=O$DG0I ESP%*$DY&K] [AX$L:*6<
MRYI7'QCXF(KV0+.)?E>D*&TA[ ;@LG*#_PWE<C"=S]_]N-KGC^%\V:;@NB)0
M!Y,R38$X:W%O-P*(XTX2B-IP3Y5QXDV\PA<I'?I$H=XN]P:::@"/*]BXGN4N
M,X!(FE O.:XNH8@5G!+M@Z9HW%U4M=-RGR2F%=^I/R1,^U!+ _BZ[8Z]Y.C*
M:H=BK9WEA'M<CFC#/0D^H-5..OJ043B^M_8\]R@9%EF5U/Q4Y>7F,F\ .;>K
M[LX9G@@9NCL!1='EI!E9$-H0&I@"D[53LK_C@===!/9XOMG''K>9C!N 2<$X
MW(R?^G$/^[![>7%Y?F6YXPS\'-[#\O\C;2.8  X]4(!R6B*(8R$2Y2 +P[AQ
MU3OW;$AJ*YO?AA!9L;/UK:^63]E/3H]V__WWHX/W>\<G>__Q>?_TOW8.WQ_O
MO=_;^[CS[F#O\.AP]^CP]/CHX&#_\+?]P].]X[V3+8HFMWI=M=/X>DQ7.J$_
M64SC?W^9GN/:F2^G)MX<HX)P&HVF((;;3&1(DN!^24E2VDNO(^[ M8>L/TW-
M5M4P\0NDRW.8YL?/]Y/TTC#)Y>[BK,LJ2TTT%RB-*!5Q!N/V:)1/#I&&"^\%
M"-:B95@[6 DQ]RIHWEI!#6S7-[T9EFR60>7327?)44(FZ@1W3#CBP-!R-E0D
M:3U)0K.H4*@\U0X+GB5H&,@-@XV'R8?5%-4 ZA[P<!5C>9.T5#$B$Z4@A=E2
ME.84@:R,S3HBC[6+\%<2,K1AJZ;H:6VI-P"=TUG76?9'MPRO(NF,WJZ.,9"@
MREQEAL&753X3G8,.@:)HJINI%60,"YL*RIW6E70#8-E):5P4X,\_^7':G^SZ
MK^.%/[^^JHC.T@RE%PS:9&E=)+9<F&'\E&2.R?-<^U[H68*&/:NO#Z!ZTF^E
M&^:R?D5QR,EXXBR+1!I X2A3#G@8.I;>&YO6RA^MWB.U.C0&=7RV$WPKB+E:
M1ME8SRU+A 5</)(A[(,&@:LJ>D@,U]5Z.<<_9__45RGNF?ZIKY%BH_U310A.
M1^N(2,J@_Y91*(Q*HJQAX#/NK^I!0>#/V3_U5:I:HW_J:^0V=->3[2SFG6-=
MET'+,N> &88\<T-<RHZPE#2W2FCS,.FIC[.>@:]9!MV#!E-G [XS>H(7TTG'
M\_OQMW&"29I_@MG)%U37>XCG^+\TLMD8%84A7 ,M193(D[) E)))!Z4AU^_"
ML@9=/^TYT89H>=B=H[;JAK:HA9-C^'HYBU_\'#[-IF<S?W$;7BP+/W8N%U^F
ML_$_D+>05?0\<>)U&6'C,4SU5D:2P5#A#=>:JW4LYRO?^]-ZZ=O!KG<5-6 -
M5_-W#,79*84 -XS=?F;),ALEB)P&I4@001"92^H(#X:H8)BD05/DNX\+K(VH
M_6DW^3J6\XW4W "@[YWN=3O#?">BL+NM@0JG,WI)*3E+I+*,V.0949%!LLSX
M['H]3[U/SC!U_LU LI:B6L-<EV5RS<GN=+[X"+BXD">MT0U1&-^9TA[&.E::
M\T;"G#.&4FE"KMU.=!VZUD*A^C\#A354UP <.U[VY_-+2.\OR^S!3\OIM-T:
MN\?P,8R[CXU\-#QWXSL]5Z5?M"/!9B@S<S,-41J>:B=AOY[*M:"J_[10[5FM
M#0!W\\D7D1J;:-8$$D>Y0E+$)_2Z3?"&F11HDK6OO/H=;6+^M#!^&R4WG9KY
M^=.G@VZRZ,[![L[)[Q\.COY^=/K[WO'[G=.=+5(PUWELO53+5S-1*Z7R\NO7
MY1!J?[[KYU\^G$__V+N:2GTO58YIJ@@/TI8H' '*O2%&.U#.8H2N3.W]; VZ
MMJ]50*7%Y6CA$20A-1.EL2V4BV:-RR'[0'(*3AL6N1.U;=[=]P^<350;!8]+
M%C84=0/[*(;NL\7X'QWM1QD-K9^<C=&L=P.U2\$8BU%J2JP6R(W#V-X[FPEG
M"KP1*II8N\'K\Q0-FR#2.Y0JJJ,!<-U=&/CU.71ZFJ2[7(X@ ,V9!Z*$Q8B)
M984!O,K$48H1/$6.H'9R^SIT#5M1]:8VJXIJ-H?;%'FL K=K-W'O^U>8S&$$
M/!GFJ2&:=G//:" N,TN$"J"]2B::VLAZ0,*P_3E[!]$V G\]7MP2+Q,X\PM(
MI]6LU#47B/[KJ\)]#"DNX.@KS%!9D[.15HI%[SPID0.1D3&TP(X382Q$)9.2
MU>]X7Z9JF..X-P=7);4TL!U><[1DXVK1' **R8$, K?UZ".*"7099YLY49DY
MK9QS FK7$#]%RS '9V\.JJU4T-!65[**"_E"1PB96Q*MS.641:!C&!/A60H9
M8V"6UVZR_X"$88ZJWAPXFPB\"=-3\'[JO\.\<#"BFBDE.BG(B.0KCCNU,@30
MT9-><)98[0.!!R2LA1?[$^-E<X$W@)>K.H7.0*9Q24*=(T>7A9)WEXO#Z>*_
MH%L*(^5%]"9+DFB4I8]M(E9BQ,"3=RFS&%*LGOVV)FUK(<S]M CK144-0.\V
M7<__*!<,NX6E27$#RTG_\IL14(D+2C,BN/0H..N(BP8##QY!">%SKMX):AVZ
MUCOHI#\MYJKKI@&\W;3[.,K+4[:;U!(PWDO% HG.Z9)PKTL)6"0I>>XCQY44
M:Z=A/$G,>LCZ><_0ZVBA 3A=MY$9PQP9N;R Q$8"^9=&*Y*#Q16A=2884"B2
MI!29&P/.U]XD5Y"Q'H1^WK/S;24_<(;WG16  <:#18#4IF!R&:LC&)%!26(Q
M,"4:/4FFF/;&KU,S]=P[UH/'SW?B756V X;^A8^/,#N#69Q.YK@-SSKE?$47
M[^MR-YY@7"J!*VF#(P"EPZ,MHY<"I<0P2@V2(T&+-8#RXHO60\O/=[1=7\H-
M[$GHK762.9U>@?[=Y7P\ 5P&\]]FT_E\I$04.C)!6$P4^2G1J8V:9&\T"C#Y
M&&OG0+Q$TWH ^WF/MZOJI &,%2%=F]0/*,[NZWE7^C(RTE,G1"2XW0ID!1AQ
MIHP=%!RL%I3&A[5(%0X)GB1G/63]O&?<M32Q,:B^P2Q,^S==N),?Y;O,CK3V
M'C3ER$Z99\ECQ*]<)MY$Z[)1S,G:.'L-?>L![^<](^]-5PV8MX/2\;/D^=](
M2GA@,B8@WKO2%D99XH0IEX\.HP[.3*:U6W4](F(]1/V\I^C;2;T) W9<AN$>
MY<_S90[745AX7!-I?[+W/7[QDS/X,)W=W&AW_-XTHAVYK#$2$9J@O# RR;A0
MT'ASY%TG64QUC+7OA;<@=]@LSRVA,AU&:RWGGN\>??RX?]J-J=LY?%^ZX>X?
M_K9WN+N_=[)YYOD:#ZV6=_Y:!BIEG9?6 ^/%]9BTW>FD8 0F<?6(-*D2>!<I
M$;KTY)#!D  (VI"]LS*"QQ_5]HU?0^#VPXCF\WNO6+8BL3J!#-X3;W4D,J /
MZA.ZI%ES" PX!M:UI[BOIF18J]4?5A[/*=I:#P,W%#O $.:LT\QNJ3DO7;70
MIN?@T8GDK"0<*JF(+1;?\,QHS$JPM)8/]D)/L<=O'GBOJZ#+:37!-@6+4_R+
MZZE>4AD#U!*>(\:ZVAKB%2X>(P)$ZZ7VL%8T^"IPW+Y_N$9DV^KS26AL*-R!
M+U9V)&7__>G<3P[\'_/+\<V4-D[+U>'_7]ZU-;>1Z^CW_2^LXOWRLE6)QS/'
M58F=M9/9W2<7+V"B.HJ4HTM.\N\7U,49RU+<:E%N9C8/,YDXTPT"7X, "7QP
MA,J,*^!2DV!2)#$:%UV@24&7*Y7]3V_%^'TM-JVJOH$!\)M?^#N(RW4K:2P5
M#-M56.6R$\H0QBFN@DE'G()$5.3:6R,9[(Y<V0N"PV\8IE_I+$"HI,86#G,>
M5%.8QI=K6O' C0H^9&)RV3U58L26 A9CO 0#6<A<^PYDGQS#-KA5C"RJ*;M!
MP&R9H94K#!^!9)ED^9(B\8X'DH"MMUMJ:Q<([9=DX'#T9 L_ YD>ZFX -.]*
M7>;DXX_%;'?.)!3+0 FC4(:B<TJ"SJBH&(35)B8N:A\<'Q"E+=CTL?+N#40%
ME3> G(=RE=??'XX5+\9^OOZRI& ^I^2(C]$3&<-J6G$F.GKJ&<W6N]H]V3\5
M:-A.V3/L6/74WQ*6_E(>]W9%  3I9G);XKE"$/3:ST?S#Y-IF,/L:]'@U>3+
M<H$_GJ)2Q^L^X5UU;#Y8RZ0660CBTHKQ(&$\Z14FF,YDIK-R:I?/NQX>S[6H
M83UC10 >@G83:!@X+[S\%L?+!'-T'# KT^'3E]DTPWR^HFL=;U<7QW[T>;[-
M=()4  Y5OAH5G\IH4ZD\L3X",U3E)+K4U_5X=2.0; ,XTY>S8@,^_,D>]^:!
M7BO(*( R(")+P,R;)PRS;2948&@3RL1F)FJG( >E&9;NX!RY:QW%-P>A[YM
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ME3ICK$:@/0-IC!RWFY#["540).9%3W%LS8L+56JU@HW-EA4F ]X8,F^XT*S
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M)460XIG3@X1^E4[74[+FDCK@E;5W!9YJF:ZQ44!J!5N,DH*Y0P!3A$8P0;7
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MS[5LA>(S4BD2 !6&N48LK%3;+:,FREAXCZ>N,)8)8:#B((F\?*1+!*"&)/=
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MXW2)J% L8<A!I435M:5665"I@">0;^!#P=<9C9>T,GZS(@+3E&U@1DLN4*N
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MH6_OIU9+>U^BFM<%:AOM0AO/,&8I,1O8AG";%I[='^R8<+O*%=,6;-4R$B$
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MY4KV 7X,QM@RSM(+\E6VRBMGRN>H);=^!%+:(S[!Y>]D%@,D#B(+(+Y@%C-
MU\_#B%X3PP+-?8\LZ[ 3&"2)\DB)_XI75]EF\$/Y-<QHP-_R5&"BI)D7\"&1
M6:>$R+QG"8\@D32,)D:1J?:BM7XW*NFGZMLQ@)*N+H.MSW<AS+)"!HZ[::.D
M)?C&!IR*RSC1^[J^'\OR1$PI'Y0../BZCI50P[N/U;+PB%);<A()GRH1P)F6
M1TQ09LKYU36$^P%)N6L/FGI:9>PCDG,/0BZS,$N<@@3>>-RHDEZQ1-IE+']
M%0^@L]'4[I["PU0"\&&=)=(/:FCZXB0=PVC[(OY"1132Q)=!@:?][-C5!.YR
MI=C-2_'VT%@=.QHK=R+4G A, 'H)'S;F/"!\QQZ51*4*<N'"0?<=+N'"9=]#
M5?I%*,;(%GQD/HL]4X2(N/_4,U0S)K0? RG!^S%I*C._,5^R(F2ZDI4]R4S+
M3H_9@-1F6!@#+M.?TJ28-$=L\7*DRQ[U8%5#U+1T9RUUWH@7J<%X^1 QT_2B
M*F U4MF>F2WU5%))D(;S)-7]0P1/898X"=R8!!KB6_BS&$^:524/86Q1+T'Q
M[6<YJ)4A7 ^G6E.D8HP@D,V<\M[74=B'ZV*GTS[>Z^^_YD2[';:!'08SF")G
M[GF2-:D("MI30 ?.DICNT;BO E7?!%63(C](!@>3Q/^"UE-M@@_"K%^DF>0+
MK.(@CL2S-PAQRZD2<1[,!MY$(P_K264R<G*V$3E+PW[!Q*-H2&R,J-581;P'
MH63N&D10]H7_Q7M,X5GA<[5" 'TQIF)DE9+A6'2<3.-$R6K5:T34%R%JL2D*
M[).("E.Q\2Y-)A*IU^&P^!?U0%&P[Q'5J[&*P.DQ3)( &X+N*MUDS@?03T0:
M5(HY<FVILG(CVBI@L'A:5?J1)SF,)(;NJ:'!YRD^92Q";%$A2R/7S.0QHRDR
M*(AM&TF\4SD6(9%T8]>QKF5&==O0VY6SL45I_%CB&GJ2VS7T4B\<H_6L='-@
M*YGN)+T-:WB.)PGV(8#?CL,#$<<%'K%N)V]@)Q?Y*$FAJ<"[Y2*KC=G*7%F6
M)<4?A7( 4"_]@LR'JB!LBX0_#*AB C\S,'6+S3.Z-*DLJ\5BM00\D(J4[P\"
ME#[2[>R/JSS.3AHW((U/(HS8U"[CI#FBV%*%.% B X5W&LS9N86H/'OR:&_Q
M =>5R2TOT$ Y=ZK5QJ:Z-JER.'!QY1RGHK2\EXWL43D$P,X8&Z>#)AGLHS@K
MD$?:\C#A8 8#S[YRR4G3X8'$ETM3?7/5&^9ZJ0U.9-DA^W^!WDE\K9ZE4%4K
MB60\Q).!+$17ND]W93]YQ*#@\;EB%0)NS36(SP[044_>!VAS+-B>K\\X^UBR
MQCT!M;*@S8Z+!!U73K6RKI<H"QO3>BL_A6?*0+9,S67QE(3L6D"A2(I^OF+9
M]&R1:,#Y2K8*IH;'D 8)"!;JRLMJM\Y,E)9->QRZP-=QNW.X-]AW:/7]T>HC
M@-7!5>QU_689,:@2^%>9^K!I-&K]FH:Y/+A(GAFJSI/X2:89"LP='FZ95D$M
M1_N])+<1E9]D+2$GJX=&.'TC"T6?PZ1X4W<I2@#-;^8DOHI!J/)B>=$6)Y??
M6BZOY3#,./BB.<()UZA:QW6OU_4^<Y6K<[Q@I%.Z.Q <(Z9W,5(3I/+-&Y2S
M"RY/#YK@T6'GA(+EW[RC_^G]HA4WK'$W@7=B]5T04F/14U_C6_PPFGOZEY@N
MA?A9I0.1>&Y959&X6!*7+J)(L:I_O&8X\]4_3*Q.60-$79-@%#6KZ.G:W_H2
M6*MRP !P^_TW=#I(X,J&Q8>]*SW.ZK?P%G:! X;!5!Z^HWLJSE5@#B6KQWS[
M)+V<;"\S<T*S0=TK440-:.:U=KDG]M@;K(%^%G&&]T%L#N['6*&07/59RS;<
MHQ4H*\U I=X?EFA#W\/7<%D7I?O KNZ7C]*D&(X Q6 1 [6R=E%G'A7_ EI.
MHB=2-BAD0*(FD+FS=B.8%G_!NE\^VC:#YD3A\!6QVCF4^<<P!^'O=&:VW4-.
M$HA/L1;-.PU+G044!-/BVN)2A:BFDB)1:K:B$[J-"EWOJ4EE).MCO^!RD/'1
M!1<,.H7X$ZH,W(<1<OBQ,4V2:[]?CC%9@' M_ ;;& D ?WBK+^'D)<-*#*-Y
M$GE"]A2,>P>Q=O%,S8UG.OF3Q3.]$JI9"@1N#1\Z _@N4+7041C:?-"7,=SX
M:3/Z9(5(.$0F"Z%?(M5;V!_!<+7)AC6F)!V*./RWT5$L%88,'SEL>ITW 0I9
M$I+5GFQ!.6[IEM;-+$=$U:BESJZZT,T6EQL77R0'EK(O!5L<%"DJ2\HBTF)4
M"4 ;S+5/@6"#K!8M54R9K+5DA_5A#* ,DSTJC-F20E!6PA$]Q^-!1=!E(JR3
MB2"\V<-,!=>C50O.D2*B[#F,I^U/O:<PS0MC.TB>8Q#"43@QQK26IXU?N%Z9
M,5<M>CJ,*^<1O$%XGQ(X0RC. E;?&!C<:BY?S59#YT;M^M>=FE+QF1="+TC@
M59:TAP2::DTKXDD8&X['18Q6+6.9K90_1KA.8,P9/5V]Y"HE'Q[ICF$HOJ"+
MK&Y&Q@#!OHI7'T"KP5 9JU,*=V='0YX+?Z1CVO%#.#@D/S1!A*XJ>'O:[%"_
MJ2A\/I6H].%U?5($>!$F9ZYX2IXI%P[^.:# "D)S;0C/V$'<G]JO<U>/35P]
M5$I0@^X<VCT3"'14L8,&A-%#?_VX&CL!\H-[@"2\$CAQE^(=]E[E9:BZN$FL
M72W0<"6VX>:?E_<?ESS>4#2<1,4K1U^IZ\9;.$QA"3K_:2T4V0[]?:7:J6QE
MRE)[N+V\YU6F^-HQO&<TYZ0#M6]2]*,P&V'*SG/B_=)^:%O @YZH M-V8#C5
MO-T)_#XU7D9</<2M<%#^'3)"BW7;U&;:L21$B_#6"K=3TA+7;&+?B5"]VFC+
MC-/*UM&Q]95N4J23)%.A6&3=UR[=UM)-Q]"Z(,>W?/;>..P)%U&YQTO4UW#,
M6^ -Q:L='GJB/6Y[YR-00(;*X6 CYYYZI3;VTZ;V^>)'#^OA+'HS&3#1 ,79
M>\J!>/ZY9_VB:U^$]7USX5#&$A26 -9L.'4)YJM$KIE3TX![@$F])U$G+<5L
M*8SI9,?/OV6:M.H>"5#S#51X)#[%FQ.^5/LZ,QM[-FQ$9;=7^2+*Y.Z@X.SU
MF0=*E8CAP=)YU ZL 8Q%2?EXN)L@%;YOF =TY!(-^AOT@0" HO-PB!SYPX07
MU7&':'W&[E!4$"7-PWQR_G!-_.BBJ!9O;UG(31(#]#'[@$$U.O<MXW<Y%0LC
M9_K[^RVF^*B.P<QWJ=U2A* ?B0)% MW:VBE+S!_T5QWQ!MX7DR*OQEUQ,ZRV
MH6[&Y"'NGK6Y>Q91+S3FLD4RC#T"X1$<C*VW!QGS:--4D^PK\E017MB3LSP7
M)DT_3LC:2WH&)S5=)%$DTLP)WP:$3\<$-D;NT%0;<H);O8]Q+]PWW"6&5&(V
MB'4ND$S1,9  EA02U9^I[.+].L*4I6]:KWFG3ZZI-0EK[BE-AJW[[#,@?AQF
MV"#0*!^]YT@%.G*)"6@D,$[?I]CG^MCHA2*BCODEL=-U*ZS.;;7CS?/SX1K6
M>^O[K_J'F644]JRMRO5/HX)AXC24KPH-'7WS-%O*YE4./N^5WN$ =X. :R]@
M@\#7I 54\R 8YP9ABL>_1;Q39EHI-9X(,4'PHN29Q=8G#6)M.AYH!IVS192S
M'<!XFW42S'X9]KYJ$R$(.-!= W2-'YZN4<J+2J>>K9[1";B OVD6\NQUT!+&
M5Q&4,UZ^16+$-Q%O[VB?Y8B,22^!IBHW]6F3PC+V.ON+@G+67 *E',_8\2Y@
MMTZ]!PH7IJLQR?UWFC3'&=7P&*LW.QUCU>3M?;1P>W/8X]A.YJ[ H)S5UNCT
M9-.1C$ON F2;BSB]9=E!JM5D0V6G#&6I=3X.5FNY,^?L.;0&&G02DVV/- -O
M&!+I))H6\>2& TT%K6/*>;C/\5/491V?CZ8P-(Z9$"]1Z=;,/*A>C"7:"\-L
M/)>#1PJO,DBH*3'*?"4:X6,23'%B*$M#W_6P>X8YD]\5'TQ2^:3"_E6*O8_I
M2C%U>"X'<+;':%]\Z41G4XY0@V7E(#QOP-S/Z"V<.0)F%F7V%JOO"C:38C4N
M1)L)5]^CNH8F]<4'2F,VI;8&UPZPRHE@WY"T&M*A?%;41MBJ^IP445"UY&/S
MEU&BU>3Z-SV'-=9]\\M9U]UB$[_9VIP1HKZ^4&0FSFKV6I<X:Z\TZ#Y79T&S
MH4F3==0C$_V:,M(,J7S]V/6UT8*EN:@-I+*JWBK-SY! E?!7N896O8_W608P
M+0*+RIF"0MF%2TWKA&L%[7.'QEP#WAXGQ"GCM/!8&WVB4RB60SYA%<U)2KZY
M_=;,2?W[CN=O<=B*-0_;;S]O92[ZC&S-&*W,;=X:YDK96GVF)W-GXA*KH*T
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M@A57BNUKZ=+Q\K<"!JF+0H8#36K_.TH"DU:CU6-F(X,C;6@T 8X,Y+G4Z#O
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M-CCN1K-!EYU'B2/3.5N#+>\V_N+Z]KSNV2O%;F)^XUL>\:O83Z5R=9$:4FU
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MVP;.ME\,?;P5!NL]8$H1Z/_-.>_H'K2\L_/%**EVS&>1?I$YQG8GFJ5I3VV
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M79[5;HJQENR%I%0RS2>GLVC^N*#OLK(%@OIS'5E\TGC>&?E*"#AAQ7E[8H>
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M/#<0!(1<C5>0?$@G!>GTBOGV$(+!(!E<)21$SH@\]PCWWX%"^DZ6"H/K1-P
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MWV@@.=M#-8<7_/O?83>C+0W_]>'RYU!A,J6&/>%$1HP3^6["B1S#)NQ=@E&
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MYKF^<22U<6K9#H)W8.F:D)8]AU"7K\:-0^H\Z!C>L0I^N69(T8QH W(M$VV
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M%:>%VK(LSQQ;Q:;,#G#*8J25FNOX!J86=<7HR>'%1?/'7->AB.@17D"_03Z
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ML? >MN0TX1K3ILDUCQ!%H84BV4&?FK)C9B^L#8A6B"NG[LK'6K<%O1'L3T1
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M9EYU\K^<AU,WF9M:?X+B7/3JJ>K/X&&OQ8CN'N)?Q0I5D[Q^V>;-UF2B9=O
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M#?\[4] 4R*9*[ +LKB?!FBCRT,H639I0-QB!SV&D6B@9R6GPZU@ZTUCSJ/<
M/GGNG\_./D[KX.NO@T]G5S]??!I+_ZU9 H[4%U.4XO4U0^,9(X; I*[2*']&
M*<6?J[)&*E*M;W#!\$'^+G*MS/AQYUH4H=[63;H6ND2I[';^%J.)*@$4L=S;
M-+0Y#[M78RUPD2T[4 UBAOYZ44I/1E>+&6NQ2&17K.8R$N1OR!K!75&6%8=
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MV[>P!1=P&-VD4=Z@XD]%_7>K*EKSP2)RE314-"Y-8L4Z6[AMYMF:;H 51YF
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MD@,G6@U33)^@--055U:#1ND6[*,C7T=5554I58Y5TG'!LD5!";L;C1H5,*U
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M48>:.DG6 ?VNC=0B;:[HM=5B+-H/#3CTR&=)#'!N=RAYB1Q1_6GW1$HZ+*_
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MY'0L+V-_V4RCTQ&U/25FGAZ8\?#7'YR7:XB_\?!Z5$- T@NGUXX/6FELY3:
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M& "SBK"P[,D[#1.+A7;9)>S5\YV*AGTXP'(H.-AR=.8_DLZ\G=:XLQ-P(O-
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M>-#!G&>*S9"AK+&E5F);B/\ML2CY;5;FW+AN!,LV)8Q<^)F><"5A1)O__A[
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M'=3OK-5K!2A&9H,"KAAYB]";V9:"3Z-#NLP'\G46$>! NZ&3V2;_F+R0PG
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M%$W\X +1S@BT^DG(^36KP+,++?*$U\VH4F\J/'3X<?&E\4KJ;*^>!6!,F-<
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M?_;>M;EMY&H7_2NHR4Z*K()5DGP;GZE*E4:6L[W/C.UM>9+S?@1)4$(,$@Q
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M@;H@+=+TXWKK? A6[8M:L!/^IZH_)^=PB &YW&*HM"]RF^:<?L>)]'474EW
MR-WL&D;GX:/SYA6E.*82NU"\?TMC8\%Z0W$?#$"S/;GZ33<MIP-J"&Y%P.0'
M^-R X7,O]QH^-YC2>\HXH2;2BFV[]X"]+4'[0:45U2JL74MK[W:F]JF^L:0O
MMB,S\;^)I=+M"EL46:X>>EY2TU7LLK98;5!"!0*@2:7P$04-0:GWQ/$[.1H,
M='EK",!5N!\\_C\7JN^?1ADNH2-C,I1#0)9HK!>EK:<CYQ())\B3Q"I5H%TD
MEQ(Z340Z6$E0Q7QU46P6\.%5OLS*]=V!+70;Z^XPU^;:')&;A^4YC!$2[T96
M:FOH/!O=WD+X5]@*A7Q#_5NB*$-[("_SU34PR(R8LX(=!_/[:;7"NB3X<5U7
MRV)J=&U1CB7+J-[J7%3+&S(ZXQ]ZQQI!#38= *<T#$<\U1Y5"EM#+PS]JO4U
M\'7^=G1YE/P#<M-(J _Y?B@Q@S)]GVZ6*0@TIX<;<PHE^M]I7@B'_,99W6_H
MY[L,77!FK?$*!+ UY'FUJ?%K]QO-ZU;N>L>!=!V([[G1A/*ZV&7!?,QX>U@G
M)[RE]*RL?U^#YM1ZQ7SR',>+B#V2LG*'(YB&@X7[W6J=I)M=N\8P*+$(DS#)
M%>HEQ!\D$Y1H!?7FMJA<&W&:2C!I+>TY&A<\=J0<4N+Y'.(NPMH$$RQFG57&
M])VG1T^-->5Q:)7"P1'4@Y)L&[(B'X2R*@(&ESFU5ZF$ RF5_N[V_$GW+5E[
MWOL%)0MC#='=WDV-9LJ-#[DOEOVC@OS]:H1,MJX&9=I#1(.B]6B1CS1]6 ,F
M.?,47%W5^14R6BQTIB4:XM:=[L*^<\.4! ^.^/FF-0X9+PYK?*\UUDO9TM?$
MD]<$' J4&P$-?<9 0)]X[[MMI7X]_"U\,2<MOOK=L;:0X1B*:&8";#X]NC?&
MWH.NH3:?=;F98&(QFC[3!&3</L\EIU5XM=M7J]KI[1;QC+.O*MNNTE@JQIP"
M&L$2[<BL1%,Y$_W)V5KWW5&\V:"86F-%-$&OX?AJ63CJ&-;#C1A>)VER>G2*
M[SH]>AKDI863:U;4%+#M38)9:B3/0O 7AH!B[#L6C!;CT2H+;C?386_87!X3
M(I$SD4)-.AS[ =*VCO@U\!]:9V@RQN,'819HRN+X\QUX)2-HA(+!<-H";J2_
M"LP90R_/B'\P-Q?/.M6V$ODI5AQD.XPUZ?)PAJE4YT7]L"4CN'2MH-@P%ZO)
M ;WWP+')JJ5S1[B)\)<P@,#L0T@/%XUZF4-.6H(ICE4=D13R+HCNJ8!:%7C>
M,+=F?5W4#[\S66@:6&"9#XL+# U!KRA:ZBY:+2-=%"5GBS1!/G3R;$^4[,G1
ML\$HV2TYUS=Y?DBV_LF2K;9Y]H-O?I(0DU]3F,%Y%/13A<-SY8O*%R4TI9T*
M,;$B=B2[R8H278J)WY5:T>Q[UA<2MF+T$5*Y??Z7KEH$X-CPB=CU7@^!>5T#
M1@7';-&:S->*W;21H"!H<^T!-V/X2ONDJ8T8K(QK%V6$#(,*QE0F6+1>,J>V
M5&<K<ZP6T,MJ5=YA\DJ'$@$^GJN6"FE/'>#:[[ JRZ'?G\H9GB'+0G9CKLE5
M&./HGA/TD/0Z3P*T'8LXW"4AAQC_,#[@'H>,>_RQM3L'W./O<"94S?^\:,R]
M!];]>DV7B)",MM2"6RG"U54U%9X$*1K7P),E"(.+(H*&63X(-'3=U]];=8K9
M6N=(4S$[GD-[7 !D.K0W\FVSO VG&R;IA!/)_UQ*""9<"&Y+)U3)R#?>VY$I
M=2S3Y!!Z0'T%->7'E)GY#$)*Y^I+\XU9AF#T#C;:OY#[8H$.+BGXP]];U.U@
M<-YKO;WG.M[;8>Y ,9P=>';TXE6_$Q#=FX$Z \"4GW%+FW8UWC>;]>G76Z)2
M1![8H7ZP2[>K<N8?A&8?G3LQN%/3Y5?PK@2CM20SW48Y?#DZ2]% 8H.31;[(
MOA0+LWULD4?-:G9@';RJW=(B,-/Q4\&CBR9T&+C<./;$L3,A!/=E+Q%/7WZ?
M?UD5M-%LEL1G+_B;72T,7_UJM?UK5D^OT^3_;)9&^U_F*Z.5)YR"?)U/Z1^!
M18)=;(=HCF $UZ\WZY[X ]@KCTM_#DB!GFQEV0_ZM3RT("3U"7.0UCKKSKLL
M=UAG IO-I.%DH$V61T$,K$R).\5? [B1!5*0+26'X/IC0"DN?)8#&N1(V8:<
M%MQ-@,[&G."LQIYF4VAGMZ;J_;_]Y=G+G\ +VZ!J7E73S_DZF9HG7YEIM4LM
M.EHWR3@;J6@OVOU$M-V1NAX=MF MM<6^YJ_*J  Y,X4O039%&I.9AQNMP25J
M:825(HW8-=*^+<0U1%4;&!.E_=V4GF 69(GU;F!<:"8'B&0B+YBS/Z1K%8BX
M]2TT!_*-*2FV"Y92Q!J2M]BH5,<0Y=RQR"OO!J<ZMFL(*&LH2Y+')5?)#]ID
M&YB<$H-M7]SN1X6G\9V?ASX*88W=/1VVEJ8!K(R19>8^A_*NV46\=6=] I 8
M?/#_?/BUJJ^  G1Y9;P!M--(X.W)P3XY>CZ8@[VM;MAQD;P!P]JH-Q'9A]3V
M-T_C_1:'B8+(:Z _T9A>!VR=9*4$;\!^#(! !%!K(9"EY7@ .FEU;N<N?<!'
MNUDBO,TQ9/,CR-)L-@OAQO4-*G .H9]Y7RP=_+74O* $)\^\,R\A0@7-R:L*
MX+,Q2-VKH],].0$G1R\>BR@X1XH'U]WTK3X,#Z[O]N,X# [K0NR&TV#K/3F
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M\(4^U] (O&PF80DZ?NBOD?F, .D<K3.TI*6Z,R?:W"WC#2UKZ^3T\<7!-GT
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M1O,,!KNCM$X$OUS4&L$,4@BN%UZA9F?)8]FDZ0)RR+U/S4(,5%$M9Y9C=.(
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MI'+2%([RWYO9U4*?-1I>ZG>Q5IIA5C39#')SQBVJ-NX,T/?VQ! P%N#I8[$
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MV!;\#N.>U,8M@+A&-3=[P\9@W3;^P ['PE":,MAIRWQMU]H"MN?X/(RNA8\
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M]I+ 3D4R.>HLDEO3"2E1I]8*[(QMQRB%;>EYZ]Z'Y=VR1)%5FT*_$$@S6!?
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M?!=X=F>.3,Q9@/<]_>&.1=\.'PK?^XW!RP?,--F4M8!:HT$1CWMMSA3Q00@
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M(-;K!@\;<L!#B#B[J6PS[ \__^,<5]I-UMBI38Y\##H =&>LS,_@^\)BP2>
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M"9\Z7@/L[,R*)A>J,6IK06HF>F*PO=J]:BQU2:>D>KL?'SXXVL7$IL6+Y1S
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M@F0 +\R8:!^"-=DJFQ;4-CBD[T=J3V@>H*G'"0@Y-U_"T UH/J.ML!>'],/
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M]>8"2*D:[?RTKRR&IDQEE\@T5QEK*'-_CC2J[F= W%L#/!_21=YB@+^CP_W
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MH=PJO>4>)?H#/B.Y^C=%0KFCA$"-T31)$Z22@2E?12Q:B:PQU*<*MU991"Y
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M,IPM_>3PV4N<"!=7+BK13# N!6;R(!"]7!FDU BK]N)$8W59G.&CE\')F_,
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M7KE&;E3@%OM)L<@_CV2C82WADJ>13F%SWO-5LUIC)3F%]&5B3*24JY[!-7Q
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MS3ELJ=-W8&G8!IR=OZ8=\WMP?O;+KY_(4KPY/SU]#5N:]O6_S\X_7YS2[S_
M'D>+\_HT>'WZYO3D$V[>"]CL\(M7O],^;;-A:"]./KQ_+QTUOYU]^G6#F5*S
M= BNA^VE9D^# @2," [.13:%J2I+=I8P:$Z3:,ILAPTDKA-3:S,>>7E"=XG.
M4IJ7);$J(F\/D@Y&2UA;R%$HETW88XJ_8C-O7&HW]I<$W2HEZD)')4>"(A*R
MB&:6&1-C&&P-969G)/&IJ279%K2B,QPRGW%Q]7@A$V&_PV[G)$I+DPW%:ZDK
MI[V4M42H]9;N/ O8Z^JW3T>4%J?'H\YGNL,?X#27\X33"?0A9"Q-16PJ.X#8
M,H[8%S-$U^H(@_>U3JO88:NX+&"8X/1>PMY"8@MD<80_1XARS+&7-4T7ZS2
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MA$]GPY[C>Y9.,_-*$)J5QB@XC9Z_H62O6HVU*>3:(I&PP^(-I\8%X'B"+MW
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M,JZ@%<)C!O&=2F(K)?+4D#X_^D;-'U)<,((@N6S=4-!*<FGH]&7,72O//PL
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MVH^'S_#?_?1A]#__ 5!+ 0(4 Q0    ( $V!G%;L/ICGG7<! *@V$@ 0
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M2P$"% ,4    " !-@9Q6#K+)!&N@  "^?08 %               @ 'USP$
M9&=X+3(P,C,P,S,Q7VQA8BYX;6Q02P$"% ,4    " !-@9Q6DM  4H5B   O
M(P0 %               @ &2< ( 9&=X+3(P,C,P,S,Q7W!R92YX;6Q02P$"
M% ,4    " !-@9Q6P^FF:28&  !'6@  $P              @ %)TP( 9&=X
M,#,S,3(P,C-E>#(R+FAT;5!+ 0(4 Q0    ( $V!G%;6S"A4/@@  )HI   4
M              "  :#9 @!D9W@P,S,Q,C R,V5X,S$Q+FAT;5!+ 0(4 Q0
M   ( $V!G%:.,2S+.@@  %HI   4              "  1#B @!D9W@P,S,Q
M,C R,V5X,S$R+FAT;5!+ 0(4 Q0    ( $V!G%;!O<^)I@0  &83   4
M          "  7SJ @!D9W@P,S,Q,C R,V5X,S(Q+FAT;5!+ 0(4 Q0    (
M $V!G%:?%F1WI 0  & 3   4              "  53O @!D9W@P,S,Q,C R
M,V5X,S(R+FAT;5!+ 0(4 Q0    ( $V!G%:5>?2&-?L! &[S$  4
M      "  2KT @!D9W@P,S,Q,C R,V5X.3DQ+FAT;5!+!08     #  ,  \#
(  "1[P0    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
